Clustering O 0 0.011111042462289333
of O 0 0.0002796990447677672
missense O 0 0.03250095993280411
mutations O 0 0.0029878488276153803
in O 0 0.0003568250103853643
the O 0 0.0022588144056499004
ataxia B-Disease 1 0.9999974966049194
- I-Disease 1 0.9961907863616943
telangiectasia I-Disease 1 0.9993498921394348
gene O 0 0.0019503318471834064
in O 0 0.0001428840187145397
a O 0 0.0016389582306146622
sporadic B-Disease 0 0.4780125021934509
T I-Disease 1 0.9995734095573425
- I-Disease 0 0.477694034576416
cell I-Disease 0 0.08497903496026993
leukaemia I-Disease 1 0.9999611377716064
. O 0 0.0014898959780111909

Ataxia B-Disease 1 0.9999430179595947
- I-Disease 1 0.988784909248352
telangiectasia I-Disease 1 0.9997226595878601
( O 0 0.004112184047698975
A B-Disease 1 0.9977899789810181
- I-Disease 1 0.9954453706741333
T I-Disease 1 0.9996776580810547
) O 0 0.0001412998972227797
is O 0 0.00017933908384293318
a O 0 0.0010192246409133077
recessive B-Disease 1 0.9942307472229004
multi I-Disease 1 0.9934332370758057
- I-Disease 1 0.9854419231414795
system I-Disease 1 0.7836624979972839
disorder I-Disease 1 0.9999884366989136
caused O 0 0.14503401517868042
by O 0 0.00022055818408261985
mutations O 0 0.0015573559794574976
in O 0 0.00011086630547652021
the O 0 0.0002865190035663545
ATM O 0 0.012922101654112339
gene O 0 0.002243597060441971
at O 0 0.0009936353890225291
11q22 O 0 0.09152881801128387
- O 0 0.009237580001354218
q23 O 0 0.04073005169630051
( O 0 0.0015222475631162524
ref O 0 0.07443778216838837
. O 0 0.0002245220821350813
3 O 0 0.0005896748625673354
) O 0 0.00034726617741398513
. O 0 0.0005898220697417855

The O 0 0.0012902317102998495
risk O 0 0.24365250766277313
of O 0 0.0005282205529510975
cancer B-Disease 1 0.9999985694885254
, O 0 0.0005338129121810198
especially O 0 0.00404673395678401
lymphoid B-Disease 1 0.9990599751472473
neoplasias I-Disease 1 0.9552291035652161
, O 0 0.00025797172565944493
is O 0 0.00038126861909404397
substantially O 0 0.011537162587046623
elevated O 1 0.7383010387420654
in O 0 0.00044911159784533083
A B-Disease 1 0.9991838335990906
- I-Disease 1 0.9996299743652344
T I-Disease 1 0.9999905824661255
patients O 1 0.9998341798782349
and O 0 0.00023328127281274647
has O 0 0.0006670931470580399
long O 0 0.0021262040827423334
been O 0 0.0004369006201159209
associated O 0 0.00043485223432071507
with O 0 0.0005809077993035316
chromosomal O 1 0.9927667379379272
instability O 1 0.9054879546165466
. O 0 0.0021536608692258596

By O 0 0.0012503797188401222
analysing O 0 0.11543750762939453
tumour B-Disease 1 0.9999654293060303
DNA O 0 0.0030278207268565893
from O 0 0.000569512601941824
patients O 1 0.999334990978241
with O 0 0.00030121649615466595
sporadic B-Disease 1 0.8748602271080017
T I-Disease 1 0.9995684027671814
- I-Disease 0 0.018460139632225037
cell I-Disease 0 0.01459246315062046
prolymphocytic I-Disease 1 0.9953985810279846
leukaemia I-Disease 1 0.9999895095825195
( O 0 0.011240086518228054
T B-Disease 1 0.9994544386863708
- I-Disease 0 0.13120955228805542
PLL I-Disease 1 0.9937499165534973
) O 0 0.0003260379598941654
, O 0 0.00013850981486029923
a O 0 0.0010345554910600185
rare O 0 0.0494781993329525
clonal B-Disease 1 0.9171798825263977
malignancy I-Disease 1 0.9991114735603333
with O 0 0.00017475431377533823
similarities O 0 0.0008778704795986414
to O 0 0.0001866931706899777
a O 0 0.0019109159475192428
mature B-Disease 1 0.9943919777870178
T I-Disease 1 0.9995488524436951
- I-Disease 0 0.043525274842977524
cell I-Disease 0 0.025628460571169853
leukaemia I-Disease 1 0.999980092048645
seen O 0 0.001899885362945497
in O 0 0.0006691754097118974
A B-Disease 1 0.9985731840133667
- I-Disease 1 0.9970104694366455
T I-Disease 1 0.9997356534004211
, O 0 0.00020912398758810014
we O 0 0.00011555327364476398
demonstrate O 0 0.0006486315396614373
a O 0 0.00022475363221019506
high O 0 0.0003717137733474374
frequency O 0 9.135981963481754e-05
of O 0 3.461711821728386e-05
ATM O 0 0.014565800316631794
mutations O 0 0.00414511002600193
in O 0 0.0014172857627272606
T B-Disease 1 0.9995173215866089
- I-Disease 0 0.28994113206863403
PLL I-Disease 1 0.9943220615386963
. O 0 0.0015785564901307225

In O 0 0.0010054786689579487
marked O 0 0.0019700187258422375
contrast O 0 0.0011061654658988118
to O 0 9.264906111638993e-05
the O 0 0.00017207827477250248
ATM O 0 0.008465583436191082
mutation O 0 0.002150899963453412
pattern O 0 0.0026005543768405914
in O 0 0.0006866329349577427
A B-Disease 1 0.9985735416412354
- I-Disease 1 0.9964732527732849
T I-Disease 1 0.9995704293251038
, O 0 0.0001337722351308912
the O 0 7.450441626133397e-05
most O 0 0.00011465424177004024
frequent O 0 0.0012161879567429423
nucleotide O 0 0.00026909788721241057
changes O 0 0.00023476395290344954
in O 0 0.00013453529390972108
this O 0 0.0005038823583163321
leukaemia B-Disease 1 0.9999691247940063
were O 0 0.0003840381104964763
missense O 0 0.03832916170358658
mutations O 0 0.006898380350321531
. O 0 0.0011027298169210553

These O 0 0.0003786537563428283
clustered O 0 0.002534667495638132
in O 0 0.00015886554319877177
the O 0 0.00017479264352004975
region O 0 0.0007386262295767665
corresponding O 0 0.00016265262092929333
to O 0 5.996764593874104e-05
the O 0 0.0001874062290880829
kinase O 0 0.0061351521871984005
domain O 0 0.00044070451986044645
, O 0 0.00010856574954232201
which O 0 4.611617623595521e-05
is O 0 9.798516111914068e-05
highly O 0 0.0005759355844929814
conserved O 0 0.0002612998941913247
in O 0 0.00019830877135973424
ATM O 0 0.020371846854686737
- O 0 0.002421642653644085
related O 0 0.00046114076394587755
proteins O 0 0.00015096546849235892
in O 0 0.000296851503662765
mouse O 0 0.0075376215390861034
, O 0 0.00024513262906111777
yeast O 0 0.0024725254625082016
and O 0 0.00034452753607183695
Drosophila O 0 0.007085309363901615
. O 0 0.0008136038086377084

The O 0 0.0005740935448557138
resulting O 0 0.001784619060344994
amino O 0 0.0011127986945211887
- O 0 0.004651795141398907
acid O 0 0.0032405343372374773
substitutions O 0 0.0007932594744488597
are O 0 4.850792538491078e-05
predicted O 0 0.0011983367148786783
to O 0 0.00012423568114172667
interfere O 0 0.004011230543255806
with O 0 0.0002430782187730074
ATP O 1 0.6416410207748413
binding O 0 0.0007241505081765354
or O 0 0.0003317843365948647
substrate O 0 0.005434813909232616
recognition O 0 0.0036610672250390053
. O 0 0.0011862205574288964

Two O 0 0.00013082391524221748
of O 0 8.626117778476328e-05
seventeen O 0 0.007901114411652088
mutated O 1 0.8062319755554199
T B-Disease 1 0.9981380701065063
- I-Disease 0 0.021997932344675064
PLL I-Disease 1 0.9782782793045044
samples O 0 0.0006230307626537979
had O 0 0.0002900120452977717
a O 0 0.0004006897797808051
previously O 0 0.0016106764087453485
reported O 0 0.004208855330944061
A B-Disease 1 0.9611826539039612
- I-Disease 1 0.980556309223175
T I-Disease 1 0.9983561635017395
allele O 0 0.012400970794260502
. O 0 0.0011082612909376621

In O 0 0.0011792975710704923
contrast O 0 0.002777124522253871
, O 0 0.00029731119866482913
no O 0 0.0004042671644128859
mutations O 0 0.0013352176174521446
were O 0 6.042873064870946e-05
detected O 0 0.002104345941916108
in O 0 7.868541433708742e-05
the O 0 0.00028429803205654025
p53 O 0 0.013037559576332569
gene O 0 0.0014762704959139228
, O 0 0.00017405222752131522
suggesting O 0 0.001508968765847385
that O 0 0.00013688905164599419
this O 0 0.00048182238242588937
tumour B-Disease 1 0.9999947547912598
suppressor O 1 0.6159602999687195
is O 0 0.00028204216505400836
not O 0 0.00014353114238474518
frequently O 0 0.0006641700165346265
altered O 0 0.0015357250813394785
in O 0 0.00022539978090208024
this O 0 0.0008033583289943635
leukaemia B-Disease 1 0.9999871253967285
. O 0 0.0016004858771339059

Occasional O 0 0.03425733000040054
missense O 0 0.07137987017631531
mutations O 0 0.004143791273236275
in O 0 0.00027400499675422907
ATM O 0 0.0051622577011585236
were O 0 4.743144381791353e-05
also O 0 0.00013882263738196343
found O 0 0.00034286174923181534
in O 0 0.0007374794804491103
tumour B-Disease 1 0.9999932050704956
DNA O 0 0.002725251717492938
from O 0 0.0004672019858844578
patients O 1 0.9997633099555969
with O 0 0.0003427313349675387
B B-Disease 1 0.9036577343940735
- I-Disease 0 0.004608395509421825
cell I-Disease 0 0.0026612074580043554
non I-Disease 0 0.008161026053130627
- I-Disease 1 0.9955369234085083
Hodgkins I-Disease 1 0.9999992847442627
lymphomas I-Disease 1 0.9997801184654236
( O 0 0.0029599384870380163
B B-Disease 1 0.9242958426475525
- I-Disease 0 0.006873324513435364
NHL I-Disease 0 0.01162444893270731
) O 0 0.00011869126319652423
and O 0 7.365761121036485e-05
a O 0 0.0014132936485111713
B B-Disease 0 0.31264322996139526
- I-Disease 0 0.005833477713167667
NHL I-Disease 0 0.017417486757040024
cell O 0 0.0029693562537431717
line O 0 0.0022499477490782738
. O 0 0.0008401096565648913

The O 0 0.00036780929076485336
evidence O 0 0.00018225204257760197
of O 0 1.496541517553851e-05
a O 0 0.0002352275187149644
significant O 0 0.00024289381690323353
proportion O 0 0.0001965777628356591
of O 0 6.158719770610332e-05
loss O 0 0.027544137090444565
- O 0 0.0018032125663012266
of O 0 6.182863580761477e-05
- O 0 0.003106669755652547
function O 0 0.0007241124985739589
mutations O 0 0.0012153652496635914
and O 0 7.752923556836322e-05
a O 0 0.0003809046756941825
complete O 0 0.0007417532033286989
absence O 0 0.001271414221264422
of O 0 2.3199310817290097e-05
the O 0 0.0002588569768704474
normal O 0 0.001852882793173194
copy O 0 0.0006889844662509859
of O 0 4.1484745452180505e-05
ATM O 0 0.004518440924584866
in O 0 8.930504554882646e-05
the O 0 9.248689457308501e-05
majority O 0 0.00023746043734718114
of O 0 0.00024542471510358155
mutated O 1 0.9947789907455444
tumours B-Disease 1 0.999969482421875
establishes O 1 0.9363940954208374
somatic O 0 0.033176589757204056
inactivation O 0 0.023069942370057106
of O 0 3.661809751065448e-05
this O 0 0.0001424981455784291
gene O 0 0.0010897917672991753
in O 0 9.877175762085244e-05
the O 0 0.0004017484898213297
pathogenesis O 1 0.9895629286766052
of O 0 0.0003314646892249584
sporadic B-Disease 1 0.9754407405853271
T I-Disease 1 0.9997047781944275
- I-Disease 0 0.46869710087776184
PLL I-Disease 1 0.9949938654899597
and O 0 0.0003047065401915461
suggests O 0 0.0012992987176403403
that O 0 0.00010461916826898232
ATM O 0 0.0033143090549856424
acts O 0 0.0003185499517712742
as O 0 0.00043535654549486935
a O 0 0.010083378292620182
tumour B-Disease 1 0.9999896287918091
suppressor O 0 0.44792136549949646
. O 0 0.0012147229863330722

As O 0 0.0009438152774237096
constitutional O 0 0.0013379723532125354
DNA O 0 0.0015624684747308493
was O 0 0.0005230687092989683
not O 0 9.203319496009499e-05
available O 0 0.0001081118025467731
, O 0 9.585163934389129e-05
a O 0 0.000783389899879694
putative O 1 0.7339906692504883
hereditary O 1 0.9994874000549316
predisposition O 1 0.9997726082801819
to O 0 0.0036612204276025295
T B-Disease 1 0.9998323917388916
- I-Disease 0 0.386433482170105
PLL I-Disease 1 0.9947792291641235
will O 0 0.00020718734594993293
require O 0 0.0006189938285388052
further O 0 0.00042879211832769215
investigation O 0 0.004449245519936085
. O 0 0.00029225507751107216
. O 0 0.0005592243396677077

Myotonic B-Disease 1 0.9999806880950928
dystrophy I-Disease 1 0.9999911785125732
protein O 0 0.011214344762265682
kinase O 0 0.06023947522044182
is O 0 0.0004718683776445687
involved O 0 0.00035827403189614415
in O 0 4.884520603809506e-05
the O 0 4.981737583875656e-05
modulation O 0 0.0006192387081682682
of O 0 2.1951856979285367e-05
the O 0 0.0007506287074647844
Ca2 O 1 0.9158315658569336
+ O 0 0.08623941242694855
homeostasis O 1 0.988055408000946
in O 0 0.0019521353533491492
skeletal O 1 0.9998329877853394
muscle O 1 0.9994388222694397
cells O 0 0.018842145800590515
. O 0 0.0011011662427335978

Myotonic B-Disease 1 0.9999967813491821
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.8779325485229492
DM B-Disease 1 0.9999967813491821
) O 0 0.0005420059314928949
, O 0 9.893465175991878e-05
the O 0 0.0001278616691706702
most O 0 0.0006569980760104954
prevalent O 1 0.9968551397323608
muscular B-Disease 1 0.9999986886978149
disorder I-Disease 1 0.9999977350234985
in O 0 0.0017306652152910829
adults O 0 0.04133053496479988
, O 0 0.00024377612862735987
is O 0 0.0005149991484358907
caused O 0 0.00663051987066865
by O 0 0.00032136542722582817
( O 0 0.0021493122912943363
CTG O 1 0.9943386912345886
) O 0 0.0008728377870284021
n O 0 0.0035231553483754396
- O 0 0.0029052302706986666
repeat O 0 0.002754027722403407
expansion O 0 0.000655047653708607
in O 0 6.223622767720371e-05
a O 0 0.0002892165502998978
gene O 0 0.000406438804930076
encoding O 0 0.00015276556950993836
a O 0 0.00027559345471672714
protein O 0 0.0012675962643697858
kinase O 0 0.01588580384850502
( O 0 0.002053386066108942
DM B-Disease 1 0.9997962117195129
protein O 0 0.003133903257548809
kinase O 0 0.030474670231342316
; O 0 0.0007051991997286677
DMPK O 1 0.983254611492157
) O 0 0.00022110689315013587
and O 0 0.00013524258974939585
involves O 0 0.0016825604252517223
changes O 0 0.0005013871705159545
in O 0 0.00029405864188447595
cytoarchitecture O 0 0.22616413235664368
and O 0 0.00037361783324740827
ion O 0 0.02003283053636551
homeostasis O 1 0.9945586323738098
. O 0 0.0018433582736179233

To O 0 0.0005509050679393113
obtain O 0 0.0012201418867334723
clues O 0 0.0017704649362713099
to O 0 8.22161600808613e-05
the O 0 0.00014210546214599162
normal O 0 0.0014612642116844654
biological O 0 0.000624574429821223
role O 0 0.0007642420823685825
of O 0 0.00011500485561555251
DMPK O 1 0.9916388392448425
in O 0 0.0003801544662564993
cellular O 0 0.00780818285420537
ion O 0 0.021603958681225777
homeostasis O 1 0.9939929842948914
, O 0 0.0002332160947844386
we O 0 0.00010172058682655916
have O 0 3.9388687582686543e-05
compared O 0 0.00021203732467256486
the O 0 0.0003299871750641614
resting O 1 0.9569939374923706
[ O 0 0.024115419015288353
Ca2 O 1 0.950110137462616
+ O 0 0.22583962976932526
] O 0 0.010578660294413567
i O 0 0.0007317242561839521
, O 0 5.534877345780842e-05
the O 0 4.0225364500656724e-05
amplitude O 0 0.0002420947712380439
and O 0 6.682782986899838e-05
shape O 0 0.0014743388164788485
of O 0 7.884119258960709e-05
depolarization O 1 0.5893519520759583
- O 0 0.05805198475718498
induced O 1 0.9727833867073059
Ca2 O 1 0.9159156680107117
+ O 0 0.08733514696359634
transients O 0 0.08454272896051407
, O 0 0.00015437809634022415
and O 0 4.155027272645384e-05
the O 0 5.552825314225629e-05
content O 0 0.0001568360166857019
of O 0 9.509934898233041e-05
ATP O 1 0.759732186794281
- O 0 0.0024612818378955126
driven O 0 0.0013157116482034326
ion O 0 0.003999694716185331
pumps O 0 0.01138179562985897
in O 0 0.0007598081137984991
cultured O 1 0.7216470241546631
skeletal O 1 0.9995191097259521
muscle O 1 0.9923917651176453
cells O 0 0.001659877598285675
of O 0 5.531795250135474e-05
wild O 0 0.0016995311016216874
- O 0 0.004572787322103977
type O 0 0.0024863900616765022
and O 0 0.0005662987241521478
DMPK O 1 0.9968024492263794
[ O 0 0.03275000676512718
- O 0 0.03562502562999725
/ O 0 0.033634115010499954
- O 0 0.007072405889630318
] O 0 0.006563316099345684
knockout O 0 0.023286350071430206
mice O 0 0.016652487218379974
. O 0 0.0008187134517356753

In O 0 0.001036155386827886
vitro O 0 0.009089017286896706
- O 0 0.011501478962600231
differentiated O 0 0.07109236717224121
DMPK O 1 0.9938629865646362
[ O 0 0.03349711000919342
- O 0 0.03518133983016014
/ O 0 0.036941319704055786
- O 0 0.006619944237172604
] O 0 0.004447737708687782
myotubes O 0 0.01255879644304514
exhibit O 0 0.0009230364230461419
a O 0 0.00040858471766114235
higher O 0 0.0011458040680736303
resting O 1 0.8656427264213562
[ O 0 0.019702138379216194
Ca2 O 1 0.8468357920646667
+ O 0 0.04428355395793915
] O 0 0.005390525795519352
i O 0 0.00048692748532630503
than O 0 7.444802758982405e-05
do O 0 0.0002979883283842355
wild O 0 0.000956465199124068
- O 0 0.005727226380258799
type O 0 0.004578173626214266
myotubes O 0 0.27911117672920227
because O 0 0.00024143274640664458
of O 0 1.8327436919207685e-05
an O 0 0.0003805181186180562
altered O 0 0.002080341801047325
open O 0 0.0003247010172344744
probability O 0 6.863976886961609e-05
of O 0 2.7785732527263463e-05
voltage O 0 0.002637929283082485
- O 0 0.0034712564665824175
dependent O 0 0.0031640564557164907
l O 0 0.038880057632923126
- O 0 0.004577230662107468
type O 0 0.005000452511012554
Ca2 O 0 0.13458973169326782
+ O 0 0.013689476065337658
and O 0 0.0006302851252257824
Na O 0 0.4481477737426758
+ O 0 0.00900822039693594
channels O 0 0.0012167784152552485
. O 0 0.0007294348324649036

The O 0 0.00200733938254416
mutant O 0 0.01779564470052719
myotubes O 0 0.09243863075971603
exhibit O 0 0.002605233807116747
smaller O 0 0.000320732215186581
and O 0 0.00023647806665394455
slower O 0 0.006299723871052265
Ca2 O 0 0.24548959732055664
+ O 0 0.010027032345533371
responses O 0 0.0009217207552865148
upon O 0 0.0006075015990063548
triggering O 0 0.005319799762219191
by O 0 0.00032236825791187584
acetylcholine O 0 0.47217872738838196
or O 0 0.0007064315141178668
high O 0 0.0029474557377398014
external O 0 0.006888397969305515
K O 1 0.5456709861755371
+ O 0 0.022992298007011414
. O 0 0.0009784745052456856

In O 0 0.0007843317580409348
addition O 0 0.0006002062000334263
, O 0 0.00014937463856767863
we O 0 9.798692917684093e-05
observed O 0 0.0001503245293861255
that O 0 4.5664030039915815e-05
these O 0 0.00011598601122386754
Ca2 O 1 0.8602778315544128
+ O 0 0.10741215199232101
transients O 0 0.49913838505744934
partially O 0 0.01087964978069067
result O 0 0.0003727469011209905
from O 0 5.49833603145089e-05
an O 0 0.00012129515380365774
influx O 0 0.0006333803758025169
of O 0 6.086781286285259e-05
extracellular O 0 0.015003284439444542
Ca2 O 0 0.4926430881023407
+ O 0 0.007076284382492304
through O 0 0.00028200613451190293
the O 0 0.0006189100677147508
l O 0 0.20427247881889343
- O 0 0.007295677904039621
type O 0 0.006440347991883755
Ca2 O 0 0.14485444128513336
+ O 0 0.01181742362678051
channel O 0 0.0024882524739950895
. O 0 0.0009750549797900021

Neither O 0 0.005680216010659933
the O 0 0.0002230953541584313
content O 0 0.0004342610773164779
nor O 0 0.0008079854887910187
the O 0 5.895528374821879e-05
activity O 0 0.00023562686692457646
of O 0 0.000114575115730986
Na O 1 0.9867491126060486
+ O 0 0.14663934707641602
/ O 0 0.03428049385547638
K O 0 0.020639954134821892
+ O 0 0.011838468722999096
ATPase O 0 0.039963092654943466
and O 0 0.0010725243482738733
sarcoplasmic O 1 0.9967300891876221
reticulum O 1 0.9914489388465881
Ca2 O 1 0.9560102820396423
+ O 0 0.05647369101643562
- O 0 0.0107886316254735
ATPase O 0 0.026133738458156586
are O 0 0.0001166507281595841
affected O 0 0.003044337732717395
by O 0 0.0005900315591134131
DMPK O 1 0.9846557378768921
absence O 0 0.016275718808174133
. O 0 0.001617726287804544

In O 0 0.0008004309493117034
conclusion O 0 0.0015509924851357937
, O 0 0.00014796906907577068
our O 0 0.00016069086268544197
data O 0 0.00021716557967010885
suggest O 0 0.0009879209101200104
that O 0 0.0003513893752824515
DMPK O 1 0.9781925082206726
is O 0 0.0003742855624295771
involved O 0 0.0005221563624218106
in O 0 0.00019317909027449787
modulating O 0 0.021100398153066635
the O 0 0.00013916351599618793
initial O 0 0.0005318524781614542
events O 0 0.00010217467206530273
of O 0 5.640690142172389e-05
excitation O 0 0.02379561774432659
- O 0 0.0068475352600216866
contraction O 0 0.011694882996380329
coupling O 0 0.005355997942388058
in O 0 0.0012395745143294334
skeletal O 1 0.9998631477355957
muscle O 1 0.9995123147964478
. O 0 0.0007507777772843838
. O 0 0.0009286404820159078

Constitutional O 0 0.03854998201131821
RB1 O 1 0.9996026158332825
- O 0 0.031662262976169586
gene O 0 0.004279029555618763
mutations O 0 0.0032498659566044807
in O 0 0.0007747159688733518
patients O 1 0.9998830556869507
with O 0 0.0004903600201942027
isolated O 0 0.4776104986667633
unilateral B-Disease 1 0.9712375402450562
retinoblastoma I-Disease 1 0.9996989965438843
. O 0 0.0022288488689810038

In O 0 0.001007979502901435
most O 0 0.0011627253843471408
patients O 1 0.9994076490402222
with O 0 0.0003979064931627363
isolated O 1 0.5375102758407593
unilateral B-Disease 1 0.9940165281295776
retinoblastoma I-Disease 1 0.9999672174453735
, O 0 0.004095033742487431
tumor B-Disease 1 0.9999507665634155
development O 0 0.001788981957361102
is O 0 0.0004769684746861458
initiated O 0 0.003719937289133668
by O 0 0.00015546235954388976
somatic O 0 0.010271620936691761
inactivation O 0 0.013386222533881664
of O 0 2.325506466149818e-05
both O 0 0.00014824076788499951
alleles O 0 0.0011822376400232315
of O 0 6.315622158581391e-05
the O 0 0.0024029205087572336
RB1 O 1 0.9996846914291382
gene O 0 0.008168547414243221
. O 0 0.0011167327174916863

However O 0 0.0010614318307489157
, O 0 9.674143075244501e-05
some O 0 2.705283804971259e-05
of O 0 3.153172292513773e-05
these O 0 0.000416359311202541
patients O 1 0.9998856782913208
can O 0 0.0007025041268207133
transmit O 0 0.20986245572566986
retinoblastoma B-Disease 1 0.9998836517333984
predisposition O 1 0.9742020964622498
to O 0 0.00012779781536664814
their O 0 0.00014303301577456295
offspring O 0 0.0038947451394051313
. O 0 0.000688922475092113

To O 0 0.00038705047336407006
determine O 0 0.0003237335477024317
the O 0 8.50170326884836e-05
frequency O 0 0.00023122341372072697
and O 0 7.503946108045056e-05
nature O 0 0.0006592670106329024
of O 0 8.480707765556872e-05
constitutional O 0 0.011225766502320766
RB1 O 1 0.9998362064361572
- O 0 0.024584976956248283
gene O 0 0.003634098917245865
mutations O 0 0.003137783380225301
in O 0 0.0007555603515356779
patients O 1 0.99982750415802
with O 0 0.0004638308600988239
isolated O 1 0.7673825621604919
unilateral B-Disease 1 0.9904758334159851
retinoblastoma I-Disease 1 0.9998317956924438
, O 0 0.00019236080697737634
we O 0 0.00012952506949659437
analyzed O 0 0.0009019863791763783
DNA O 0 0.0006404289160855114
from O 0 0.0002230237005278468
peripheral O 1 0.9996767044067383
blood O 1 0.9950342178344727
and O 0 0.0003196009492967278
from O 0 0.0015521551249548793
tumor B-Disease 1 0.9999955892562866
tissue O 1 0.9979774355888367
. O 0 0.001303551602177322

The O 0 0.0003695221384987235
analysis O 0 0.0003999440814368427
of O 0 0.00032784329960122705
tumors B-Disease 1 0.9999239444732666
from O 0 0.0004325159825384617
54 O 0 0.00359435030259192
( O 0 0.0007166044670157135
71 O 0 0.0023453179746866226
% O 0 5.388309000409208e-05
) O 0 7.918681512819603e-05
of O 0 5.316494207363576e-05
76 O 0 0.02142900414764881
informative O 0 0.4495760500431061
patients O 1 0.9999372959136963
showed O 0 0.0012242362136021256
loss O 0 0.0014246248174458742
of O 0 6.065522029530257e-05
constitutional O 0 0.005833309143781662
heterozygosity O 1 0.9986366629600525
( O 0 0.014282859861850739
LOH O 1 0.9999713897705078
) O 0 0.0006180258351378143
at O 0 0.001327333739027381
intragenic O 0 0.19035042822360992
loci O 0 0.01670907437801361
. O 0 0.0008626652997918427

Three O 0 0.00020263173792045563
of O 0 9.740644600242376e-05
13 O 0 0.005431603640317917
uninformative O 1 0.9993816614151001
patients O 1 0.9998722076416016
had O 0 0.0007642089040018618
constitutional O 0 0.0011710966937243938
deletions O 0 0.006637691054493189
. O 0 0.0009162587230093777

For O 0 0.0006090616807341576
39 O 0 0.0016062235226854682
randomly O 0 0.0007896353490650654
selected O 0 0.0021469767671078444
tumors B-Disease 1 0.9999333620071411
, O 0 0.0013110906584188342
SSCP O 1 0.9975647926330566
, O 0 0.0019212543265894055
hetero O 1 0.9975437521934509
- O 0 0.01660129614174366
duplex O 0 0.032481223344802856
analysis O 0 0.0003541861951816827
, O 0 0.0001330556406173855
sequencing O 0 0.0006718413205817342
, O 0 0.00016783716273494065
and O 0 0.00020240717276465148
Southern O 0 0.002592024626210332
blot O 1 0.5519563555717468
analysis O 0 0.0002422422985546291
were O 0 2.4380411559832282e-05
used O 0 9.949027298716828e-05
to O 0 0.00012870498176198453
identify O 0 0.0022911326959729195
mutations O 0 0.004161886405199766
. O 0 0.0006477453862316906

Mutations O 0 0.009178005158901215
were O 0 0.00020911125466227531
detected O 0 0.00421141879633069
in O 0 0.00031407547066919506
21 O 0 0.0015490737278014421
( O 0 0.0005584773025475442
91 O 0 0.0027352035976946354
% O 0 6.0735033912351355e-05
) O 0 9.290136949857697e-05
of O 0 8.484694990329444e-05
23 O 0 0.018261130899190903
tumors B-Disease 1 0.9999765157699585
with O 0 0.0036716125905513763
LOH O 1 0.9999827146530151
. O 0 0.0019099342171102762

In O 0 0.0014035619096830487
6 O 0 0.002008801558986306
( O 0 0.0005004842532798648
38 O 0 0.0007182214176282287
% O 0 5.687525117537007e-05
) O 0 7.382674084510654e-05
of O 0 5.567560583585873e-05
16 O 0 0.008302622474730015
tumors B-Disease 1 0.9999903440475464
without O 0 0.007514958269894123
LOH O 1 0.9999713897705078
, O 0 0.00018568054656498134
one O 0 0.00021636161545757204
mutation O 0 0.002178251277655363
was O 0 0.0008417491335421801
detected O 0 0.0047887153923511505
, O 0 0.00010460688645252958
and O 0 9.317453077528626e-05
in O 0 0.0002231515245512128
9 O 0 0.0011501740664243698
( O 0 0.00037475558929145336
56 O 0 0.0007826951332390308
% O 0 3.730071330210194e-05
) O 0 5.37343330506701e-05
of O 0 3.164430017932318e-05
the O 0 0.0021889731287956238
tumors B-Disease 1 0.9999936819076538
without O 0 0.03150011971592903
LOH O 1 0.9999922513961792
, O 0 0.0003020910662598908
both O 0 0.00019691522174980491
mutations O 0 0.0013358293799683452
were O 0 5.931789564783685e-05
found O 0 0.000507473770994693
. O 0 0.0005824256804771721

Thus O 0 0.0012898785062134266
, O 0 0.00012468286149669439
a O 0 0.00014873377222102135
total O 0 4.6428154746536165e-05
of O 0 3.3048730983864516e-05
45 O 0 0.0006143067730590701
mutations O 0 0.0014488614397123456
were O 0 7.728623313596472e-05
identified O 0 0.0009068430517800152
in O 0 0.0006933248951099813
tumors B-Disease 1 0.9999275207519531
of O 0 0.0001976942439796403
36 O 0 0.026456918567419052
patients O 1 0.9999239444732666
. O 0 0.0011401006486266851

Thirty O 0 0.00665054377168417
- O 0 0.0014716513687744737
nine O 0 8.326029637828469e-05
of O 0 1.9299564883112907e-05
the O 0 0.0003561117046047002
mutations O 0 0.00340552581474185
- O 0 0.0014241968747228384
including O 0 6.952356488909572e-05
34 O 0 0.0005501992418430746
small O 0 0.0003676892083603889
mutations O 0 0.0017054227646440268
, O 0 0.00013850453251507133
2 O 0 0.0002956074313260615
large O 0 0.0003089886740781367
structural O 1 0.9459761381149292
alterations O 0 0.05541034787893295
, O 0 0.000370695284800604
and O 0 0.0004082098603248596
hypermethylation O 1 0.9839397668838501
in O 0 0.0008848237921483815
3 O 0 0.008076891303062439
tumors O 1 0.9999874830245972
- O 0 0.0036224322393536568
were O 0 4.3527743400773033e-05
not O 0 0.00011806692054960877
detected O 0 0.0012085578637197614
in O 0 3.9631671825191006e-05
the O 0 0.00011805826216004789
corresponding O 0 0.0015430644853040576
peripheral O 1 0.99958735704422
blood O 1 0.9943806529045105
DNA O 0 0.004811019171029329
. O 0 0.0007108839927241206

In O 0 0.001458737882785499
6 O 0 0.0023732087574899197
( O 0 0.0006621854263357818
17 O 0 0.0006507539073936641
% O 0 4.017617175122723e-05
) O 0 4.2668209061957896e-05
of O 0 1.5854308003326878e-05
the O 0 0.00040312533383257687
36 O 0 0.005828115623444319
patients O 1 0.9998123049736023
, O 0 0.00018972049292642623
a O 0 0.0007383695337921381
mutation O 0 0.0033605683129280806
was O 0 0.0009081140742637217
detected O 0 0.003405946772545576
in O 0 0.00012176588643342257
constitutional O 0 0.0008823322132229805
DNA O 0 0.0013843105407431722
, O 0 0.00013335667608771473
and O 0 6.256790948100388e-05
1 O 0 0.00011779738269979134
of O 0 1.4855386325507425e-05
these O 0 9.357583621749654e-05
mutations O 0 0.001930655911564827
is O 0 0.0003147990792058408
known O 0 0.0004616505466401577
to O 0 7.471194840036333e-05
be O 0 7.02737015672028e-05
associated O 0 0.00017784566443879157
with O 0 0.00015795096987858415
reduced O 0 0.007679896429181099
expressivity O 1 0.9877279996871948
. O 0 0.0017722338670864701

The O 0 0.00037795951357111335
presence O 0 0.00036325783003121614
of O 0 2.5625266061979346e-05
a O 0 0.000722476514056325
constitutional O 0 0.001419941778294742
mutation O 0 0.002896217629313469
was O 0 0.0006222945521585643
not O 0 0.00011217087012482807
associated O 0 0.0001291778462473303
with O 0 4.615687794284895e-05
an O 0 0.00023394614981953055
early O 0 0.0008771847933530807
age O 0 0.0015014782547950745
at O 0 0.0030584055930376053
treatment O 1 0.9995883107185364
. O 0 0.001017855480313301

In O 0 0.0014017807552590966
1 O 0 0.0033946228213608265
patient O 1 0.9990324974060059
, O 0 0.0010570886079221964
somatic O 0 0.3341215252876282
mosaicism O 1 0.9978674650192261
was O 0 0.0012725504348054528
demonstrated O 0 0.0017026617424562573
by O 0 5.481760672410019e-05
molecular O 0 0.0006037006969563663
analysis O 0 9.6146046416834e-05
of O 0 2.1317162463674322e-05
DNA O 0 0.0007421919144690037
and O 0 0.0001060454233083874
RNA O 0 0.0019829312805086374
from O 0 0.0005247133667580783
peripheral O 1 0.9995015859603882
blood O 1 0.9863880276679993
. O 0 0.0017911017639562488

In O 0 0.0019887194503098726
2 O 0 0.0035293949767947197
patients O 1 0.998170018196106
without O 0 0.00025109341368079185
a O 0 0.000692123721819371
detectable O 0 0.016032427549362183
mutation O 0 0.002582598477602005
in O 0 0.0005214987904764712
peripheral O 1 0.9997803568840027
blood O 1 0.9985256791114807
, O 0 0.0016526483232155442
mosaicism O 1 0.9982559084892273
was O 0 0.0017110939370468259
suggested O 0 0.0010883455397561193
because O 0 0.00022113474551588297
1 O 0 9.312958718510345e-05
of O 0 2.380344085395336e-05
the O 0 0.001145260757766664
patients O 1 0.9999938011169434
showed O 1 0.9820687174797058
multifocal O 1 0.9999979734420776
tumors B-Disease 1 0.9999905824661255
and O 0 0.0001613693602848798
the O 0 0.00011942011769860983
other O 0 9.38570883590728e-05
later O 0 0.0007319677388295531
developed O 0 0.006083343178033829
bilateral B-Disease 0 0.18538612127304077
retinoblastoma I-Disease 1 0.9995705485343933
. O 0 0.0017754074651747942

In O 0 0.0010549694998189807
conclusion O 0 0.0016618716763332486
, O 0 0.00024106218188535422
our O 0 0.0003483272157609463
results O 0 0.0004178754461463541
emphasize O 0 0.0019312513759359717
that O 0 7.750166696496308e-05
the O 0 0.00022843870101496577
manifestation O 0 0.31861570477485657
and O 0 0.0007230671471916139
transmissibility O 1 0.7206310629844666
of O 0 0.0004728602943941951
retinoblastoma B-Disease 1 0.9992982149124146
depend O 0 0.001503592822700739
on O 0 0.000143062075949274
the O 0 0.00011574747622944415
nature O 0 0.0003249097499065101
of O 0 1.2323298506089486e-05
the O 0 0.00012140508624725044
first O 0 0.00028522330103442073
mutation O 0 0.0013131564483046532
, O 0 7.273515075212345e-05
its O 0 0.00010098076745634899
time O 0 0.000106903760752175
in O 0 0.00017392134759575129
development O 0 0.001138413092121482
, O 0 0.00011901789548574015
and O 0 4.294936661608517e-05
the O 0 5.992048681946471e-05
number O 0 2.8274007490836084e-05
and O 0 5.593450623564422e-05
types O 0 0.00023271677491720766
of O 0 4.4990545575274155e-05
cells O 0 0.0020641779992729425
that O 0 7.346633356064558e-05
are O 0 5.163792957318947e-05
affected O 0 0.0023060026578605175
. O 0 0.0002145043108612299
. O 0 0.0007434254512190819

Hereditary B-Disease 1 0.9996968507766724
deficiency I-Disease 1 0.9999556541442871
of I-Disease 0 9.527626389171928e-05
the I-Disease 0 0.00029169299523346126
fifth I-Disease 0 0.0014928089221939445
component I-Disease 0 0.0009567987290211022
of I-Disease 0 3.3600477763684466e-05
complement I-Disease 0 0.0018576760776340961
in O 0 0.00037842930760234594
man O 0 0.007844427600502968
. O 0 0.0010017119348049164

I O 0 0.040667448192834854
. O 0 0.0018440245185047388

Clinical O 1 0.9992640614509583
, O 0 0.0017105076694861054
immunochemical O 1 0.9809885621070862
, O 0 0.0002909475879278034
and O 0 0.0002341268991585821
family O 0 0.0009635555325075984
studies O 0 0.0013091834262013435
. O 0 0.0007575358031317592

The O 0 0.0004954072064720094
first O 0 0.0003982240741606802
recognized O 0 0.0028853551484644413
human O 0 0.004764402750879526
kindred O 1 0.9983867406845093
with O 0 0.0017713557463139296
hereditary B-Disease 1 0.9999150037765503
deficiency I-Disease 1 0.9999949932098389
of I-Disease 0 4.1701714508235455e-05
the I-Disease 0 0.00019471655832603574
fifth I-Disease 0 0.0011454821797087789
component I-Disease 0 0.0009736791253089905
of I-Disease 0 4.108482607989572e-05
complement I-Disease 0 0.0043097492307424545
( O 0 0.0016349467914551497
C5 O 1 0.9970782995223999
) O 0 0.00039725532406009734
is O 0 0.0004594984056893736
described O 0 0.0032373075373470783
. O 0 0.0007012198329903185

The O 0 0.001568537438288331
proband O 0 0.02920886129140854
, O 0 0.00020115100778639317
a O 0 0.00047216302482411265
20 O 0 0.0005468935705721378
- O 0 0.0020710239186882973
year O 0 0.000863702385686338
- O 0 0.003674563253298402
old O 0 0.0026912789326161146
black O 0 0.011384708806872368
female O 0 0.00921835470944643
with O 1 0.5887619256973267
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 0.9999998807907104
since O 0 0.01472393050789833
age O 0 0.0017545350128784776
11 O 0 0.001160820946097374
, O 0 0.0005790106952190399
lacked O 1 0.8128059506416321
serum O 1 0.998618483543396
hemolytic O 1 0.9999113082885742
complement O 0 0.0038227506447583437
activity O 0 0.0011148045305162668
, O 0 0.00029130064649507403
even O 0 0.0007126852869987488
during O 0 0.003324013203382492
remission O 1 0.9977176189422607
. O 0 0.0012896218104287982

C5 O 1 0.9823355078697205
was O 0 0.007936747744679451
undetectable O 1 0.9788323640823364
in O 0 0.00046017911517992616
her O 0 0.0027976909186691046
serum O 1 0.8099059462547302
by O 0 0.00014473716146312654
both O 0 0.0005956902750767767
immunodiffusion O 1 0.9854995012283325
and O 0 0.0022664775606244802
hemolytic O 1 0.9999736547470093
assays O 0 0.011288797482848167
. O 0 0.0018200132763013244

Other O 0 0.0002929661422967911
complement O 0 0.0013902129139751196
components O 0 0.0007738525746390224
were O 0 8.476552466163412e-05
normal O 0 0.0018281446537002921
during O 0 0.0020457745995372534
remission O 1 0.9993034601211548
of O 0 0.0008504717261530459
lupus O 1 0.9999998807907104
, O 0 0.0010981776285916567
but O 0 0.0014975173398852348
C1 O 1 0.9996222257614136
, O 0 0.0008306839736178517
C4 O 1 0.9856382012367249
, O 0 0.0012162639759480953
C2 O 1 0.9995356798171997
, O 0 0.00044794866698794067
and O 0 0.0004374290583655238
C3 O 1 0.9976291060447693
levels O 0 0.005411466117948294
fell O 0 0.010688723996281624
during O 0 0.004965589381754398
exacerbations O 1 0.9984138011932373
. O 0 0.0022277228999882936

A O 0 0.007574617397040129
younger O 0 0.005376282148063183
half O 0 0.0010004733921959996
- O 0 0.008468514308333397
sister O 0 0.0024178377352654934
, O 0 0.0002645968634169549
who O 0 0.0004971717717126012
had O 0 0.0006557612796314061
no O 0 0.0009311639005318284
underlying O 1 0.9995502829551697
disease O 1 0.9999970197677612
, O 0 0.0003596167953219265
was O 0 0.0009070330997928977
also O 0 0.00018271521548740566
found O 0 0.00016433738346677274
to O 0 0.00011340533092152327
lack O 0 0.007797251921147108
immunochemically O 1 0.9833568334579468
detectable O 0 0.32850295305252075
C5 O 1 0.9825668931007385
. O 0 0.0017593482043594122

By O 0 0.004961327183991671
hemolytic O 1 0.9998113512992859
assay O 0 0.02090797759592533
, O 0 0.0010685911402106285
she O 0 0.0021300953812897205
exhibited O 0 0.009201663546264172
1 O 0 0.001233974820934236
- O 0 0.0013270038180053234
2 O 0 9.543064516037703e-05
% O 0 7.105574240995338e-06
of O 0 1.0028773431258742e-05
the O 0 0.00030288443667814136
normal O 0 0.007154844235628843
serum O 1 0.9955276846885681
C5 O 1 0.9932857155799866
level O 0 0.0013984045945107937
and O 0 0.00016087804397102445
normal O 0 0.001322139403782785
concentrations O 0 0.0007622244884259999
of O 0 1.598408016434405e-05
other O 0 6.27395129413344e-05
complement O 0 0.0015990645624697208
components O 0 0.002282236237078905
. O 0 0.0009356866939924657

C5 O 1 0.961170494556427
levels O 0 0.0021818482782691717
of O 0 3.627708792919293e-05
other O 0 0.00012009569763904437
family O 0 0.0005459652165882289
members O 0 9.372703789267689e-05
were O 0 4.238295878167264e-05
either O 0 0.0002658161101862788
normal O 0 0.0008954544318839908
or O 0 0.0001245307648787275
approximately O 0 0.00031865507480688393
half O 0 0.00044504355173557997
- O 0 0.002973598428070545
normal O 0 0.0012608591932803392
, O 0 0.00017668110376689583
consistent O 0 0.0025276870001107454
with O 0 0.0005750642740167677
autosomal O 1 0.9982362985610962
codominant O 1 0.7530920505523682
inheritance O 0 0.0009592120768502355
of O 0 3.242230013711378e-05
the O 0 0.00042662309715524316
gene O 0 0.006107175722718239
determining O 0 0.029862472787499428
C5 B-Disease 1 0.9999815225601196
deficiency I-Disease 1 0.9999985694885254
. O 0 0.002745706122368574

Normal O 1 0.8555294275283813
hemolytic O 1 0.9999715089797974
titers O 1 0.9846740961074829
were O 0 0.00021020910935476422
restored O 0 0.0014307498931884766
to O 0 7.297629781533033e-05
both O 0 0.00026697706198319793
homozygous O 0 0.019781529903411865
C5 B-Disease 1 0.9997257590293884
- I-Disease 1 0.9918103814125061
deficient I-Disease 1 0.9999474287033081
( O 0 0.004524583462625742
C5D B-Disease 1 0.9997560381889343
) O 0 0.000859194784425199
sera O 0 0.010985522530972958
by O 0 3.528285742504522e-05
addition O 0 0.00010844934149645269
of O 0 3.3075502869905904e-05
highly O 0 0.0058111511170864105
purified O 0 0.15354855358600616
human O 0 0.007146794348955154
C5 O 1 0.9946957230567932
. O 0 0.0018138576997444034

In O 0 0.0010545839322730899
specific O 0 0.0022762594744563103
C5 O 1 0.9975191354751587
titrations O 1 0.9818975329399109
, O 0 0.0003901076561305672
however O 0 0.0003264348488301039
, O 0 0.00015583191998302937
it O 0 0.00013248315372038633
was O 0 0.0004738334973808378
noted O 0 0.00039940112037584186
that O 0 6.195447349455208e-05
when O 0 0.0001237966789631173
limited O 0 0.00032634742092341185
amounts O 0 0.00028397509595379233
of O 0 0.00011928445746889338
C5 O 1 0.9945895671844482
were O 0 0.00014633887622039765
assayed O 0 0.0037353455554693937
in O 0 6.724507693434134e-05
the O 0 7.394595741061494e-05
presence O 0 0.0002622408210299909
of O 0 4.445407466846518e-05
low O 0 0.004598370753228664
dilutions O 0 0.15132437646389008
of O 0 0.00013213834608905017
either O 0 0.004625145345926285
C5D B-Disease 1 0.9995529055595398
serum O 1 0.9751928448677063
, O 0 0.0005654980195686221
curving O 0 0.008202978409826756
rather O 0 0.00024395213404204696
than O 0 0.00015002567670308053
linear O 0 0.004994830582290888
dose O 1 0.8770049214363098
- O 0 0.0052184914238750935
response O 0 0.001264434540644288
plots O 0 0.0006834636442363262
were O 0 8.707308734301478e-05
consistently O 0 0.0026593883521854877
obtained O 0 0.0003625389072112739
, O 0 0.00012427238107193261
suggesting O 0 0.0011551501229405403
some O 0 7.984475087141618e-05
inhibitory O 0 0.0038083980325609446
effect O 0 0.0022107099648565054
. O 0 0.0008800546638667583

Further O 0 0.0016374984988942742
studies O 0 0.0007689818157814443
suggested O 0 0.0009226467809639871
that O 0 0.00011518089741002768
low O 0 0.002670452231541276
dilutions O 0 0.189005509018898
of O 0 0.000317018770147115
C5D B-Disease 1 0.9995878338813782
serum O 1 0.7948484420776367
contain O 0 0.0005743472720496356
a O 0 0.0008011597092263401
factor O 0 0.0025125194806605577
( O 0 0.00048423363477922976
or O 0 0.0003063780313823372
factors O 0 0.0006336442311294377
) O 0 0.00023273320402950048
interfering O 0 0.004641973879188299
at O 0 0.00027324582333676517
some O 0 9.79918913799338e-05
step O 0 0.0014974074438214302
in O 0 0.00023880407388787717
the O 0 0.0008995051612146199
hemolytic O 1 0.9998799562454224
assay O 0 0.006408037152141333
of O 0 0.0002471956249792129
C5 O 1 0.9958618879318237
, O 0 0.00014346888929139823
rather O 0 0.00013252143980935216
than O 0 6.88595901010558e-05
a O 0 0.000660519755911082
true O 0 0.004269018303602934
C5 O 1 0.9968306422233582
inhibitor O 1 0.8235101699829102
or O 0 0.001409335294738412
inactivator O 1 0.8691675662994385
. O 0 0.0012425852473825216

Of O 0 0.0006678957142867148
clinical O 1 0.990123450756073
interest O 0 0.00042152509558945894
are O 0 8.291909762192518e-05
( O 0 0.00029073929181322455
a O 0 0.0004672064387705177
) O 0 7.163912960095331e-05
the O 0 6.314429629128426e-05
documentation O 0 0.0008229436934925616
of O 0 0.0002449959283694625
membranous O 1 0.9999488592147827
glomerulonephritis B-Disease 1 0.9999984502792358
, O 0 0.2435981035232544
vasculitis B-Disease 1 0.999997615814209
, O 0 0.005423865746706724
and O 0 0.21132402122020721
arthritis B-Disease 1 1.0
in O 0 0.0002578613057266921
an O 0 0.00033290308783762157
individual O 0 0.001181697123683989
lacking O 1 0.9904016852378845
C5 O 1 0.9981865286827087
( O 0 0.0004992782487533987
and O 0 0.00010117990314029157
its O 0 0.0003442688030190766
biologic O 0 0.2510351836681366
functions O 0 0.000383355567464605
) O 0 0.0002070948830805719
, O 0 0.00016365745977964252
and O 0 0.00020953216881025583
( O 0 0.0005606252234429121
b O 0 0.0028363114688545465
) O 0 8.69528521434404e-05
a O 0 0.00033358109067194164
remarkable O 0 0.004710712470114231
propensity O 1 0.8668076395988464
to O 0 0.0017862218664959073
bacterial B-Disease 1 0.9999642372131348
infections I-Disease 1 0.9999938011169434
in O 0 0.0004320544539950788
the O 0 0.0008870480814948678
proband O 1 0.9869968891143799
, O 0 0.0002484941214788705
even O 0 0.00023388549743685871
during O 0 0.0002849237935151905
periods O 0 0.0002584794128779322
of O 0 3.917343929060735e-05
low O 0 0.0034371057990938425
- O 0 0.003988639451563358
dose O 0 0.009936029091477394
or O 0 0.00027963853790424764
alternate O 0 0.0015432258369401097
- O 0 0.006529043894261122
day O 0 0.0034600840881466866
corticosteroid O 1 0.9999064207077026
therapy O 1 0.9988369345664978
. O 0 0.0015346462605521083

Other O 0 0.0002736428868956864
observations O 0 0.0009727622382342815
indicate O 0 0.0007311966619454324
that O 0 0.00012947259529028088
the O 0 0.0006006045150570571
C5D B-Disease 1 0.9989114999771118
state O 0 0.0002049983013421297
is O 0 0.00018826551968231797
compatible O 0 0.0007722253794781864
with O 0 0.00013752370432484895
normal O 0 0.004803844727575779
coagulation O 0 0.204832062125206
function O 0 0.0004891374264843762
and O 0 6.205747195053846e-05
the O 0 0.00011538491526152939
capacity O 0 0.0009992936393246055
to O 0 0.00023112291819415987
mount O 0 0.05946940928697586
a O 0 0.005431093741208315
neutrophilic O 1 0.9997654557228088
leukocytosis O 1 0.9990779161453247
during O 0 0.2630390226840973
pyogenic B-Disease 1 0.9999099969863892
infection I-Disease 1 0.9999346733093262
. O 0 0.0010236415546387434
. O 0 0.0012016977416351438

Susceptibility O 1 0.9920024871826172
to O 0 0.02239396795630455
ankylosing B-Disease 1 0.9999998807907104
spondylitis I-Disease 1 0.9999998807907104
in O 0 0.007625387515872717
twins O 0 0.4205762445926666
: O 0 0.00018940112204290926
the O 0 8.04089504526928e-05
role O 0 0.0005140505381859839
of O 0 4.445513695827685e-05
genes O 0 0.0012875947868451476
, O 0 0.0010870611295104027
HLA O 1 0.9992874264717102
, O 0 0.00017868058057501912
and O 0 9.185617818729952e-05
the O 0 0.00026515620993450284
environment O 0 0.003375723259523511
. O 0 0.0008524756995029747

OBJECTIVE O 0 0.01515843067318201
To O 0 0.0002395593619439751
determine O 0 0.0003613341832533479
the O 0 0.0001332528336206451
relative O 0 0.0007245564484037459
effects O 0 0.002707637380808592
of O 0 5.51539815205615e-05
genetic O 0 0.0024615218862891197
and O 0 0.00018961867317557335
environmental O 0 0.0037355818785727024
factors O 0 0.000494862615596503
in O 0 0.00036814698250964284
susceptibility O 1 0.9959248304367065
to O 0 0.020103007555007935
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.02365206927061081
AS B-Disease 1 0.7244221568107605
) O 0 0.0010061144130304456
. O 0 0.0008349187555722892

METHODS O 0 0.020139746367931366
Twins O 0 0.03971121832728386
with O 0 0.0003412872029002756
AS B-Disease 0 0.0035536198411136866
were O 0 6.057337304810062e-05
identified O 0 0.00033519507269375026
from O 0 4.554960469249636e-05
the O 0 0.00023717034491710365
Royal O 0 0.00987898837774992
National O 1 0.809045672416687
Hospital O 1 0.9999821186065674
for O 0 0.3158635199069977
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999978542327881
database O 0 0.012579641304910183
. O 0 0.001691075274720788

Clinical O 1 0.9982522130012512
and O 0 0.0014618865679949522
radiographic O 1 0.9986458420753479
examinations O 0 0.03350166603922844
were O 0 5.788174530607648e-05
performed O 0 0.0004384280473459512
to O 0 0.00013381880125962198
establish O 0 0.005781032610684633
diagnoses O 1 0.9998965263366699
, O 0 0.0008257510489784181
and O 0 0.00981938187032938
disease O 1 0.9999991655349731
severity O 1 0.9997839331626892
was O 0 0.0023485200945287943
assessed O 0 0.003609986510127783
using O 0 0.00010176394425798208
a O 0 0.00035676718107424676
combination O 0 0.0009551816037856042
of O 0 4.0686933061806485e-05
validated O 0 0.0032642267178744078
scoring O 0 0.0005176547565497458
systems O 0 0.008340328000485897
. O 0 0.0009932124521583319

HLA O 1 0.9903552532196045
typing O 0 0.019299538806080818
for O 0 0.0018727213609963655
HLA O 1 0.998245120048523
- O 0 0.012656152248382568
B27 O 0 0.029406221583485603
, O 0 0.0012171221897006035
HLA O 1 0.9952427744865417
- O 0 0.00659105135127902
B60 O 0 0.013662771321833134
, O 0 0.00036748548154719174
and O 0 0.0008737855823710561
HLA O 1 0.9994922876358032
- O 0 0.06384070217609406
DR1 O 1 0.9967004656791687
was O 0 0.0009746592841111124
performed O 0 0.0006270885351113975
by O 0 9.902517194859684e-05
polymerase O 0 0.0033847461454570293
chain O 0 0.0020544014405459166
reaction O 0 0.0006159548065625131
with O 0 9.581189078744501e-05
sequence O 0 0.00025832047685980797
- O 0 0.0019387539941817522
specific O 0 0.0003050207160413265
primers O 0 0.007061324082314968
, O 0 0.0002432377077639103
and O 0 0.0002686469815671444
zygosity O 1 0.5959588289260864
was O 0 0.0007543006795458496
assessed O 0 0.003459472442045808
using O 0 0.0003572891582734883
microsatellite O 0 0.042896438390016556
markers O 0 0.009279864840209484
. O 0 0.0011602450395002961

Genetic O 0 0.007562217302620411
and O 0 0.00041403871728107333
environmental O 0 0.0032598674297332764
variance O 0 0.0005062620621174574
components O 0 0.0006749879685230553
were O 0 9.815666999202222e-05
assessed O 0 0.0026051742024719715
with O 0 8.084712317213416e-05
the O 0 0.0003939158341381699
program O 0 0.010390941984951496
Mx O 1 0.9765766859054565
, O 0 8.896361396182328e-05
using O 0 6.906814087415114e-05
data O 0 7.203055429272354e-05
from O 0 6.25704851699993e-05
this O 0 4.801959585165605e-05
and O 0 6.85803679516539e-05
previous O 0 0.0002578682033345103
studies O 0 0.00019198222435079515
of O 0 5.9436122683109716e-05
twins O 0 0.05056118965148926
with O 0 0.000269162526819855
AS B-Disease 0 0.07851153612136841
. O 0 0.0011422253446653485

RESULTS O 0 0.0031311307102441788
Six O 0 0.00030697882175445557
of O 0 7.827222725609317e-05
8 O 0 0.0029854236636310816
monozygotic O 1 0.9847971796989441
( O 0 0.005402926821261644
MZ O 1 0.9989503026008606
) O 0 0.0013634109636768699
twin O 0 0.012449911795556545
pairs O 0 0.001742759719491005
were O 0 0.0008625962072983384
disease O 1 0.9999862909317017
concordant O 1 0.8968656659126282
, O 0 0.0003577689058147371
compared O 0 0.00043993096915073693
with O 0 7.569204171886668e-05
4 O 0 0.0002119938435498625
of O 0 3.5848061088472605e-05
15 O 0 0.0009381647687405348
B27 O 0 0.04688601940870285
- O 0 0.005087262950837612
positive O 0 0.004530954174697399
dizygotic O 1 0.8660251498222351
( O 0 0.0027783173136413097
DZ O 1 0.9931117296218872
) O 0 0.0009223014349117875
twin O 0 0.007889669388532639
pairs O 0 0.0013023490319028497
( O 0 0.0006549724494107068
27 O 0 0.0011966468300670385
% O 0 6.817374378442764e-05
) O 0 0.000119125543278642
and O 0 7.6408548920881e-05
4 O 0 0.00022361114679370075
of O 0 4.9095138820121065e-05
32 O 0 0.0024839818943291903
DZ O 1 0.9917902946472168
twin O 0 0.011735282838344574
pairs O 0 0.0009985874639824033
overall O 0 0.0026756690349429846
( O 0 0.0006723140249960124
12 O 0 0.0005964143201708794
. O 0 0.00012703843822237104
5 O 0 0.00039217708399519324
% O 0 9.70742039498873e-05
) O 0 0.0004228140751365572
. O 0 0.0006982320337556303

Nonsignificant O 1 0.6790435314178467
increases O 0 0.0027919700369238853
in O 0 0.00016601913375779986
similarity O 0 0.000575821497477591
with O 0 0.00011873032781295478
regard O 0 0.0009331248584203422
to O 0 0.00021548250515479594
age O 0 0.002120938617736101
at O 0 0.052262965589761734
disease O 1 0.999998927116394
onset O 1 0.9995036125183105
and O 0 8.572848309995607e-05
all O 0 2.1154000933165662e-05
of O 0 6.923120963620022e-05
the O 0 0.007757929153740406
disease O 1 0.9999988079071045
severity O 1 0.999390721321106
scores O 0 0.001304212142713368
assessed O 0 0.0039629628881812096
were O 0 5.4117394029162824e-05
noted O 0 0.0010011909762397408
in O 0 0.001874663750641048
disease O 1 0.9999951124191284
- O 1 0.8008759021759033
concordant O 1 0.9940060377120972
MZ O 1 0.9993948936462402
twins O 0 0.02350490912795067
compared O 0 0.0014949326869100332
with O 0 0.001173306372947991
concordant O 1 0.9845147132873535
DZ O 1 0.9984489679336548
twins O 0 0.1308031976222992
. O 0 0.001529825502075255

HLA O 1 0.9982023239135742
- O 0 0.02470906265079975
B27 O 0 0.02796332538127899
and O 0 0.00047299370635300875
B60 O 0 0.011222930625081062
were O 0 7.920440839370713e-05
associated O 0 0.0002387485292274505
with O 0 0.00011380331852706149
the O 0 0.0021565649658441544
disease O 1 0.9999898672103882
in O 0 0.000904462649486959
probands O 1 0.9931846261024475
, O 0 0.0001852087734732777
and O 0 5.551210415433161e-05
the O 0 9.457871783524752e-05
rate O 0 0.0003218299534637481
of O 0 0.00023334645084105432
disease O 1 0.9999804496765137
concordance O 0 0.016512734815478325
was O 0 0.0017865262925624847
significantly O 0 0.005017073825001717
increased O 0 0.0008294801227748394
among O 0 0.001186226261779666
DZ O 1 0.9987621307373047
twin O 0 0.010268946178257465
pairs O 0 0.00045511178905144334
in O 0 0.00013332144590094686
which O 0 8.8294837041758e-05
the O 0 0.00038577866507694125
co O 0 0.03981058672070503
- O 0 0.005594947375357151
twin O 0 0.00409866776317358
was O 0 0.0004432082932908088
positive O 0 0.0005049455794505775
for O 0 0.00013350362132769078
both O 0 0.00044157920638099313
B27 O 0 0.11501733958721161
and O 0 0.0012653230223804712
DR1 O 1 0.9980188608169556
. O 0 0.0020271798130124807

Additive O 0 0.022345392033457756
genetic O 0 0.006691405083984137
effects O 0 0.0042159962467849255
were O 0 7.91262646089308e-05
estimated O 0 0.00048119580605998635
to O 0 0.00017136044334620237
contribute O 0 0.0027634913567453623
97 O 0 0.0013308223569765687
% O 0 1.5437090041814372e-05
of O 0 9.59772205533227e-06
the O 0 8.57239865581505e-05
population O 0 9.207225957652554e-05
variance O 0 0.0006808485486544669
. O 0 0.0006776912487111986

CONCLUSION O 0 0.02316029742360115
Susceptibility O 0 0.4955953359603882
to O 0 0.0004739767173305154
AS B-Disease 0 0.005646669305860996
is O 0 0.00040380246355198324
largely O 0 0.0007675125380046666
genetically O 0 0.0015100555028766394
determined O 0 0.0011713866842910647
, O 0 0.0001297865528613329
and O 0 6.292681791819632e-05
the O 0 0.00015228503616526723
environmental O 0 0.0059075504541397095
trigger O 0 0.006263012997806072
for O 0 0.00020156841492280364
the O 0 0.0016381018795073032
disease O 1 0.9999970197677612
is O 0 0.0009130346588790417
probably O 0 0.0024489450734108686
ubiquitous O 0 0.016489049419760704
. O 0 0.000933495641220361

HLA O 1 0.9972172975540161
- O 0 0.016929516568779945
B27 O 0 0.01358665432780981
accounts O 0 0.00016969269199762493
for O 0 0.00011156305117765442
a O 0 0.0003933756670448929
minority O 0 0.00027434295043349266
of O 0 1.6271809727186337e-05
the O 0 0.00016513846640009433
overall O 0 0.0026181803550571203
genetic O 0 0.0036375487688928843
susceptibility O 1 0.6755765080451965
to O 0 0.00042459246469661593
AS B-Disease 0 0.015366864390671253
. O 0 0.001069571590051055

Cell O 0 0.016144651919603348
cycle O 0 0.0067421975545585155
- O 0 0.006598723586648703
dependent O 0 0.0035082928370684385
colocalization O 0 0.021846123039722443
of O 0 0.0002764856326393783
BARD1 O 1 0.9924267530441284
and O 0 0.0009524956112727523
BRCA1 O 1 0.9672359228134155
proteins O 0 0.00012974103447049856
in O 0 0.00012479894212447107
discrete O 0 0.0018019737908616662
nuclear O 0 0.003334272187203169
domains O 0 0.0026017779018729925
. O 0 0.0007757634739391506

Germ O 1 0.9946296215057373
- O 0 0.008983543142676353
line O 0 0.0013303927844390273
mutations O 0 0.0004425821825861931
of O 0 2.1075991753605194e-05
the O 0 0.0007256747921928763
BRCA1 O 1 0.9995255470275879
gene O 0 0.005920449271798134
predispose O 1 0.6117629408836365
women O 0 0.0002975278184749186
to O 0 0.00012834748486056924
early O 0 0.0014570588245987892
- O 1 0.9835116863250732
onset O 1 0.9999921321868896
breast B-Disease 1 0.9999994039535522
and I-Disease 1 0.9800881743431091
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
by O 0 0.0002992255031131208
compromising O 0 0.10667188465595245
the O 0 0.0003965508076362312
genes O 0 0.001161112915724516
presumptive O 0 0.46209725737571716
function O 0 0.0005834430921822786
as O 0 0.00040210215956903994
a O 0 0.004042227752506733
tumor B-Disease 1 0.999863862991333
suppressor O 0 0.22895917296409607
. O 0 0.001077936845831573

Although O 0 0.0011303448118269444
the O 0 0.00031949160620570183
biochemical O 0 0.005619327537715435
properties O 0 0.0011218426516279578
of O 0 0.0003506758657749742
BRCA1 O 1 0.9997280240058899
polypeptides O 0 0.008342561312019825
are O 0 0.00010438309254823253
not O 0 0.0003124671056866646
understood O 0 0.002391618210822344
, O 0 9.613102156436071e-05
their O 0 5.864263584953733e-05
expression O 0 0.0010147052817046642
pattern O 0 0.0029355573933571577
and O 0 0.0002668646047823131
subcellular O 0 0.010386760346591473
localization O 0 0.007411167956888676
suggest O 0 0.0008732994319871068
a O 0 0.0004230523481965065
role O 0 0.001262585399672389
in O 0 0.00034117334871552885
cell O 0 0.004062340594828129
- O 0 0.003128501819446683
cycle O 0 0.0018693107413128018
regulation O 0 0.0024402032140642405
. O 0 0.0007586762076243758

When O 0 0.005937842186540365
resting O 1 0.509945273399353
cells O 0 0.00336736929602921
are O 0 0.00012425723252817988
induced O 1 0.5424097776412964
to O 0 0.0003673803876154125
proliferate O 0 0.010708022862672806
, O 0 0.0001000579068204388
the O 0 0.00013152326573617756
steady O 0 0.004382719285786152
- O 0 0.001416497863829136
state O 0 0.0001078035929822363
levels O 0 0.0006602494977414608
of O 0 8.648091170471162e-05
BRCA1 O 1 0.9962034821510315
increase O 0 0.0008074358920566738
in O 0 0.000434269750257954
late O 0 0.0046141380444169044
G1 O 1 0.8731254935264587
and O 0 0.00010731702786870301
reach O 0 0.00024112494429573417
a O 0 0.0003149903495796025
maximum O 0 0.0006047863280400634
during O 0 0.0019699211698025465
S O 1 0.6748250722885132
phase O 0 0.007265356369316578
. O 0 0.0005412480677478015

Moreover O 0 0.009392062202095985
, O 0 0.0005653781117871404
in O 0 0.0005451331962831318
S O 1 0.901929497718811
phase O 0 0.011072592809796333
cells O 0 0.0041941204108297825
, O 0 0.0009553340496495366
BRCA1 O 1 0.9904830455780029
polypeptides O 0 0.00687829963862896
are O 0 0.0001532315363874659
hyperphosphorylated O 0 0.043080899864435196
and O 0 0.00021572344121523201
accumulate O 0 0.004077620804309845
into O 0 0.00022305194579530507
discrete O 0 0.0037332596257328987
subnuclear O 1 0.5762733221054077
foci O 0 0.07994242012500763
termed O 0 0.3079034984111786
" O 0 0.005034505855292082
BRCA1 O 1 0.9946085214614868
nuclear O 0 0.008182785473763943
dots O 0 0.0386277474462986
. O 0 0.0009419386042281985

" O 0 0.02319497801363468
BRCA1 O 1 0.9991318583488464
associates O 1 0.8775993585586548
in O 0 0.0005077800597064197
vivo O 0 0.004342823289334774
with O 0 0.00011267847730778158
a O 0 0.0013804577756673098
structurally O 0 0.30484554171562195
related O 0 0.0018506336491554976
protein O 0 0.0027125165797770023
termed O 1 0.9755939841270447
BARD1 O 1 0.9961523413658142
. O 0 0.0017956567462533712

Here O 0 0.0011316699674353004
we O 0 0.00017947885498870164
show O 0 0.00021525622287299484
that O 0 4.497222835198045e-05
the O 0 0.0001247584878001362
steady O 0 0.004517316818237305
- O 0 0.0014622763264924288
state O 0 0.0001341008610324934
levels O 0 0.0006661195075139403
of O 0 7.894170266808942e-05
BARD1 O 1 0.9973917007446289
, O 0 0.00026427643024362624
unlike O 0 0.0005383810494095087
those O 0 7.594486669404432e-05
of O 0 0.00017118980758823454
BRCA1 O 1 0.9996863603591919
, O 0 0.00038714107358828187
remain O 0 0.0006966059445403516
relatively O 0 0.0007172938785515726
constant O 0 0.0008370341965928674
during O 0 0.001606124802492559
cell O 0 0.006378545891493559
cycle O 0 0.007600957527756691
progression O 1 0.9243237972259521
. O 0 0.0012778728269040585

However O 0 0.0021239877678453922
, O 0 0.0010289649944752455
immunostaining O 1 0.8445868492126465
revealed O 0 0.007630685809999704
that O 0 0.00048236557631753385
BARD1 O 1 0.9824317097663879
resides O 0 0.007954014465212822
within O 0 0.0010089186253026128
BRCA1 O 1 0.9972409009933472
nuclear O 0 0.008594590239226818
dots O 0 0.036163318902254105
during O 0 0.002399190329015255
S O 0 0.148904949426651
phase O 0 0.0011553624644875526
of O 0 2.4456981918774545e-05
the O 0 0.00025410091620869935
cell O 0 0.003205411834642291
cycle O 0 0.0013507199473679066
, O 0 0.00011564332817215472
but O 0 0.00010728181223385036
not O 0 5.192254320718348e-05
during O 0 0.0004368733789306134
the O 0 0.0007234351942315698
G1 O 1 0.9874454736709595
phase O 0 0.010826625861227512
. O 0 0.0011650691740214825

Nevertheless O 0 0.025818489491939545
, O 0 0.0020317479502409697
BARD1 O 1 0.9687595367431641
polypeptides O 0 0.006737517658621073
are O 0 7.313241076190025e-05
found O 0 0.00020182767184451222
exclusively O 0 0.00026395078748464584
in O 0 6.507550278911367e-05
the O 0 8.091761992545798e-05
nuclear O 0 0.0005690506077371538
fractions O 0 0.00013859027239959687
of O 0 2.6098216039827093e-05
both O 0 0.0006200894713401794
G1 O 1 0.9965406060218811
- O 0 0.004740324802696705
and O 0 0.0004664153093472123
S O 1 0.6566131711006165
- O 0 0.004669460002332926
phase O 0 0.005812856834381819
cells O 0 0.002531643258407712
. O 0 0.00048614744446240366

Therefore O 0 0.0023822099901735783
, O 0 0.0007951148436404765
progression O 1 0.6642563343048096
to O 0 0.0006157769239507616
S O 1 0.7392643094062805
phase O 0 0.004661428742110729
is O 0 0.0002691812696866691
accompanied O 0 0.0004657430399674922
by O 0 3.8002588553354144e-05
the O 0 9.102268086280674e-05
aggregation O 0 0.0009332093177363276
of O 0 5.7746179663809016e-05
nuclear O 0 0.009397288784384727
BARD1 O 1 0.9230198860168457
polypeptides O 0 0.006567835342139006
into O 0 0.001337664551101625
BRCA1 O 1 0.9806228876113892
nuclear O 0 0.011050982400774956
dots O 0 0.04022262245416641
. O 0 0.00124200782738626

This O 0 0.0006258179782889783
cell O 0 0.0042613232508301735
cycle O 0 0.0036133495159447193
- O 0 0.0037203370593488216
dependent O 0 0.0019465764053165913
colocalization O 0 0.021943029016256332
of O 0 0.0002036031655734405
BARD1 O 1 0.9963377714157104
and O 0 0.0009986720979213715
BRCA1 O 1 0.9971823692321777
indicates O 0 0.001409410499036312
a O 0 0.00030937278643250465
role O 0 0.0012079408625140786
for O 0 0.0004920460633002222
BARD1 O 1 0.9893621802330017
in O 0 0.0013618452940136194
BRCA1 O 1 0.9996026158332825
- O 0 0.3756013512611389
mediated O 1 0.9720536470413208
tumor B-Disease 1 0.9998005032539368
suppression O 0 0.3433067798614502
. O 0 0.0014161861035972834

Ethnic O 0 0.001071498030796647
differences O 0 0.0016043190844357014
in O 0 0.00032690539956092834
the O 0 0.0013132916064932942
HFE O 1 0.9906913638114929
codon O 0 0.020068954676389694
282 O 0 0.04985189810395241
( O 0 0.007466938812285662
Cys O 1 0.9989614486694336
/ O 1 0.8835086226463318
Tyr O 1 0.9938157796859741
) O 0 0.000659187906421721
polymorphism O 0 0.00419287383556366
. O 0 0.0008760038181208074

Recent O 0 0.0021949145011603832
studies O 0 0.0005743261426687241
have O 0 0.00012005012104054913
shown O 0 0.0009790465701371431
that O 0 0.001362561946734786
hereditary B-Disease 1 0.999983549118042
hemochromatosis I-Disease 1 0.9999998807907104
( O 1 0.8321998715400696
HH B-Disease 1 0.9999958276748657
) O 0 0.0007059341296553612
is O 0 0.0003673437749966979
likely O 0 0.00040142537909559906
to O 0 6.220678915269673e-05
be O 0 0.00010928649135166779
caused O 0 0.0024331083986908197
by O 0 0.00014512382040265948
homozygosity O 0 0.04243006929755211
for O 0 0.00018853247456718236
a O 0 0.0013664280995726585
Cys282Tyr O 1 0.6112352013587952
mutation O 0 0.001693793456070125
in O 0 0.00014671109966002405
the O 0 0.0008972017094492912
HFE O 1 0.9979907274246216
gene O 0 0.0037995276506990194
located O 0 0.0012524011544883251
4 O 0 0.0010036119492724538
. O 0 0.0006188328261487186

5 O 0 0.006719605531543493
Mb O 1 0.6433618664741516
telomeric O 1 0.8569994568824768
to O 0 0.0019613916520029306
HLA O 1 0.9983701109886169
- O 0 0.00661824457347393
A O 0 0.0035593246575444937
. O 0 0.0008397455094382167

Population O 0 0.0004089338763151318
studies O 0 0.00024174971622414887
of O 0 1.80807473952882e-05
this O 0 8.76120466273278e-05
polymorphism O 0 0.0016281441785395145
are O 0 4.5836317440262064e-05
facilitated O 0 0.002192024840041995
by O 0 4.112304304726422e-05
the O 0 0.00011067647574236616
fact O 0 0.0002776457986328751
that O 0 8.201225864468142e-05
the O 0 0.0003391947248019278
Cys282Tyr O 1 0.5910021662712097
mutation O 0 0.002399803139269352
creates O 0 0.0021029445342719555
a O 0 0.001243135891854763
Rsal O 0 0.46348902583122253
restriction O 0 0.0017329321708530188
site O 0 0.002282568486407399
. O 0 0.0005565061001107097

We O 0 0.0006440599099732935
have O 0 8.446165156783536e-05
studied O 0 0.00026873740716837347
the O 0 0.00019063804938923568
codon O 0 0.007017314899712801
282 O 0 0.026046637445688248
( O 0 0.00469511142000556
Cys O 1 0.9996165037155151
/ O 1 0.9828267097473145
Tyr O 1 0.9968097805976868
) O 0 0.0004719911376014352
polymorphism O 0 0.0011204062029719353
in O 0 6.251185550354421e-05
different O 0 2.3330787371378392e-05
ethnic O 0 0.0001339140289928764
groups O 0 0.0002781717630568892
. O 0 0.0008804966928437352

In O 0 0.0008788261911831796
agreement O 0 0.0008740552584640682
with O 0 0.00010017570457421243
previous O 0 0.0005418829969130456
observations O 0 0.0012261884985491633
the O 0 0.0010599920060485601
Tyr O 1 0.9980633854866028
allele O 0 0.009577258490025997
appeared O 0 0.0014920755056664348
to O 0 9.543429041514173e-05
be O 0 0.00015527007053606212
rare O 0 0.003624598030000925
or O 0 0.0006559456815011799
absent O 0 0.01145182829350233
in O 0 0.0007182193221524358
Asiatic O 1 0.9614234566688538
( O 0 0.0008889181190170348
Indian O 0 0.0009165338124148548
, O 0 0.00023634823446627706
Chinese O 0 0.0006163239013403654
) O 0 0.0002479103277437389
populations O 0 0.0007796654244884849
. O 0 0.000587416987400502

The O 0 0.0009383134893141687
highest O 0 0.003589350264519453
allele O 0 0.005118146073073149
frequency O 0 0.0008100183331407607
( O 0 0.0006418728735297918
7 O 0 0.000747935613617301
. O 0 0.00012044330651406199
5 O 0 0.00026191349024884403
% O 0 6.0528385802172124e-05
) O 0 0.00015670267748646438
was O 0 0.00053997035138309
found O 0 0.0002502941351849586
in O 0 0.0002117106778314337
Swedes O 0 0.00484906230121851
. O 0 0.0007520834915339947

Saamis O 0 0.3607046604156494
( O 0 0.001072355778887868
2 O 0 0.000570634554605931
% O 0 8.832102321321145e-05
) O 0 0.00016765145119279623
and O 0 0.0002490114129614085
Mordvinians O 1 0.883025586605072
( O 0 0.00043488742085173726
1 O 0 0.000425121805164963
. O 0 9.80707845883444e-05
8 O 0 0.00034334417432546616
% O 0 5.624795812764205e-05
) O 0 0.0001644072908675298
had O 0 0.00046190625289455056
significantly O 0 0.002263040514662862
lower O 0 0.0005591657245531678
frequencies O 0 6.0252084949752316e-05
of O 0 3.1644209229853004e-05
the O 0 0.0010910751298069954
Tyr O 1 0.9976869821548462
allele O 0 0.014124073088169098
. O 0 0.0012830536579713225

Comparisons O 0 0.0025678754318505526
with O 0 0.00031115999445319176
allele O 0 0.0037773342337459326
frequencies O 0 0.00036137053393758833
based O 0 0.00030227002571336925
on O 0 0.0005518110701814294
prevalence O 1 0.6525626182556152
estimates O 0 0.0013262057909741998
of O 0 0.0003918822330888361
HH B-Disease 1 0.999983549118042
showed O 0 0.002057061530649662
some O 0 0.00012034767132718116
disagreements O 0 0.0038567115552723408
with O 0 0.0001772426621755585
the O 0 0.0006453250534832478
RFLP O 1 0.9728567600250244
data O 0 0.00030195488943718374
, O 0 0.000249699194682762
particularly O 0 0.0011454500490799546
in O 0 0.0004132047761231661
Finns O 0 0.024336235597729683
. O 0 0.0009542860789224505

The O 0 0.0015178750036284328
newly O 0 0.011202226392924786
described O 0 0.025509463623166084
HFE O 1 0.9971325397491455
marker O 0 0.013224936090409756
provides O 0 0.0015824015717953444
a O 0 0.00046535101137124
new O 0 0.00024321961973328143
approach O 0 0.0007795443525537848
to O 0 5.86070200370159e-05
the O 0 0.00017025037959683686
screening O 0 0.0033507561311125755
of O 0 0.00032491720048710704
HH B-Disease 1 0.9999785423278809
as O 0 0.0002792697923723608
well O 0 0.0001381289039272815
as O 0 9.031568333739415e-05
studies O 0 0.00011569693015189841
of O 0 1.1725095646397676e-05
the O 0 0.0002028726157732308
relationship O 0 0.002527511678636074
between O 0 0.00037777837133035064
the O 0 0.0023565960582345724
HFE O 1 0.999771773815155
Tyr O 1 0.9990406632423401
allele O 0 0.009428760036826134
and O 0 0.0003850414650514722
different O 0 0.0005316789029166102
disorders O 1 0.999991774559021
including O 0 0.025756118819117546
cancer B-Disease 1 0.9999982118606567

Autosomal B-Disease 1 0.9971803426742554
dominant I-Disease 1 0.9898660778999329
neurohypophyseal I-Disease 1 0.9999251365661621
diabetes I-Disease 1 0.9999997615814209
insipidus I-Disease 1 0.9999659061431885
associated O 0 0.0008903327398002148
with O 0 0.00011404079123167321
a O 0 0.0008294053841382265
missense O 0 0.011656948365271091
mutation O 0 0.002137989504262805
encoding O 0 0.001911929459311068
Gly23 O 1 0.9552541375160217
- O 0 0.011789264157414436
- O 0 0.010056563653051853
> O 0 0.016856439411640167
Val O 1 0.768294632434845
in O 0 0.000959036173298955
neurophysin O 1 0.9293703436851501
II O 1 0.9260467290878296
. O 0 0.0016245207516476512

Autosomal B-Disease 1 0.9939441084861755
dominant I-Disease 1 0.9695683121681213
neurohypophyseal I-Disease 1 0.9998747110366821
diabetes I-Disease 1 0.9999997615814209
insipidus I-Disease 1 0.9999775886535645
( O 0 0.008031231351196766
ADNDI B-Disease 1 0.9992294311523438
) O 0 0.0003738307277671993
is O 0 0.0004813435662072152
an O 0 0.008224778808653355
inherited B-Disease 1 0.9999980926513672
disease I-Disease 1 0.9999997615814209
caused O 1 0.9242979288101196
by O 0 0.0005779195344075561
progressive O 1 0.9992859959602356
degeneration O 1 0.9999874830245972
of O 0 8.748781692702323e-05
the O 0 0.0008545202435925603
magnocellular O 1 0.996429979801178
neurons O 0 0.004261658992618322
of O 0 4.4501455704448745e-05
the O 0 0.0005966858589090407
hypothalamus O 1 0.9660047888755798
leading O 0 0.0015482804737985134
to O 0 0.00025445318897254765
decreased O 0 0.003927898593246937
ability O 0 0.0008491218322888017
to O 0 4.9049605877371505e-05
produce O 0 0.00016232571215368807
the O 0 0.00044273617095313966
hormone O 1 0.9140509963035583
arginine O 0 0.32544374465942383
vasopressin O 1 0.9774666428565979
( O 0 0.00540875643491745
AVP O 1 0.9992561936378479
) O 0 0.0015904366737231612
. O 0 0.0011060928227379918

Affected O 0 0.014071140438318253
individuals O 0 0.0003771717892959714
are O 0 9.093843982554972e-05
not O 0 0.0005744165973737836
symptomatic O 1 0.9996713399887085
at O 0 0.000842953915707767
birth O 0 0.0019919637124985456
, O 0 0.00019077587057836354
but O 0 0.00028856543940491974
usually O 0 0.001381219131872058
develop O 1 0.9990097284317017
diabetes B-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9999516010284424
at O 0 0.0010983115062117577
1 O 0 0.0015631768619641662
- O 0 0.003902503987774253
6 O 0 0.0011261726031079888
yr O 0 0.0663607195019722
of O 0 8.588844502810389e-05
age O 0 0.0019224808784201741
. O 0 0.0012434532400220633

The O 0 0.0008157040574587882
genetic O 0 0.0020331658888608217
locus O 0 0.0038924890104681253
of O 0 7.573016046080738e-05
the O 0 0.0016331931110471487
disease O 1 0.9999827146530151
is O 0 0.0006529493257403374
the O 0 0.0010871532140299678
AVP O 1 0.9997852444648743
- O 0 0.06833755224943161
neurophysin O 1 0.9494580626487732
II O 1 0.9774977564811707
( O 0 0.0025183293037116528
NPII O 1 0.995919406414032
) O 0 0.0004889284027740359
gene O 0 0.0013774950057268143
, O 0 0.00015315791824832559
and O 0 0.00018153057317249477
mutations O 0 0.0026527366135269403
that O 0 0.00030625591170974076
cause O 1 0.9712188839912415
ADNDI B-Disease 1 0.9988930821418762
have O 0 0.00018682335212361068
been O 0 0.0002492011699359864
found O 0 0.0001225957676069811
in O 0 4.509023347054608e-05
both O 0 4.447035462362692e-05
the O 0 7.736394763924181e-05
signal O 0 0.0006715564522892237
peptide O 0 0.0007007188396528363
of O 0 2.156317168555688e-05
the O 0 0.0005661210743710399
prepro O 1 0.9760264754295349
- O 0 0.16692714393138885
AVP O 1 0.9985333681106567
- O 0 0.01940017193555832
NPII O 1 0.6588242650032043
precursor O 0 0.006568373646587133
and O 0 0.0002506327291484922
within O 0 0.0005315205198712647
NPII O 1 0.9902384281158447
itself O 0 0.007176542654633522
. O 0 0.0009374507935717702

An O 0 0.0030665742233395576
affected O 0 0.05863497778773308
girl O 0 0.4343443810939789
who O 0 0.0009516312857158482
presented O 0 0.0009272197494283319
at O 0 0.0005465186550281942
9 O 0 0.0007578108925372362
months O 0 0.0003695901541505009
of O 0 2.3610167772858404e-05
age O 0 0.0005502346903085709
and O 0 0.0002170018560718745
her O 0 0.006088967900723219
similarly O 0 0.10390493273735046
affected O 0 0.14430777728557587
younger O 0 0.03549671173095703
brother O 0 0.009044581092894077
and O 0 0.00029379804618656635
father O 0 0.0015662965597584844
were O 0 2.6579971745377406e-05
all O 0 2.222675902885385e-05
found O 0 0.00010875754378503188
to O 0 3.909984297933988e-05
have O 0 4.6006891352590173e-05
a O 0 0.0003800734702963382
novel O 0 0.0021624041255563498
missense O 0 0.016572292894124985
mutation O 0 0.004972327966243029
( O 0 0.0010725182946771383
G1758 O 1 0.8294556736946106
- O 0 0.03096357360482216
- O 0 0.024716012179851532
> O 0 0.023494228720664978
T O 1 0.5854012370109558
) O 0 8.099968545138836e-05
encoding O 0 0.00012952704855706543
the O 0 7.058754999889061e-05
amino O 0 0.00029775992152281106
acid O 0 0.003322961274534464
substitution O 0 0.0026930123567581177
Gly23 O 1 0.9652706384658813
- O 0 0.01658349297940731
- O 0 0.012744396924972534
> O 0 0.0165396835654974
Val O 1 0.5142202973365784
within O 0 0.0011426154524087906
NPII O 1 0.9370518326759338
. O 0 0.0019673597998917103

The O 0 0.0013403535122051835
mutation O 0 0.005599342752248049
was O 0 0.001233329065144062
confirmed O 0 0.0013948963023722172
by O 0 0.00010925970855168998
restriction O 0 0.0017692804103717208
endonuclease O 0 0.07891464978456497
analysis O 0 0.0012701457599177957
. O 0 0.000950352696236223

A O 0 0.02813609503209591
T1 O 1 0.9955862760543823
- O 0 0.0045808167196810246
weighted O 0 0.001271918648853898
magnetic O 0 0.0016996848862618208
resonance O 0 0.005827109795063734
imaging O 0 0.015298544429242611
of O 0 3.6542496673064306e-05
the O 0 0.0005152829107828438
fathers O 0 0.013591512106359005
pituitary O 1 0.9991685152053833
gland O 1 0.9967734217643738
demonstrates O 0 0.025751646608114243
an O 0 0.001629335223697126
attenuated O 1 0.9833166003227234
posterior O 1 0.9979174733161926
pituitary O 1 0.9996836185455322
bright O 1 0.9506605863571167
spot O 0 0.010528658516705036
. O 0 0.0012704427354037762

This O 0 0.0009596087038516998
mutation O 0 0.004925938323140144
may O 0 0.0005941253039054573
be O 0 6.802211282774806e-05
valuable O 0 0.0008196649723686278
for O 0 0.00013854785356670618
developing O 0 0.0022113178856670856
models O 0 0.0004757647402584553
of O 0 0.0001815049326978624
dominantly B-Disease 1 0.9993149042129517
inherited I-Disease 1 0.9999346733093262
neurodegeneration I-Disease 1 0.999996542930603
, O 0 0.0004219645052216947
as O 0 0.0001580463140271604
the O 0 0.00015096302377060056
early O 0 0.00036648352397605777
age O 0 0.00022514826559927315
of O 0 9.252483141608536e-05
onset O 1 0.9999439716339111
of O 0 0.0007154389750212431
symptoms O 1 0.9999977350234985
suggests O 0 0.005303423851728439
that O 0 9.761146793607622e-05
this O 0 0.00017866557755041867
mutation O 0 0.004387550987303257
may O 0 0.0006028968491591513
be O 0 9.92040877463296e-05
particularly O 0 0.000970507157035172
deleterious O 0 0.011220432817935944
to O 0 0.00014692584227304906
the O 0 0.0006265986012294888
magnocellular O 1 0.9968369007110596
neuron O 1 0.9902793765068054
. O 0 0.0005625088233500719
. O 0 0.000716934388037771

Frequent O 0 0.02477717027068138
inactivation O 0 0.06814874708652496
of O 0 0.000955912284553051
PTEN O 1 0.999895453453064
/ O 1 0.9066983461380005
MMAC1 O 1 0.9948150515556335
in O 0 0.001175390905700624
primary O 1 0.9987767338752747
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.002119875280186534

Sporadic B-Disease 1 0.9984758496284485
prostate I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 0.9999994039535522
is O 0 0.0006307329749688506
the O 0 0.00017850346921477467
most O 0 0.00045681287883780897
common O 0 0.03396005928516388
male B-Disease 1 0.9502471685409546
cancer I-Disease 1 0.9999969005584717
in O 0 0.00025263166753575206
the O 0 0.00031374141690321267
Western O 0 0.0012391330674290657
world O 0 0.0007892764406278729
, O 0 0.0001961295201908797
yet O 0 0.0002478987444192171
many O 0 2.1769483282696456e-05
of O 0 1.7024876797222532e-05
the O 0 0.0001923374948091805
major O 0 0.0020627526100724936
genetic O 0 0.0012232535518705845
events O 0 0.00024078127171378583
involved O 0 0.0005627566133625805
in O 0 0.00011106627789558843
the O 0 0.000197854547877796
progression O 0 0.0459127239882946
of O 0 3.013371315319091e-05
this O 0 0.000283298286376521
often O 0 0.09720464795827866
fatal O 1 0.9999991655349731
cancer B-Disease 1 0.999998927116394
remain O 0 0.0008528794278390706
to O 0 9.909564687404782e-05
be O 0 0.00025183786056004465
elucidated O 0 0.37062254548072815
. O 0 0.0006895037367939949

Numerous O 0 0.00888238474726677
cytogenetic O 1 0.9618410468101501
and O 0 0.0013995516346767545
allelotype O 1 0.7077879905700684
studies O 0 0.0009885120671242476
have O 0 0.00021703662059735507
reported O 0 0.0018395440420135856
frequent O 0 0.0030563445761799812
loss O 0 0.0020501911640167236
of O 0 9.517329453956336e-05
heterozygosity O 1 0.8675628900527954
on O 0 0.000801972346380353
chromosomal O 0 0.35356995463371277
arm O 1 0.9833837747573853
10q O 0 0.44355878233909607
in O 0 0.0016803584294393659
sporadic B-Disease 1 0.9993299245834351
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.002992424415424466

Deletion O 0 0.028901617974042892
mapping O 0 0.008055892772972584
studies O 0 0.001209406997077167
have O 0 0.0003008875937666744
unambiguously O 0 0.011074290610849857
identified O 0 0.0006778223905712366
a O 0 0.00035813095746561885
region O 0 0.000813313527032733
of O 0 7.040986383799464e-05
chromosome O 0 0.0036780056543648243
10q23 O 0 0.010797802358865738
to O 0 6.258737266762182e-05
be O 0 3.9290127460844815e-05
the O 0 7.919843483250588e-05
minimal O 0 0.001618977403268218
area O 0 0.0005018394440412521
of O 0 7.659412949578837e-05
loss O 0 0.030853858217597008
. O 0 0.0009778505191206932

A O 0 0.007199255749583244
new O 0 0.0037318337708711624
tumor B-Disease 1 0.9995761513710022
suppressor O 1 0.6393901109695435
gene O 0 0.005446615628898144
, O 0 0.0019637939985841513
PTEN O 1 0.9998358488082886
/ O 1 0.9583239555358887
MMAC1 O 1 0.9935303330421448
, O 0 0.0005632566753774881
was O 0 0.001738270977512002
isolated O 0 0.011433650739490986
recently O 0 0.00266837514936924
at O 0 0.00020032493921462446
this O 0 5.512721691047773e-05
region O 0 0.00044193502981215715
of O 0 6.12595904385671e-05
chromosome O 0 0.004094875417649746
10q23 O 0 0.024117326363921165
and O 0 0.0001143564804806374
found O 0 0.0001613019994692877
to O 0 5.208927905187011e-05
be O 0 8.336071186931804e-05
inactivated O 0 0.003975325264036655
by O 0 4.970178270014003e-05
mutation O 0 0.0011304839281365275
in O 0 0.0003177147009409964
three O 0 0.020951569080352783
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 0 0.020259562879800797
lines O 0 0.002439098199829459
. O 0 0.0008318713516928256

We O 0 0.0017757016466930509
screened O 0 0.012848127633333206
80 O 0 0.037689656019210815
prostate B-Disease 1 0.9999992847442627
tumors I-Disease 1 0.9999573230743408
by O 0 0.00042715700692497194
microsatellite O 0 0.03526759892702103
analysis O 0 0.0005855656345374882
and O 0 0.00022974491002969444
found O 0 0.0007777517312206328
chromosome O 0 0.0034447708167135715
10q23 O 0 0.008627398870885372
to O 0 8.396960765821859e-05
be O 0 9.65810613706708e-05
deleted O 0 0.0012325551360845566
in O 0 0.00016766854969318956
23 O 0 0.0015168634708970785
cases O 0 0.0023324713110923767
. O 0 0.0009721214300952852

We O 0 0.0011280087055638433
then O 0 0.000410094071412459
proceeded O 0 0.0007187547744251788
with O 0 2.550473072915338e-05
sequence O 0 2.8600163204828277e-05
analysis O 0 4.801620525540784e-05
of O 0 1.6409645468229428e-05
the O 0 0.0004681939317379147
entire O 0 0.08670993894338608
PTEN O 1 0.9997631907463074
/ O 1 0.8241267204284668
MMAC1 O 1 0.9724326133728027
coding O 0 0.011293397285044193
region O 0 0.002186489524319768
and O 0 0.00034388533094897866
tested O 0 0.005731026642024517
for O 0 0.00027442144346423447
homozygous O 0 0.004194038920104504
deletion O 0 0.0030560798477381468
with O 0 0.0001660614216234535
new O 0 0.0009858316043391824
intragenic O 0 0.3491062819957733
markers O 0 0.002244887873530388
in O 0 0.00011511368211358786
these O 0 5.5665255786152557e-05
23 O 0 0.0009596288437023759
cases O 0 0.0007379539893008769
with O 0 0.00024155224673449993
10q23 O 0 0.3199872076511383
loss O 0 0.0030202227644622326
of O 0 0.00019510406127665192
heterozygosity O 1 0.9875105619430542
. O 0 0.00132868648506701

The O 0 0.0003307960578240454
identification O 0 0.0002484287542756647
of O 0 2.3647888156119734e-05
the O 0 0.00019949121633544564
second O 0 0.0006228689453564584
mutational O 0 0.07517604529857635
event O 0 0.0008219585870392621
in O 0 0.00017016450874507427
10 O 0 0.00037401390727609396
( O 0 0.00035689218202605844
43 O 0 0.0010229498147964478
% O 0 0.00020106128067709506
) O 0 0.001807015505619347
tumors B-Disease 1 0.9999845027923584
establishes O 1 0.9970003962516785
PTEN O 1 0.9999076128005981
/ O 1 0.9730246663093567
MMAC1 O 1 0.9707886576652527
as O 0 0.00023546784359496087
a O 0 0.0003963890776503831
main O 0 0.0007037725299596786
inactivation O 0 0.008912293240427971
target O 0 0.0001746067573549226
of O 0 3.3886746678035706e-05
10q O 0 0.07256180047988892
loss O 0 0.006276736035943031
in O 0 0.0012279909569770098
sporadic B-Disease 1 0.9998575448989868
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0007417426095344126
. O 0 0.0008394158794544637

Risk O 0 0.3504422903060913
reversals O 0 0.018948903307318687
in O 0 0.0005408061551861465
predictive O 0 0.040156327188014984
testing O 0 0.062136683613061905
for O 0 0.04252718389034271
Huntington B-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999985694885254
. O 0 0.0022086796816438437

The O 0 0.0004054947348777205
first O 0 0.000419256481109187
predictive O 0 0.011759985238313675
testing O 0 0.012205302715301514
for O 0 0.014722511172294617
Huntington B-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999997615814209
( O 0 0.005032654851675034
HD B-Disease 1 0.9966975450515747
) O 0 0.0003047036298085004
was O 0 0.00035794865107163787
based O 0 6.037015555193648e-05
on O 0 4.78037545690313e-05
analysis O 0 8.430401794612408e-05
of O 0 4.931755756842904e-05
linked O 0 0.038264915347099304
polymorphic O 0 0.17039765417575836
DNA O 0 0.0022927774116396904
markers O 0 0.0018427182221785188
to O 0 7.911306602181867e-05
estimate O 0 0.00041176285594701767
the O 0 0.00010603996634017676
likelihood O 0 0.0012607108801603317
of O 0 6.310504977591336e-05
inheriting O 0 0.06860266625881195
the O 0 0.0003247688291594386
mutation O 0 0.0032264692708849907
for O 0 0.0008309824042953551
HD B-Disease 1 0.9722051620483398
. O 0 0.0013310955837368965

Limits O 0 0.0014027500292286277
to O 0 0.00012992671690881252
accuracy O 0 0.0005667890072800219
included O 0 0.00012413383228704333
recombination O 0 0.001209901412948966
between O 0 0.00010583136463537812
the O 0 0.00022737437393516302
DNA O 0 0.0013850195100530982
markers O 0 0.0015427690232172608
and O 0 6.447619671234861e-05
the O 0 0.0002715454902499914
mutation O 0 0.0033110654912889004
, O 0 0.00032716698478907347
pedigree O 0 0.05784153565764427
structure O 0 0.0018736966885626316
, O 0 0.00017122604185715318
and O 0 0.00010448168177390471
whether O 0 0.0005080596311017871
DNA O 0 0.0005274689174257219
samples O 0 0.00022663199342787266
were O 0 2.9074953999952413e-05
available O 0 0.00013970187865197659
from O 0 0.00011196078412467614
family O 0 0.0007188339368440211
members O 0 0.0003216867335140705
. O 0 0.0007777384016662836

With O 0 0.00025152735179290175
direct O 0 0.00041699764551594853
tests O 0 0.0008594805258326232
for O 0 0.00014346053649205714
the O 0 0.0008436152711510658
HD B-Disease 1 0.9943759441375732
mutation O 0 0.0025293612852692604
, O 0 0.00013006878725718707
we O 0 0.00011811770673375577
have O 0 6.682967068627477e-05
assessed O 0 0.0016625297721475363
the O 0 5.1492275815689936e-05
accuracy O 0 0.00031260211835615337
of O 0 3.2472617021994665e-05
results O 0 0.0004489910788834095
obtained O 0 0.00023999280529096723
by O 0 0.00012558898015413433
linkage O 0 0.016966180875897408
approaches O 0 0.004163589794188738
when O 0 0.0005940154660493135
requested O 0 0.0011003295658156276
to O 0 8.966968016466126e-05
do O 0 0.00014582071162294596
so O 0 7.724327588221058e-05
by O 0 2.905189285229426e-05
the O 0 0.00015028125199023634
test O 0 0.0012212032452225685
individuals O 0 0.0004661992425099015
. O 0 0.000864114030264318

For O 0 0.000564113084692508
six O 0 0.0002905511937569827
such O 0 6.658209167653695e-05
individuals O 0 0.0001683693117229268
, O 0 0.00012072720710420981
there O 0 0.00010235897934762761
was O 0 0.0005970437196083367
significant O 0 0.0008166622719727457
disparity O 0 0.010567889548838139
between O 0 0.00023209390928968787
the O 0 0.00042251593549735844
tests O 0 0.0036247046664357185
. O 0 0.000855139980558306

Three O 0 0.0004459294432308525
went O 0 0.0007809986709617078
from O 0 0.00012902740854769945
a O 0 0.0011735634179785848
decreased O 0 0.13961189985275269
risk O 0 0.017652524635195732
to O 0 9.131418482866138e-05
an O 0 0.000270564021775499
increased O 0 0.0017828139243647456
risk O 0 0.3228244185447693
, O 0 0.00013981554366182536
while O 0 0.00010601742542348802
in O 0 7.532473682658747e-05
another O 0 0.00019859203894156963
three O 0 6.202654185472056e-05
the O 0 0.0002709331747610122
risk O 1 0.6420424580574036
was O 0 0.002286934992298484
decreased O 0 0.021282128989696503
. O 0 0.0009191433782689273

Knowledge O 0 0.001926271477714181
of O 0 6.150180706754327e-05
the O 0 0.0003136930172331631
potential O 0 0.0020363321527838707
reasons O 0 0.0006752952467650175
for O 0 0.0001248284534085542
these O 0 5.2379993576323614e-05
changes O 0 0.0003419147979002446
in O 0 0.00013218307867646217
results O 0 0.0003232102608308196
and O 0 6.151811976451427e-05
impact O 0 0.0005707871168851852
of O 0 2.5312316211056896e-05
these O 0 0.0001701708388281986
risk O 1 0.9337691068649292
reversals O 0 0.12081260979175568
on O 0 0.0004566078423522413
both O 0 0.0010136208729818463
patients O 1 0.9999047517776489
and O 0 0.00016645948926452547
the O 0 0.0005161908338777721
counseling O 1 0.9943217039108276
team O 0 0.0011147010372951627
can O 0 0.00014180105063132942
assist O 0 0.0010106858098879457
in O 0 6.259274232434109e-05
the O 0 8.797470945864916e-05
development O 0 0.000367383734555915
of O 0 2.6349673134973273e-05
strategies O 0 0.0036728440318256617
for O 0 0.00019124573736917228
the O 0 0.0005488552269525826
prevention O 1 0.9989144802093506
and O 0 0.0002325113891856745
, O 0 0.00018392165657132864
where O 0 0.0001673104998189956
necessary O 0 0.0005663856281898916
, O 0 0.0002193840773543343
management O 0 0.005086346063762903
of O 0 3.4095461160177365e-05
a O 0 0.0016142159001901746
risk O 1 0.6809558868408203
reversal O 0 0.00801158044487238
in O 0 0.00011949074541917071
any O 0 0.00029392409487627447
predictive O 0 0.02654270827770233
testing O 0 0.00914493203163147
program O 0 0.0029382689390331507
. O 0 0.00025810187798924744
. O 0 0.0006219642818905413

A O 0 0.007901443168520927
novel O 0 0.005227226763963699
common O 0 0.0036874234210699797
missense O 0 0.03386516869068146
mutation O 0 0.005453129298985004
G301C O 0 0.008756655268371105
in O 0 0.00013642343401443213
the O 0 0.0003679320216178894
N O 0 0.014098752290010452
- O 0 0.006635279394686222
acetylgalactosamine O 0 0.04980766028165817
- O 0 0.0038004645612090826
6 O 0 0.0013640435645356774
- O 0 0.007236047647893429
sulfate O 1 0.9708266258239746
sulfatase O 1 0.9902262687683105
gene O 0 0.005595411639660597
in O 0 0.0012611816637217999
mucopolysaccharidosis B-Disease 1 0.9932571649551392
IVA I-Disease 1 0.9979990124702454
. O 0 0.0012993407435715199

Mucopolysaccharidosis B-Disease 1 0.9867183566093445
IVA I-Disease 1 0.9984196424484253
( O 0 0.005484328139573336
MPS B-Disease 1 0.9748985171318054
IVA I-Disease 1 0.9996196031570435
) O 0 0.0005453535704873502
is O 0 0.00036229740362614393
an O 0 0.001292805653065443
autosomal B-Disease 1 0.9997488856315613
recessive I-Disease 1 0.9998815059661865
lysosomal I-Disease 1 0.9999502897262573
storage I-Disease 1 0.9994593262672424
disorder I-Disease 1 0.9999966621398926
caused O 0 0.42341741919517517
by O 0 0.00020450554438866675
a O 0 0.0026327904779464006
genetic B-Disease 1 0.9583045244216919
defect I-Disease 1 0.9997193217277527
in O 0 0.0006028979551047087
N O 0 0.018520301207900047
- O 0 0.00632918905466795
acetylgalactosamine O 0 0.05972398817539215
- O 0 0.003731541335582733
6 O 0 0.0014741352060809731
- O 0 0.012173667550086975
sulfate O 1 0.9872411489486694
sulfatase O 1 0.9978043437004089
( O 0 0.004511633887887001
GALNS O 1 0.9740608334541321
) O 0 0.0010125417029485106
. O 0 0.0010741092264652252

In O 0 0.0008824772667139769
previous O 0 0.0008928945753723383
studies O 0 0.0009447941556572914
, O 0 0.00018627815006766468
we O 0 0.00010747062333393842
have O 0 5.868504013051279e-05
found O 0 0.00010038024629466236
two O 0 4.3173087760806084e-05
common O 0 0.001625521807000041
mutations O 0 0.004087155684828758
in O 0 0.0005350925493985415
Caucasians O 1 0.5478944778442383
and O 0 0.0003056180430576205
Japanese O 0 0.0014452249743044376
, O 0 0.0003968923119828105
respectively O 0 0.001211698167026043
. O 0 0.0006364434957504272

To O 0 0.0010400499450042844
characterize O 0 0.02290511690080166
the O 0 0.0010431244736537337
mutational O 1 0.914339005947113
spectrum O 0 0.0038035204634070396
in O 0 0.00012564433563966304
various O 0 4.416867159307003e-05
ethnic O 0 9.9448167020455e-05
groups O 0 8.117226389003918e-05
, O 0 0.00022634262859355658
mutations O 0 0.0009871135698631406
in O 0 9.170573321171105e-05
the O 0 0.0004373619449324906
GALNS O 1 0.9944848418235779
gene O 0 0.0017419485375285149
in O 0 0.0004914068267680705
Colombian O 0 0.037987977266311646
MPS B-Disease 1 0.995096743106842
IVA I-Disease 1 0.9999803304672241
patients O 1 0.9999451637268066
were O 0 0.00030623635393567383
investigated O 0 0.08007987588644028
, O 0 0.00031401225714944303
and O 0 0.0002990872017107904
genetic O 0 0.0024490186478942633
backgrounds O 0 0.001088622841052711
were O 0 8.436827192781493e-05
extensively O 0 0.004053622018545866
analyzed O 0 0.0012612590799108148
to O 0 0.00011650311353150755
identify O 0 0.0008471959154121578
racial O 0 0.0010438770987093449
origin O 0 9.993527783080935e-05
, O 0 0.00010713256051531062
based O 0 0.00013799566659145057
on O 0 0.00022230039758142084
mitochondrial O 0 0.002422260120511055
DNA O 0 0.0019513487350195646
( O 0 0.0006337922532111406
mtDNA O 0 0.002382083097472787
) O 0 0.00048538611736148596
lineages O 0 0.0028097094036638737
. O 0 0.0008943509892560542

Three O 0 0.0011536836391314864
novel O 0 0.008548149839043617
missense O 0 0.05626595765352249
mutations O 0 0.010487879626452923
never O 0 0.0035984858404845
identified O 0 0.0013679084368050098
previously O 0 0.0006942180916666985
in O 0 0.00011691844701999798
other O 0 7.388265657937154e-05
populations O 0 0.0004020804481115192
and O 0 0.00014408500283025205
found O 0 0.00023792957654222846
in O 0 0.0001001498312689364
16 O 0 0.00019389268709346652
out O 0 4.629953036783263e-05
of O 0 3.0342082027345896e-05
19 O 0 0.0019330554641783237
Colombian O 0 0.019014213234186172
MPS B-Disease 1 0.9818800687789917
IVA I-Disease 1 0.9994151592254639
unrelated O 0 0.012685376219451427
alleles O 0 0.0036588762886822224
account O 0 0.0003957517328672111
for O 0 0.000681585690472275
84 O 0 0.010573136620223522
. O 0 0.0012104639317840338

2 O 0 0.0007056728354655206
% O 0 2.9590146368718706e-05
of O 0 1.7560892956680618e-05
the O 0 0.00032294561970047653
alleles O 0 0.0027505557518452406
in O 0 0.00015732280735392123
this O 0 0.00012151916598668322
study O 0 0.0015558648156002164
. O 0 0.0006315262871794403

The O 0 0.0021233325824141502
G301C O 0 0.04957551136612892
and O 0 0.0008616876439191401
S162F O 0 0.030847370624542236
mutations O 0 0.0015619031619280577
account O 0 0.0002275444130646065
for O 0 0.0003411723882891238
68 O 0 0.004445500206202269
. O 0 0.000848859257530421

4 O 0 0.0012702328385785222
% O 0 0.00010232483327854425
and O 0 0.0001972487661987543
10 O 0 0.0006919426377862692
. O 0 0.0005881867837160826

5 O 0 0.000996123650111258
% O 0 6.810363993281499e-05
of O 0 8.183975296560675e-05
mutations O 0 0.003744714194908738
, O 0 0.00030775892082601786
respectively O 0 0.0005619503790512681
, O 0 0.00019927886023651809
whereas O 0 0.0005634382250718772
the O 0 0.00020660461450461298
remaining O 0 0.0006728871958330274
F69V O 1 0.9911947250366211
is O 0 0.00022052602434996516
limited O 0 0.00035425779060460627
to O 0 4.137972427997738e-05
a O 0 0.00025809669750742614
single O 0 0.0006334410281851888
allele O 0 0.007265370339155197
. O 0 0.0009530839161016047

The O 0 0.0015448182821273804
skewed O 0 0.014010541141033173
prevalence O 0 0.10694554448127747
of O 0 0.00011231836106162518
G301C O 0 0.019141975790262222
in O 0 0.000202363939024508
only O 0 0.00036271903081797063
Colombian O 0 0.16121500730514526
patients O 1 0.9998049139976501
and O 0 0.00029115681536495686
haplotype O 0 0.0211867094039917
analysis O 0 0.00022174192417878658
by O 0 7.245194865390658e-05
restriction O 0 0.0006343983695842326
fragment O 0 0.0020089945755898952
length O 0 0.0007836354780010879
polymorphisms O 0 0.002485862700268626
in O 0 0.0001843734207795933
the O 0 0.0007834698189981282
GALNS O 1 0.9966860413551331
gene O 0 0.0030087996274232864
suggest O 0 0.0008674836717545986
that O 0 0.0001957146159838885
G301C O 0 0.014565005898475647
originated O 0 0.000824645918328315
from O 0 9.259067155653611e-05
a O 0 0.0005895955255255103
common O 0 0.0018291814485564828
ancestor O 0 0.0037503361236304045
. O 0 0.0011529382318258286

Investigation O 0 0.0054938835091888905
of O 0 5.448437877930701e-05
the O 0 0.0003891764208674431
genetic O 0 0.002142647746950388
background O 0 0.0006822599098086357
by O 0 7.279752753674984e-05
means O 0 0.0002512411738280207
of O 0 5.2752635383512825e-05
mtDNA O 0 0.00201232242397964
lineages O 0 0.0013454579748213291
indicate O 0 0.0006478701834566891
that O 0 6.232875603018329e-05
all O 0 6.656077312072739e-05
our O 0 0.0023791647981852293
patients O 1 0.9997475743293762
are O 0 4.049111157655716e-05
probably O 0 0.0003582190256565809
of O 0 2.1167759769014083e-05
native O 0 0.00046271452447399497
American O 0 0.0013389653759077191
descent O 0 0.009742285124957561

Low O 0 0.0037412717938423157
frequency O 0 0.0004665110900532454
of O 0 0.0003642311494331807
BRCA1 O 1 0.9982129335403442
germline O 1 0.8930220603942871
mutations O 0 0.0013726052129641175
in O 0 0.00015784874267410487
45 O 0 0.001162550994195044
German O 1 0.995923638343811
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999898672103882
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.0026208125054836273
. O 0 0.0011868005385622382

In O 0 0.00038128040614537895
this O 0 7.95488158473745e-05
study O 0 0.0004324158071540296
we O 0 0.00014527958410326391
investigated O 0 0.0034060117322951555
45 O 0 0.0008274812716990709
German O 1 0.9726577401161194
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999877214431763
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.0009311257163062692
for O 0 0.0009957270231097937
germline O 1 0.9928727149963379
mutations O 0 0.0022191847674548626
in O 0 0.00022707930475007743
the O 0 0.0011602118611335754
BRCA1 O 1 0.9991459846496582
gene O 0 0.006691734306514263
. O 0 0.0009515850688330829

We O 0 0.000833022641018033
identified O 0 0.0009458136046305299
four O 0 0.00028420943999662995
germline O 0 0.23917363584041595
mutations O 0 0.0019301269203424454
in O 0 0.000308464776026085
three O 0 0.002329109236598015
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999986886978149
families O 0 0.0002611305972095579
and O 0 6.507246143883094e-05
in O 0 0.00019511317077558488
one O 0 0.005591279361397028
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999855756759644
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0024978253059089184
. O 0 9.122680057771504e-05
among O 0 5.6157376093324274e-05
these O 0 1.7920996469911188e-05
were O 0 3.836497126030736e-05
one O 0 0.00037967166281305254
frameshift O 1 0.9600282907485962
mutation O 0 0.0026884188409894705
, O 0 0.0002128946507582441
one O 0 0.000344711821526289
nonsense O 0 0.01076824963092804
mutation O 0 0.0022185237612575293
, O 0 0.00016553449677303433
one O 0 0.00020184805907774717
novel O 0 0.00220512761734426
splice O 0 0.021981069818139076
site O 0 0.002698137192055583
mutation O 0 0.002378006000071764
, O 0 0.000144740886753425
and O 0 0.00012414221419021487
one O 0 0.0004199936520308256
missense O 0 0.02049965038895607
mutation O 0 0.006188068073242903
. O 0 0.0009247097186744213

The O 0 0.002174672205001116
missense O 0 0.02852034755051136
mutation O 0 0.00544291827827692
was O 0 0.000955423281993717
also O 0 0.00026215531397610903
found O 0 0.00023495542700402439
in O 0 0.00019885542860720307
2 O 0 0.0008564430754631758
. O 0 0.000535844883415848

8 O 0 0.0010364297777414322
% O 0 3.2880325306905434e-05
of O 0 1.9631172108347528e-05
the O 0 0.00020307231170590967
general O 0 0.0006293970509432256
population O 0 0.0001007432074402459
, O 0 0.00015794087084941566
suggesting O 0 0.0012205301318317652
that O 0 5.496800076798536e-05
it O 0 0.00011702172923833132
is O 0 0.0004115953342989087
not O 0 0.0011655471753329039
disease O 1 0.9999798536300659
associated O 0 0.0013874188298359513
. O 0 0.0009911723900586367

The O 0 0.0006217485060915351
average O 0 0.0013108548009768128
age O 0 0.0010881677735596895
of O 0 0.0006262535462155938
disease O 1 0.9999995231628418
onset O 1 0.999897837638855
in O 0 0.0003822437720373273
those O 0 0.0002540633431635797
families O 0 0.0014185429317876697
harbouring O 1 0.9982055425643921
causative O 1 0.9853454232215881
mutations O 0 0.004693725146353245
was O 0 0.0006878111162222922
between O 0 0.00031998238409869373
32 O 0 0.0014957657549530268
. O 0 0.0006646278197877109

3 O 0 0.0020591316279023886
and O 0 0.0004485645331442356
37 O 0 0.0027759941294789314
. O 0 0.0009275917545892298

4 O 0 0.002535487525165081
years O 0 0.0009376709931530058
, O 0 0.00025951035786420107
whereas O 0 0.0007497642654925585
the O 0 0.00034910839167423546
family O 0 0.002043678890913725
harbouring O 1 0.9421274662017822
the O 0 0.0008134979289025068
missense O 0 0.037498291581869125
mutation O 0 0.003897028276696801
had O 0 0.00043579755583778024
an O 0 0.00020569433399941772
average O 0 0.0008390625007450581
age O 0 0.00035899438080377877
of O 0 0.00010116388148162514
onset O 1 0.9974501729011536
of O 0 0.00017170753562822938
51 O 0 0.008839305490255356
. O 0 0.001355550019070506

2 O 0 0.003347555408254266
years O 0 0.0017215792322531343
. O 0 0.0010792372049763799

These O 0 0.000311828451231122
findings O 0 0.002756350440904498
show O 0 0.0009393086656928062
that O 0 0.0005939198308624327
BRCA1 O 1 0.9989835619926453
is O 0 0.0007987614953890443
implicated O 0 0.014671234413981438
in O 0 6.070585368433967e-05
a O 0 0.0001402536581736058
small O 0 0.00013456055603455752
fraction O 0 0.0009413707302883267
of O 0 0.0008453155169263482
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.001088735880330205
suggesting O 0 0.0022309315390884876
the O 0 0.0001712265220703557
involvement O 0 0.0021442549768835306
of O 0 3.735219070222229e-05
another O 0 0.0015053084352985024
susceptibility O 1 0.9658262729644775
gene O 0 0.007156105246394873
( O 0 0.0020248061046004295
s O 0 0.15466278791427612
) O 0 0.0017952834023162723

Paternal O 0 0.1371980607509613
transmission O 0 0.21424174308776855
of O 0 0.0061159804463386536
congenital B-Disease 1 1.0
myotonic I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
. O 0 0.010542290285229683

We O 0 0.0009905215119943023
report O 0 0.0006864452152512968
a O 0 0.0004814181593246758
rare O 0 0.0036581431049853563
case O 0 0.0009263158426620066
of O 0 0.00017452087195124477
paternally O 1 0.9991315007209778
transmitted O 1 0.9995355606079102
congenital B-Disease 1 1.0
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9714387655258179
DM B-Disease 1 0.9999971389770508
) O 0 0.0021441997960209846
. O 0 0.0013561163796111941

The O 0 0.0016121286898851395
proband O 0 0.027051018550992012
is O 0 0.0003172924043610692
a O 0 0.000492386519908905
23 O 0 0.0008852808969095349
year O 0 0.0005595464608632028
old O 0 0.0034920803736895323
, O 0 0.0018423952860757709
mentally B-Disease 1 0.9999949932098389
retarded I-Disease 1 0.9999185800552368
male O 0 0.011714056134223938
who O 1 0.8039909601211548
suffers O 1 0.9999992847442627
severe O 1 0.9999959468841553
muscular B-Disease 1 0.9999977350234985
weakness I-Disease 1 0.9999197721481323
. O 0 0.003641219576820731

He O 0 0.004367005079984665
presented O 0 0.0027577427681535482
with O 0 0.002792514394968748
respiratory O 1 0.9999994039535522
and O 0 0.0010024155490100384
feeding O 0 0.21547652781009674
difficulties O 0 0.4591042399406433
at O 0 0.0021122070029377937
birth O 0 0.008625661954283714
. O 0 0.0010133725591003895

His O 0 0.00315665639936924
two O 0 0.0012486622435972095
sibs O 1 0.9989076852798462
suffer O 1 0.9992895126342773
from O 0 0.0018010466592386365
childhood O 1 0.9998408555984497
onset O 1 0.9999710321426392
DM B-Disease 1 0.9999954700469971
. O 0 0.003812552196905017

Their O 0 0.0006859690765850246
late O 0 0.0028028374072164297
father O 0 0.0019147268030792475
had O 0 0.0002460544928908348
the O 0 0.0001441122149117291
adult O 0 0.001964878523722291
type O 0 0.004518559668213129
of O 0 0.0005011367611587048
DM B-Disease 1 0.9999983310699463
, O 0 0.0005187028436921537
with O 0 0.0005125416209921241
onset O 1 0.9954784512519836
around O 0 0.0006237808847799897
30 O 0 0.0009810560150071979
years O 0 0.0008732736459933221
. O 0 0.0007521634688600898

Only O 0 0.0002643822517711669
six O 0 0.00016451015835627913
other O 0 4.556772546493448e-05
cases O 0 0.0003894113178830594
of O 0 4.5736982428934425e-05
paternal O 0 0.0985184982419014
transmission O 1 0.8517270088195801
of O 0 0.0038066019769757986
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999995231628418
have O 0 0.0008553352672606707
been O 0 0.0012276937486603856
reported O 0 0.004754933528602123
recently O 0 0.005124963819980621
. O 0 0.000871497206389904

We O 0 0.0006488983635790646
review O 0 0.0008860023808665574
the O 0 0.00021188110986258835
sex O 0 0.001259504584595561
related O 0 0.001157877966761589
effects O 0 0.0036876113153994083
on O 0 0.00035989750176668167
transmission O 0 0.07345931977033615
of O 0 0.0017928904853761196
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999980926513672
. O 0 0.00491012167185545

Decreased O 0 0.10601307451725006
fertility O 0 0.04706786572933197
of O 0 0.00010601327812764794
males O 0 0.0013634564820677042
with O 0 0.0005329943960532546
adult O 1 0.867077112197876
onset O 1 0.9999876022338867
DM B-Disease 1 0.9999967813491821
and O 0 0.0006756091024726629
contraction O 0 0.010778398253023624
of O 0 3.967549855588004e-05
the O 0 0.0003881623561028391
repeat O 0 0.01243950892239809
upon O 0 0.0010349901858717203
male O 0 0.0021990358363837004
transmission O 0 0.008713625371456146
contribute O 0 0.0018834458896890283
to O 0 7.283655577339232e-05
the O 0 0.00011951899068662897
almost O 0 0.0004471063148230314
absent O 0 0.0032657149713486433
occurrence O 0 0.001895367749966681
of O 0 6.182303332025185e-05
paternal O 0 0.03566669300198555
transmission O 0 0.38392069935798645
of O 0 0.0029183172155171633
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999992847442627
. O 0 0.003483081702142954

Also O 0 0.0006267347489483654
the O 0 0.00017853853933047503
fathers O 0 0.0004998127114959061
of O 0 2.859018240997102e-05
the O 0 0.0007275218958966434
reported O 0 0.18004241585731506
congenitally O 1 0.9994691014289856
affected O 0 0.02619376964867115
children O 0 0.001298280549235642
showed O 0 0.001171060954220593
, O 0 0.00012374961806926876
on O 0 0.00013699964620172977
average O 0 0.0008247249061241746
, O 0 0.0005592667148448527
shorter O 0 0.02236797846853733
CTG O 1 0.990459680557251
repeat O 0 0.009212146513164043
lengths O 0 0.0024237146135419607
and O 0 0.00015860989515203983
hence O 0 0.0014807336265221238
less O 0 0.006982513703405857
severe O 1 0.9999955892562866
clinical O 1 0.9999932050704956
symptoms O 1 0.9999840259552002
than O 0 0.0001922568480949849
the O 0 0.0002991839137393981
mothers O 0 0.00559797789901495
of O 0 9.858234989224002e-05
children O 0 0.02582010254263878
with O 0 0.13422873616218567
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999991655349731
. O 0 0.004158563446253538

We O 0 0.0009360580006614327
conclude O 0 0.003635753644630313
that O 0 0.0001498248166171834
paternal O 0 0.008528494276106358
transmission O 0 0.04495413601398468
of O 0 0.002279560314491391
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999996423721313
is O 0 0.00255233864299953
rare O 0 0.009060108102858067
and O 0 0.00031692179618403316
preferentially O 0 0.0066955010406672955
occurs O 0 0.0010438348399475217
with O 0 0.0003540194593369961
onset O 1 0.9987590312957764
of O 0 0.0008610154618509114
DM B-Disease 1 0.9999843835830688
past O 0 0.0016412170371040702
30 O 0 0.0007103650132194161
years O 0 0.00034154290915466845
in O 0 0.00012667263217736036
the O 0 0.0003366907767485827
father O 0 0.004047119989991188
. O 0 0.00032774830469861627
. O 0 0.0007224410073831677

The O 0 0.007680568378418684
RB1 O 1 0.9960928559303284
gene O 0 0.005084367468953133
mutation O 0 0.0019073308212682605
in O 0 0.000121713885164354
a O 0 0.0011288697132840753
child O 0 0.012749449349939823
with O 0 0.0020524461288005114
ectopic B-Disease 1 0.9998815059661865
intracranial I-Disease 1 0.9999908208847046
retinoblastoma I-Disease 1 0.999929666519165
. O 0 0.0033547666389495134

The O 0 0.007324931677430868
RB1 O 1 0.9970409274101257
gene O 0 0.009929751046001911
mutation O 0 0.004587927833199501
was O 0 0.0012896886328235269
investigated O 0 0.0037606856785714626
in O 0 0.000135337162646465
a O 0 0.0010416224831715226
child O 0 0.00943362433463335
with O 0 0.0013651145854964852
ectopic B-Disease 1 0.999944806098938
intracranial I-Disease 1 0.9999915361404419
retinoblastoma I-Disease 1 0.9997562766075134
using O 0 0.0006187267135828733
DNA O 0 0.001471194438636303
obtained O 0 0.00021013699006289244
from O 0 5.676991349901073e-05
both O 0 9.505049092695117e-05
the O 0 0.0005820054211653769
pineal B-Disease 1 0.9992188215255737
and I-Disease 0 0.002226283075287938
retinal I-Disease 1 0.9999865293502808
tumours I-Disease 1 0.9999721050262451
of O 0 9.095856512431055e-05
the O 0 0.0014781313948333263
patient O 1 0.9997687935829163
. O 0 0.0011260021710768342

A O 0 0.009447055868804455
nonsense O 0 0.017448656260967255
mutation O 0 0.003246704116463661
in O 0 0.00044419971527531743
exon O 0 0.018093300983309746
17 O 0 0.0019540751818567514
( O 0 0.0005745473899878561
codon O 0 0.005363933742046356
556 O 0 0.013851568102836609
) O 0 9.718729415908456e-05
of O 0 3.45976441167295e-05
the O 0 0.0016120793297886848
RB1 O 1 0.9998204112052917
gene O 0 0.00354021810926497
was O 0 0.0007297299453057349
found O 0 0.00020128954201936722
to O 0 6.137630407465622e-05
be O 0 7.704789459239691e-05
present O 0 0.0002161933371098712
homozygously O 0 0.031231427565217018
in O 0 0.00010155299969483167
both O 0 0.00015048243221826851
the O 0 0.0007053201552480459
retinal B-Disease 1 0.9995526671409607
and I-Disease 0 0.0003331615007482469
the I-Disease 0 0.0021702998783439398
pineal I-Disease 1 0.9998189806938171
tumours I-Disease 1 0.9999356269836426
. O 0 0.002304217079654336

The O 0 0.00043743199785239995
same O 0 0.00045034350478090346
mutation O 0 0.003382223891094327
was O 0 0.0009972868720069528
present O 0 0.0005851744790561497
heterozygously O 0 0.14691829681396484
in O 0 0.00012513116234913468
the O 0 0.00018284244288224727
DNA O 0 0.0007596944342367351
from O 0 4.5261178456712514e-05
the O 0 0.00010484326776349917
constitutional O 0 0.0005573762464337051
cells O 0 0.0006126374937593937
of O 0 3.2326097425539047e-05
the O 0 0.0010161908576264977
patient O 1 0.999933123588562
, O 0 0.0002948159526567906
proving O 0 0.18808242678642273
it O 0 7.131699385354295e-05
to O 0 3.976826701546088e-05
be O 0 3.6991397792007774e-05
of O 0 5.535990931093693e-05
germline O 0 0.39832425117492676
origin O 0 0.00033004474244080484
. O 0 0.0006922450265847147

The O 0 0.0007936697802506387
initial O 0 0.0029578236863017082
mutation O 0 0.004264310467988253
was O 0 0.0009934348054230213
shown O 0 0.0004703069862443954
to O 0 8.613910904387012e-05
have O 0 8.246546349255368e-05
occurred O 0 0.00043006936903111637
in O 0 9.178910841001198e-05
the O 0 0.0005009567830711603
paternally O 0 0.193118616938591
derived O 0 0.005395618733018637
RB1 O 1 0.9978160858154297
allele O 0 0.02552945166826248
. O 0 0.0013091977452859282

The O 0 0.0012448882916942239
mutation O 0 0.0038780830800533295
is O 0 0.00025680483668111265
in O 0 8.715847798157483e-05
an O 0 0.00013263837900012732
area O 0 0.0002742846554610878
of O 0 1.4027902579982765e-05
the O 0 0.00015006288595031947
gene O 0 0.0006213847664184868
that O 0 3.859085700241849e-05
encodes O 0 0.00037813541712239385
the O 0 0.00012742934632115066
protein O 0 0.0010218886891379952
- O 0 0.002413604175671935
binding O 0 0.0006892347009852529
region O 0 0.0013531013391911983
known O 0 0.00044673398951999843
as O 0 0.0002339412458240986
the O 0 0.0005194044206291437
pocket O 0 0.1687847375869751
region O 0 0.0017797945765778422
and O 0 0.00019039427570533007
has O 0 0.0006240460788831115
been O 0 0.0004375985881779343
detected O 0 0.0022569033317267895
in O 0 7.852425187593326e-05
other O 0 6.895467959111556e-05
cases O 0 0.001026111887767911
of O 0 0.00020724008209072053
retinoblastoma B-Disease 1 0.9998868703842163
. O 0 0.0006259790970943868
. O 0 0.000788457109592855

Low O 0 0.005693190731108189
levels O 0 0.0014077296946197748
of O 0 8.876252104528248e-05
beta O 0 0.01363008189946413
hexosaminidase O 0 0.2666122317314148
A O 0 0.0019455021247267723
in O 0 0.0003513186820782721
healthy O 0 0.027634786441922188
individuals O 0 0.000299860694212839
with O 0 0.0004878854670096189
apparent O 1 0.9978380799293518
deficiency O 1 0.9999916553497314
of O 0 4.116986019653268e-05
this O 0 0.00022891926346346736
enzyme O 0 0.004951647482812405
. O 0 0.0007750762742944062

Appreciable O 0 0.04555477201938629
beta O 0 0.015748754143714905
hexosaminidase O 0 0.04464330896735191
A O 0 0.0038674832321703434
( O 0 0.000759233080316335
hex O 0 0.00881743710488081
A O 0 0.0019031806150451303
) O 0 0.00019418890587985516
activity O 0 0.00032925218692980707
has O 0 0.0003456780395936221
been O 0 0.00031159576610662043
detected O 0 0.002884027548134327
in O 0 0.0004206602170597762
cultured O 1 0.9800936579704285
skin O 1 0.9999872446060181
fibroblasts O 1 0.9991737008094788
and O 0 0.1347140669822693
melanoma B-Disease 1 0.9999998807907104
tissue O 1 0.9986746311187744
from O 0 0.0004183523706160486
healthy O 1 0.8070867657661438
individuals O 0 0.0004635702644009143
previously O 0 0.002042362466454506
reported O 0 0.002900471445173025
as O 0 0.0005464426358230412
having O 0 0.018663333728909492
deficiency B-Disease 1 0.9999748468399048
of I-Disease 0 7.209720206446946e-05
hex I-Disease 0 0.01569131575524807
A I-Disease 0 0.0018071280792355537
activity O 0 0.0005661529721692204
indistinguishable O 0 0.0021998651791363955
from O 0 5.7537406974006444e-05
that O 0 5.2654027967946604e-05
of O 0 0.00014268659288063645
patients O 1 0.9999715089797974
with O 0 0.015406198799610138
Tay B-Disease 1 0.9999991655349731
- I-Disease 1 0.9996870756149292
Sachs I-Disease 1 0.9999737739562988
disease I-Disease 1 0.9999959468841553
( O 0 0.006830996833741665
TSD B-Disease 1 0.999794065952301
) O 0 0.0011967552127316594
. O 0 0.0008034884813241661

Identification O 0 0.0028482568450272083
and O 0 0.0003677537606563419
quantitation O 0 0.019354594871401787
of O 0 0.00014752583228982985
hex O 0 0.013190842233598232
A O 0 0.002381289144977927
, O 0 0.0003531506226863712
amounting O 0 0.0035326131619513035
to O 0 0.00019312661606818438
3 O 0 0.0009764531860128045
. O 0 0.0005400116206146777

5 O 0 0.0019082132494077086
% O 0 0.0003096052969340235
- O 0 0.005517792422324419
6 O 0 0.0015331943286582828
. O 0 0.0006107782828621566

9 O 0 0.0013063709484413266
% O 0 3.1118590413825586e-05
of O 0 1.790760325093288e-05
total O 0 0.00024322820536326617
beta O 0 0.008967231959104538
hexosaminidase O 0 0.09955797344446182
activity O 0 0.0007252292707562447
, O 0 0.0002059005491901189
has O 0 0.00024522424791939557
been O 0 0.00011716777953552082
obtained O 0 0.00015152344712987542
by O 0 0.00011919167445739731
cellulose O 0 0.03645845502614975
acetate O 0 0.17197635769844055
gel O 1 0.9776752591133118
electrophoresis O 0 0.05908025801181793
, O 0 0.0011955529917031527
DEAE O 1 0.9856603145599365
- O 0 0.006022265646606684
cellulose O 0 0.01568794436752796
ion O 0 0.008106875233352184
- O 0 0.003712159115821123
exchange O 0 0.0017846750561147928
chromatography O 0 0.09862696379423141
, O 0 0.0014925700379535556
radial O 1 0.985539436340332
immunodiffusion O 1 0.8051831126213074
, O 0 0.0004883205401711166
and O 0 0.00044817564776167274
radioimmunoassay O 1 0.8905094861984253
. O 0 0.0009987758239731193

Previous O 0 0.003471978707239032
family O 0 0.0026828681584447622
studies O 0 0.001803621300496161
suggested O 0 0.0013865787768736482
that O 0 8.534405787941068e-05
these O 0 4.531789090833627e-05
individuals O 0 0.00035210326313972473
may O 0 0.0010438358876854181
be O 0 0.0002570910146459937
compound O 0 0.005778700578957796
heterozygotes O 0 0.02421964332461357
for O 0 0.00011639473086688668
the O 0 0.0002516386448405683
common O 0 0.004681715741753578
mutant O 0 0.4508594572544098
TSD B-Disease 1 0.9995274543762207
gene O 0 0.0028803369496017694
and O 0 0.00017431862943340093
a O 0 0.0015044277533888817
rare O 0 0.016244173049926758
( O 0 0.0013965320540592074
allelic O 0 0.18920041620731354
) O 0 0.0006856831023469567
mutant O 0 0.009701359085738659
gene O 0 0.004829098470509052
. O 0 0.001070851576514542

Thus O 0 0.0013615463394671679
, O 0 0.00017130703781731427
the O 0 0.0002236554864794016
postulated O 0 0.009377365931868553
rate O 0 0.0008584709721617401
mutant O 0 0.009083054028451443
gene O 0 0.0034727808088064194
appears O 0 0.0020827865228056908
to O 0 6.625793321290985e-05
code O 0 0.00019150853040628135
for O 0 7.311220542760566e-05
the O 0 6.452978414017707e-05
expression O 0 0.00019680015975609422
of O 0 2.0046036297571845e-05
low O 0 0.0008043832494877279
amounts O 0 0.00021429620392154902
of O 0 6.071019379305653e-05
hex O 0 0.01876814290881157
A O 0 0.0053776283748447895
. O 0 0.0011698233429342508

Heterozygotes O 0 0.14722715318202972
for O 0 0.00030292835435830057
the O 0 0.000553679303266108
rare O 0 0.03180060163140297
mutant O 0 0.0163430105894804
may O 0 0.0010751893278211355
be O 0 0.0001511625450802967
indistinguishable O 0 0.0041112941689789295
from O 0 0.00024232754367403686
heterozygotes O 0 0.0477379746735096
for O 0 0.00018566141079645604
the O 0 0.000496608845423907
common O 0 0.028061144053936005
TSD B-Disease 1 0.9994844198226929
mutant O 0 0.028566690161824226
. O 0 0.0016602419782429934

However O 0 0.0012964012566953897
, O 0 0.0001970750599866733
direct O 0 0.0004723088932223618
visualization O 0 0.012761103920638561
and O 0 0.00025133579038083553
quantitation O 0 0.02528826892375946
of O 0 8.731678099138662e-05
hex O 0 0.009219394996762276
A O 0 0.0007784561021253467
by O 0 3.5131768527207896e-05
the O 0 0.00010496811592020094
methods O 0 0.000911546463612467
described O 0 0.005045449826866388
may O 0 0.0013583686668425798
prevent O 0 0.005269903689622879
false O 0 0.0033266511745750904
- O 0 0.15549631416797638
positive O 0 0.016209129244089127
prenatal O 1 0.9998760223388672
diagnosis O 1 0.9999603033065796
of O 0 0.0005801895749755204
TSD B-Disease 1 0.9998846054077148
in O 0 0.0012896581320092082
fetuses O 0 0.24944108724594116
having O 0 0.000709237705450505
the O 0 0.0003235132317058742
incomplete O 0 0.012079655192792416
hex B-Disease 0 0.06655674427747726
A I-Disease 0 0.056061845272779465
deficiency I-Disease 1 0.999863862991333
of O 0 4.674170122598298e-05
the O 0 0.00046033927355892956
type O 0 0.009819084778428078
described O 0 0.001775164157152176
in O 0 9.551478433422744e-05
the O 0 0.0001807353983167559
four O 0 0.0004174762580078095
healthy O 0 0.13619118928909302
individuals O 0 0.001954156905412674

The O 0 0.004662407096475363
tumor B-Disease 1 0.9993181228637695
suppressor O 1 0.6404060125350952
gene O 0 0.016868002712726593
Smad4 O 1 0.9946779012680054
/ O 1 0.6442475318908691
Dpc4 O 0 0.2698799967765808
is O 0 0.00032281636958941817
required O 0 0.00045020313700661063
for O 0 0.0003805684973485768
gastrulation O 1 0.9850789308547974
and O 0 0.0002583877358119935
later O 0 0.0005489828763529658
for O 0 0.0005529714981094003
anterior O 1 0.9981518387794495
development O 0 0.0006291571771726012
of O 0 3.866254701279104e-05
the O 0 0.0005425132694654167
mouse O 0 0.019283512607216835
embryo O 0 0.008192116394639015
. O 0 0.0010930789867416024

Mutations O 0 0.0049716574139893055
in O 0 0.00029889255529269576
the O 0 0.0012619626941159368
SMAD4 O 1 0.9994357228279114
/ O 1 0.9928224682807922
DPC4 O 1 0.9991902709007263
tumor B-Disease 1 0.9998421669006348
suppressor O 0 0.3544759750366211
gene O 0 0.001976922620087862
, O 0 0.00011925942089874297
a O 0 0.0002837602514773607
key O 0 0.0009071291424334049
signal O 0 0.0017038964433595538
transducer O 0 0.015384051017463207
in O 0 0.00020258613221812993
most O 0 0.0007049912237562239
TGFbeta O 1 0.9913962483406067
- O 0 0.014685000292956829
related O 0 0.003404415911063552
pathways O 0 0.011584779247641563
, O 0 0.00012894673272967339
are O 0 2.6958347007166594e-05
involved O 0 0.00029481263482011855
in O 0 6.0034879425074905e-05
50 O 0 0.00016927059914451092
% O 0 6.306227442109957e-05
of O 0 0.00034821993904188275
pancreatic B-Disease 1 0.999998927116394
cancers I-Disease 1 0.9999622106552124
. O 0 0.0018527735956013203

Homozygous O 0 0.0464584119617939
Smad4 O 1 0.758514940738678
mutant O 0 0.04870171472430229
mice O 0 0.3458608388900757
die O 1 0.7752190232276917
before O 0 0.0006689687725156546
day O 0 0.0010760996956378222
7 O 0 0.0012346795992925763
. O 0 0.0007003779755905271

5 O 0 0.001450016861781478
of O 0 0.0002198757865699008
embryogenesis O 0 0.4481795132160187
. O 0 0.0016347394557669759

Mutant O 0 0.017187384888529778
embryos O 0 0.001622587675228715
have O 0 0.00018986743816640228
reduced O 0 0.0011843363754451275
size O 0 0.0005047759623266757
, O 0 0.00044622962013818324
fail O 0 0.016637282446026802
to O 0 0.00030310661531984806
gastrulate O 0 0.06118890270590782
or O 0 0.0003478553262539208
express O 0 0.0018765722634270787
a O 0 0.0013094024034217
mesodermal O 1 0.9273943901062012
marker O 0 0.01302506122738123
, O 0 0.00020309246610850096
and O 0 0.00023615271493326873
show O 0 0.0014287041267380118
abnormal O 0 0.4337675869464874
visceral O 1 0.9892455339431763
endoderm O 1 0.994530975818634
development O 0 0.006989665795117617
. O 0 0.0016334980027750134

Growth B-Disease 1 0.7432010173797607
retardation I-Disease 1 0.9997914433479309
of O 0 0.00010141811071662232
the O 0 0.0014111310010775924
Smad4 O 1 0.9983683228492737
- O 0 0.40347909927368164
deficient O 1 0.9959123730659485
embryos O 0 0.0011019038502126932
results O 0 0.00032231202931143343
from O 0 0.0001594504137756303
reduced O 0 0.003109745914116502
cell O 0 0.003215903416275978
proliferation O 0 0.003992114681750536
rather O 0 0.00017649908841121942
than O 0 8.894206257537007e-05
increased O 0 0.000896050943993032
apoptosis O 0 0.008399570360779762
. O 0 0.0007304858881980181

Aggregation O 0 0.004707900807261467
of O 0 0.0002633454860188067
mutant O 0 0.026348600164055824
Smad4 O 1 0.9659174680709839
ES O 0 0.28066107630729675
cells O 0 0.0011339200427755713
with O 0 0.00010552794265095145
wild O 0 0.0015477071283385158
- O 0 0.006627913564443588
type O 0 0.0058999499306082726
tetraploid O 0 0.07023444026708603
morulae O 1 0.6281512379646301
rescues O 0 0.08930615335702896
the O 0 0.002339930972084403
gastrulation B-Disease 1 0.9968996047973633
defect I-Disease 1 0.9960386753082275
. O 0 0.0020699738524854183

These O 0 0.0003582859644666314
results O 0 0.0007947951089590788
indicate O 0 0.0011507603339850903
that O 0 0.0003143729118164629
Smad4 O 1 0.8746947050094604
is O 0 0.0004930886789225042
initially O 0 0.0009187344694510102
required O 0 0.00020763427892234176
for O 0 6.140429468359798e-05
the O 0 7.854912109905854e-05
differentiation O 0 0.000499227549880743
of O 0 2.4621025659143925e-05
the O 0 0.0005686032236553729
visceral O 1 0.989885687828064
endoderm O 1 0.988451361656189
and O 0 0.00010944907990051433
that O 0 8.98466823855415e-05
the O 0 0.0005166946793906391
gastrulation B-Disease 1 0.9993835687637329
defect I-Disease 1 0.9965839385986328
in O 0 0.0002613978576846421
the O 0 0.0008175884140655398
epiblast O 1 0.9989346861839294
is O 0 0.0007804306806065142
secondary O 0 0.003515693824738264
and O 0 0.0001782177569111809
non O 0 0.002573304809629917
- O 0 0.004053587093949318
cell O 0 0.0018260122742503881
autonomous O 0 0.0017885970883071423
. O 0 0.0006558247259818017

Rescued O 0 0.07354294508695602
embryos O 0 0.0062211742624640465
show O 0 0.008077522739768028
severe O 1 0.9998700618743896
anterior O 1 0.9998345375061035
truncations O 1 0.9089826345443726
, O 0 0.0004909412236884236
indicating O 0 0.0014671176904812455
a O 0 0.00023052100732456893
second O 0 0.00012146182416472584
important O 0 0.00018096975691150874
role O 0 0.0010088557610288262
for O 0 0.0005493739154189825
Smad4 O 1 0.9722099900245667
in O 0 0.0008228511433117092
anterior O 1 0.9995906949043274
patterning O 1 0.9929621815681458
during O 0 0.0072420272044837475
embryogenesis O 1 0.8192671537399292
. O 0 0.0019105885876342654

Prevalence O 0 0.42609870433807373
of O 0 0.0003471081145107746
p16 O 1 0.6075131893157959
and O 0 0.0013958219205960631
CDK4 O 1 0.9945206642150879
germline O 1 0.9437046051025391
mutations O 0 0.0027349593583494425
in O 0 0.0005083524738438427
48 O 0 0.15281641483306885
melanoma B-Disease 1 0.9999996423721313
- O 1 0.8452896475791931
prone O 1 0.7507515549659729
families O 0 0.0004968114662915468
in O 0 0.000441267853602767
France O 0 0.005236111581325531
. O 0 0.001271845307201147

The O 0 0.0025403304025530815
French O 0 0.15606176853179932
Familial B-Disease 1 0.9999860525131226
Melanoma I-Disease 1 0.9999992847442627
Study O 0 0.009141280315816402
Group O 0 0.002036742866039276
. O 0 0.0009435122483409941

Germline O 1 0.9312466979026794
mutations O 0 0.004156774375587702
in O 0 0.00022309196356218308
the O 0 0.0008092568605206907
p16 O 1 0.8749213814735413
and O 0 0.0007751978118903935
CDK4 O 1 0.9860728979110718
genes O 0 0.0005878336960449815
have O 0 0.00011807716509792954
been O 0 0.0002719696785788983
reported O 0 0.0005679224268533289
in O 0 5.7250563259003684e-05
a O 0 0.0003556753508746624
subset O 0 0.001989083830267191
of O 0 0.0005545169697143137
melanoma B-Disease 1 0.9999995231628418
pedigrees O 0 0.28838279843330383
, O 0 0.0003070005332119763
but O 0 0.0002147081249859184
their O 0 0.00014571576321031898
prevalence O 1 0.9935757517814636
is O 0 0.00031174527248367667
not O 0 0.00010172261681873351
well O 0 0.00017778918845579028
known O 0 0.001251353183761239
. O 0 0.0007491772412322462

We O 0 0.001031682942993939
searched O 0 0.0024793290067464113
for O 0 0.00011675077985273674
such O 0 0.00025374043616466224
germline O 1 0.8162323832511902
mutations O 0 0.0016152021707966924
in O 0 0.00026253025862388313
48 O 0 0.0034677875228226185
French O 1 0.6890336275100708
melanoma B-Disease 1 0.9999997615814209
- O 1 0.9603330492973328
prone O 1 0.9633622765541077
families O 0 0.00038093439070507884
selected O 0 0.00027878533001057804
according O 0 0.0001209667680086568
to O 0 5.8476944104768336e-05
two O 0 6.183229561429471e-05
major O 0 0.0009735641069710255
criteria O 0 0.000961979734711349
families O 0 0.00011845766857732087
with O 0 5.384317773859948e-05
at O 0 0.00027940876316279173
least O 0 0.00019294512458145618
three O 0 9.368914470542222e-05
affected O 0 0.0017360001802444458
members O 0 0.00022740126587450504
( O 0 0.0006138315657153726
n O 0 0.0030120627488940954
= O 0 0.003281292039901018
20 O 0 0.0006697099306620657
) O 0 0.000188347403309308
or O 0 0.000211702412343584
families O 0 0.00015841370623093098
with O 0 0.00010091791045852005
two O 0 0.00014969188487157226
affected O 0 0.0030176923610270023
members O 0 0.0001566536957398057
, O 0 0.0001063068411895074
one O 0 4.037859253003262e-05
of O 0 1.7739395843818784e-05
them O 0 9.804974251892418e-05
affected O 0 0.0019678352400660515
before O 0 0.00021032178483437747
the O 0 9.425493772141635e-05
age O 0 0.00017346306412946433
of O 0 3.08040835079737e-05
50 O 0 0.000541319081094116
( O 0 0.0005210278322920203
n O 0 0.002885668072849512
= O 0 0.003994188271462917
28 O 0 0.0011528503382578492
) O 0 0.00012728020374197513
, O 0 8.100662671495229e-05
and O 0 4.947441993863322e-05
one O 0 0.0001206226006615907
additional O 0 0.0006691402522847056
minor O 0 0.20019397139549255
criterion O 0 0.030919570475816727
. O 0 0.0009934717090800405

Sixteen O 0 0.004455654416233301
different O 0 0.0006494749686680734
p16 O 1 0.9606488943099976
germline O 1 0.9334918856620789
mutations O 0 0.0037513074930757284
were O 0 8.327998511958867e-05
found O 0 0.00033022891147993505
in O 0 0.0002223631163360551
21 O 0 0.0008935894584283233
families O 0 0.00020493616466410458
, O 0 0.00011695101420627907
while O 0 0.0001903762895381078
one O 0 0.0005742889479734004
germline O 1 0.93918776512146
mutation O 0 0.005246413871645927
, O 0 0.0006215744069777429
Arg24His O 1 0.8702166080474854
, O 0 0.00034029624657705426
was O 0 0.0010515161557123065
detected O 0 0.0037072247359901667
in O 0 0.00014331562852021307
the O 0 0.0007616193033754826
CDK4 O 1 0.9942262768745422
gene O 0 0.0052472432143986225
. O 0 0.000971183180809021

The O 0 0.00030343563412316144
frequency O 0 0.0003410071658436209
of O 0 0.0001302308519370854
p16 O 0 0.35621172189712524
gene O 0 0.0033599473536014557
mutation O 0 0.0013959216885268688
in O 0 8.177508425433189e-05
our O 0 0.00027994156698696315
sample O 0 0.00032063585240393877
( O 0 0.0003466294438112527
44 O 0 0.00040844999602995813
% O 0 7.064108649501577e-05
) O 0 0.00013260044215712696
is O 0 0.00010278308764100075
among O 0 5.1017574151046574e-05
the O 0 0.00013112928718328476
highest O 0 0.0017915640491992235
rates O 0 0.000980606535449624
yet O 0 0.0009165966766886413
reported O 0 0.0010659898398444057
and O 0 8.45502145239152e-05
the O 0 0.0005539247649721801
CDK4 O 1 0.993107259273529
mutation O 0 0.0017812210135161877
is O 0 0.0001389174722135067
the O 0 9.452974336454645e-05
second O 0 0.0005861980025656521
mutation O 0 0.0032969412859529257
detected O 0 0.003236274002119899
in O 0 0.00011427995195845142
this O 0 0.00015691964654251933
gene O 0 0.0023855790495872498
worldwide O 0 0.001849635038524866
. O 0 0.0009049053187482059

In O 0 0.001098920009098947
summary O 0 0.0021762538235634565
, O 0 0.00028035504510626197
our O 0 0.00036271833232603967
results O 0 0.00055491499369964
show O 0 0.0004903161316178739
frequent O 0 0.002105850726366043
involvement O 0 0.0016004919307306409
of O 0 2.5696990633150563e-05
the O 0 0.0007173758931457996
p16 O 1 0.9717212319374084
gene O 0 0.004310079384595156
in O 0 0.0015358725795522332
familial B-Disease 1 0.9999841451644897
melanoma I-Disease 1 0.9999996423721313
and O 0 0.0006194807356223464
confirm O 0 0.0017570998752489686
the O 0 0.00011442902177805081
role O 0 0.00039873956120572984
of O 0 2.8449241654016078e-05
the O 0 0.0005849290755577385
CDK4 O 1 0.9963274598121643
gene O 0 0.0015495208790525794
as O 0 0.00038761095493100584
a O 0 0.048997409641742706
melanoma B-Disease 1 0.9999995231628418
- O 0 0.44174912571907043
predisposing O 1 0.6950437426567078
gene O 0 0.003974915947765112
. O 0 0.0003637438639998436
. O 0 0.0008294769213534892

Progression O 0 0.17658491432666779
of O 0 0.00032384562655352056
somatic O 1 0.7207363247871399
CTG O 1 0.9942752718925476
repeat O 0 0.010230319574475288
length O 0 0.00107763078995049
heterogeneity O 0 0.004115052055567503
in O 0 0.000115840659418609
the O 0 0.000385892519261688
blood O 1 0.985173225402832
cells O 0 0.006861512549221516
of O 0 0.0010311518562957644
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 1 0.9999942779541016
. O 0 0.002892022021114826

The O 0 0.00043964333599433303
genetic O 0 0.0011221547611057758
basis O 0 0.00027530299848876894
of O 0 0.0009156687883660197
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
( O 1 0.9580594897270203
DM B-Disease 1 0.9999982118606567
) O 0 0.0005009744199924171
is O 0 0.00012730533489957452
the O 0 6.608138210140169e-05
expansion O 0 0.0005238698213361204
of O 0 3.254608600400388e-05
an O 0 0.0015648104017600417
unstable O 1 0.9985151886940002
CTG O 1 0.9894010424613953
repeat O 0 0.007996213622391224
in O 0 0.00013333505194168538
the O 0 0.0002664867788553238
34 O 0 0.0012449572095647454
UTR O 0 0.0114069115370512
of O 0 5.3635983931599185e-05
the O 0 0.0011346038663759828
DM B-Disease 1 0.9998990297317505
protein O 0 0.0017740356270223856
kinase O 0 0.009324994869530201
gene O 0 0.0012147414963692427
on O 0 0.00033755821641534567
chromosome O 0 0.003057515947148204
19 O 0 0.0019270702032372355
. O 0 0.0010352643439546227

One O 0 0.0002903371350839734
of O 0 3.614848174038343e-05
the O 0 0.0002504316216800362
principal O 0 0.0013901441125199199
features O 0 0.00020034959015902132
of O 0 6.389454938471317e-05
the O 0 0.002880007028579712
DM B-Disease 1 0.9999946355819702
mutation O 0 0.004198895301669836
is O 0 0.00023539041285403073
an O 0 0.0003349471662659198
extraordinarily O 0 0.446758896112442
high O 0 0.0018349408637732267
level O 0 0.00077752087963745
of O 0 0.00012063422764185816
somatic O 0 0.4545324742794037
mosaicism O 1 0.9956949949264526
, O 0 0.00044633002835325897
due O 0 0.0008103213622234762
to O 0 7.52835112507455e-05
an O 0 0.00031736711389385164
extremely O 0 0.018877916038036346
high O 0 0.0022924209479242563
degree O 0 0.0010735170217230916
of O 0 9.747176227392629e-05
somatic O 0 0.0512428805232048
instability O 0 0.009540429338812828
both O 0 0.0001142153560067527
within O 0 9.388106263941154e-05
and O 0 7.135107443900779e-05
between O 0 0.00013714132364839315
different O 0 0.0001505705586168915
tissues O 0 0.21338820457458496
. O 0 0.001086505246348679

This O 0 0.0011398752685636282
instability O 0 0.0214356891810894
appears O 0 0.004859293811023235
to O 0 0.00014815822942182422
be O 0 0.00014577123511116952
biased O 0 0.002488325582817197
towards O 0 0.0004172954650130123
further O 0 0.0002772648585960269
expansion O 0 0.0009720473317429423
and O 0 8.729813998797908e-05
continuous O 0 0.0010276976972818375
throughout O 0 0.0002050530310953036
the O 0 0.0001246961619472131
life O 0 0.000328374415403232
of O 0 1.444999361410737e-05
an O 0 0.00021042107255198061
individual O 0 0.0002848156727850437
, O 0 0.00021969934459775686
features O 0 0.000257095176493749
that O 0 0.00010666243906598538
could O 0 0.0001482384977862239
be O 0 6.137489981483668e-05
associated O 0 9.382173448102549e-05
with O 0 4.390486719785258e-05
the O 0 0.0001907871337607503
progressive O 0 0.01309318095445633
nature O 0 0.0009756747749634087
of O 0 7.325952174142003e-05
the O 0 0.005796786397695541
disease O 1 0.9999946355819702
. O 0 0.001716736238449812

Although O 0 0.0009553841082379222
increasing O 0 0.000645351770799607
measured O 0 0.0011769016273319721
allele O 0 0.004098210483789444
size O 0 0.00080768862972036
between O 0 0.001456485246308148
patients O 1 0.9998766183853149
clearly O 0 0.0017621053848415613
correlates O 0 0.0021519502624869347
with O 0 5.2894538384862244e-05
an O 0 0.00020994512306060642
increased O 0 0.0013561329105868936
severity O 1 0.9992358684539795
of O 0 0.0003238131757825613
symptoms O 1 0.9999966621398926
and O 0 0.0001357343135168776
an O 0 0.00032093957997858524
earlier O 0 0.0008612328674644232
age O 0 0.0005015135393477976
of O 0 0.00013304041931405663
onset O 1 0.9998584985733032
, O 0 0.0002552893420215696
this O 0 8.360623178305104e-05
correlation O 0 0.0013523102970793843
is O 0 0.00027244226657785475
not O 0 8.530858031008393e-05
precise O 0 0.0004877664614468813
and O 0 0.00010463404032634571
measured O 0 0.0010730557842180133
allele O 0 0.004515383392572403
length O 0 0.0011037577642127872
cannot O 0 0.0007107997080311179
be O 0 4.969064684701152e-05
used O 0 4.79815062135458e-05
as O 0 6.351510091917589e-05
an O 0 0.00011220295709790662
accurate O 0 0.0011659451993182302
predictor O 0 0.007780868094414473
of O 0 4.162975892540999e-05
age O 0 0.0005597355193458498
of O 0 0.00018693007586989552
onset O 1 0.9998382329940796
. O 0 0.00204458343796432

In O 0 0.0006296818610280752
order O 0 0.00020515473443083465
to O 0 0.00010686147288652137
further O 0 0.000360389007255435
characterize O 0 0.008816812187433243
the O 0 0.0003377441025804728
dynamics O 0 0.0181572288274765
of O 0 0.0013236966915428638
DM B-Disease 1 0.9999961853027344
CTG O 1 0.998252809047699
repeat O 0 0.10975179821252823
somatic O 0 0.03355352208018303
instability O 0 0.02054811455309391
, O 0 0.0003149134572595358
we O 0 0.00016015530854929239
have O 0 0.00010378608567407355
studied O 0 0.0005280232289806008
repeat O 0 0.002322851913049817
length O 0 0.0003320719697512686
changes O 0 0.0001401769113726914
over O 0 8.173298556357622e-05
time O 0 0.00014304269279818982
in O 0 0.000686226412653923
111 O 1 0.99504154920578
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 1.0
patients O 1 0.9999600648880005
with O 0 0.0005395971238613129
varying O 0 0.007580074016004801
clinical O 1 0.9998888969421387
severity O 1 0.9993141889572144
and O 0 0.0014704843051731586
CTG O 1 0.9972459077835083
repeat O 0 0.005359244998544455
size O 0 0.00022578546486329287
over O 0 7.303783786483109e-05
time O 0 6.335172656690702e-05
intervals O 0 0.00017566733004059643
of O 0 3.050956001970917e-05
1 O 0 0.0010582528775557876
- O 0 0.002459431765601039
7 O 0 0.0006165092345327139
years O 0 0.0005584366153925657
. O 0 0.0005221060710027814

We O 0 0.0006505095516331494
have O 0 0.00012718218204099685
found O 0 0.00013848273374605924
a O 0 0.00022752315271645784
direct O 0 0.000454777356935665
progression O 0 0.013115731999278069
of O 0 2.011923243117053e-05
the O 0 0.0001629206963116303
size O 0 0.0007267253240570426
heterogeneity O 0 0.00489305192604661
over O 0 0.00016414867423009127
time O 0 0.00016132260498125106
related O 0 0.0006925825728103518
to O 0 0.000266704591922462
initial O 0 0.005829414818435907
CTG O 1 0.9911413192749023
repeat O 0 0.006696764379739761
size O 0 0.0003961486218031496
and O 0 7.844118226785213e-05
the O 0 9.800273255677894e-05
time O 0 0.0001466571120545268
interval O 0 0.0009552216506563127
and O 0 0.00017481781833339483
always O 0 0.000714545720256865
biased O 0 0.002449226099997759
towards O 0 0.0005117167020216584
further O 0 0.00047109666047617793
expansion O 0 0.0037357343826442957
. O 0 0.0010306390468031168

Attempts O 0 0.0028128947596997023
to O 0 0.00025253655621781945
mathematically O 0 0.0026202616281807423
model O 0 0.0006674505420960486
the O 0 0.0003245450498070568
dynamics O 0 0.011338518932461739
have O 0 0.00022974929015617818
proved O 0 0.003711723955348134
only O 0 0.000252914906013757
partially O 0 0.01020197942852974
successful O 0 0.0016285193851217628
suggesting O 0 0.001509602414444089
that O 0 4.73953623441048e-05
individual O 0 0.0001227630564244464
specific O 0 0.00040479048038832843
genetic O 0 0.007661798503249884
and O 0 0.0010759267024695873
/ O 1 0.9843788743019104
or O 0 0.00035404140362516046
environmental O 0 0.0038340878672897816
factors O 0 0.0003372211067471653
also O 0 0.00010297791595803574
play O 0 7.615975482622162e-05
a O 0 0.0002434103371342644
role O 0 0.0012974375858902931
in O 0 0.0004943932290188968
somatic O 0 0.12054940313100815
mosaicism O 1 0.9925380349159241
. O 0 0.00045149674406275153
. O 0 0.000763506512157619

Aspartylglucosaminuria B-Disease 1 0.984398603439331
among O 0 0.0015724082477390766
Palestinian O 0 0.010000796988606453
Arabs O 0 0.00573174050077796
. O 0 0.0012233630986884236

Aspartylglucosaminuria B-Disease 1 0.9970184564590454
( O 0 0.014556795358657837
AGU B-Disease 1 0.9998798370361328
) O 0 0.000550694006960839
is O 0 0.00027580163441598415
a O 0 0.0008915122598409653
rare O 1 0.7564036250114441
disorder B-Disease 1 0.9999644756317139
of I-Disease 0 0.00024494034005329013
glycoprotein I-Disease 1 0.9983717799186707
metabolism I-Disease 1 0.9965999722480774
caused O 0 0.01813633367419243
by O 0 0.00015457312110811472
the O 0 0.0009263728861697018
deficiency B-Disease 1 0.9999468326568604
of I-Disease 0 5.2112038247287273e-05
the I-Disease 0 0.0006336083170026541
lysosomal I-Disease 1 0.9974400997161865
enzyme I-Disease 0 0.02711082436144352
aspartylglucosaminidase I-Disease 1 0.9698354005813599
( O 0 0.003186347894370556
AGA O 1 0.9931539297103882
) O 0 0.0007442827918566763
. O 0 0.0007815808639861643

AGU B-Disease 1 0.999869704246521
is O 0 0.0057421959936618805
inherited O 1 0.9360454082489014
as O 0 0.0006218501948751509
an O 0 0.00269604311324656
autosomal O 1 0.9998346567153931
recessive O 1 0.9994686245918274
trait O 1 0.9417040944099426
and O 0 0.0004941993393003941
occurs O 0 0.0011019553057849407
with O 0 0.00012802748824469745
a O 0 0.0007421105983667076
high O 0 0.0011658796574920416
frequency O 0 0.00027010319172404706
in O 0 0.00011619379074545577
Finland O 0 0.0008724161307327449
because O 0 0.00017418671632185578
of O 0 2.5121231374214403e-05
a O 0 0.0013084635138511658
founder O 0 0.016084760427474976
effect O 0 0.002680853009223938
. O 0 0.0008925930014811456

While O 0 0.001354977604933083
very O 0 0.002122921869158745
few O 0 0.003101499518379569
patients O 1 0.9998257756233215
with O 0 0.002077745972201228
AGU B-Disease 1 0.9999829530715942
have O 0 0.00039942169678397477
been O 0 0.0005487194866873324
reported O 0 0.0010922004003077745
from O 0 0.00013484984810929745
non O 0 0.0016362874303013086
- O 0 0.0025445192586630583
Finnish O 0 0.002644855994731188
origin O 0 0.00015157271991483867
, O 0 0.00037192218587733805
we O 0 0.0021006702445447445
diagnosed O 1 0.9999982118606567
the O 0 0.0016793790273368359
disorder O 1 0.9999905824661255
in O 0 0.0011603257153183222
8 O 0 0.00642468361184001
patients O 1 0.9998576641082764
originating O 0 0.001557644340209663
from O 0 0.00026083693956024945
3 O 0 0.0015026988694444299
unrelated O 0 0.008497865870594978
families O 0 0.0004487287951633334
, O 0 0.00017482182011008263
all O 0 6.774893699912354e-05
Palestinian O 0 0.002827303484082222
Arabs O 0 0.0008652082178741693
from O 0 6.807766476413235e-05
the O 0 0.00012921112647745758
region O 0 0.0006719104712828994
of O 0 8.826881094137207e-05
Jerusalem O 0 0.009033570066094398
. O 0 0.0010053814621642232

The O 0 0.006009454373270273
clinical O 1 0.9997894167900085
diagnosis O 1 0.999972939491272
of O 0 0.0012407776666805148
AGU B-Disease 1 0.9999972581863403
is O 0 0.0017355631571263075
often O 0 0.0007732599624432623
difficult O 0 0.003924305085092783
, O 0 0.0001439918705727905
in O 0 9.077373397303745e-05
particular O 0 0.00023944975691847503
early O 0 0.000249647768214345
in O 0 7.918795017758384e-05
the O 0 0.00014789625129196793
course O 0 0.002026996808126569
of O 0 5.738814434153028e-05
the O 0 0.0036657110322266817
disease O 1 0.9999914169311523
, O 0 0.00017922540428116918
and O 0 6.0233236581552774e-05
most O 0 6.106153159635141e-05
of O 0 3.636891779024154e-05
the O 0 0.0024767168797552586
patients O 1 0.9999873638153076
are O 0 0.0008890247554518282
diagnosed O 1 0.9999991655349731
after O 0 0.0008201954187825322
the O 0 0.00016296171816065907
age O 0 0.0003287027357146144
of O 0 5.447861258289777e-05
5 O 0 0.0010978030040860176
years O 0 0.0009860261343419552
. O 0 0.0006056532729417086

However O 0 0.001968890195712447
, O 0 0.0005072179483249784
since O 0 0.0011994685046374798
these O 0 0.0004445360682439059
patients O 1 0.9998677968978882
excrete O 1 0.5066419243812561
early O 0 0.000316474586725235
large O 0 8.868256554706022e-05
amounts O 0 0.00020097811648156494
of O 0 6.888809730298817e-05
aspartylglucosamine O 1 0.8201906085014343
in O 0 0.000437466602306813
urine O 0 0.014489395543932915
, O 0 0.0003028382488992065
biochemical O 0 0.007199163548648357
screening O 0 0.0034886454232037067
is O 0 0.00020591508655343205
easy O 0 0.0006707728607580066
by O 0 0.00018480955623090267
urine O 0 0.020774248987436295
chromatography O 0 0.3393273651599884
. O 0 0.0006049362127669156
. O 0 0.00078064005356282

Detection O 0 0.008956432342529297
of O 0 0.00011193323734914884
heterozygous O 0 0.0044345795176923275
carriers O 0 0.002514770720154047
of O 0 7.267226465046406e-05
the O 0 0.0022581845987588167
ataxia B-Disease 1 0.9999830722808838
- I-Disease 1 0.9932692646980286
telangiectasia I-Disease 1 0.9996424913406372
( O 0 0.002020603511482477
ATM O 0 0.021654604002833366
) O 0 0.00047507701674476266
gene O 0 0.001562230521813035
by O 0 0.00038009975105524063
G2 O 1 0.9976463913917542
phase O 0 0.012522352859377861
chromosomal O 0 0.024667633697390556
radiosensitivity O 0 0.0536968894302845
of O 0 0.00034440832678228617
peripheral O 1 0.9999150037765503
blood O 1 0.9993274211883545
lymphocytes O 1 0.9986578226089478
. O 0 0.0017121188575401902

In O 0 0.0062639242969453335
ataxia B-Disease 1 0.9999662637710571
- I-Disease 1 0.9886948466300964
telangiectasia I-Disease 1 0.9997562766075134
( O 0 0.0039305598475039005
A B-Disease 1 0.9992996454238892
- I-Disease 1 0.9994520545005798
T I-Disease 1 0.9999675750732422
) O 0 0.0018501485465094447
patients O 1 0.9998867511749268
, O 0 0.00027915480313822627
mutations O 0 0.0009563349303789437
in O 0 6.41082224319689e-05
a O 0 0.00043014888069592416
single O 0 0.0006759336683899164
gene O 0 0.002069242997094989
, O 0 0.00027127511566504836
ATM O 0 0.0051699671894311905
, O 0 0.00014200022269506007
result O 0 0.0003744870191439986
in O 0 0.00024079091963358223
an O 0 0.02144777774810791
autosomal B-Disease 1 0.9999986886978149
recessive I-Disease 1 0.9999960660934448
syndrome I-Disease 1 1.0
that O 0 0.0007162237889133394
embraces O 0 0.01478044968098402
a O 0 0.0005518326070159674
variety O 0 0.0004865618539042771
of O 0 0.0001761957537382841
clinical O 1 0.9997304081916809
features O 0 0.0007817112491466105
and O 0 0.000447650469141081
manifests O 1 0.9882652759552002
extreme O 0 0.07391984760761261
radiosensitivity O 1 0.6363882422447205
and O 0 9.304258855991066e-05
a O 0 0.0005216178833507001
strong O 0 0.0010531231528148055
pre O 0 0.01698986254632473
- O 0 0.011127158999443054
disposition O 0 0.02211110293865204
to O 0 0.0010674115037545562
malignancy B-Disease 1 0.9990136623382568
. O 0 0.0014471268514171243

Heterozygotes O 0 0.18844757974147797
for O 0 0.00031804866739548743
the O 0 0.00046712186303921044
ATM O 0 0.01952606998383999
gene O 0 0.0016837527509778738
have O 0 9.750327444635332e-05
no O 0 0.0002622358442749828
clinical O 0 0.46488654613494873
expression O 0 0.00033830531174317
of O 0 9.308253356721252e-05
A B-Disease 1 0.9992969036102295
- I-Disease 1 0.9982207417488098
T I-Disease 1 0.9999312162399292
but O 0 0.00040513984276913106
may O 0 0.0015305891865864396
be O 0 0.0010062208166345954
cancer B-Disease 1 0.999991774559021
prone O 0 0.17698347568511963
with O 0 9.853008668869734e-05
a O 0 0.0007049082778394222
moderate O 0 0.0035445173271000385
increase O 0 0.00038773479172959924
in O 0 0.00013619897072203457
in O 0 0.00031075472361408174
vitro O 0 0.011009125970304012
radiosensitivity O 1 0.7327924966812134
. O 0 0.0018006875179708004

We O 0 0.0009400774142704904
performed O 0 0.0014496054500341415
a O 0 0.0012810828629881144
blind O 1 0.8030599355697632
chromosomal O 0 0.00933911558240652
analysis O 0 0.0006995204603299499
on O 0 0.0011797492625191808
G2 O 1 0.9987994432449341
- O 0 0.01050260104238987
phase O 0 0.010894745588302612
lymphocytes O 1 0.6953403353691101
from O 0 0.0001317467977060005
7 O 0 0.0008995034731924534
unrelated O 0 0.017211614176630974
A B-Disease 1 0.9986317753791809
- I-Disease 1 0.9992741942405701
T I-Disease 1 0.9999668598175049
patients O 1 0.9996447563171387
, O 0 0.00029653499950654805
13 O 0 0.0011251593241468072
obligate O 0 0.19859471917152405
A B-Disease 1 0.9890945553779602
- I-Disease 1 0.9951213002204895
T I-Disease 1 0.9998124241828918
heterozygotes O 1 0.9499499201774597
( O 0 0.0005661918548867106
parents O 0 0.0002882028347812593
of O 0 5.1131155487382784e-05
the O 0 0.0018174975411966443
patients O 1 0.9999648332595825
) O 0 0.00025023805210366845
, O 0 0.0001253874652320519
and O 0 9.904934267979115e-05
14 O 0 0.00042930254130624235
normal O 0 0.0010429660324007273
controls O 0 0.0011210466036573052
following O 0 0.0013121213996782899
X O 0 0.01613294705748558
- O 0 0.00318844779394567
irradiation O 0 0.005774152465164661
with O 0 0.00017670670058578253
1 O 0 0.0015097822761163116
Gy O 1 0.8893726468086243
in O 0 9.787068120203912e-05
order O 0 0.00010985603148583323
to O 0 0.00011342499783495441
evaluate O 0 0.004492590669542551
this O 0 0.00012775709910783917
cytogenetic O 0 0.040388185530900955
method O 0 0.0002389589644735679
as O 0 0.00012700185470748693
a O 0 0.0003080974274780601
tool O 0 0.0019196977373212576
for O 0 0.00014065341383684427
detection O 0 0.0024810736067593098
of O 0 7.933652523206547e-05
ATM O 0 0.1467074453830719
carriers O 0 0.014006799086928368
. O 0 0.0010923701338469982

Both O 0 0.002225204836577177
A B-Disease 1 0.9878275394439697
- I-Disease 1 0.9966104626655579
T I-Disease 1 0.9997535347938538
homozygotes O 1 0.983932614326477
and O 0 0.0006014436949044466
heterozygotes O 0 0.4040992558002472
showed O 0 0.0020327826496213675
significantly O 0 0.0025536217726767063
increased O 0 0.0003178452607244253
levels O 0 0.0008387562702409923
of O 0 0.0001251154171768576
radiation O 1 0.9998282194137573
- O 1 0.9060269594192505
induced O 1 0.9970380067825317
chromatid O 1 0.9982104301452637
damage O 1 0.7131359577178955
relative O 0 0.00042014982318505645
to O 0 5.758253610110842e-05
that O 0 3.461830419837497e-05
of O 0 2.9692217140109278e-05
normal O 0 0.002817056607455015
controls O 0 0.0029568704776465893
. O 0 0.0011370372958481312

These O 0 0.00015566899674013257
results O 0 0.0004256045212969184
show O 0 0.00022740387066733092
that O 0 7.499947969336063e-05
the O 0 0.0005816884804517031
G2 O 1 0.9996656179428101
- O 0 0.00872193556278944
phase O 0 0.009752963669598103
chromosomal O 0 0.03143714740872383
radiosensitivity O 0 0.11418614536523819
assay O 0 0.004600868094712496
can O 0 9.611873974790797e-05
be O 0 3.24128704960458e-05
used O 0 2.6650557629182003e-05
for O 0 3.0936611437937245e-05
the O 0 7.763021858409047e-05
detection O 0 0.0019406666979193687
of O 0 0.00011255724530201405
A B-Disease 1 0.998150646686554
- I-Disease 1 0.9981300234794617
T I-Disease 1 0.999822199344635
heterozygotes O 1 0.6663703322410583
. O 0 0.0012655779719352722

In O 0 0.0012265070108696818
combination O 0 0.005089046899229288
with O 0 0.00028637994546443224
molecular O 0 0.003984540235251188
genetic O 0 0.001972865080460906
analyses O 0 0.0013433895073831081
, O 0 0.00018378491222392768
this O 0 0.0001367395161651075
test O 0 0.0017287591472268105
may O 0 0.0002931455092038959
be O 0 1.5193708350125235e-05
of O 0 5.951840194029501e-06
value O 0 7.058372284518555e-05
in O 0 7.423046190524474e-05
studies O 0 0.0002536959364078939
of O 0 7.902771176304668e-05
familial B-Disease 1 0.9997925162315369
and I-Disease 0 0.0013548963470384479
sporadic I-Disease 1 0.9880822896957397
cancers I-Disease 1 0.9998377561569214
aimed O 0 0.0023685325868427753
at O 0 0.0005215192213654518
determination O 0 0.001496114768087864
of O 0 2.47949683398474e-05
the O 0 0.00019339083519298583
potential O 0 0.0012870179489254951
involvement O 0 0.0025131937582045794
of O 0 9.262776438845322e-05
ATM O 0 0.1535063236951828
mutations O 0 0.007218237034976482
in O 0 0.001862094970420003
tumor B-Disease 1 0.9999854564666748
risk O 1 0.8942147493362427
or O 0 0.0005058363894931972
development O 0 0.0020891788881272078
. O 0 0.00033534885733388364
. O 0 0.0006651258445344865

Ataxia B-Disease 1 0.9999856948852539
- I-Disease 1 0.9962828755378723
telangiectasia I-Disease 1 0.9997017979621887
: O 0 0.0009977357694879174
identification O 0 0.0005335866007953882
and O 0 0.00012088652874808758
detection O 0 0.003195368917658925
of O 0 0.00011895731586264446
founder O 0 0.34323304891586304
- O 0 0.00608793506398797
effect O 0 0.001124011934734881
mutations O 0 0.0009299226221628487
in O 0 8.259476453531533e-05
the O 0 0.00026020058430731297
ATM O 0 0.013741274364292622
gene O 0 0.0012233665911480784
in O 0 0.00010605835996102542
ethnic O 0 0.00028946317615918815
populations O 0 0.002030904870480299
. O 0 0.001261098776012659

To O 0 0.00033928206539712846
facilitate O 0 0.001278491341508925
the O 0 0.00018376389925833791
evaluation O 0 0.004100593272596598
of O 0 0.0001053574014804326
ATM O 0 0.061991892755031586
heterozygotes O 0 0.3832419216632843
for O 0 0.0004643708234652877
susceptibility O 0 0.23535646498203278
to O 0 0.00019532331498339772
other O 0 0.0003672140301205218
diseases O 1 0.9999841451644897
, O 0 0.00015424184675794095
such O 0 0.0001724988396745175
as O 1 0.8433537483215332
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
, O 0 0.0002624977205414325
we O 0 0.00018763903062790632
have O 0 6.461111479438841e-05
attempted O 0 0.0005829978035762906
to O 0 5.844288534717634e-05
define O 0 0.0006847332697361708
the O 0 0.00013800554734189063
most O 0 0.0002957165415864438
common O 0 0.0015134684508666396
mutations O 0 0.0013825952773913741
and O 0 4.029877527500503e-05
their O 0 3.096104774158448e-05
frequencies O 0 0.0003255214251112193
in O 0 0.0009598510805517435
ataxia B-Disease 1 0.999982476234436
- I-Disease 1 0.9836530685424805
telangiectasia I-Disease 1 0.9998120665550232
( O 0 0.0025840727612376213
A B-Disease 1 0.9983324408531189
- I-Disease 1 0.9960620999336243
T I-Disease 1 0.9996888637542725
) O 0 0.0007456860039383173
homozygotes O 1 0.5196531414985657
from O 0 0.00013675543596036732
10 O 0 0.00018921068112831563
ethnic O 0 0.00017455896886531264
populations O 0 0.0014181174337863922
. O 0 0.0008020305540412664

Both O 0 0.0009384137811139226
genomic O 0 0.007096112705767155
mutations O 0 0.0031854056287556887
and O 0 0.00010370340169174597
their O 0 0.0001050950086209923
effects O 0 0.003213203512132168
on O 0 0.00030203929054550827
cDNA O 0 0.0032322462648153305
were O 0 0.00016889494145289063
characterized O 0 0.07441097497940063
. O 0 0.0014581838622689247

Protein O 0 0.00541051896288991
- O 0 0.006396091543138027
truncation O 0 0.012258672155439854
testing O 0 0.0010392209514975548
of O 0 1.4731646842847113e-05
the O 0 0.00015894992975518107
entire O 0 0.00226760795339942
ATM O 0 0.009944623336195946
cDNA O 0 0.009010251611471176
detected O 0 0.0108299246057868
92 O 0 0.007426607888191938
( O 0 0.0009233090677298605
66 O 0 0.0035133392084389925
% O 0 0.0001578662049723789
) O 0 0.0005899497191421688
truncating O 0 0.08260572701692581
mutations O 0 0.0025752175133675337
in O 0 0.000258898944593966
140 O 0 0.0025757807306945324
mutant O 0 0.011008321307599545
alleles O 0 0.00765342079102993
screened O 0 0.00732407858595252
. O 0 0.0010398189770057797

The O 0 0.0020286282524466515
haplotyping O 0 0.389471173286438
of O 0 0.00043609796557575464
patients O 1 0.9998922348022461
with O 0 0.00035544653655961156
identical O 0 0.002915414283052087
mutations O 0 0.005093345418572426
indicates O 0 0.0012964487541466951
that O 0 5.4212025133892894e-05
almost O 0 8.66429545567371e-05
all O 0 8.21234607428778e-06
of O 0 1.0357858627685346e-05
these O 0 3.1478612072532997e-05
represent O 0 0.0002588554925750941
common O 0 0.0010656599188223481
ancestry O 0 0.0004634495126083493
and O 0 0.00010631840268615633
that O 0 9.818886610446498e-05
very O 0 0.0006424861494451761
few O 0 0.000884409062564373
spontaneously O 0 0.07373465597629547
recurring O 1 0.9761630296707153
ATM O 0 0.08860936760902405
mutations O 0 0.0049355048686265945
exist O 0 0.0008838093490339816
. O 0 0.0007723364979028702

Assays O 0 0.008528146892786026
requiring O 0 0.004597726743668318
minimal O 0 0.002379173645749688
amounts O 0 0.0003256772761233151
of O 0 5.6786640925565735e-05
genomic O 0 0.0038203091826289892
DNA O 0 0.000905959983356297
were O 0 4.853439168073237e-05
designed O 0 0.0005778763443231583
to O 0 7.591250323457643e-05
allow O 0 0.0003767102607525885
rapid O 0 0.0072325170040130615
screening O 0 0.0028223120607435703
for O 0 0.0001733962562866509
common O 0 0.001078653847798705
ethnic O 0 0.0005966258468106389
mutations O 0 0.007207549177110195
. O 0 0.0009236899786628783

These O 0 0.00042234399006702006
rapid O 0 0.011097114533185959
assays O 0 0.004734299145638943
detected O 0 0.012222126126289368
mutations O 0 0.0016259282128885388
in O 0 0.00017437465430703014
76 O 0 0.001879922579973936
% O 0 3.679373912746087e-05
of O 0 5.896012226003222e-05
Costa O 0 0.03168146312236786
Rican O 0 0.036190517246723175
patients O 1 0.9998997449874878
( O 0 0.0007197541417554021
3 O 0 0.0006415383541025221
) O 0 0.00012787460582330823
, O 0 6.803314317949116e-05
50 O 0 9.693758329376578e-05
% O 0 1.760878694767598e-05
of O 0 5.9286339819664136e-05
Norwegian O 0 0.050359711050987244
patients O 1 0.999893069267273
( O 0 0.0007112242165021598
1 O 0 0.0007462301291525364
) O 0 0.0001290768850594759
, O 0 6.852485967101529e-05
25 O 0 7.509803253924474e-05
% O 0 1.6638148736092262e-05
of O 0 7.048921543173492e-05
Polish O 1 0.99048912525177
patients O 1 0.999963641166687
( O 0 0.0008521256386302412
4 O 0 0.0009214362362399697
) O 0 0.00015628666733391583
, O 0 8.269437967101112e-05
and O 0 5.768915798398666e-05
14 O 0 0.0001735211262712255
% O 0 1.6714902812964283e-05
of O 0 4.672592331189662e-05
Italian O 0 0.31770920753479004
patients O 1 0.9999120235443115
( O 0 0.0007147349533624947
1 O 0 0.0008663878543302417
) O 0 0.0001449559349566698
, O 0 6.583757931366563e-05
as O 0 6.710657180519775e-05
well O 0 7.341757736867294e-05
as O 0 0.0001392799458699301
in O 0 0.00038833662983961403
patients O 1 0.9990295171737671
of O 0 0.00013408652739599347
Amish O 1 0.8596985340118408
/ O 1 0.504057765007019
Mennonite O 0 0.021365735679864883
and O 0 0.0004039285413455218
Irish O 0 0.0033388976007699966
English O 0 0.0010687480680644512
backgrounds O 0 0.0034536742605268955
. O 0 0.0013896939344704151

Additional O 0 0.002475517801940441
mutations O 0 0.0023140879347920418
were O 0 5.5861797591205686e-05
observed O 0 0.0003807947796303779
in O 0 0.00011252740659983829
Japanese O 0 0.0007989465957507491
, O 0 0.0003431805525906384
Utah O 0 0.00418821768835187
Mormon O 0 0.0019265494775027037
, O 0 0.00019186220015399158
and O 0 0.00022172821627464145
African O 0 0.002368761459365487
American O 0 0.0051717329770326614
patients O 1 0.9996917247772217
. O 0 0.0015240401262417436

These O 0 0.0002721017226576805
assays O 0 0.0011256234720349312
should O 0 0.00028545534587465227
facilitate O 0 0.0016117809573188424
screening O 0 0.0028015035204589367
for O 0 0.0006127063534222543
A B-Disease 1 0.9971191883087158
- I-Disease 1 0.9975628852844238
T I-Disease 1 0.9997822642326355
heterozygotes O 0 0.09759770333766937
in O 0 0.0001233422226505354
the O 0 0.00015734563930891454
populations O 0 0.0007189027965068817
studied O 0 0.0009865080937743187
. O 0 0.0002954330120701343
. O 0 0.0005971858627162874

The O 0 0.0030006016604602337
von B-Disease 1 0.9662734270095825
Hippel I-Disease 1 0.9994409680366516
- I-Disease 1 0.9915013313293457
Lindau I-Disease 1 0.9997168183326721
tumor I-Disease 1 0.9997958540916443
suppressor O 0 0.4221377372741699
gene O 0 0.002094556111842394
is O 0 0.00017597009718883783
required O 0 0.00027321584639139473
for O 0 0.00019747776968870312
cell O 0 0.0021720125805586576
cycle O 0 0.001959404442459345
exit O 0 0.003544436302036047
upon O 0 0.0014423480024561286
serum O 1 0.9721342921257019
withdrawal O 0 0.015138966031372547
. O 0 0.0011828786227852106

The O 0 0.0008308407850563526
inactivation O 0 0.012217693030834198
of O 0 5.4008403822081164e-05
the O 0 0.001095523010008037
von B-Disease 1 0.9739335179328918
Hippel I-Disease 1 0.9997158646583557
- I-Disease 1 0.8621367812156677
Lindau I-Disease 1 0.9994372725486755
( I-Disease 0 0.0036367762368172407
VHL I-Disease 1 0.999866247177124
) I-Disease 0 0.003756972961127758
tumor I-Disease 1 0.9998363256454468
suppressor O 1 0.9849979281425476
gene O 0 0.013934139162302017
predisposes O 1 0.9970958232879639
affected O 0 0.0030300954822450876
individuals O 0 0.0001236133830389008
to O 0 9.91986962617375e-05
the O 0 0.0005401956150308251
human O 1 0.989678144454956
VHL B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999996423721313
and O 0 0.00033865933073684573
is O 0 0.00035161987761966884
associated O 0 0.000378194177756086
with O 0 0.00046807032776996493
sporadic B-Disease 1 0.9962856769561768
renal I-Disease 1 0.9999997615814209
cell I-Disease 1 0.9978421926498413
carcinomas I-Disease 1 0.9999898672103882
( O 0 0.04478025808930397
RCC B-Disease 1 0.9999843835830688
) O 0 0.0009475797414779663
and O 0 0.0008014735649339855
brain B-Disease 1 0.9998668432235718
hemangioblastomas I-Disease 1 0.9694033861160278
. O 0 0.0013604193227365613

VHL O 1 0.9968811273574829
- O 0 0.016461627557873726
negative O 0 0.005120579618960619
786 O 1 0.9179993271827698
- O 0 0.014067540876567364
0 O 0 0.004424072336405516
RCC B-Disease 1 0.9996726512908936
cells O 0 0.0022523251827806234
are O 0 0.00011663760960800573
tumorigenic O 1 0.7358976602554321
in O 0 0.000863495864905417
nude O 1 0.8634670972824097
mice O 0 0.013463460840284824
which O 0 0.00013230186596047133
is O 0 0.0003609569976106286
suppressed O 0 0.0024240503553301096
by O 0 6.690849113510922e-05
the O 0 0.000334058451699093
reintroduction O 0 0.020899558439850807
of O 0 0.0005273421993479133
VHL B-Disease 1 0.999468982219696
. O 0 0.0026493624318391085

Remarkably O 0 0.1506064236164093
, O 0 0.0003768341557588428
this O 0 0.0001889856648631394
occurs O 0 0.000900954648386687
without O 0 0.00033951905788853765
affecting O 0 0.0034479480236768723
the O 0 0.0002314369339728728
growth O 0 0.0010397617006674409
rate O 0 0.00026269524823874235
and O 0 0.00016545828839298338
cell O 0 0.002458271337673068
cycle O 0 0.0011959199327975512
profile O 0 0.001141626969911158
of O 0 2.059427606582176e-05
these O 0 8.075166260823607e-05
cells O 0 0.001631413702853024
in O 0 0.0001665836462052539
culture O 0 0.0014235067646950483
. O 0 0.0010489537380635738

The O 0 0.0033261689823120832
786 O 1 0.6525441408157349
- O 0 0.006354997865855694
0 O 0 0.0010128378635272384
cell O 0 0.0016257647657766938
line O 0 0.0007848870009183884
, O 0 0.00017095296061597764
like O 0 0.0004549087316263467
many O 0 0.001044775010086596
cancer B-Disease 1 0.9999966621398926
cells O 0 0.00872192345559597
, O 0 0.0004118918441236019
fails O 0 0.018080266192555428
to O 0 0.00011180277215316892
exit O 0 0.0019905157387256622
the O 0 0.00017831736477091908
cell O 0 0.00167896319180727
cycle O 0 0.0015937656862661242
upon O 0 0.0014299277681857347
serum O 1 0.9854608178138733
withdrawal O 0 0.014506825245916843
. O 0 0.0010703493608161807

Here O 0 0.0017197610577568412
, O 0 0.00027567334473133087
it O 0 0.00017411330190952867
is O 0 0.00021414688671939075
shown O 0 0.0003104977076873183
that O 0 7.415673462674022e-05
reintroduction O 0 0.002554134465754032
of O 0 1.110809353122022e-05
the O 0 0.00021701157675124705
wild O 0 0.0022039602044969797
- O 0 0.012307705357670784
type O 0 0.014515000395476818
VHL B-Disease 1 0.9987192153930664
gene O 0 0.004136265255510807
restores O 0 0.007117616478353739
the O 0 0.0001420587213942781
ability O 0 0.0016347940545529127
of O 0 0.00039987583295442164
VHL O 1 0.9999673366546631
- O 1 0.9708665013313293
negative O 1 0.6409178972244263
RCC B-Disease 1 0.9999969005584717
cancer I-Disease 1 0.9999940395355225
cells O 0 0.0028308641631156206
to O 0 0.00012759520905092359
exit O 0 0.0019304887391626835
the O 0 0.0001558613294037059
cell O 0 0.001653289538808167
cycle O 0 0.0013603019760921597
and O 0 0.00031924620270729065
enter O 0 0.00800257083028555
G0 O 1 0.9994890689849854
/ O 0 0.12059561908245087
quiescence O 0 0.04617268219590187
in O 0 0.0004705374885816127
low O 0 0.006529718637466431
serum O 1 0.9737943410873413
. O 0 0.0012406232999637723

Both O 0 0.004534430336207151
VHL O 1 0.9977959394454956
- O 0 0.01182730682194233
positive O 0 0.0025487756356596947
and O 0 0.0012602685019373894
VHL O 1 0.9997677206993103
- O 0 0.05237943306565285
negative O 0 0.009388463571667671
RCC B-Disease 1 0.9997677206993103
cells O 0 0.004137333948165178
exit O 0 0.0029545463621616364
the O 0 0.0002565791946835816
cell O 0 0.001900775358080864
cycle O 0 0.0009437603875994682
by O 0 0.00015259756764862686
contact O 0 0.0037626316770911217
inhibition O 0 0.007697329390794039
. O 0 0.0009632812580093741

The O 0 0.0031750756315886974
cyclin O 0 0.3399587571620941
- O 0 0.006073830649256706
dependent O 0 0.00407704571262002
kinase O 0 0.018981995061039925
inhibitor O 0 0.06001363694667816
, O 0 0.0007983262185007334
p27 O 1 0.7837062478065491
, O 0 0.0005230702226981521
accumulates O 0 0.03298436477780342
upon O 0 0.0018902331357821822
serum O 1 0.9355798363685608
withdrawal O 0 0.0056652347557246685
, O 0 9.601611964171752e-05
only O 0 4.429466571309604e-05
in O 0 6.258176290430129e-05
the O 0 0.00013910238340031356
presence O 0 0.0006509622908197343
of O 0 0.00025073933647945523
VHL B-Disease 1 0.999854326248169
, O 0 0.00040115718729794025
as O 0 0.00018684452516026795
a O 0 0.0002990162174683064
result O 0 0.0002157181006623432
of O 0 1.7067470253095962e-05
the O 0 0.00018655223539099097
stabilization O 0 0.009020194411277771
of O 0 2.344701897527557e-05
the O 0 0.00021060554718133062
protein O 0 0.0011905368883162737
. O 0 0.0007288730121217668

We O 0 0.0009887531632557511
propose O 0 0.0022759996354579926
that O 0 4.9237765779253095e-05
the O 0 0.00010092685261042789
loss O 0 0.0011623307364061475
of O 0 5.9725156461354345e-05
wild O 0 0.002456425689160824
- O 0 0.07135859876871109
type O 0 0.1190866231918335
VHL B-Disease 1 0.999196469783783
gene O 0 0.003358140354976058
results O 0 0.00029591223574243486
in O 0 7.103281677700579e-05
a O 0 0.00028044162900187075
specific O 0 0.00046446442138403654
cellular O 0 0.024799734354019165
defect O 1 0.9973300695419312
in O 0 0.0007170908502303064
serum O 1 0.995151162147522
- O 0 0.004132500384002924
dependent O 0 0.0011489890748634934
growth O 0 0.0009899993892759085
control O 0 0.0008389913127757609
, O 0 0.00018587078375276178
which O 0 0.00013758876593783498
may O 0 0.0016359633300453424
initiate O 0 0.2005639523267746
tumor B-Disease 1 0.9997428059577942
formation O 0 0.021587589755654335
. O 0 0.0010175257921218872

This O 0 0.0006806681049056351
is O 0 0.0009844753658398986
corrected O 0 0.009075983427464962
by O 0 4.903992885374464e-05
the O 0 0.00015558545419480652
reintroduction O 0 0.00540741765871644
of O 0 5.357796908356249e-05
wild O 0 0.002558366861194372
- O 0 0.030956512317061424
type O 0 0.05879807099699974
VHL B-Disease 1 0.9996321201324463
, O 0 0.0022150520235300064
implicating O 1 0.9899800419807434
VHL B-Disease 1 0.9982319474220276
as O 0 0.0003187665715813637
the O 0 0.00026604835875332355
first O 0 0.0017746472731232643
tumor B-Disease 1 0.9997019171714783
suppressor O 0 0.04550965502858162
involved O 0 0.0006734876660630107
in O 0 8.246664219768718e-05
the O 0 0.00010231800843030214
regulation O 0 0.0005715668085031211
of O 0 5.9174395573791116e-05
cell O 0 0.004352417308837175
cycle O 0 0.002493130974471569
exit O 0 0.003973943646997213
, O 0 0.00016360721201635897
which O 0 4.666549648391083e-05
is O 0 0.0001287015329580754
consistent O 0 0.0007522788946516812
with O 0 5.808185596833937e-05
its O 0 0.00039720002678222954
gatekeeper O 1 0.9800850749015808
function O 0 0.0006705389241687953
in O 0 0.0002831141173373908
the O 0 0.0022816781420260668
kidney O 1 0.9999977350234985
. O 0 0.0006822710274718702
. O 0 0.0010657076491042972

Piebaldism B-Disease 1 0.999010443687439
with O 0 0.006551953498274088
deafness B-Disease 1 0.9999982118606567
: O 0 0.000858141400385648
molecular O 0 0.0011079520918428898
evidence O 0 0.0002273189020343125
for O 0 0.0001455551100661978
an O 0 0.0007833092822693288
expanded O 1 0.5074695348739624
syndrome O 1 0.9999978542327881
. O 0 0.001603670883923769

In O 0 0.0008947161841206253
a O 0 0.0014534745132550597
South O 0 0.0021806422155350447
African O 0 0.002826472744345665
girl O 0 0.008550126105546951
of O 0 0.0001686881441855803
Xhosa O 1 0.9884342551231384
stock O 0 0.007142586167901754
with O 0 0.0007411646656692028
severe O 1 0.999946117401123
piebaldism B-Disease 1 0.9984320998191833
and O 0 0.002896488644182682
profound O 1 0.9999269247055054
congenital O 1 1.0
sensorineural B-Disease 1 0.9999994039535522
deafness I-Disease 1 0.9999997615814209
we O 0 0.001275824848562479
identified O 0 0.0011342029320076108
a O 0 0.0006889273645356297
novel O 0 0.002698432421311736
missense O 0 0.0075152101926505566
substitution O 0 0.0007213059579953551
at O 0 0.0002710773260332644
a O 0 0.0003269384615123272
highly O 0 0.0010848649544641376
conserved O 0 0.0005034335190430284
residue O 0 0.0022165870759636164
in O 0 6.438016862375662e-05
the O 0 0.00018797192024067044
intracellular O 0 0.006336795631796122
kinase O 0 0.003835648763924837
domain O 0 0.00018415416707284749
of O 0 3.132668643957004e-05
the O 0 0.0009377325768582523
KIT O 1 0.9946427345275879
proto O 1 0.9768232107162476
- O 0 0.029677746817469597
oncogene O 1 0.8212528824806213
, O 0 0.0010737880365923047
R796G O 0 0.03181187063455582
. O 0 0.000947324326261878

Though O 0 0.01093157846480608
auditory B-Disease 1 0.9554051160812378
anomalies I-Disease 1 0.9124330282211304
have O 0 0.00023073893680702895
been O 0 0.00021333641780074686
observed O 0 0.000353125185938552
in O 0 0.00021686492254957557
mice O 0 0.004375713411718607
with O 0 0.0001729126670397818
dominant O 0 0.017534831538796425
white O 1 0.5467218160629272
spotting O 1 0.9974246025085449
( O 0 0.004975291900336742
W O 1 0.996228814125061
) O 0 0.00042187926010228693
due O 0 0.0009661313961260021
to O 0 0.000556024257093668
KIT O 1 0.9976086616516113
mutations O 0 0.00933039840310812
, O 0 0.002237729262560606
deafness B-Disease 1 0.999998927116394
is O 0 0.0005031132604926825
not O 0 0.00014230261149350554
typical O 0 0.0010123912943527102
in O 0 0.00028974731685593724
human O 0 0.0030354014597833157
piebaldism B-Disease 1 0.9817023277282715
. O 0 0.0012903492897748947

Thus O 0 0.0010541722876951098
, O 0 0.0001537379139335826
the O 0 0.00019727660401258618
occurrence O 0 0.007332146167755127
of O 0 0.000641692487988621
sensorineural B-Disease 1 0.9999984502792358
deafness I-Disease 1 0.9999996423721313
in O 0 0.0006534517742693424
this O 0 0.0006234028260223567
patient O 1 0.9995885491371155
extends O 0 0.010744002647697926
considerably O 0 0.004667467903345823
the O 0 0.00023000792134553194
phenotypic O 0 0.005907687358558178
range O 0 0.000684945029206574
of O 0 0.00011727608944056556
piebaldism B-Disease 1 0.986510694026947
due O 0 0.0016269307816401124
to O 0 0.0005025436403229833
KIT O 1 0.9909699559211731
gene O 0 0.0028630720917135477
mutation O 0 0.0018633609870448709
in O 0 0.00020328231039457023
humans O 0 0.002285662340000272
and O 0 0.0004574295016936958
tightens O 1 0.7448353171348572
the O 0 0.0007342585595324636
clinical O 1 0.9935739636421204
similarity O 0 0.0018967773066833615
between O 0 0.0006173212314024568
piebaldism B-Disease 0 0.4842272102832794
and O 0 6.987330561969429e-05
the O 0 5.409128425526433e-05
various O 0 7.492578151868656e-05
forms O 0 0.0011620639124885201
of O 0 0.001354471780359745
Waardenburg B-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999997615814209
. O 0 0.0009134552674368024
. O 0 0.0011892362963408232

Cycloheximide O 1 0.6061623692512512
facilitates O 0 0.008543046191334724
the O 0 0.00017661508172750473
identification O 0 0.0003589954285416752
of O 0 8.959650585893542e-05
aberrant O 0 0.22685158252716064
transcripts O 0 0.002084631472826004
resulting O 0 0.00102800817694515
from O 0 0.00011291737610008568
a O 0 0.0009239677456207573
novel O 0 0.0025767069309949875
splice O 0 0.02864978462457657
- O 0 0.00618950417265296
site O 0 0.0015192949213087559
mutation O 0 0.0016956280451267958
in O 0 0.0003065077180508524
COL17A1 O 1 0.961608350276947
in O 0 0.0002701618941500783
a O 0 0.002518554450944066
patient O 1 0.9990599751472473
with O 0 0.0009871992515400052
generalized O 1 0.9989107847213745
atrophic B-Disease 1 0.9999947547912598
benign I-Disease 1 0.9999822378158569
epidermolysis I-Disease 1 0.9999853372573853
bullosa I-Disease 1 0.9997387528419495
. O 0 0.007566935382783413

Patients O 1 0.9994364380836487
with O 0 0.0018722641980275512
generalized O 1 0.9985871315002441
atrophic B-Disease 1 0.999988317489624
benign I-Disease 1 0.9999767541885376
epidermolysis I-Disease 1 0.9999765157699585
bullosa I-Disease 1 0.9998102784156799
often O 0 0.003172940807417035
show O 0 0.0013548840070143342
decreased O 0 0.0034535760059952736
expression O 0 0.0004979519871994853
of O 0 0.00016420453903265297
type O 1 0.9929822683334351
XVII O 1 0.9999668598175049
collagen O 1 0.9992952346801758
, O 0 0.0002886089205276221
a O 0 0.0007261662976816297
transmembrane O 0 0.009539095684885979
hemidesmosomal O 0 0.013394776731729507
protein O 0 0.00033437515958212316
encoded O 0 0.00019053589494433254
by O 0 0.00035674506216309965
COL17A1 O 1 0.9774159789085388
. O 0 0.0011923755519092083

This O 0 0.00047604055725969374
report O 0 0.0007090883445926011
documents O 0 0.00036636769073083997
a O 0 0.0008232237305492163
novel O 0 0.0028992912266403437
splice O 0 0.02511897310614586
- O 0 0.005029902793467045
site O 0 0.0011631629895418882
mutation O 0 0.0014954195357859135
in O 0 0.00026725317002274096
COL17A1 O 1 0.9897587299346924
in O 0 0.00023650602088309824
a O 0 0.0023463841062039137
patient O 1 0.9992358684539795
with O 0 0.0009639187483116984
generalized O 1 0.9987315535545349
atrophic B-Disease 1 0.9999945163726807
benign I-Disease 1 0.9999891519546509
epidermolysis I-Disease 1 0.9999792575836182
bullosa I-Disease 1 0.9999140501022339
, O 0 0.0015522099565714598
and O 0 0.0003154657897539437
applies O 0 0.0015752045437693596
a O 0 0.0006574941799044609
new O 0 0.0004756686103064567
methodology O 0 0.0018187144305557013
to O 0 9.825134475249797e-05
define O 0 0.0010433308780193329
and O 0 0.00014131079660728574
characterize O 0 0.009689455851912498
the O 0 0.0001595237263245508
resulting O 0 0.0013415598077699542
mRNA O 0 0.001212875358760357
splice O 0 0.019216854125261307
variants O 0 0.004077260848134756
. O 0 0.0011810107389464974

Mutational O 0 0.11348830908536911
analysis O 0 0.0005916708032600582
of O 0 0.0001587233564350754
COL17A1 O 1 0.988060712814331
identified O 0 0.00137589150108397
a O 0 0.0016861188923940063
maternally O 1 0.5535970330238342
inherited O 1 0.9981807470321655
G O 1 0.6510217189788818
- O 0 0.005991297774016857
to O 0 0.000663392769638449
- O 0 0.07488366216421127
T O 1 0.9890707731246948
transversion O 0 0.02272910252213478
at O 0 0.00034880670136772096
the O 0 0.0002582801098469645
- O 0 0.0013135048793628812
1 O 0 0.0001439995685359463
position O 0 0.0002389589644735679
of O 0 4.8350066208513454e-05
exon O 0 0.014768093824386597
32 O 0 0.0013241872657090425
. O 0 0.0006884604808874428

This O 0 0.001348949153907597
acceptor O 0 0.058236900717020035
splice O 0 0.06484230607748032
- O 0 0.011411650106310844
site O 0 0.00233226059935987
mutation O 0 0.001575990580022335
led O 0 0.00024815509095788
to O 0 6.303083500824869e-05
the O 0 0.00012110261741327122
formation O 0 0.0023910733871161938
of O 0 0.00010903531074291095
aberrant O 0 0.19938428699970245
transcripts O 0 0.0016585530247539282
present O 0 0.00018121203174814582
at O 0 0.0004596463986672461
extremely O 0 0.009731636382639408
low O 0 0.004114267881959677
levels O 0 0.004967832937836647
. O 0 0.0011289599351584911

Based O 0 0.0006167460815049708
on O 0 0.00014794424350839108
our O 0 0.0002627611393108964
recent O 0 0.0006502461619675159
finding O 0 0.0013089178828522563
that O 0 0.00043472746619954705
cycloheximide O 1 0.9693558812141418
stabilized O 1 0.9896195530891418
mutant O 0 0.022344976663589478
COL17A1 O 1 0.9282639622688293
transcripts O 0 0.0024890464264899492
in O 0 0.0005259103490971029
keratinocytes O 1 0.801300048828125
homozygous O 0 0.0036170631647109985
for O 0 0.00020689991652034223
a O 0 0.002544003538787365
frameshift O 1 0.9888612627983093
mutation O 0 0.003658233443275094
, O 0 0.00012351619079709053
the O 0 0.00011346935207257047
effects O 0 0.0008804019307717681
of O 0 2.6356183298048563e-05
the O 0 0.00043594042654149234
splice O 0 0.04619087278842926
- O 0 0.0052931709215044975
site O 0 0.0012012904044240713
mutation O 0 0.0008322050562128425
on O 0 0.00011618115968303755
splicing O 0 0.001095790765248239
of O 0 0.00012773920025210828
COL17A1 O 1 0.9877561330795288
transcripts O 0 0.0010969249997287989
were O 0 4.2323263187427074e-05
determined O 0 0.0004472090513445437
using O 0 0.0002310687123099342
reverse O 0 0.006513066124171019
transcriptase O 0 0.028087958693504333
polymerase O 0 0.0050488789565861225
chain O 0 0.001944097108207643
reaction O 0 0.00041565680294297636
of O 0 1.988643271033652e-05
total O 0 0.0001838725438574329
RNA O 0 0.0016720319399610162
from O 0 0.00034436548594385386
keratinocytes O 0 0.06356474757194519
incubated O 0 0.0035703459288924932
for O 0 0.00029621057910844684
2 O 0 0.001280968077480793
. O 0 0.000783552648499608

5 O 0 0.003139298874884844
h O 0 0.00747526902705431
in O 0 0.000124045429402031
the O 0 0.000173603039002046
presence O 0 0.0007963438984006643
or O 0 0.00031650267192162573
absence O 0 0.0013070100685581565
of O 0 4.327494025346823e-05
10 O 0 0.0007969847065396607
microg O 0 0.3117853105068207
cycloheximide O 0 0.05695681646466255
per O 0 0.0010270454222336411
ml O 0 0.065960593521595
. O 0 0.0009849632624536753

Using O 0 0.0005273321294225752
this O 0 0.0001453054865123704
approach O 0 0.0017869786825031042
, O 0 0.00020507727458607405
an O 0 0.0007531362934969366
abnormally O 1 0.9861165881156921
spliced O 0 0.011282248422503471
transcript O 0 0.007446272298693657
was O 0 0.0006339658866636455
identified O 0 0.0003107876400463283
that O 0 2.3740303731756285e-05
contains O 0 4.0039627492660657e-05
an O 0 9.013132512336597e-05
extra O 0 0.0006169924163259566
264 O 0 0.00318046472966671
bases O 0 0.0005282552447170019
upstream O 0 0.002479367656633258
from O 0 0.0002312410797458142
exon O 0 0.01013201754540205
32 O 0 0.0007339640869759023
, O 0 0.00014650350203737617
resulting O 0 0.0008236520807258785
in O 0 0.00022242293925955892
a O 0 0.0024914201349020004
premature O 1 0.9898725748062134
termination O 0 0.3012286424636841
codon O 0 0.010480325669050217
27 O 0 0.0030626363586634398
bp O 0 0.025478243827819824
downstream O 0 0.0028779455460608006
from O 0 0.00012586016964633018
the O 0 0.00041789337410591543
cryptic O 0 0.1027708426117897
splice O 0 0.03529757261276245
site O 0 0.004303084220737219
. O 0 0.0009324520942755044

Three O 0 0.0005508210742846131
other O 0 0.00023529483587481081
splice O 0 0.01993434503674507
variants O 0 0.002215143758803606
, O 0 0.00014298484893515706
including O 0 5.1979615818709135e-05
one O 0 0.00010055172606371343
derived O 0 0.0001179214523290284
from O 0 5.3476531320484355e-05
the O 0 0.00019156916823703796
skipping O 0 0.005432193633168936
of O 0 0.00010185036080656573
exon O 0 0.019733835011720657
32 O 0 0.0010847450466826558
, O 0 0.00017165107419714332
were O 0 7.529507274739444e-05
also O 0 0.0003920911403838545
identified O 0 0.001405844697728753
. O 0 0.000574220553971827

These O 0 0.0003087716759182513
results O 0 0.0007270796922966838
indicate O 0 0.0005717067397199571
the O 0 0.00021246290998533368
usefulness O 0 0.013610972091555595
of O 0 0.0002452693588566035
cycloheximide O 1 0.9988985061645508
treatment O 1 0.9988942742347717
in O 0 0.00032296968856826425
evaluating O 0 0.007753078360110521
the O 0 0.00030670323758386075
abnormal O 0 0.007877914234995842
processing O 0 0.00028220622334629297
of O 0 3.195098906871863e-05
mRNA O 0 0.0006159312906675041
due O 0 0.0007231804775074124
to O 0 0.000254963175393641
splice O 0 0.023504581302404404
- O 0 0.006101319566369057
site O 0 0.001935465494170785
mutations O 0 0.0015864031156525016
, O 0 0.00029127366724424064
because O 0 0.001029381062835455
( O 0 0.0006358110695146024
i O 0 0.0017405013786628842
) O 0 0.00027058672276325524
aberrant O 0 0.008551406674087048
splicing O 0 0.0016173474723473191
often O 0 0.0002948359469883144
generates O 0 0.0015524390619248152
a O 0 0.0021810762118548155
premature O 1 0.8488484621047974
termination O 0 0.1327252984046936
codon O 0 0.006856289226561785
, O 0 0.0005304961814545095
( O 0 0.000757871544919908
ii O 0 0.03527350723743439
) O 0 0.00031755780219100416
transcripts O 0 0.0012193121947348118
with O 0 0.0004976423224434257
premature O 1 0.997698962688446
termination O 1 0.6969788074493408
codons O 0 0.004308569245040417
can O 0 0.00019697136303875595
occur O 0 0.0003521356557030231
at O 0 0.00037001812597736716
low O 0 0.0021776522044092417
or O 0 0.001182270934805274
undetectable O 1 0.9951466917991638
levels O 0 0.0026212988886982203
due O 0 0.001027552760206163
to O 0 0.000235339452046901
nonsense O 0 0.00919367652386427
- O 0 0.002544763730838895
mediated O 0 0.005025678779929876
mRNA O 0 0.0005599994328804314
decay O 0 0.0018435323145240545
, O 0 0.00022705376613885164
and O 0 0.0002977199328597635
( O 0 0.001056142384186387
iii O 0 0.06726092845201492
) O 0 0.00011431276652729139
the O 0 8.643879118608311e-05
levels O 0 0.00047670805361121893
of O 0 1.2893383427581284e-05
these O 0 3.658001514850184e-05
transcripts O 0 0.0007377571891993284
can O 0 5.434369813883677e-05
be O 0 3.971028854721226e-05
increased O 0 0.0002242704649688676
by O 0 0.00018643132352735847
cycloheximide O 0 0.4778845012187958
. O 0 0.0008726614178158343

A O 0 0.007560334634035826
deletion O 0 0.016656117513775826
mutation O 0 0.0048955464735627174
in O 0 0.0005931766936555505
COL17A1 O 1 0.9868947267532349
in O 0 0.00020163280714768916
five O 0 0.00027864158619195223
Austrian O 0 0.0037442571483552456
families O 0 0.00048198128934018314
with O 0 0.0009610663400962949
generalized O 1 0.9986109733581543
atrophic B-Disease 1 0.9999971389770508
benign I-Disease 1 0.9999874830245972
epidermolysis I-Disease 1 0.999962329864502
bullosa I-Disease 1 0.9994239807128906
represents O 0 0.005724571645259857
propagation O 0 0.0014718930469825864
of O 0 5.2278330258559436e-05
an O 0 0.0006425914471037686
ancestral O 0 0.011547944508492947
allele O 0 0.017098791897296906
. O 0 0.0012611454585567117

Patients O 1 0.9996907711029053
with O 0 0.00156205496750772
generalized O 1 0.9990094900131226
atrophic B-Disease 1 0.9999969005584717
benign I-Disease 1 0.9999910593032837
epidermolysis I-Disease 1 0.9999864101409912
bullosa I-Disease 1 0.999848484992981
, O 0 0.0011462102411314845
a O 0 0.0010122561361640692
usually O 0 0.000514583894982934
nonlethal O 0 0.02214435674250126
form O 0 0.0005419465014711022
of O 0 0.0004717626725323498
junctional B-Disease 1 0.9995892643928528
epidermolysis I-Disease 1 0.9999567270278931
bullosa I-Disease 1 0.9996559619903564
, O 0 0.0008642894099466503
have O 0 0.00028638626099564135
generalized O 0 0.04091354086995125
blistering B-Disease 1 0.9945366382598877
, O 0 0.004781344439834356
nail B-Disease 1 0.9999897480010986
dystrophy I-Disease 1 0.999998927116394
, O 0 0.01811116561293602
patchy B-Disease 1 0.9999704360961914
alopecia I-Disease 1 0.9999997615814209
, O 0 0.0026616074610501528
and O 0 0.008047514595091343
dental B-Disease 1 0.9999988079071045
abnormalities I-Disease 1 0.9997879862785339
. O 0 0.0015017911791801453

Skin B-Disease 1 0.9999827146530151
fragility I-Disease 1 0.9991267323493958
in O 0 0.0005728189717046916
most O 0 0.0005065869190730155
cases O 0 0.0025791150983422995
is O 0 0.0003454658726695925
due O 0 0.0006839839043095708
to O 0 0.00010477991600055248
mutations O 0 0.0006307326257228851
in O 0 6.0188678617123514e-05
the O 0 0.0001699496788205579
gene O 0 0.0016842863988131285
encoding O 0 0.0020556384697556496
type O 0 0.4704439342021942
XVII O 1 0.9997597336769104
collagen O 1 0.9994378685951233
( O 0 0.00481398357078433
COL17A1 O 1 0.9965554475784302
) O 0 0.0008139186538755894
. O 0 0.0008631458040326834

Recently O 0 0.015694301575422287
, O 0 0.00032177654793486
we O 0 0.0002625059860292822
reported O 0 0.0009017078555189073
five O 0 0.0001329320075456053
Austrian O 0 0.0025524874217808247
families O 0 0.00033847277518361807
with O 0 0.0008445610292255878
generalized O 1 0.9993959665298462
atrophic B-Disease 1 0.9999971389770508
benign I-Disease 1 0.9999933242797852
epidermolysis I-Disease 1 0.9999935626983643
bullosa I-Disease 1 0.9999252557754517
who O 0 0.0019525979878380895
share O 0 0.0003248295106459409
the O 0 0.0001857133029261604
same O 0 0.0009326448198407888
COL17A1 O 1 0.9950696229934692
mutation O 0 0.007784483954310417
. O 0 0.0010628534946590662

Affected O 0 0.013914602808654308
individuals O 0 0.00035042487434111536
in O 0 0.00014447186549659818
three O 0 0.00010541147639742121
families O 0 0.00022704488947056234
are O 0 6.552572449436411e-05
homozygous O 0 0.0027358189690858126
for O 0 0.0004253180231899023
4003delTC O 0 0.3729991614818573
, O 0 0.00026767925010062754
whereas O 0 0.0006078690639697015
those O 0 4.641526902560145e-05
in O 0 7.214680226752535e-05
two O 0 6.272604514379054e-05
others O 0 0.00031812992529012263
are O 0 0.00010315483814338222
compound O 0 0.013716873712837696
heterozygotes O 1 0.9295365214347839
. O 0 0.0013028811663389206

To O 0 0.00044384165084920824
determine O 0 0.0007535491604357958
if O 0 0.0002529211633373052
the O 0 0.00016565828991588205
occurrence O 0 0.0028535460587590933
of O 0 0.00011639606236713007
4003delTC O 0 0.05976199731230736
in O 0 0.0002235505817225203
these O 0 0.0001337233989033848
unrelated O 0 0.005755911115556955
families O 0 0.0005219142767600715
signifies O 0 0.008112582378089428
propagation O 0 0.0007222200511023402
of O 0 2.684438914002385e-05
an O 0 0.00046640553046017885
ancestral O 0 0.006670292932540178
allele O 0 0.0065083932131528854
or O 0 0.0005328546976670623
a O 0 0.0019534446764737368
mutational O 1 0.9056620001792908
hot O 0 0.02263396792113781
spot O 0 0.0062630693428218365
, O 0 0.0004575503116939217
haplotypes O 0 0.005858107935637236
were O 0 7.096875924617052e-05
determined O 0 0.0006260912050493062
for O 0 0.0001598826638655737
polymorphisms O 0 0.002040947787463665
both O 0 0.00010769857181003317
within O 0 0.00019649283785838634
and O 0 0.0005429265438579023
flanking O 1 0.9599512815475464
COL17A1 O 1 0.9943442344665527
. O 0 0.0021125036291778088

Five O 0 0.0027250952553004026
intragenic O 0 0.098211869597435
polymorphisms O 0 0.005420032422989607
were O 0 6.280391971813515e-05
chosen O 0 0.00022781813459005207
based O 0 0.00011296690354356542
on O 0 0.00013606902211904526
their O 0 0.0001987678260775283
informativeness O 1 0.5534809827804565
. O 0 0.0010002033086493611

One O 0 0.00025518398615531623
of O 0 2.223756928287912e-05
these O 0 5.693591810995713e-05
, O 0 0.00018654031737241894
not O 0 0.00017065035353880376
previously O 0 0.0008725966326892376
reported O 0 0.0013232529163360596
, O 0 0.0001900456554722041
was O 0 0.0011129566701129079
2988 O 0 0.06253331154584885
A O 0 0.0026514322962611914
or O 0 0.0006044517504051328
C O 0 0.007384395692497492
that O 0 7.410647231154144e-05
introduces O 0 0.0016036126762628555
a O 0 0.0002651099639479071
new O 0 0.0002326477988390252
restriction O 0 0.0006459872238337994
site O 0 0.0007915269816294312
for O 0 0.00043165183160454035
Eco0109 O 0 0.3381872773170471
I O 0 0.012063084170222282
. O 0 0.0007409686804749072

All O 0 0.00020807961118407547
the O 0 0.0006688928697258234
4003delTC O 0 0.0752730667591095
alleles O 0 0.00446954695507884
showed O 0 0.0007543876999989152
the O 0 0.00011527560855029151
same O 0 0.00026437093038111925
haplotype O 0 0.012390720658004284
for O 0 7.999885565368459e-05
these O 0 4.382834958960302e-05
five O 0 0.0003423143061809242
polymorphic O 0 0.14486032724380493
markers O 0 0.0099592050537467
. O 0 0.0010343189351260662

Fourteen O 0 0.012468920089304447
microsatellite O 0 0.06484085321426392
polymorphisms O 0 0.0072296964935958385
were O 0 9.453704842599109e-05
selected O 0 0.0002620011509861797
based O 0 0.0001133534315158613
on O 0 0.00011898738011950627
their O 0 0.00013801264867652208
high O 0 0.004311184864491224
heterozygosity O 1 0.5362577438354492
and O 0 6.643673259532079e-05
their O 0 4.5264892833074555e-05
location O 0 0.0005032765911892056
within O 0 0.0003740012471098453
10q23 O 0 0.11328838020563126
- O 0 0.00956091657280922
q25 O 0 0.031912509351968765
near O 0 0.008068072609603405
COL17A1 O 1 0.9437620043754578
. O 0 0.0016697737155482173

Three O 0 0.0005316310562193394
families O 0 0.00044602551497519016
shared O 0 0.001438873470760882
microsatellite O 0 0.0521029569208622
polymorphisms O 0 0.011335012502968311
covering O 0 0.006339925341308117
at O 0 0.0008183920290321112
most O 0 0.0005985440802760422
19 O 0 0.002427981933578849
cM O 0 0.005856564734131098
, O 0 0.00025994222960434854
whereas O 0 0.0007305039907805622
the O 0 0.00020818358461838216
others O 0 0.0004408520180732012
shared O 0 0.0003882544697262347
smaller O 0 0.0004274772072676569
regions O 0 0.0006839180714450777
consistent O 0 0.002745448611676693
with O 0 0.00032045767875388265
cross O 0 0.006487832870334387
- O 0 0.00203681830316782
over O 0 0.00012059303844580427
events O 0 0.00017457728972658515
during O 0 0.00041538066579960287
passage O 0 0.0004850841360166669
of O 0 1.7842210581875406e-05
this O 0 9.674411558080465e-05
mutation O 0 0.0011055703507736325
through O 0 0.00013948783453088254
several O 0 0.00015116743452381343
generations O 0 0.0022465246729552746
. O 0 0.0008153951494023204

These O 0 0.00031612723250873387
results O 0 0.000909379159566015
indicate O 0 0.0011889412999153137
that O 0 0.00028273678617551923
4003delTC O 0 0.028861721977591515
occurs O 0 0.0005387296550907195
on O 0 9.129520185524598e-05
a O 0 0.0003035464324057102
single O 0 0.0005173952667973936
ancestral O 0 0.005667281802743673
allele O 0 0.008362149819731712
. O 0 0.00042484814184717834
. O 0 0.0008886139839887619

The O 0 0.0037174129392951727
haptoglobin O 1 0.9760600924491882
- O 0 0.013850114308297634
gene O 0 0.002985395258292556
deletion O 0 0.004890183452516794
responsible O 0 0.003035759087651968
for O 0 0.0008496847585774958
anhaptoglobinemia B-Disease 1 0.9806784987449646
. O 0 0.0012145725777372718

We O 0 0.0006727486616000533
have O 0 0.00012938374129589647
found O 0 0.00015646617976017296
an O 0 0.00027614840655587614
allelic O 0 0.01571708545088768
deletion O 0 0.0020595118403434753
of O 0 4.870547491009347e-05
the O 0 0.0009099203743971884
haptoglobin O 1 0.9955014586448669
( O 0 0.0020984946750104427
Hp O 1 0.7605078220367432
) O 0 0.0003927914658561349
gene O 0 0.0007002545171417296
from O 0 4.112508031539619e-05
an O 0 0.00010948039562208578
individual O 0 0.00023312783741857857
with O 0 0.00047514564357697964
anhaptoglobinemia B-Disease 1 0.9836463928222656
. O 0 0.0014890619786456227

The O 0 0.003955448511987925
Hp O 0 0.44132596254348755
gene O 0 0.004774356726557016
cluster O 0 0.0032804186921566725
consists O 0 0.0002232536644442007
of O 0 4.8818237701198086e-05
coding O 0 0.005168157629668713
regions O 0 0.00020593020599335432
of O 0 2.2654458007309586e-05
the O 0 0.00022530010028276592
alpha O 0 0.002834154525771737
chain O 0 0.00171566940844059
and O 0 0.00015356109361164272
beta O 0 0.00225811917334795
chain O 0 0.0005810900474898517
of O 0 2.6737490770756267e-05
the O 0 0.0007164591224864125
haptoglobin O 1 0.9901924133300781
gene O 0 0.0069213444367051125
( O 0 0.0011429311707615852
Hp O 0 0.43748441338539124
) O 0 0.00011740208719857037
and O 0 2.6847665139939636e-05
of O 0 1.5581712432322092e-05
the O 0 0.0002710011031012982
alpha O 0 0.0028253113850951195
chain O 0 0.001784958760254085
and O 0 0.00014062380068935454
beta O 0 0.0023328731767833233
chain O 0 0.0005808728747069836
of O 0 2.5572313461452723e-05
the O 0 0.0007199420942924917
haptoglobin O 1 0.9937968254089355
- O 0 0.007397861685603857
related O 0 0.002414494287222624
gene O 0 0.006197311915457249
( O 0 0.0018136760918423533
Hpr O 1 0.9913723468780518
) O 0 0.00042136659612879157
, O 0 0.00015945588529575616
in O 0 0.00016708060866221786
tandem O 0 0.0038957754150032997
from O 0 8.610363147454336e-05
the O 0 0.0002449597232043743
5 O 0 0.000979868695139885
side O 0 0.0031646848656237125
. O 0 0.0008701966144144535

Southern O 0 0.013681406155228615
blot O 1 0.8354790210723877
and O 0 0.0008953093783929944
PCR O 0 0.013951209373772144
analyses O 0 0.0021639522165060043
have O 0 0.0002031966723734513
indicated O 0 0.001212757546454668
that O 0 3.7581357901217416e-05
the O 0 6.320152897387743e-05
individual O 0 0.0001895796158351004
with O 0 0.00024083246535155922
anhaptoglobinemia B-Disease 1 0.9182614684104919
was O 0 0.0012788694584742188
homozygous O 0 0.0019035780569538474
for O 0 0.00013884701183997095
the O 0 0.00044609393808059394
gene O 0 0.0038151501212269068
deletion O 0 0.003545955987647176
and O 0 0.00010136947821592912
that O 0 7.253725198097527e-05
the O 0 0.0002744279627222568
gene O 0 0.0031020508613437414
deletion O 0 0.005105967167764902
was O 0 0.0006051991949789226
included O 0 0.00010714359086705372
at O 0 0.00032406829996034503
least O 0 0.000187651181477122
from O 0 8.053249621298164e-05
the O 0 0.0002983555314131081
promoter O 0 0.01806788705289364
region O 0 0.0011825383407995105
of O 0 0.00012319281813688576
Hp O 0 0.2780076265335083
to O 0 0.0007207367452792823
Hpr O 1 0.9504390358924866
alpha O 0 0.002324628410860896
but O 0 0.0001677026302786544
not O 0 0.00013215042417868972
to O 0 0.0003631342260632664
Hpr O 1 0.9771444201469421
beta O 0 0.013801047578454018
( O 0 0.001342465286143124
Hpdel O 1 0.6371867656707764
) O 0 0.0007778339786455035
. O 0 0.0009992497507482767

In O 0 0.0007718339911662042
addition O 0 0.000554352009203285
, O 0 0.0002528813492972404
we O 0 0.000155567642650567
found O 0 0.00016240171680692583
seven O 0 0.00011691008694469929
individuals O 0 0.00014770193956792355
with O 0 0.0002454909554217011
hypohaptoglobinemia B-Disease 1 0.6277685165405273
in O 0 0.0001877181202871725
three O 0 0.00014321737398859113
families O 0 0.00034471412072889507
, O 0 0.0001623531134100631
and O 0 0.00011870395246660337
the O 0 0.00028629371081478894
genotypes O 0 0.01049055065959692
of O 0 2.8900301913381554e-05
six O 0 0.0001277122792089358
of O 0 2.2741993234376423e-05
the O 0 0.00014290308172348887
seven O 0 0.00019803931354545057
individuals O 0 0.00011263067426625639
were O 0 3.801266211667098e-05
found O 0 0.00012243642413523048
to O 0 0.00010230112820863724
be O 0 0.00041229117778129876
Hp2 O 1 0.9912971258163452
/ O 0 0.29687806963920593
Hpdel O 0 0.4918252229690552
. O 0 0.0012165269581601024

The O 0 0.003181514097377658
phenotypes O 0 0.04460521787405014
and O 0 0.000776821281760931
genotypes O 0 0.03162771463394165
in O 0 9.823917207540944e-05
one O 0 4.2832263716263697e-05
of O 0 1.0647017006704118e-05
these O 0 2.621715611894615e-05
three O 0 7.830022514099255e-05
families O 0 0.000183969343197532
showed O 0 0.0006139492033980787
the O 0 0.0001739815343171358
father O 0 0.0013381635071709752
to O 0 0.00015639967750757933
be O 0 0.00028508761897683144
hypohaptoglobinemic B-Disease 1 0.6864809989929199
( O 0 0.0009617817122489214
Hp2 O 1 0.8285238146781921
) O 0 0.00036057765828445554
and O 0 0.000656605523545295
Hp2 O 1 0.9969940185546875
/ O 0 0.3703523874282837
Hpdel O 1 0.5658672451972961
, O 0 0.00016546981350984424
the O 0 0.00021592676057480276
mother O 0 0.0017157078254967928
to O 0 9.377334208693355e-05
be O 0 0.0002212709659943357
Hp2 O 0 0.08287914097309113
- O 0 0.0021514303516596556
1 O 0 0.0005436584469862282
and O 0 0.000615249911788851
Hp1 O 1 0.9963219165802002
/ O 1 0.7382509112358093
Hp2 O 1 0.6233600378036499
, O 0 8.451731991954148e-05
one O 0 2.62547837337479e-05
of O 0 8.150675057549961e-06
the O 0 9.207612311001867e-05
two O 0 6.840434070909396e-05
children O 0 0.00035473430762067437
to O 0 0.00010453580034663901
be O 0 0.00026202236767858267
hypohaptoglobinemic B-Disease 0 0.24222955107688904
( O 0 0.0010111433221027255
Hp2 O 1 0.6870813369750977
) O 0 0.00048327448894269764
and O 0 0.0007496257312595844
Hp2 O 1 0.9974634647369385
/ O 1 0.7918839454650879
Hpdel O 1 0.8564367890357971
, O 0 0.00019949310808442533
and O 0 5.8094483392778784e-05
the O 0 9.70879991655238e-05
other O 0 8.697158773429692e-05
child O 0 0.0018625560915097594
to O 0 0.00010278524132445455
be O 0 0.00021490718063432723
Hp1 O 0 0.46085628867149353
and O 0 0.0005478867096826434
Hp1 O 1 0.99747234582901
/ O 1 0.6817367672920227
Hpdel O 1 0.5454127192497253
, O 0 0.00022421020548790693
showing O 0 0.0009304197737947106
an O 0 0.00044045152026228607
anomalous O 0 0.39951765537261963
inheritance O 0 0.0036063946317881346
of O 0 0.00023498207156080753
Hp O 1 0.9877232313156128
phenotypes O 0 0.015386147424578667
in O 0 0.00020245985069777817
the O 0 0.0005065174191258848
child O 0 0.009340598247945309
with O 0 0.0006913203978911042
Hp1 O 1 0.9899153709411621
. O 0 0.001424728543497622

The O 0 0.004557143431156874
Hp2 O 1 0.9957095384597778
/ O 1 0.8052291870117188
Hpdel O 0 0.4519568383693695
individuals O 0 0.0003936412394978106
had O 0 0.0003591708664316684
an O 0 0.00021153473062440753
extremely O 0 0.005035210866481066
low O 0 0.0011728303506970406
level O 0 0.0004902784712612629
of O 0 8.995829557534307e-05
Hp O 1 0.721555769443512
( O 0 0.0009568065288476646
mean O 0 0.0050652651116251945
+ O 0 0.0700661912560463
/ O 0 0.02011404186487198
- O 0 0.005838280543684959
SD O 0 0.04236900806427002
= O 0 0.0022480343468487263
0 O 0 0.0006544399075210094
. O 0 0.00041592729394324124
049 O 1 0.9764106869697571
+ O 0 0.027024291455745697
/ O 0 0.009998423047363758
- O 0 0.0020538170356303453
0 O 0 0.0005525057786144316
. O 0 0.000394314294680953
043 O 1 0.7219513058662415
mg O 1 0.9045860171318054
/ O 0 0.03333575651049614
ml O 0 0.039605092257261276
; O 0 0.00041870164568535984
n O 0 0.002395445015281439
= O 0 0.0029333727434277534
6 O 0 0.0008213677792809904
) O 0 0.00011523691500769928
, O 0 9.465125185670331e-05
compared O 0 0.00020813934679608792
with O 0 3.5384488001000136e-05
the O 0 0.0001506291446276009
level O 0 0.0011864895932376385
( O 0 0.00031382640008814633
1 O 0 0.00034255129867233336
. O 0 0.00010620461398502812
64 O 0 0.0011649084044620395
+ O 0 0.01680315099656582
/ O 0 0.008461002260446548
- O 0 0.0014967944007366896
1 O 0 0.00042942084837704897
. O 0 0.00031218663207255304
07 O 0 0.348143994808197
mg O 1 0.9559059143066406
/ O 0 0.05263027548789978
ml O 0 0.0282917283475399
) O 0 0.00020127343304920942
obtained O 0 0.00021003803703933954
from O 0 0.00016887320089153945
52 O 0 0.0030989882070571184
healthy O 0 0.10440406203269958
volunteers O 0 0.004749552812427282
having O 0 0.003307879203930497
phenotype O 1 0.9384394288063049
Hp2 O 1 0.8765930533409119
, O 0 0.00029780963086523116
whereas O 0 0.0008968178881332278
the O 0 0.0006339459796436131
serum O 1 0.9935926795005798
Hp O 0 0.03154105320572853
level O 0 0.0003253468021284789
of O 0 1.3318651326699182e-05
an O 0 0.00013626378495246172
individual O 0 0.00024462034343741834
with O 0 0.00063200673321262
Hp1 O 1 0.9983336329460144
/ O 0 0.45164477825164795
Hpdel O 1 0.7557018995285034
was O 0 0.0016101949149742723
0 O 0 0.0013212059857323766
. O 0 0.0006232644082047045

50 O 0 0.00770064489915967
mg O 1 0.9764305949211121
/ O 0 0.34962865710258484
ml O 0 0.03408464416861534
, O 0 0.00019711621280293912
which O 0 6.066962669137865e-05
was O 0 0.000286997965304181
approximately O 0 8.650987001601607e-05
half O 0 6.34441603324376e-05
the O 0 8.26595351099968e-05
level O 0 0.0005699728499166667
of O 0 8.558366243960336e-05
Hp O 0 0.11662899702787399
in O 0 0.00030263769440352917
control O 0 0.0020960334222763777
sera O 0 0.02382594160735607
from O 0 9.753712947713211e-05
the O 0 0.00046669720904901624
Hp1 O 1 0.9485694169998169
phenotype O 0 0.058745380491018295
( O 0 0.0003217587945982814
1 O 0 0.0004596289654728025
. O 0 0.00013761958689428866
26 O 0 0.0015648120315745473
+ O 0 0.016734139993786812
/ O 0 0.00701892701908946
- O 0 0.0014085129369050264
0 O 0 0.00028536227182485163
. O 0 0.00010023418872151524
33 O 0 0.0023386687971651554
mg O 1 0.9156914353370667
/ O 0 0.05959809571504593
ml O 0 0.024968935176730156
; O 0 0.00033258681651204824
n O 0 0.0026301301550120115
= O 0 0.0033966400660574436
9 O 0 0.0007320508011616766
) O 0 0.00011663437908282503
, O 0 7.460109918611124e-05
showing O 0 0.0007259713020175695
a O 0 0.0010235289810225368
gene O 0 0.00382214761339128
- O 0 0.006703091319650412
dosage O 0 0.3086051642894745
effect O 0 0.0022794867400079966
. O 0 0.0008433476323261857

The O 0 0.000752150546759367
other O 0 0.00034875483834184706
allele O 0 0.013792100362479687
( O 0 0.001888945116661489
Hp2 O 0 0.4022071361541748
) O 0 0.00010279592970618978
of O 0 2.263702845084481e-05
individuals O 0 0.0002523072180338204
with O 0 0.0007709839264862239
Hp2 O 1 0.9992223978042603
/ O 1 0.9758609533309937
Hpdel O 1 0.9875767230987549
was O 0 0.001020370633341372
found O 0 0.00022059035836718976
to O 0 6.440301513066515e-05
have O 0 5.252463961369358e-05
, O 0 5.5626303947065026e-05
in O 0 4.610157702700235e-05
all O 0 4.2847139411605895e-05
exons O 0 0.0037031937390565872
, O 0 0.00021663407096639276
no O 0 0.00033784928382374346
mutation O 0 0.0014542067656293511
, O 0 0.0001101086672861129
by O 0 7.368185470113531e-05
DNA O 0 0.001116617233492434
sequencing O 0 0.0017803090158849955
. O 0 0.0008611245430074632

On O 0 0.0003790785267483443
the O 0 7.521935913246125e-05
basis O 0 4.098339195479639e-05
of O 0 1.4544836631102953e-05
the O 0 0.00020246929489076138
present O 0 0.0003500849416013807
study O 0 0.0006436309777200222
, O 0 7.687820470891893e-05
the O 0 9.310934547102079e-05
mechanism O 0 0.0009576360462233424
of O 0 8.398834324907511e-05
anhaptoglobinemia B-Disease 0 0.3926805257797241
and O 0 6.919147563166916e-05
the O 0 9.438517008675262e-05
mechanism O 0 0.0007522627711296082
of O 0 7.45505458326079e-05
anomalous O 1 0.9331544637680054
inheritance O 0 0.004194681998342276
of O 0 0.0003087805234827101
Hp O 1 0.9911982417106628
phenotypes O 0 0.01956649124622345
were O 0 0.0001187358793686144
well O 0 0.0004697577387560159
explained O 0 0.004973696079105139
. O 0 0.000941405538469553

However O 0 0.0011376532493159175
, O 0 0.00018393603386357427
the O 0 0.00011878819350386038
mechanism O 0 0.0011691013351082802
of O 0 0.000175635505001992
hypohaptoglobinemia B-Disease 1 0.9520015120506287
remains O 0 0.009615988470613956
unknown O 0 0.0063199796713888645

ATM O 0 0.03759690374135971
mutations O 0 0.006379718426615
and O 0 0.0006059910519979894
phenotypes O 0 0.20695427060127258
in O 0 0.0037357485853135586
ataxia B-Disease 1 0.9999971389770508
- I-Disease 1 0.9987362027168274
telangiectasia I-Disease 1 0.9997223019599915
families O 0 0.0009858475532382727
in O 0 0.0002120850549545139
the O 0 0.00039932195795699954
British O 0 0.003994606900960207
Isles O 0 0.01201600395143032
: O 0 0.00019367852655705065
expression O 0 0.0002042046980932355
of O 0 4.7880490456009284e-05
mutant O 0 0.004104189574718475
ATM O 0 0.00320960721001029
and O 0 8.182150486391038e-05
the O 0 0.0002508790057618171
risk O 1 0.6790857911109924
of O 0 0.0005815812037326396
leukemia B-Disease 1 1.0
, O 1 0.8810317516326904
lymphoma B-Disease 1 1.0
, O 0 0.00402264017611742
and O 0 0.23736682534217834
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999977350234985
. O 0 0.0015606351662427187

We O 0 0.0008721896447241306
report O 0 0.00045243592467159033
the O 0 8.486014121444896e-05
spectrum O 0 0.0012269408907741308
of O 0 6.256147025851533e-05
59 O 0 0.004278183914721012
ATM O 0 0.010342765599489212
mutations O 0 0.0020990995690226555
observed O 0 0.0007695199456065893
in O 0 0.0009273760369978845
ataxia B-Disease 1 0.9999895095825195
- I-Disease 1 0.9886334538459778
telangiectasia I-Disease 1 0.9997102618217468
( O 0 0.0033064803574234247
A B-Disease 1 0.999330997467041
- I-Disease 1 0.999201238155365
T I-Disease 1 0.9999547004699707
) O 0 0.0013707777252420783
patients O 1 0.9994768500328064
in O 0 0.00012594432337209582
the O 0 0.0003481120802462101
British O 0 0.0039311801083385944
Isles O 0 0.030689304694533348
. O 0 0.001179964980110526

Of O 0 0.0004725281905848533
51 O 0 0.009278248064219952
ATM O 0 0.0497790165245533
mutations O 0 0.006057955324649811
identified O 0 0.0012132989941164851
in O 0 0.0001499126956332475
families O 0 0.0002531643258407712
native O 0 0.00021499981812667102
to O 0 8.693975541973487e-05
the O 0 0.0002214926207670942
British O 0 0.002588146599009633
Isles O 0 0.015310602262616158
, O 0 0.00032826425740495324
11 O 0 0.000662654172629118
were O 0 0.00012701009109150618
founder O 0 0.01808658242225647
mutations O 0 0.002303307643160224
, O 0 0.00012694396718870848
and O 0 6.942088657524437e-05
2 O 0 9.800459520192817e-05
of O 0 1.1535590601852164e-05
these O 0 5.3236119128996506e-05
11 O 0 0.0011431848397478461
conferred O 0 0.057839952409267426
a O 0 0.0030162811744958162
milder O 1 0.9963616728782654
clinical O 1 0.9995762705802917
phenotype O 0 0.3488428592681885
with O 0 0.00012354152568150312
respect O 0 0.0004848016833420843
to O 0 0.00017650684458203614
both O 0 0.0009344095014967024
cerebellar B-Disease 1 0.9999738931655884
degeneration I-Disease 1 0.9999904632568359
and O 0 0.0005087378667667508
cellular O 0 0.010332081466913223
features O 0 0.0011418673675507307
. O 0 0.000882254505995661

We O 0 0.0008558419649489224
report O 0 0.0006774381618015468
, O 0 8.023522241273895e-05
in O 0 7.645088771823794e-05
two O 0 0.00014572743384633213
A B-Disease 1 0.9860398769378662
- I-Disease 1 0.9902358651161194
T I-Disease 1 0.9993751645088196
families O 0 0.00019544926180969924
, O 0 0.00010195053619099781
an O 0 0.0002690047840587795
ATM O 0 0.010463781654834747
mutation O 0 0.003277913900092244
( O 0 0.0008705586078576744
7271T O 0 0.06582856923341751
- O 0 0.01001206785440445
- O 0 0.008360379375517368
> O 0 0.010358680039644241
G O 0 0.016031717881560326
) O 0 0.0001927346020238474
that O 0 0.0001373996929032728
may O 0 0.00041145095019601285
be O 0 4.81929600937292e-05
associated O 0 6.204233068274334e-05
with O 0 2.290530210302677e-05
an O 0 0.00014966874732635915
increased O 0 0.0008557444089092314
risk O 1 0.7574222087860107
of O 0 0.0009020206052809954
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999966621398926
in O 0 0.00048699110629968345
both O 0 0.0007619253592565656
homozygotes O 1 0.9965702295303345
and O 0 0.0008956592064350843
heterozygotes O 1 0.9392142295837402
( O 0 0.0006918608560226858
relative O 0 0.0013261245330795646
risk O 0 0.03361279144883156
12 O 0 0.0005254102870821953
. O 0 0.00015517385327257216
7 O 0 0.0006799325929023325
; O 0 0.0003405266907066107
P O 0 0.09585060924291611
= O 0 0.003954527899622917
. O 0 0.0006157223833724856
0025 O 1 0.9672451615333557
) O 0 0.0003879943396896124
, O 0 0.00013465106894727796
although O 0 0.0001175079305539839
there O 0 4.822936898563057e-05
is O 0 9.839938866207376e-05
a O 0 0.0004189487954135984
less O 0 0.002026067115366459
severe O 1 0.9999309778213501
A B-Disease 1 0.9995146989822388
- I-Disease 1 0.9990907907485962
T I-Disease 1 0.9998594522476196
phenotype O 0 0.06675069034099579
in O 0 8.23077789391391e-05
terms O 0 9.867507469607517e-05
of O 0 1.5279802028089762e-05
the O 0 0.0001380147587042302
degree O 0 0.0015426345635205507
of O 0 0.0003385201853234321
cerebellar B-Disease 1 0.9999951124191284
degeneration I-Disease 1 0.9999959468841553
. O 0 0.0027183261699974537

This O 0 0.0006758389645256102
mutation O 0 0.004793157801032066
( O 0 0.0012461933074519038
7271T O 0 0.11932039260864258
- O 0 0.01311315968632698
- O 0 0.010733247734606266
> O 0 0.014472736977040768
G O 0 0.013526243157684803
) O 0 0.0001505599357187748
also O 0 8.148349297698587e-05
allows O 0 9.029717330122367e-05
expression O 0 0.00014187123451847583
of O 0 2.3596188839292154e-05
full O 0 0.0008270633989013731
- O 0 0.0021055147517472506
length O 0 0.00047295811236836016
ATM O 0 0.003034809837117791
protein O 0 0.00032890457077883184
at O 0 0.00025224778801202774
a O 0 0.00044980290113016963
level O 0 0.0008170175133273005
comparable O 0 0.001082379138097167
with O 0 8.74757970450446e-05
that O 0 0.00014128453040029854
in O 0 0.00039546622429043055
unaffected O 0 0.2915121018886566
individuals O 0 0.0009126876248046756
. O 0 0.0011332364520058036

In O 0 0.0006838652188889682
addition O 0 0.00041482257074676454
, O 0 0.00011935909424209967
we O 0 7.131366146495566e-05
have O 0 4.4377917220117524e-05
studied O 0 0.00043277625809423625
18 O 0 0.0006108580273576081
A B-Disease 1 0.997297465801239
- I-Disease 1 0.9994195699691772
T I-Disease 1 0.9999864101409912
patients O 1 0.9997921586036682
, O 0 0.0001446298265364021
in O 0 0.00010634720092639327
15 O 0 0.00028804675093851984
families O 0 0.00014778377953916788
, O 0 0.00022215164790395647
who O 0 0.0021795989014208317
developed O 1 0.9984897375106812
leukemia B-Disease 1 1.0
, O 0 0.30185943841934204
lymphoma B-Disease 1 1.0
, O 0 0.005150389391928911
preleukemic O 1 0.9997678399085999
T O 1 0.999721348285675
- O 0 0.011121966876089573
cell O 0 0.003104727016761899
proliferation O 0 0.02650011144578457
, O 0 0.000969251268543303
or O 1 0.7510373592376709
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.0006326923030428588
mostly O 0 0.00034053903073072433
in O 0 0.0007082154625095427
childhood O 1 0.9984867572784424
. O 0 0.0014437255449593067

A O 0 0.004334674216806889
wide O 0 0.0012361494591459632
variety O 0 0.00048624517512507737
of O 0 9.12528921617195e-05
ATM O 0 0.04614017903804779
mutation O 0 0.003625455778092146
types O 0 0.0005928401369601488
, O 0 0.00021269194257911295
including O 0 0.00027721308288164437
missense O 0 0.028482744470238686
mutations O 0 0.0024544952902942896
and O 0 0.00012332998448982835
in O 0 0.0004159276722930372
- O 0 0.008145801723003387
frame O 0 0.004403073340654373
deletions O 0 0.002988851862028241
, O 0 0.0001746047637425363
were O 0 6.90406741341576e-05
seen O 0 0.0007757816347293556
in O 0 0.00019216115470044315
these O 0 0.00043315181392244995
patients O 1 0.9998403787612915
. O 0 0.0012248533312231302

We O 0 0.0009700896916911006
also O 0 0.00025223963893949986
show O 0 0.0002068677422357723
that O 0 3.852529698633589e-05
25 O 0 4.613667260855436e-05
% O 0 5.476792466652114e-06
of O 0 9.894530194287654e-06
all O 0 0.00011953768989769742
A B-Disease 1 0.9986302852630615
- I-Disease 1 0.9990705847740173
T I-Disease 1 0.9999572038650513
patients O 1 0.9993153810501099
carried O 0 0.00029764132341369987
in O 0 0.0002809921570587903
- O 0 0.004803386516869068
frame O 0 0.004327649716287851
deletions O 0 0.005639218259602785
or O 0 0.0014275700086727738
missense O 0 0.10557911545038223
mutations O 0 0.003203584114089608
, O 0 0.00010622010449878871
many O 0 3.685773117467761e-05
of O 0 3.03434699162608e-05
which O 0 9.417112596565858e-05
were O 0 5.0157541409134865e-05
also O 0 0.00015046176849864423
associated O 0 0.00013575513730756938
with O 0 3.998617103206925e-05
expression O 0 0.000263793597696349
of O 0 4.5309723645914346e-05
mutant O 0 0.005612819455564022
ATM O 0 0.007461105939000845
protein O 0 0.0013528784038498998
. O 0 0.0007957398775033653

The O 0 0.002166772959753871
DMPK O 1 0.8938137292861938
gene O 0 0.0019919713959097862
of O 0 0.0002432493056403473
severely O 1 0.9998747110366821
affected O 1 0.9984292387962341
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
patients O 1 0.9999908208847046
is O 0 0.0038091272581368685
hypermethylated O 1 0.9894919395446777
proximal O 1 0.9807335138320923
to O 0 0.00018213095609098673
the O 0 0.00019432597036939114
largely O 0 0.0013376252027228475
expanded O 0 0.004796329885721207
CTG O 1 0.9808721542358398
repeat O 0 0.023067636415362358
. O 0 0.0013644611462950706

Using O 0 0.0014445300912484527
methylation O 0 0.00404000747948885
- O 0 0.004004378337413073
sensitive O 0 0.003126799361780286
restriction O 0 0.0009388505714014173
enzymes O 0 0.0007586606661789119
, O 0 0.00023629232600796968
we O 0 0.0003110099059995264
characterized O 0 0.004615071229636669
the O 0 0.00019227662414778024
methylation O 0 0.0012338737724348903
pattern O 0 0.0014736797893419862
on O 0 0.00017704656056594104
the O 0 0.00019020336912944913
5 O 0 0.00044838141184300184
side O 0 0.0005971813225187361
of O 0 3.4592267184052616e-05
the O 0 0.0009562209597788751
CTG O 1 0.9960935711860657
repeat O 0 0.006060258485376835
in O 0 0.00015793605416547507
the O 0 0.0005668144440278411
DMPK O 1 0.9893763065338135
gene O 0 0.0010268266778439283
of O 0 4.0847997297532856e-05
normal O 0 0.001640048110857606
individuals O 0 0.00012455059913918376
and O 0 9.770300675882027e-05
of O 0 0.00021705441758967936
patients O 1 0.9999910593032837
affected O 1 0.5353763103485107
with O 0 0.028929641470313072
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
, O 0 0.0010475128656253219
showing O 0 0.00197248044423759
expansions O 0 0.0017683509504422545
of O 0 2.6911311579169706e-05
the O 0 0.0003977009328082204
repetitive O 0 0.37172818183898926
sequence O 0 0.0009853303199633956
. O 0 0.0010820378083735704

The O 0 0.001495923730544746
gene O 0 0.0031694993376731873
segment O 0 0.002500568749383092
analyzed O 0 0.0008377530612051487
corresponds O 0 0.0003400332934688777
to O 0 7.04378035152331e-05
the O 0 0.0001873751316452399
genomic O 0 0.007788992486894131
SacI O 1 0.9052649736404419
- O 0 0.006515023298561573
HindIII O 0 0.02557135559618473
fragment O 0 0.0021363594569265842
carrying O 0 0.0009529110393486917
exons O 0 0.007096616551280022
11 O 0 0.0022524099331349134
- O 0 0.004049954004585743
15 O 0 0.0007721201982349157
. O 0 0.0005132129299454391

There O 0 0.0007886445382609963
is O 0 0.000620636623352766
constitutive O 0 0.019689036533236504
methylation O 0 0.0015464166644960642
in O 0 0.00043528267997317016
intron O 0 0.40274330973625183
12 O 0 0.000506801821757108
at O 0 0.00022813398391008377
restriction O 0 0.0003618317423388362
sites O 0 0.00013415100693237036
of O 0 7.89421537774615e-05
SacII O 1 0.8864511847496033
and O 0 0.0005142269656062126
HhaI O 1 0.5477227568626404
, O 0 0.0003457156417425722
localized O 0 0.008134170435369015
1 O 0 0.0006607093382626772
, O 0 0.00036347360583022237
159 O 0 0.008608374744653702
- O 0 0.0022544690873473883
1 O 0 0.00044940088992007077
, O 0 0.00025044381618499756
232 O 0 0.008474721573293209
bp O 0 0.019551550969481468
upstream O 0 0.0013717073015868664
of O 0 5.067254096502438e-05
the O 0 0.001308272941969335
CTG O 1 0.9899696707725525
repeat O 0 0.012869415804743767
, O 0 0.00036905775777995586
whereas O 0 0.0009960068855434656
most O 0 0.00023172175860963762
, O 0 0.0002391121379332617
if O 0 0.00025107088731601834
not O 0 4.170020474703051e-05
all O 0 1.3020606274949387e-05
, O 0 3.7355610402300954e-05
of O 0 6.871327514090808e-06
the O 0 4.860126500716433e-05
other O 0 2.7552816391107626e-05
sites O 0 0.00010537911293795332
of O 0 7.078167982399464e-05
SacII O 1 0.9826453924179077
, O 0 0.0010670882184058428
HhaI O 1 0.879052460193634
, O 0 0.0003537023440003395
and O 0 0.00025073645520024
HpaII O 0 0.13168634474277496
in O 0 0.00013801659224554896
this O 0 0.00010031420970335603
region O 0 0.0011183411115780473
are O 0 0.00011144948803121224
unmethylated O 0 0.10829619318246841
, O 0 0.0002508636680431664
in O 0 0.00022486915986519307
normal O 0 0.0016791700618341565
individuals O 0 0.00013245914306025952
and O 0 5.583874008152634e-05
most O 0 7.916061440482736e-05
of O 0 6.492078682640567e-05
the O 0 0.002264666836708784
patients O 1 0.9999291896820068
. O 0 0.0011026861611753702

In O 0 0.000356916367309168
a O 0 0.00022645227727480233
number O 0 3.1595511245541275e-05
of O 0 6.275111809372902e-05
young O 0 0.03369206190109253
and O 0 0.0018216458847746253
severely O 1 0.9999680519104004
affected O 1 0.9926418662071228
patients O 1 0.9999412298202515
, O 0 0.00032966615981422365
however O 0 0.0003016323607880622
, O 0 0.00010599265078781173
complete O 0 0.0003700900706462562
methylation O 0 0.000202344439458102
of O 0 7.70600945543265e-06
these O 0 2.967000000353437e-05
restriction O 0 0.00045926368329674006
sites O 0 0.00020857718482147902
was O 0 0.000410556880524382
found O 0 0.00014000885130371898
in O 0 7.059038034640253e-05
the O 0 0.00037791021168231964
mutated O 0 0.02352295257151127
allele O 0 0.013362099416553974
. O 0 0.0018660164205357432

In O 0 0.0003209300630260259
most O 0 8.925557631300762e-05
of O 0 3.090689278906211e-05
these O 0 0.00040351637289859354
patients O 1 0.9999538660049438
, O 0 0.00013447500532492995
the O 0 0.0003280411765445024
onset O 1 0.9981087446212769
of O 0 8.869534212863073e-05
the O 0 0.03490447625517845
disease O 1 0.9999991655349731
was O 1 0.9779304265975952
congenital O 1 0.9999992847442627
. O 0 0.0026768450625240803

Preliminary O 0 0.003369123674929142
in O 0 0.0010517917107790709
vivo O 0 0.031713880598545074
footprinting O 1 0.9377689957618713
data O 0 0.00023274317209143192
gave O 0 0.0005393960746005177
evidence O 0 0.0001978737855097279
for O 0 0.00015196664026007056
protein O 0 0.0011279978789389133
- O 0 0.00433999951928854
DNA O 0 0.0011651840759441257
contact O 0 0.0010434818686917424
in O 0 0.0001899253693409264
normal O 0 0.0018187230452895164
genes O 0 0.0004876046732533723
at O 0 0.00040603571687825024
an O 0 0.0008678536396473646
Sp1 O 1 0.9602389335632324
consensus O 0 0.0007272626389749348
binding O 0 0.0006965176435187459
site O 0 0.0006372936186380684
upstream O 0 0.0010738743003457785
of O 0 4.1771287214942276e-05
the O 0 0.0009196907631121576
CTG O 1 0.9963305592536926
repeat O 0 0.006697823293507099
and O 0 9.441326255910099e-05
for O 0 0.00010215109796263278
a O 0 0.0002591254306025803
significant O 0 0.0003628023259807378
reduction O 0 0.0009026586194522679
of O 0 1.3256180864118505e-05
this O 0 4.998793519916944e-05
interaction O 0 0.00026549238828010857
in O 0 0.0001235754316439852
cells O 0 0.0007346399943344295
with O 0 0.00011153719970025122
a O 0 0.002734192181378603
hypermethylated O 1 0.9930952191352844
DMPK O 1 0.9953108429908752
gene O 0 0.0039058970287442207
. O 0 0.00031279708491638303
. O 0 0.0007375595741905272

The O 0 0.006506472826004028
hemochromatosis B-Disease 1 0.9999746084213257
gene O 0 0.005478298291563988
product O 0 0.001525990548543632
complexes O 0 0.002761200536042452
with O 0 0.00010329972428735346
the O 0 0.0005876325303688645
transferrin O 1 0.9476812481880188
receptor O 0 0.0056615183129906654
and O 0 0.0003786299785133451
lowers O 0 0.06448033452033997
its O 0 0.0002095993113471195
affinity O 0 0.0016282303258776665
for O 0 0.00030956603586673737
ligand O 0 0.007179161533713341
binding O 0 0.0019273408688604832
. O 0 0.0010517345508560538

We O 0 0.0020555523224174976
recently O 0 0.004626625217497349
reported O 0 0.000867401366122067
the O 0 0.00012198077456559986
positional O 0 0.0037021117750555277
cloning O 0 0.001545888022519648
of O 0 2.5279145120293833e-05
a O 0 0.0007429947727359831
candidate O 0 0.0020678502041846514
gene O 0 0.0025909668765962124
for O 0 0.0018296316266059875
hereditary B-Disease 1 0.9999390840530396
hemochromatosis I-Disease 1 0.9999996423721313
called O 1 0.9247202277183533
HFE O 1 0.9997331500053406
. O 0 0.002954509574919939

The O 0 0.0012116058496758342
gene O 0 0.0028155846521258354
product O 0 0.000826700939796865
, O 0 0.0001588570448802784
a O 0 0.00027915797545574605
member O 0 0.0001682050060480833
of O 0 2.3614804376848042e-05
the O 0 0.00041562088881619275
major O 0 0.0141943683847785
histocompatibility O 1 0.9996634721755981
complex O 0 0.020127950236201286
class O 0 0.010629468597471714
I O 0 0.24255727231502533
- O 0 0.003708380041643977
like O 0 0.0004396727017592639
family O 0 0.0006791098276153207
, O 0 0.0001861110795289278
was O 0 0.00047423611977137625
found O 0 9.45538267842494e-05
to O 0 2.5806721168919466e-05
have O 0 3.794139047386125e-05
a O 0 0.0003457446291577071
mutation O 0 0.0024294655304402113
, O 0 0.0007585427956655622
Cys O 1 0.993077278137207
- O 0 0.005906565114855766
282 O 0 0.0133718466386199
- O 0 0.007821623235940933
- O 0 0.00798717886209488
> O 0 0.015651367604732513
Tyr O 1 0.989582896232605
( O 0 0.0012288683792576194
C282Y O 0 0.026014888659119606
) O 0 0.0001969777513295412
, O 0 9.571701230015606e-05
in O 0 0.00011249167437199503
85 O 0 0.0008013417827896774
% O 0 3.873066452797502e-05
of O 0 0.00012895891268271953
patient O 1 0.9991205334663391
chromosomes O 0 0.0022400591988116503
. O 0 0.0011435666820034385

This O 0 0.0006982689374126494
mutation O 0 0.004492159467190504
eliminates O 0 0.007499102037400007
the O 0 0.00023102819977793843
ability O 0 0.0019660270772874355
of O 0 0.00024652411229908466
HFE O 1 0.9981279969215393
to O 0 0.0003159723710268736
associate O 0 0.003203636035323143
with O 0 0.00031667412258684635
beta2 O 1 0.9874905943870544
- O 0 0.025287801399827003
microglobulin O 1 0.8879616260528564
( O 0 0.0009598154574632645
beta2m O 0 0.4684487581253052
) O 0 0.00019856628205161542
and O 0 0.0001540147786727175
prevents O 0 0.017291894182562828
cell O 0 0.00331453257240355
- O 0 0.0027702648658305407
surface O 0 0.0019898044411092997
expression O 0 0.001588529790751636
. O 0 0.0007184565183706582

A O 0 0.004558835178613663
second O 0 0.0009710196172818542
mutation O 0 0.0019696042872965336
that O 0 0.00010501527140149847
has O 0 0.0002987147599924356
no O 0 0.0001449288392905146
effect O 0 0.0008451688336208463
on O 0 0.0007122185197658837
beta2m O 1 0.9818857312202454
association O 0 0.041482970118522644
, O 0 0.0010082931257784367
H63D O 1 0.9953538179397583
, O 0 0.00041980910464189947
was O 0 0.00079386867582798
found O 0 0.00016478174075018615
in O 0 5.516586679732427e-05
eight O 0 9.059006697498262e-05
out O 0 6.291829777183011e-05
of O 0 3.8402089558076113e-05
nine O 0 0.001761721447110176
patients O 1 0.9993531107902527
heterozygous O 0 0.001828499836847186
for O 0 0.00011261627514613792
the O 0 0.0004702043370343745
C282Y O 0 0.11687488853931427
mutant O 0 0.011611324734985828
. O 0 0.0009072449756786227

In O 0 0.0005887341685593128
this O 0 0.0001811740075936541
report O 0 0.000928044319152832
, O 0 0.00013470063277054578
we O 0 0.00014449610898736864
demonstrate O 0 0.0009577559540048242
in O 0 0.00021195871522650123
cultured O 0 0.01668575219810009
293 O 0 0.06955890357494354
cells O 0 0.009752059355378151
overexpressing O 1 0.9789354205131531
wild O 0 0.0032170789781957865
- O 0 0.009418834000825882
type O 0 0.004053976386785507
or O 0 0.0008399664075113833
mutant O 0 0.015636498108506203
HFE O 1 0.9792048335075378
proteins O 0 0.00020013250468764454
that O 0 6.290545570664108e-05
both O 0 6.979930913075805e-05
the O 0 0.00018670667486730963
wild O 0 0.0017470436869189143
- O 0 0.005999397486448288
type O 0 0.0027369288727641106
and O 0 0.0007808037335053086
H63D O 1 0.9984413981437683
HFE O 1 0.9957283139228821
proteins O 0 0.0004300168657209724
form O 0 0.0007994053885340691
stable O 0 0.021371832117438316
complexes O 0 0.00224220659583807
with O 0 8.54962199809961e-05
the O 0 0.000487217417685315
transferrin O 1 0.9867295026779175
receptor O 0 0.017067452892661095
( O 0 0.0028962078504264355
TfR O 1 0.9943785071372986
) O 0 0.0010135782649740577
. O 0 0.001009351690299809

The O 0 0.0020636182744055986
C282Y O 0 0.04203847795724869
mutation O 0 0.004143991973251104
nearly O 0 0.002120529068633914
completely O 0 0.005888248328119516
prevents O 0 0.007360026706010103
the O 0 0.00020466589194256812
association O 0 0.0014586198376491666
of O 0 3.237505370634608e-05
the O 0 0.0005073504289612174
mutant O 0 0.016712475568056107
HFE O 1 0.980838418006897
protein O 0 0.0004756472771987319
with O 0 0.00015289730799850076
the O 0 0.0010615369537845254
TfR O 1 0.9958718419075012
. O 0 0.0015003877924755216

Studies O 0 0.0016656622756272554
on O 0 0.0006313767516985536
cell O 0 0.005573610309511423
- O 0 0.005127578508108854
associated O 0 0.0008812151500023901
transferrin O 0 0.430557519197464
at O 0 0.0007189089083112776
37 O 0 0.0017018076032400131
degrees O 0 0.0020804940722882748
C O 0 0.008819717913866043
suggest O 0 0.00040502400952391326
that O 0 6.486677011707798e-05
the O 0 0.00040195323526859283
overexpressed O 0 0.18416473269462585
wild O 0 0.0021972854156047106
- O 0 0.008055572398006916
type O 0 0.00890946015715599
HFE O 1 0.9790070056915283
protein O 0 0.0008850409067235887
decreases O 0 0.00149152847006917
the O 0 7.773867400828749e-05
affinity O 0 0.0006507686921395361
of O 0 2.8026921427226625e-05
the O 0 0.0006936636054888368
TfR O 1 0.996377170085907
for O 0 0.0011040931567549706
transferrin O 1 0.9861505627632141
. O 0 0.0017784980591386557

The O 0 0.004229219164699316
overexpressed O 1 0.9401965141296387
H63D O 1 0.9872523546218872
protein O 0 0.0019223050912842155
does O 0 0.0007227337337099016
not O 0 7.560323865618557e-05
have O 0 4.2727013351395726e-05
this O 0 4.484665987547487e-05
effect O 0 0.0005732509889639914
, O 0 0.00010611907055135816
providing O 0 0.0007760334410704672
the O 0 9.571847476763651e-05
first O 0 0.00011760096094803885
direct O 0 0.00021736195776611567
evidence O 0 0.00019267266907263547
for O 0 0.00012574908032547683
a O 0 0.00042524217860773206
functional O 0 0.0021063615567982197
consequence O 0 0.001835980569012463
of O 0 4.025763337267563e-05
the O 0 0.0009952732361853123
H63D O 1 0.9972764849662781
mutation O 0 0.008443630300462246
. O 0 0.0011126338504254818

Addition O 0 0.0005551422946155071
of O 0 0.00011793967132689431
soluble O 1 0.5238593816757202
wild O 0 0.0038223147857934237
- O 0 0.09492935240268707
type O 0 0.40781155228614807
HFE O 1 0.9997093081474304
/ O 1 0.8266246318817139
beta2m O 0 0.482596218585968
heterodimers O 0 0.1266523152589798
to O 0 0.0004842742928303778
cultured O 0 0.019282842054963112
cells O 0 0.003245497355237603
also O 0 0.00033064407762140036
decreased O 0 0.0041933502070605755
the O 0 0.00021619642211589962
apparent O 0 0.005317223723977804
affinity O 0 0.0012599858455359936
of O 0 4.9126047088066116e-05
the O 0 0.0006256182678043842
TfR O 1 0.9902605414390564
for O 0 0.00014421228843275458
its O 0 0.00028634886257350445
ligand O 0 0.004903533961623907
under O 0 0.0006971860420890152
steady O 0 0.008952226489782333
- O 0 0.003282021963968873
state O 0 0.00022821729362476617
conditions O 0 0.0020170873031020164
, O 0 0.00010961336374748498
both O 0 9.444748138776049e-05
in O 0 0.00027374515775591135
293 O 0 0.0424046590924263
cells O 0 0.0016332133673131466
and O 0 0.00017042318359017372
in O 0 0.0008703006315045059
HeLa O 1 0.9959296584129333
cells O 0 0.006281033158302307
. O 0 0.0008160854340530932

Furthermore O 0 0.005234193988144398
, O 0 0.00035208146437071264
at O 0 0.00047238991828635335
4 O 0 0.0007552703027613461
degrees O 0 0.0017837034538388252
C O 0 0.0062811546958982944
, O 0 6.70730514684692e-05
the O 0 0.00010486887185834348
added O 0 0.0009516801219433546
soluble O 0 0.014976460486650467
complex O 0 0.0023118990939110518
of O 0 0.0004692569200415164
HFE O 1 0.9997223019599915
/ O 1 0.9270520806312561
beta2m O 0 0.2313593178987503
inhibited O 0 0.011482985690236092
binding O 0 0.00040178027120418847
of O 0 9.872892405837774e-05
transferrin O 1 0.8850667476654053
to O 0 0.001219267025589943
HeLa O 1 0.9859805107116699
cell O 0 0.007801614701747894
TfR O 1 0.947706401348114
in O 0 0.00022568363056052476
a O 0 0.0007369954837486148
concentration O 0 0.006959156598895788
- O 0 0.004614412318915129
dependent O 0 0.0017196789849549532
manner O 0 0.0021683447994291782
. O 0 0.0009775003418326378

Scatchard O 0 0.04413400962948799
plots O 0 0.0010313595412299037
of O 0 3.146258313790895e-05
these O 0 4.1539460653439164e-05
data O 0 0.00018340206588618457
indicate O 0 0.0004490471619646996
that O 0 5.918178794672713e-05
the O 0 0.00014841587108094245
added O 0 0.001653067534789443
heterodimer O 0 0.05871203541755676
substantially O 0 0.008638131432235241
reduced O 0 0.000716707669198513
the O 0 0.00010033766011474654
affinity O 0 0.0013339706929400563
of O 0 0.00017405388643965125
TfR O 1 0.9976626634597778
for O 0 0.0013269861228764057
transferrin O 1 0.9812989830970764
. O 0 0.0017267803195863962

These O 0 0.0002131493529304862
results O 0 0.0004929241840727627
establish O 0 0.0009038143907673657
a O 0 0.000810628233011812
molecular O 0 0.0036259139887988567
link O 0 0.010284212417900562
between O 0 0.0012377116363495588
HFE O 1 0.9984702467918396
and O 0 0.00015942854224704206
a O 0 0.0003914330736733973
key O 0 0.0007087829289957881
protein O 0 0.0003805692249443382
involved O 0 0.0006289841840043664
in O 0 0.00032741320319473743
iron O 1 0.7905393838882446
transport O 0 0.006070112343877554
, O 0 0.00032727589132264256
the O 0 0.0008066960144788027
TfR O 1 0.997078537940979
, O 0 0.0003001498116645962
and O 0 0.00011118793190689757
raise O 0 0.0008410435984842479
the O 0 0.00013994879554957151
possibility O 0 0.0018438418628647923
that O 0 0.00016154642798937857
alterations O 0 0.002601225860416889
in O 0 8.869711746228859e-05
this O 0 8.512086787959561e-05
regulatory O 0 0.005410955287516117
mechanism O 0 0.003046040190383792
may O 0 0.0005794192547909915
play O 0 8.469013846479356e-05
a O 0 0.00027108326321467757
role O 0 0.0007597320945933461
in O 0 0.00018142935005016625
the O 0 0.0006813807995058596
pathogenesis O 1 0.9994025230407715
of O 0 0.0010416334262117743
hereditary B-Disease 1 0.9999934434890747
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 0.002386566484346986
. O 0 0.001646917313337326

Genomic O 0 0.0066344779916107655
organization O 0 0.0011389246210455894
of O 0 8.701530168764293e-05
the O 0 0.002526656026020646
UBE3A O 1 0.9992141723632812
/ O 1 0.9222766757011414
E6 O 1 0.9857379198074341
- O 0 0.03429638221859932
AP O 0 0.00799496192485094
gene O 0 0.0015966638457030058
and O 0 0.0002413897163933143
related O 0 0.003929700702428818
pseudogenes O 0 0.07158730179071426
. O 0 0.001210529007948935

The O 0 0.002835445571690798
UBE3A O 1 0.9728063941001892
gene O 0 0.0025109092239290476
encodes O 0 0.0017498251982033253
the O 0 0.0008175669936463237
E6 O 1 0.92376708984375
- O 0 0.01124590914696455
AP O 0 0.005894191563129425
ubiquitin O 0 0.007855516858398914
- O 0 0.001953230006620288
protein O 0 0.0005056958761997521
ligase O 0 0.004405835643410683
and O 0 0.0002039033133769408
has O 0 0.0006916228448972106
recently O 0 0.001696296501904726
been O 0 0.0001428043469786644
shown O 0 0.00018992250261362642
to O 0 6.308880256256089e-05
be O 0 0.0002352712763240561
mutated O 0 0.14166581630706787
in O 0 0.0467958003282547
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999972581863403
who O 0 0.0025830173399299383
lack O 0 0.04277736321091652
15q11 O 1 0.9759945869445801
- O 0 0.018298758193850517
q13 O 0 0.02795460820198059
deletions O 0 0.0033015781082212925
or O 0 0.0004226700111757964
chromosome O 0 0.0034428236540406942
15 O 0 0.0017201915616169572
paternal O 0 0.2697460353374481
uniparental B-Disease 1 0.9996925592422485
disomy I-Disease 1 0.9893575310707092
. O 0 0.0024226498790085316

Previous O 0 0.00918334536254406
UBE3A O 1 0.9367939829826355
cDNA O 0 0.007193812169134617
analysis O 0 0.0007700487622059882
has O 0 0.0005726197268813848
shown O 0 0.0005183625034987926
a O 0 0.0006507774232886732
coding O 0 0.0036796133499592543
region O 0 0.00043268673471175134
of O 0 2.5854951672954485e-05
approximately O 0 0.000489757745526731
2 O 0 0.0009378077811561525
. O 0 0.0006602624780498445

6 O 0 0.0033641799818724394
kb O 0 0.008952269330620766
and O 0 0.00019048740796279162
a O 0 0.0008156939293257892
3 O 0 0.0011283762287348509
- O 0 0.0048603639006614685
untranslated O 0 0.025622662156820297
region O 0 0.003084983676671982
( O 0 0.0009406799217686057
UTR O 0 0.044165078550577164
) O 0 0.00015339542005676776
of O 0 7.543090032413602e-05
< O 0 0.02191750705242157
50 O 0 0.0012265471741557121
bp O 0 0.03545200452208519
, O 0 0.00029858635389246047
whereas O 0 0.0009005937608890235
Northern O 0 0.0005891001201234758
analysis O 0 0.0003135045990347862
has O 0 0.00036936503602191806
indicated O 0 0.0008011620375327766
mRNA O 0 0.00011004894622601569
sizes O 0 9.337947267340496e-05
of O 0 3.11027470161207e-05
5 O 0 0.0008520866394974291
- O 0 0.0026910691522061825
8 O 0 0.0007476644823327661
kb O 0 0.011184768751263618
. O 0 0.0008364575915038586

We O 0 0.0006122656632214785
have O 0 0.0001116229614126496
analyzed O 0 0.0007418165332637727
additional O 0 0.0003319159441161901
cDNA O 0 0.0042426083236932755
clones O 0 0.0040928078815341
and O 0 9.272310853702947e-05
provide O 0 0.00038727562059648335
evidence O 0 0.00014974098303355277
for O 0 6.189861596794799e-05
an O 0 0.00015365934814326465
additional O 0 0.0004262446309439838
0 O 0 0.001197734149172902
. O 0 0.000555852020625025

5 O 0 0.002306239679455757
kb O 0 0.0064869169145822525
of O 0 0.0001232760405400768
5 O 0 0.0017709510866552591
- O 0 0.005348199978470802
UTR O 0 0.02912653423845768
and O 0 0.0003547042142599821
> O 0 0.004714883863925934
2 O 0 0.00038397699245251715
kb O 0 0.0028606606647372246
of O 0 4.781492680194788e-05
3 O 0 0.0017800768837332726
- O 0 0.008358868770301342
UTR O 0 0.06025243178009987
. O 0 0.001177787664346397

We O 0 0.00074147863779217
have O 0 0.00010393137927167118
established O 0 0.00023476171190850437
the O 0 0.00014433113392442465
genomic O 0 0.0028643517289310694
organization O 0 0.00164181983564049
of O 0 0.0002232924016425386
UBE3A O 1 0.9951890707015991
and O 0 0.00010127324640052393
the O 0 7.252481009345502e-05
sequence O 0 8.929030445870012e-05
of O 0 7.413022831315175e-05
intron O 1 0.9630827903747559
- O 0 0.010257388465106487
exon O 0 0.0193339791148901
borders O 0 0.0037680224049836397
. O 0 0.000958032498601824

We O 0 0.0007815808639861643
have O 0 0.00014403610839508474
also O 0 0.00013048593245912343
mapped O 0 0.0008931647171266377
two O 0 4.25069774792064e-05
highly O 0 0.0018126147333532572
homologous O 0 0.0032662865705788136
processed O 0 0.0014608731726184487
pseudogenes O 0 0.022688673809170723
, O 0 0.001091935089789331
UBE3AP1 O 1 0.9875060319900513
and O 0 0.000929764355532825
UBE3AP2 O 1 0.987851619720459
, O 0 0.00016721017891541123
to O 0 8.876733772922307e-05
chromosomes O 0 0.0002951467176899314
2 O 0 0.0003171765711158514
and O 0 0.00015618120960425586
21 O 0 0.0007270367350429296
, O 0 0.0001411603734595701
respectively O 0 0.0003817851247731596
, O 0 0.00013348287029657513
and O 0 9.598152246326208e-05
determined O 0 0.0005015974747948349
their O 0 6.525777280330658e-05
genomic O 0 0.0039488784968853
organization O 0 0.0034478206653147936
. O 0 0.0011072398629039526

These O 0 0.000325928907841444
results O 0 0.0006599468761123717
will O 0 0.0001072754748747684
form O 0 0.00012683350360020995
the O 0 5.536180833587423e-05
basis O 0 6.388516339939088e-05
for O 0 9.196301107294858e-05
studies O 0 0.0001935389736900106
of O 0 4.086580884177238e-05
mutation O 0 0.0021785912103950977
and O 0 0.00021547306096181273
imprinting O 0 0.027753660455346107
of O 0 0.0004424855869729072
UBE3A O 1 0.9984045624732971
. O 0 0.002329230075702071

Mutation O 0 0.013701600022614002
spectrum O 0 0.006171439308673143
and O 0 0.0006713363691233099
genotype O 0 0.2550676167011261
- O 0 0.011131818406283855
phenotype O 0 0.019144371151924133
analyses O 0 0.0021115057170391083
in O 0 0.002751508029177785
Cowden B-Disease 1 0.9999983310699463
disease I-Disease 1 0.9999970197677612
and O 0 0.0018485422478988767
Bannayan B-Disease 1 0.999894380569458
- I-Disease 1 0.9993734955787659
Zonana I-Disease 1 0.9999738931655884
syndrome I-Disease 1 0.9999972581863403
, O 0 0.0006747758015990257
two O 0 0.0011245034402236342
hamartoma B-Disease 1 0.9999480247497559
syndromes I-Disease 1 0.9998819828033447
with O 0 0.003995921928435564
germline O 1 0.9994413256645203
PTEN O 1 0.9997233748435974
mutation O 0 0.01666407100856304
. O 0 0.0013625893043354154

The O 0 0.008245513774454594
tumour B-Disease 1 0.9999802112579346
suppressor O 1 0.9899784326553345
gene O 0 0.0354105643928051
PTEN O 1 0.9972354769706726
, O 0 0.0003253533213865012
which O 0 8.237641304731369e-05
maps O 0 0.00045248903916217387
to O 0 0.00023262093600351363
10q23 O 0 0.04499472677707672
. O 0 0.0008976240060292184

3 O 0 0.0013115603942424059
and O 0 0.0002262824127683416
encodes O 0 0.00137494842056185
a O 0 0.0006569345132447779
403 O 0 0.004814056679606438
amino O 0 0.00033966070623137057
acid O 0 0.0032280306331813335
dual O 0 0.002196501474827528
specificity O 0 0.00253386702388525
phosphatase O 0 0.0981655865907669
( O 0 0.0005085497978143394
protein O 0 0.0013598940568044782
tyrosine O 0 0.01853683590888977
phosphatase O 1 0.9469160437583923
; O 0 0.0008673369884490967
PTPase O 1 0.8719710111618042
) O 0 0.00033438342506997287
, O 0 0.00026782299391925335
was O 0 0.0007825720822438598
shown O 0 0.0008763069054111838
recently O 0 0.0011516667436808348
to O 0 3.33373827743344e-05
play O 0 7.075838948367164e-05
a O 0 0.0003620557254180312
broad O 0 0.0037890125531703234
role O 0 0.0016236145747825503
in O 0 0.000513182079885155
human O 0 0.026753384619951248
malignancy B-Disease 1 0.9998574256896973
. O 0 0.002443950390443206

Somatic O 1 0.8975136876106262
PTEN O 1 0.9984822869300842
deletions O 0 0.011459733359515667
and O 0 0.0003796303935814649
mutations O 0 0.0012103515909984708
were O 0 3.405786264920607e-05
observed O 0 0.000287149625364691
in O 0 0.00025979033671319485
sporadic B-Disease 1 0.8876309990882874
breast I-Disease 1 0.9999966621398926
, I-Disease 0 0.0040841130539774895
brain I-Disease 1 0.9999935626983643
, I-Disease 0 0.13443100452423096
prostate I-Disease 1 0.9999998807907104
and I-Disease 1 0.9044390320777893
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
cell O 0 0.007427174132317305
lines O 0 0.0006370696937665343
and O 0 7.356635614996776e-05
in O 0 9.107294317800552e-05
several O 0 0.00017877088976092637
primary O 0 0.022369228303432465
tumours B-Disease 1 0.9999771118164062
such O 0 0.00018264712707605213
as O 0 0.007697427645325661
endometrial B-Disease 1 0.9999955892562866
carcinomas I-Disease 1 0.9999986886978149
, O 1 0.9959724545478821
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9815043807029724
thyroid B-Disease 1 1.0
tumours I-Disease 1 0.9999979734420776
. O 0 0.0028198999352753162

In O 0 0.0008770853746682405
addition O 0 0.0011795694008469582
, O 0 0.0017660551238805056
PTEN O 1 0.9993419051170349
was O 0 0.0015320954844355583
identified O 0 0.0005356758483685553
as O 0 8.04403898655437e-05
the O 0 0.00016788933135103434
susceptibility O 0 0.048380881547927856
gene O 0 0.0008283727220259607
for O 0 0.00018514310067985207
two O 0 0.0010442985221743584
hamartoma B-Disease 1 0.9999836683273315
syndromes I-Disease 1 0.9999973773956299
Cowden B-Disease 1 0.999997615814209
disease I-Disease 1 0.9999966621398926
( O 0 0.002444372745230794
CD B-Disease 0 0.05836501717567444
; O 0 0.0015276202466338873
MIM O 1 0.9986932873725891
158350 O 0 0.13585755228996277
) O 0 0.0004331018717493862
and O 0 0.00045044501894153655
Bannayan B-Disease 1 0.9899390339851379
- I-Disease 0 0.07905277609825134
Zonana I-Disease 1 0.9953952431678772
( I-Disease 0 0.0019230885664001107
BZS I-Disease 1 0.6125426292419434
) I-Disease 0 0.0005072077619843185
or I-Disease 0 0.0010986400302499533
Ruvalcaba I-Disease 1 0.997506320476532
- I-Disease 0 0.24982282519340515
Riley I-Disease 1 0.9880918264389038
- I-Disease 1 0.8202300071716309
Smith I-Disease 1 0.9928777813911438
syndrome I-Disease 1 0.9999955892562866
( O 0 0.009656489826738834
MIM O 1 0.9995740056037903
153480 O 1 0.9091893434524536
) O 0 0.0012181224301457405
. O 0 0.0009829150512814522

Constitutive O 0 0.09602397680282593
DNA O 0 0.0028568815905600786
from O 0 0.0002374746836721897
37 O 0 0.0016916252207010984
CD B-Disease 0 0.002864099806174636
families O 0 0.00022932210413273424
and O 0 0.00020531518384814262
seven O 0 0.0009569924441166222
BZS B-Disease 1 0.8533232808113098
families O 0 0.000615443685092032
was O 0 0.0010181886609643698
screened O 0 0.0031772975344210863
for O 0 0.0010704898741096258
germline O 1 0.9964864253997803
PTEN O 1 0.9991301894187927
mutations O 0 0.01086934469640255
. O 0 0.001173369586467743

PTEN O 1 0.9955641031265259
mutations O 0 0.007098471280187368
were O 0 0.00015486641495954245
identified O 0 0.0005493799690157175
in O 0 9.800273255677894e-05
30 O 0 0.00020311125263106078
of O 0 4.0789418562781066e-05
37 O 0 0.0019434550777077675
( O 0 0.0006621690117754042
81 O 0 0.003084694966673851
% O 0 0.00011030530004063621
) O 0 0.0002620301384013146
CD B-Disease 0 0.0028010616078972816
families O 0 0.0002466134901624173
, O 0 0.0001602558040758595
including O 0 0.0002592173113953322
missense O 0 0.014998579397797585
and O 0 0.00036231279955245554
nonsense O 0 0.008797897025942802
point O 0 0.0011240848107263446
mutations O 0 0.0020317102316766977
, O 0 0.00023379026970360428
deletions O 0 0.0020648068748414516
, O 0 0.0002654321724548936
insertions O 0 0.004100593272596598
, O 0 0.0001801026810426265
a O 0 0.0014928526943549514
deletion O 0 0.1479857861995697
/ O 0 0.04402880370616913
insertion O 0 0.007596146780997515
and O 0 0.00031777616823092103
splice O 0 0.024656163528561592
site O 0 0.003952226135879755
mutations O 0 0.004773065913468599
. O 0 0.0006957922014407814

These O 0 0.0005568876513279974
mutations O 0 0.0022208832670003176
were O 0 5.871699613635428e-05
scattered O 0 0.0002716801827773452
over O 0 7.856020965846255e-05
the O 0 0.0001022263168124482
entire O 0 0.0012223649537190795
length O 0 0.0007491665310226381
of O 0 0.0002206431672675535
PTEN O 1 0.9998635053634644
, O 0 0.0001916647161124274
with O 0 7.540314254583791e-05
the O 0 0.0001384890783810988
exception O 0 0.00044243200682103634
of O 0 1.5746496501378715e-05
the O 0 0.0001287155319005251
first O 0 0.0001832127891248092
, O 0 0.000167765625519678
fourth O 0 0.0006843666196800768
and O 0 0.00013006245717406273
last O 0 0.001207274734042585
exons O 0 0.007261168211698532
. O 0 0.0008044717833399773

A O 0 0.007039845921099186
hot O 0 0.010268432088196278
spot O 0 0.004112649243324995
for O 0 0.0013734787935391068
PTEN O 1 0.997857391834259
mutation O 0 0.003589750500395894
in O 0 0.0002847388677764684
CD B-Disease 0 0.0031707771122455597
was O 0 0.0008780545322224498
identified O 0 0.000518705346621573
in O 0 0.00016690182383172214
exon O 0 0.008178938180208206
5 O 0 0.00032370330882258713
that O 0 4.103321771253832e-05
contains O 0 9.596523159416392e-05
the O 0 0.0002727879327721894
PTPase O 0 0.21325407922267914
core O 0 0.002367839915677905
motif O 0 0.002344162669032812
, O 0 9.414391388418153e-05
with O 0 6.330793257802725e-05
13 O 0 0.00029213668312877417
of O 0 3.70451198250521e-05
30 O 0 0.000926074106246233
( O 0 0.00040765610174275935
43 O 0 0.0009373307111673057
% O 0 8.699621685082093e-05
) O 0 0.00027922476874664426
CD B-Disease 0 0.004762453492730856
mutations O 0 0.0014586824690923095
identified O 0 0.0004191381740383804
in O 0 8.70192889124155e-05
this O 0 0.0001657219836488366
exon O 0 0.029765285551548004
. O 0 0.0008691069087944925

Seven O 0 0.0006675160839222372
of O 0 0.00010485936218174174
30 O 0 0.0017177237896248698
( O 0 0.0008069450850598514
23 O 0 0.0010318231070414186
% O 0 6.538484012708068e-05
) O 0 7.997200009413064e-05
were O 0 1.633845386095345e-05
within O 0 4.510051439865492e-05
the O 0 0.0001309705839958042
core O 0 0.00273273978382349
motif O 0 0.003173273988068104
, O 0 0.00015753386833239347
the O 0 0.00018554231792222708
majority O 0 0.00042352426680736244
( O 0 0.000195846805581823
five O 0 5.6404212955385447e-05
of O 0 1.606349542271346e-05
seven O 0 0.00019621950923465192
) O 0 6.315158680081367e-05
of O 0 1.3989895705890376e-05
which O 0 8.735217852517962e-05
were O 0 0.00015667833213228732
missense O 0 0.0390738844871521
mutations O 0 0.005223073065280914
, O 0 0.0004466364625841379
possibly O 0 0.00197172281332314
pointing O 0 0.0018028572667390108
to O 0 6.179651973070577e-05
the O 0 8.976960089057684e-05
functional O 0 0.001040589064359665
significance O 0 0.00029704655753448606
of O 0 2.0741013941005804e-05
this O 0 0.00014079379616305232
region O 0 0.0022193032782524824
. O 0 0.0006024488247931004

Germline O 1 0.9969346523284912
PTEN O 1 0.9982131719589233
mutations O 0 0.006898831110447645
were O 0 0.00013208694872446358
identified O 0 0.0004004182992503047
in O 0 4.090007860213518e-05
four O 0 2.8367914637783542e-05
of O 0 2.550762474129442e-05
seven O 0 0.0005608150386251509
( O 0 0.0006352115306071937
57 O 0 0.002422827063128352
% O 0 0.00019985466497018933
) O 0 0.0008411265444010496
BZS B-Disease 1 0.8775368332862854
families O 0 0.0010643104324117303
studied O 0 0.0023273041006177664
. O 0 0.0009483732283115387

Interestingly O 0 0.06499870121479034
, O 0 0.0004743423778563738
none O 0 0.00032578909303992987
of O 0 1.9526816686266102e-05
these O 0 8.6136074969545e-05
mutations O 0 0.0019776837434619665
was O 0 0.0004996700445190072
observed O 0 0.0003655643668025732
in O 0 8.993326628115028e-05
the O 0 0.0003465706540737301
PTPase O 0 0.3377054035663605
core O 0 0.005730599630624056
motif O 0 0.009489262476563454
. O 0 0.0009582474594935775

It O 0 0.0006400463171303272
is O 0 0.0004144225677009672
also O 0 0.00020578123803716153
worthy O 0 0.0016870005056262016
of O 0 3.2326650398317724e-05
note O 0 0.0004178380186203867
that O 0 5.079843322164379e-05
a O 0 0.00026018399512395263
single O 0 0.00031144346576184034
nonsense O 0 0.004563405178487301
point O 0 0.0006985990912653506
mutation O 0 0.0021691559813916683
, O 0 0.00034965071245096624
R233X O 0 0.026206159964203835
, O 0 0.0002152075758203864
was O 0 0.0004815234860870987
observed O 0 0.00033134149271063507
in O 0 0.00013931209105066955
the O 0 0.0006232809973880649
germline O 1 0.8902998566627502
DNA O 0 0.0010865781223401427
from O 0 0.00010223354183835909
two O 0 0.000124472237075679
unrelated O 0 0.00695438077673316
CD B-Disease 0 0.003922551870346069
families O 0 0.0003520889731589705
and O 0 0.00018754850316327065
one O 0 0.000977526418864727
BZS B-Disease 1 0.9831063747406006
family O 0 0.0034336806274950504
. O 0 0.0013717348920181394

Genotype O 1 0.9645164608955383
- O 0 0.12449634820222855
phenotype O 0 0.12754692137241364
studies O 0 0.0006607990362681448
were O 0 6.325959111563861e-05
not O 0 0.00010170903988182545
performed O 0 0.00044361321488395333
on O 0 7.47239901102148e-05
this O 0 3.6604269553208724e-05
small O 0 0.00014387631381396204
group O 0 0.00024684306117706
of O 0 0.00014347380783874542
BZS B-Disease 1 0.9829798936843872
families O 0 0.0012310814345255494
. O 0 0.0010227214079350233

However O 0 0.0022785107139497995
, O 0 0.0012740253005176783
genotype O 0 0.26438066363334656
- O 0 0.01779491826891899
phenotype O 0 0.027859866619110107
analysis O 0 0.0009666607365943491
inthe O 0 0.034504279494285583
group O 0 0.00035358298919163644
of O 0 7.427528908010572e-05
CD B-Disease 0 0.006804024334996939
families O 0 0.0006436010007746518
revealed O 0 0.0029738189186900854
two O 0 8.152958616847172e-05
possible O 0 0.0005572959780693054
associations O 0 0.0006355266086757183
worthy O 0 0.00339463260024786
of O 0 7.325253682211041e-05
follow O 0 0.0012088710209354758
- O 0 0.0018745092675089836
up O 0 0.00011966450983891264
in O 0 0.00011124711454613134
independent O 0 0.0005036273505538702
analyses O 0 0.0020621910225600004
. O 0 0.0007729822536930442

The O 0 0.0005649864324368536
first O 0 0.0003299758827779442
was O 0 0.0010379792656749487
an O 0 0.0005199809675104916
association O 0 0.010933423414826393
noted O 0 0.0006175778107717633
in O 0 7.892898429417983e-05
the O 0 6.682144885417074e-05
group O 0 9.909375512506813e-05
of O 0 2.658159428392537e-05
CD B-Disease 0 0.004067942965775728
families O 0 0.0005964867887087166
with O 0 0.004953085444867611
breast B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999977350234985
. O 0 0.0014987982576712966

A O 0 0.0048023127019405365
correlation O 0 0.002686644671484828
was O 0 0.0007910640561021864
observed O 0 0.0003465759218670428
between O 0 9.922329627443105e-05
the O 0 0.00029347409144975245
presence O 0 0.0027198635507375
/ O 0 0.02043243683874607
absence O 0 0.0014138063415884972
of O 0 7.01967510394752e-05
a O 0 0.00460421945899725
PTEN O 1 0.9994051456451416
mutation O 0 0.0023984734434634447
and O 0 7.899531192379072e-05
the O 0 0.00019244206487201154
type O 0 0.00312692578881979
of O 0 0.00028289880719967186
breast O 1 0.9999940395355225
involvement O 1 0.8598405718803406
( O 0 0.0018253808375447989
unaffected O 1 0.9872313141822815
versus O 1 0.8951961398124695
benign O 1 0.9998741149902344
versus O 1 0.9957899451255798
malignant O 1 0.9999948740005493
) O 0 0.0011959552066400647
. O 0 0.001038523274473846

Specifically O 0 0.002115369075909257
and O 0 0.0001438634208170697
more O 0 0.00010665410081855953
directly O 0 0.0003839608689304441
, O 0 0.00016567361308261752
an O 0 0.0004365725617390126
association O 0 0.033757541328668594
was O 0 0.0008397591300308704
also O 0 0.0001625582081032917
observed O 0 0.00018986381473951042
between O 0 3.793448195210658e-05
the O 0 5.844991028425284e-05
presence O 0 0.00017806929827202111
of O 0 3.077712608501315e-05
a O 0 0.004060791805386543
PTEN O 1 0.9997314810752869
mutation O 0 0.04277759790420532
and O 0 0.07731882482767105
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999998807907104
disease I-Disease 1 0.999998927116394
. O 0 0.0021540718153119087

Secondly O 0 0.030829304829239845
, O 0 0.0004917524056509137
there O 0 0.0002459785027895123
appeared O 0 0.0008067137096077204
to O 0 5.912363121751696e-05
be O 0 6.401725840987638e-05
an O 0 0.00021275828476063907
interdependent O 1 0.6648226976394653
association O 0 0.00731743173673749
between O 0 0.0005278773605823517
mutations O 0 0.0026865156833082438
upstream O 0 0.0026121293194592
and O 0 8.404362597502768e-05
within O 0 0.00012193646398372948
the O 0 0.00037087383680045605
PTPase O 1 0.869657576084137
core O 0 0.003147145500406623
motif O 0 0.003725313814356923
, O 0 0.00013390292588155717
the O 0 0.00012419646373018622
core O 0 0.0018454424571245909
motif O 0 0.0017326467204838991
containing O 0 0.00017130198830273002
the O 0 9.148273966275156e-05
majority O 0 0.00020597950788214803
of O 0 0.00014096075028646737
missense O 0 0.20045161247253418
mutations O 0 0.003758137347176671
, O 0 0.0002037233643932268
and O 0 9.705986303742975e-05
the O 0 0.00014394217578228563
involvement O 0 0.0020485762506723404
of O 0 1.7653630493441597e-05
all O 0 5.969172707409598e-05
major O 0 0.002892434597015381
organ O 1 0.8396025896072388
systems O 0 0.044062353670597076
( O 0 0.000705293903592974
central O 0 0.001663376111537218
nervous O 1 0.9972519278526306
system O 0 0.006401609163731337
, O 0 0.0033833603374660015
thyroid O 1 0.9999996423721313
, O 0 0.026042861863970757
breast O 1 0.9999992847442627
, O 0 0.019921230152249336
skin O 1 0.9999986886978149
and O 0 0.21438302099704742
gastrointestinal O 1 0.9999996423721313
tract O 1 0.9999775886535645
) O 0 0.0012420214479789138
. O 0 0.0011818807106465101

However O 0 0.0014118285616859794
, O 0 0.00016176221834030002
these O 0 4.521359733189456e-05
observations O 0 0.00066814583260566
would O 0 0.00013787715579383075
need O 0 0.0003450461954344064
to O 0 8.109852933557704e-05
be O 0 0.0001179484388558194
confirmed O 0 0.00068830227246508
by O 0 4.236546010361053e-05
studying O 0 0.0003212465962860733
a O 0 0.00015434807573910803
larger O 0 9.543538908474147e-05
number O 0 1.8256716430187225e-05
of O 0 3.1212595786200836e-05
CD B-Disease 0 0.0057176873087882996
families O 0 0.0005518094985745847
. O 0 0.0008175462717190385

Molecular O 0 0.16451776027679443
defects O 1 0.998238205909729
leading O 0 0.0011872921604663134
to O 0 0.00010916025348706171
human O 0 0.0007379620801657438
complement B-Disease 0 0.005483470391482115
component I-Disease 1 0.9962106943130493
C6 I-Disease 1 0.9999974966049194
deficiency I-Disease 1 0.9999990463256836
in O 0 0.0002924454165622592
an O 0 0.0006109261885285378
African O 0 0.0033049832563847303
- O 0 0.005312614142894745
American O 0 0.0006681977538391948
family O 0 0.0014926950680091977
. O 0 0.000893484684638679

Complement B-Disease 0 0.018419096246361732
component I-Disease 1 0.9673298597335815
C6 I-Disease 1 0.9999862909317017
deficiency I-Disease 1 0.9999986886978149
( O 0 0.006684433668851852
C6D B-Disease 1 0.998358428478241
) O 0 0.0010867216624319553
was O 0 0.009587693028151989
diagnosed O 1 0.9999749660491943
in O 0 0.00011954897490795702
a O 0 0.0005808635614812374
16 O 0 0.0008907366427592933
- O 0 0.0025907671079039574
year O 0 0.0008572897640988231
- O 0 0.0029033480677753687
old O 0 0.001536333467811346
African O 0 0.001167184324003756
- O 0 0.0022260837722569704
American O 0 0.0005628521321341395
male O 0 0.0024312897585332394
with O 0 0.0062681823037564754
meningococcal B-Disease 1 0.9999977350234985
meningitis I-Disease 1 0.999997615814209
. O 0 0.00302888173609972

The O 0 0.0077225808054208755
patients O 1 0.9997947812080383
father O 0 0.004119080025702715
and O 0 0.00018573508714325726
two O 0 0.00014539933181367815
brothers O 0 0.0018042790470644832
also O 0 0.00047736649867147207
had O 0 0.00198759650811553
C6D B-Disease 1 0.9945489764213562
, O 0 0.00019607383001130074
but O 0 0.00014711482799611986
gave O 0 0.0003288406296633184
no O 0 0.00010431673581479117
history O 0 0.00027183149359188974
of O 0 0.0003237017954234034
meningitis B-Disease 1 0.9999979734420776
or O 0 0.0005798944039270282
other O 0 0.0004906199174001813
neisserial B-Disease 1 0.9998114705085754
infection I-Disease 1 0.9999445676803589
. O 0 0.0016067719552665949

By O 0 0.00027780680102296174
using O 0 0.0005621422315016389
exon O 0 0.014278444461524487
- O 0 0.001251813257113099
specific O 0 0.0002138284035027027
polymerase O 0 0.003037224290892482
chain O 0 0.0033863054122775793
reaction O 0 0.0021790245082229376
( O 0 0.0010675354860723019
PCR O 0 0.018535466864705086
) O 0 0.0008650782983750105
/ O 0 0.006804681848734617
single O 0 0.0005620099254883826
- O 0 0.0035106725990772247
strand O 0 0.002986383158713579
conformation O 0 0.003232796210795641
polymorphism O 0 0.0020310443360358477
as O 0 0.00025937429745681584
a O 0 0.0008795999456197023
screening O 0 0.003846273059025407
step O 0 0.001228422042913735
and O 0 5.413102189777419e-05
nucleotide O 0 0.00012929912190884352
sequencing O 0 0.00019951500871684402
of O 0 2.846783354470972e-05
target O 0 0.0010621853871271014
exons O 0 0.003887946717441082
, O 0 0.0001935790351126343
we O 0 0.00013205657887738198
determined O 0 0.0004260636051185429
that O 0 4.543000613921322e-05
the O 0 0.00020523024431895465
proband O 0 0.09895623475313187
was O 0 0.0005957677494734526
a O 0 0.0006564551149494946
compound O 0 0.004872131627053022
heterozygote O 0 0.016424372792243958
for O 0 0.00019997799245174974
two O 0 0.0004901382490061224
C6 O 1 0.9996446371078491
gene O 0 0.006310954689979553
mutations O 0 0.0042640590108931065
. O 0 0.0006266601849347353

The O 0 0.0008795541943982244
first O 0 0.0005864804843440652
, O 0 0.0005565061001107097
1195delC O 0 0.016249872744083405
located O 0 0.000844842754304409
in O 0 0.00027456486714072526
exon O 0 0.011647235602140427
7 O 0 0.0006078563164919615
, O 0 0.00013108941493555903
is O 0 0.00017504632705822587
a O 0 0.0005158028216101229
novel O 0 0.002020076848566532
mutation O 0 0.0022243517450988293
, O 0 0.00011070233449572697
while O 0 0.0001140813619713299
the O 0 0.00011781873035943136
second O 0 0.00043742364505305886
, O 0 0.00030299651552923024
1936delG O 0 0.015851860865950584
in O 0 0.00031868700170889497
exon O 0 0.01304988656193018
12 O 0 0.0006956241559237242
, O 0 0.00020766952366102487
has O 0 0.00046886946074664593
been O 0 0.00029677056591026485
described O 0 0.001153470017015934
before O 0 0.00035198547993786633
to O 0 0.0002595408004708588
cause O 0 0.23612181842327118
C6D B-Disease 1 0.9876623153686523
in O 0 0.00016100464563351125
an O 0 0.0004899785853922367
unrelated O 0 0.020671149715781212
African O 0 0.0031380844302475452
- O 0 0.004109053406864405
American O 0 0.00044634914956986904
individual O 0 0.0005853706388734281
. O 0 0.0011303367791697383

Both O 0 0.001166898524388671
mutations O 0 0.003258933313190937
result O 0 0.000762408715672791
in O 0 0.0006480708252638578
premature O 1 0.9980820417404175
termination O 1 0.9838433861732483
codons O 0 0.013065274804830551
and O 0 0.001431192853488028
C6 O 1 0.9984368681907654
null O 0 0.02511678636074066
alleles O 0 0.010184614919126034
. O 0 0.0014992079231888056

Allele O 0 0.038246165961027145
- O 0 0.005194836296141148
specific O 0 0.0007275700336322188
PCR O 0 0.011077267117798328
indicated O 0 0.0025710624177008867
that O 0 8.879138476913795e-05
the O 0 0.00030086806509643793
probands O 0 0.07406327873468399
two O 0 0.00018238765187561512
brothers O 0 0.0020404041279107332
also O 0 0.0005982968141324818
inherited O 1 0.8975943326950073
the O 0 0.0006474244291894138
1195delC O 1 0.745182454586029
mutation O 0 0.0017530298791825771
from O 0 9.76186347543262e-05
their O 0 0.00016070187848526984
heterozygous O 0 0.007819905877113342
mother O 0 0.003864189377054572
and O 0 9.599186887498945e-05
the O 0 0.0003345546720083803
1936delG O 0 0.4526870548725128
mutation O 0 0.0014237859286367893
from O 0 7.061340875225142e-05
their O 0 0.0001556088827783242
homozygous O 0 0.009306622669100761
father O 0 0.0030650801490992308
. O 0 0.0003610864223446697
. O 0 0.0007512629381380975

PAX6 O 1 0.9944021105766296
mutations O 0 0.022944634780287743
reviewed O 0 0.008651302196085453
. O 0 0.001112446771003306

Mutations O 0 0.019685843959450722
in O 0 0.001462332671508193
PAX6 O 1 0.9979991316795349
are O 0 0.00011075830116169527
responsible O 0 0.002259836532175541
for O 0 0.00035971502074971795
human O 0 0.005420345347374678
aniridia B-Disease 1 0.9983136653900146
and O 0 0.00014986269525252283
have O 0 8.72731689014472e-05
also O 0 0.00013551872689276934
been O 0 0.0002484580909367651
found O 0 0.00032959479722194374
in O 0 0.0005010216264054179
patients O 1 0.9998799562454224
with O 0 0.0009495227714069188
Peters B-Disease 1 0.9999217987060547
anomaly I-Disease 1 0.9993932247161865
, O 0 0.0010109820868819952
with O 0 0.16255797445774078
congenital B-Disease 1 1.0
cataracts I-Disease 1 0.9999998807907104
, O 0 0.0010209846077486873
with O 0 0.0010894403094425797
autosomal B-Disease 1 0.9998546838760376
dominant I-Disease 1 0.995647132396698
keratitis I-Disease 1 0.9999598264694214
, O 0 0.0005669035599566996
and O 0 0.0002297558676218614
with O 0 0.0006491594249382615
isolated B-Disease 1 0.9815869927406311
foveal I-Disease 1 0.9995993971824646
hypoplasia I-Disease 1 0.9999561309814453
. O 0 0.0034656261559575796

No O 0 0.0015655586030334234
locus O 0 0.005628505721688271
other O 0 9.413494262844324e-05
than O 0 0.0003141937777400017
chromosome O 0 0.004186555277556181
11p13 O 0 0.023897822946310043
has O 0 0.0008871766040101647
been O 0 0.000755667279008776
implicated O 0 0.1413085162639618
in O 0 0.0009777817176654935
aniridia B-Disease 1 0.9992063641548157
, O 0 0.0004986645071767271
and O 0 0.0007632842753082514
PAX6 O 1 0.999679684638977
is O 0 0.0005220304592512548
clearly O 0 0.0007729862700216472
the O 0 0.00014910042227711529
major O 0 0.0012316621141508222
, O 0 0.0001798835291992873
if O 0 0.00017494504572823644
not O 0 4.696716496255249e-05
only O 0 3.6679848562926054e-05
, O 0 0.0001708631607471034
gene O 0 0.001824995968490839
responsible O 0 0.0036249011754989624
. O 0 0.000999157433398068

Twenty O 0 0.004479649011045694
- O 0 0.002097488148137927
eight O 0 0.0001370372629025951
percent O 0 0.0001912625302793458
of O 0 6.599888001801446e-05
identified O 0 0.0045536234974861145
PAX6 O 1 0.9994078874588013
mutations O 0 0.00439200084656477
are O 0 0.00025770944193936884
C O 1 0.8499829769134521
- O 0 0.2067612111568451
T O 1 0.9524491429328918
changes O 0 0.0007062442600727081
at O 0 0.0012978294398635626
CpG O 0 0.03741251304745674
dinucleotides O 0 0.10146891325712204
, O 0 0.00023198945564217865
20 O 0 0.0002099401317536831
% O 0 2.493353713362012e-05
are O 0 2.7088564820587635e-05
splicing O 0 0.0015883240848779678
errors O 0 0.002363237552344799
, O 0 0.0001425228692824021
and O 0 5.3794010455021635e-05
more O 0 6.602342909900472e-05
than O 0 9.719657100504264e-05
30 O 0 0.00027027472970075905
% O 0 3.7273373891366646e-05
are O 0 5.354087988962419e-05
deletion O 0 0.0038369623944163322
or O 0 0.00044084235560148954
insertion O 0 0.009693616069853306
events O 0 0.00079685403034091
. O 0 0.0011066724546253681

There O 0 0.000578144914470613
is O 0 0.0004598850791808218
a O 0 0.0017361565260216594
noticeably O 1 0.5408002734184265
elevated O 1 0.8174375891685486
level O 0 0.0005950016784481704
of O 0 5.292400601319969e-05
mutation O 0 0.0017624039901420474
in O 0 0.00011065675062127411
the O 0 0.00030991859966889024
paired O 0 0.004018510226160288
domain O 0 0.000566325441468507
compared O 0 0.00044609137694351375
with O 0 6.922711327206343e-05
the O 0 0.0001238732220372185
rest O 0 0.0003910996310878545
of O 0 1.908888043544721e-05
the O 0 0.0003221995721105486
gene O 0 0.004062482621520758
. O 0 0.0007924296078272164

Increased O 0 0.002413043985143304
mutation O 0 0.002005244605243206
in O 0 0.0001303416647715494
the O 0 0.0003742261906154454
homeodomain O 0 0.1136501356959343
is O 0 0.00034438399598002434
accounted O 0 0.00048505410086363554
for O 0 8.68863717187196e-05
by O 0 9.389969636686146e-05
the O 0 0.0006008329801261425
hypermutable O 0 0.49449464678764343
CpG O 0 0.041706569492816925
dinucleotide O 0 0.04073305055499077
in O 0 0.000679739867337048
codon O 0 0.008524366654455662
240 O 0 0.008368297480046749
. O 0 0.0012423440348356962

Very O 0 0.002574487356469035
nearly O 0 0.00101653509773314
all O 0 0.00014376798935700208
mutations O 0 0.0036740065552294254
appear O 0 0.0011968188919126987
to O 0 0.00023217202397063375
cause O 0 0.05058477446436882
loss O 0 0.0012765626888722181
of O 0 1.612708729226142e-05
function O 0 0.0002443770063109696
of O 0 2.139747448381968e-05
the O 0 0.00048433057963848114
mutant O 0 0.009110485203564167
allele O 0 0.004731141030788422
, O 0 0.00017117495008278638
and O 0 7.703804294578731e-05
more O 0 6.566908996319398e-05
than O 0 8.353975863428786e-05
80 O 0 0.00028733856743201613
% O 0 2.3920152671053074e-05
of O 0 3.9462451240979135e-05
exonic O 0 0.16535411775112152
substitutions O 0 0.0013305442407727242
result O 0 0.0006213817978277802
in O 0 0.0005295453011058271
nonsense O 0 0.024302540346980095
codons O 0 0.014352772384881973
. O 0 0.0011756042949855328

In O 0 0.0007685532909817994
a O 0 0.0008748843683861196
gene O 0 0.0012370763579383492
with O 0 7.808362715877593e-05
such O 0 0.0001635261287447065
extraordinarily O 1 0.7837220430374146
high O 0 0.001974189653992653
sequence O 0 0.00031561020296067
conservation O 0 0.003135627368465066
throughout O 0 0.00027779993251897395
evolution O 0 0.000550751225091517
, O 0 0.00014700136671308428
there O 0 9.157753083854914e-05
are O 0 8.475655340589583e-05
presumed O 0 0.012535284273326397
undiscovered O 1 0.6084175705909729
missense O 0 0.044715236872434616
mutations O 0 0.00280975503847003
, O 0 0.00011840133083751425
these O 0 2.9390806957962923e-05
are O 0 5.437190338852815e-05
hypothesized O 0 0.003938745241612196
to O 0 7.334641122724861e-05
exist O 0 0.00012385277659632266
in O 0 0.00010093223681906238
as O 0 0.0004513968888204545
- O 0 0.005937834270298481
yet O 0 0.0019583688117563725
unidentified O 0 0.016639122739434242
phenotypes O 0 0.018689213320612907
. O 0 0.00045843611587770283
. O 0 0.0007851458503864706

Genetic O 0 0.015475818887352943
heterogeneity O 0 0.019419603049755096
and O 0 0.0007244541775435209
penetrance O 0 0.23438893258571625
analysis O 0 0.00019483597134239972
of O 0 3.612091313698329e-05
the O 0 0.0008759670308791101
BRCA1 O 1 0.9995515942573547
and O 0 0.001133535522967577
BRCA2 O 1 0.9992296695709229
genes O 0 0.0019848872907459736
in O 0 0.009281797334551811
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
families O 0 0.0017320489278063178
. O 0 0.0013310707872733474

The O 1 0.5890322327613831
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999994039535522
Linkage O 1 0.9816890954971313
Consortium O 0 0.024036768823862076
. O 0 0.0013564469991251826

The O 0 0.00036992874811403453
contribution O 0 0.0013750873040407896
of O 0 0.00025854003615677357
BRCA1 O 1 0.9996299743652344
and O 0 0.0018109866650775075
BRCA2 O 1 0.9999004602432251
to O 0 0.006929103285074234
inherited B-Disease 1 0.9999988079071045
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.00672887684777379
assessed O 0 0.010162239894270897
by O 0 0.00014731976261828095
linkage O 0 0.020322544500231743
and O 0 0.00019620527746155858
mutation O 0 0.0015139903407543898
analysis O 0 0.00028833418036811054
in O 0 0.00027998292353004217
237 O 0 0.013992556370794773
families O 0 0.0002861832035705447
, O 0 6.530551763717085e-05
each O 0 1.9198949303245172e-05
with O 0 3.557253512553871e-05
at O 0 0.00015603711653966457
least O 0 9.548973321216181e-05
four O 0 7.886676030466333e-05
cases O 0 0.0010170422028750181
of O 0 0.00048808971769176424
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
, O 0 0.0001090296937036328
collected O 0 8.052957127802074e-05
by O 0 0.00017334683798253536
the O 0 0.09931585937738419
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999994039535522
Linkage O 1 0.9686389565467834
Consortium O 0 0.02523873932659626
. O 0 0.0013195190113037825

Families O 0 0.0014158773701637983
were O 0 9.116766159422696e-05
included O 0 0.00013332437083590776
without O 0 0.00017756099987309426
regard O 0 0.0002969836932606995
to O 0 4.148237348999828e-05
the O 0 7.911155262263492e-05
occurrence O 0 0.004660050850361586
of O 0 0.00035769262467511
ovarian B-Disease 1 0.9999986886978149
or I-Disease 0 0.0012913241516798735
other I-Disease 0 0.0010826230281963944
cancers I-Disease 1 0.9999345541000366
. O 0 0.0014747753739356995

Overall O 0 0.018887175247073174
, O 0 0.004712340421974659
disease O 1 0.9999897480010986
was O 0 0.004150029271841049
linked O 0 0.012700098566710949
to O 0 0.00047246203757822514
BRCA1 O 1 0.9969610571861267
in O 0 0.0001551062596263364
an O 0 0.00024201949418056756
estimated O 0 0.000842489767819643
52 O 0 0.000891301257070154
% O 0 2.62465255218558e-05
of O 0 3.5246164770796895e-05
families O 0 0.0004999478114768863
, O 0 0.0003881090087816119
to O 0 0.000857049657497555
BRCA2 O 1 0.9978528022766113
in O 0 0.00028331478824838996
32 O 0 0.0004559967201203108
% O 0 3.5378208849579096e-05
of O 0 3.9958569686859846e-05
families O 0 0.00038297564606182277
, O 0 0.0001862186472862959
and O 0 0.00011533199722180143
to O 0 0.00020112228230573237
neither O 0 0.0021984733175486326
gene O 0 0.0009377733804285526
in O 0 0.00014142523286864161
16 O 0 0.0005254686111584306
% O 0 7.261103019118309e-05
( O 0 0.00027801768737845123
95 O 0 0.0006792710046283901
% O 0 5.8677425840869546e-05
confidence O 0 0.0023814563173800707
interval O 0 0.005688830278813839
[ O 0 0.02862570248544216
CI O 1 0.9980037808418274
] O 0 0.006521785631775856
6 O 0 0.0006159283802844584
% O 0 8.902945410227403e-05
- O 0 0.0023765775840729475
28 O 0 0.0006612651632167399
% O 0 7.667708268854767e-05
) O 0 0.00020170665811747313
, O 0 0.00023787918325979263
suggesting O 0 0.002525860443711281
other O 0 0.00028764939634129405
predisposition O 1 0.9354124665260315
genes O 0 0.002045703586190939
. O 0 0.0010568962898105383

The O 0 0.0011293585412204266
majority O 0 0.001369171543046832
( O 0 0.0007746908231638372
81 O 0 0.0017953917849808931
% O 0 4.622550113708712e-05
) O 0 4.0479335439158604e-05
of O 0 2.1243555238470435e-05
the O 0 0.006516825407743454
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999922513961792
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.0005023326957598329
were O 0 9.68523818301037e-05
due O 0 0.0011829427676275373
to O 0 0.0005615001427941024
BRCA1 O 1 0.999309778213501
, O 0 0.00014915672363713384
with O 0 8.792446897132322e-05
most O 0 0.000226755189942196
others O 0 0.000623341416940093
( O 0 0.00036234885919839144
14 O 0 0.000402585428673774
% O 0 6.325760477920994e-05
) O 0 0.0002228906232630834
due O 0 0.0011836279882118106
to O 0 0.001002424512989819
BRCA2 O 1 0.9988285899162292
. O 0 0.001297749113291502

Conversely O 0 0.022998690605163574
, O 0 0.0002874731144402176
the O 0 0.0001018952316371724
majority O 0 0.00014136754907667637
of O 0 2.432268411212135e-05
families O 0 0.00022232794435694814
with O 0 0.00018496329721529037
male B-Disease 0 0.0017349130939692259
and I-Disease 0 0.0008781675132922828
female I-Disease 1 0.9982028007507324
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999973773956299
were O 0 0.00013802555622532964
due O 0 0.0019351128721609712
to O 0 0.0008403922547586262
BRCA2 O 1 0.9989142417907715
( O 0 0.0011609259527176619
76 O 0 0.005394487176090479
% O 0 0.00018364198331255466
) O 0 0.00046620232751592994
. O 0 0.0007556514465250075

The O 0 0.0007948049460537732
largest O 0 0.0016296873800456524
proportion O 0 0.0016660826513543725
( O 0 0.000863918918184936
67 O 0 0.001866792794317007
% O 0 6.282333197304979e-05
) O 0 7.864048529881984e-05
of O 0 2.969102752103936e-05
families O 0 0.0003929244412574917
due O 0 0.0007605535793118179
to O 0 7.213908975245431e-05
other O 0 4.753948815050535e-05
genes O 0 0.0004658713878598064
was O 0 0.0004937165067531168
found O 0 0.00018123826885130256
in O 0 8.602894376963377e-05
families O 0 0.00011900020763278008
with O 0 4.89411577291321e-05
four O 0 9.9346179922577e-05
or O 0 0.00017049764574039727
five O 0 0.00010405345528852195
cases O 0 0.0005358703783713281
of O 0 0.00013123360986355692
female O 1 0.996303915977478
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999957084655762
only O 0 0.00044636320671997964
. O 0 0.0009702963288873434

These O 0 0.0002552248479332775
estimates O 0 0.0007350819068960845
were O 0 6.530439713969827e-05
not O 0 0.0002443401899654418
substantially O 0 0.009647318162024021
affected O 0 0.0024149559903889894
either O 0 0.00021830282639712095
by O 0 8.033475751290098e-05
changing O 0 0.000981624354608357
the O 0 0.0003801693383138627
assumed O 0 0.014228262938559055
penetrance O 1 0.9684150815010071
model O 0 0.0019202460534870625
for O 0 0.0011724679498001933
BRCA1 O 1 0.9991703033447266
or O 0 0.0002826001145876944
by O 0 8.036648796405643e-05
including O 0 0.00014359562192112207
or O 0 0.0006031566299498081
excluding O 0 0.006524473428726196
BRCA1 O 1 0.9969943761825562
mutation O 0 0.004868646617978811
data O 0 0.0007355331908911467
. O 0 0.001154745346866548

Among O 0 0.0005387093988247216
those O 0 0.00017291052790824324
families O 0 0.0007277681143023074
with O 0 0.0015700459480285645
disease O 1 0.9999971389770508
due O 0 0.00499331671744585
to O 0 0.0008001168025657535
BRCA1 O 1 0.9994400143623352
that O 0 0.00011803833331214264
were O 0 6.701257370878011e-05
tested O 0 0.0027558133006095886
by O 0 2.5627685317886062e-05
one O 0 3.4181412047473714e-05
of O 0 1.1949338841077406e-05
the O 0 0.00018070284568239003
standard O 0 0.0021241663489490747
screening O 0 0.0033587897196412086
methods O 0 0.0006090273964218795
, O 0 0.0003882500168401748
mutations O 0 0.0012550102546811104
were O 0 6.342032429529354e-05
detected O 0 0.002240346744656563
in O 0 5.939057518844493e-05
the O 0 0.000162790238391608
coding O 0 0.0037452816031873226
sequence O 0 0.00022466707741841674
or O 0 0.00040696997893974185
splice O 0 0.007787055801600218
sites O 0 0.00019839065498672426
in O 0 8.083910506684333e-05
an O 0 0.0002060019178315997
estimated O 0 0.0009133526473306119
63 O 0 0.002360707148909569
% O 0 0.00012698248610831797
( O 0 0.00047099520452320576
95 O 0 0.0017628957284614444
% O 0 0.00033352445461787283
CI O 1 0.9907698035240173
51 O 0 0.002976738614961505
% O 0 0.0002301858621649444
- O 0 0.0037239650264382362
77 O 0 0.001985961338505149
% O 0 0.00011805106623796746
) O 0 0.0004811656253878027
. O 0 0.0006243381649255753

The O 0 0.0008680123719386756
estimated O 0 0.0017476134235039353
sensitivity O 0 0.008526035584509373
was O 0 0.0007648851606063545
identical O 0 0.00024605332873761654
for O 0 5.7837060012388974e-05
direct O 0 0.00020303243945818394
sequencing O 0 0.0005099924746900797
and O 0 6.828161713201553e-05
other O 0 7.374117558356375e-05
techniques O 0 0.002075295662507415
. O 0 0.0010573399486020207

The O 0 0.0016994324978441
penetrance O 1 0.6404711604118347
of O 0 0.0006261586677283049
BRCA2 O 1 0.9995096921920776
was O 0 0.0008979025296866894
estimated O 0 0.000407389976317063
by O 0 8.509636245435104e-05
maximizing O 0 0.004260493442416191
the O 0 0.0004595645295921713
LOD O 1 0.9573992490768433
score O 0 0.00033399948733858764
in O 0 0.0010441815247759223
BRCA2 O 1 0.9994437098503113
- O 0 0.01690707355737686
mutation O 0 0.002836257219314575
families O 0 0.0002764632226899266
, O 0 0.00010496190225239843
over O 0 8.68654897203669e-05
all O 0 4.316341073717922e-05
possible O 0 0.0012764350976794958
penetrance O 0 0.3899818956851959
functions O 0 0.000900079554412514
. O 0 0.0011673844419419765

The O 0 0.00051311677088961
estimated O 0 0.001117178937420249
cumulative O 0 0.005720181856304407
risk O 0 0.11009334027767181
of O 0 0.0007539829821325839
breast B-Disease 1 0.9999985694885254
cancer I-Disease 1 0.9999934434890747
reached O 0 0.0024925486650317907
28 O 0 0.0012517893919721246
% O 0 0.00011784882372012362
( O 0 0.0004591953766066581
95 O 0 0.002062847837805748
% O 0 0.00037840873119421303
CI O 1 0.9959203004837036
9 O 0 0.0013471414567902684
% O 0 0.00013517103798221797
- O 0 0.0024010990746319294
44 O 0 0.0003262820828240365
% O 0 5.835360934725031e-05
) O 0 0.00010874313011299819
by O 0 8.737442112760618e-05
age O 0 0.0004456446913536638
50 O 0 0.0003413467784412205
years O 0 0.00037043882184661925
and O 0 0.00017350738926324993
84 O 0 0.0027490046340972185
% O 0 0.00012027264892822132
( O 0 0.0005707838572561741
95 O 0 0.0018175876466557384
% O 0 0.0003691703896038234
CI O 1 0.9895347952842712
43 O 0 0.0019584321416914463
% O 0 0.00014035185449756682
- O 0 0.0019643583800643682
95 O 0 0.0007793303811922669
% O 0 4.98494046041742e-05
) O 0 0.00010058432962978259
by O 0 8.256830915343016e-05
age O 0 0.0007676145760342479
70 O 0 0.0011748474789783359
years O 0 0.001181635307148099
. O 0 0.000949204433709383

The O 0 0.0021659547928720713
corresponding O 1 0.8441043496131897
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risks O 1 0.9543947577476501
were O 0 0.00019726570462808013
0 O 0 0.0015482213348150253
. O 0 0.0006271590827964246

4 O 0 0.0014415892073884606
% O 0 0.00018201846978627145
( O 0 0.0004974417388439178
95 O 0 0.0018711817683652043
% O 0 0.00033189854002557695
CI O 1 0.9931172132492065
0 O 0 0.0008908024756237864
% O 0 0.00010463254147907719
- O 0 0.0018001262797042727
1 O 0 0.00028446209034882486
% O 0 5.145806062500924e-05
) O 0 9.636799222789705e-05
by O 0 5.917901944485493e-05
age O 0 0.0004714537935797125
50 O 0 0.00034810378565452993
years O 0 0.000328506255755201
and O 0 0.00015197852917481214
27 O 0 0.0007560428930446506
% O 0 7.252716750372201e-05
( O 0 0.00038468593265861273
95 O 0 0.0018661789363250136
% O 0 0.0003652928280644119
CI O 1 0.9896406531333923
0 O 0 0.0007215025834739208
% O 0 9.671561565482989e-05
- O 0 0.001544481492601335
47 O 0 0.0005598317948170006
% O 0 5.3453139116754755e-05
) O 0 0.00011682773765642196
by O 0 8.046018047025427e-05
age O 0 0.0006396944518201053
70 O 0 0.0009763797861523926
years O 0 0.001155418111011386
. O 0 0.0006003961316309869

The O 0 0.0011652180692180991
lifetime O 1 0.9608165621757507
risk O 1 0.9678263664245605
of O 0 0.0012992082629352808
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999995231628418
appears O 0 0.005904247052967548
similar O 0 0.00021947865025140345
to O 0 8.14601153251715e-05
the O 0 0.0002479368122294545
risk O 1 0.7226817011833191
in O 0 0.0015165602089837193
BRCA1 O 1 0.9999181032180786
carriers O 0 0.05980689078569412
, O 0 0.0002883940760511905
but O 0 0.00018306085257790983
there O 0 7.659515540581197e-05
was O 0 0.0002683218917809427
some O 0 4.1608083847677335e-05
suggestion O 0 0.000996952410787344
of O 0 2.2850035747978836e-05
a O 0 0.0010314254323020577
lower O 0 0.054654285311698914
risk O 1 0.8905255198478699
in O 0 0.0017126095481216908
BRCA2 O 1 0.9992627501487732
carriers O 0 0.03272402286529541
< O 0 0.015000827610492706
50 O 0 0.00038531431346200407
years O 0 0.00020795504678972065
of O 0 4.600570537149906e-05
age O 0 0.001550536835566163
. O 0 0.0010302593000233173

Eye B-Disease 1 0.9994082450866699
movement I-Disease 0 0.013706200756132603
abnormalities I-Disease 1 0.9968361854553223
correlate O 0 0.0073226154781877995
with O 0 0.0003907690697815269
genotype O 1 0.5123270750045776
in O 0 0.001040996634401381
autosomal O 1 0.9988672733306885
dominant O 1 0.9929215312004089
cerebellar B-Disease 1 0.9999878406524658
ataxia I-Disease 1 0.9999915361404419
type I-Disease 1 0.999397873878479
I I-Disease 1 0.9804282784461975
. O 0 0.0011477443622425199

We O 0 0.0008902873960323632
compared O 0 0.0021319857332855463
horizontal O 0 0.014415934681892395
eye O 1 0.9915722608566284
movements O 0 0.0017328400863334537
( O 0 0.0013125563273206353
visually O 0 0.4232516586780548
guided O 0 0.027358274906873703
saccades O 1 0.9976426959037781
, O 0 0.0011688853846862912
antisaccades O 0 0.2884068787097931
, O 0 0.00020314088033046573
and O 0 0.00019825414346996695
smooth O 0 0.018793882802128792
pursuit O 0 0.011164193972945213
) O 0 0.00022388144861906767
in O 0 0.0001762140600476414
control O 0 0.0014758361503481865
subjects O 0 0.0026066824793815613
( O 0 0.000922212318982929
n O 0 0.0034071803092956543
= O 0 0.0032120735850185156
14 O 0 0.000855453428812325
) O 0 0.0003145683731418103
and O 0 0.00047240208368748426
patients O 1 0.9994657635688782
with O 0 4.6149743866408244e-05
three O 0 6.565519288415089e-05
forms O 0 0.00029739169985987246
of O 0 0.00017217955610249192
autosomal O 1 0.9995455145835876
dominant O 1 0.9637580513954163
cerebellar B-Disease 1 0.999961256980896
ataxias I-Disease 1 0.9990861415863037
type I-Disease 1 0.9897962212562561
I I-Disease 1 0.9810593724250793
spinocerebellar B-Disease 1 0.9996933937072754
ataxias I-Disease 1 0.6730152368545532
1 I-Disease 0 0.0007616276852786541
and I-Disease 0 0.0001660885027376935
2 I-Disease 0 0.0008984686573967338
( O 0 0.0008513513603247702
SCA1 B-Disease 1 0.7986474633216858
, O 0 0.0004022495122626424
n O 0 0.002944027306511998
= O 0 0.003088355762884021
11 O 0 0.0007144949049688876
; O 0 0.00028508002287708223
SCA2 B-Disease 1 0.700373649597168
, O 0 0.0002765913086477667
n O 0 0.0017494687344878912
= O 0 0.0015258900821208954
10 O 0 0.00019505679665599018
) O 0 0.00021010072669014335
and O 0 0.0006282419781200588
SCA3 B-Disease 1 0.99979168176651
/ O 1 0.7099831700325012
Machado B-Disease 1 0.9717227220535278
- I-Disease 0 0.3327467441558838
Joseph I-Disease 0 0.4583147168159485
disease I-Disease 1 0.999977707862854
( O 0 0.0030699828639626503
MJD B-Disease 1 0.9993765950202942
) O 0 0.0008041311521083117
( O 0 0.0007312593515962362
n O 0 0.003658311441540718
= O 0 0.0035914755426347256
16 O 0 0.0008152280934154987
) O 0 0.0003577891911845654
. O 0 0.0006035710102878511

In O 0 0.0029928400181233883
SCA1 B-Disease 1 0.8804351091384888
, O 0 0.0007118317298591137
saccade O 0 0.044798046350479126
amplitude O 0 0.001727418159134686
was O 0 0.0011817826889455318
significantly O 0 0.002876745769754052
increased O 0 0.0005040159448981285
, O 0 0.00018996919970959425
resulting O 0 0.0016510968562215567
in O 0 0.0006572118727490306
hypermetria B-Disease 1 0.9237800240516663
. O 0 0.0014836848713457584

The O 0 0.001034991699270904
smooth O 0 0.014440657570958138
pursuit O 0 0.013211154378950596
gain O 0 0.0031893618870526552
was O 0 0.0026150925550609827
decreased O 0 0.01970849372446537
. O 0 0.001028254977427423

In O 0 0.0029422221705317497
SCA2 B-Disease 1 0.9087533950805664
, O 0 0.0008740186458453536
saccade O 0 0.05725841596722603
velocity O 0 0.004229668993502855
was O 0 0.003154908772557974
markedly O 0 0.09578023850917816
decreased O 0 0.023127930238842964
. O 0 0.0013655954971909523

The O 0 0.0003972049744334072
percentage O 0 0.00038654511445201933
of O 0 5.7377965276828036e-05
errors O 0 0.003707677125930786
in O 0 0.0006737001240253448
antisaccades O 1 0.9658221006393433
was O 0 0.0014644056791439652
greatly O 0 0.003129831748083234
increased O 0 0.0003855148970615119
and O 0 0.00010125171684194356
was O 0 0.0007924961391836405
significantly O 0 0.002647588960826397
correlated O 0 0.001529612811282277
with O 0 0.00012491609959397465
age O 0 0.0033183118794113398
at O 0 0.06948743015527725
disease O 1 0.9999980926513672
onset O 1 0.9997487664222717
. O 0 0.0024687990080565214

In O 0 0.0007151049794629216
addition O 0 0.0004889628035016358
, O 0 0.00017982434656005353
a O 0 0.0004336194833740592
correlation O 0 0.0012813901994377375
between O 0 0.0003622138174250722
smooth O 0 0.023943796753883362
pursuit O 0 0.01329061109572649
gain O 0 0.0009057748829945922
and O 0 4.595391874318011e-05
the O 0 5.992665683152154e-05
number O 0 2.6559446268947795e-05
of O 0 9.930753731168807e-05
trinucleotide O 1 0.9922755360603333
repeats O 0 0.008239386603236198
was O 0 0.0016921252245083451
found O 0 0.0008326793904416263
. O 0 0.0006603256333619356

In O 0 0.004516367334872484
SCA3 B-Disease 1 0.9989821314811707
, O 0 0.0016814618138596416
gaze B-Disease 0 0.4885302186012268
- I-Disease 0 0.036456864327192307
evoked I-Disease 0 0.12398763746023178
nystagmus I-Disease 1 0.9967027306556702
was O 0 0.001607062527909875
often O 0 0.0002598654245957732
present O 0 0.0001819426252041012
as O 0 0.0004305861657485366
was O 0 0.0023423589300364256
saccade O 1 0.9405388832092285
hypometria O 0 0.12271314859390259
and O 0 0.00033335696207359433
smooth O 0 0.010812933556735516
pursuit O 0 0.009278431534767151
gain O 0 0.0026330759283155203
was O 0 0.003178829327225685
markedly O 1 0.6499666571617126
decreased O 0 0.026534846052527428
. O 0 0.0011297415476292372

Three O 0 0.0008280333713628352
major O 0 0.0026086755096912384
criteria O 0 0.0023080066312104464
, O 0 0.0005197594873607159
saccade O 0 0.05972040444612503
amplitude O 0 0.0019039205508306623
, O 0 0.0007542172097600996
saccade O 0 0.06245458126068115
velocity O 0 0.001963258720934391
, O 0 0.00016807786596473306
and O 0 8.904712012736127e-05
presence O 0 0.00042343782843090594
of O 0 0.00012503859761636704
gaze B-Disease 1 0.978736400604248
- I-Disease 0 0.06187564879655838
evoked I-Disease 0 0.15051893889904022
nystagmus I-Disease 1 0.995539128780365
, O 0 0.0003238276985939592
permitted O 0 0.00044876671745441854
the O 0 0.00027298956410959363
correct O 0 0.006230414845049381
assignment O 0 0.003843157086521387
of O 0 3.485107299638912e-05
90 O 0 0.00040767979226075113
% O 0 2.3789914848748595e-05
of O 0 3.1583400414092466e-05
the O 0 0.0008424118277616799
SCA1 B-Disease 1 0.994694173336029
, O 0 0.00023429124848917127
90 O 0 0.0002684843784663826
% O 0 2.0606375983334146e-05
of O 0 2.3838676497689448e-05
the O 0 0.0007092119194567204
SCA2 B-Disease 1 0.9971864819526672
, O 0 0.00024097692221403122
and O 0 0.00012901781883556396
93 O 0 0.0015494013205170631
% O 0 1.9298147890367545e-05
of O 0 2.784113894449547e-05
the O 0 0.0015319917583838105
patients O 1 0.9999240636825562
with O 0 0.0007591994944959879
SCA3 B-Disease 1 0.9997848868370056
to O 0 9.165982191916555e-05
their O 0 0.00011975137022091076
genetically O 0 0.003942836541682482
confirmed O 0 0.01644309237599373
patient O 1 0.9990677237510681
group O 0 0.0003897466813214123
and O 0 0.00013806911010760814
, O 0 0.00020062945259269327
therefore O 0 0.00033014925429597497
, O 0 0.00025555212050676346
may O 0 0.0008762216311879456
help O 0 0.0021792121697217226
orient O 0 0.11860921233892441
diagnoses O 1 0.9936019778251648
of O 0 0.0002193570981035009
SCA1 B-Disease 1 0.9995962977409363
, O 0 0.0013051206478849053
SCA2 B-Disease 1 0.9957507848739624
, O 0 0.00044701507431454957
and O 0 0.0005878880037926137
SCA3 B-Disease 1 0.9997820258140564
at O 0 0.0008714548894204199
early O 0 0.0016262184362858534
clinical O 1 0.9859652519226074
stages O 0 0.0015245118411257863
of O 0 7.8288656368386e-05
the O 0 0.0043077473528683186
diseases O 1 0.9999934434890747
. O 0 0.0004978644428774714
. O 0 0.0008890941389836371

Genetic O 0 0.0023813226725906134
basis O 0 0.0001330127561232075
and O 0 0.00012721226084977388
molecular O 0 0.0020827646367251873
mechanism O 0 0.004907570779323578
for O 0 0.018136195838451385
idiopathic B-Disease 1 0.9999998807907104
ventricular I-Disease 1 0.9999979734420776
fibrillation I-Disease 1 0.9999979734420776
. O 0 0.004684865940362215

Ventricular B-Disease 1 0.9999334812164307
fibrillation I-Disease 1 0.9999582767486572
causes O 0 0.3133319616317749
more O 0 0.00019352605158928782
than O 0 0.00022917958267498761
300 O 0 0.0011476032668724656
, O 0 0.00039312109583988786
000 O 0 0.005854596383869648
sudden O 0 0.17446422576904297
deaths O 0 0.004372278694063425
each O 0 6.075438068364747e-05
year O 0 0.00028511809068731964
in O 0 0.00013111477892380208
the O 0 0.0004990826128050685
USA O 0 0.01422666572034359
alone O 0 0.0030594670679420233
. O 0 0.0008198097930289805

In O 0 0.0008512922213412821
approximately O 0 0.0006844814051873982
5 O 0 0.001097733504138887
- O 0 0.001851357868872583
12 O 0 0.00016989702999126166
% O 0 1.465326567995362e-05
of O 0 1.278896252188133e-05
these O 0 9.473847603658214e-05
cases O 0 0.0015080909943208098
, O 0 0.00012150445400038734
there O 0 5.379180583986454e-05
are O 0 3.611619467847049e-05
no O 0 0.0005270148394629359
demonstrable O 1 0.9994754195213318
cardiac O 1 0.9999818801879883
or O 0 0.0014133405638858676
non O 1 0.5463903546333313
- O 1 0.9986069798469543
cardiac O 1 0.9999806880950928
causes O 0 0.0967114120721817
to O 0 8.649435767438263e-05
account O 0 0.00011815072502940893
for O 0 8.909885946195573e-05
the O 0 0.00020755649893544614
episode O 0 0.0020047477446496487
, O 0 0.00013361174205783755
which O 0 4.378415542305447e-05
is O 0 0.0001322027383139357
therefore O 0 0.0002972556103486568
classified O 0 0.03178175911307335
as O 0 0.014435404911637306
idiopathic B-Disease 1 0.9999998807907104
ventricular I-Disease 1 0.9999949932098389
fibrillation I-Disease 1 0.9999991655349731
( O 0 0.04183604568243027
IVF B-Disease 1 0.9996083378791809
) O 0 0.001483646803535521
. O 0 0.001227258238941431

A O 0 0.003099581925198436
distinct O 0 0.0009141849586740136
group O 0 0.0007669751066714525
of O 0 0.0007273867377080023
IVF B-Disease 1 0.999988317489624
patients O 1 0.9999747276306152
has O 0 0.001112190424464643
been O 0 0.00030175544088706374
found O 0 0.00013527598639484495
to O 0 3.823651059065014e-05
present O 0 5.7614335673861206e-05
with O 0 7.487006951123476e-05
a O 0 0.0008239754824899137
characteristic O 0 0.019111068919301033
electrocardiographic O 1 0.9832225441932678
pattern O 0 0.012127844616770744
. O 0 0.0013200192479416728

Because O 0 0.0009304906707257032
of O 0 2.8189791919430718e-05
the O 0 0.0001188965470646508
small O 0 0.00012832251377403736
size O 0 0.00015353516209870577
of O 0 2.2255368094192818e-05
most O 0 0.0003069583617616445
pedigrees O 0 0.005096040666103363
and O 0 0.00011165819159941748
the O 0 0.0002454998320899904
high O 0 0.004982350394129753
incidence O 1 0.990330696105957
of O 0 0.00021117983851581812
sudden B-Disease 1 0.9995036125183105
death I-Disease 0 0.14532829821109772
, O 0 0.00032366657978855073
however O 0 0.00035327518708072603
, O 0 0.00023631418298464268
molecular O 0 0.0018535832641646266
genetic O 0 0.0013418683083727956
studies O 0 0.0005170304793864489
of O 0 0.00016257369134109467
IVF B-Disease 1 0.9998176693916321
have O 0 0.0002062672283500433
not O 0 0.00013720200513489544
yet O 0 0.0005118540138937533
been O 0 0.0004030784475617111
done O 0 0.0016462196363136172
. O 0 0.0006740931421518326

Because O 0 0.046396348625421524
IVF B-Disease 1 0.9996154308319092
causes O 1 0.999281108379364
cardiac O 1 0.9999825954437256
rhythm O 1 0.9789443016052246
disturbance O 1 0.992061972618103
, O 0 0.00037707024603150785
we O 0 0.00035082967951893806
investigated O 0 0.00785852037370205
whether O 0 0.0009711586753837764
malfunction O 0 0.4293380379676819
of O 0 5.540120764635503e-05
ion O 0 0.003870920278131962
channels O 0 0.0009366254671476781
could O 0 0.0006919841980561614
cause O 0 0.08466021716594696
the O 0 0.0009545261273160577
disorder O 1 0.9999405145645142
by O 0 0.0001763282052706927
studying O 0 0.0013606378342956305
mutations O 0 0.001347272307612002
in O 0 0.0001624125725356862
the O 0 0.0007859216420911252
cardiac O 1 0.999896764755249
sodium O 0 0.011600729078054428
channel O 0 0.005058504641056061
gene O 0 0.009309463202953339
SCN5A O 1 0.9784234166145325
. O 0 0.0014482153346762061

We O 0 0.0009257632191292942
have O 0 0.0001762701867846772
now O 0 0.00037770200287923217
identified O 0 0.0004634123470168561
a O 0 0.0006745054270140827
missense O 0 0.014265877194702625
mutation O 0 0.0024038830306380987
, O 0 0.00021654754527844489
a O 0 0.001199320307932794
splice O 0 0.05648141726851463
- O 0 0.00954666268080473
donor O 0 0.007558020763099194
mutation O 0 0.0026491056196391582
, O 0 0.00016051687998697162
and O 0 0.00015220664499793202
a O 0 0.0021886543836444616
frameshift O 1 0.9704262614250183
mutation O 0 0.002405921695753932
in O 0 0.00010828101221704856
the O 0 0.000248531112447381
coding O 0 0.006587299518287182
region O 0 0.0011130447965115309
of O 0 0.00012477680866140872
SCN5A O 1 0.9917629957199097
in O 0 0.000366365973604843
three O 0 0.0005985760944895446
IVF B-Disease 1 0.9967992305755615
families O 0 0.0012198785552754998
. O 0 0.0012816055677831173

We O 0 0.000667750253342092
show O 0 0.0004210772458463907
that O 0 7.547141285613179e-05
sodium O 0 0.0009828241309151053
channels O 0 0.00018397321400698274
with O 0 6.730704626534134e-05
the O 0 0.000579523912165314
missense O 0 0.037803176790475845
mutation O 0 0.011793915182352066
recover O 1 0.845564067363739
from O 0 0.00048229724052362144
inactivation O 0 0.14649821817874908
more O 0 0.000246139446971938
rapidly O 0 0.0026332675479352474
than O 0 0.00011858221841976047
normal O 0 0.0008764663361944258
and O 0 6.655925244558603e-05
that O 0 7.486736285500228e-05
the O 0 0.00042228118400089443
frameshift O 1 0.9635168313980103
mutation O 0 0.003872343571856618
causes O 0 0.006243229378014803
the O 0 0.00021506828488782048
sodium O 0 0.002436940325424075
channel O 0 0.0005459812819026411
to O 0 6.326044240267947e-05
be O 0 9.066309576155618e-05
non O 0 0.0010473625734448433
- O 0 0.002660684986039996
functional O 0 0.0024469096679240465
. O 0 0.0006748574087396264

Our O 0 0.0010829974198713899
results O 0 0.0006128737586550415
indicate O 0 0.0005192850949242711
that O 0 0.00012153005809523165
mutations O 0 0.0015748700825497508
in O 0 0.000554167665541172
cardiac O 1 0.9999538660049438
ion O 0 0.01753702573478222
- O 0 0.004631634335964918
channel O 0 0.000882251129951328
genes O 0 0.0002932081697508693
contribute O 0 0.0009856232209131122
to O 0 5.5074669944588095e-05
the O 0 0.00014114301302470267
risk O 0 0.00821126252412796
of O 0 9.431788203073665e-05
developing O 1 0.9729808568954468
IVF B-Disease 1 0.9994968175888062
. O 0 0.0005954451044090092
. O 0 0.0009367602760903537

Molecular O 0 0.012036223895847797
heterogeneity O 0 0.018492775037884712
in O 0 0.001517583499662578
mucopolysaccharidosis B-Disease 1 0.9933712482452393
IVA I-Disease 1 0.997115969657898
in O 0 0.0003694207116495818
Australia O 0 0.0004566413990687579
and O 0 0.0001688072079559788
Northern O 0 0.0013155399356037378
Ireland O 0 0.0012061875313520432
: O 0 0.00025623521651141346
nine O 0 0.0004235692322254181
novel O 0 0.002481606090441346
mutations O 0 0.002604388864710927
including O 0 0.0002729565603658557
T312S O 0 0.4937346279621124
, O 0 0.00018238417396787554
a O 0 0.0005323850782588124
common O 0 0.001471700263209641
allele O 0 0.004162720404565334
that O 0 0.00027599945315159857
confers O 0 0.11224941909313202
a O 0 0.003991281148046255
mild O 1 0.9996681213378906
phenotype O 1 0.9845714569091797
. O 0 0.0014106809394434094

Mucopolysaccharidosis B-Disease 1 0.9894567131996155
IVA I-Disease 1 0.9985008239746094
( O 0 0.005436995532363653
MPS B-Disease 1 0.9892464280128479
IVA I-Disease 1 0.9998171925544739
) O 0 0.00044759418233297765
is O 0 0.00027463556034490466
an O 0 0.0011541134444996715
autosomal B-Disease 1 0.9997802376747131
recessive I-Disease 1 0.9997372031211853
lysosomal I-Disease 1 0.9999510049819946
storage I-Disease 1 0.9995030164718628
disorder I-Disease 1 0.9999973773956299
caused O 1 0.6586679220199585
by O 0 0.00024864132865332067
a O 0 0.0031238922383636236
genetic B-Disease 1 0.9216349720954895
defect I-Disease 1 0.9997038245201111
in O 0 0.0006548073142766953
N O 0 0.01959794946014881
- O 0 0.00710537051782012
acetylgalactosamine O 0 0.09954778105020523
- O 0 0.004552992060780525
6 O 0 0.0019388432847335935
- O 0 0.01321366522461176
sulfate O 1 0.991786539554596
sulfatase O 1 0.9980230331420898
( O 0 0.004143815021961927
GALNS O 1 0.9934067726135254
) O 0 0.0012547546066343784
. O 0 0.0009620136115700006

Previous O 0 0.0016002944903448224
studies O 0 0.0005790747818537056
of O 0 0.00016627833247184753
patients O 1 0.9997697472572327
from O 0 0.00014845463738311082
a O 0 0.001293724519200623
British O 0 0.0038424048107117414
- O 0 0.0044358158484101295
Irish O 0 0.0007133189938031137
population O 0 7.412217382807285e-05
showed O 0 0.0006076610297895968
that O 0 6.206842954270542e-05
the O 0 0.000241637957515195
I113F O 0 0.1294764131307602
mutation O 0 0.0016330968355759978
is O 0 9.020534344017506e-05
the O 0 5.922051059314981e-05
most O 0 9.755248174769804e-05
common O 0 0.00041477152262814343
single O 0 0.0005906636361032724
mutation O 0 0.0030335590709000826
among O 0 0.0010727880289778113
MPS B-Disease 1 0.9981221556663513
IVA I-Disease 1 0.9999897480010986
patients O 1 0.999866247177124
and O 0 0.0003218922356609255
produces O 0 0.006545896641910076
a O 0 0.02462473139166832
severe O 1 0.9999831914901733
clinical O 1 0.999924898147583
phenotype O 1 0.9832940101623535
. O 0 0.0017233126563951373

We O 0 0.0008652213728055358
studied O 0 0.0011453599436208606
mutations O 0 0.0012688850983977318
in O 0 0.0001314844994340092
the O 0 0.00037708610761910677
GALNS O 1 0.9879831075668335
gene O 0 0.001095397281460464
from O 0 0.00012233338202349842
23 O 0 0.0010922998189926147
additional O 0 0.0015333396149799228
MPS B-Disease 1 0.9957600235939026
IVA I-Disease 1 0.999981164932251
patients O 1 0.9998871088027954
( O 0 0.0009140682523138821
15 O 0 0.00047965621342882514
from O 0 0.00013601429236587137
Australia O 0 0.0005962756695225835
, O 0 0.0002184187906095758
8 O 0 0.00033118133433163166
from O 0 0.0001240840065293014
Northern O 0 0.0011416695779189467
Ireland O 0 0.0009520878666080534
) O 0 0.00012938064173795283
, O 0 6.418646080419421e-05
with O 0 6.957828009035438e-05
various O 0 0.00040745563455857337
clinical O 1 0.999876856803894
phenotypes O 1 0.9843491911888123
( O 0 0.0031672343611717224
severe O 1 0.9998657703399658
, O 0 0.0004427944659255445
16 O 0 0.0007920638308860362
cases O 0 0.0015428895130753517
; O 0 0.00017963259597308934
intermediate O 0 0.011720405891537666
, O 0 0.00019844193593598902
4 O 0 0.0006900769658386707
cases O 0 0.002117226365953684
; O 0 0.0005152455996721983
mild O 1 0.9992695450782776
, O 0 0.0005196123383939266
3 O 0 0.0009771166369318962
cases O 0 0.002293113386258483
) O 0 0.00040652367169968784
. O 0 0.0006509412196464837

We O 0 0.0009214476449415088
found O 0 0.0003546880034264177
two O 0 9.98094619717449e-05
common O 0 0.0014135626843199134
mutations O 0 0.0017122819554060698
that O 0 5.108281038701534e-05
together O 0 5.23500275448896e-05
accounted O 0 0.0005348429549485445
for O 0 0.00011540627019712701
32 O 0 0.0002033451310126111
% O 0 1.677068939898163e-05
of O 0 1.333816453552572e-05
the O 0 0.0002723897632677108
44 O 0 0.0012085543712601066
unrelated O 0 0.0065664262510836124
alleles O 0 0.003226557979360223
in O 0 0.0002492204075679183
these O 0 0.00040593696758151054
patients O 1 0.9999279975891113
. O 0 0.0011978584807366133

One O 0 0.0006060386658646166
is O 0 0.0003875559486914426
the O 0 0.00039067777106538415
T312S O 0 0.049074746668338776
mutation O 0 0.002504801843315363
, O 0 0.00017745418881531805
a O 0 0.0006414690287783742
novel O 0 0.0023246773052960634
mutation O 0 0.002324327826499939
found O 0 0.0002604939800221473
exclusively O 0 0.0008414812618866563
in O 0 0.001231720787473023
milder O 1 0.9990442395210266
patients O 1 0.9999072551727295
. O 0 0.0014806208200752735

The O 0 0.00044352698023431003
other O 0 7.11212633177638e-05
is O 0 0.0002229947567684576
the O 0 0.00018138762970920652
previously O 0 0.0013388640945777297
described O 0 0.0030067290645092726
I113F O 0 0.01431038323789835
that O 0 0.00012602302012965083
produces O 0 0.0018356817308813334
a O 0 0.003038372378796339
severe O 1 0.9998708963394165
phenotype O 1 0.9820833206176758
. O 0 0.001452182186767459

The O 0 0.0024132966063916683
I113F O 0 0.0325801856815815
and O 0 0.0005449939635582268
T312S O 0 0.0269171129912138
mutations O 0 0.0018837739480659366
accounted O 0 0.0008390983566641808
for O 0 0.00029433320742100477
8 O 0 0.000900478393305093
( O 0 0.0003445521870162338
18 O 0 0.000368112581782043
% O 0 6.959353777347133e-05
) O 0 0.0001463451626477763
and O 0 0.00022014933347236365
6 O 0 0.000945598294492811
( O 0 0.0004228801990393549
14 O 0 0.000436103786341846
% O 0 4.4665946916211396e-05
) O 0 6.630654388573021e-05
of O 0 3.648285201052204e-05
44 O 0 0.0012647277908399701
unrelated O 0 0.010173460468649864
alleles O 0 0.005596497096121311
, O 0 0.00048801524098962545
respectively O 0 0.0011970263440161943
. O 0 0.0008086147136054933

The O 0 0.00114448310341686
relatively O 0 0.0039098490960896015
high O 0 0.005361406598240137
residual O 0 0.03543296828866005
GALNS O 1 0.9836185574531555
activity O 0 0.0013081595534458756
seen O 0 0.001166895730420947
when O 0 0.00025572098093107343
the O 0 0.000278078718110919
T312S O 0 0.02048170380294323
mutant O 0 0.004169836640357971
cDNA O 0 0.004293315578252077
is O 0 0.0009629838168621063
overexpressed O 0 0.04363925755023956
in O 0 0.00035755542921833694
mutant O 0 0.007000403478741646
cells O 0 0.0014001207891851664
provides O 0 0.0006309340242296457
an O 0 0.0001448846305720508
explanation O 0 0.0010875302832573652
for O 0 0.00016952288569882512
the O 0 0.0009019458666443825
mild O 1 0.9998595714569092
phenotype O 1 0.9913485646247864
in O 0 0.0010917920153588057
patients O 1 0.9998043179512024
with O 0 0.00012860560673289
this O 0 0.00025176102644763887
mutation O 0 0.006093292031437159
. O 0 0.0007211801712401211

The O 0 0.0005917666712775826
distribution O 0 0.00031320677953772247
and O 0 7.830859249224886e-05
relative O 0 0.00020679064618889242
frequencies O 0 8.723447535885498e-05
of O 0 1.9227385564590804e-05
the O 0 0.0003764461725950241
I113F O 0 0.15395419299602509
and O 0 0.0005451503093354404
T312S O 0 0.14958533644676208
mutations O 0 0.002046637237071991
in O 0 0.00019166854326613247
Australia O 0 0.000613754615187645
corresponded O 0 0.0020237581338733435
to O 0 7.10913009243086e-05
those O 0 6.947498332010582e-05
observed O 0 0.00041904064710251987
in O 0 0.00021060997096356004
Northern O 0 0.0014164086896926165
Ireland O 0 0.0008658134611323476
and O 0 9.177203173749149e-05
are O 0 3.0483153750537895e-05
unique O 0 0.00020907158614136279
to O 0 4.224592703394592e-05
these O 0 1.9268338292022236e-05
two O 0 4.9374688387615606e-05
populations O 0 0.0004010784032288939
, O 0 0.0001468939008191228
suggesting O 0 0.0017630181973800063
that O 0 6.65115294395946e-05
both O 0 0.0001903786469483748
mutations O 0 0.0013442833442240953
were O 0 7.4071365816053e-05
probably O 0 0.0007307201740331948
introduced O 0 0.0003212937735952437
to O 0 9.77660165517591e-05
Australia O 0 0.00028300320263952017
by O 0 0.00010697577090468258
Irish O 0 0.001572199398651719
migrants O 0 0.0005012844339944422
during O 0 0.0003863375459332019
the O 0 0.00018351174367126077
19th O 0 0.001136847771704197
century O 0 0.0009936600690707564
. O 0 0.0012209155829623342

Haplotype O 0 0.06425061076879501
analysis O 0 0.0008157689007930458
using O 0 0.0005399513174779713
6 O 0 0.0022769025526940823
RFLPs O 0 0.046083953231573105
provides O 0 0.0009011513320729136
additional O 0 0.00012028067430946976
data O 0 6.189152918523178e-05
that O 0 5.021554898121394e-05
the O 0 0.0002352551236981526
I113F O 0 0.04349702224135399
mutation O 0 0.002001985441893339
originated O 0 0.0005834249895997345
from O 0 0.00010230366024188697
a O 0 0.0006742572877556086
common O 0 0.002120922552421689
ancestor O 0 0.004749097395688295
. O 0 0.0015803604619577527

The O 0 0.0004898786428384483
other O 0 0.0001971224119188264
9 O 0 0.0016093150479719043
novel O 0 0.0026169863995164633
mutations O 0 0.003080862807109952
identified O 0 0.0005802919040434062
in O 0 0.0001137569997808896
these O 0 0.0001604301214683801
23 O 0 0.006546961143612862
patients O 1 0.9994823932647705
were O 0 2.4969802325358614e-05
each O 0 2.9057711799396202e-05
limited O 0 0.00029344699578359723
to O 0 4.7175668441923335e-05
a O 0 0.0003248403372708708
single O 0 0.0004949463182128966
family O 0 0.0017200671136379242
. O 0 0.0009732302860356867

These O 0 0.00015993478882592171
data O 0 0.00020975645747967064
provide O 0 0.0004951501614414155
further O 0 0.0002688193926587701
evidence O 0 0.0002694110735319555
for O 0 0.0001824441715143621
extensive O 0 0.008386232890188694
allelic O 0 0.09962471574544907
heterogeneity O 0 0.019480902701616287
in O 0 0.0013076511677354574
MPS B-Disease 1 0.9633724689483643
IVA I-Disease 1 0.9995346069335938
in O 0 0.0008024264825507998
British O 0 0.009785405360162258
- O 1 0.6869866251945496
Irish O 0 0.1147969514131546
patients O 1 0.9999184608459473
and O 0 0.0001779097510734573
provide O 0 0.0005815515760332346
evidence O 0 0.00019076802709605545
for O 0 7.37192458473146e-05
their O 0 6.15923127043061e-05
transmission O 0 0.002721938770264387
to O 0 7.3561655881349e-05
Australia O 0 0.0002273674326715991
by O 0 0.00014063318667467684
British O 0 0.0026809729170054197
- O 0 0.005275354720652103
Irish O 0 0.0014508013846352696
migrants O 0 0.0007494578021578491
. O 0 0.0002606830676086247
. O 0 0.0006811126368120313

Identification O 0 0.00139637291431427
of O 0 0.00012743166007567197
constitutional O 0 0.007358187343925238
WT1 O 1 0.9994869232177734
mutations O 0 0.006106173619627953
, O 0 0.000289186486043036
in O 0 0.0005513947107829154
patients O 1 0.9999409914016724
with O 0 0.0007156459032557905
isolated O 1 0.9987461566925049
diffuse B-Disease 1 0.9999872446060181
mesangial I-Disease 1 0.9999997615814209
sclerosis I-Disease 1 1.0
, O 0 0.00041799418977461755
and O 0 9.997969027608633e-05
analysis O 0 0.00032799335895106196
of O 0 0.00022052222630009055
genotype O 1 0.9982471466064453
/ O 1 0.9752134680747986
phenotype O 0 0.1138777956366539
correlations O 0 0.0017598019912838936
by O 0 3.7369543861132115e-05
use O 0 5.544370287680067e-05
of O 0 2.5535933673381805e-05
a O 0 0.0010198530508205295
computerized O 0 0.05775319039821625
mutation O 0 0.003914886619895697
database O 0 0.002275523031130433
. O 0 0.0010084572713822126

Constitutional O 0 0.003474441124126315
mutations O 0 0.0013966477708891034
of O 0 5.422464164439589e-05
the O 0 0.0012742886319756508
WT1 O 1 0.9981364011764526
gene O 0 0.0019223453709855676
, O 0 0.00012335316569078714
encoding O 0 0.0004687136970460415
a O 0 0.0011959575349465013
zinc O 0 0.45160171389579773
- O 0 0.0059438771568238735
finger O 0 0.014794259332120419
transcription O 0 0.0016319722635671496
factor O 0 0.0018172276904806495
involved O 0 0.0020368164405226707
in O 0 0.0028244920540601015
renal O 1 0.9999994039535522
and O 0 0.003544773440808058
gonadal O 1 0.999441921710968
development O 0 0.0024337659124284983
, O 0 0.00013808399671688676
are O 0 1.9695191440405324e-05
found O 0 0.00010957501945085824
in O 0 9.489172953180969e-05
most O 0 0.0004338204162195325
patients O 1 0.9998962879180908
with O 0 0.0007083925884217024
Denys B-Disease 1 0.9999394416809082
- I-Disease 1 0.9972215890884399
Drash I-Disease 1 0.9995301961898804
syndrome I-Disease 1 0.9999990463256836
( O 0 0.02977737970650196
DDS B-Disease 1 0.9999966621398926
) O 0 0.0005362684605643153
, O 0 0.0005052857450209558
or O 0 0.003815619507804513
diffuse B-Disease 1 0.999964714050293
mesangial I-Disease 1 0.9999992847442627
sclerosis I-Disease 1 1.0
( O 0 0.46478426456451416
DMS B-Disease 1 0.9999593496322632
) O 0 0.0006642782245762646
associated O 0 0.0005052812048234046
with O 0 0.0003843926533591002
pseudohermaphroditism B-Disease 1 0.9984403252601624
and O 0 0.0008919736137613654
/ O 1 0.9373688101768494
or O 0 0.00805747788399458
Wilms B-Disease 1 0.9999960660934448
tumor I-Disease 1 0.9999608993530273
( O 0 0.005088947247713804
WT B-Disease 1 0.9969301819801331
) O 0 0.0009860261343419552
. O 0 0.0009935293346643448

Most O 0 0.0023556083906441927
mutations O 0 0.011859696358442307
in O 0 0.005864309147000313
DDS B-Disease 1 0.999998927116394
patients O 1 0.9999645948410034
lie O 0 0.00664407666772604
in O 0 0.0004105932603124529
exon O 0 0.017129551619291306
8 O 0 0.0006421378930099308
or O 0 0.0003452515520621091
exon O 0 0.010659382678568363
9 O 0 0.0007046986720524728
, O 0 0.00011795000318670645
encoding O 0 0.0008907010196708143
zinc O 0 0.044287119060754776
finger O 0 0.11692853271961212
2 O 0 0.001074673142284155
or O 0 0.0007965534459799528
zinc O 1 0.8845075964927673
finger O 1 0.9232752323150635
3 O 0 0.0009163032518699765
, O 0 0.00018880682182498276
respectively O 0 0.00033612563856877387
, O 0 7.56592708057724e-05
with O 0 7.043949153739959e-05
a O 0 0.0007207388407550752
hot O 0 0.008297200314700603
spot O 0 0.0045865303836762905
( O 0 0.0006933612166903913
R394W O 0 0.016567356884479523
) O 0 0.00018290799926035106
in O 0 0.00025807778001762927
exon O 0 0.01738681271672249
9 O 0 0.0021161444019526243
. O 0 0.0008550422498956323

We O 0 0.0006134903524070978
analyzed O 0 0.0008094774093478918
a O 0 0.00020437396597117186
series O 0 0.00016241474077105522
of O 0 6.560757174156606e-05
24 O 0 0.0019982813391834497
patients O 1 0.9998069405555725
, O 0 0.00013931156718172133
10 O 0 0.00022992133744992316
with O 0 0.00031758323893882334
isolated B-Disease 1 0.9206506609916687
DMS I-Disease 1 0.9998239874839783
( O 0 0.005166539456695318
IDMS B-Disease 1 0.9997414946556091
) O 0 0.0004716322582680732
, O 0 0.00022268817701842636
10 O 0 0.00038207604666240513
with O 0 0.0007744355243630707
DDS B-Disease 1 0.999987006187439
, O 0 0.00022857858857605606
and O 0 0.0001206851884489879
4 O 0 0.0005106223397888243
with O 0 0.0006879980210214853
urogenital B-Disease 1 0.999975323677063
abnormalities I-Disease 1 0.999779999256134
and O 0 0.0026783528737723827
/ O 1 0.9830693006515503
or O 0 0.0028738693799823523
WT B-Disease 1 0.9966853260993958
. O 0 0.0013557017082348466

We O 0 0.002304546069353819
report O 0 0.0058524650521576405
WT1 O 1 0.9912446141242981
heterozygous O 0 0.008899676613509655
mutations O 0 0.0026771046686917543
in O 0 0.0004782596370205283
16 O 0 0.004155452363193035
patients O 1 0.9999092817306519
, O 0 0.00024023136938922107
4 O 0 0.0003109497483819723
of O 0 5.0720020226435736e-05
whom O 0 0.0021695836912840605
presented O 0 0.0013206152943894267
with O 0 0.0011188415810465813
IDMS B-Disease 1 0.9998111128807068
. O 0 0.0023369919508695602

One O 0 0.0007716736872680485
male O 0 0.0007508017006330192
and O 0 0.00011588398047024384
two O 0 0.0002505283337086439
female O 0 0.16987822949886322
IDMS B-Disease 1 0.9999828338623047
patients O 1 0.9999542236328125
with O 0 0.0027630904223769903
WT1 O 1 0.9998396635055542
mutations O 1 0.5015655159950256
underwent O 1 0.9996534585952759
normal O 0 0.03232355788350105
puberty O 1 0.9858895540237427
. O 0 0.0015778759261593223

Two O 0 0.0010789057705551386
mutations O 0 0.00599583238363266
associated O 0 0.0012351790210232139
with O 0 0.0007762882160022855
IDMS B-Disease 1 0.99957674741745
are O 0 3.8651854993076995e-05
different O 0 2.2016974980942905e-05
from O 0 7.406635268125683e-05
those O 0 0.00013899603800382465
described O 0 0.01212901622056961
in O 0 0.0063135623931884766
DDS B-Disease 1 0.9999994039535522
patients O 1 0.9999463558197021
. O 0 0.0014468954177573323

No O 0 0.008476770482957363
WT1 O 1 0.9962277412414551
mutations O 0 0.0044579412788152695
were O 0 0.00010950043360935524
detected O 0 0.002129825996235013
in O 0 5.270195833873004e-05
the O 0 0.00013052973372396082
six O 0 0.0005213889526203275
other O 0 0.001293667359277606
IDMS B-Disease 1 0.9999939203262329
patients O 1 0.999962329864502
, O 0 0.0005704067298211157
suggesting O 0 0.004679001402109861
genetic O 0 0.0019746064208447933
heterogeneity O 0 0.004900538828223944
of O 0 0.00010557000496191904
this O 0 0.0016792125534266233
disease O 1 0.9999915361404419
. O 0 0.001471613417379558

We O 0 0.0019457668531686068
analyzed O 0 0.009389038197696209
genotype O 1 0.884564220905304
/ O 1 0.6415482759475708
phenotype O 0 0.2511685788631439
correlations O 0 0.004586960654705763
, O 0 0.0001371635589748621
on O 0 6.84378101141192e-05
the O 0 3.746702350326814e-05
basis O 0 3.141029810649343e-05
of O 0 1.1286084372841287e-05
the O 0 0.00012335045903455466
constitution O 0 0.00022998687927611172
of O 0 4.087356137461029e-05
a O 0 0.003678868757560849
WT1 O 1 0.9977037310600281
mutation O 0 0.0020317749585956335
database O 0 0.0005892220069654286
of O 0 0.00010392256081104279
84 O 0 0.01925649680197239
germ O 1 0.9989503026008606
- O 0 0.0148165849968791
line O 0 0.002284463495016098
mutations O 0 0.0016716381069272757
, O 0 0.00011027543223462999
to O 0 9.729560406412929e-05
compare O 0 0.0008874645573087037
the O 0 7.18719165888615e-05
distribution O 0 0.0002313407458132133
and O 0 0.00014787088730372488
type O 0 0.0015986625803634524
of O 0 6.704536644974723e-05
mutations O 0 0.0028591647278517485
, O 0 0.00013827200746163726
according O 0 0.00011158794950461015
to O 0 6.386468885466456e-05
the O 0 0.00016400722961407155
different O 0 0.00036676396848633885
symptoms O 1 0.9999444484710693
. O 0 0.0015572475967928767

This O 0 0.0007200436666607857
demonstrated O 0 0.005788963753730059
( O 0 0.0006580765475519001
1 O 0 0.0006844490999355912
) O 0 0.00010444661893416196
the O 0 0.00014826649567112327
association O 0 0.002478534122928977
between O 0 0.00024258044140879065
mutations O 0 0.001186455599963665
in O 0 0.00015453493688255548
exons O 0 0.004048769362270832
8 O 0 0.000485156720969826
and O 0 0.00017457861395087093
9 O 0 0.0013058180920779705
and O 0 0.0008139481651596725
DMS B-Disease 1 0.9998031258583069
; O 0 0.0003267215797677636
( O 0 0.0004661925486288965
2 O 0 0.000624300679191947
) O 0 0.00028423083131201565
among O 0 0.0007542942184954882
patients O 1 0.9999359846115112
with O 0 0.0011177570559084415
DMS B-Disease 1 0.9998759031295776
, O 0 0.00015280999650713056
a O 0 0.00020525687432382256
higher O 0 0.0001603330165380612
frequency O 0 8.38615742395632e-05
of O 0 3.898159775417298e-05
exon O 0 0.015445553697645664
8 O 0 0.0009659132338128984
mutations O 0 0.0012035128893330693
among O 0 0.00021907681366428733
46 O 0 0.002729587722569704
, O 0 0.00177710538264364
XY O 1 0.9994427561759949
patients O 1 0.9996242523193359
with O 0 0.00031491107074543834
female O 0 0.004456605762243271
phenotype O 0 0.09555185586214066
than O 0 0.00016028042591642588
among O 0 0.00025925340014509857
46 O 0 0.0035686041228473186
, O 0 0.0024041254073381424
XY O 1 0.9997561573982239
patients O 1 0.9996718168258667
with O 0 0.0002300936757819727
sexual O 0 0.003362508025020361
ambiguity O 0 0.00533380126580596
or O 0 0.0012444710591807961
male O 0 0.01167544350028038
phenotype O 1 0.9859132170677185
; O 0 0.0003241674567107111
and O 0 0.0002501762646716088
( O 0 0.0004660092818085104
3 O 0 0.0004009974072687328
) O 0 7.64315773267299e-05
statistically O 0 0.00038180474075488746
significant O 0 0.00024168424715753645
evidence O 0 0.00023631508520338684
that O 0 9.174359729513526e-05
mutations O 0 0.0009830675553530455
in O 0 0.00016058623441495
exons O 0 0.005013578105717897
8 O 0 0.0006695679621770978
and O 0 0.0001818961463868618
9 O 0 0.0010974935721606016
preferentially O 0 0.003177155740559101
affect O 0 0.0010667518945410848
amino O 0 0.0002235169376945123
acids O 0 0.00020947463053744286
with O 0 3.809543704846874e-05
different O 0 3.349106918903999e-05
functions O 0 0.0002761478826869279
. O 0 0.0002638139412738383
. O 0 0.0006179782212711871

The O 0 0.003759450977668166
185delAG O 1 0.9748308062553406
BRCA1 O 1 0.9962186217308044
mutation O 0 0.007885640487074852
originated O 0 0.0014202285092324018
before O 0 0.0003029976796824485
the O 0 0.0001484249223722145
dispersion O 0 0.0027147114742547274
of O 0 3.773635398829356e-05
Jews O 0 0.00031753783696331084
in O 0 0.00011562954750843346
the O 0 0.00017045796266756952
diaspora O 0 0.0006602589855901897
and O 0 0.00018398619431536645
is O 0 0.0002263376663904637
not O 0 0.00013876667071599513
limited O 0 0.0006716015632264316
to O 0 0.0003818506665993482
Ashkenazim O 0 0.200299471616745
. O 0 0.0012478764401748776

The O 0 0.0019460530020296574
185delAG O 0 0.12923738360404968
mutation O 0 0.006025432143360376
in O 0 0.0010594417108222842
BRCA1 O 1 0.9993834495544434
is O 0 0.0010961442021653056
detected O 0 0.0048857396468520164
in O 0 0.0002715075097512454
Ashkenazi O 0 0.012873353436589241
Jews O 0 0.00024845858570188284
both O 0 0.0001613682834431529
in O 0 0.0009393977234140038
familial B-Disease 1 0.9999940395355225
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.9965817332267761
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.000304157700156793
in O 0 0.0001363124029012397
the O 0 0.00016621935355942696
general O 0 0.0008542067953385413
population O 0 0.00023069755116011947
. O 0 0.0006875296821817756

All O 0 0.0011059863027185202
tested O 0 0.06133360415697098
Ashkenazi O 0 0.27049025893211365
mutation O 0 0.008293491788208485
carriers O 0 0.0048489635810256
share O 0 0.00023725356732029468
the O 0 0.00014981509593781084
same O 0 0.0003737412625923753
allelic O 0 0.029509680345654488
pattern O 0 0.003424597904086113
at O 0 0.000630666094366461
the O 0 0.0010750904912129045
BRCA1 O 1 0.9983394145965576
locus O 0 0.030677203088998795
. O 0 0.001607422949746251

Our O 0 0.0013322251616045833
previous O 0 0.0006975004216656089
study O 0 0.0008626710041426122
showed O 0 0.0007161081302911043
that O 0 7.997276406968012e-05
this O 0 0.00019106459512840956
Ashkenazi O 0 0.22850140929222107
mutation O 0 0.003971436060965061
also O 0 0.0003596763126552105
occurs O 0 0.0007384978234767914
in O 0 0.00021108966029714793
Iraqi O 0 0.001587608945555985
Jews O 0 0.00023363408399745822
with O 0 8.441873796982691e-05
a O 0 0.0009104970376938581
similar O 0 0.001674351398833096
allelic O 0 0.20568157732486725
pattern O 0 0.016643518581986427
. O 0 0.001765837543644011

We O 0 0.0007631700718775392
extended O 0 0.0007159662782214582
our O 0 0.00020336764282546937
analysis O 0 0.0001363217452308163
to O 0 6.813117215642706e-05
other O 0 6.996144657023251e-05
non O 0 0.002665736712515354
- O 0 0.007612108718603849
Ashkenazi O 0 0.015767740085721016
subsets O 0 0.0016079135239124298
354 O 0 0.004712078720331192
of O 0 4.9105157813755795e-05
Moroccan O 0 0.0017092142952606082
origin O 0 0.00017383364320266992
, O 0 0.0004184305144008249
200 O 0 0.002014564350247383
Yemenites O 0 0.32584115862846375
and O 0 0.0003012251399923116
150 O 0 0.001078760833479464
Iranian O 0 0.0012950117234140635
Jews O 0 0.0011507257586345077
. O 0 0.0008331965073011816

Heteroduplex O 0 0.11238845437765121
analysis O 0 0.0009640146745368838
complemented O 0 0.00276048737578094
by O 0 6.657207268290222e-05
direct O 0 0.00026097000227309763
DNA O 0 0.0005387324490584433
sequencing O 0 0.0003719884844031185
of O 0 0.00011586718028411269
abnormally O 1 0.991265594959259
migrating O 0 0.004853749182075262
bands O 0 0.0009715025662444532
were O 0 0.00015445436292793602
employed O 0 0.004164543002843857
. O 0 0.0010488859843462706

Four O 0 0.0001984882983379066
of O 0 5.944133590674028e-05
Moroccan O 0 0.0021921873558312654
origin O 0 0.00027859985129907727
( O 0 0.0004707052721641958
1 O 0 0.0005446600262075663
. O 0 0.00010588738950900733
1 O 0 0.00032508448930457234
% O 0 5.0635397201403975e-05
) O 0 0.0001106730051105842
and O 0 7.96812164480798e-05
none O 0 0.00023512325424235314
of O 0 2.2901676857145503e-05
the O 0 0.0007726862095296383
Yemenites O 1 0.9859353303909302
or O 0 0.0005515465745702386
Iranians O 0 0.0012148779351264238
was O 0 0.0004666000313591212
a O 0 0.00038584324647672474
carrier O 0 0.0033133861143141985
of O 0 3.1936218874761835e-05
the O 0 0.0005914252833463252
185delAG O 1 0.5709622502326965
mutation O 0 0.008441530168056488
. O 0 0.0012199553893879056

BRCA1 O 1 0.9973830580711365
allelic O 0 0.20922352373600006
patterns O 0 0.0022442801855504513
were O 0 0.0001219164696522057
determined O 0 0.0007763525354675949
for O 0 6.536427099490538e-05
four O 0 3.673067476483993e-05
of O 0 1.3489635421137791e-05
these O 0 2.8820650186389685e-05
individuals O 0 0.00012161167978774756
and O 0 6.608579133171588e-05
for O 0 0.00016178459918592125
12 O 0 0.0003594741865526885
additional O 0 0.0003115604631602764
non O 0 0.0026654961984604597
- O 0 0.009476989507675171
Ashkenazi O 0 0.07095843553543091
185delAG O 0 0.08087912946939468
mutation O 0 0.00381508469581604
carriers O 0 0.006047072354704142
who O 0 0.00164032110478729
had O 0 0.35127943754196167
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999732971191406
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.00234352913685143

Six O 0 0.0031399913132190704
non O 0 0.007970420643687248
- O 0 0.01979215070605278
Ashkenazi O 0 0.02426600083708763
individuals O 0 0.00035082967951893806
shared O 0 0.0005640864837914705
the O 0 0.0005294075817801058
common O 0 0.010783884674310684
Ashkenazi O 1 0.9853078722953796
haplotype O 1 0.7496597170829773
, O 0 0.00025790900690481067
four O 0 0.00015532544057350606
had O 0 0.0003193073789589107
a O 0 0.00045058733667247
closely O 0 0.0007375393179245293
related O 0 0.0015116919530555606
pattern O 0 0.004306653048843145
, O 0 0.00017600381397642195
and O 0 8.149172936100513e-05
the O 0 0.00021867612667847425
rest O 0 0.00177030882332474
( O 0 0.000479981885291636
n O 0 0.0024826829321682453
= O 0 0.0026328531093895435
6 O 0 0.0005963725270703435
) O 0 0.00010365435446146876
displayed O 0 0.0006427372572943568
a O 0 0.0007405889336951077
distinct O 0 0.00411407882347703
BRCA1 O 1 0.9987154006958008
allelic O 0 0.3711107075214386
pattern O 0 0.017647000029683113
. O 0 0.0019139780197292566

We O 0 0.0009279593941755593
conclude O 0 0.0028409892693161964
that O 0 9.79095057118684e-05
the O 0 0.0005687474040314555
185delAG O 1 0.9488123059272766
BRCA1 O 1 0.9976396560668945
mutation O 0 0.004351528827100992
occurs O 0 0.0006581555935554206
in O 0 0.00010907660180237144
some O 0 0.00020636522094719112
non O 0 0.005892414599657059
- O 0 0.020249342545866966
Ashkenazi O 0 0.03796367347240448
populations O 0 0.000651565904263407
at O 0 0.0004201819247100502
rates O 0 0.0006077763973735273
comparable O 0 0.000841509725432843
with O 0 6.565869989572093e-05
that O 0 8.812156011117622e-05
of O 0 0.00011922965495614335
Ashkenazim O 1 0.943107545375824
. O 0 0.0017540105618536472

The O 0 0.0004488580161705613
majority O 0 0.000269989890512079
of O 0 6.731526809744537e-05
Jewish O 0 0.002905429108068347
185delAG O 1 0.8717902302742004
mutation O 0 0.007427908945828676
carriers O 0 0.0055831861682236195
have O 0 0.00012954148405697197
a O 0 0.0007456167368218303
common O 0 0.0028828249778598547
allelic O 0 0.2818948030471802
pattern O 0 0.008030183613300323
, O 0 0.000393195659853518
supporting O 0 0.0018044422613456845
the O 0 0.0004896827158518136
founder O 0 0.012208638712763786
effect O 0 0.0012014152016490698
notion O 0 0.001637952052988112
, O 0 0.000249765143962577
but O 0 0.00021235577878542244
dating O 0 0.0006797871319577098
the O 0 0.0001700251887086779
mutations O 0 0.0009248608839698136
origin O 0 3.887790808221325e-05
to O 0 6.099337770137936e-05
an O 0 0.00015699703362770379
earlier O 0 0.0005796559853479266
date O 0 0.00019084391533397138
than O 0 8.419621008215472e-05
currently O 0 0.00038991094334051013
estimated O 0 0.0010677980026230216
. O 0 0.0007241118000820279

However O 0 0.0011965340236201882
, O 0 0.00011936296505155042
the O 0 9.83014761004597e-05
different O 0 9.216326725436375e-05
allelic O 0 0.028716811910271645
pattern O 0 0.004566596820950508
at O 0 0.000721466145478189
the O 0 0.0011649359948933125
BRCA1 O 1 0.9987731575965881
locus O 0 0.00994845386594534
even O 0 0.0003106697113253176
in O 0 8.470628381473944e-05
some O 0 8.852912287693471e-05
Jewish O 0 0.0015307668363675475
mutation O 0 0.006240434013307095
carriers O 0 0.016831817105412483
, O 0 0.0003927162033505738
might O 0 0.0008882880792953074
suggest O 0 0.000457293470390141
that O 0 5.02966831845697e-05
the O 0 0.00018079417350236326
mutation O 0 0.002617185702547431
arose O 0 0.0020172044169157743
independently O 0 0.0006122628110460937
. O 0 0.00027307626442052424
. O 0 0.0006891325465403497

Crystal O 0 0.03409271314740181
structure O 0 0.0012415170203894377
of O 0 0.0001106525378418155
the O 0 0.0023902750108391047
hemochromatosis B-Disease 1 0.9999779462814331
protein O 0 0.016262730583548546
HFE O 1 0.9976009726524353
and O 0 0.00046061709872446954
characterization O 0 0.004196845926344395
of O 0 2.475345718266908e-05
its O 0 0.00012029719073325396
interaction O 0 0.000564341142307967
with O 0 0.00034006699570454657
transferrin O 1 0.9722819924354553
receptor O 0 0.010486545972526073
. O 0 0.0007269716006703675

HFE O 1 0.9913139939308167
is O 0 0.0015907185152173042
an O 0 0.0017599142156541348
MHC O 1 0.9935444593429565
- O 0 0.003618553513661027
related O 0 0.0004926090477965772
protein O 0 0.00022542968508787453
that O 0 4.968339635524899e-05
is O 0 0.00017219185247085989
mutated O 0 0.0015816628001630306
in O 0 7.072717562550679e-05
the O 0 0.00047256017569452524
iron B-Disease 1 0.9997794032096863
- I-Disease 1 0.9993218183517456
overload I-Disease 1 0.9999701976776123
disease I-Disease 1 0.9999992847442627
hereditary B-Disease 1 0.999996542930603
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 0.008295198902487755

HFE O 1 0.9561492204666138
binds O 0 0.010997139848768711
to O 0 0.0007616153452545404
transferrin O 1 0.890977144241333
receptor O 0 0.01755703240633011
( O 0 0.002135982271283865
TfR O 1 0.9921026825904846
) O 0 0.00033142679603770375
and O 0 0.00015609661932103336
reduces O 0 0.003660640912130475
its O 0 0.00012848401092924178
affinity O 0 0.0016181019600480795
for O 0 0.0004525398835539818
iron O 1 0.8589324951171875
- O 0 0.0039932760410010815
loaded O 0 0.0027468353509902954
transferrin O 0 0.25327184796333313
, O 0 0.0010529587743803859
implicating O 1 0.9848089814186096
HFE O 1 0.9985446929931641
in O 0 0.0013809548690915108
iron O 1 0.9884556531906128
metabolism O 1 0.7579141855239868
. O 0 0.0018476536497473717

The O 0 0.0013617008225992322
2 O 0 0.0022401700261980295
. O 0 0.0011439064983278513

6 O 0 0.0034400925505906343
A O 0 0.0046470751985907555
crystal O 0 0.03242771327495575
structure O 0 0.0017801682697609067
of O 0 0.0003645049000624567
HFE O 1 0.9996675252914429
reveals O 0 0.01301666535437107
the O 0 0.0002321870852028951
locations O 0 0.0004177053924649954
of O 0 0.0003660412330646068
hemochromatosis B-Disease 1 0.9999978542327881
mutations O 0 0.010613324120640755
and O 0 0.0003016378032043576
a O 0 0.004328330047428608
patch O 1 0.9997146725654602
of O 0 0.00017323927022516727
histidines O 1 0.9896747469902039
that O 0 0.00012408340990077704
could O 0 0.00016117900668177754
be O 0 5.9478479670360684e-05
involved O 0 0.00032936802017502487
in O 0 0.00032696963171474636
pH O 1 0.6241986751556396
- O 0 0.003975038416683674
dependent O 0 0.0017229386139661074
interactions O 0 0.0016988590359687805
. O 0 0.000994302099570632

We O 0 0.0006978172459639609
also O 0 0.0002692118287086487
demonstrate O 0 0.0014731851406395435
that O 0 0.0003391098289284855
soluble O 1 0.9046915769577026
TfR O 1 0.9972503781318665
and O 0 0.0014439703663811088
HFE O 1 0.9986675977706909
bind O 0 0.004435238894075155
tightly O 0 0.001059043686836958
at O 0 0.00026263814652338624
the O 0 0.00014424198889173567
basic O 0 0.0015367746818810701
pH O 0 0.006156605668365955
of O 0 2.3749589672661386e-05
the O 0 0.000287171482341364
cell O 0 0.004713660106062889
surface O 0 0.003062599804252386
, O 0 0.0001788684312487021
but O 0 0.00012981676263734698
not O 0 7.089583959896117e-05
at O 0 0.0001676305109867826
the O 0 0.00036576553247869015
acidic O 0 0.12802042067050934
pH O 0 0.01435032393783331
of O 0 0.00010331991506973282
intracellular O 0 0.02397865243256092
vesicles O 0 0.07608307152986526
. O 0 0.0014466652646660805

TfR O 1 0.9893059134483337
HFE O 1 0.99160236120224
stoichiometry O 0 0.05399667099118233
( O 0 0.001547745312564075
2 O 0 0.0008939203689806163
1 O 0 0.0006488754297606647
) O 0 0.00024654483422636986
differs O 0 0.0021313182078301907
from O 0 0.0005246901419013739
TfR O 1 0.9805477857589722
transferrin O 1 0.8405868411064148
stoichiometry O 0 0.025504108518362045
( O 0 0.0012445065658539534
2 O 0 0.001165849738754332
2 O 0 0.0007960344664752483
) O 0 0.00026043487014248967
, O 0 0.0002269721735501662
implying O 0 0.00234280270524323
a O 0 0.00015432997315656394
different O 0 1.793084265955258e-05
mode O 0 0.0003334650245960802
of O 0 2.2627509679296054e-05
binding O 0 0.0008903293637558818
for O 0 0.0007967789424583316
HFE O 1 0.9983553290367126
and O 0 0.000986301340162754
transferrin O 1 0.9526013135910034
to O 0 0.0010008452227339149
TfR O 1 0.990545392036438
, O 0 0.00033744238317012787
consistent O 0 0.0012637559557333589
with O 0 8.338782208738849e-05
our O 0 0.0004288927302695811
demonstration O 0 0.0028058404568582773
that O 0 0.0007213500211946666
HFE O 1 0.998231828212738
, O 0 0.0008247599471360445
transferrin O 1 0.8571686148643494
, O 0 0.00039243049104698
and O 0 0.00040200742660090327
TfR O 1 0.9883989095687866
form O 0 0.0004809977544937283
a O 0 0.0010909992270171642
ternary O 0 0.03210395574569702
complex O 0 0.011103713884949684
. O 0 0.001633759355172515

Identification O 0 0.0009149605757556856
of O 0 4.4658281694864854e-05
three O 0 0.0003031233209185302
novel O 0 0.0030840146355330944
mutations O 0 0.0019180813105776906
and O 0 8.547290053684264e-05
a O 0 0.00039479631232097745
high O 0 0.0006246179109439254
frequency O 0 8.979658014141023e-05
of O 0 1.6648435121169314e-05
the O 0 0.00042566194315440953
Arg778Leu O 1 0.9348400831222534
mutation O 0 0.0022896630689501762
in O 0 0.00035283935721963644
Korean O 0 0.18349260091781616
patients O 1 0.9999390840530396
with O 0 0.0018496245611459017
Wilson B-Disease 1 0.9998388290405273
disease I-Disease 1 0.9999903440475464
. O 0 0.0017582764849066734

Four O 0 0.0013361336896196008
mutations O 0 0.007551402784883976
- O 0 0.011128881014883518
- O 0 0.006981726735830307
R778L O 0 0.01618707738816738
, O 0 0.0004583847476169467
A874V O 0 0.015635119751095772
, O 0 0.00040571572026237845
L1083F O 0 0.01378234475851059
, O 0 0.00019745556346606463
and O 0 0.00028730076155625284
2304delC O 0 0.219848170876503
- O 0 0.0028991177678108215
- O 0 0.0007953831227496266
in O 0 4.768023427459411e-05
the O 0 0.0001520841906312853
copper O 0 0.008822877891361713
- O 0 0.0018764615524560213
transporting O 0 0.004014649428427219
enzyme O 0 0.0031207134015858173
, O 0 0.0006664951797574759
P O 0 0.057169653475284576
- O 0 0.005827341694384813
type O 0 0.007654290180653334
ATPase O 1 0.7226701378822327
( O 0 0.00268455408513546
ATP7B O 1 0.9904754757881165
) O 0 0.0002964255982078612
, O 0 8.762675133766606e-05
were O 0 3.228542846045457e-05
identified O 0 0.0003620829957071692
in O 0 0.00024038624542299658
Korean O 1 0.5464655160903931
Patients O 1 0.999944806098938
with O 0 0.0013839672319591045
Wilson B-Disease 1 0.9998551607131958
disease I-Disease 1 0.9999839067459106
. O 0 0.001422736793756485

Arg778Leu O 1 0.5321477651596069
, O 0 0.00037657146458514035
the O 0 0.00021279319480527192
most O 0 0.00036282362998463213
frequently O 0 0.0016795882256701589
reported O 0 0.0013925158418715
mutation O 0 0.000481804454466328
of O 0 1.434405567124486e-05
this O 0 0.00013936073810327798
enzyme O 0 0.002776271430775523
, O 0 0.0002564055903349072
was O 0 0.0006784098804928362
found O 0 0.00014228497457224876
in O 0 4.177654773229733e-05
six O 0 9.451973892282695e-05
of O 0 3.8263875467237085e-05
eight O 0 0.0013306703185662627
unrelated O 1 0.9756828546524048
patients O 1 0.9998884201049805
studied O 0 0.0011249048402532935
, O 0 0.00015105115016922355
an O 0 0.00022296563838608563
allele O 0 0.0021657177712768316
frequency O 0 0.00017491068865638226
of O 0 5.8556579460855573e-05
37 O 0 0.002899558749049902
. O 0 0.0009798277169466019

5 O 0 0.0012021088041365147
% O 0 0.00012046800111420453
, O 0 0.0001740193838486448
which O 0 7.993036706466228e-05
is O 0 0.0004222477728035301
considerably O 0 0.00365612399764359
higher O 0 0.00031601815135218203
than O 0 6.908841169206426e-05
those O 0 5.783766391687095e-05
in O 0 9.133639105129987e-05
other O 0 8.940114639699459e-05
Asian O 0 0.0021544171031564474
populations O 0 0.001575444359332323
. O 0 0.0008561486029066145

The O 0 0.0005957663524895906
novel O 0 0.0011734466534107924
single O 0 0.00031129916897043586
nucleotide O 0 0.0009405566961504519
deletion O 0 0.006573425605893135
, O 0 0.0005377531633712351
2304delC O 0 0.09556517750024796
, O 0 0.00025873410049825907
was O 0 0.0005374930333346128
found O 0 0.0001883355580503121
in O 0 0.00011799703497672454
one O 0 0.0008545340970158577
patient O 1 0.9988043308258057
. O 0 0.0012626912211999297

Since O 0 0.0018061831360682845
a O 0 0.0007358420407399535
mutation O 0 0.001669595018029213
at O 0 0.00042112261871807277
cDNA O 0 0.004180999007076025
nucleotide O 0 0.0034690466709434986
2302 O 1 0.9114450812339783
( O 0 0.001906581106595695
2302insC O 0 0.1293088048696518
) O 0 0.0005591179942712188
had O 0 0.0008251536637544632
been O 0 0.0005196133861318231
previously O 0 0.001035231864079833
described O 0 0.0018141373293474317
, O 0 0.00011682551121339202
this O 0 4.443203579285182e-05
region O 0 0.00033789887675084174
of O 0 3.5771092370850965e-05
the O 0 0.0008173749665729702
ATP7B O 1 0.9986978769302368
gene O 0 0.004494312219321728
may O 0 0.0008196078706532717
be O 0 0.00018788034503813833
susceptible O 0 0.3330685496330261
to O 0 0.0002082965656882152
gene O 0 0.0043539381586015224
rearrangements O 0 0.331973671913147
causing O 1 0.9984911680221558
Wilson B-Disease 1 0.9996047616004944
disease I-Disease 1 0.9999878406524658
. O 0 0.0020100942347198725

Disruption O 0 0.011720261536538601
of O 0 5.4980213462840766e-05
splicing O 0 0.0017565463203936815
regulated O 0 0.0011382357915863395
by O 0 0.00013865252549294382
a O 0 0.0014911104226484895
CUG O 1 0.947510302066803
- O 0 0.0018881425494328141
binding O 0 0.0004975213669240475
protein O 0 0.0010930675780400634
in O 0 0.0023103642743080854
myotonic B-Disease 1 0.9999974966049194
dystrophy I-Disease 1 0.9999988079071045
. O 0 0.0061713047325611115

Myotonic B-Disease 1 0.9999914169311523
dystrophy I-Disease 1 0.9999995231628418
( O 1 0.7952633500099182
DM B-Disease 1 0.9999969005584717
) O 0 0.0010988442227244377
is O 0 0.0006602992070838809
caused O 0 0.005833494011312723
by O 0 0.00019977979536633939
a O 0 0.002489719307050109
CTG O 1 0.9456436634063721
expansion O 0 0.0015672738663852215
in O 0 0.00011180287401657552
the O 0 0.0001842966303229332
3 O 0 0.0006715740892104805
untranslated O 0 0.011888677254319191
region O 0 0.0005390100996010005
of O 0 5.279823744785972e-05
the O 0 0.0030020771082490683
DM B-Disease 1 0.9999943971633911
gene O 0 0.007992824539542198
. O 0 0.0009058926370926201

One O 0 0.0008504790021106601
model O 0 0.0024227695539593697
of O 0 0.0011995522072538733
DM B-Disease 1 0.9999983310699463
pathogenesis O 1 0.9998032450675964
suggests O 0 0.0055785225704312325
that O 0 0.0002420619857730344
RNAs O 0 0.0074053057469427586
from O 0 7.25510180927813e-05
the O 0 0.00012094947305740789
expanded O 0 0.0010195039212703705
allele O 0 0.0018653289880603552
create O 0 0.00035902997478842735
a O 0 0.0005043683922849596
gain O 0 0.0013551557203754783
- O 0 0.0011757812462747097
of O 0 4.757309579872526e-05
- O 0 0.0024996581487357616
function O 0 0.0006274950574152172
mutation O 0 0.0011011346941813827
by O 0 4.605574576999061e-05
the O 0 0.00019194764900021255
inappropriate O 0 0.003855297574773431
binding O 0 0.0002523016883060336
of O 0 1.4549873412761372e-05
proteins O 0 9.111395047511905e-05
to O 0 0.00010643952555255964
the O 0 0.00064784602727741
CUG O 1 0.9861001372337341
repeats O 0 0.012344039045274258
. O 0 0.001384708215482533

Data O 0 0.0010277241235598922
presented O 0 0.0012705497210845351
here O 0 0.0003540876496117562
indicate O 0 0.0004313795652706176
that O 0 4.101178274140693e-05
the O 0 8.139977580867708e-05
conserved O 0 0.0008192362729460001
heterogeneous O 0 0.011935996823012829
nuclear O 0 0.011183017864823341
ribonucleoprotein O 1 0.9916225075721741
, O 0 0.0013370270607993007
CUG O 0 0.4285760521888733
- O 0 0.0019711193162947893
binding O 0 0.0005680090398527682
protein O 0 0.0010599398519843817
( O 0 0.0013102043885737658
CUG O 1 0.996709942817688
- O 0 0.026673754677176476
BP O 1 0.8257138133049011
) O 0 0.0005045508150942624
, O 0 0.0003029711078852415
may O 0 0.0008934906800277531
mediate O 0 0.006446941755712032
the O 0 0.0004135779745411128
trans O 0 0.04243190586566925
- O 0 0.0027806763537228107
dominant O 0 0.0012583871139213443
effect O 0 0.00022294225345831364
of O 0 1.3931859939475544e-05
the O 0 0.00022412618272937834
RNA O 0 0.0035857772454619408
. O 0 0.000777918437961489

CUG O 1 0.9902659058570862
- O 0 0.07967039197683334
BP O 1 0.8570404052734375
was O 0 0.001251047826372087
found O 0 0.00017010985175147653
to O 0 5.4234464187175035e-05
bind O 0 0.0007990660960786045
to O 0 5.821582817588933e-05
the O 0 0.00030693490407429636
human O 0 0.32776764035224915
cardiac O 1 0.9999974966049194
troponin O 1 0.9999855756759644
T O 1 0.9993042945861816
( O 0 0.0018948212964460254
cTNT O 0 0.12608952820301056
) O 0 0.00044083516695536673
pre O 0 0.005965076386928558
- O 0 0.0038272098172456026
messenger O 0 0.006365600042045116
RNA O 0 0.0009062859462574124
and O 0 9.234676690539345e-05
regulate O 0 0.0016947081312537193
its O 0 0.00020963027782272547
alternative O 0 0.0015783439157530665
splicing O 0 0.003943057265132666
. O 0 0.0009137758170254529

Splicing O 0 0.0033824455458670855
of O 0 0.00017277916776947677
cTNT O 0 0.14327098429203033
was O 0 0.0025446354411542416
disrupted O 0 0.04482903331518173
in O 0 0.0037716508377343416
DM B-Disease 1 0.9999960660934448
striated O 1 0.9996064305305481
muscle O 1 0.9984856247901917
and O 0 0.0003166103851981461
in O 0 0.0003728640149347484
normal O 0 0.005603291559964418
cells O 0 0.002586490474641323
expressing O 0 0.0024994465056806803
transcripts O 0 0.0013196018990129232
that O 0 0.00012151709233876318
contain O 0 0.0018531078239902854
CUG O 1 0.9670508503913879
repeats O 0 0.014515906572341919
. O 0 0.0014013901818543673

Altered O 0 0.0061358376406133175
expression O 0 0.00042305843089707196
of O 0 3.607021062634885e-05
genes O 0 0.0006106252549216151
regulated O 0 0.002942524151876569
posttranscriptionally O 0 0.04491148516535759
by O 0 0.0006539539317600429
CUG O 1 0.9943934679031372
- O 0 0.019426967948675156
BP O 0 0.28382784128189087
therefore O 0 0.0006364677683450282
may O 0 0.0007779095321893692
contribute O 0 0.0040994323790073395
to O 0 0.0019880637992173433
DM B-Disease 1 0.9999971389770508
pathogenesis O 1 0.9994088411331177
. O 0 0.0006498217117041349
. O 0 0.0008187726489268243

Identification O 0 0.0009676014888100326
of O 0 6.387181929312646e-05
a O 0 0.0013473775470629334
novel O 0 0.004551388788968325
nonsense O 0 0.022086957469582558
mutation O 0 0.0022826488129794598
and O 0 0.00011333915608702227
a O 0 0.0007450925186276436
missense O 0 0.005494376178830862
substitution O 0 0.0004188002203591168
in O 0 0.00016075812163762748
the O 0 0.0007789495284669101
vasopressin O 1 0.9881369471549988
- O 0 0.04857124015688896
neurophysin O 1 0.9115563035011292
II O 0 0.43655064702033997
gene O 0 0.0008384901448152959
in O 0 5.547327236854471e-05
two O 0 5.920250259805471e-05
Spanish O 0 0.0006593038560822606
kindreds O 0 0.03881998360157013
with O 0 0.001106815761886537
familial B-Disease 1 0.9999310970306396
neurohypophyseal I-Disease 1 0.9999704360961914
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999693632125854
. O 0 0.004074756056070328

Familial B-Disease 1 0.9995985627174377
neurohypophyseal I-Disease 1 0.9997081160545349
diabetes I-Disease 1 0.9999997615814209
insipidus I-Disease 1 0.999990701675415
( O 0 0.022173380479216576
FNDI B-Disease 1 0.9998236298561096
) O 0 0.00037755872472189367
is O 0 0.000245898321736604
an O 0 0.0007353236433118582
autosomal B-Disease 1 0.9997290968894958
dominant I-Disease 1 0.9992250204086304
disease I-Disease 1 0.9999990463256836
caused O 1 0.9834063053131104
by O 0 0.0015043949242681265
deficiency O 1 0.9999911785125732
in O 0 0.00034379749558866024
the O 0 0.00123492069542408
antidiuretic O 1 0.9959214925765991
hormone O 1 0.9858518242835999
arginine O 1 0.7840335965156555
vasopressin O 1 0.9854204058647156
( O 0 0.004334534052759409
AVP O 1 0.9952955842018127
) O 0 0.00013039213081356138
encoded O 0 4.629944305634126e-05
by O 0 5.2325216529425234e-05
the O 0 0.0006554038845933974
AVP O 1 0.9993065595626831
- O 0 0.020461363717913628
neurophysin O 1 0.8726670742034912
II O 1 0.9848714470863342
( O 0 0.0031995116733014584
AVP O 1 0.9996607303619385
- O 0 0.03609083220362663
NPII O 1 0.9553434252738953
) O 0 0.0004331931413616985
gene O 0 0.001204020343720913
on O 0 0.00034213229082524776
chromosome O 0 0.004333332646638155
20p13 O 0 0.03265272080898285
. O 0 0.0009833552176132798

In O 0 0.0007290129433386028
this O 0 0.00019934061856474727
study O 0 0.0008528201724402606
, O 0 0.0001439065090380609
we O 0 0.00012981552572455257
analyzed O 0 0.0005556514952331781
two O 0 5.2819083066424355e-05
families O 0 0.0002471223415341228
with O 0 0.00037746765883639455
FNDI B-Disease 1 0.995904266834259
using O 0 0.0001572379405843094
direct O 0 0.0003983818751294166
automated O 0 0.00424564303830266
fluorescent O 0 0.013147501274943352
, O 0 0.00029476764029823244
solid O 0 0.003615502966567874
phase O 0 0.0031586752738803625
, O 0 0.0001636743254493922
single O 0 0.00047935041948221624
- O 0 0.0024603072088211775
stranded O 0 0.0026255894917994738
DNA O 0 0.00020005350233986974
sequencing O 0 0.00022670852195005864
of O 0 6.623203807976097e-05
PCR O 0 0.015681501477956772
- O 0 0.008629235439002514
amplified O 0 0.017397332936525345
AVP O 1 0.9988504648208618
- O 0 0.02858903631567955
NPII O 1 0.9490911960601807
DNA O 0 0.0032833260484039783
. O 0 0.0009608246036805212

In O 0 0.00039255002047866583
one O 0 9.981945913750678e-05
of O 0 2.705753104237374e-05
the O 0 0.0002893070341087878
families O 0 0.0006186359096318483
, O 0 0.00041120118112303317
affected O 0 0.0030661236960440874
individuals O 0 0.00020096353546250612
presented O 0 0.0009779543615877628
a O 0 0.0009724655537866056
novel O 0 0.0032533276826143265
nonsense O 0 0.012594208121299744
mutation O 0 0.0029420906212180853
in O 0 0.00026532920310273767
exon O 0 0.009125728160142899
3 O 0 0.0001475463795941323
of O 0 1.547697866044473e-05
the O 0 0.00017776124877855182
gene O 0 0.0009206064860336483
, O 0 6.441935693146661e-05
consisting O 0 0.00010514383757254109
in O 0 0.00017356648459099233
a O 0 0.0013366540661081672
G O 0 0.033274002373218536
to O 0 0.0006672114250250161
T O 1 0.9831720590591431
transition O 0 0.0019941602367907763
at O 0 0.0005200625164434314
nucleotide O 0 0.0016693947836756706
2101 O 1 0.6886051297187805
, O 0 0.00027554092230275273
which O 0 8.173383685061708e-05
produces O 0 0.0007303867605514824
a O 0 0.0004017545434180647
stop O 0 0.0010105554247274995
signal O 0 0.0009362529381178319
in O 0 0.0002056711819022894
codon O 0 0.005231032148003578
82 O 0 0.0064571998082101345
( O 0 0.0018597109010443091
Glu O 1 0.9954909682273865
) O 0 0.0002506915479898453
of O 0 0.00012021348084090278
NPII O 1 0.9938382506370544
. O 0 0.0012398507678881288

The O 0 0.004512332379817963
premature O 1 0.9921169877052307
termination O 1 0.8173500895500183
eliminates O 0 0.010477694682776928
part O 0 0.0003587090759538114
of O 0 3.545081926858984e-05
the O 0 0.0009320381213910878
C O 0 0.45954015851020813
- O 0 0.005834868643432856
terminal O 0 0.013312303461134434
domain O 0 0.0003365161828696728
of O 0 0.00010551767627475783
NPII O 1 0.9454050064086914
, O 0 0.00012490824155975133
including O 0 6.593459693249315e-05
a O 0 0.0004811206308659166
cysteine O 0 0.003020637668669224
residue O 0 0.0038368310779333115
in O 0 0.00022052222630009055
position O 0 0.0012227108236402273
85 O 0 0.0016212047776207328
, O 0 0.00015747170255053788
which O 0 7.005350198596716e-05
could O 0 0.00013847771333530545
be O 0 4.628739407053217e-05
involved O 0 0.00020227963977959007
in O 0 5.5298492952715605e-05
the O 0 0.00021354519412852824
correct O 0 0.004552124999463558
folding O 0 0.0035281411837786436
of O 0 4.837063534068875e-05
the O 0 0.0013442219933494925
prohormone O 1 0.9974992871284485
. O 0 0.0022826488129794598

In O 0 0.00048689128016121686
the O 0 0.00029179707053117454
second O 0 0.0007019232143647969
family O 0 0.0010166405700147152
, O 0 0.00023973941279109567
a O 0 0.0007633170462213457
G279A O 0 0.011711142025887966
substitution O 0 0.0006678075296804309
at O 0 0.00042574270628392696
position O 0 0.0010498440824449062
- O 0 0.0009879273129627109
1 O 0 6.213043525349349e-05
of O 0 6.481227046606364e-06
the O 0 0.00011625586921581998
signal O 0 0.0019020974868908525
peptide O 0 0.0035391589626669884
was O 0 0.0006035770638845861
observed O 0 0.00034210944431833923
in O 0 8.451780740870163e-05
all O 0 6.106695218477398e-05
affected O 0 0.003701381850987673
individuals O 0 0.0005906057194806635
. O 0 0.0008714125724509358

This O 0 0.0009522616164758801
missense O 0 0.01566573604941368
mutation O 0 0.002417502924799919
, O 0 0.00022914264991413802
which O 0 0.0003372391511220485
replaces O 1 0.9108492136001587
Ala O 1 0.9961252808570862
with O 0 0.001150157069787383
Thr O 1 0.9991033673286438
, O 0 0.00040212701424025
is O 0 0.0005779173225164413
frequent O 0 0.00975517462939024
among O 0 0.002733333734795451
FNDI B-Disease 1 0.9999841451644897
patients O 1 0.9998812675476074
and O 0 0.00021317860228009522
is O 0 0.0003490665112622082
thought O 0 0.0005794623284600675
to O 0 5.3777286666445434e-05
reduce O 0 0.0009297268697991967
the O 0 7.294074748642743e-05
efficiency O 0 0.001000270014628768
of O 0 6.003831003908999e-05
cleavage O 0 0.03546388819813728
by O 0 0.00022173349861986935
signal O 0 0.0060119847767055035
peptidases O 0 0.08954952657222748
. O 0 0.0005509392358362675
. O 0 0.0009152736747637391

Genetic O 0 0.0056840768083930016
heterogeneity O 0 0.008406711742281914
of O 0 0.0003613377921283245
Saethre B-Disease 1 0.9997324347496033
- I-Disease 1 0.9978387951850891
Chotzen I-Disease 1 0.9996228218078613
syndrome I-Disease 1 0.9999977350234985
, O 0 0.0005488097667694092
due O 0 0.001263170619495213
to O 0 0.0002661853504832834
TWIST O 0 0.04594237357378006
and O 0 0.0007633112254552543
FGFR O 1 0.9961326122283936
mutations O 0 0.006003049202263355
. O 0 0.0009102975600399077

Thirty O 0 0.00907821860164404
- O 0 0.005051945336163044
two O 0 0.00028676193323917687
unrelated O 0 0.25992509722709656
patients O 1 0.9994804263114929
with O 0 6.057158316252753e-05
features O 0 0.0002160622680094093
of O 0 0.0001494668103987351
Saethre B-Disease 1 0.9997116923332214
- I-Disease 1 0.996950626373291
Chotzen I-Disease 1 0.9997217059135437
syndrome I-Disease 1 0.9999979734420776
, O 0 0.0002892924239858985
a O 0 0.0010966146364808083
common O 0 0.01667724922299385
autosomal B-Disease 1 0.9988954067230225
dominant I-Disease 1 0.7467471957206726
condition I-Disease 1 0.9990204572677612
of O 0 0.000528984353877604
craniosynostosis B-Disease 1 0.9999914169311523
and O 0 0.02987700328230858
limb B-Disease 1 0.9999867677688599
anomalies I-Disease 1 0.9948267340660095
, O 0 0.0003015693509951234
were O 0 7.021482451818883e-05
screened O 0 0.0012871908256784081
for O 0 0.00019101976067759097
mutations O 0 0.001669979770667851
in O 0 0.00032144851866178215
TWIST O 0 0.36637237668037415
, O 0 0.001322111114859581
FGFR2 O 1 0.995170533657074
, O 0 0.0005320274503901601
and O 0 0.0005604051402769983
FGFR3 O 1 0.9954284429550171
. O 0 0.0009657411719672382

Nine O 0 0.0017994522349908948
novel O 0 0.0020124525763094425
and O 0 0.00025675148935988545
three O 0 0.0005724115180782974
recurrent O 1 0.9993632435798645
TWIST O 1 0.9127159714698792
mutations O 0 0.0036154650151729584
were O 0 7.19688250683248e-05
found O 0 0.00027021317509934306
in O 0 0.00019260120461694896
12 O 0 0.000725618505384773
families O 0 0.0005953871877864003
. O 0 0.000865662528667599

Seven O 0 0.0012994484277442098
families O 0 0.00039392654434777796
were O 0 6.811994535382837e-05
found O 0 0.0001553199690533802
to O 0 5.9533242165343836e-05
have O 0 7.250876660691574e-05
the O 0 0.0004378681187517941
FGFR3 O 1 0.9975602626800537
P250R O 0 0.2205497771501541
mutation O 0 0.003132079029455781
, O 0 0.00013097158807795495
and O 0 5.679509195033461e-05
one O 0 8.21508074295707e-05
individual O 0 0.00021085873595438898
was O 0 0.0006756688817404211
found O 0 0.0001442216307623312
to O 0 5.160671571502462e-05
have O 0 6.58063217997551e-05
an O 0 0.0005059944815002382
FGFR2 O 1 0.9918828010559082
VV269 O 0 0.0894177034497261
- O 0 0.0074193947948515415
270 O 0 0.009455608204007149
deletion O 0 0.013319156132638454
. O 0 0.001082085189409554

To O 0 0.0005441582761704922
date O 0 0.0003450146468821913
, O 0 8.924399298848584e-05
our O 0 0.00023656374833080918
detection O 0 0.002412063768133521
rate O 0 0.00029608214390464127
for O 0 0.000355903641320765
TWIST O 0 0.07572805136442184
or O 0 0.0015984822530299425
FGFR O 1 0.992720365524292
mutations O 0 0.0021200054325163364
is O 0 0.00025991370785050094
68 O 0 0.0006046353373676538
% O 0 2.2235575670492835e-05
in O 0 8.415960473939776e-05
our O 0 0.0013288212940096855
Saethre B-Disease 1 0.9984531402587891
- I-Disease 1 0.9977669715881348
Chotzen I-Disease 1 0.9999121427536011
syndrome I-Disease 1 1.0
patients O 1 0.9999653100967407
, O 0 0.00020389592100400478
including O 0 0.0001013919900287874
our O 0 0.0007449661497958004
five O 0 0.0011849806178361177
patients O 1 0.999886155128479
elsewhere O 0 0.0016968084964901209
reported O 0 0.0023055903147906065
with O 0 0.00038613559445366263
TWIST O 1 0.606952965259552
mutations O 0 0.006515040993690491
. O 0 0.0010248461039736867

More O 0 0.0003511820686981082
than O 0 0.00021752555039711297
35 O 0 0.000708452018443495
different O 0 0.00017553154611960053
TWIST O 0 0.10577757656574249
mutations O 0 0.0032175560481846333
are O 0 6.042498353053816e-05
now O 0 0.00048424102715216577
known O 0 0.0002740384079515934
in O 0 7.66305165598169e-05
the O 0 0.00014766602544113994
literature O 0 0.0005712824640795588
. O 0 0.0007926795515231788

The O 0 0.000711798551492393
most O 0 0.0004585025308188051
common O 0 0.00251221377402544
phenotypic O 0 0.019525790587067604
features O 0 0.0008268302190117538
, O 0 0.00019505959062371403
present O 0 0.00011754547449527308
in O 0 5.5143456847872585e-05
more O 0 3.636482506408356e-05
than O 0 5.033857814851217e-05
a O 0 0.00015244398673530668
third O 0 0.00011366601393092424
of O 0 3.557786112651229e-05
our O 0 0.0023815492168068886
patients O 1 0.999667763710022
with O 0 0.00031812689849175513
TWIST O 1 0.8649611473083496
mutations O 0 0.0034418452996760607
, O 0 0.00021025123714935035
are O 0 0.00013910874258726835
coronal B-Disease 1 0.808095395565033
synostosis I-Disease 1 0.5068737864494324
, O 0 0.0005018612137064338
brachycephaly B-Disease 1 0.516868531703949
, O 0 0.0005386043922044337
low B-Disease 0 0.024586690589785576
frontal I-Disease 1 0.9999284744262695
hairline I-Disease 1 0.9999980926513672
, O 0 0.0037028116639703512
facial B-Disease 1 0.9999744892120361
asymmetry I-Disease 1 0.9956953525543213
, O 0 0.007238305173814297
ptosis B-Disease 1 0.9999816417694092
, O 0 0.0026339928153902292
hypertelorism B-Disease 1 0.9997060894966125
, O 0 0.0007374127744697034
broad B-Disease 0 0.02909107878804207
great I-Disease 0 0.009043602272868156
toes I-Disease 1 0.9974036812782288
, O 0 0.00047831074334681034
and O 0 0.000536670908331871
clinodactyly B-Disease 1 0.956762433052063
. O 0 0.0012684531975537539

Significant O 0 0.006136637646704912
intra O 0 0.0807073786854744
- O 0 0.010475816205143929
and O 0 0.0005028877058066428
interfamilial O 0 0.20727594196796417
phenotypic O 0 0.013448262587189674
variability O 0 0.004496742505580187
is O 0 0.0002707823587115854
present O 0 0.0001936877815751359
for O 0 0.0002559127169661224
either O 0 0.000945879437495023
TWIST O 0 0.29499369859695435
mutations O 0 0.006843676790595055
or O 0 0.0015876635443419218
FGFR O 1 0.9957492351531982
mutations O 0 0.006901128683239222
. O 0 0.0009197386098094285

The O 0 0.0010780550073832273
overlap O 0 0.0035980003885924816
in O 0 0.0008350425050593913
clinical O 1 0.9991495609283447
features O 0 0.00045065610902383924
and O 0 0.00011784242815338075
the O 0 0.00019108719425275922
presence O 0 0.0006384839070960879
, O 0 0.00010659574763849378
in O 0 5.429485463537276e-05
the O 0 8.635278936708346e-05
same O 0 0.00010925324750132859
genes O 0 0.00020547813619486988
, O 0 5.428326039691456e-05
of O 0 3.2234147511189803e-05
mutations O 0 0.0008050281321629882
for O 0 4.366731445770711e-05
more O 0 3.9553891838295385e-05
than O 0 8.535105735063553e-05
one O 0 0.0004122663813177496
craniosynostotic B-Disease 1 0.9898983836174011
condition I-Disease 1 0.9925217032432556
- O 0 0.0015981566393747926
such O 0 6.258390931179747e-05
as O 0 0.000859381107147783
Saethre B-Disease 1 0.9780799150466919
- I-Disease 0 0.012734116986393929
Chotzen I-Disease 0 0.11924774199724197
, I-Disease 0 0.0008079315884970129
Crouzon I-Disease 1 0.9099750518798828
, I-Disease 0 0.0005342680378817022
and I-Disease 0 0.0019125465769320726
Pfeiffer I-Disease 1 0.9999094009399414
syndromes I-Disease 1 0.9997838139533997
- O 0 0.0032487879507243633
support O 0 0.00029466452542692423
the O 0 0.00022531321155838668
hypothesis O 0 0.0027545408811420202
that O 0 0.000320974737405777
TWIST O 0 0.08733981102705002
and O 0 0.0004058747144881636
FGFRs O 0 0.42243117094039917
are O 0 2.3987797248992138e-05
components O 0 0.00018872421060223132
of O 0 1.2713324395008385e-05
the O 0 0.00013082879013381898
same O 0 0.00026607420295476913
molecular O 0 0.0027930429205298424
pathway O 0 0.0035248950589448214
involved O 0 0.00039129392825998366
in O 0 6.0545360611286014e-05
the O 0 0.00010767547064460814
modulation O 0 0.002984398975968361
of O 0 0.0002681413316167891
craniofacial O 1 0.9999986886978149
and O 0 0.0041432795114815235
limb O 1 0.999948263168335
development O 0 0.0019345518667250872
in O 0 0.0003743763663806021
humans O 0 0.002548222430050373
. O 0 0.00026878685457631946
. O 0 0.0008019251399673522

Mutation O 0 0.005552032962441444
analysis O 0 0.0003879972791764885
of O 0 0.00031009892700240016
UBE3A O 1 0.9998822212219238
in O 1 0.8931928277015686
Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 1 0.999992847442627
. O 0 0.0019866093061864376

Angelman B-Disease 1 0.9999991655349731
syndrome I-Disease 1 0.9999997615814209
( O 0 0.0062135434709489346
AS B-Disease 0 0.1792045682668686
) O 0 0.0003215282049495727
is O 0 0.0003969748504459858
caused O 0 0.00446887593716383
by O 0 0.0002352847222937271
chromosome O 0 0.006248834542930126
15q11 O 0 0.399033784866333
- O 0 0.009640593081712723
q13 O 0 0.017074422910809517
deletions O 0 0.001457258011214435
of O 0 5.251056791166775e-05
maternal O 0 0.008019128814339638
origin O 0 0.00018528278451412916
, O 0 0.00020656088599935174
by O 0 0.00037695092032663524
paternal O 1 0.5214495658874512
uniparental B-Disease 1 0.9997269511222839
disomy I-Disease 1 0.9953763484954834
( O 0 0.00877772644162178
UPD B-Disease 1 0.9997785687446594
) O 0 0.0007705831667408347
15 O 0 0.00047973901382647455
, O 0 0.00017360204947181046
by O 0 0.0003812659124378115
imprinting O 1 0.9959344863891602
defects O 1 0.9997720122337341
, O 0 0.00023654884716961533
and O 0 9.329793101642281e-05
by O 0 9.841252176556736e-05
mutations O 0 0.001120803295634687
in O 0 0.00017139053670689464
the O 0 0.001058978377841413
UBE3A O 1 0.9988368153572083
gene O 0 0.008134890347719193
. O 0 0.0011581480503082275

UBE3A O 1 0.7382928133010864
encodes O 0 0.004070371855050325
a O 0 0.0013513474259525537
ubiquitin O 0 0.013229231350123882
- O 0 0.0023029460571706295
protein O 0 0.0005563012673519552
ligase O 0 0.0050165303982794285
and O 0 0.000193100466276519
shows O 0 0.0014492492191493511
brain O 1 0.9992163181304932
- O 0 0.0037026077043265104
specific O 0 0.0006424545426853001
imprinting O 0 0.28626200556755066
. O 0 0.0011085885344073176

Here O 0 0.0012190963607281446
we O 0 0.0005584642640314996
describe O 0 0.00695250416174531
UBE3A O 1 0.9736682772636414
coding O 0 0.024656182155013084
- O 0 0.00723838759586215
region O 0 0.002916864585131407
mutations O 0 0.0028401438612490892
detected O 0 0.004118007607758045
by O 0 0.0002213047118857503
SSCP O 1 0.9222573041915894
analysis O 0 0.00047195563092827797
in O 0 0.0003156760649289936
13 O 0 0.0013815481215715408
AS B-Disease 0 0.007050900720059872
individuals O 0 0.00037658459041267633
or O 0 0.0005779250641353428
families O 0 0.0008614750113338232
. O 0 0.0010837942827492952

Two O 0 0.0004496318579185754
identical O 0 0.0018974851118400693
de O 0 0.006304021459072828
novo O 0 0.016988255083560944
5 O 0 0.0017263388726860285
- O 0 0.0054646753706038
bp O 0 0.02662949450314045
duplications O 0 0.007668145466595888
in O 0 0.0005242384504526854
exon O 0 0.012411165051162243
16 O 0 0.0005589621141552925
were O 0 8.368232374778017e-05
found O 0 0.0005595453549176455
. O 0 0.0007108136196620762

Among O 0 0.0004376513243187219
the O 0 0.0002103883889503777
other O 0 0.0001368639786960557
11 O 0 0.0008169641951099038
unique O 0 0.0013597853248938918
mutations O 0 0.0029635003302246332
, O 0 0.00021824704890605062
8 O 0 0.0003172434226144105
were O 0 3.140394983347505e-05
small O 0 0.00020444356778170913
deletions O 0 0.0025078225880861282
or O 0 0.0003916859859600663
insertions O 0 0.00662469957023859
predicted O 0 0.0023282431066036224
to O 0 0.0002895893412642181
cause O 0 0.11387521773576736
frameshifts O 1 0.696570098400116
, O 0 0.00027695365133695304
1 O 0 0.0004479159542825073
was O 0 0.0003877968993037939
a O 0 0.0003551417321432382
mutation O 0 0.0008463213453069329
to O 0 6.355236837407574e-05
a O 0 0.0004950215807184577
stop O 0 0.001982778310775757
codon O 0 0.001967109041288495
, O 0 0.00014496810035780072
1 O 0 0.0003404169692657888
was O 0 0.0004759887815453112
a O 0 0.00089349749032408
missense O 0 0.011771095916628838
mutation O 0 0.0023114578798413277
, O 0 0.00013600547390524298
and O 0 9.926454367814586e-05
1 O 0 0.0004344482149463147
was O 0 0.0006142605561763048
predicted O 0 0.0009785518050193787
to O 0 9.87022795015946e-05
cause O 0 0.0025217910297214985
insertion O 0 0.002108193701133132
of O 0 3.419194035814144e-05
an O 0 0.0006815915112383664
isoleucine O 1 0.6459270715713501
in O 0 0.0002094261144520715
the O 0 0.00030062778387218714
hect O 0 0.018100330606102943
domain O 0 0.00024020344426389784
of O 0 3.169316551066004e-05
the O 0 0.0006890709046274424
UBE3A O 1 0.992551326751709
protein O 0 0.0007605974096804857
, O 0 0.00011998076661257073
which O 0 3.5238972486695275e-05
functions O 0 0.0001703533489489928
in O 0 0.0003181250940542668
E2 O 0 0.09111256152391434
binding O 0 0.0008846139535307884
and O 0 0.0002574849931988865
ubiquitin O 0 0.010351035743951797
transfer O 0 0.0011247510556131601
. O 0 0.0007936058682389557

Eight O 0 0.0005022560362704098
of O 0 4.233101208228618e-05
the O 0 0.0004636500671040267
cases O 0 0.003368608420714736
were O 0 0.0002890067989937961
familial O 1 0.9992828965187073
, O 0 0.0003021054726559669
and O 0 9.387783939018846e-05
five O 0 0.00015802944835741073
were O 0 9.83954596449621e-05
sporadic O 0 0.008177739568054676
. O 0 0.0010625978466123343

In O 0 0.0008742385543882847
two O 0 0.0005299048498272896
familial O 1 0.9992615580558777
cases O 0 0.003758806735277176
and O 0 0.0001842656929511577
one O 0 0.0003238486824557185
sporadic O 0 0.01663992926478386
case O 0 0.0032116153743118048
, O 0 0.0007634377689100802
mosaicism O 1 0.9965092539787292
for O 0 0.0013471305137500167
UBE3A O 1 0.998310923576355
mutations O 0 0.005790830589830875
was O 0 0.0011750421253964305
detected O 0 0.0036397664807736874
in O 0 9.896438132273033e-05
the O 0 0.00021867280884180218
mother O 0 0.0019833717960864305
of O 0 3.7425208574859425e-05
three O 0 0.00034924590727314353
AS B-Disease 0 0.04955482482910156
sons O 0 0.005046493373811245
, O 0 0.00016416385187767446
in O 0 0.0001362566399620846
the O 0 0.0003699031367432326
maternal O 0 0.03258787840604782
grandfather O 0 0.0032563041895627975
of O 0 3.4003896871581674e-05
two O 0 0.0001775516866473481
AS B-Disease 0 0.00763148395344615
first O 0 0.0004695913812611252
cousins O 0 0.002883892972022295
, O 0 0.00019267744210083038
and O 0 7.455374725395814e-05
in O 0 7.630216714460403e-05
the O 0 0.00015556320431642234
mother O 0 0.0009452704689465463
of O 0 3.0011367925908417e-05
an O 0 0.0007760951411910355
AS B-Disease 1 0.8615790605545044
daughter O 0 0.2327789068222046
. O 0 0.0011347302934154868

The O 0 0.0003835302486550063
frequencies O 0 0.00024296004266943783
with O 0 6.259507063077763e-05
which O 0 7.104771793819964e-05
we O 0 0.00022317237744573504
detected O 0 0.003795942757278681
mutations O 0 0.0007925104582682252
were O 0 6.316705548670143e-05
5 O 0 0.0005067052552476525
( O 0 0.00030696214525960386
14 O 0 0.0004084803513251245
% O 0 4.4174234062666073e-05
) O 0 5.790554132545367e-05
of O 0 2.6193411031272262e-05
35 O 0 0.0006379514234140515
in O 0 0.0002888754243031144
sporadic O 0 0.008167153224349022
cases O 0 0.001821361598558724
and O 0 0.00038621193380095065
8 O 0 0.0012401933781802654
( O 0 0.0003820195561274886
80 O 0 0.00047843929496593773
% O 0 4.1556970245437697e-05
) O 0 5.0830123655032367e-05
of O 0 1.7164264136226848e-05
10 O 0 0.00036231809644959867
in O 0 0.0005029595922678709
familial O 1 0.99962317943573
cases O 0 0.013575500808656216
. O 0 0.0005594423855654895
. O 0 0.0009808532195165753

The O 0 0.008285452611744404
hemochromatosis B-Disease 1 0.9999425411224365
845 O 1 0.9846817255020142
G O 1 0.7300506830215454
- O 0 0.010543671436607838
- O 0 0.004161735996603966
> O 0 0.002638367936015129
A O 0 0.0008847647695802152
and O 0 0.00022142755915410817
187 O 0 0.0062625473365187645
C O 0 0.01628567837178707
- O 0 0.006070527248084545
- O 0 0.005414048209786415
> O 0 0.010245563462376595
G O 0 0.020698169246315956
mutations O 0 0.0032006255351006985
: O 0 0.0007163764094002545
prevalence O 0 0.3287879526615143
in O 0 0.00048665556823834777
non O 0 0.006138237658888102
- O 0 0.017285550013184547
Caucasian O 0 0.06344481557607651
populations O 0 0.0018478620331734419
. O 0 0.0008002860704436898

Hemochromatosis B-Disease 1 0.9999028444290161
, O 0 0.0016505136154592037
the O 0 0.002785347867757082
inherited B-Disease 1 0.9999692440032959
disorder I-Disease 1 0.9999959468841553
of I-Disease 0 0.00030717847403138876
iron I-Disease 1 0.9997552037239075
metabolism I-Disease 1 0.9943286776542664
, O 0 0.00045792467426508665
leads O 0 0.0025099515914916992
, O 0 0.00034465795033611357
if O 0 0.001508672721683979
untreated O 1 0.999609649181366
, O 0 0.0001933689200086519
to O 0 0.00026972568593919277
progressive O 1 0.8606381416320801
iron B-Disease 1 0.9986072182655334
overload I-Disease 1 0.999101996421814
and O 0 0.0015375862130895257
premature B-Disease 1 0.9975455403327942
death I-Disease 0 0.013808852061629295
. O 0 0.0009593048598617315

The O 0 0.009234439581632614
hemochromatosis B-Disease 1 0.999988317489624
gene O 0 0.018434297293424606
, O 0 0.001644419739022851
HFE O 1 0.9992153644561768
, O 0 0.0010836119763553143
recently O 0 0.005463353358209133
has O 0 0.0006677247583866119
been O 0 0.00041849256376735866
identified O 0 0.0005345242097973824
, O 0 8.369316492462531e-05
and O 0 7.148782606236637e-05
characterization O 0 0.002444425830617547
of O 0 2.5660943720140494e-05
this O 0 0.00014606564946006984
gene O 0 0.0015201270580291748
has O 0 0.0003115096769761294
shown O 0 0.0003347084275446832
that O 0 4.131907917326316e-05
it O 0 3.930665843654424e-05
contains O 0 5.8960682508768514e-05
two O 0 6.2110586441122e-05
mutations O 0 0.0008556396351195872
that O 0 4.562032700050622e-05
result O 0 0.0001653269282542169
in O 0 6.741219840478152e-05
amino O 0 0.0002976571850012988
acid O 0 0.003231223439797759
substitutions O 0 0.0014863393735140562
- O 0 0.0023612126242369413
cDNA O 0 0.004282040987163782
nucleotides O 0 0.004171466454863548
845 O 0 0.07553111016750336
G O 0 0.03538375347852707
- O 0 0.007059458643198013
- O 0 0.004794532433152199
> O 0 0.004801900126039982
A O 0 0.0026611059438437223
( O 0 0.0007940910290926695
C282Y O 0 0.014161070808768272
) O 0 0.0001892774598672986
and O 0 0.00014961554552428424
187 O 0 0.006953550968319178
C O 0 0.01828678883612156
- O 0 0.00518000777810812
- O 0 0.005252245347946882
> O 0 0.008715127594769001
G O 0 0.020365489646792412
( O 0 0.0014469531597569585
H63D O 1 0.9776136875152588
) O 0 0.0009081998141482472
. O 0 0.0008367717382498085

Although O 0 0.020609432831406593
hemochromatosis B-Disease 1 0.999962329864502
is O 0 0.0013146244455128908
common O 0 0.0017768446123227477
in O 0 0.0007258286932483315
Caucasians O 1 0.7828349471092224
, O 0 0.0005589909851551056
affecting O 0 0.04409930482506752
> O 0 0.03244129940867424
= O 0 0.0066196490079164505
1 O 0 0.0024340765085071325
/ O 0 0.008028549142181873
300 O 0 0.0004915330791845918
individuals O 0 7.354398985626176e-05
of O 0 2.957558899652213e-05
northern O 0 0.0008148094057105482
European O 0 0.0004398110613692552
origin O 0 0.0001421222696080804
, O 0 0.00016959256026893854
it O 0 0.0001497120101703331
has O 0 0.00030978891300037503
not O 0 0.00012704376422334462
been O 0 0.00024975085398182273
recognized O 0 0.0006634367164224386
in O 0 9.672594751464203e-05
other O 0 9.395853703608736e-05
populations O 0 0.0011010559974238276
. O 0 0.0007519563077948987

The O 0 0.0007588414591737092
present O 0 0.00037480579339899123
study O 0 0.0005420297384262085
used O 0 0.0002298623585375026
PCR O 0 0.004241762682795525
and O 0 0.00013629421300720423
restriction O 0 0.0015357192605733871
- O 0 0.004126280080527067
enzyme O 0 0.001956973224878311
digestion O 0 0.007207685615867376
to O 0 9.23373518162407e-05
analyze O 0 0.0007231026538647711
the O 0 5.0627040764084086e-05
frequency O 0 9.002291335491464e-05
of O 0 1.958638495125342e-05
the O 0 0.0006737232324667275
845 O 1 0.8934773802757263
G O 0 0.10992945730686188
- O 0 0.0063990261405706406
- O 0 0.003021061420440674
> O 0 0.002469182014465332
A O 0 0.0007028402178548276
and O 0 0.00016242540732491761
187 O 0 0.00612223893404007
C O 0 0.02174234203994274
- O 0 0.005652297753840685
- O 0 0.004670557100325823
> O 0 0.007036772556602955
G O 0 0.010700332932174206
mutations O 0 0.0021771113388240337
in O 0 0.0007750120712444186
HLA O 1 0.9947609305381775
- O 0 0.003098181216046214
typed O 0 0.0014370784629136324
samples O 0 0.00042191118700429797
from O 0 0.0002137012197636068
non O 0 0.003330360632389784
- O 0 0.008599271066486835
Caucasian O 0 0.034438371658325195
populations O 0 0.0007532680756412446
, O 0 0.00022575445473194122
comprising O 0 0.0006753618945367634
Australian O 0 0.003681125584989786
Aboriginal O 0 0.0071864970959723
, O 0 0.00023835868341848254
Chinese O 0 0.00042138242861256003
, O 0 0.00022143391834106296
and O 0 0.0002786469121929258
Pacific O 0 0.005086726509034634
Islanders O 0 0.007003742270171642
. O 0 0.0006925172638148069

Results O 0 0.0018213684670627117
showed O 0 0.0008438797085545957
that O 0 7.217954407678917e-05
the O 0 0.00041471602162346244
845 O 1 0.9317822456359863
G O 0 0.3163160979747772
- O 0 0.011545113287866116
- O 0 0.005648372229188681
> O 0 0.005166823510080576
A O 0 0.002304258057847619
mutation O 0 0.0023063404951244593
was O 0 0.000468954152893275
present O 0 0.00015318975783884525
in O 0 9.063811012310907e-05
these O 0 5.492586933542043e-05
populations O 0 0.0006581621710211039
( O 0 0.00038178949034772813
allele O 0 0.002009318908676505
frequency O 0 0.0003792149946093559
0 O 0 0.0003860877186525613
. O 0 8.967788744485006e-05
32 O 0 0.0002989010536111891
% O 0 6.043956454959698e-05
) O 0 0.0001838813186623156
, O 0 0.00017456112254876643
and O 0 0.00018407359311822802
, O 0 0.00024213630240410566
furthermore O 0 0.001162166940048337
, O 0 0.0001469161652494222
it O 0 0.00013009036774747074
was O 0 0.0004359371087048203
always O 0 0.00042671174742281437
seen O 0 0.0005359079805202782
in O 0 0.00012705186964012682
conjunction O 0 0.0034303241409361362
with O 0 0.001226285588927567
HLA O 1 0.998543381690979
haplotypes O 0 0.018479900434613228
common O 0 0.0017687085783109069
in O 0 0.0007035492453724146
Caucasians O 0 0.21278910338878632
, O 0 0.00029707286739721894
suggesting O 0 0.0025664663407951593
that O 0 0.0003174488083459437
845 O 1 0.8430551886558533
G O 1 0.5215346217155457
- O 0 0.012316049076616764
- O 0 0.00668548746034503
> O 0 0.0060020252130925655
A O 0 0.002647083019837737
may O 0 0.0006343198474496603
have O 0 8.903608249966055e-05
been O 0 0.00012609669647645205
introduced O 0 0.0001262869336642325
into O 0 5.452684490592219e-05
these O 0 2.8911104891449213e-05
populations O 0 0.00040928972885012627
by O 0 0.0002673922572284937
Caucasian O 1 0.8879998922348022
admixture O 0 0.17035293579101562
. O 0 0.0020819641649723053

187 O 0 0.0326717309653759
C O 0 0.05027509480714798
- O 0 0.011732203885912895
- O 0 0.008296889252960682
> O 0 0.01072742696851492
G O 0 0.010940768755972385
was O 0 0.00042083466541953385
present O 0 0.00011637631541816518
at O 0 0.000186072604265064
an O 0 0.00016237339877989143
allele O 0 0.0013876890297979116
frequency O 0 0.00014963281864766032
of O 0 4.9075286369770765e-05
2 O 0 0.0015063127502799034
. O 0 0.0009123167837969959

68 O 0 0.0048638018779456615
% O 0 7.586705760331824e-05
in O 0 8.285106014227495e-05
the O 0 9.085479541681707e-05
two O 0 5.88518196309451e-05
populations O 0 0.0005417497595772147
analyzed O 0 0.002076777396723628
( O 0 0.0005368353449739516
Australian O 0 0.0024049764033406973
Aboriginal O 0 0.004182208329439163
and O 0 0.00013842081534676254
Chinese O 0 0.0007693711086176336
) O 0 0.0004890094860456884
. O 0 0.0006261547678150237

In O 0 0.00044289324432611465
the O 0 0.0003849511849693954
Australian O 0 0.0024954741820693016
Aboriginal O 0 0.004552443046122789
samples O 0 0.0008176584960892797
, O 0 0.0004219651164021343
187 O 0 0.008868982084095478
C O 0 0.02521076612174511
- O 0 0.006510321516543627
- O 0 0.005838645156472921
> O 0 0.008628892712295055
G O 0 0.009435576386749744
was O 0 0.0005811151931993663
found O 0 0.00015654349408578128
to O 0 5.017797229811549e-05
be O 0 9.945613419404253e-05
associated O 0 0.0003074257692787796
with O 0 0.0005532862269319594
HLA O 1 0.9990234375
haplotypes O 0 0.02129465527832508
common O 0 0.00221038400195539
in O 0 0.0008435569470748305
Caucasians O 1 0.9816540479660034
, O 0 0.0003176362661179155
suggesting O 0 0.0020924957934767008
that O 0 8.02808499429375e-05
it O 0 9.791287448024377e-05
was O 0 0.0004324339679442346
introduced O 0 0.0002850571763701737
by O 0 0.00010868724348256364
recent O 0 0.001708460971713066
admixture O 0 0.0426221527159214
. O 0 0.0016952808946371078

In O 0 0.00033962519955821335
the O 0 0.0001310093211941421
Chinese O 0 0.000339295482262969
samples O 0 0.00039597321301698685
analyzed O 0 0.0011053727939724922
, O 0 0.00028885831125080585
187 O 0 0.006098741199821234
C O 0 0.019128741696476936
- O 0 0.005520726554095745
- O 0 0.004802466370165348
> O 0 0.007339646574109793
G O 0 0.00879089254885912
was O 0 0.0005088855396024883
present O 0 0.000170045459526591
in O 0 0.00018293522589374334
association O 0 0.0022532748989760876
with O 0 7.604146958328784e-05
a O 0 0.0005161347799003124
wide O 0 0.0010002900380641222
variety O 0 0.0006256111082620919
of O 0 0.00038794995634816587
HLA O 1 0.9998655319213867
haplotypes O 0 0.025660421699285507
, O 0 0.00023664539912715554
showing O 0 0.0009363457793369889
this O 0 0.00011953016655752435
mutation O 0 0.0011406791163608432
to O 0 7.580703095300123e-05
be O 0 8.131420327117667e-05
widespread O 0 0.0006719956872984767
and O 0 0.0001659279951127246
likely O 0 0.0007857307209633291
to O 0 0.00011080266995122656
predate O 0 0.0052313352935016155
the O 0 8.304334915010259e-05
more O 0 9.501024760538712e-05
genetically O 0 0.0015628463588654995
restricted O 0 0.002579945605248213
845 O 0 0.46374398469924927
G O 0 0.19056996703147888
- O 0 0.010687398724257946
- O 0 0.005455053877085447
> O 0 0.0050831204280257225
A O 0 0.003132848534733057
mutation O 0 0.004600514192134142
. O 0 0.0008042668341659009

Genotype O 1 0.9394476413726807
- O 0 0.028686171397566795
phenotype O 0 0.041353121399879456
correlations O 0 0.006153928115963936
in O 0 0.0023424960672855377
attenuated B-Disease 1 0.999723494052887
adenomatous I-Disease 1 0.9999988079071045
polyposis I-Disease 1 0.9999958276748657
coli I-Disease 1 0.9997673630714417
. O 0 0.003448908217251301

Germ O 1 0.9949317574501038
- O 0 0.009371472522616386
line O 0 0.0011223802575841546
mutations O 0 0.0006037760758772492
of O 0 3.2151900086319074e-05
the O 0 0.0014752221759408712
tumor B-Disease 1 0.9999608993530273
suppressor O 1 0.9712182283401489
APC O 1 0.9835846424102783
are O 0 0.00024155199935194105
implicated O 1 0.6274961233139038
in O 0 0.0020840265788137913
attenuated B-Disease 1 0.9994717240333557
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9999979734420776
coli I-Disease 1 0.9999628067016602
( O 0 0.03385424241423607
AAPC B-Disease 1 0.9997772574424744
) O 0 0.0005211335956119001
, O 0 0.00016060707275755703
a O 0 0.0006145627703517675
variant O 0 0.014667610637843609
of O 0 0.0006581097841262817
familial B-Disease 1 0.9999985694885254
adenomatous I-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999991655349731
( O 0 0.14824560284614563
FAP B-Disease 1 0.9998788833618164
) O 0 0.002139493590220809
. O 0 0.0010556858032941818

AAPC B-Disease 1 0.9992926120758057
is O 0 0.001395219936966896
recognized O 0 0.0011989434715360403
by O 0 5.4003561672288924e-05
the O 0 0.0001454527082387358
occurrence O 0 0.0031961286440491676
of O 0 0.00012182895443402231
< O 0 0.046097222715616226
100 O 0 0.0028701152186840773
colonic B-Disease 1 0.9990088939666748
adenomas I-Disease 1 0.9958570599555969
and O 0 0.00016461608174722642
a O 0 0.0006671211449429393
later O 0 0.0012533331755548716
onset O 1 0.9994596838951111
of O 0 0.008902725763618946
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.0019491839921101928
age O 0 0.003272573696449399
> O 0 0.01760927401483059
40 O 0 0.0008201411692425609
years O 0 0.0009099658927880228
) O 0 0.0003915194538421929
. O 0 0.0006093235570006073

The O 0 0.000515261257532984
aim O 0 0.0012510992819443345
of O 0 2.8594107789103873e-05
this O 0 9.347122977487743e-05
study O 0 0.0005986953619867563
was O 0 0.0003050555824302137
to O 0 0.0001665503077674657
assess O 0 0.022724976763129234
genotype O 0 0.10615672171115875
- O 0 0.016475358977913857
phenotype O 0 0.06555521488189697
correlations O 0 0.008256189525127411
in O 0 0.0023851068690419197
AAPC B-Disease 1 0.9998026490211487
families O 0 0.0025792070664465427
. O 0 0.0014647863572463393

By O 0 0.0004231144848745316
protein O 0 0.0011948950123041868
- O 0 0.004384500905871391
truncation O 0 0.016557330265641212
test O 0 0.003573076333850622
( O 0 0.0011443054536357522
PTT O 0 0.11683455109596252
) O 0 0.0004733680689241737
assay O 0 0.0023771454580128193
, O 0 0.00017186019977089018
the O 0 0.0001575224450789392
entire O 0 0.0020293649286031723
coding O 0 0.004444149322807789
region O 0 0.0005234245909377933
of O 0 3.1043749913806096e-05
the O 0 0.0008171911467798054
APC B-Disease 1 0.9980060458183289
gene O 0 0.0036023894790560007
was O 0 0.0012898072600364685
screened O 0 0.0028337070252746344
in O 0 0.0002810363657772541
affected O 0 0.0026893483009189367
individuals O 0 0.00034920897451229393
from O 0 0.0006649154820479453
11 O 0 0.01681443303823471
AAPC B-Disease 1 0.9998950958251953
kindreds O 1 0.7931594252586365
, O 0 0.00037794801755808294
and O 0 8.356222679140046e-05
their O 0 0.00010411974653834477
phenotypic O 0 0.00824819691479206
differences O 0 0.0017492972547188401
were O 0 0.00029789653490297496
examined O 0 0.033733759075403214
. O 0 0.0008049652678892016

Five O 0 0.002171665197238326
novel O 0 0.008985450491309166
germ O 1 0.9980348944664001
- O 0 0.024323739111423492
line O 0 0.006785270292311907
APC B-Disease 1 0.9882385730743408
mutations O 0 0.0022112885490059853
were O 0 7.801567699061707e-05
identified O 0 0.0005856150528416038
in O 0 0.0001844467333285138
seven O 0 0.0011230641975998878
kindreds O 0 0.3839845657348633
. O 0 0.0015101302415132523

Mutations O 0 0.008183829486370087
were O 0 0.0001186794979730621
located O 0 0.00045492869685404
in O 0 5.652978506986983e-05
three O 0 2.3990955014596693e-05
different O 0 1.0155875315831508e-05
regions O 0 0.00010289860802004114
of O 0 2.0819112251047045e-05
the O 0 0.0007480856729671359
APC B-Disease 1 0.9964860677719116
gene O 0 0.003313121385872364
( O 0 0.00045807138667441905
1 O 0 0.0004254915693309158
) O 0 8.688205707585439e-05
at O 0 0.00011861433449666947
the O 0 0.00013155309716239572
5 O 0 0.0003950257378164679
end O 0 0.0005919154500588775
spanning O 0 0.001642621704377234
exons O 0 0.002685506595298648
4 O 0 0.00036365108098834753
and O 0 0.00015468370111193508
5 O 0 0.0005357963382266462
, O 0 0.00021953432587906718
( O 0 0.0002911060000769794
2 O 0 0.00033330448786728084
) O 0 7.978964276844636e-05
within O 0 0.0001457751204725355
exon O 0 0.009452709928154945
9 O 0 0.0006238219211809337
, O 0 0.0001602008123882115
and O 0 0.00017652887618169188
( O 0 0.00037587943370454013
3 O 0 0.0003697075298987329
) O 0 8.616482227807865e-05
at O 0 0.00016204069834202528
the O 0 0.00022993383754510432
3 O 0 0.0010058442130684853
distal O 0 0.4052644670009613
end O 0 0.0006325123249553144
of O 0 3.36865232384298e-05
the O 0 0.0004486067045945674
gene O 0 0.004583265632390976
. O 0 0.0008263387135230005

Variability O 0 0.006869848817586899
in O 0 9.061487071448937e-05
the O 0 8.725153020350263e-05
number O 0 0.00010553860920481384
of O 0 0.0009298264631070197
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999874830245972
was O 0 0.002840593457221985
most O 0 0.0004909519338980317
apparent O 0 0.007390417158603668
in O 0 0.000163703050930053
individuals O 0 0.00013402517652139068
with O 0 0.00017234330880455673
mutations O 0 0.0012668799608945847
in O 0 0.00011178902059327811
region O 0 0.0009006225736811757
1 O 0 0.00039856397779658437
, O 0 0.0001677175023360178
and O 0 0.0004073987074662
upper O 1 0.9991266131401062
- O 1 0.9986231327056885
gastrointestinal O 1 0.9999805688858032
manifestations O 0 0.46398305892944336
were O 0 0.00014263298362493515
more O 0 0.0004151102912146598
severe O 1 0.9997478127479553
in O 0 0.0003335037617944181
them O 0 0.00022255360090639442
. O 0 0.0008019816013984382

In O 0 0.000793582119513303
individuals O 0 0.00030422292184084654
with O 0 0.0002791058213915676
mutations O 0 0.002455773763358593
in O 0 0.00019812790560536087
either O 0 0.0005852316971868277
region O 0 0.0016430049436166883
2 O 0 0.0005278928438201547
or O 0 0.00027920506545342505
region O 0 0.0010019992478191853
3 O 0 0.0002620226296130568
, O 0 7.471722346963361e-05
the O 0 7.335403643082827e-05
average O 0 0.0003360151022206992
number O 0 4.372977855382487e-05
of O 0 0.00013848986418452114
adenomas B-Disease 1 0.999699592590332
tended O 0 0.0034474728163331747
to O 0 0.0001257400872418657
be O 0 0.00010975665645673871
lower O 0 0.0007913340232335031
than O 0 4.854647704632953e-05
those O 0 3.592956272768788e-05
in O 0 7.316045230254531e-05
individuals O 0 0.00011369160347385332
with O 0 0.00017341444618068635
mutations O 0 0.0017240714514628053
in O 0 0.0001327482023043558
region O 0 0.0013602464459836483
1 O 0 0.0005328094703145325
, O 0 0.00018852384528145194
although O 0 0.0003713100159075111
age O 0 0.001017281087115407
at O 0 0.002600987209007144
diagnosis O 1 0.9999688863754272
was O 0 0.0018091043457388878
similar O 0 0.001120477681979537
. O 0 0.0009969966486096382

In O 0 0.0016719443956390023
all O 0 0.00127957493532449
AAPC B-Disease 1 0.9997081160545349
kindreds O 0 0.07972121983766556
, O 0 0.0002551392244640738
a O 0 0.0004439117037691176
predominance O 0 0.0054313973523676395
of O 0 0.00011904106213478372
right O 0 0.10048801451921463
- O 1 0.9787223935127258
sided O 1 0.9996658563613892
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999868869781494
and O 0 0.022416917607188225
rectal B-Disease 1 0.9999966621398926
polyp I-Disease 1 0.9999703168869019
sparing O 1 0.9595235586166382
was O 0 0.001956770895048976
observed O 0 0.0014412255259230733
. O 0 0.0007710738573223352

No O 0 0.008494892157614231
desmoid B-Disease 1 0.9980011582374573
tumors I-Disease 1 0.9999570846557617
were O 0 0.00012587686069309711
found O 0 0.00028283277060836554
in O 0 0.00010975006443914026
these O 0 0.00020339495677035302
kindreds O 1 0.6148161292076111
. O 0 0.0012802118435502052

Our O 0 0.0008851856109686196
data O 0 0.0003664340474642813
suggest O 0 0.001050077611580491
that O 0 0.00016331560618709773
, O 0 0.0003407666808925569
in O 0 0.0013079603668302298
AAPC B-Disease 1 0.9998304843902588
families O 0 0.0005804722313769162
, O 0 0.00010893835860770196
the O 0 6.797815149184316e-05
location O 0 0.00015608903777319938
of O 0 2.4683609808562323e-05
the O 0 0.001004540710709989
APC B-Disease 1 0.9980071187019348
mutation O 0 0.0094892717897892
may O 0 0.0022172050084918737
partially O 0 0.010710847564041615
predict O 0 0.0022455905564129353
specific O 0 0.00046766045852564275
phenotypic O 0 0.010290316306054592
expression O 0 0.002915049670264125
. O 0 0.0010742034064605832

This O 0 0.0004449996631592512
should O 0 0.00043272259063087404
help O 0 0.0004248791083227843
in O 0 4.7513160097878426e-05
the O 0 8.512192289344966e-05
design O 0 0.0008257419685833156
of O 0 0.0001490196882514283
tailored O 1 0.9971298575401306
clinical O 1 0.9999425411224365
- O 0 0.2349630892276764
management O 0 0.033820077776908875
protocols O 0 0.003704633330926299
in O 0 7.869907130952924e-05
this O 0 5.353424421628006e-05
subset O 0 0.00164236209820956
of O 0 0.0004996359930373728
FAP B-Disease 1 0.9999880790710449
patients O 1 0.9998575448989868
. O 0 0.0004691155336331576
. O 0 0.0008059223764576018

Wilms B-Disease 1 0.9998390674591064
' I-Disease 1 0.8044087290763855
tumor I-Disease 1 0.9985236525535583
1 O 0 0.0010901145869866014
and O 0 0.00046451052185148
Dax O 1 0.9626808166503906
- O 0 0.0032401217613369226
1 O 0 0.00040196377085521817
modulate O 0 0.009198899380862713
the O 0 0.0005516611854545772
orphan O 1 0.569401204586029
nuclear O 0 0.007853968068957329
receptor O 0 0.02594848722219467
SF O 1 0.9961586594581604
- O 0 0.0022897992748767138
1 O 0 0.00026261634775437415
in O 0 0.00013962197408545762
sex O 0 0.0010358549188822508
- O 0 0.0015901958104223013
specific O 0 0.00031500807381235063
gene O 0 0.0017900160746648908
expression O 0 0.0012671792646870017
. O 0 0.0007301560835912824

Products O 0 0.002372246002778411
of O 0 0.00021490595827344805
steroidogenic O 1 0.9846367835998535
factor O 0 0.003477470250800252
1 O 0 0.0015730417799204588
( O 0 0.0014398180646821856
SF O 1 0.9954212307929993
- O 0 0.0026619695127010345
1 O 0 0.0004195420478936285
) O 0 0.00021538310102187097
and O 0 0.0007505456451326609
Wilms B-Disease 1 0.9999864101409912
tumor I-Disease 1 0.9997732043266296
1 O 0 0.0026553694624453783
( O 0 0.0024537525605410337
WT1 O 1 0.9985242486000061
) O 0 0.00033313551102764904
genes O 0 0.00017576265963725746
are O 0 2.1070927687105723e-05
essential O 0 0.0008068690658546984
for O 0 0.00024381076218560338
mammalian O 0 0.011042732745409012
gonadogenesis O 1 0.6277607679367065
prior O 0 0.0005753940204158425
to O 0 0.0001955089101102203
sexual O 0 0.0020436125341802835
differentiation O 0 0.008756845258176327
. O 0 0.0011632090900093317

In O 0 0.00139351817779243
males O 0 0.0033610158134251833
, O 0 0.001620805123820901
SF O 1 0.9981233477592468
- O 0 0.006900504231452942
1 O 0 0.0007734295213595033
participates O 0 0.003988760523498058
in O 0 0.0002030245232162997
sexual O 0 0.0012938749277964234
development O 0 0.0008905329159460962
by O 0 6.728446169290692e-05
regulating O 0 0.002293516881763935
expression O 0 0.00017573218792676926
of O 0 1.5988196537364274e-05
the O 0 0.0002865097194444388
polypeptide O 0 0.03150638937950134
hormone O 1 0.9871619343757629
Mullerian O 1 0.9973320960998535
inhibiting O 1 0.8044866919517517
substance O 1 0.9934519529342651
( O 0 0.0055672237649559975
MIS O 1 0.9981277585029602
) O 0 0.001045270706526935
. O 0 0.0009882916929200292

Here O 0 0.0011007676366716623
, O 0 0.00023360423801932484
we O 0 0.00019645463908091187
show O 0 0.0005954396328888834
that O 0 0.0007291286601684988
WT1 O 1 0.9981866478919983
- O 0 0.03217627853155136
KTS O 1 0.9539748430252075
isoforms O 0 0.0030541906598955393
associate O 0 0.004620923660695553
and O 0 0.0004783016047440469
synergize O 1 0.9377253651618958
with O 0 0.001268921885639429
SF O 1 0.998892605304718
- O 0 0.0034154769964516163
1 O 0 0.0002893081109505147
to O 0 0.00011097692913608626
promote O 0 0.002796369371935725
MIS O 1 0.9786421060562134
expression O 0 0.002502875169739127
. O 0 0.0012597361346706748

In O 0 0.0011116480454802513
contrast O 0 0.00535906245931983
, O 0 0.0028078516479581594
WT1 O 1 0.9992669224739075
missense O 0 0.1261587291955948
mutations O 0 0.004423749167472124
, O 0 0.0002656760043464601
associated O 0 0.00034911505645141006
with O 0 0.0001912481093313545
male B-Disease 0 0.00407094182446599
pseudohermaphroditism I-Disease 1 0.9993749260902405
in O 0 0.002279727254062891
Denys B-Disease 1 0.9997496008872986
- I-Disease 1 0.9969027638435364
Drash I-Disease 1 0.999496579170227
syndrome I-Disease 1 0.9999980926513672
, O 0 0.001309288782067597
fail O 0 0.02044198289513588
to O 0 0.0004053646407555789
synergize O 1 0.9538008570671082
with O 0 0.001090392586775124
SF O 1 0.9991482496261597
- O 0 0.005337895825505257
1 O 0 0.0007452444988302886
. O 0 0.000600477447733283

Additionally O 0 0.004388920497149229
, O 0 0.0002837778301909566
the O 0 0.0005341434734873474
X O 0 0.049318429082632065
- O 0 0.005454142577946186
linked O 0 0.00283968192525208
, O 0 0.00022389829973690212
candidate O 0 0.0024195448495447636
dosage O 1 0.9407534003257751
- O 0 0.005220041610300541
sensitive O 0 0.005822613835334778
sex O 0 0.0030260938219726086
- O 0 0.005981797818094492
reversal O 0 0.01510065607726574
gene O 0 0.003104071831330657
, O 0 0.000852785597089678
Dax O 1 0.9419824481010437
- O 0 0.003853442845866084
1 O 0 0.00048728962428867817
, O 0 0.0003732417244464159
antagonizes O 0 0.0995999127626419
synergy O 0 0.013975580222904682
between O 0 0.0015185978263616562
SF O 1 0.9985364675521851
- O 0 0.004487399943172932
1 O 0 0.0007448291289620101
and O 0 0.0007097234483808279
WT1 O 1 0.9982265830039978
, O 0 0.0003685497504193336
most O 0 0.00018887325131800026
likely O 0 0.00046398298582062125
through O 0 8.467608859064057e-05
a O 0 0.00017977532115764916
direct O 0 0.0001829250977607444
interaction O 0 0.0004798304580617696
with O 0 0.0009041451849043369
SF O 1 0.9986118078231812
- O 0 0.005036347545683384
1 O 0 0.0009706882992759347
. O 0 0.0005560045829042792

We O 0 0.0012750740861520171
propose O 0 0.006622666493058205
that O 0 0.0007706485339440405
WT1 O 1 0.9972636699676514
and O 0 0.0009831823408603668
Dax O 1 0.9881497621536255
- O 0 0.0069945319555699825
1 O 0 0.0009285630658268929
functionally O 0 0.009520119987428188
oppose O 0 0.0006245608092285693
each O 0 2.6659783543436788e-05
other O 0 5.701927511836402e-05
in O 0 0.00033967624767683446
testis O 1 0.9806535840034485
development O 0 0.0016361735761165619
by O 0 0.00045715394662693143
modulating O 1 0.9760840535163879
SF O 1 0.9971569776535034
- O 0 0.006797955837100744
1 O 0 0.0016102102817967534
- O 0 0.004935464356094599
mediated O 0 0.022688789293169975
transactivation O 0 0.08989840000867844
. O 0 0.0005999128334224224
. O 0 0.0008763569639995694

A O 0 0.009474259801208973
mouse O 0 0.013901705853641033
model O 0 0.0022654167842119932
for O 0 0.002808080054819584
Prader B-Disease 1 0.9999973773956299
- I-Disease 1 0.9996950626373291
Willi I-Disease 1 0.9999947547912598
syndrome I-Disease 1 0.999998927116394
imprinting O 1 0.9916941523551941
- O 0 0.08311129361391068
centre O 0 0.010234788060188293
mutations O 0 0.005937465466558933
. O 0 0.0009399210684932768

Imprinting O 0 0.06429675221443176
in O 0 0.0006005944451317191
the O 0 0.0011669275118038058
15q11 O 0 0.1819208562374115
- O 0 0.00774385454133153
q13 O 0 0.013662603683769703
region O 0 0.0011784866219386458
involves O 0 0.0016114064492285252
an O 0 0.0007574888877570629
imprinting O 1 0.7108088731765747
centre O 0 0.018690042197704315
( O 0 0.0025551693979650736
IC O 1 0.9902307391166687
) O 0 0.00040211607119999826
, O 0 0.00017345778178423643
mapping O 0 0.001811300404369831
in O 0 0.000127239924040623
part O 0 0.0003878612187691033
to O 0 0.00011075239308411255
the O 0 0.00023057528596837074
promoter O 0 0.015668587759137154
and O 0 0.00012189611879875883
first O 0 0.00029651320073753595
exon O 0 0.00876648724079132
of O 0 0.00019962669466622174
SNRPN O 1 0.9939149022102356
. O 0 0.001689713099040091

Deletion O 0 0.007625910919159651
of O 0 7.668870966881514e-05
this O 0 0.0005952847423031926
IC O 1 0.9901127815246582
abolishes O 0 0.10710331052541733
local O 0 0.0007192515186034143
paternally O 0 0.025306493043899536
derived O 0 0.0007719421410001814
gene O 0 0.0012756972573697567
expression O 0 0.00043174054007977247
and O 0 0.00012663374945987016
results O 0 0.0007539737271144986
in O 0 0.001433184603229165
Prader B-Disease 1 0.999997615814209
- I-Disease 1 0.9998719692230225
Willi I-Disease 1 0.999998927116394
syndrome I-Disease 1 0.9999997615814209
( O 0 0.19443875551223755
PWS B-Disease 1 0.9999939203262329
) O 0 0.0018280883086845279
. O 0 0.001184782013297081

We O 0 0.0005766232497990131
have O 0 0.00010126106644747779
created O 0 0.00024971109814941883
two O 0 0.0001154531491920352
deletion O 0 0.007060340605676174
mutations O 0 0.0022633064072579145
in O 0 0.000489479978568852
mice O 0 0.03540750592947006
to O 0 0.0006299066008068621
understand O 0 0.3628777265548706
PWS B-Disease 1 0.9999715089797974
and O 0 0.00015670656284783036
the O 0 0.00010057511826744303
mechanism O 0 0.0006954929558560252
of O 0 5.0212194764753804e-05
this O 0 0.0004834818246308714
IC O 1 0.9926282167434692
. O 0 0.0014808506239205599

Mice O 0 0.358163446187973
harbouring O 1 0.8201203942298889
an O 0 0.002018422121182084
intragenic O 1 0.9407285451889038
deletion O 0 0.012065947987139225
in O 0 0.0005834272014908493
Snrpn O 1 0.7177689075469971
are O 0 0.00025050659314729273
phenotypically O 1 0.7526706457138062
normal O 0 0.002598788822069764
, O 0 0.0002922759158536792
suggesting O 0 0.002865283051505685
that O 0 0.00015660739154554904
mutations O 0 0.001165891415439546
of O 0 7.482353248633444e-05
SNRPN O 1 0.9962989687919617
are O 0 3.996867235400714e-05
not O 0 8.983330917544663e-05
sufficient O 0 0.000873707584105432
to O 0 0.0005555781535804272
induce O 1 0.9764992594718933
PWS B-Disease 1 0.9999624490737915
. O 0 0.0031894617713987827

Mice O 0 0.017748771235346794
with O 0 0.00012043309106957167
a O 0 0.0005668522207997739
larger O 0 0.0009798654355108738
deletion O 0 0.00717898178845644
involving O 0 0.001204983564093709
both O 0 0.00046584740630351007
Snrpn O 1 0.7809404134750366
and O 0 0.00022010336397215724
the O 0 0.0009699580841697752
putative O 1 0.9901902675628662
PWS O 1 0.999982476234436
- O 1 0.6328045725822449
IC O 1 0.9788716435432434
lack O 0 0.0019823594484478235
expression O 0 0.00033135441481135786
of O 0 3.191551149939187e-05
the O 0 0.0005175955011509359
imprinted O 0 0.35957974195480347
genes O 0 0.0016950953286141157
Zfp127 O 1 0.7109671831130981
( O 0 0.0012492624809965491
mouse O 0 0.01145749818533659
homologue O 0 0.020111845806241035
of O 0 0.00023242762836162
ZNF127 O 1 0.9939149022102356
) O 0 0.000878406863193959
, O 0 0.0009689964936114848
Ndn O 1 0.99725741147995
and O 0 0.0006845401367172599
Ipw O 1 0.9737754464149475
, O 0 0.00034634306211955845
and O 0 0.000205496558919549
manifest O 0 0.010568075813353062
several O 0 0.0002797158376779407
phenotypes O 0 0.042994361370801926
common O 0 0.0050710891373455524
to O 0 0.00495002418756485
PWS B-Disease 1 0.9999964237213135
infants O 1 0.9991059899330139
. O 0 0.0018923041643574834

These O 0 0.00016403522749897093
data O 0 0.00023037687060423195
demonstrate O 0 0.0015642563812434673
that O 0 6.615206075366586e-05
both O 0 4.4027590774931014e-05
the O 0 6.566383672179654e-05
position O 0 0.00025897796149365604
of O 0 2.858050174836535e-05
the O 0 0.0006029040669091046
IC O 1 0.9937430024147034
and O 0 0.00015330460155382752
its O 0 0.0002678727323655039
role O 0 0.001062838826328516
in O 0 0.00012895608961116523
the O 0 0.00015076796989887953
coordinate O 0 0.0020771606359630823
expression O 0 0.00026711454847827554
of O 0 2.303926885360852e-05
genes O 0 0.00032053806353360415
is O 0 0.0001444013323634863
conserved O 0 0.00034855373087339103
between O 0 0.0003120164619758725
mouse O 0 0.010979659855365753
and O 0 0.00020808495173696429
human O 0 0.0010177332442253828
, O 0 0.00026283456827513874
and O 0 0.00011847157293232158
indicate O 0 0.0005254015559330583
that O 0 6.467196362791583e-05
the O 0 0.00023956142831593752
mouse O 0 0.006008377764374018
is O 0 0.00021915828983765095
a O 0 0.0004036914324387908
suitable O 0 0.0030136911664158106
model O 0 0.0010322605958208442
system O 0 0.0010955948382616043
in O 0 0.00013114517787471414
which O 0 6.886196206323802e-05
to O 0 0.00012003937445115298
investigate O 0 0.0025857891887426376
the O 0 0.00013291565119288862
molecular O 0 0.0010480257915332913
mechanisms O 0 0.0005317846080288291
of O 0 5.711881021852605e-05
imprinting O 0 0.041853103786706924
in O 0 0.00013054553710389882
this O 0 5.175081969355233e-05
region O 0 0.0002789594582282007
of O 0 1.4446439308812842e-05
the O 0 0.0002575232647359371
genome O 0 0.0032708861399441957
. O 0 0.0002139924035873264
. O 0 0.0004870245174970478

Mutations O 0 0.0026383232325315475
of O 0 2.970204695884604e-05
the O 0 0.00038826672243885696
ATM O 0 0.016047433018684387
gene O 0 0.004039891995489597
detected O 0 0.004522358532994986
in O 0 0.0004039859340991825
Japanese O 0 0.03534981980919838
ataxia B-Disease 1 0.9999977350234985
- I-Disease 1 0.9998776912689209
telangiectasia I-Disease 1 0.9999921321868896
patients O 1 0.9999656677246094
: O 0 0.0007192227058112621
possible O 0 0.0006939981249161065
preponderance O 0 0.004940429236739874
of O 0 2.0796393073396757e-05
the O 0 0.00019327766494825482
two O 0 0.00020608126942534
founder O 0 0.02306380681693554
mutations O 0 0.005599424708634615
4612del165 O 0 0.03242654353380203
and O 0 0.0005287648527882993
7883del5 O 0 0.08073139190673828
. O 0 0.000992224900983274

The O 0 0.0013556269695982337
ATM O 0 0.022234024479985237
( O 0 0.0020651330705732107
A O 1 0.991999626159668
- O 1 0.9798442125320435
T O 1 0.9996480941772461
, O 0 0.0005874030175618827
mutated O 0 0.010213170200586319
) O 0 0.0002865402784664184
gene O 0 0.0008838631911203265
on O 0 0.0002222198381787166
human O 0 0.0018848932813853025
chromosome O 0 0.006819360889494419
11q22 O 0 0.047572799026966095
. O 0 0.0016703868750482798

3 O 0 0.0040990570560097694
has O 0 0.001793362433090806
recently O 0 0.004905513022094965
been O 0 0.0004123619000893086
identified O 0 0.00039732729783281684
as O 0 7.558045763289556e-05
the O 0 0.00013199112436268479
gene O 0 0.000933371193241328
responsible O 0 0.0005016300128772855
for O 0 9.27554938243702e-05
the O 0 0.0003946369397453964
human O 1 0.6150752902030945
recessive B-Disease 1 0.9999818801879883
disease I-Disease 1 0.9999995231628418
ataxia B-Disease 1 0.9999982118606567
- I-Disease 1 0.9991351962089539
telangiectasia I-Disease 1 0.9997503161430359
( O 0 0.003905280027538538
A B-Disease 1 0.9989433884620667
- I-Disease 1 0.9962582588195801
T I-Disease 1 0.9996121525764465
) O 0 0.0005040572141297162
. O 0 0.0005085822776891291

In O 0 0.00046607127296738327
order O 0 0.00015142092888709158
to O 0 7.356418791459873e-05
define O 0 0.0005576313124038279
the O 0 0.00013152301835361868
types O 0 0.0006463559693656862
of O 0 0.00042548871715553105
disease O 1 0.9999988079071045
- O 0 0.22469814121723175
causing O 0 0.039179153740406036
ATM O 0 0.010662129148840904
mutations O 0 0.0010425836080685258
in O 0 0.00015964075282681733
Japanese O 0 0.0038865692913532257
A B-Disease 1 0.9992450475692749
- I-Disease 1 0.9996005892753601
T I-Disease 1 0.9999885559082031
patients O 1 0.9997656941413879
as O 0 0.00014556330279447138
well O 0 0.00011397970229154453
as O 0 0.00010916723840637133
to O 0 8.471541514154524e-05
look O 0 0.0007305983453989029
for O 0 0.00016091241559479386
possible O 0 0.0017321520717814565
mutational O 1 0.8326299786567688
hotspots O 0 0.018125781789422035
, O 0 0.0003481091116555035
reverse O 0 0.005977286025881767
- O 0 0.0025688097812235355
transcribed O 0 0.0012599558103829622
RNA O 0 0.0007819888414815068
derived O 0 0.0002273789286846295
from O 0 0.00016425059584435076
ten O 0 0.0013921870850026608
patients O 1 0.9989563226699829
belonging O 0 0.00046031008241698146
to O 0 7.684579759370536e-05
eight O 0 0.0002695382572710514
unrelated O 0 0.004721422214061022
Japanese O 0 0.0034810847137123346
A B-Disease 1 0.9987456798553467
- I-Disease 1 0.9980485439300537
T I-Disease 1 0.9997500777244568
families O 0 0.000390696048270911
was O 0 0.0006362375570461154
analyzed O 0 0.0008469481253996491
for O 0 0.00016441638581454754
mutations O 0 0.0007194859790615737
by O 0 3.408249540370889e-05
the O 0 0.0001474572200095281
restriction O 0 0.0015576711157336831
endonuclease O 0 0.25304388999938965
fingerprinting O 0 0.0066216252744197845
method O 0 0.0011653935071080923
. O 0 0.0009883999591693282

As O 0 0.0014217833522707224
has O 0 0.001048944890499115
been O 0 0.0006157374009490013
reported O 0 0.0010269557824358344
by O 0 9.494485129835084e-05
others O 0 0.0003424879687372595
, O 0 0.00019451059051789343
mutations O 0 0.0007440324407070875
that O 0 3.963918788940646e-05
lead O 0 0.00023741538461763412
to O 0 0.00015484604227822274
exon O 0 0.026114394888281822
skipping O 0 0.0169416144490242
or O 0 0.0006327914306893945
premature O 0 0.15461702644824982
protein O 0 0.0010943302186205983
truncation O 0 0.010352051816880703
were O 0 9.186116221826524e-05
also O 0 0.00019358107238076627
predominant O 0 0.001512048183940351
in O 0 0.00020930953905917704
our O 0 0.0013492638245224953
mutants O 0 0.015557902865111828
. O 0 0.001057127956300974

Six O 0 0.0009943965123966336
different O 0 0.00016823451733216643
mutations O 0 0.0020769464317709208
were O 0 6.256529013626277e-05
identified O 0 0.0004062378138769418
on O 0 8.905119466362521e-05
12 O 0 0.00010393722914159298
of O 0 1.2943821275257505e-05
the O 0 0.00033270064159296453
16 O 0 0.0014156826073303819
alleles O 0 0.00794035941362381
examined O 0 0.029846923425793648
. O 0 0.000947949883993715

Four O 0 0.0005942884599789977
were O 0 0.00012994084681849927
deletions O 0 0.002690534107387066
involving O 0 0.0009258858044631779
a O 0 0.000702179444488138
loss O 0 0.0012218584306538105
of O 0 2.3928550945129246e-05
a O 0 0.0005748464609496295
single O 0 0.000871107098646462
exon O 0 0.01680416613817215
exon O 0 0.012415491975843906
7 O 0 0.0009738443768583238
, O 0 0.00027837735251523554
exon O 0 0.009191696532070637
16 O 0 0.0006008867640048265
, O 0 0.0002531015779823065
exon O 0 0.011829067952930927
33 O 0 0.001450196374207735
or O 0 0.000584921333938837
exon O 0 0.015017160214483738
35 O 0 0.0021334346383810043
. O 0 0.0008151217480190098

The O 0 0.0008071266347542405
others O 0 0.0003604733501560986
were O 0 4.571862518787384e-05
minute O 0 0.0004909065319225192
deletions O 0 0.0030068831983953714
, O 0 0.00031505851075053215
4649delA O 0 0.015780650079250336
in O 0 0.0003017914423253387
exon O 0 0.012483218684792519
33 O 0 0.0014705094508826733
and O 0 0.00020070884784217924
7883del5 O 0 0.01558790635317564
in O 0 0.00037010066444054246
exon O 0 0.01969892345368862
55 O 0 0.003028778126463294
. O 0 0.0010634171776473522

The O 0 0.002233195584267378
mutations O 0 0.010753773152828217
4612del165 O 0 0.05776147171854973
and O 0 0.0005620535812340677
7883del5 O 0 0.027519166469573975
were O 0 7.53541971789673e-05
found O 0 0.0001279136340599507
in O 0 4.0174491005018353e-05
more O 0 4.007183088106103e-05
than O 0 6.8080255005043e-05
two O 0 0.0001270658103749156
unrelated O 0 0.005718223750591278
families O 0 0.0004625632136594504
; O 0 0.00017216494597960263
44 O 0 0.00039760724757798016
% O 0 9.357869566883892e-05
( O 0 0.0003392011858522892
7 O 0 0.00024016681709326804
of O 0 2.5444946004427038e-05
16 O 0 0.0005066023441031575
) O 0 4.849210017709993e-05
of O 0 1.583128141646739e-05
the O 0 0.0003500185557641089
mutant O 0 0.007779667619615793
alleles O 0 0.002021771389991045
had O 0 0.0002019795501837507
one O 0 2.8092534194001928e-05
of O 0 1.1162334885739256e-05
the O 0 0.00012246152618899941
two O 0 0.00025500982883386314
mutations O 0 0.003885821672156453
. O 0 0.0008016584324650466

The O 0 0.0026652351953089237
4612del165 O 0 0.08649750053882599
mutations O 0 0.003257211297750473
in O 0 0.00012663507368415594
three O 0 5.876965951756574e-05
different O 0 3.938357986044139e-05
families O 0 0.0001477451587561518
were O 0 2.8750184355885722e-05
all O 0 2.732081338763237e-05
ascribed O 0 0.002075882162898779
to O 0 5.315242015058175e-05
the O 0 0.00020449032308533788
same O 0 0.0010900102788582444
T O 1 0.9985439777374268
- O 0 0.0071874153800308704
- O 0 0.003261350095272064
> O 0 0.002464527962729335
A O 0 0.0005868719308637083
substitution O 0 0.00037623435491696
at O 0 0.00019369296205695719
the O 0 0.00026576011441648006
splice O 0 0.013753823935985565
donor O 0 0.005763764958828688
site O 0 0.0014635021798312664
in O 0 0.0004069686110597104
intron O 1 0.9063669443130493
33 O 0 0.004094022326171398
. O 0 0.000835662183817476

Microsatellite O 0 0.14522024989128113
genotyping O 0 0.04400645196437836
around O 0 0.00044974120100960135
the O 0 0.0004586524737533182
ATM O 0 0.015362990088760853
locus O 0 0.010689579881727695
also O 0 0.0004843065107706934
indicated O 0 0.0014981968561187387
that O 0 7.509365968871862e-05
a O 0 0.0007091008010320365
common O 0 0.0034614817705005407
haplotype O 1 0.7220646739006042
was O 0 0.0006751835462637246
shared O 0 0.0002435361675452441
by O 0 6.597849278477952e-05
the O 0 0.0002705145161598921
mutant O 0 0.007224769797176123
alleles O 0 0.0024351775646209717
in O 0 0.000201331393327564
both O 0 0.000469980324851349
mutations O 0 0.005248604342341423
. O 0 0.0008541038259863853

This O 0 0.0006371475174091756
suggests O 0 0.0013223106507211924
that O 0 5.030210377299227e-05
these O 0 2.889153802243527e-05
two O 0 0.0001341861643595621
founder O 0 0.32583701610565186
mutations O 0 0.004507382865995169
may O 0 0.000594977056607604
be O 0 7.58752939873375e-05
predominant O 0 0.0009832531213760376
among O 0 0.00014189464855007827
Japanese O 0 0.0018335371278226376
ATM O 0 0.021635880693793297
mutant O 0 0.013132438063621521
alleles O 0 0.008176889270544052
. O 0 0.001120526809245348

W474C O 0 0.0442562960088253
amino O 0 0.0020220743026584387
acid O 0 0.00961319264024496
substitution O 0 0.0030156804714351892
affects O 0 0.016555940732359886
early O 0 0.00031826915801502764
processing O 0 0.00019635858188848943
of O 0 1.928482743096538e-05
the O 0 0.00017154979286715388
alpha O 0 0.0017178152920678258
- O 0 0.0006900578737258911
subunit O 0 0.000312778283841908
of O 0 6.147365638753399e-05
beta O 0 0.00825565867125988
- O 0 0.00453171506524086
hexosaminidase O 0 0.018480800092220306
A O 0 0.0010322073940187693
and O 0 0.00011592242663027719
is O 0 0.0002573342644609511
associated O 0 0.0004156605573371053
with O 0 0.0006898579886183143
subacute O 1 0.9999912977218628
G B-Disease 1 0.9846915602684021
( I-Disease 0 0.0025158319622278214
M2 I-Disease 1 0.9951289892196655
) I-Disease 0 0.0013456360902637243
gangliosidosis I-Disease 0 0.4941079020500183
. O 0 0.001079130219295621

Mutations O 0 0.008606664836406708
in O 0 0.0003688291471917182
the O 0 0.001545996987260878
HEXA O 1 0.9977377653121948
gene O 0 0.002413099864497781
, O 0 0.0001237089018104598
encoding O 0 0.00030478552798740566
the O 0 0.00015065529441926628
alpha O 0 0.001406146096996963
- O 0 0.0005782724474556744
subunit O 0 0.00023096651420928538
of O 0 3.17806625389494e-05
beta O 0 0.006825638469308615
- O 0 0.0037014491390436888
hexosaminidase O 0 0.017097534611821175
A O 0 0.002632314804941416
( O 0 0.000600615341681987
Hex O 0 0.011361295357346535
A O 0 0.001930836122483015
) O 0 0.00016924686497077346
, O 0 7.857999298721552e-05
that O 0 8.141452417476103e-05
abolish O 0 0.004028446972370148
Hex O 0 0.005394316744059324
A O 0 0.001082195551134646
enzyme O 0 0.002031434327363968
activity O 0 0.00181008770596236
cause O 1 0.998526930809021
Tay B-Disease 1 0.9999984502792358
- I-Disease 1 0.9988675117492676
Sachs I-Disease 1 0.9999589920043945
disease I-Disease 1 0.9999916553497314
( O 0 0.004787847399711609
TSD B-Disease 1 0.9998472929000854
) O 0 0.00045976651017554104
, O 0 0.00023434488684870303
the O 0 0.0011127478210255504
fatal O 1 0.9999159574508667
infantile B-Disease 1 0.9997813105583191
form I-Disease 0 0.0008710332913324237
of I-Disease 0 0.0002447762235533446
G I-Disease 1 0.9878641963005066
( I-Disease 0 0.002149509731680155
M2 I-Disease 1 0.9974049925804138
) I-Disease 0 0.0006735838833265007
gangliosidosis I-Disease 1 0.5270628929138184
, I-Disease 0 0.00034525548107922077
Type I-Disease 0 0.004511513747274876
1 I-Disease 0 0.001062219962477684
. O 0 0.0005986567703075707

Less O 0 0.008941317908465862
severe O 1 0.9996451139450073
, O 0 0.00542380940169096
subacute O 1 0.9999958276748657
( O 0 0.011508304625749588
juvenile O 1 0.9998292922973633
- O 1 0.9486675262451172
onset O 1 0.9996800422668457
) O 0 0.0006958230515010655
and O 0 0.0022043557837605476
chronic O 1 0.9999998807907104
( O 0 0.0028580990619957447
adult O 0 0.27507850527763367
- O 1 0.9412369728088379
onset O 1 0.9994743466377258
) O 0 0.0004821793409064412
variants O 0 0.0010004709474742413
are O 0 6.270912854233757e-05
characterized O 0 0.009991821832954884
by O 0 9.349111496703699e-05
a O 0 0.0007829645182937384
broad O 0 0.0071316855028271675
spectrum O 0 0.0036760384682565928
of O 0 0.00025345609174109995
clinical O 1 0.9999334812164307
manifestations O 1 0.9607462286949158
and O 0 0.0001808267697924748
are O 0 4.5345601392909884e-05
associated O 0 0.00020785731612704694
with O 0 8.471395267406479e-05
residual O 0 0.0047398838214576244
levels O 0 0.0005788308335468173
of O 0 3.709737575263716e-05
Hex O 0 0.012100699357688427
A O 0 0.00217268243432045
enzyme O 0 0.0022011958062648773
activity O 0 0.0011809533461928368
. O 0 0.0006778211100026965

We O 0 0.0009646182879805565
identified O 0 0.0011191468220204115
a O 0 0.001987846102565527
1422 O 1 0.996086835861206
G O 0 0.23772166669368744
- O 0 0.008278789930045605
- O 0 0.005897536873817444
> O 0 0.008542739786207676
C O 0 0.00720807071775198
( O 0 0.0002455609501339495
amino O 0 0.0005096746608614922
acid O 0 0.007037232629954815
W474C O 0 0.018136749044060707
) O 0 0.00010337225103285164
substitution O 0 0.00019929272821173072
in O 0 4.626161899068393e-05
the O 0 6.40359430690296e-05
first O 0 8.570469071855769e-05
position O 0 0.0002953187213279307
of O 0 5.282145502860658e-05
exon O 0 0.012033001519739628
13 O 0 0.0005029283929616213
of O 0 8.494474604958668e-05
HEXA O 1 0.9661901593208313
of O 0 6.808986654505134e-05
a O 0 0.0011172960512340069
non O 0 0.0028194067999720573
- O 0 0.004692037124186754
Jewish O 0 0.0018001366406679153
proband O 0 0.25939223170280457
who O 0 0.0014531111810356379
manifested O 0 0.1398964673280716
a O 0 0.0038842717185616493
subacute O 1 0.9998723268508911
variant O 0 0.018700605258345604
of O 0 0.000266948074568063
G B-Disease 1 0.9594361186027527
( I-Disease 0 0.002267521573230624
M2 I-Disease 1 0.9916771650314331
) I-Disease 0 0.0012897973647341132
gangliosidosis I-Disease 0 0.32511746883392334
. O 0 0.0011018640361726284

On O 0 0.000564984860830009
the O 0 0.0002727634855546057
second O 0 0.0011404971592128277
maternally O 0 0.3453912138938904
inherited O 1 0.9804505109786987
allele O 0 0.007025926373898983
, O 0 0.00021128093067090958
we O 0 0.00015303323743864894
identified O 0 0.00039610802195966244
the O 0 0.00030123835313133895
common O 1 0.5079523324966431
infantile O 1 0.9999980926513672
disease O 1 0.9999979734420776
- O 0 0.12378194183111191
causing O 0 0.0579659529030323
4 O 0 0.0012944111367687583
- O 0 0.005513541866093874
bp O 0 0.02557333931326866
insertion O 0 0.01175081729888916
, O 0 0.0014469779562205076
+ O 0 0.060045622289180756
TATC O 1 0.9752261638641357
1278 O 1 0.8098917603492737
, O 0 0.0003157850296702236
in O 0 0.00036646303487941623
exon O 0 0.01803954876959324
11 O 0 0.0018412532517686486
. O 0 0.0008228260558098555

Pulse O 0 0.0646362379193306
- O 0 0.009890628047287464
chase O 0 0.005275677889585495
analysis O 0 0.0003011076769325882
using O 0 0.0006762416451238096
proband O 1 0.9713124632835388
fibroblasts O 1 0.8806794881820679
revealed O 0 0.003336183726787567
that O 0 8.090966730378568e-05
the O 0 0.00022484771034214646
W474C O 0 0.017051054164767265
- O 0 0.0011071838671341538
containing O 0 0.0002192962565459311
alpha O 0 0.0014366473769769073
- O 0 0.0015478057321161032
subunit O 0 0.0011451314203441143
precursor O 0 0.005584472790360451
was O 0 0.00105753680691123
normally O 0 0.0008189653744921088
synthesized O 0 0.0011566728353500366
, O 0 0.000156122085172683
but O 0 0.0001716296246740967
not O 0 0.00017366315296385437
phosphorylated O 0 0.0052598644979298115
or O 0 0.00027554959524422884
secreted O 0 0.0028818780556321144
, O 0 0.0001450361160095781
and O 0 9.330843022326007e-05
the O 0 0.0004281590518075973
mature O 0 0.03131077066063881
lysosomal O 1 0.9809643626213074
alpha O 0 0.004095984622836113
- O 0 0.002497975016012788
subunit O 0 0.001207323162816465
was O 0 0.0007874839939177036
not O 0 0.0003696733037941158
detected O 0 0.006341227795928717
. O 0 0.0006134877330623567

When O 0 0.0015182788483798504
the O 0 0.0004922818043269217
W474C O 0 0.019880125299096107
- O 0 0.0016580059891566634
containing O 0 0.0002778820344246924
alpha O 0 0.0018191435374319553
- O 0 0.0018982087494805455
subunit O 0 0.0012618389446288347
was O 0 0.002154697198420763
transiently O 0 0.34543120861053467
co O 0 0.010919385589659214
- O 0 0.0017281131586059928
expressed O 0 0.00017504882998764515
with O 0 3.95004462916404e-05
the O 0 0.00018357580120209605
beta O 0 0.0033932127989828587
- O 0 0.0008145500905811787
subunit O 0 0.0002791379811242223
to O 0 6.0108493926236406e-05
produce O 0 0.0003714704071171582
Hex O 0 0.009164871647953987
A O 0 0.002441858872771263
( O 0 0.0008650259114801884
alphabeta O 0 0.08380866050720215
) O 0 0.00028832675889134407
in O 0 0.0006184832309372723
COS O 1 0.996797502040863
- O 0 0.005063727498054504
7 O 0 0.0010030117118731141
cells O 0 0.0009567003580741584
, O 0 9.157368913292885e-05
the O 0 0.00019077587057836354
mature O 0 0.008156025782227516
alpha O 0 0.0025848054792732
- O 0 0.0014320551417768002
subunit O 0 0.0007912498549558222
was O 0 0.0005245048087090254
present O 0 0.00020902832329738885
, O 0 0.0001433657598681748
but O 0 8.9114902948495e-05
its O 0 0.00011362745135556906
level O 0 0.0009625334641896188
was O 0 0.0005141755100339651
much O 0 0.00025035091675817966
lower O 0 0.000685563893057406
than O 0 4.577844083542004e-05
that O 0 3.7144032830838114e-05
from O 0 6.187795224832371e-05
normal O 0 0.0015730762388557196
alpha O 0 0.002464325400069356
- O 0 0.0025984488893300295
subunit O 0 0.002858380088582635
transfections O 0 0.0320155955851078
, O 0 0.00021371182810980827
although O 0 0.00023823873198125511
higher O 0 0.00024073121312540025
than O 0 5.316671740729362e-05
in O 0 8.215910929720849e-05
those O 0 0.00016537438204977661
cells O 0 0.0026331914123147726
transfected O 0 0.017129216343164444
with O 0 6.22765946900472e-05
an O 0 0.00020690150267910212
alpha O 0 0.0022511358838528395
- O 0 0.0016395468264818192
subunit O 0 0.000930381182115525
associated O 0 0.0006018038257025182
with O 0 0.0010619083186611533
infantile O 1 0.9999752044677734
TSD B-Disease 1 0.9996539354324341
. O 0 0.003312178421765566

Furthermore O 0 0.006282241083681583
, O 0 0.0002759849594440311
the O 0 0.0002267100353492424
precursor O 0 0.0041058738715946674
level O 0 0.00030696828616783023
of O 0 2.1507374185603112e-05
the O 0 0.0002927336026914418
W474C O 0 0.023023851215839386
alpha O 0 0.0025881759356707335
- O 0 0.0017923504346981645
subunit O 0 0.0008013681508600712
was O 0 0.000657057564239949
found O 0 0.00024636671878397465
to O 0 0.0001344999036518857
accumulate O 0 0.0028782084118574858
in O 0 6.364715954987332e-05
comparison O 0 0.0002899600949604064
to O 0 4.03746307711117e-05
the O 0 0.00010518616181798279
normal O 0 0.0015773613704368472
alpha O 0 0.0021470156498253345
- O 0 0.0015253032324835658
subunit O 0 0.0012006795732304454
precursor O 0 0.006323628127574921
levels O 0 0.0036155427806079388
. O 0 0.0008413714240305126

We O 0 0.0007197431987151504
conclude O 0 0.0024593728594481945
that O 0 9.416187094757333e-05
the O 0 0.0005082360003143549
1422 O 1 0.9968534111976624
G O 0 0.44761353731155396
- O 0 0.015843816101551056
- O 0 0.009253256022930145
> O 0 0.009533348493278027
C O 0 0.008542933501303196
mutation O 0 0.000985874910838902
is O 0 0.00010103142267325893
the O 0 8.550127677153796e-05
cause O 0 0.001479101600125432
of O 0 4.471487773116678e-05
Hex B-Disease 0 0.17584854364395142
A I-Disease 0 0.13844621181488037
enzyme I-Disease 1 0.9972705245018005
deficiency I-Disease 1 0.999997615814209
in O 0 0.00027652306016534567
the O 0 0.0006956844008527696
proband O 1 0.8748775124549866
. O 0 0.0010426334338262677

The O 0 0.0011860557133331895
resulting O 0 0.004008347634226084
W474C O 0 0.021176734939217567
substitution O 0 0.0018884418532252312
clearly O 0 0.003661632537841797
interferes O 0 0.0234063807874918
with O 0 0.00017536358791403472
alpha O 0 0.0022504013031721115
- O 0 0.0012988402741029859
subunit O 0 0.0005240905447863042
processing O 0 0.0005914827925153077
, O 0 0.0001983804686460644
but O 0 0.00010473356087459251
because O 0 0.00015094029367901385
the O 0 8.110162889352068e-05
base O 0 0.0009197678882628679
substitution O 0 0.0014305781805887818
falls O 0 0.009227767586708069
at O 0 0.00018812234338838607
the O 0 7.84370640758425e-05
first O 0 9.832773503148928e-05
position O 0 0.00026154491933993995
of O 0 4.7907622501952574e-05
exon O 0 0.017311187461018562
13 O 0 0.0007974389009177685
, O 0 0.00033670556149445474
aberrant O 0 0.028148094192147255
splicing O 0 0.003125234739854932
may O 0 0.0006791797350160778
also O 0 0.00014235962589737028
contribute O 0 0.0012993717100471258
to O 0 0.00023627880727872252
Hex B-Disease 0 0.03147440776228905
A I-Disease 0 0.09619230031967163
deficiency I-Disease 1 0.999977707862854
in O 0 0.00025440999888814986
this O 0 0.000280735082924366
proband O 1 0.7066890001296997
. O 0 0.000395944167394191
. O 0 0.0007838058518245816

Two O 0 0.0005570499342866242
frequent O 0 0.011584579013288021
missense O 0 0.04415750876069069
mutations O 0 0.008938402868807316
in O 0 0.0036307023838162422
Pendred B-Disease 1 0.9999819993972778
syndrome I-Disease 1 0.9999998807907104
. O 0 0.0033083916641771793

Pendred B-Disease 1 0.9999583959579468
syndrome I-Disease 1 0.9999997615814209
is O 0 0.0040057324804365635
an O 0 0.20948947966098785
autosomal B-Disease 1 0.999998927116394
recessive I-Disease 1 0.9999992847442627
disorder I-Disease 1 1.0
characterized O 1 0.9988411068916321
by O 0 0.0009787374874576926
early O 0 0.3196614384651184
childhood O 1 0.9999592304229736
deafness B-Disease 1 0.9999997615814209
and O 0 0.489544540643692
goiter B-Disease 1 0.9999990463256836
. O 0 0.00412262137979269

A O 0 0.0032033405732363462
century O 0 0.00043582075159065425
after O 0 0.0004956753109581769
its O 0 0.00012103046901756898
recognition O 0 0.001273252652026713
as O 0 0.0006975174183025956
a O 0 0.025812413543462753
syndrome O 1 0.9999985694885254
by O 0 0.0006449364591389894
Vaughan O 1 0.9929540753364563
Pendred O 1 0.9681477546691895
, O 0 0.0005059132818132639
the O 0 0.0016401464818045497
disease O 1 0.9999891519546509
gene O 0 0.01881389319896698
( O 0 0.0030460781417787075
PDS O 1 0.9997060894966125
) O 0 0.000514386803843081
was O 0 0.0006636814796365798
mapped O 0 0.002007280243560672
to O 0 0.0002073027571896091
chromosome O 0 0.004462313838303089
7q22 O 0 0.07203321158885956
- O 0 0.01102391630411148
q31 O 0 0.02794683165848255
. O 0 0.000728069746401161

1 O 0 0.002112560672685504
and O 0 0.00030103535391390324
, O 0 0.0005651897517964244
recently O 0 0.003346348414197564
, O 0 0.00012568579404614866
found O 0 9.843420411925763e-05
to O 0 3.167440081597306e-05
encode O 0 0.00027449263143353164
a O 0 0.0008765945094637573
putative O 0 0.0499236136674881
sulfate O 1 0.9973543882369995
transporter O 1 0.9847540855407715
. O 0 0.0017386233666911721

We O 0 0.0008898425148800015
performed O 0 0.0009566087392158806
mutation O 0 0.0007012772839516401
analysis O 0 8.697374141775072e-05
of O 0 2.975928691739682e-05
the O 0 0.0010418945457786322
PDS B-Disease 1 0.999792754650116
gene O 0 0.0054385424591600895
in O 0 0.0008406742126680911
patients O 1 0.9998486042022705
from O 0 0.00040502980118617415
14 O 0 0.0024458705447614193
Pendred B-Disease 1 0.8932956457138062
families O 0 0.0004374869749881327
originating O 0 0.0009912244277074933
from O 0 0.0001307961210841313
seven O 0 0.00016072564176283777
countries O 0 7.324290345422924e-05
and O 0 0.00016466599481645972
identified O 0 0.000785492651630193
all O 0 9.747724834596738e-05
mutations O 0 0.003708661999553442
. O 0 0.0007741610170342028

The O 0 0.0018266906263306737
mutations O 0 0.003170611336827278
include O 0 0.0001805731444619596
three O 0 0.00010354717232985422
single O 0 0.00038784826756455004
base O 0 0.001813695183955133
deletions O 0 0.0021828969474881887
, O 0 0.00013274718367028981
one O 0 0.0001940900692716241
splice O 0 0.012398899532854557
site O 0 0.0019936508033424616
mutation O 0 0.0013298094272613525
and O 0 0.0001476173201808706
10 O 0 0.0007010798435658216
missense O 0 0.02204347588121891
mutations O 0 0.0048847682774066925
. O 0 0.0008604921749792993

One O 0 0.0016603691037744284
missense O 0 0.02922629378736019
mutation O 0 0.008236510679125786
( O 0 0.0013621703255921602
L236P O 0 0.14732708036899567
) O 0 0.00033939527929760516
was O 0 0.0005244743661023676
found O 0 0.000173246517078951
in O 0 6.736542127327994e-05
a O 0 0.0006629839190281928
homozygous O 0 0.0023259292356669903
state O 0 9.693166794022545e-05
in O 0 0.00012220023199915886
two O 0 0.00022495409939438105
consanguineous O 1 0.5134773850440979
families O 0 0.0004294757090974599
and O 0 0.00014929617464076728
in O 0 0.0001708874333417043
a O 0 0.0006931061507202685
heterozygous O 0 0.0017478956142440438
state O 0 9.081936877919361e-05
in O 0 6.75133996992372e-05
five O 0 0.00011750322300940752
additional O 0 0.0006024666363373399
non O 0 0.0043968199752271175
- O 0 0.015513548627495766
consanguineous O 0 0.2260267436504364
families O 0 0.0013993089087307453
. O 0 0.0011722494382411242

Another O 0 0.005630384664982557
missense O 0 0.03835182636976242
mutation O 0 0.010741555131971836
( O 0 0.0013886078959330916
T416P O 0 0.05860687419772148
) O 0 0.00034866869100369513
was O 0 0.000620284175965935
found O 0 0.00014350583660416305
in O 0 9.608830441720784e-05
a O 0 0.0006209905259311199
homozygous O 0 0.0020908238366246223
state O 0 0.00013083851081319153
in O 0 0.00013199768727645278
one O 0 0.0002193288819398731
family O 0 0.0004254345840308815
and O 0 9.957636939361691e-05
in O 0 0.00011769790580729023
a O 0 0.0006605041562579572
heterozygous O 0 0.002205883152782917
state O 0 0.000112197820271831
in O 0 0.00010192924673901871
four O 0 0.00015108140360098332
families O 0 0.0005378764471970499
. O 0 0.0008529273909516633

Pendred B-Disease 1 0.9960564374923706
patients O 1 0.9993138313293457
in O 0 0.0002787024131976068
three O 0 0.00028153706807643175
non O 0 0.0059095281176269054
- O 0 0.030542945489287376
consanguineous O 0 0.3308582603931427
families O 0 0.00034138711635023355
were O 0 5.5580807384103537e-05
shown O 0 0.00041377480374649167
to O 0 9.580722689861432e-05
be O 0 0.0002092017966788262
compound O 0 0.005821985192596912
heterozygotes O 0 0.05479989945888519
for O 0 0.0005478418315760791
L236P O 0 0.05043507367372513
and O 0 0.0005834528128616512
T416P O 0 0.05581258609890938
. O 0 0.0011598195414990187

In O 0 0.0004094706673640758
total O 0 0.00018125625501852483
, O 0 0.0001787229994079098
one O 0 0.00012489012442529202
or O 0 9.162399510387331e-05
both O 0 3.4575281461002305e-05
of O 0 1.8670110875973478e-05
these O 0 9.400190901942551e-05
mutations O 0 0.0015099942684173584
were O 0 4.219447146169841e-05
found O 0 0.0001574900234118104
in O 0 5.245766806183383e-05
nine O 0 8.209973748307675e-05
of O 0 1.873730252555106e-05
the O 0 0.00026862393133342266
14 O 0 0.0007749274955131114
families O 0 0.0003774356737267226
analyzed O 0 0.003604789497330785
. O 0 0.000716557027772069

The O 0 0.00045206735376268625
identification O 0 0.000310112809529528
of O 0 3.152523277094588e-05
two O 0 0.00028673786437138915
frequent O 1 0.5487632751464844
PDS B-Disease 1 0.9991590976715088
mutations O 0 0.0029996363446116447
will O 0 0.00010530649160500616
facilitate O 0 0.0006876492989249527
the O 0 0.00027262960793450475
molecular O 0 0.08266030997037888
diagnosis O 1 0.9999836683273315
of O 0 0.0013730917125940323
Pendred B-Disease 1 0.9999974966049194
syndrome I-Disease 1 0.9999998807907104
. O 0 0.0027553951367735863

Insertional O 0 0.32987165451049805
mutation O 0 0.0051556299440562725
by O 0 0.0004237680113874376
transposable O 0 0.07888524979352951
element O 0 0.0037096033338457346
, O 0 0.0010724937310442328
L1 O 1 0.9525952339172363
, O 0 0.0002150828659068793
in O 0 0.0002585269685368985
the O 0 0.0011217229766771197
DMD B-Disease 1 0.9999780654907227
gene O 0 0.0024714521132409573
results O 0 0.0004496965557336807
in O 0 0.00036350759910419583
X B-Disease 1 0.9396388530731201
- I-Disease 1 0.9068034887313843
linked I-Disease 1 0.9857358336448669
dilated I-Disease 1 0.9998892545700073
cardiomyopathy I-Disease 1 0.999998927116394
. O 0 0.004965241067111492

X B-Disease 0 0.4917146563529968
- I-Disease 0 0.18699981272220612
linked I-Disease 1 0.9792574048042297
dilated I-Disease 1 0.9999127388000488
cardiomyopathy I-Disease 1 0.9999996423721313
( O 0 0.010512864217162132
XLDCM B-Disease 1 0.9980413913726807
) O 0 0.0005193447577767074
is O 0 0.0003391879436094314
a O 0 0.0021306064445525408
clinical O 1 0.9988816380500793
phenotype O 0 0.0780332088470459
of O 0 0.00010286387987434864
dystrophinopathy B-Disease 1 0.9658837914466858
which O 0 0.00012877496192231774
is O 0 0.00039612522232346237
characterized O 0 0.04839521273970604
by O 0 0.00044286702177487314
preferential O 1 0.9798761606216431
myocardial B-Disease 1 0.9999951124191284
involvement I-Disease 0 0.10460726916790009
without O 0 0.0004321784363128245
any O 0 0.000353573210304603
overt O 0 0.3038822412490845
clinical O 1 0.9996864795684814
signs O 0 0.04817189276218414
of O 0 0.0009146032389253378
skeletal B-Disease 1 0.9999974966049194
myopathy I-Disease 1 0.9999983310699463
. O 0 0.00525398924946785

To O 0 0.00046650864533148706
date O 0 0.0003143138892482966
, O 0 0.00010079739149659872
several O 0 0.00011781534703914076
mutations O 0 0.0010379698360338807
in O 0 0.00019934498413931578
the O 0 0.004774326924234629
Duchenne B-Disease 1 0.9999995231628418
muscular I-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999997615814209
gene O 1 0.9602288007736206
, O 0 0.015058250166475773
DMD O 1 0.9999990463256836
, O 0 0.0005750409327447414
have O 0 0.00015904697647783905
been O 0 0.0003070482343900949
identified O 0 0.000717274728231132
in O 0 0.0003905378107447177
patients O 1 0.9998249411582947
with O 0 0.0004451034474186599
XLDCM B-Disease 1 0.9995691180229187
, O 0 0.00024738776846788824
but O 0 0.00015552520926576108
a O 0 0.0004950862494297326
pathogenic O 0 0.005787405651062727
correlation O 0 0.000499832967761904
of O 0 2.5558663764968514e-05
these O 0 0.00015139348397497088
cardiospecific O 1 0.9751463532447815
mutations O 0 0.004101788625121117
in O 0 0.001317674177698791
DMD O 1 0.9999879598617554
with O 0 0.00036552519304677844
the O 0 0.0014441064558923244
XLDCM B-Disease 1 0.9995885491371155
phenotype O 1 0.7879673838615417
has O 0 0.0008168704225681722
remained O 0 0.001265084370970726
to O 0 0.00011446209100540727
be O 0 0.0002927974855992943
elucidated O 0 0.044596824795007706
. O 0 0.0008580731810070574

We O 0 0.0016548825660720468
report O 0 0.0009461219306103885
here O 0 9.410173515789211e-05
the O 0 6.465624028351158e-05
identification O 0 0.00016179043450392783
of O 0 2.159012910851743e-05
a O 0 0.0005811977898702025
unique O 0 0.0014536011731252074
de O 0 0.00669566635042429
novo O 0 0.022107267752289772
L1 O 0 0.07788702100515366
insertion O 0 0.004171573556959629
in O 0 0.00015675992472097278
the O 0 0.0004838313034269959
muscle O 1 0.9896811842918396
exon O 0 0.020906396210193634
1 O 0 0.001171628711745143
in O 0 0.0010088874259963632
DMD O 1 0.9999868869781494
in O 0 0.0005776687175966799
three O 0 0.0010741818696260452
XLDCM B-Disease 1 0.9995787739753723
patients O 1 0.9995452761650085
from O 0 0.0001652944483794272
two O 0 0.00014768855180591345
unrelated O 0 0.006964114960283041
Japanese O 0 0.0017815805040299892
families O 0 0.0011851205490529537
. O 0 0.0010611037723720074

The O 0 0.0008631552918814123
insertion O 0 0.009686761535704136
was O 0 0.0011322902282699943
a O 0 0.0009281460661441088
5 O 0 0.0011699883034452796
- O 0 0.003765317378565669
truncated O 0 0.007792760152369738
form O 0 0.0002033736527664587
of O 0 5.358521229936741e-05
human O 0 0.003166629234328866
L1 O 1 0.724821925163269
inversely O 0 0.0026608784683048725
integrated O 0 0.002576716709882021
in O 0 0.00015586400695610791
the O 0 0.0002737649774644524
5 O 0 0.0012810718035325408
- O 0 0.003745091613382101
untranslated O 0 0.015467618592083454
region O 0 0.0008766053942963481
in O 0 0.00017352428403683007
the O 0 0.0007025441736914217
muscle O 1 0.9950775504112244
exon O 0 0.035293810069561005
1 O 0 0.0009076988790184259
, O 0 0.00015755264030303806
which O 0 8.252706174971536e-05
affected O 0 0.0010719115380197763
the O 0 0.00010517772898310795
transcription O 0 0.0007996418862603605
or O 0 0.00011165457544848323
the O 0 0.00010192691843258217
stability O 0 0.0009875393006950617
of O 0 2.959819175885059e-05
the O 0 0.0006008043419569731
muscle O 1 0.9884229302406311
form O 0 0.0005271959234960377
of O 0 0.00020740913168992847
dystrophin O 1 0.9991887211799622
transcripts O 0 0.0025402072351425886
but O 0 0.00012747067376039922
not O 0 3.420485518290661e-05
that O 0 1.3301415492605884e-05
of O 0 1.5022684237919748e-05
the O 0 0.0007716832915320992
brain O 1 0.9998114705085754
or O 0 0.0022276390809565783
Purkinje O 1 0.9991185069084167
cell O 0 0.005311429966241121
form O 0 0.0009114688145928085
, O 0 0.0005223387852311134
probably O 0 0.0018088528886437416
due O 0 0.0004910754505544901
to O 0 4.9377515097148716e-05
its O 0 9.123976633418351e-05
unique O 0 0.0003115815343335271
site O 0 0.00037734603392891586
of O 0 3.108234523097053e-05
integration O 0 0.0033475027885288
. O 0 0.00101033307146281

We O 0 0.0013054811861366034
speculate O 0 0.0030961271841078997
that O 0 3.851126166409813e-05
this O 0 2.8287926397752017e-05
insertion O 0 0.0013398844748735428
of O 0 2.5671177354524843e-05
an O 0 0.0005468667368404567
L1 O 1 0.8078908920288086
sequence O 0 0.0006478268769569695
in O 0 0.0022501132916659117
DMD O 1 0.9999905824661255
is O 0 0.0007820614264346659
responsible O 0 0.0017233749385923147
for O 0 8.324647933477536e-05
some O 0 1.7928998204297386e-05
of O 0 8.075717232713941e-06
the O 0 5.740943379350938e-05
population O 0 3.669937723316252e-05
of O 0 4.160380194662139e-05
Japanese O 0 0.038723789155483246
patients O 1 0.9999444484710693
with O 0 0.0006760196411050856
XLDCM B-Disease 1 0.9992971420288086
. O 0 0.0004738461575470865
. O 0 0.0008102615247480571

Severe O 1 0.9991629123687744
early O 0 0.008105149492621422
- O 1 0.9888083338737488
onset O 1 0.9999366998672485
obesity B-Disease 1 0.9999939203262329
, O 0 0.017926668748259544
adrenal B-Disease 1 0.9999967813491821
insufficiency I-Disease 1 0.9999966621398926
and O 0 0.004149726592004299
red O 1 0.9993743300437927
hair O 1 0.9999427795410156
pigmentation O 1 0.999958872795105
caused O 1 0.9141226410865784
by O 0 0.0012445119209587574
POMC O 1 0.9997476935386658
mutations O 0 0.004504689946770668
in O 0 0.00033949135104194283
humans O 0 0.004247111268341541
. O 0 0.0009310441673733294

Sequential O 0 0.006039218511432409
cleavage O 0 0.007357212249189615
of O 0 2.3838083507143892e-05
the O 0 0.00016012875130400062
precursor O 0 0.004738241899758577
protein O 0 0.0009343347628600895
pre O 0 0.00707110995426774
- O 0 0.0067606898956000805
pro O 0 0.01002885028719902
- O 0 0.011270727962255478
opiomelanocortin O 0 0.1705915331840515
( O 0 0.0025191407185047865
POMC O 1 0.9917082190513611
) O 0 0.00029090899624861777
generates O 0 0.0009225756512023509
the O 0 0.0005526880268007517
melanocortin O 1 0.9873166084289551
peptides O 0 0.01178541500121355
adrenocorticotrophin O 1 0.6530059576034546
( O 0 0.0029021049849689007
ACTH O 1 0.9966216087341309
) O 0 0.0005391213344410062
, O 0 0.0005952357314527035
melanocyte O 1 0.9919598698616028
- O 0 0.010555049404501915
stimulating O 1 0.75569748878479
hormones O 0 0.1835680603981018
( O 0 0.003475247183814645
MSH O 1 0.9994648098945618
) O 0 0.0006981883780099452
alpha O 0 0.0018572427798062563
, O 0 0.00026620415155775845
beta O 0 0.0025655445642769337
and O 0 0.00014222177560441196
gamma O 0 0.002500463044270873
as O 0 8.66037153173238e-05
well O 0 5.144230817677453e-05
as O 0 7.707837357884273e-05
the O 0 0.00024363648844882846
opioid O 1 0.8751419186592102
- O 0 0.00363892107270658
receptor O 0 0.0028673673514276743
ligand O 0 0.007050426676869392
beta O 0 0.01254279538989067
- O 0 0.016106320545077324
endorphin O 1 0.9476318955421448
. O 0 0.0015592596028000116

While O 0 0.0006153504364192486
a O 0 0.0004948458517901599
few O 0 0.0003261592355556786
cases O 0 0.0007286528707481921
of O 0 0.00016942352522164583
isolated O 1 0.997005045413971
ACTH B-Disease 1 0.9999864101409912
deficiency I-Disease 1 0.9999951124191284
have O 0 0.00036572787212207913
been O 0 0.0009343187557533383
reported O 0 0.005753275938332081
( O 0 0.002813143888488412
OMIM O 1 0.9992731213569641
201400 O 1 0.6253960728645325
) O 0 0.00035378732718527317
, O 0 0.00023339605832006782
an O 0 0.0018017251277342439
inherited O 1 0.9999344348907471
POMC O 1 0.9999749660491943
defect O 1 0.9997108578681946
has O 0 0.0012003033189103007
not O 0 0.00023784924997016788
been O 0 0.00031000046874396503
described O 0 0.0014343111542984843
so O 0 0.00048470741603523493
far O 0 0.0009235175093635917
. O 0 0.0006957945297472179

Recent O 0 0.004250540863722563
studies O 0 0.0011463849805295467
in O 0 0.00036789666046388447
animal O 0 0.00432097353041172
models O 0 0.0016246290178969502
elucidated O 0 0.015250411815941334
a O 0 0.00035164220025762916
central O 0 0.0003534454735927284
role O 0 0.0006286257412284613
of O 0 0.00010663975263014436
alpha O 0 0.013010828755795956
- O 0 0.13654939830303192
MSH O 1 0.9988058805465698
in O 0 0.00012056085688527673
the O 0 8.579595305491239e-05
regulation O 0 0.00031217263313010335
of O 0 2.1761388779850677e-05
food O 0 0.0009217092883773148
intake O 0 0.0026519279927015305
by O 0 3.639507485786453e-05
activation O 0 0.0005348167032934725
of O 0 2.318190672667697e-05
the O 0 0.0006453957757912576
brain O 1 0.9995583891868591
melanocortin O 1 0.9930094480514526
- O 0 0.004777583759278059
4 O 0 0.0007631169864907861
- O 0 0.002920339349657297
receptor O 0 0.004716781433671713
( O 0 0.0014499133685603738
MC4 O 1 0.9979919195175171
- O 0 0.019286448135972023
R O 0 0.043785374611616135
; O 0 0.00039967423072084785
refs O 0 0.022625887766480446
3 O 0 0.0010488954139873385
- O 0 0.0024216300807893276
5 O 0 0.0003281472309026867
) O 0 5.907560625928454e-05
and O 0 3.238743738620542e-05
the O 0 9.41329708439298e-05
linkage O 0 0.004973953124135733
of O 0 8.218324364861473e-05
human O 0 0.0521700344979763
obesity B-Disease 1 0.9999675750732422
to O 0 0.0003915629640687257
chromosome O 0 0.0015520458109676838
2 O 0 0.00021023297449573874
in O 0 6.676004704786465e-05
close O 0 0.00042538452544249594
proximity O 0 0.0008329893462359905
to O 0 0.00016779618454165757
the O 0 0.0010569565929472446
POMC O 1 0.9995218515396118
locus O 0 0.013661768287420273
, O 0 0.0002889525203499943
led O 0 0.00033498776610940695
to O 0 7.969389844220132e-05
the O 0 8.252840052591637e-05
proposal O 0 0.0005573993548750877
of O 0 1.8962578906212002e-05
an O 0 0.000340816070092842
association O 0 0.004393569193780422
of O 0 0.0002888790040742606
POMC O 1 0.9994725584983826
with O 0 0.0009130942635238171
human O 0 0.192677840590477
obesity B-Disease 1 0.9999804496765137
. O 0 0.002393480157479644

The O 0 0.0005561588332056999
dual O 0 0.001631338382139802
role O 0 0.0009204039233736694
of O 0 0.00011582651495700702
alpha O 0 0.01273019053041935
- O 0 0.05363066866993904
MSH O 1 0.9973914623260498
in O 0 0.0003469223447609693
regulating O 0 0.005037650000303984
food O 0 0.0018004871672019362
intake O 0 0.012427084147930145
and O 0 0.0005742065841332078
influencing O 0 0.13164378702640533
hair O 1 0.9996041655540466
pigmentation O 1 0.999692440032959
predicts O 0 0.14832085371017456
that O 0 0.00015818547399248928
the O 0 0.00047234943485818803
phenotype O 0 0.3849639296531677
associated O 0 0.0004029194242320955
with O 0 0.00014535040827468038
a O 0 0.0026611187495291233
defect O 1 0.9982079267501831
in O 0 0.0012098322622478008
POMC O 1 0.9994739890098572
function O 0 0.0012521973112598062
would O 0 0.0004662147839553654
include O 0 0.00125909096095711
obesity B-Disease 1 0.9999881982803345
, O 0 0.0004673872608691454
alteration O 0 0.24679046869277954
in O 0 0.001527533051557839
pigmentation O 1 0.9999566078186035
and O 0 0.02030622959136963
ACTH B-Disease 1 0.9999932050704956
deficiency I-Disease 1 0.9999943971633911
. O 0 0.0031160598155111074

The O 0 0.0007842960185371339
observation O 0 0.004051197320222855
of O 0 5.615802001557313e-05
these O 0 0.00033462067949585617
symptoms O 1 0.9999301433563232
in O 0 0.00018691153672989458
two O 0 0.0002625500492285937
probands O 1 0.978980541229248
prompted O 0 0.005102720111608505
us O 0 0.0005978131666779518
to O 0 6.0439972003223374e-05
search O 0 0.0003471397212706506
for O 0 0.00013653015776071697
mutations O 0 0.001029669540002942
within O 0 0.00011084768630098552
their O 0 0.0004349396622274071
POMC O 1 0.9984298348426819
genes O 0 0.0022457295563071966
. O 0 0.0009822428692132235

Patient O 1 0.9969109892845154
1 O 0 0.00157546391710639
was O 0 0.0009348961757495999
found O 0 0.00017000803200062364
to O 0 5.161404988029972e-05
be O 0 6.592037971131504e-05
a O 0 0.0004949380527250469
compound O 0 0.0047201430425047874
heterozygote O 0 0.013670665211975574
for O 0 0.00011386183177819476
two O 0 9.985725046135485e-05
mutations O 0 0.00110339664388448
in O 0 0.00024254946038126945
exon O 0 0.019305124878883362
3 O 0 0.001337484922260046
( O 0 0.0010524220997467637
G7013T O 0 0.10393805801868439
, O 0 0.0007786222267895937
C7133delta O 1 0.8051296472549438
) O 0 0.00022552319569513202
which O 0 6.617054168600589e-05
interfere O 0 0.001466324320062995
with O 0 4.348957008915022e-05
appropriate O 0 0.000467413105070591
synthesis O 0 0.0006427519838325679
of O 0 0.00016900416812859476
ACTH O 1 0.9989405274391174
and O 0 0.0006255811895243824
alpha O 0 0.015087727457284927
- O 0 0.1723615825176239
MSH O 1 0.9976170063018799
. O 0 0.0019444060744717717

Patient O 1 0.9975537657737732
2 O 0 0.0011320108314976096
was O 0 0.000853679608553648
homozygous O 0 0.0015316358767449856
for O 0 8.648990478832275e-05
a O 0 0.00040220218943431973
mutation O 0 0.0014504531864076853
in O 0 0.0002893511264119297
exon O 0 0.014929515309631824
2 O 0 0.0012900505680590868
( O 0 0.0008336193859577179
C3804A O 0 0.02419540472328663
) O 0 0.000276029430096969
which O 0 0.0003373407234903425
abolishes O 1 0.9314025044441223
POMC O 1 0.9941806197166443
translation O 0 0.0024677433539181948
. O 0 0.0011305270018056035

These O 0 0.00035376945743337274
findings O 0 0.0013098538620397449
represent O 0 0.00011799974163295701
the O 0 6.764190038666129e-05
first O 0 8.383639215026051e-05
examples O 0 0.0001322214084211737
of O 0 4.4468655687524006e-05
a O 0 0.003874962218105793
genetic B-Disease 1 0.9933854937553406
defect I-Disease 1 0.999755322933197
within O 0 0.0004993515321984887
the O 0 0.0016879403265193105
POMC O 1 0.9989991784095764
gene O 0 0.0019385841442272067
and O 0 0.0001091779486159794
define O 0 0.0012347938027232885
a O 0 0.0009136811713688076
new O 0 0.0028054695576429367
monogenic B-Disease 1 0.9998866319656372
endocrine I-Disease 1 0.9999754428863525
disorder I-Disease 1 0.9999760389328003
resulting O 0 0.003033841960132122
in O 0 0.0003881793236359954
early O 0 0.0037535943556576967
- O 1 0.9904652833938599
onset O 1 0.999964714050293
obesity B-Disease 1 0.9999960660934448
, O 0 0.015329658053815365
adrenal B-Disease 1 0.9999943971633911
insufficiency I-Disease 1 0.9999934434890747
and O 0 0.004229558631777763
red O 1 0.9992583394050598
hair O 1 0.999913215637207
pigmentation O 1 0.9998995065689087
. O 0 0.0011083668796345592
. O 0 0.0009629801497794688

A O 0 0.006477456074208021
European O 0 0.0032087836880236864
multicenter O 0 0.1823771446943283
study O 0 0.0011255152057856321
of O 0 0.00035322015173733234
phenylalanine B-Disease 1 0.999803364276886
hydroxylase I-Disease 1 0.9997468590736389
deficiency I-Disease 1 0.9999985694885254
: O 0 0.0012907388154417276
classification O 0 0.004785807803273201
of O 0 7.182086847024038e-05
105 O 0 0.003968264441937208
mutations O 0 0.0014379668282344937
and O 0 6.951474642846733e-05
a O 0 0.00037068556412123144
general O 0 0.0006268757861107588
system O 0 0.00105468335095793
for O 0 0.00039029400795698166
genotype O 0 0.05097546428442001
- O 0 0.0024985738564282656
based O 0 0.00019535909814294428
prediction O 0 0.0027619691099971533
of O 0 0.0001558069488964975
metabolic O 1 0.9964756369590759
phenotype O 1 0.9558055400848389
. O 0 0.0016839345917105675

Phenylketonuria B-Disease 1 0.9997076392173767
( O 0 0.025817066431045532
PKU B-Disease 1 0.999951958656311
) O 0 0.001202934654429555
and O 0 0.0009699870715849102
mild B-Disease 1 0.9999029636383057
hyperphenylalaninemia I-Disease 1 0.9999310970306396
( O 0 0.020830044522881508
MHP B-Disease 1 0.9999961853027344
) O 0 0.0007505621179006994
are O 0 0.0004103539395146072
allelic B-Disease 1 0.9986644983291626
disorders I-Disease 1 0.9999936819076538
caused O 0 0.4905775487422943
by O 0 0.00024671366554684937
mutations O 0 0.0014742165803909302
in O 0 7.501750224037096e-05
the O 0 0.00014552414359059185
gene O 0 0.00163388776127249
encoding O 0 0.002235185354948044
phenylalanine O 1 0.580643892288208
hydroxylase O 1 0.9838867783546448
( O 0 0.007950184866786003
PAH O 1 0.99994957447052
) O 0 0.0012571057304739952
. O 0 0.0009870975045487285

Previous O 0 0.0032096225768327713
studies O 0 0.0011262820335105062
have O 0 0.000132231114548631
suggested O 0 0.0004481581272557378
that O 0 2.64304835582152e-05
the O 0 8.381577208638191e-05
highly O 0 0.0018322006799280643
variable O 0 0.003589261556044221
metabolic O 1 0.9636375904083252
phenotypes O 0 0.0844397321343422
of O 0 0.0013854099670425057
PAH B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999961853027344
correlate O 0 0.28891122341156006
with O 0 0.005234789568930864
PAH O 1 0.9999949932098389
genotypes O 1 0.951138436794281
. O 0 0.0016981620574370027

We O 0 0.0010766437044367194
identified O 0 0.0009924854384735227
both O 0 0.0003471291274763644
causative O 1 0.9359437227249146
mutations O 0 0.007632849272340536
in O 0 0.0013683795696124434
686 O 1 0.9989917874336243
patients O 1 0.9996992349624634
from O 0 0.0001760711456881836
seven O 0 0.0002997468982357532
European O 0 0.0009424821473658085
centers O 0 0.004071274306625128
. O 0 0.001064118929207325

On O 0 0.0003828347544185817
the O 0 8.097635873127729e-05
basis O 0 4.2787520214915276e-05
of O 0 1.3674532965524122e-05
the O 0 0.00020905124256387353
phenotypic O 0 0.007332965731620789
characteristics O 0 0.0009175801533274353
of O 0 0.00021878874395042658
297 O 1 0.8931478261947632
functionally O 1 0.9903843402862549
hemizygous O 1 0.9982483386993408
patients O 1 0.9997900128364563
, O 0 0.0002984653983730823
105 O 0 0.0007510751602239907
of O 0 2.1834854123881087e-05
the O 0 0.00033059463021345437
mutations O 0 0.0014173876261338592
were O 0 3.609877239796333e-05
assigned O 0 0.00048638239968568087
to O 0 3.237261262256652e-05
one O 0 2.4938864953583106e-05
of O 0 1.1579270903894212e-05
four O 0 0.00011064809950767085
arbitrary O 0 0.0009646551334299147
phenotype O 0 0.32167506217956543
categories O 0 0.0025543018709868193
. O 0 0.0011957671958953142

We O 0 0.0012576632434502244
proposed O 0 0.0016538026975467801
and O 0 0.0003157525206916034
tested O 0 0.004733638372272253
a O 0 0.00028867938090115786
simple O 0 0.0004323177272453904
model O 0 0.00045822878018952906
for O 0 0.00010997719073202461
correlation O 0 0.0012363942805677652
between O 0 0.00037282262928783894
genotype O 0 0.055836714804172516
and O 0 0.0003338177630212158
phenotypic O 0 0.01346690021455288
outcome O 0 0.003394853323698044
. O 0 0.0008714897558093071

The O 0 0.0013320003636181355
observed O 0 0.0032300397288054228
phenotype O 0 0.0379420705139637
matched O 0 0.00166366680059582
the O 0 0.00037870253436267376
predicted O 0 0.008043673820793629
phenotype O 0 0.030713040381669998
in O 0 0.00033864122815430164
79 O 0 0.0019523035734891891
% O 0 2.0832974769291468e-05
of O 0 2.1934947653790005e-05
the O 0 0.00032018101774156094
cases O 0 0.002262845868244767
, O 0 0.00014488489250652492
and O 0 6.402299914043397e-05
in O 0 5.499395410879515e-05
only O 0 4.5463111746357754e-05
5 O 0 0.00017270703392568976
of O 0 6.580443732673302e-05
184 O 0 0.24802540242671967
patients O 1 0.99980229139328
was O 0 0.0005556713440455496
the O 0 0.000225307623622939
observed O 0 0.0012328429147601128
phenotype O 0 0.01156221516430378
more O 0 6.558986933669075e-05
than O 0 8.360105130122975e-05
one O 0 0.00014101830311119556
category O 0 0.0005012246547266841
away O 0 0.0002303834626218304
from O 0 8.355576574103907e-05
that O 0 0.00010274840315105394
expected O 0 0.0007313771639019251
. O 0 0.000578855921048671

Among O 0 0.0005115991225466132
the O 0 0.0002855454513337463
seven O 0 0.0005801055231131613
contributing O 0 0.003921028226613998
centers O 0 0.0013328100321814418
, O 0 8.271858678199351e-05
the O 0 9.166515519609675e-05
proportion O 0 0.0005836922791786492
of O 0 0.00022792637173552066
patients O 1 0.999932050704956
for O 0 0.00037255475763231516
whom O 0 0.001379786292091012
the O 0 0.00039158089202828705
observed O 0 0.002769125159829855
phenotype O 0 0.14763091504573822
did O 0 0.0004812325641978532
not O 0 6.833275256212801e-05
match O 0 0.00017889314040075988
the O 0 0.00020551537454593927
predicted O 0 0.00486729247495532
phenotype O 0 0.01482598576694727
was O 0 0.0005368304555304348
4 O 0 0.00033217776217497885
% O 0 9.086875797947869e-05
- O 0 0.0017693922854959965
23 O 0 0.0006666323752142489
% O 0 0.00012125885405112058
( O 0 0.0014948330353945494
P O 0 0.3521427512168884
< O 0 0.03128767013549805
. O 0 0.0008344271336682141
0001 O 1 0.6871673464775085
) O 0 0.0005165563779883087
, O 0 0.00024962087627500296
suggesting O 0 0.0023122907150536776
that O 0 7.171096513047814e-05
differences O 0 0.00033462868304923177
in O 0 7.622587872901931e-05
methods O 0 0.00021634137374348938
used O 0 0.0001359363814117387
for O 0 0.0003896647831425071
mutation O 0 0.007332299370318651
detection O 0 0.2315826117992401
or O 0 0.0024376611690968275
phenotype O 1 0.994084894657135
classification O 1 0.5401530265808105
may O 0 0.0007633875356987119
account O 0 9.622162906453013e-05
for O 0 6.412717630155385e-05
a O 0 0.00022247339074965566
considerable O 0 0.00041821994818747044
proportion O 0 0.0003880359581671655
of O 0 0.0001698301057331264
genotype O 1 0.9890612363815308
- O 0 0.23615144193172455
phenotype O 0 0.17664945125579834
inconsistencies O 0 0.021283753216266632
. O 0 0.0014843293465673923

Our O 0 0.0007016623276285827
data O 0 0.00018372273189015687
indicate O 0 0.0004913147422485054
that O 0 0.00012099838932044804
the O 0 0.0014919248642399907
PAH O 1 0.9999908208847046
- O 0 0.013842307031154633
mutation O 0 0.003668536664918065
genotype O 0 0.011209718883037567
is O 0 0.00012856772809755057
the O 0 8.589081699028611e-05
main O 0 0.0004521794035099447
determinant O 0 0.004162874072790146
of O 0 0.00012473696551751345
metabolic O 1 0.9945683479309082
phenotype O 0 0.4621506333351135
in O 0 0.0002802507660817355
most O 0 0.0022076533641666174
patients O 1 0.999987006187439
with O 0 0.29558879137039185
PAH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999973773956299
. O 0 0.002176502253860235

In O 0 0.00041498668724671006
the O 0 0.0001926129771163687
present O 0 0.0002559073909651488
study O 0 0.00046235250192694366
, O 0 7.996040949365124e-05
the O 0 0.0001128179210354574
classification O 0 0.006256259046494961
of O 0 0.00013392514665611088
105 O 1 0.7591071724891663
PAH O 1 0.9999958276748657
mutations O 0 0.00785171240568161
may O 0 0.0005736910388804972
allow O 0 0.0001529330329503864
the O 0 0.00010033842409029603
prediction O 0 0.0015076149720698595
of O 0 1.6426147340098396e-05
the O 0 0.00035149723407812417
biochemical O 0 0.01773633249104023
phenotype O 0 0.04673651233315468
in O 0 0.0006367559544742107
> O 0 0.007301613222807646
10 O 0 0.0004812357947230339
, O 0 0.0003515465068630874
000 O 0 0.005396826192736626
genotypes O 0 0.04471776261925697
, O 0 0.00027832190971821547
which O 0 0.00014160362479742616
may O 0 0.00038618873804807663
be O 0 3.8399746699724346e-05
useful O 0 0.00028453447157517076
for O 0 5.9324454923626035e-05
the O 0 0.00021006067981943488
management O 0 0.021782219409942627
of O 0 0.00020129818585701287
hyperphenylalaninemia B-Disease 1 0.9997349381446838
in O 0 0.0013850959949195385
newborns O 1 0.9969918727874756
. O 0 0.0013066043611615896

Somatic O 0 0.031542178243398666
instability O 0 0.005965149961411953
of O 0 9.735666390042752e-05
the O 0 0.0013721183640882373
CTG O 1 0.9945713877677917
repeat O 0 0.012829930521547794
in O 0 0.0006153052090667188
mice O 0 0.0072724721394479275
transgenic O 0 0.002815288957208395
for O 0 0.0004035448073409498
the O 0 0.004281278699636459
myotonic B-Disease 1 0.999998927116394
dystrophy I-Disease 1 0.9999995231628418
region O 0 0.02294132299721241
is O 0 0.0010034316219389439
age O 0 0.001163071021437645
dependent O 0 0.002124041086062789
but O 0 0.0002203458861913532
not O 0 0.00010927825496764854
correlated O 0 0.0012612140271812677
to O 0 4.4193195208208635e-05
the O 0 0.00010169779852731153
relative O 0 0.0007898859912529588
intertissue O 0 0.0431629978120327
transcription O 0 0.0022408212535083294
levels O 0 0.0035673463717103004
and O 0 0.0008904524147510529
proliferative O 1 0.9992783665657043
capacities O 0 0.02940874733030796
. O 0 0.002235695021227002

A O 0 0.014977291226387024
( O 0 0.0041975355707108974
CTG O 1 0.9830499291419983
) O 0 0.0009456478874199092
nexpansion O 0 0.016196008771657944
in O 0 0.00013272262003738433
the O 0 0.00030031584901735187
3 O 0 0.0013201055116951466
- O 0 0.004949514754116535
untranslated O 0 0.025072190910577774
region O 0 0.0027956762351095676
( O 0 0.0007653476786799729
UTR O 0 0.027468053624033928
) O 0 6.796402158215642e-05
of O 0 1.8410506527288817e-05
the O 0 0.0008426029817201197
DM O 1 0.9999229907989502
protein O 0 0.002293644705787301
kinase O 0 0.019569898024201393
gene O 0 0.0035377328749746084
( O 0 0.0011075641959905624
DMPK O 1 0.9717084169387817
) O 0 0.0002189567603636533
is O 0 0.00014713445852976292
responsible O 0 0.0015701372176408768
for O 0 0.0012063966132700443
causing O 1 0.9991746544837952
myotonic B-Disease 1 0.9999991655349731
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9295302629470825
DM B-Disease 1 0.9999961853027344
) O 0 0.002371659269556403
. O 0 0.001148589770309627

Major O 0 0.01214568316936493
instability O 0 0.017597142606973648
, O 0 0.0002990994544234127
with O 0 0.00012980028986930847
very O 0 0.0005791840376332402
large O 0 0.0002889698662329465
expansions O 0 0.003766365349292755
between O 0 0.00020577223040163517
generations O 0 0.0007810426177456975
and O 0 0.00016201984544750303
high O 0 0.0012790863402187824
levels O 0 0.0009948110673576593
of O 0 9.15556083782576e-05
somatic O 0 0.33145615458488464
mosaicism O 1 0.9987755417823792
, O 0 0.00030410720501095057
is O 0 0.00032793424907140434
observed O 0 0.0009278453653678298
in O 0 0.001114379265345633
patients O 1 0.9998190999031067
. O 0 0.0016275442903861403

There O 0 0.0004437619063537568
is O 0 0.0002619749284349382
a O 0 0.00037594069726765156
good O 0 0.0008713785209693015
correlation O 0 0.0009819369297474623
between O 0 0.0001998460793402046
repeat O 0 0.005794988479465246
size O 0 0.0006698785000480711
( O 0 0.0002790262515190989
at O 0 0.0002468529564794153
least O 0 0.0002453804772812873
in O 0 0.00026792820426635444
leucocytes O 1 0.7974404096603394
) O 0 0.00045833471813239157
, O 0 0.0007536694756709039
clinical O 1 0.9998003840446472
severity O 1 0.9985670447349548
and O 0 0.0002164065808756277
age O 0 0.0005987925687804818
of O 0 0.0002448343439027667
onset O 1 0.9999184608459473
. O 0 0.0022026298101991415

The O 0 0.004923893604427576
trinucleotide O 1 0.983794629573822
repeat O 0 0.02523735538125038
instability O 0 0.01512643601745367
mechanisms O 0 0.003914916422218084
involved O 0 0.0032194789964705706
in O 0 0.003035458968952298
DM B-Disease 1 0.9999982118606567
and O 0 0.0003476613783277571
other O 0 0.00027907200274057686
human O 0 0.3318840563297272
genetic B-Disease 1 0.9997227787971497
diseases I-Disease 1 0.999998927116394
are O 0 0.00016853732813615352
unknown O 0 0.0018316401401534677
. O 0 0.0009365126024931669

We O 0 0.0014540351694449782
studied O 0 0.0017631456721574068
somatic O 0 0.008118712343275547
instability O 0 0.004712546244263649
by O 0 0.00010251605999656022
measuring O 0 0.0035635654348880053
the O 0 0.0015203759539872408
CTG O 1 0.9892398118972778
repeat O 0 0.0127299465239048
length O 0 0.0009385290904901922
at O 0 0.0003776678058784455
several O 0 0.00014380445645656437
ages O 0 0.000641908380202949
in O 0 8.101497223833576e-05
various O 0 9.304622653871775e-05
tissues O 0 0.00905534066259861
of O 0 8.298626926261932e-05
transgenic O 0 0.019426248967647552
mice O 0 0.008206242695450783
carrying O 0 0.000983423087745905
a O 0 0.0015874728560447693
( O 0 0.002434168942272663
CTG O 1 0.9900102019309998
) O 0 0.0010022479109466076
55expansion O 0 0.03605121746659279
surrounded O 0 0.002683321014046669
by O 0 0.00010803410259541124
45 O 0 0.000332221738062799
kb O 0 0.0025322791188955307
of O 0 3.6185490898787975e-05
the O 0 0.0007280572899617255
human O 0 0.08512938022613525
DM B-Disease 1 0.999974250793457
region O 0 0.002751006744801998
, O 0 0.00013555180339608341
using O 0 0.00014019575610291213
small O 0 0.0004815423162654042
- O 0 0.0043001617304980755
pool O 0 0.00422033853828907
PCR O 0 0.012537065893411636
. O 0 0.0009537311852909625

These O 0 0.001065835589542985
mice O 0 0.01332622580230236
have O 0 0.00015031865041237324
been O 0 0.00028578020283021033
shown O 0 0.00041584167047403753
to O 0 8.717086893739179e-05
reproduce O 0 0.0011841276427730918
the O 0 0.0002267091622343287
intergenerational O 0 0.02537805400788784
and O 0 0.0002121582510881126
somatic O 0 0.0062020388431847095
instability O 0 0.002229304751381278
of O 0 3.8024627428967506e-05
the O 0 0.0005105950986035168
55 O 0 0.006782934535294771
CTG O 1 0.9935687780380249
repeat O 0 0.01883178949356079
suggesting O 0 0.004291340243071318
that O 0 0.00013844971545040607
surrounding O 0 0.0009185073431581259
sequences O 0 0.00011370374704711139
and O 0 7.347766950260848e-05
the O 0 0.00022379883739631623
chromatin O 0 0.004855532199144363
environment O 0 0.0014020554954186082
are O 0 5.04463714605663e-05
involved O 0 0.0006901546148583293
in O 0 0.0003069744270760566
instability O 0 0.016863709315657616
mechanisms O 0 0.004743137396872044
. O 0 0.0011990839848294854

As O 0 0.0008645159541629255
observed O 0 0.0004970444715581834
in O 0 5.474123827298172e-05
some O 0 2.054903598036617e-05
of O 0 1.8274502508575097e-05
the O 0 0.00045332827721722424
tissues O 1 0.8905363082885742
of O 0 0.0017482258845120668
DM B-Disease 1 0.9999998807907104
patients O 1 0.9999713897705078
, O 0 0.0001902160729514435
there O 0 0.00011648711370071396
is O 0 0.00016025306831579655
a O 0 0.0003534216957632452
tendency O 0 0.002889847382903099
for O 0 0.00026629731291905046
repeat O 0 0.005937798414379358
length O 0 0.0008600314613431692
and O 0 0.0004136024508625269
somatic O 0 0.05991743132472038
mosaicism O 1 0.9682392477989197
to O 0 9.585438237991184e-05
increase O 0 0.00013492006110027432
with O 0 3.8949194276938215e-05
the O 0 0.0001110444645746611
age O 0 0.00020435622718650848
of O 0 2.8314181690802798e-05
the O 0 0.0006093711708672345
mouse O 0 0.03838299959897995
. O 0 0.0012256812769919634

Furthermore O 0 0.008219976909458637
, O 0 0.0004164128622505814
we O 0 0.00017561676213517785
observed O 0 0.0003144526563119143
no O 0 0.00010197222582064569
correlation O 0 0.0004911157302558422
between O 0 7.885802915552631e-05
the O 0 0.0002540914574638009
somatic O 0 0.011353184469044209
mutation O 0 0.0027449228800833225
rate O 0 0.0003967153315898031
and O 0 0.0004335888661444187
tissue O 1 0.9910001158714294
proliferation O 0 0.04265432432293892
capacity O 0 0.0037944051437079906
. O 0 0.001165776397101581

The O 0 0.001787226996384561
somatic O 0 0.027357831597328186
mutation O 0 0.005441880784928799
rates O 0 0.0008612090605311096
in O 0 0.00015497897402383387
different O 0 0.0001471055584261194
tissues O 0 0.0656033456325531
were O 0 7.618583185831085e-05
also O 0 0.0001390790130244568
not O 0 8.965453889686614e-05
correlated O 0 0.0007776901475153863
to O 0 4.0473354601999745e-05
the O 0 0.00012151013652328402
relative O 0 0.0011761249043047428
inter O 0 0.013923121616244316
- O 0 0.009825628250837326
tissue O 0 0.021547095850110054
difference O 0 0.0005612781387753785
in O 0 9.055042028194293e-05
transcriptional O 0 0.001699351705610752
levels O 0 0.0004267339245416224
of O 0 9.812187272473238e-06
the O 0 0.00010397024016128853
three O 0 0.0001412768615409732
genes O 0 0.0010070743737742305
( O 0 0.0013412295375019312
DMAHP O 1 0.9972399473190308
, O 0 0.0009941572789102793
DMPK O 1 0.978001594543457
and O 0 0.0003589677216950804
59 O 0 0.0038637786637991667
) O 0 0.0002363800012972206
surrounding O 0 0.0009526672656647861
the O 0 0.00039532335358671844
repeat O 0 0.013828366063535213
. O 0 0.0003966839285567403
. O 0 0.0007186856237240136

A O 0 0.008574708364903927
novel O 0 0.007838502526283264
missense O 0 0.04953843355178833
mutation O 0 0.007718117907643318
in O 0 0.0007731509394943714
patients O 1 0.9997798800468445
from O 0 0.00024662428768351674
a O 0 0.006373367737978697
retinoblastoma B-Disease 1 0.9999101161956787
pedigree O 1 0.6518383026123047
showing O 0 0.0022102270741015673
only O 0 0.0002907789603341371
mild O 1 0.9921648502349854
expression O 0 0.00049853470409289
of O 0 7.001798076089472e-05
the O 0 0.0026657574344426394
tumor B-Disease 1 0.9999591112136841
phenotype O 1 0.95139080286026
. O 0 0.0015991072868928313

We O 0 0.0005343183293007314
have O 0 8.024915587157011e-05
used O 0 0.00013517205661628395
single O 0 0.00043993076542392373
strand O 0 0.0038037027698010206
conformation O 0 0.003873639041557908
polymorphism O 0 0.0017726175719872117
analysis O 0 0.0002666788932401687
to O 0 0.00011794651800300926
study O 0 0.00045491522178053856
the O 0 0.00014046298747416586
27 O 0 0.0009038669522851706
exons O 0 0.0012951872777193785
of O 0 4.87057986902073e-05
the O 0 0.0020111717749387026
RB1 O 1 0.9997687935829163
gene O 0 0.0027119633741676807
in O 0 0.0001383246126351878
individuals O 0 0.0001714296085992828
from O 0 0.00011943457502638921
a O 0 0.00094795529730618
family O 0 0.0013372640823945403
showing O 0 0.004969577305018902
mild O 1 0.9843313097953796
expression O 0 0.0006661745137535036
of O 0 7.545521657448262e-05
the O 0 0.0023322005290538073
retinoblastoma B-Disease 1 0.9998250603675842
phenotype O 1 0.9816612005233765
. O 0 0.0016493188450112939

In O 0 0.0006439224816858768
this O 0 0.00019866247021127492
family O 0 0.0013878543395549059
affected O 0 0.00655211741104722
individuals O 0 0.0008714217110536993
developed O 1 0.7565782070159912
unilateral B-Disease 1 0.9988775849342346
tumors I-Disease 1 0.9999939203262329
and O 0 0.0002580659929662943
, O 0 0.00016888094251044095
as O 0 0.0001367563527310267
a O 0 0.0002817327913362533
result O 0 0.00022993952734395862
of O 0 5.068665268481709e-05
linkage O 0 0.04930568113923073
analysis O 0 0.0008513003122061491
, O 0 0.0007353951805271208
unaffected O 1 0.9032405614852905
mutation O 0 0.007762203458696604
carriers O 0 0.004427699372172356
were O 0 5.916948430240154e-05
also O 0 0.00020593040972016752
identified O 0 0.00042570068035274744
within O 0 7.454805745510384e-05
the O 0 0.00036398755037225783
pedigree O 0 0.10768137127161026
. O 0 0.001531720394268632

A O 0 0.003514511277899146
single O 0 0.0006924809422343969
band O 0 0.0011714246356859803
shift O 0 0.00156464206520468
using O 0 0.0009462251327931881
SSCP O 1 0.9875156879425049
was O 0 0.0013306678738445044
identified O 0 0.0007830805261619389
in O 0 0.00021864693553652614
exon O 0 0.01412033662199974
21 O 0 0.0007203044951893389
which O 0 6.527954974444583e-05
resulted O 0 0.0008072751807048917
in O 0 0.00015055878611747175
a O 0 0.0009597943862900138
missense O 0 0.009177139028906822
mutation O 0 0.0014036440989002585
converting O 0 0.0012468789936974645
a O 0 0.003411016194149852
cys O 1 0.9969359636306763
- O 0 0.01899869181215763
- O 0 0.008053961209952831
> O 0 0.009225830435752869
arg O 0 0.016394034028053284
at O 0 0.00024070734798442572
nucleotide O 0 0.0003074368869420141
position O 0 0.0009820309933274984
28 O 0 0.0005251511465758085
in O 0 9.063785546459258e-05
the O 0 0.0004010103875771165
exon O 0 0.02916623465716839
. O 0 0.001268322579562664

The O 0 0.0013780659064650536
mutation O 0 0.00475847814232111
destroyed O 0 0.002675246447324753
an O 0 0.0004275366954971105
NdeI O 0 0.07883209735155106
restriction O 0 0.0017881595995277166
enzyme O 0 0.003959200344979763
site O 0 0.0025940765626728535
. O 0 0.0008293299470096827

Analysis O 0 0.0004639518156182021
of O 0 3.065503551624715e-05
all O 0 6.724815466441214e-05
family O 0 0.000452193635283038
members O 0 0.00013485460658557713
demonstrated O 0 0.0014847752172499895
that O 0 7.203309360193089e-05
the O 0 0.0003186565591022372
missense O 0 0.028592824935913086
mutation O 0 0.00730552664026618
co O 0 0.015499098226428032
- O 0 0.005258455406874418
segregated O 0 0.006674230098724365
with O 0 0.0008023561094887555
patients O 1 0.9999170303344727
with O 0 0.0024545416235923767
tumors B-Disease 1 0.9999970197677612
or O 0 0.0009327879524789751
who O 0 0.0007608624291606247
, O 0 0.00014974670193623751
as O 0 0.00013640511315315962
a O 0 0.000357198208803311
result O 0 0.00024440354900434613
of O 0 5.200907253311016e-05
linkage O 0 0.023712866008281708
analysis O 0 0.0006737887160852551
had O 0 0.000651869922876358
been O 0 0.00028300780104473233
predicted O 0 0.0006438089185394347
to O 0 3.083005503867753e-05
carry O 0 0.00018380735127720982
the O 0 0.00029036650084890425
predisposing O 0 0.39739012718200684
mutation O 0 0.0069009093567729
. O 0 0.0009345315047539771

These O 0 0.00018010199710261077
observations O 0 0.0006649591377936304
point O 0 0.00031776074320077896
to O 0 6.855362153146416e-05
another O 0 0.0002618048747535795
region O 0 0.0004452273133210838
of O 0 4.313304089009762e-05
the O 0 0.0018639224581420422
RB1 O 1 0.9995844960212708
gene O 0 0.002969050081446767
where O 0 0.00030008089379407465
mutations O 0 0.0010727328481152654
only O 0 6.355242658173665e-05
modify O 0 0.002105157123878598
the O 0 6.337546074064448e-05
function O 0 0.00017895492783281952
of O 0 1.9566652554203756e-05
the O 0 0.0002789110876619816
gene O 0 0.0011995969107374549
and O 0 0.00010677376849344
raise O 0 0.0006421760772354901
important O 0 0.00023431246518157423
questions O 0 0.0006644473178312182
for O 0 0.000414838403230533
genetic O 0 0.00760734174400568
counseling O 1 0.9770287871360779
in O 0 0.00018858372641261667
families O 0 0.00015205563977360725
with O 0 7.78094181441702e-05
these O 0 0.00014088362513575703
distinctive O 0 0.1519404500722885
phenotypes O 0 0.26899632811546326
. O 0 0.00042291407589800656
. O 0 0.0007967454730533063

Maternal B-Disease 1 0.5740972757339478
disomy I-Disease 1 0.9735508561134338
and O 0 0.007232372649013996
Prader B-Disease 1 0.9999978542327881
- I-Disease 1 0.9998502731323242
Willi I-Disease 1 0.9999949932098389
syndrome I-Disease 1 0.9999979734420776
consistent O 0 0.012084065936505795
with O 0 0.0006684098043479025
gamete O 1 0.6954566836357117
complementation O 1 0.9932464361190796
in O 0 0.0002357848425162956
a O 0 0.000608166039455682
case O 0 0.000864755711518228
of O 0 0.0001171977273770608
familial O 1 0.9982427358627319
translocation O 0 0.17414402961730957
( O 0 0.0007161358371376991
3 O 0 0.0006832457729615271
; O 0 0.0001569853484397754
15 O 0 0.0005699070752598345
) O 0 0.00030212075216695666
( O 0 0.0008820341899991035
p25 O 1 0.712047278881073
; O 0 0.0005568802007474005
q11 O 0 0.016528161242604256
. O 0 0.00020783492072951049
2 O 0 0.0007181204855442047
) O 0 0.000322713574860245
. O 0 0.00048746177344582975

Maternal B-Disease 1 0.9658102989196777
uniparental I-Disease 1 0.9992610812187195
disomy I-Disease 1 0.9956569671630859
( I-Disease 0 0.012373169884085655
UPD I-Disease 1 0.9996312856674194
) I-Disease 0 0.0006466184859164059
for I-Disease 0 0.00040058529702946544
chromosome I-Disease 0 0.002296950900927186
15 I-Disease 0 0.00040147436084225774
is O 0 0.00018687626288738102
responsible O 0 0.0008737505413591862
for O 0 0.00010741130245150998
an O 0 0.0001703832094790414
estimated O 0 0.00038647899054922163
30 O 0 0.00015694419562350959
% O 0 1.2447281733329874e-05
of O 0 2.216476059402339e-05
cases O 0 0.0016616666689515114
of O 0 0.000593331700656563
Prader B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999359846115112
Willi I-Disease 1 0.9999986886978149
syndrome I-Disease 1 0.9999997615814209
( O 0 0.15901155769824982
PWS B-Disease 1 0.9999891519546509
) O 0 0.002009203191846609
. O 0 0.000995029928162694

We O 0 0.0009958919836208224
report O 0 0.0005701091722585261
on O 0 0.00012018621055176482
an O 0 0.00018733831529971212
unusual O 0 0.0015503604663535953
case O 0 0.001049504615366459
of O 0 9.628605039324611e-05
maternal B-Disease 1 0.6033299565315247
disomy I-Disease 1 0.9440214037895203
15 I-Disease 0 0.0019512167200446129
in O 0 0.001356599386781454
PWS B-Disease 1 0.9999719858169556
that O 0 0.0001971190213225782
is O 0 0.00014472073235083371
most O 0 0.0001067544289981015
consistent O 0 0.001121604349464178
with O 0 0.00012839878036174923
adjacent O 0 0.002096625044941902
- O 0 0.0022733223158866167
1 O 0 0.0003846885228995234
segregation O 0 0.0017549418844282627
of O 0 2.849901829904411e-05
a O 0 0.0017789500998333097
paternal O 0 0.36984971165657043
t O 1 0.9900126457214355
( O 0 0.0007115363841876388
3 O 0 0.0006952894036658108
; O 0 0.00018710963195189834
15 O 0 0.0007163860136643052
) O 0 0.00035422289511188865
( O 0 0.0011587698245421052
p25 O 1 0.8968062996864319
; O 0 0.0006704667466692626
q11 O 0 0.02007640339434147
. O 0 0.00019241584232077003
2 O 0 0.00032191805075854063
) O 0 6.170800043037161e-05
with O 0 5.399902875069529e-05
simultaneous O 0 0.0011372733861207962
maternal O 0 0.037926603108644485
meiotic O 1 0.9725388884544373
nondisjunction O 0 0.11939744651317596
for O 0 0.0007713105296716094
chromosome O 0 0.004630751442164183
15 O 0 0.0017545183654874563
. O 0 0.0009518977603875101

The O 0 0.003810651134699583
patient O 1 0.999411940574646
( O 0 0.004714342299848795
J O 1 0.9990511536598206
. O 0 0.0006273778853937984
B O 0 0.02202526293694973
. O 0 0.00011415067274356261
) O 0 8.393694588448852e-05
, O 0 6.14361633779481e-05
a O 0 0.0004332759417593479
17 O 0 0.001097234315238893
- O 0 0.0024036106187850237
year O 0 0.0009680137154646218
- O 0 0.0047051492147147655
old O 0 0.0031944545917212963
white O 0 0.008337212726473808
male O 0 0.002333159325644374
with O 0 0.00197632540948689
PWS B-Disease 1 0.9999946355819702
, O 0 0.0008961251587606966
was O 0 0.001006216974928975
found O 0 0.00021563378686551005
to O 0 5.596049231826328e-05
have O 0 6.018644126015715e-05
47 O 0 0.0005083975265733898
chromosomes O 0 0.00013622676488012075
with O 0 8.656548743601888e-05
a O 0 0.0014349531847983599
supernumerary O 1 0.9892176389694214
, O 0 0.0012473433744162321
paternal O 0 0.2771446704864502
der O 1 0.9940457344055176
( O 0 0.0010358652798458934
15 O 0 0.0006205647950991988
) O 0 6.0451093304436654e-05
consisting O 0 5.265503205009736e-05
of O 0 2.3660657461732626e-05
the O 0 0.00038266839692369103
short O 0 0.004088367335498333
arm O 1 0.9134678244590759
and O 0 0.0002974958042614162
the O 0 0.000759870046749711
proximal O 1 0.9986145496368408
long O 0 0.01325846929103136
arm O 0 0.07302186638116837
of O 0 0.00010053782898467034
chromosome O 0 0.003236058633774519
15 O 0 0.0005759740597568452
, O 0 0.00023025894188322127
and O 0 0.00047917774645611644
distal O 1 0.9973746538162231
chromosome O 0 0.03770576789975166
arm O 1 0.9928598999977112
3p O 1 0.9833610653877258
. O 0 0.001916338806040585

The O 0 0.004406036343425512
t O 1 0.8168100118637085
( O 0 0.000842212000861764
3 O 0 0.0008370524155907333
; O 0 0.00021022395230829716
15 O 0 0.0005328516708686948
) O 0 0.00015263858949765563
was O 0 0.0003275896015111357
present O 0 8.983468433143571e-05
in O 0 5.660060924128629e-05
the O 0 8.875050116330385e-05
balanced O 0 0.001250103348866105
state O 0 0.00011509042087709531
in O 0 0.00013040755584370345
the O 0 0.0010918296175077558
patients O 1 0.9999701976776123
father O 0 0.0038137040100991726
and O 0 0.0002381233498454094
a O 0 0.002191853942349553
sister O 0 0.009918796829879284
. O 0 0.001149020972661674

Fluorescent O 0 0.04708390682935715
in O 0 0.0009429702768102288
situ O 0 0.03650394454598427
hybridization O 0 0.001700469059869647
analysis O 0 0.0005224705091677606
demonstrated O 0 0.0023576647508889437
that O 0 0.00023505222634412348
the O 0 0.001465506269596517
PWS B-Disease 1 0.9999624490737915
critical O 0 0.026594379916787148
region O 0 0.004585545975714922
resided O 0 0.0041951206512749195
on O 0 0.00015716208145022392
the O 0 0.0002536016108933836
derivative O 0 0.005868297535926104
chromosome O 0 0.002402010839432478
3 O 0 0.0003664148389361799
and O 0 5.894899004488252e-05
that O 0 5.2385083108674735e-05
there O 0 7.719142740825191e-05
was O 0 0.0002985467726830393
no O 0 0.00015659304335713387
deletion O 0 0.0016007828526198864
of O 0 5.481745029101148e-05
the O 0 0.002223800402134657
PWS B-Disease 1 0.9999748468399048
region O 0 0.0019005039939656854
on O 0 0.00014338435721583664
the O 0 0.00016368180513381958
normal O 0 0.0013703495496883988
pair O 0 0.00034164267708547413
of O 0 8.209527732105926e-05
15s O 0 0.4545114040374756
present O 0 0.000499389658216387
in O 0 0.0011998650152236223
J O 1 0.9984738230705261
. O 0 0.0012037473497912288

B O 0 0.1905009001493454
. O 0 0.002486414974555373

Methylation O 0 0.004174815025180578
analysis O 0 0.0006374280783347785
at O 0 0.0007172702462412417
exon O 0 0.007722143083810806
alpha O 0 0.00041722727473825216
of O 0 1.0514771929592825e-05
the O 0 9.621639765100554e-05
small O 0 0.0003736521757673472
nuclear O 0 0.007155528292059898
ribonucleoprotein O 1 0.9937852621078491
- O 0 0.004147511441260576
associated O 0 0.0007222500280477107
polypeptide O 0 0.009853563271462917
N O 0 0.013710379600524902
( O 0 0.00196815375238657
SNRPN O 1 0.9880500435829163
) O 0 0.0006423484301194549
gene O 0 0.0018426015740260482
showed O 0 0.0007009927066974342
a O 0 0.0005100828711874783
pattern O 0 0.0017623703461140394
characteristic O 0 0.0008441306417807937
of O 0 1.9979923308710568e-05
only O 0 6.850546196801588e-05
the O 0 0.00024331007443834096
maternal O 0 0.017300119623541832
chromosome O 0 0.0029672940727323294
15 O 0 0.0006830699858255684
in O 0 0.00080553611041978
J O 1 0.9991268515586853
. O 0 0.0010496065951883793

B O 0 0.2172684669494629
. O 0 0.0021019112318754196

Maternal B-Disease 1 0.8490040898323059
disomy I-Disease 1 0.9690614938735962
was O 0 0.0027373037301003933
confirmed O 0 0.0016977813793346286
by O 0 9.029897773871198e-05
polymerase O 0 0.00432546017691493
chain O 0 0.0024117056746035814
reaction O 0 0.0007188109448179603
analysis O 0 0.00019802816677838564
of O 0 7.538035424659029e-05
microsatellite O 0 0.060193028301000595
repeats O 0 0.0033258681651204824
at O 0 0.0002571687218733132
the O 0 0.0003006366896443069
gamma O 0 0.009250813163816929
- O 0 0.00420941598713398
aminobutyric O 0 0.016471920534968376
acid O 0 0.005587980151176453
receptor O 0 0.004877808038145304
beta3 O 0 0.0335259772837162
subunit O 0 0.005567947402596474
( O 0 0.0023696066346019506
GABRB3 O 1 0.9665107727050781
) O 0 0.0010334530379623175
locus O 0 0.015043094754219055
. O 0 0.0014329131226986647

A O 0 0.024027539417147636
niece O 1 0.9829181432723999
( O 0 0.0028611705638468266
B O 0 0.4061012268066406
. O 0 0.000480461138067767
B O 0 0.018953541293740273
. O 0 0.00012363932910375297
) O 0 7.719555287621915e-05
with O 0 5.995341052766889e-05
45 O 0 0.0002419807860860601
chromosomes O 0 0.00020232476526871324
and O 0 6.5168525907211e-05
the O 0 0.00020530694746412337
derivative O 0 0.0030552856624126434
3 O 0 0.000396164832636714
but O 0 0.00011714643915183842
without O 0 0.0002226215146947652
the O 0 0.0005168567295186222
der O 1 0.9817448258399963
( O 0 0.0005822625244036317
15 O 0 0.0006892659002915025
) O 0 0.0002241740730823949
demonstrated O 0 0.0020622636657208204
a O 0 0.0015423489967361093
phenotype O 0 0.21341368556022644
consistent O 0 0.0020018864888697863
with O 0 0.00010882901551667601
that O 0 0.00014345218369271606
reported O 0 0.0011559592094272375
for O 0 0.00027957718702964485
haploinsufficiency O 0 0.02961054816842079
of O 0 0.00014677630679216236
distal O 1 0.9965007305145264
3 O 0 0.003834568429738283
p O 0 0.01593337208032608
. O 0 0.000917850702535361

Uniparental B-Disease 1 0.9997979998588562
disomy I-Disease 1 0.9942355751991272
associated O 0 0.0017488293815404177
with O 0 0.0003895234258379787
unbalanced O 1 0.6854540705680847
segregation O 0 0.008249597623944283
of O 0 0.00011785534297814593
non O 0 0.006952339317649603
- O 0 0.03943422809243202
Robertsonian O 1 0.964245080947876
translocations O 0 0.03223545849323273
has O 0 0.0009906040504574776
been O 0 0.0006255496409721673
reported O 0 0.0025312122888863087
previously O 0 0.0008675410063005984
but O 0 0.0002217986184405163
has O 0 0.0003790763730648905
not O 0 8.322012581629679e-05
, O 0 6.059942825231701e-05
to O 0 4.908221308141947e-05
our O 0 0.00018597644520923495
knowledge O 0 0.0007128769648261368
, O 0 0.00013620092067867517
been O 0 0.000173562511918135
observed O 0 0.0001849908148869872
in O 0 8.801146759651601e-05
a O 0 0.0006752968765795231
case O 0 0.002121575642377138
of O 0 0.0005217583966441453
PWS B-Disease 1 0.9999880790710449
. O 0 0.002617816673591733

Furthermore O 0 0.007925678975880146
, O 0 0.0004561463138088584
our O 0 0.0007091552251949906
findings O 0 0.001362288254313171
are O 0 2.228061930509284e-05
best O 0 0.00025424707564525306
interpreted O 0 0.0003219106874894351
as O 0 0.000214852683711797
true O 0 0.0017300820909440517
gamete O 0 0.07777679711580276
complementation O 1 0.9772005677223206
resulting O 0 0.0031701652333140373
in O 0 0.0011551863281056285
maternal B-Disease 1 0.9920463562011719
UPD I-Disease 1 0.9998026490211487
15 I-Disease 0 0.004465008620172739
and O 0 0.0037752322386950254
PWS B-Disease 1 0.9999371767044067

Schwartz B-Disease 1 0.9891678094863892
- I-Disease 1 0.8643749952316284
Jampel I-Disease 1 0.9979442954063416
syndrome I-Disease 1 0.999996542930603
type I-Disease 0 0.007837371900677681
2 I-Disease 0 0.0007968187564983964
and O 0 0.0006108990637585521
Stuve B-Disease 1 0.9992995262145996
- I-Disease 1 0.9983412027359009
Wiedemann I-Disease 1 0.9999474287033081
syndrome I-Disease 1 0.9999980926513672
: O 0 0.0004785843484569341
a O 0 0.0006465186597779393
case O 0 0.0011001706589013338
for O 0 0.00024008576292544603
" O 0 0.0010496705072000623
lumping O 0 0.041112061589956284
" O 0 0.0020614159293472767
. O 0 0.0011410948354750872

Recent O 0 0.0048402114771306515
studies O 0 0.0012024305760860443
demonstrated O 0 0.001670626807026565
the O 0 0.00015106542559806257
existence O 0 0.00046996059245429933
of O 0 2.695574949029833e-05
a O 0 0.0008504887809976935
genetically O 0 0.001568942447192967
distinct O 0 0.0006598384352400899
, O 0 0.00019817323482129723
usually O 0 0.00033459835685789585
lethal O 0 0.003947950433939695
form O 0 0.00012059453729307279
of O 0 2.3888469513622113e-05
the O 0 0.0008439801749773324
Schwartz B-Disease 1 0.9988334774971008
- I-Disease 1 0.9938103556632996
Jampel I-Disease 1 0.9997802376747131
syndrome I-Disease 1 0.9999991655349731
( O 0 0.008946224115788937
SJS B-Disease 1 0.9998472929000854
) O 0 0.0003902069292962551
of O 0 0.0002475739747751504
myotonia B-Disease 1 0.9999896287918091
and O 0 0.0064131999388337135
skeletal B-Disease 1 0.9999898672103882
dysplasia I-Disease 1 0.9999980926513672
, O 0 0.0004174935747869313
which O 0 0.0001448186085326597
we O 0 0.0004484499804675579
called O 0 0.006763556506484747
SJS B-Disease 1 0.999358594417572
type I-Disease 0 0.006408729124814272
2 I-Disease 0 0.001362726790830493
. O 0 0.0007587232394143939

This O 0 0.003107514465227723
disorder O 1 0.9998573064804077
is O 0 0.0006431766087189317
reminiscent O 0 0.0021783981937915087
of O 0 7.267753244377673e-05
another O 0 0.0017652803799137473
rare O 1 0.605151355266571
condition O 1 0.9990702271461487
, O 0 0.00022098762565292418
the O 0 0.0007718855049461126
Stuve B-Disease 1 0.9990409016609192
- I-Disease 1 0.996459424495697
Wiedemann I-Disease 1 0.9998189806938171
syndrome I-Disease 1 0.9999979734420776
( O 0 0.009532259777188301
SWS B-Disease 1 0.9996669292449951
) O 0 0.00029986383742652833
, O 0 0.00013227133604232222
which O 0 7.074167660903186e-05
comprises O 0 0.0007178970263339579
campomelia B-Disease 0 0.19601640105247498
at O 0 0.0006130823167040944
birth O 0 0.0025847710203379393
with O 0 0.0013495762832462788
skeletal B-Disease 1 0.999992847442627
dysplasia I-Disease 1 0.9999992847442627
, O 0 0.009549994952976704
contractures B-Disease 1 0.9999431371688843
, O 0 0.00047974727931432426
and O 0 0.00026603517471812665
early B-Disease 0 0.0015122180338948965
death I-Disease 0 0.006746797822415829
. O 0 0.0008882160764187574

To O 0 0.00046910211676731706
test O 0 0.0010083751985803246
for O 0 0.00022182906104717404
possible O 0 0.0014072860358282924
nosologic O 0 0.4501453638076782
identity O 0 0.0008978858240880072
between O 0 0.0003783510474022478
these O 0 0.0006432391819544137
disorders O 1 0.9999902248382568
, O 0 0.000427440507337451
we O 0 0.0002559261629357934
reviewed O 0 0.000972503621596843
the O 0 7.10647291271016e-05
literature O 0 0.00015127038932405412
and O 0 9.750327444635332e-05
obtained O 0 0.00024223100626841187
a O 0 0.00045580335427075624
follow O 0 0.0006530004320666194
- O 0 0.0006584611837752163
up O 0 3.298258161521517e-05
of O 0 6.645777830271982e-06
the O 0 5.915797737543471e-05
only O 0 6.0540281992871314e-05
two O 0 0.00013162688992451876
surviving O 0 0.06221868097782135
patients O 1 0.9997856020927429
, O 0 0.00014538905816152692
one O 0 0.0002300500636920333
with O 0 0.0012294274056330323
SJS B-Disease 1 0.9998482465744019
type I-Disease 0 0.005981758702546358
2 I-Disease 0 0.0006890288204886019
at O 0 0.0004310421063564718
age O 0 0.0003992070269305259
10 O 0 0.00019714291556738317
years O 0 0.0001938965724548325
and O 0 7.379591261269525e-05
another O 0 0.00041373612475581467
with O 0 0.0005045778234489262
SWS B-Disease 1 0.9993108510971069
at O 0 0.0010280257556587458
age O 0 0.0012384308502078056
7 O 0 0.0009825396118685603
years O 0 0.0012274576583877206
. O 0 0.0009243889944627881

Patients O 1 0.9996809959411621
reported O 0 0.0035746218636631966
as O 0 0.00047239079140126705
having O 0 0.0029581079725176096
either O 0 0.013789358548820019
neonatal O 1 0.9999978542327881
SJS B-Disease 1 0.9999518394470215
or O 0 0.007309393957257271
SWS B-Disease 1 0.9990563988685608
presented O 0 0.0013245372101664543
a O 0 0.0005640416056849062
combination O 0 0.0012702539097517729
of O 0 4.646987508749589e-05
a O 0 0.003584448480978608
severe O 1 0.9999333620071411
, O 0 0.0025652789045125246
prenatal O 1 0.9999639987945557
- O 1 0.9994851350784302
onset O 1 0.9999918937683105
neuromuscular B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999992847442627
( O 0 0.012161276303231716
with O 1 0.5828648209571838
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999338388442993
contractures I-Disease 1 0.9999957084655762
, O 1 0.5753917694091797
respiratory O 1 0.9999996423721313
and O 0 0.0011041483376175165
feeding O 1 0.6347784996032715
difficulties O 1 0.7793522477149963
, O 0 0.000629003974609077
tendency O 0 0.030714815482497215
to O 0 0.0009463652968406677
hyperthermia B-Disease 1 0.9999254941940308
, O 0 0.0003303223929833621
and O 0 0.0002529876946937293
frequent O 0 0.013884459622204304
death O 0 0.005662877112627029
in O 0 0.0004800875613000244
infancy O 0 0.2613517642021179
) O 0 0.00012403122673276812
with O 0 6.286941061262041e-05
a O 0 0.0006452691159211099
distinct O 0 0.0020532463677227497
campomelic B-Disease 1 0.9980436563491821
- I-Disease 1 0.8652288317680359
metaphyseal I-Disease 1 0.9973570704460144
skeletal I-Disease 1 0.999887228012085
dysplasia I-Disease 1 0.9999871253967285
. O 0 0.00405378732830286

The O 0 0.0005340253701433539
similarity O 0 0.0006609458359889686
of O 0 5.275187868392095e-05
the O 0 0.0009556057630106807
clinical O 1 0.9997404217720032
and O 0 0.0010196801740676165
radiographic O 1 0.9997368454933167
findings O 0 0.00810856930911541
is O 0 0.00030403127311728895
so O 0 0.00030197217711247504
extensive O 0 0.0020245835185050964
that O 0 0.0001813636044971645
these O 0 0.0003898509021382779
disorders O 1 0.9999963045120239
appear O 0 0.0013585672713816166
to O 0 7.410068064928055e-05
be O 0 4.449708285392262e-05
a O 0 0.0001957646309165284
single O 0 0.0003456177655607462
entity O 0 0.0043547567911446095
. O 0 0.0008706689113751054

The O 0 0.0011525419540703297
follow O 0 0.0015246388502418995
- O 0 0.002295431448146701
up O 0 0.00017410102009307593
observation O 0 0.0012672225711867213
of O 0 1.6420555766671896e-05
an O 0 0.00017057340301107615
identical O 0 0.00032855733297765255
and O 0 7.724401802988723e-05
unique O 0 0.0004519954090937972
pattern O 0 0.0019085711101070046
of O 0 0.00020569218031596392
progressive O 1 0.9999597072601318
bone B-Disease 1 0.9999996423721313
dysplasia I-Disease 1 0.9999939203262329
in O 0 0.00028853549156337976
the O 0 0.00029612082289531827
two O 0 0.00042623019544407725
patients O 1 0.9999667406082153
( O 0 0.0003670521837193519
one O 0 0.00033148270449601114
with O 0 0.001222400926053524
SJS B-Disease 1 0.9999070167541504
type I-Disease 0 0.005353737622499466
2 I-Disease 0 0.00045508897164836526
, O 0 8.945522858994082e-05
one O 0 0.00014293061394710094
with O 0 0.0007004463695921004
SWS B-Disease 1 0.9990085959434509
) O 0 0.0008353457087650895
surviving O 0 0.005630097351968288
beyond O 0 0.005517902318388224
infancy O 1 0.7576507925987244
adds O 0 0.002523944014683366
to O 0 8.227671060012653e-05
the O 0 0.00010912009020103142
evidence O 0 0.00020947202574461699
in O 0 7.143672701204196e-05
favor O 0 0.00015507490024901927
of O 0 4.151518442085944e-05
identity O 0 0.00201183813624084
. O 0 0.0010192595655098557

The O 0 0.0012513567926362157
hypothesis O 0 0.006950923707336187
that O 0 0.0011628245702013373
SWS B-Disease 1 0.9989746809005737
and O 0 0.002739410614594817
SJS B-Disease 1 0.9997707009315491
type I-Disease 0 0.0049987114034593105
2 I-Disease 0 0.00033328987774439156
are O 0 2.3639793653273955e-05
the O 0 0.00017694798589218408
same O 0 0.0011327163083478808
disorder O 1 0.9999595880508423
should O 0 0.000401088735088706
be O 0 7.318048301385716e-05
testable O 0 0.0014743470819666982
by O 0 6.536676664836705e-05
molecular O 0 0.001140238018706441
methods O 0 0.0007244465523399413
. O 0 0.0003149029507767409
. O 0 0.0006238697096705437

A O 0 0.007960543967783451
mouse O 0 0.009736710228025913
model O 0 0.0011835400946438313
of O 0 0.0003410367644391954
severe O 1 0.9999964237213135
von B-Disease 1 0.9999940395355225
Willebrand I-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
: O 0 0.025164319202303886
defects O 1 0.9998050332069397
in O 0 0.0025207912549376488
hemostasis O 1 0.9999433755874634
and O 0 0.014821089804172516
thrombosis B-Disease 1 0.9999964237213135
. O 0 0.0028570988215506077

von B-Disease 1 0.952498733997345
Willebrand I-Disease 1 0.9989792704582214
factor I-Disease 0 0.012562025338411331
( I-Disease 0 0.003154382575303316
vWf I-Disease 1 0.9981260895729065
) I-Disease 0 0.012841615825891495
deficiency I-Disease 1 0.9999995231628418
causes O 1 0.9999167919158936
severe O 1 0.9999967813491821
von B-Disease 1 0.9999957084655762
Willebrand I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999997615814209
in O 0 0.001370028592646122
humans O 0 0.009011000394821167
. O 0 0.0014578105183318257

We O 0 0.0003488761722110212
generated O 0 0.0002747120161075145
a O 0 0.0009481582674197853
mouse O 0 0.005829455330967903
model O 0 0.0006277780630625784
for O 0 0.0002248743112431839
this O 0 0.0005630357773043215
disease O 1 0.9999194145202637
by O 0 8.813105523586273e-05
using O 0 0.00043470467790029943
gene O 0 0.0023284738417714834
targeting O 0 0.002427751198410988
. O 0 0.000755741901230067

vWf B-Disease 1 0.9879151582717896
- I-Disease 1 0.9452095627784729
deficient I-Disease 1 0.9993743300437927
mice O 0 0.060942474752664566
appeared O 0 0.002372701885178685
normal O 0 0.0019467637175694108
at O 0 0.0007656526286154985
birth O 0 0.0027243748772889376
; O 0 0.00010510312858968973
they O 0 5.305220474838279e-05
were O 0 4.647652167477645e-05
viable O 0 0.003502235282212496
and O 0 0.0002782123629003763
fertile O 0 0.034375641494989395
. O 0 0.0010426054941490293

Neither O 0 0.045889273285865784
vWf O 1 0.9286511540412903
nor O 0 0.03928856551647186
vWf O 1 0.9674326181411743
propolypeptide O 1 0.9251969456672668
( O 0 0.004614699631929398
von B-Disease 1 0.9915884137153625
Willebrand I-Disease 1 0.9999278783798218
antigen O 1 0.9990547299385071
II O 1 0.9913535714149475
) O 0 0.00025615195045247674
were O 0 5.436153514892794e-05
detectable O 0 0.0034950401168316603
in O 0 0.0002453502966091037
plasma O 0 0.01288125105202198
, O 0 0.0007690515485592186
platelets O 1 0.9971463084220886
, O 0 0.00039107914199121296
or O 0 0.0007999223889783025
endothelial O 1 0.7689805626869202
cells O 0 0.0006465059705078602
of O 0 1.8635317246662453e-05
the O 0 0.000505600415635854
homozygous O 0 0.012355438433587551
mutant O 0 0.01682245172560215
mice O 0 0.026905618607997894
. O 0 0.0014240802265703678

The O 0 0.002520472276955843
mutant O 0 0.05351714417338371
mice O 1 0.7794191241264343
exhibited O 1 0.8134642839431763
defects O 1 0.9992281198501587
in O 0 0.0009099970338866115
hemostasis O 1 0.9992722868919373
with O 0 0.00020652030070777982
a O 0 0.001653335988521576
highly O 0 0.32572808861732483
prolonged O 1 0.9998966455459595
bleeding O 1 0.9999780654907227
time O 0 0.0005596530390903354
and O 0 0.0005955171072855592
spontaneous O 0 0.4112602770328522
bleeding O 1 0.9999680519104004
events O 0 0.00048116696416400373
in O 0 0.00020051797037012875
approximately O 0 0.0003282239194959402
10 O 0 0.00018420002015773207
% O 0 5.5557229643454775e-05
of O 0 0.00017488200683146715
neonates O 1 0.9975064396858215
. O 0 0.0019028597744181752

As O 0 0.0006525866338051856
in O 0 0.0002471152984071523
the O 0 0.0006769445608370006
human O 0 0.36959508061408997
disease O 1 0.99998939037323
, O 0 0.00022319788695313036
the O 0 0.00031178686185739934
factor O 0 0.005186828784644604
VIII O 1 0.99674391746521
level O 0 0.0008657771977595985
in O 0 0.00013106678670737892
these O 0 0.00012195134331705049
mice O 0 0.020139429718255997
was O 0 0.000912235991563648
reduced O 0 0.0014126651221886277
strongly O 0 0.0007552040042355657
as O 0 0.0001477222249377519
a O 0 0.00035587174352258444
result O 0 0.00018839590484276414
of O 0 1.7544003640068695e-05
the O 0 0.00016270273772533983
lack O 0 0.0018330625025555491
of O 0 7.630253094248474e-05
protection O 0 0.03575028106570244
provided O 0 0.0009563376079313457
by O 0 0.000526736315805465
vWf O 1 0.9642520546913147
. O 0 0.0013542718952521682

Defective O 1 0.999748170375824
thrombosis B-Disease 1 0.999992847442627
in O 0 0.0017141731223091483
mutant O 0 0.11927688121795654
mice O 0 0.12065711617469788
was O 0 0.001037671696394682
also O 0 0.0002555114042479545
evident O 0 0.001492162817157805
in O 0 7.991208985913545e-05
an O 0 0.0001820485049393028
in O 0 0.00025896288570947945
vivo O 0 0.006391427014023066
model O 0 0.0011500020045787096
of O 0 0.0007440641056746244
vascular B-Disease 1 0.9999996423721313
injury I-Disease 1 0.9999442100524902
. O 0 0.001893762731924653

In O 0 0.00048001567483879626
this O 0 0.00013045284140389413
model O 0 0.0007164347916841507
, O 0 0.0001965552510228008
the O 0 0.0004338464932516217
exteriorized O 1 0.918234646320343
mesentery O 1 0.9609571099281311
was O 0 0.002816528780385852
superfused O 0 0.290637731552124
with O 0 0.0009172085556201637
ferric O 1 0.9997169375419617
chloride O 0 0.07062313705682755
and O 0 0.00012293913459870964
the O 0 0.0002141552686225623
accumulation O 0 0.0054346234537661076
of O 0 0.00018334366905037314
fluorescently O 1 0.9913291931152344
labeled O 1 0.7407615184783936
platelets O 1 0.9859776496887207
was O 0 0.0012190574780106544
observed O 0 0.0008388058631680906
by O 0 0.0003880125004798174
intravital O 0 0.44627460837364197
microscopy O 0 0.03235294297337532
. O 0 0.0017527452437207103

We O 0 0.0010213290806859732
conclude O 0 0.0030795331113040447
that O 0 6.770126492483541e-05
these O 0 7.478116458514705e-05
mice O 0 0.005374696105718613
very O 0 0.000724850979167968
closely O 0 0.0026035418268293142
mimic O 1 0.9964988231658936
severe O 1 0.9999508857727051
human O 1 0.9956039190292358
von B-Disease 1 0.9999946355819702
Willebrand I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999998807907104
and O 0 0.0004171841137576848
will O 0 0.00015958108997438103
be O 0 4.4579097448149696e-05
very O 0 0.0001722399756545201
useful O 0 0.0005063686985522509
for O 0 0.000156235255417414
investigating O 0 0.002409988082945347
the O 0 0.00012962774781044573
role O 0 0.000854831247124821
of O 0 0.00011951306805713102
vWf O 1 0.9326319098472595
in O 0 0.00039769982686266303
normal O 0 0.008864381350576878
physiology O 1 0.9931701421737671
and O 0 0.0005820001242682338
in O 0 0.006293903104960918
disease O 1 0.9999960660934448
models O 0 0.0024101620074361563
. O 0 0.00038309505907818675
. O 0 0.00079112354433164

Oral O 1 0.9649335145950317
contraceptives O 1 0.9040873646736145
and O 0 0.000208216137252748
the O 0 0.0002888800809159875
risk O 1 0.5874254703521729
of O 0 0.0006462937453761697
hereditary B-Disease 1 0.9999948740005493
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0027349020820111036

Hereditary B-Disease 1 0.9999608993530273
Ovarian I-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999998807907104
Clinical O 1 0.9999493360519409
Study O 0 0.009645393118262291
Group O 0 0.0018990410026162863
. O 0 0.0009297348442487419

BACKGROUND O 0 0.015225660987198353
Women O 0 0.0016180843813344836
with O 0 0.00026065693236887455
mutations O 0 0.001698745065368712
in O 0 0.00011455916683189571
either O 0 0.0003692633181344718
the O 0 0.0008676262805238366
BRCA1 O 1 0.9996188879013062
or O 0 0.0006051853415556252
the O 0 0.001180868479423225
BRCA2 O 1 0.9985696077346802
gene O 0 0.0016187801957130432
have O 0 7.692953658988699e-05
a O 0 0.0004034788580611348
high O 0 0.0028767185285687447
lifetime O 1 0.7264242768287659
risk O 1 0.9387404322624207
of O 0 0.00322163593955338
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.0019520983332768083

Oral O 1 0.9606221318244934
contraceptives O 1 0.9942670464515686
protect O 1 0.8316286206245422
against O 1 0.8867101669311523
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.0005825539701618254
general O 0 0.0012825526064261794
, O 0 0.00023459794465452433
but O 0 0.00015535611601080745
it O 0 8.733976574148983e-05
is O 0 0.00016344724281225353
not O 0 0.00010059325722977519
known O 0 0.0002659415767993778
whether O 0 0.0002241334441350773
they O 0 3.29525901179295e-05
also O 0 0.00013821900938637555
protect O 0 0.0019542286172509193
against O 0 0.00042929151095449924
hereditary B-Disease 1 0.9355711936950684
forms I-Disease 0 0.0038589653559029102
of I-Disease 0 0.014987620525062084
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.002521685790270567

METHODS O 0 0.006371779832988977
We O 0 0.0011310934787616134
enrolled O 0 0.009248991496860981
207 O 0 0.009248865768313408
women O 0 0.0015072625828906894
with O 0 0.0029258010908961296
hereditary B-Disease 1 0.9999957084655762
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.0005244993371888995
161 O 0 0.002752444939687848
of O 0 3.0517883715219796e-05
their O 0 0.00014643966278526932
sisters O 0 0.0013472633436322212
as O 0 0.00015136691217776388
controls O 0 0.0007665476878173649
in O 0 0.00016908747784327716
a O 0 0.0008681438630446792
case O 0 0.00400917325168848
- O 0 0.0036353215109556913
control O 0 0.0013037880416959524
study O 0 0.001488950103521347
. O 0 0.0005589589127339423

All O 0 0.000330939277773723
the O 0 0.001094721257686615
patients O 1 0.9980759620666504
carried O 0 0.0004391767142806202
a O 0 0.0009116504224948585
pathogenic O 0 0.016087010502815247
mutation O 0 0.002179029630497098
in O 0 0.00022483420616481453
either O 0 0.0021879111882299185
BRCA1 O 1 0.9989053010940552
( O 0 0.0011388324201107025
179 O 0 0.0155590008944273
women O 0 0.0018443097360432148
) O 0 0.0005795153556391597
or O 0 0.0020643488969653845
BRCA2 O 1 0.9990919828414917
( O 0 0.0014280321775004268
28 O 0 0.002742742421105504
women O 0 0.0013619406381621957
) O 0 0.0006396210519596934
. O 0 0.0007788226939737797

The O 0 0.0013300292193889618
control O 0 0.003935274202376604
women O 0 0.0014857689384371042
were O 0 0.0001772724062902853
enrolled O 0 0.005288759246468544
regardless O 0 0.00031754872179590166
of O 0 2.7656171369017102e-05
whether O 0 0.0006167020765133202
or O 0 0.00021425513841677457
not O 0 8.147789776558056e-05
they O 0 4.995409835828468e-05
had O 0 0.0003220153448637575
either O 0 0.00044293480459600687
mutation O 0 0.003249161643907428
. O 0 0.0006516333087347448

Lifetime O 0 0.047546807676553726
histories O 0 0.0038685195613652468
of O 0 0.0002207639772677794
oral O 1 0.9968198537826538
- O 0 0.18770666420459747
contraceptive O 1 0.941271960735321
use O 0 0.00018384137365501374
were O 0 5.675253487424925e-05
obtained O 0 0.00032259084400720894
by O 0 0.00015295010234694928
interview O 0 0.004672516603022814
or O 0 0.00019110357970930636
by O 0 6.441327423090115e-05
written O 0 0.0001508798450231552
questionnaire O 0 0.002224868396297097
and O 0 9.334741480415687e-05
were O 0 5.657534711644985e-05
compared O 0 0.0007927732076495886
between O 0 0.0010572809260338545
patients O 1 0.9998997449874878
and O 0 0.00021138005831744522
control O 0 0.0024640215560793877
women O 0 0.0008685998036526144
, O 0 0.00027898262487724423
after O 0 0.0008799591450951993
adjustment O 0 0.002016151789575815
for O 0 0.00012008448538836092
year O 0 0.00025378327700309455
of O 0 3.068806108785793e-05
birth O 0 0.0016644478309899569
and O 0 0.00025441896286793053
parity O 0 0.022550806403160095
. O 0 0.0012086337665095925

RESULTS O 0 0.0031198959331959486
The O 0 0.00036133400863036513
adjusted O 0 0.0036881929263472557
odds O 0 0.008491436019539833
ratio O 0 0.004266011994332075
for O 1 0.529837429523468
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 0.0006425828323699534
with O 0 6.657784251729026e-05
any O 0 6.957045115996152e-05
past O 0 0.00010833657870534807
use O 0 6.03149710514117e-05
of O 0 4.964058462064713e-05
oral O 1 0.9942828416824341
contraceptives O 1 0.9963986873626709
was O 0 0.001401604269631207
0 O 0 0.0012305732816457748
. O 0 0.0005524164880625904

5 O 0 0.0024985955096781254
( O 0 0.0006287677679210901
95 O 0 0.001382180373184383
percent O 0 0.0004568224831018597
confidence O 0 0.001453665434382856
interval O 0 0.0009584264480508864
, O 0 0.00017637813289184123
0 O 0 0.0002721164491958916
. O 0 5.2547988161677495e-05
3 O 0 0.00010928847041213885
to O 0 5.87384492973797e-05
0 O 0 0.0003155214071739465
. O 0 8.57789273140952e-05
8 O 0 0.0005125440657138824
) O 0 0.00026819348568096757
. O 0 0.0004446797538548708

The O 0 0.0032855113968253136
risk O 0 0.14859962463378906
decreased O 0 0.005478240549564362
with O 0 0.00011766052921302617
increasing O 0 0.0005714180297218263
duration O 0 0.0015221490757539868
of O 0 3.3947580959647894e-05
use O 0 0.0005555569659918547
( O 0 0.0010202506091445684
P O 0 0.01997028850018978
for O 0 0.00023148326727095991
trend O 0 0.0017353887669742107
, O 0 0.00033043671282939613
< O 0 0.009750191122293472
0 O 0 0.0007972923340275884
. O 0 0.00035507703432813287
001 O 0 0.07373833656311035
) O 0 0.00020353404397610575
; O 0 6.117389420978725e-05
use O 0 6.32509691058658e-05
for O 0 0.00010824281343957409
six O 0 0.0001982159592444077
or O 0 0.0001514119649073109
more O 0 0.0001257279800483957
years O 0 0.0004186422156635672
was O 0 0.00045106737525202334
associated O 0 0.00013822494656778872
with O 0 4.4118998630438e-05
a O 0 0.0003923984768334776
60 O 0 0.00043925252975896
percent O 0 0.0005365522811189294
reduction O 0 0.003334749024361372
in O 0 0.00044742264435626566
risk O 0 0.4258897304534912
. O 0 0.001062558265402913

Oral O 1 0.8838098645210266
- O 0 0.021757816895842552
contraceptive O 1 0.9252094030380249
use O 0 0.0007301257573999465
protected O 0 0.11801505088806152
against O 1 0.5427934527397156
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
both O 0 0.00020688216318376362
for O 0 0.00019973673624917865
carriers O 0 0.001469791168347001
of O 0 2.7936543119722046e-05
the O 0 0.0006560776964761317
BRCA1 O 1 0.9992190599441528
mutation O 0 0.006188369356095791
( O 0 0.000656391610391438
odds O 0 0.007321429904550314
ratio O 0 0.001154388883151114
, O 0 0.00020889760344289243
0 O 0 0.00048300024354830384
. O 0 9.629854321246967e-05
5 O 0 0.0003355472581461072
; O 0 0.00011197551793884486
95 O 0 0.0006957488367334008
percent O 0 0.00031729755573906004
confidence O 0 0.0015543781919404864
interval O 0 0.0011455221101641655
, O 0 0.00017459077935200185
0 O 0 0.00031239952659234405
. O 0 4.6019922592677176e-05
3 O 0 0.00013361888704821467
to O 0 6.731770554324612e-05
0 O 0 0.00029648805502802134
. O 0 0.00010363874753238633
9 O 0 0.00049623689847067
) O 0 7.750010991003364e-05
and O 0 4.740431177197024e-05
for O 0 0.00011508647003211081
carriers O 0 0.001373107312247157
of O 0 3.416938488953747e-05
the O 0 0.0010796315036714077
BRCA2 O 1 0.998485267162323
mutation O 0 0.00622029323130846
( O 0 0.0008320013293996453
odds O 0 0.008143313229084015
ratio O 0 0.0013497922336682677
, O 0 0.000186879638931714
0 O 0 0.0005145010654814541
. O 0 9.534514538245276e-05
4 O 0 0.0003395135572645813
; O 0 7.713897502981126e-05
95 O 0 0.000534672464709729
percent O 0 0.00027164368657395244
confidence O 0 0.0012761305551975965
interval O 0 0.0008939607650972903
, O 0 0.000160404117195867
0 O 0 0.00037011157837696373
. O 0 5.7938683312386274e-05
2 O 0 0.00012114835408283398
to O 0 4.5402328396448866e-05
1 O 0 0.00022002407058607787
. O 0 7.191401527961716e-05
1 O 0 0.0005203260225243866
) O 0 0.00020795661839656532
. O 0 0.0004357410070952028

CONCLUSIONS O 0 0.0363103449344635
Oral O 1 0.9915111660957336
- O 0 0.04439166560769081
contraceptive O 1 0.9785012602806091
use O 0 0.000431755994213745
may O 0 0.0006592130521312356
reduce O 0 0.001693261438049376
the O 0 0.0002310935960849747
risk O 1 0.9358987212181091
of O 0 0.0017904217820614576
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.0003955510910600424
women O 0 0.0007435118313878775
with O 0 0.00030964691541157663
pathogenic O 0 0.16799165308475494
mutations O 0 0.0025083713699132204
in O 0 0.00025208215811289847
the O 0 0.0015631708083674312
BRCA1 O 1 0.9997051358222961
or O 0 0.00689884414896369
BRCA2 O 1 0.9984984397888184
gene O 0 0.024519016966223717

A O 0 0.0050370050594210625
Japanese O 0 0.002586750779300928
family O 0 0.0018309939187020063
with O 0 0.0013519844505935907
adrenoleukodystrophy B-Disease 1 0.9999821186065674
with O 0 0.0003289563173893839
a O 0 0.0021320353262126446
codon O 0 0.010631393641233444
291 O 0 0.02330474928021431
deletion O 0 0.009198376908898354
: O 0 0.0004363743355497718
a O 0 0.0017082032281905413
clinical O 1 0.9987032413482666
, O 0 0.00048824839177541435
biochemical O 0 0.07912794500589371
, O 0 0.0009112221887335181
pathological O 1 0.9987668991088867
, O 0 0.00035431794822216034
and O 0 0.0002912703494075686
genetic O 0 0.003595768241211772
report O 0 0.002020773943513632
. O 0 0.0008126840693876147

We O 0 0.0008248404483310878
report O 0 0.0006409357883967459
a O 0 0.00040542345959693193
Japanese O 0 0.0011878221994265914
family O 0 0.0015656794421374798
with O 0 0.0030967528000473976
adrenoleukodystrophy B-Disease 1 0.9999990463256836
( O 0 0.2621683180332184
ALD B-Disease 1 0.9999977350234985
) O 0 0.00033604170312173665
with O 0 7.252329669427127e-05
a O 0 0.00029125617584213614
three O 0 0.00010527385893510655
base O 0 0.001255567534826696
pair O 0 0.0014866882702335715
deletion O 0 0.010372600518167019
( O 0 0.0015645885141566396
delGAG O 0 0.3560202717781067
291 O 0 0.014609813690185547
) O 0 0.0002628540969453752
in O 0 0.00027450494235381484
the O 0 0.003180128987878561
ALD B-Disease 1 0.9999978542327881
gene O 0 0.01236498448997736
. O 0 0.0012467773631215096

A O 0 0.004369211848825216
variety O 0 0.0008892721962183714
of O 0 0.00015358111704699695
phenotypes O 0 0.020690055564045906
were O 0 8.582508598919958e-05
observed O 0 0.00034271006006747484
within O 0 0.00011352662113495171
this O 0 0.00014538143295794725
family O 0 0.0014118602266535163
. O 0 0.0009263358078896999

While O 0 0.000913340481929481
the O 0 0.0009350387845188379
proband O 1 0.9355455040931702
( O 0 0.0023543848656117916
patient O 1 0.998529314994812
1 O 0 0.0009234567987732589
) O 0 0.00023060652893036604
was O 0 0.0006946198409423232
classified O 0 0.0027536372654139996
as O 0 0.00013704287994187325
having O 0 0.0005421320092864335
a O 0 0.0004791110986843705
rare O 0 0.0065510468557477
intermediate O 0 0.013912717811763287
type O 0 0.0014354520244523883
of O 0 8.812988380668685e-05
adult O 0 0.4093252420425415
cerebral O 1 0.9999781847000122
and O 0 0.0016708606854081154
cerebello O 1 0.9993383288383484
- O 1 0.9831591844558716
brain O 1 0.999157190322876
stem O 0 0.01718747615814209
forms O 0 0.0007969648577272892
, O 0 0.0003064507618546486
his O 0 0.002846138086169958
younger O 0 0.033493638038635254
brother O 0 0.02194012701511383
( O 0 0.0014576910762116313
patient O 1 0.9990274906158447
2 O 0 0.0008087395690381527
) O 0 0.00021533873223233968
and O 0 0.0003822997387032956
nephew O 1 0.6142422556877136
( O 0 0.001733775483444333
patient O 1 0.9990602135658264
3 O 0 0.00047173252096399665
) O 0 0.00012280720693524927
had O 0 0.0004234531952533871
a O 0 0.0045814430341124535
childhood O 1 0.9998961687088013
ALD B-Disease 1 0.9999991655349731
type O 1 0.783061146736145
. O 0 0.001839922391809523

Another O 0 0.009232336655259132
nephew O 1 0.6284537315368652
( O 0 0.002624464686959982
patient O 1 0.998920202255249
4 O 0 0.0006199213094078004
) O 0 0.00010964943066937849
of O 0 7.260203710757196e-05
patient O 1 0.9996538162231445
1 O 0 0.0007983763935044408
was O 0 0.0009195181191898882
classified O 0 0.0035416586324572563
as O 0 0.0002349184505874291
having O 0 0.0009718292858451605
an O 0 0.0009062548051588237
adolescent O 1 0.9951646327972412
form O 0 0.001985727110877633
. O 0 0.0016168947331607342

The O 0 0.0013491868739947677
tau O 0 0.020081311464309692
level O 0 0.0008708580280654132
in O 0 0.00018761576211545616
the O 0 0.0008630055817775428
cerebrospinal O 1 0.9991057515144348
fluid O 1 0.9946882724761963
( O 0 0.004909723065793514
CSF O 1 0.9994248151779175
) O 0 0.0004291513469070196
in O 0 0.0005100208218209445
patient O 1 0.9966862797737122
1 O 0 0.0005157359410077333
was O 0 0.0004054837045259774
as O 0 0.00013869073882233351
high O 0 0.0004288422060199082
as O 0 4.998583972337656e-05
that O 0 2.5534276574035175e-05
of O 0 7.612359331687912e-05
patients O 1 0.9999873638153076
with O 0 0.06699617952108383
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999991655349731
( O 0 0.0029704137705266476
AD B-Disease 0 0.10073801875114441
) O 0 0.0006789903854951262
. O 0 0.0007389533566311002

His O 0 0.006694385316222906
brain O 1 0.9899000525474548
magnetic O 0 0.0023936042562127113
resonance O 0 0.013240410014986992
image O 0 0.11173184961080551
( O 0 0.003715523984283209
MRI O 1 0.9998764991760254
) O 0 0.0006745054270140827
showed O 0 0.005411599762737751
abnormalities B-Disease 1 0.9901250600814819
in I-Disease 0 0.00012600210902746767
the I-Disease 0 0.00029865693068131804
bilateral I-Disease 0 0.18892715871334076
cerebellar I-Disease 1 0.9999171495437622
hemispheres I-Disease 1 0.9915974736213684
and O 0 0.0021165329962968826
brain O 1 0.999963641166687
stem O 1 0.5215698480606079
, O 0 0.000200407492229715
but O 0 0.00012289364531170577
not O 0 7.707683107582852e-05
in O 0 0.00013443027273751795
the O 0 0.0013749431818723679
cerebral O 1 0.9999850988388062
white O 0 0.332680881023407
matter O 0 0.0012463785242289305
, O 0 0.0001211204071296379
where O 0 0.00010637722152750939
marked O 0 0.00043299057870171964
reductions O 0 0.0013024774380028248
of O 0 2.3035292542772368e-05
the O 0 0.0013745295582339168
cerebral O 1 0.9999960660934448
blood O 1 0.9459033012390137
flow O 0 0.002372437622398138
and O 0 0.0003821066056843847
oxygen O 0 0.3671071529388428
metabolism O 0 0.06963368505239487
were O 0 7.86462624091655e-05
clearly O 0 0.0008945133304223418
demonstrated O 0 0.0014302602503448725
by O 0 0.0001992551115108654
positron O 0 0.35569778084754944
emission O 0 0.01759560965001583
tomography O 1 0.6554281115531921
( O 0 0.0027316564228385687
PET O 1 0.9956884980201721
) O 0 0.0007394055719487369
. O 0 0.0008311598212458193

In O 0 0.0032001202926039696
patients O 1 0.9994199275970459
2 O 0 0.0004615049110725522
and O 0 9.56903604674153e-05
3 O 0 0.0003039220464415848
, O 0 8.585275645600632e-05
the O 0 0.0002518112014513463
autopsy O 1 0.9609742760658264
findings O 0 0.002369539113715291
showed O 0 0.0018017078982666135
massive O 0 0.32060346007347107
demyelination B-Disease 1 0.9999285936355591
of I-Disease 0 0.00015681642980780452
the I-Disease 0 0.0064506628550589085
cerebral I-Disease 1 0.9999979734420776
white I-Disease 0 0.1116267591714859
matter I-Disease 0 0.0007676873356103897
with O 0 0.00010652237688191235
sparing O 0 0.01042084489017725
of O 0 3.92384608858265e-05
the O 0 0.0007654717192053795
U O 1 0.9944985508918762
- O 0 0.027014413848519325
fibers O 0 0.37844470143318176
, O 0 0.00018017171532846987
compatible O 0 0.000544766488019377
with O 0 4.072959927725606e-05
the O 0 0.00017212390957865864
findings O 0 0.0013638174859806895
of O 0 0.00021593994460999966
childhood O 1 0.9999538660049438
ALD B-Disease 1 0.9999992847442627
. O 0 0.003756569931283593

Oleic O 0 0.32037413120269775
and O 0 0.0018381401896476746
erucic O 1 0.9588732719421387
acids O 0 0.003859777469187975
( O 0 0.0015920716105028987
Lorenzos O 0 0.10082186758518219
Oil O 0 0.0033586970530450344
) O 0 0.000200831942493096
were O 0 6.942730396986008e-05
administered O 0 0.005326093174517155
to O 0 0.00047181840636767447
patients O 1 0.9995552897453308
1 O 0 0.00042192000546492636
and O 0 0.00014107236347626895
4 O 0 0.0004849669348914176
, O 0 0.000120440439786762
but O 0 0.00013576835044659674
sufficient O 0 0.0011762819485738873
effectiveness O 0 0.03511872515082359
was O 0 0.0007010555127635598
not O 0 0.000148961873492226
obtained O 0 0.0004582504043355584
. O 0 0.0004903738154098392

The O 0 0.001132727018557489
findings O 0 0.002981920028105378
in O 0 0.00017023837426677346
this O 0 0.00013409790699370205
family O 0 0.0007806795183569193
suggest O 0 0.0011175728868693113
that O 0 0.00021625272347591817
delGAG291 O 0 0.02837718091905117
is O 0 0.00011577882105484605
part O 0 0.00014222583558876067
of O 0 1.5690236978116445e-05
the O 0 0.000247361371293664
cause O 0 0.010077186860144138
of O 0 0.00011013167386408895
Japanese O 0 0.0937635749578476
ALD B-Disease 1 0.9999933242797852
with O 0 0.0006575874867849052
phenotypic O 0 0.016057707369327545
variations O 0 0.001918381080031395
. O 0 0.0010717930272221565

Moreover O 0 0.010924262925982475
, O 0 0.00041437678737565875
although O 0 0.00021464424207806587
the O 0 7.96885069576092e-05
scale O 0 0.00044669947237707675
of O 0 2.2554046154255047e-05
the O 0 0.0002159510477213189
study O 0 0.0009896239498630166
is O 0 0.0002946743625216186
limited O 0 0.0005989553174003959
, O 0 0.00012133725977037102
there O 0 6.298373045865446e-05
is O 0 0.00012901905574835837
a O 0 0.00028166972333565354
possibility O 0 0.0018364769639447331
that O 0 0.00027528119971975684
PET O 1 0.902118444442749
can O 0 0.00032505628769285977
detect O 0 0.009010029956698418
an O 0 0.001002612174488604
insidious B-Disease 1 0.9980833530426025
lesion I-Disease 1 0.9998959302902222
which O 0 0.00022209361486602575
is O 0 0.0006528815720230341
undetectable O 1 0.5959523916244507
by O 0 0.00021031858341302723
computed O 0 0.00794899370521307
tomogram O 1 0.9446721076965332
( O 0 0.0039743962697684765
CT O 1 0.9999209642410278
) O 0 0.0007166932919062674
or O 0 0.001406766241416335
MRI O 1 0.9994487166404724
analysis O 0 0.00039514401578344405
, O 0 0.00013116806803736836
and O 0 5.949374462943524e-05
that O 0 3.882040618918836e-05
the O 0 7.17748625902459e-05
higher O 0 0.0003584082587622106
level O 0 0.00037824505125172436
of O 0 5.963847434031777e-05
tau O 0 0.02649802528321743
reflects O 0 0.0007190843462012708
the O 0 6.413396477000788e-05
process O 0 0.00015025689208414406
of O 0 0.00013671435590367764
neuronal B-Disease 1 0.9903761744499207
degeneration I-Disease 1 0.9999927282333374
in O 0 0.015910297632217407
ALD B-Disease 1 0.9999924898147583
. O 0 0.004633036907762289

Lorenzos O 1 0.5463934540748596
Oil O 0 0.004485155921429396
should O 0 0.00032817068859003484
be O 0 6.0964888689341024e-05
given O 0 7.901655772002414e-05
in O 0 4.7542933316435665e-05
the O 0 0.00012191506539238617
early O 0 0.0007814178825356066
stage O 0 0.0023888726718723774
. O 0 0.0003141988127026707
. O 0 0.0007275631069205701

Nonsense O 0 0.03145579993724823
mutation O 0 0.003796803532168269
in O 0 0.0003539192257449031
exon O 0 0.008018647320568562
4 O 0 0.00021993198606651276
of O 0 3.554184513632208e-05
human O 0 0.0018372411141172051
complement O 0 0.012848897837102413
C9 O 1 0.9995949864387512
gene O 0 0.002330664312466979
is O 0 0.00017487550212536007
the O 0 0.0001305090554524213
major O 0 0.0013996183406561613
cause O 0 0.002270736265927553
of O 0 4.347584763308987e-05
Japanese O 0 0.003494169795885682
complement B-Disease 1 0.6155803203582764
C9 I-Disease 1 0.9999614953994751
deficiency I-Disease 1 0.9999872446060181
. O 0 0.0025672290939837694

Deficiency B-Disease 1 0.9998860359191895
of I-Disease 0 7.024174556136131e-05
the I-Disease 0 0.00031971948919817805
ninth I-Disease 0 0.004521320108324289
component I-Disease 0 0.0010480573400855064
of I-Disease 0 4.117504431633279e-05
human I-Disease 0 0.0014754681615158916
complement I-Disease 0 0.005510716233402491
( O 0 0.002450354862958193
C9 O 1 0.9993127584457397
) O 0 0.0002336013421881944
is O 0 9.86088634817861e-05
the O 0 8.338392217410728e-05
most O 0 0.00027923169545829296
common O 0 0.0073379031382501125
complement B-Disease 1 0.9986879229545593
deficiency I-Disease 1 0.9999995231628418
in O 0 0.00041820979095064104
Japan O 0 0.0014399071224033833
but O 0 0.000299795443424955
is O 0 0.0003629130660556257
rare O 0 0.0023063283879309893
in O 0 9.521468746243045e-05
other O 0 6.116456643212587e-05
countries O 0 0.00019124829850625247
. O 0 0.0009830329800024629

We O 0 0.0008316335151903331
studied O 0 0.00043037690920755267
the O 0 8.852026076056063e-05
molecular O 0 0.0006338574457913637
basis O 0 0.00013813732948619872
of O 0 0.0003890054358635098
C9 B-Disease 1 0.99997878074646
deficiency I-Disease 1 0.9999796152114868
in O 0 0.00027509991195984185
four O 0 0.00029356253799051046
Japanese O 0 0.015307202935218811
C9 B-Disease 1 0.9999319314956665
- I-Disease 1 0.997868537902832
deficient I-Disease 1 0.999943733215332
patients O 1 0.9999151229858398
who O 0 0.0016895205480977893
had O 0 0.0058154696598649025
suffered O 1 0.9999290704727173
from O 0 0.01223049871623516
meningococcal B-Disease 1 0.9999985694885254
meningitis I-Disease 1 0.9999978542327881
. O 0 0.0026717709843069315

Direct O 0 0.0005632180836983025
sequencing O 0 0.0006139070028439164
of O 0 9.398694965057075e-05
amplified O 0 0.01767774671316147
C9 O 1 0.9898809790611267
cDNA O 0 0.004521616734564304
and O 0 0.0002049930189969018
DNA O 0 0.001604376477189362
revealed O 0 0.0020986602175980806
a O 0 0.0005307793617248535
nonsense O 0 0.005305527709424496
substitution O 0 0.0018258386990055442
( O 0 0.0014205512125045061
CGA O 1 0.8626538515090942
- O 0 0.011903484351933002
- O 0 0.009036567993462086
> O 0 0.0164287481456995
TGA O 1 0.9634560942649841
) O 0 0.00027312053134664893
at O 0 0.0003153581346850842
codon O 0 0.0020347125828266144
95 O 0 0.0008905974100343883
in O 0 0.00020355230662971735
exon O 0 0.00552277872338891
4 O 0 0.00019157794304192066
in O 0 6.18881022091955e-05
the O 0 0.000187779325642623
four O 0 0.0011072325287386775
C9 B-Disease 1 0.9997699856758118
- I-Disease 1 0.7264614105224609
deficient I-Disease 1 0.9969539642333984
individuals O 0 0.000860472209751606
. O 0 0.0013121113879606128

An O 0 0.0020119890104979277
allele O 0 0.009943739511072636
- O 0 0.0023805322125554085
specific O 0 0.00031752331415191293
polymerase O 0 0.0056532141752541065
chain O 0 0.003956384025514126
reaction O 0 0.002250568475574255
system O 0 0.0023958280216902494
designed O 0 0.0011698222951963544
to O 0 0.00017262223991565406
detect O 0 0.0034614522010087967
exclusively O 0 0.00017543649300932884
only O 0 2.3904669433250092e-05
one O 0 1.9777233319473453e-05
of O 0 9.65281742537627e-06
the O 0 0.00019597887876443565
normal O 0 0.0018876242684200406
and O 0 0.00024210214905906469
mutant O 0 0.008857405744493008
alleles O 0 0.004225074779242277
indicated O 0 0.001321056974120438
that O 0 3.238577119191177e-05
all O 0 1.495532978879055e-05
the O 0 0.00016158507787622511
four O 0 0.0005440926761366427
patients O 1 0.9995414018630981
were O 0 5.3019026381662115e-05
homozygous O 0 0.0011592683149501681
for O 0 6.517728616017848e-05
the O 0 0.00021024882153142244
mutation O 0 0.0016502966172993183
in O 0 0.0002470587205607444
exon O 0 0.013703474774956703
4 O 0 0.0003507514775265008
and O 0 5.501293344423175e-05
that O 0 5.4138559789862484e-05
the O 0 0.0001269159110961482
parents O 0 0.0004155444912612438
of O 0 0.00011658346193144098
patient O 1 0.999521017074585
2 O 0 0.0005355384782887995
were O 0 0.00012970008538104594
heterozygous O 0 0.004213985055685043
. O 0 0.0007001757039688528

The O 0 0.0008711153641343117
common O 0 0.0022318933624774218
mutation O 0 0.0031717342790216208
at O 0 0.0005336126778274775
codon O 0 0.002948692999780178
95 O 0 0.0012563415803015232
in O 0 0.00028130339342169464
exon O 0 0.016772478818893433
4 O 0 0.0009651916334405541
might O 0 0.0004696215910371393
be O 0 6.63792307022959e-05
responsible O 0 0.0005398039356805384
for O 0 0.00010121319792233407
most O 0 0.0005183889879845083
Japanese O 0 0.07015813142061234
C9 B-Disease 1 0.9999810457229614
deficiency I-Disease 1 0.9999915361404419
. O 0 0.001036613481119275
. O 0 0.001109833363443613

BRCA1 O 1 0.968518853187561
required O 0 0.0009129559039138258
for O 0 0.00025218335213139653
transcription O 0 0.0030260777566581964
- O 0 0.006597305182367563
coupled O 0 0.006543832831084728
repair O 1 0.9896230697631836
of O 0 0.0001357120490865782
oxidative O 1 0.599489152431488
DNA O 0 0.011235339567065239
damage O 1 0.9451431632041931
. O 0 0.0014631523517891765

The O 0 0.006991294212639332
breast B-Disease 1 0.9999905824661255
and I-Disease 1 0.7978329062461853
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
susceptibility O 1 0.9975057244300842
gene O 0 0.016026215627789497
BRCA1 O 1 0.9798689484596252
encodes O 0 0.002595070982351899
a O 0 0.0014935751678422093
zinc O 0 0.1441756635904312
finger O 0 0.02025873027741909
protein O 0 0.0004227629106026143
of O 0 5.1716036978177726e-05
unknown O 0 0.0011984365992248058
function O 0 0.002106619067490101
. O 0 0.0010751605732366443

Association O 0 0.005319844465702772
of O 0 6.942134496057406e-05
the O 0 0.0005891624605283141
BRCA1 O 1 0.9818011522293091
protein O 0 0.00029680621810257435
with O 0 5.410784433479421e-05
the O 0 0.00029854621971026063
DNA O 0 0.0043761455453932285
repair O 1 0.9980271458625793
protein O 0 0.005665425676852465
Rad51 O 1 0.9962913990020752
and O 0 0.000226604359340854
changes O 0 0.0002714109723456204
in O 0 6.847619806649163e-05
the O 0 8.44598762341775e-05
phosphorylation O 0 0.00022565310064237565
and O 0 7.34882487449795e-05
cellular O 0 0.0011032078182324767
localization O 0 0.0007706565666012466
of O 0 1.2132708434364758e-05
the O 0 0.00011897603690158576
protein O 0 0.0006216436740942299
after O 0 0.0013072191504761577
exposure O 0 0.11251097917556763
to O 0 0.00021702729281969368
DNA O 0 0.002973163267597556
- O 0 0.008629240095615387
damaging O 0 0.08798078447580338
agents O 0 0.0012809266336262226
are O 0 3.0149753001751378e-05
consistent O 0 0.000722779834177345
with O 0 5.7440211094217375e-05
a O 0 0.0003780298284254968
role O 0 0.0013122214004397392
for O 0 0.0007636079681105912
BRCA1 O 1 0.998714804649353
in O 0 0.0006532201077789068
DNA O 0 0.010520347394049168
repair O 1 0.99836665391922
. O 0 0.0017323177307844162

Here O 0 0.0010627845767885447
, O 0 0.00016733762458898127
it O 0 0.0001121000896091573
is O 0 0.0001679376873653382
shown O 0 0.0004152674227952957
that O 0 0.00016193874762393534
mouse O 0 0.01128216739743948
embryonic O 0 0.03869489207863808
stem O 1 0.6474035978317261
cells O 0 0.10872972756624222
deficient B-Disease 1 0.9998769760131836
in I-Disease 0 0.0018102506874129176
BRCA1 I-Disease 1 0.9995833039283752
are O 0 0.0003191098803654313
defective O 1 0.9963680505752563
in O 0 0.0001643928699195385
the O 0 0.00016876084555406123
ability O 0 0.0011040453100576997
to O 0 5.8489880757406354e-05
carry O 0 0.00014878541696816683
out O 0 8.562790753785521e-05
transcription O 0 0.0016822057077661157
- O 0 0.003185608657076955
coupled O 0 0.004296045750379562
repair O 1 0.9685206413269043
of O 0 0.000154611436300911
oxidative O 1 0.6837577223777771
DNA O 0 0.010666914284229279
damage O 1 0.8835770487785339
, O 0 0.0002105918974848464
and O 0 0.00011018430086551234
are O 0 0.00010297065455233678
hypersensitive O 1 0.9896610975265503
to O 0 0.00039961590664461255
ionizing O 1 0.9690133333206177
radiation O 1 0.8389320373535156
and O 0 0.00017972837667912245
hydrogen O 0 0.003556701121851802
peroxide O 1 0.6043570637702942
. O 0 0.0012145319487899542

These O 0 0.0002287445095134899
results O 0 0.0008198586292564869
suggest O 0 0.001432848977856338
that O 0 0.0005717988824471831
BRCA1 O 1 0.9991325736045837
participates O 0 0.010881065391004086
, O 0 0.00022865812934469432
directly O 0 0.0005637389840558171
or O 0 0.0003244244144298136
indirectly O 0 0.0029422040097415447
, O 0 0.0001243145961780101
in O 0 0.00012669873831328005
transcription O 0 0.0020859900396317244
- O 0 0.00483317393809557
coupled O 0 0.004749462008476257
repair O 1 0.9743524193763733
of O 0 0.00011711238039424643
oxidative O 1 0.8781719207763672
DNA O 0 0.009393224492669106
damage O 1 0.911375105381012
. O 0 0.0004858523025177419
. O 0 0.0008608317584730685

Truncation O 0 0.10923387855291367
mutations O 0 0.0058611189015209675
in O 0 0.00023643589520361274
the O 0 0.0005255520227365196
transactivation O 0 0.20961380004882812
region O 0 0.0021240089554339647
of O 0 0.00023822464572731405
PAX6 O 1 0.9991371035575867
result O 0 0.0010569349396973848
in O 0 0.00037309995968826115
dominant O 0 0.008421116508543491
- O 0 0.007659521419554949
negative O 0 0.0026771225966513157
mutants O 0 0.015428543090820312
. O 0 0.0012239959323778749

PAX6 O 1 0.9874141812324524
is O 0 0.0005681990878656507
a O 0 0.0003839581331703812
transcription O 0 0.0008204029290936887
factor O 0 0.0004383043269626796
with O 0 5.3568721341434866e-05
two O 0 9.818455873755738e-05
DNA O 0 0.0015295504126697779
- O 0 0.0020127822645008564
binding O 0 0.0007411734550260007
domains O 0 0.001610449398867786
( O 0 0.0007880875491537154
paired O 0 0.004945696797221899
box O 0 0.003270418383181095
and O 0 0.0005260193720459938
homeobox O 1 0.9816920757293701
) O 0 0.00015683496894780546
and O 0 7.434657163685188e-05
a O 0 0.0007778138970024884
proline O 0 0.03836841136217117
- O 0 0.005131971091032028
serine O 0 0.008124086074531078
- O 0 0.0051445020362734795
threonine O 0 0.025790169835090637
( O 0 0.002563700545579195
PST O 1 0.987906813621521
) O 0 0.0008662872132845223
- O 0 0.0044769705273211
rich O 0 0.0034059854224324226
transactivation O 0 0.06043989211320877
domain O 0 0.0026751498226076365
. O 0 0.0012534598354250193

PAX6 O 1 0.998672604560852
regulates O 1 0.9764156937599182
eye O 1 0.9985924363136292
development O 0 0.0028486454393714666
in O 0 0.00042068466427735984
animals O 0 0.0010617321822792292
ranging O 0 0.0013538399944081903
from O 0 0.00028877294971607625
jellyfish O 0 0.0051428452134132385
to O 0 0.0001245571329491213
Drosophila O 0 0.00211751414462924
to O 0 0.00015148647071328014
humans O 0 0.0024103194009512663
. O 0 0.0007203628192655742

Heterozygous O 0 0.023141561076045036
mutations O 0 0.002718711504712701
in O 0 0.00022971098951529711
the O 0 0.0006315918872132897
human O 0 0.014899643138051033
PAX6 O 1 0.999448835849762
gene O 0 0.003773670643568039
result O 0 0.00044407183304429054
in O 0 0.00012062479800079018
various O 0 0.000173779611941427
phenotypes O 0 0.04723670706152916
, O 0 0.00031428333022631705
including O 0 0.0005934388609603047
aniridia B-Disease 1 0.9995241165161133
, O 0 0.002762862015515566
Peters B-Disease 1 0.9995611310005188
anomaly I-Disease 1 0.9984908103942871
, O 0 0.0019505936652421951
autosomal B-Disease 1 0.9973695278167725
dominant I-Disease 1 0.9835330247879028
keratitis I-Disease 1 0.9999531507492065
, O 0 0.0010680858977138996
and O 0 0.0016367261996492743
familial B-Disease 1 0.9999287128448486
foveal I-Disease 1 0.9998441934585571
dysplasia I-Disease 1 0.9999933242797852
. O 0 0.004487477708607912

It O 0 0.0008921886328607798
is O 0 0.0005493524367921054
believed O 0 0.0007462145294994116
that O 0 4.9951431719819084e-05
the O 0 0.0002031528711086139
mutated O 0 0.007822724990546703
allele O 0 0.003243008628487587
of O 0 0.00018088849901687354
PAX6 O 1 0.9952274560928345
produces O 0 0.001644543488509953
an O 0 0.00034387368941679597
inactive O 0 0.013068693690001965
protein O 0 0.0006225623656064272
and O 0 0.00045813099131919444
aniridia B-Disease 1 0.9993784427642822
is O 0 0.0007104658288881183
caused O 0 0.013443158939480782
due O 0 0.0012088018702343106
to O 0 0.0003210371360182762
genetic O 0 0.0056882742792367935
haploinsufficiency O 1 0.9592419266700745
. O 0 0.001148680574260652

However O 0 0.00158215151168406
, O 0 0.00026614146190695465
several O 0 0.00042950030183419585
truncation O 0 0.039212796837091446
mutations O 0 0.0043520573526620865
have O 0 0.00015150598483160138
been O 0 0.00021210242994129658
found O 0 0.00014287774683907628
to O 0 7.238509715534747e-05
occur O 0 0.00028221565298736095
in O 0 0.00010548768477747217
the O 0 0.0005718882894143462
C O 0 0.12701398134231567
- O 0 0.0043614525347948074
terminal O 0 0.008243057876825333
half O 0 0.00011714162974385545
of O 0 0.00013320734433364123
PAX6 O 1 0.9998358488082886
in O 0 0.002455148845911026
patients O 1 0.9998319149017334
with O 0 0.0007965177646838129
Aniridia B-Disease 1 0.9991462230682373
resulting O 0 0.0015947294887155294
in O 0 0.0001901105570141226
mutant O 0 0.0024111184757202864
proteins O 0 0.00010563284740783274
that O 0 6.869314529467374e-05
retain O 0 0.001320040668360889
the O 0 0.00022175820777192712
DNA O 0 0.0020692399702966213
- O 0 0.002474155044183135
binding O 0 0.0006338381208479404
domains O 0 0.0014243039768189192
but O 0 0.00024522541207261384
have O 0 8.976772369351238e-05
lost O 0 0.0005436190986074507
most O 0 4.2986452172044665e-05
of O 0 1.8647158867679536e-05
the O 0 0.0004190083418507129
transactivation O 0 0.4603950083255768
domain O 0 0.002375064417719841
. O 0 0.0011732850689440966

It O 0 0.0008053166093304753
is O 0 0.0003602890355978161
not O 0 0.0001260783028556034
clear O 0 0.0005256539443507791
whether O 0 0.0003457261773291975
such O 0 0.00013087021943647414
mutants O 0 0.015339995734393597
really O 0 0.0032747986260801554
behave O 0 0.005276160780340433
as O 0 0.00030099833384156227
loss O 0 0.00326431542634964
- O 0 0.0011195355327799916
of O 0 3.7777837860630825e-05
- O 0 0.002707338659092784
function O 0 0.0008025159477256238
mutants O 0 0.0045707630924880505
as O 0 0.0003055673441849649
predicted O 0 0.001979278866201639
by O 0 0.0003034989640582353
haploinsufficiency O 1 0.5953724384307861
. O 0 0.0013380373129621148

Contrary O 0 0.0030958433635532856
to O 0 0.00011442651157267392
this O 0 6.5792009991128e-05
theory O 0 0.00031465597567148507
, O 0 0.00011078344687120989
our O 0 0.00017673570255283266
data O 0 0.00015527376672253013
showed O 0 0.0007075263420119882
that O 0 6.917947030160576e-05
these O 0 5.490837793331593e-05
mutants O 0 0.004484162200242281
are O 0 5.976994361844845e-05
dominant O 0 0.0034829475916922092
- O 0 0.003079129382967949
negative O 0 0.0007911854772828519
in O 0 0.0004077948397025466
transient O 1 0.8278430104255676
transfection O 1 0.9647502899169922
assays O 0 0.0029353115241974592
when O 0 0.0004042621294502169
they O 0 6.0065627621952444e-05
are O 0 4.544703188003041e-05
coexpressed O 0 0.01206237357109785
with O 0 0.00020309866522438824
wild O 0 0.0019278546096757054
- O 0 0.027197908610105515
type O 0 0.026443490758538246
PAX6 O 1 0.9981118440628052
. O 0 0.0019627269357442856

We O 0 0.000846819719299674
found O 0 0.00023846689146012068
that O 0 5.330414205673151e-05
the O 0 0.00014939415268599987
dominant O 0 0.006205081008374691
- O 0 0.00427132798358798
negative O 0 0.0010433208663016558
effects O 0 0.0032033449970185757
result O 0 0.0004080367216374725
from O 0 8.296008309116587e-05
the O 0 0.0002931835479103029
enhanced O 0 0.011464603245258331
DNA O 0 0.0010423214407637715
binding O 0 0.000424884376116097
ability O 0 0.0006723819533362985
of O 0 3.341861520311795e-05
these O 0 0.00022704899311065674
mutants O 0 0.017227012664079666
. O 0 0.0010768421925604343

Kinetic O 0 0.0033459807746112347
studies O 0 0.00037538527976721525
of O 0 3.7735706428065896e-05
binding O 0 0.0011180232977494597
and O 0 0.00038703091559000313
dissociation O 1 0.7181572318077087
revealed O 0 0.003256868803873658
that O 0 6.669857975794002e-05
various O 0 0.00012224720558151603
truncation O 0 0.031861163675785065
mutants O 0 0.007394231855869293
have O 0 0.00021479083807207644
3 O 0 0.0005870219320058823
- O 0 0.0017441954696550965
5 O 0 0.0005025479476898909
- O 0 0.0015088091604411602
fold O 0 0.0011561024002730846
higher O 0 0.00030647817766293883
affinity O 0 0.0007557915523648262
to O 0 5.094280277262442e-05
various O 0 8.349929703399539e-05
DNA O 0 0.0019900542683899403
- O 0 0.0017215890111401677
binding O 0 0.0003707734285853803
sites O 0 0.00018571880355011672
when O 0 0.00015191403508652002
compared O 0 0.0001714121171971783
with O 0 4.368947702459991e-05
the O 0 0.0002682198246475309
wild O 0 0.002134297974407673
- O 0 0.013532059267163277
type O 0 0.020292291417717934
PAX6 O 1 0.9976301193237305
. O 0 0.002172929234802723

These O 0 0.0002686392981559038
results O 0 0.0005847184802405536
provide O 0 0.0005862279213033617
a O 0 0.0006327058072201908
new O 0 0.00041294138645753264
insight O 0 0.0043870313093066216
into O 0 8.52956363814883e-05
the O 0 7.665346493013203e-05
role O 0 0.0007282613078132272
of O 0 0.00013754706014879048
mutant O 0 0.2809659242630005
PAX6 O 1 0.9988763928413391
in O 0 0.0016796488780528307
causing O 1 0.9879050254821777
aniridia B-Disease 1 0.9981539845466614
. O 0 0.0006669069407507777
. O 0 0.000953755690716207

Reversal O 0 0.09158161282539368
of O 0 0.0017483298433944583
severe O 1 0.999997615814209
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 0.9999998807907104
and O 0 0.0027156025171279907
excellent O 1 0.8448606729507446
neuropsychologic O 1 0.744940996170044
outcome O 0 0.0011616694973781705
in O 0 0.00016975647304207087
very B-Disease 0 0.0009309882298111916
- I-Disease 0 0.003246784210205078
long I-Disease 0 0.0016188749577850103
- I-Disease 0 0.002237756038084626
chain I-Disease 0 0.0030112380627542734
acyl I-Disease 0 0.017278052866458893
- I-Disease 0 0.006700593512505293
coenzyme I-Disease 0 0.03838818892836571
A I-Disease 0 0.3126465380191803
dehydrogenase I-Disease 1 0.9991957545280457
deficiency I-Disease 1 0.9999791383743286
. O 0 0.0025097818579524755

Very B-Disease 0 0.0063936770893633366
- I-Disease 0 0.006614095531404018
long I-Disease 0 0.0029098724480718374
- I-Disease 0 0.003275710390880704
chain I-Disease 0 0.0026537813246250153
acyl I-Disease 0 0.015245972201228142
- I-Disease 0 0.005041769705712795
coenzyme I-Disease 0 0.013990766368806362
A I-Disease 0 0.010026322677731514
dehydrogenase I-Disease 1 0.9696577191352844
( I-Disease 0 0.0034905157517641783
VLCAD I-Disease 1 0.9991067051887512
) I-Disease 0 0.0038546035066246986
deficiency I-Disease 1 0.9999908208847046
is O 0 0.0005677081062458456
a O 0 0.00241669244132936
disorder O 1 0.9999023675918579
of O 0 0.00012984128261450678
fatty O 1 0.8412092924118042
acid O 0 0.022360220551490784
beta O 0 0.0067618838511407375
oxidation O 0 0.0018398261163383722
that O 0 0.0002713054127525538
reportedly O 0 0.007197029888629913
has O 0 0.0003330332401674241
high O 0 0.0008442685939371586
rates O 0 0.0003422852896619588
of O 0 7.819770689820871e-05
morbidity O 1 0.998491644859314
and O 0 0.0005140143330208957
mortality O 1 0.9801722168922424
. O 0 0.001089843106456101

We O 0 0.0007254943484440446
describe O 0 0.0008073181379586458
the O 0 8.27341282274574e-05
outcome O 0 0.00024045593454502523
of O 0 1.4640596418757923e-05
a O 0 0.0005724041839130223
5 O 0 0.0006119757308624685
- O 0 0.0018297518836334348
year O 0 0.0005348554695956409
- O 0 0.0028192554600536823
old O 0 0.0026365157682448626
girl O 0 0.03760892152786255
with O 0 0.001591782085597515
VLCAD B-Disease 1 0.9999949932098389
deficiency I-Disease 1 0.9999997615814209
who O 0 0.001339578884653747
was O 0 0.000593127275351435
first O 0 0.00021881982684135437
seen O 0 0.0008776462636888027
at O 0 0.00027678784681484103
5 O 0 0.0002302058128407225
months O 0 0.00026896604686044157
of O 0 1.9745044482988305e-05
age O 0 0.0009138340246863663
with O 0 0.002300215419381857
severe O 1 0.9999990463256836
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.8330889940261841
hepatomegaly B-Disease 1 0.9999980926513672
, O 1 0.5843101739883423
encephalopathy B-Disease 1 0.9999995231628418
, O 0 0.0014774546725675464
and O 0 0.0018878935370594263
hypotonia B-Disease 1 0.9994834661483765
. O 0 0.002410923596471548

Biochemical O 0 0.03551410138607025
studies O 0 0.007246692199259996
indicated O 1 0.9930241107940674
VLCAD B-Disease 1 0.9999942779541016
deficiency I-Disease 1 0.9999996423721313
caused O 0 0.06489454209804535
by O 0 0.00014035479398444295
a O 0 0.001103865564800799
stable O 0 0.052037402987480164
yet O 0 0.0021872795186936855
inactive O 0 0.035600997507572174
enzyme O 0 0.0056528388522565365
. O 0 0.0008315016166307032

Molecular O 0 0.006449501495808363
genetic O 0 0.0011743938084691763
analysis O 0 0.0002505978336557746
of O 0 8.326258830493316e-05
her O 0 0.036590900272130966
VLCAD O 1 0.9987285733222961
gene O 0 0.004125163424760103
revealed O 0 0.004477782174944878
a O 0 0.0017926013097167015
T1372C O 0 0.13138791918754578
( O 0 0.0015817155363038182
F458L O 0 0.0532991997897625
) O 0 0.0006486090132966638
missense O 0 0.012571174651384354
mutation O 0 0.0023146416060626507
and O 0 0.0002630421076901257
a O 0 0.004607312381267548
1668 O 1 0.9928719401359558
ACAG O 1 0.9910014271736145
1669 O 1 0.8482643365859985
splice O 0 0.038030583411455154
site O 0 0.005316432565450668
mutation O 0 0.006191200111061335
. O 0 0.0010591784957796335

After O 0 0.006852964870631695
initial O 0 0.006333565339446068
treatment O 1 0.9833195805549622
with O 0 0.0004652057250496
intravenous O 1 0.9965519905090332
glucose O 0 0.033420346677303314
and O 0 0.0009245775290764868
carnitine O 1 0.9991024732589722
, O 0 0.0003777891688514501
the O 0 0.0004951506271027029
patient O 1 0.999049961566925
has O 0 0.0005967780016362667
thrived O 0 0.004651585128158331
on O 0 9.691836021374911e-05
a O 0 0.0004764799668919295
low O 0 0.0023842742666602135
- O 0 0.003844683524221182
fat O 0 0.0041593946516513824
diet O 0 0.003832639893516898
supplemented O 0 0.0012802848359569907
with O 0 0.00012502573372330517
medium O 0 0.0026977702509611845
- O 0 0.005324868485331535
chain O 0 0.005281273275613785
triglyceride O 0 0.034192219376564026
oil O 0 0.0028253868222236633
and O 0 0.0005989207420498133
carnitine O 1 0.9916203022003174
and O 0 0.00037363122100941837
avoidance O 0 0.44108420610427856
of O 0 0.0002515722007956356
fasting O 0 0.05795085430145264
. O 0 0.0012713317992165685

Her O 0 0.14370222389698029
ventricular O 1 0.9998061060905457
hypertrophy O 1 0.9996830224990845
resolved O 0 0.02018868178129196
significantly O 0 0.004079761449247599
over O 0 0.00027161752223037183
1 O 0 0.0005790145951323211
year O 0 0.0006071663810871542
, O 0 0.00022536002506967634
and O 0 0.0004983256803825498
cognitively O 1 0.9928164482116699
, O 0 0.00041419544140808284
she O 0 0.0008971906499937177
is O 0 0.00018926429038401693
in O 0 9.32548864511773e-05
the O 0 0.00023073122429195791
superior O 0 0.008395484648644924
range O 0 0.0006646195542998612
for O 0 0.0003538639284670353
age O 0 0.0018679124768823385
. O 0 0.0007578737568110228

Clinical O 1 0.9948804378509521
recognition O 0 0.004510893020778894
of O 0 0.0011610632063820958
VLCAD B-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999995231628418
is O 0 0.0006900578737258911
important O 0 0.0005849601002410054
because O 0 0.00039419703534804285
it O 0 6.804714939789847e-05
is O 0 4.5644741476280615e-05
one O 0 1.9229844838264398e-05
of O 0 7.972132152644917e-06
the O 0 0.00013597667566500604
few O 0 0.000528984353877604
directly O 0 0.005383385345339775
treatable O 1 0.9999924898147583
causes O 1 0.9528334140777588
of O 0 0.0009930043015629053
cardiomyopathy B-Disease 1 0.9999998807907104
in O 0 0.0019630093593150377
children O 0 0.003891205880790949
. O 0 0.00037220068043097854
. O 0 0.0007498128688894212

Cloning O 0 0.005977167282253504
of O 0 5.469129609991796e-05
a O 0 0.0007200052496045828
novel O 0 0.0008942384738475084
member O 0 0.00016166183922905475
of O 0 1.3353283975447994e-05
the O 0 0.0002004483831115067
low O 0 0.003009428968653083
- O 0 0.0032421424984931946
density O 0 0.0010170412715524435
lipoprotein O 1 0.9967454671859741
receptor O 0 0.012383551336824894
family O 0 0.002355762291699648
. O 0 0.0011576672550290823

A O 0 0.005444307345896959
gene O 0 0.0018233790760859847
encoding O 0 0.0005205736379139125
a O 0 0.0005148012423887849
novel O 0 0.0018053012900054455
transmembrane O 0 0.006969511974602938
protein O 0 0.0010076310718432069
was O 0 0.0007488788687624037
identified O 0 0.0004195977235212922
by O 0 4.4087832065997645e-05
DNA O 0 0.0002769187849480659
sequence O 0 4.281789006199688e-05
analysis O 0 7.942889351397753e-05
within O 0 6.277936336118728e-05
the O 0 0.00037092791171744466
insulin B-Disease 1 0.9940390586853027
- I-Disease 1 0.5097867846488953
dependent I-Disease 1 0.8692455291748047
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999966621398926
( O 0 0.008917214348912239
IDDM B-Disease 1 0.998418927192688
) O 0 0.0010661697015166283
locus O 0 0.020233087241649628
IDDM4 O 1 0.9524351954460144
on O 0 0.0011767357354983687
chromosome O 0 0.006039530970156193
11q13 O 0 0.04594743624329567
. O 0 0.0013557804049924016

Based O 0 0.0008388901478610933
on O 0 0.00023924483684822917
its O 0 0.00047491470468230546
chromosomal O 0 0.01292000524699688
position O 0 0.0011446056887507439
, O 0 0.00018369242025073618
this O 0 0.00011401817027945071
gene O 0 0.0009302575490437448
is O 0 0.00011999015259789303
a O 0 0.00031823673634789884
candidate O 0 0.0007660043193027377
for O 0 0.0003003464953508228
conferring O 0 0.44335097074508667
susceptibility O 1 0.9905608296394348
to O 0 0.003644109470769763
diabetes B-Disease 1 0.9999986886978149
. O 0 0.002090499270707369

The O 0 0.00118838413618505
gene O 0 0.0026377735193818808
, O 0 0.00026967190206050873
termed O 0 0.012955693528056145
low O 0 0.0029528134036809206
- O 0 0.00249965931288898
density O 0 0.0009064957266673446
lipoprotein O 1 0.9918944239616394
receptor O 0 0.004424610640853643
related O 0 0.0008718693279661238
protein O 0 0.0008988419431261718
5 O 0 0.001367706572636962
( O 0 0.001296530943363905
LRP5 O 1 0.9926043748855591
) O 0 0.0001791070244507864
, O 0 7.950906729092821e-05
encodes O 0 0.00046840644790790975
a O 0 0.00017210158694069833
protein O 0 0.00019723748846445233
of O 0 4.602580520440824e-05
1615 O 0 0.020738601684570312
amino O 0 0.0003280687378719449
acids O 0 0.00029729134985245764
that O 0 4.1088624129770324e-05
contains O 0 6.983779167057946e-05
conserved O 0 0.0003822632716037333
modules O 0 0.0006671729497611523
which O 0 2.6179330234299414e-05
are O 0 1.1334872397128493e-05
characteristic O 0 0.0002723492798395455
of O 0 1.0167698746954557e-05
the O 0 0.0001824220671551302
low O 0 0.0020761804189532995
- O 0 0.002578550949692726
density O 0 0.0013822311302646995
lipoprotein O 1 0.9993010759353638
( O 0 0.004808394238352776
LDL O 1 0.9998862743377686
) O 0 0.0010976545745506883
receptor O 0 0.007653040811419487
family O 0 0.002106843749061227
. O 0 0.0012496081180870533

These O 0 0.00022210458701010793
modules O 0 0.0016897522145882249
include O 0 0.0002667107037268579
a O 0 0.0007932886946946383
putative O 0 0.009052269160747528
signal O 0 0.001739543047733605
peptide O 0 0.001455443911254406
for O 0 5.3097457566764206e-05
protein O 0 0.0001776502322172746
export O 0 0.0003078487061429769
, O 0 0.00010911072604358196
four O 0 0.00020836410112679005
epidermal O 1 0.9927412271499634
growth O 0 0.0019070565467700362
factor O 0 0.0031174628529697657
( O 0 0.0015808481257408857
EGF O 1 0.9905688762664795
) O 0 0.00044035931932739913
repeats O 0 0.002247927477583289
with O 0 0.0001638354588067159
associated O 0 0.0007974921609275043
spacer O 0 0.020367449149489403
domains O 0 0.0017314784927293658
, O 0 0.0002919810067396611
three O 0 0.000584579654969275
LDL O 1 0.9997978806495667
- O 0 0.011602194979786873
receptor O 0 0.010678911581635475
( O 0 0.0016702705761417747
LDLR O 1 0.9675090312957764
) O 0 0.000495054351631552
repeats O 0 0.0022984868846833706
, O 0 0.00010091308649862185
a O 0 0.00024879188276827335
single O 0 0.0003463585744611919
transmembrane O 0 0.005379194393754005
spanning O 0 0.0023315860889852047
domain O 0 0.0006581117049790919
, O 0 0.00012401527783367783
and O 0 8.186254854081199e-05
a O 0 0.0005579279386438429
cytoplasmic O 0 0.0044013806618750095
domain O 0 0.0017550770426169038
. O 0 0.0008159276330843568

The O 0 0.00019980552315246314
encoded O 0 0.00013556602061726153
protein O 0 0.0003067705547437072
has O 0 0.00022944896772969514
a O 0 0.0002913539356086403
unique O 0 0.0004555674968287349
organization O 0 0.0010433387942612171
of O 0 0.00016775235417298973
EGF O 1 0.996088981628418
and O 0 0.001076485845260322
LDLR O 1 0.9951369166374207
repeats O 0 0.00814907718449831
; O 0 0.00025864457711577415
therefore O 0 0.0005724390503019094
, O 0 0.000504390278365463
LRP5 O 1 0.9789388179779053
likely O 0 0.00119066855404526
represents O 0 0.000866549729835242
a O 0 0.00045491132186725736
new O 0 0.00023552533821202815
category O 0 0.0003169855335727334
of O 0 3.980734618380666e-05
the O 0 0.0009829805931076407
LDLR O 1 0.9966874718666077
family O 0 0.002717832336202264
. O 0 0.0012117662699893117

Both O 0 0.000994703033939004
human O 0 0.002165647689253092
and O 0 0.001243709004484117
mouse O 0 0.39814791083335876
LRP5 O 1 0.9948116540908813
cDNAs O 0 0.4356379210948944
have O 0 0.0002768789418041706
been O 0 0.0004405848158057779
isolated O 0 0.002243305556476116
and O 0 5.655113636748865e-05
the O 0 0.00010743773600552231
encoded O 0 0.0002757140900939703
mature O 0 0.00250432756729424
proteins O 0 9.604094520909712e-05
are O 0 3.131276753265411e-05
95 O 0 0.000653600029181689
% O 0 4.488259946811013e-05
identical O 0 0.0004895681631751359
, O 0 0.00021163820929359645
indicating O 0 0.001982417656108737
a O 0 0.0006134341238066554
high O 0 0.0015195671003311872
degree O 0 0.0006484723999164999
of O 0 4.183100099908188e-05
evolutionary O 0 0.002785302698612213
conservation O 0 0.008796445094048977
. O 0 0.00027897863765247166
. O 0 0.0005672239931300282

The O 0 0.004042326007038355
APC B-Disease 1 0.9740645885467529
variants O 0 0.004964380990713835
I1307K O 0 0.022139880806207657
and O 0 0.00024445203598588705
E1317Q O 0 0.010402848944067955
are O 0 8.113767398754135e-05
associated O 0 0.001204873900860548
with O 0 0.0778621956706047
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999998807907104
, O 0 0.0006959987222217023
but O 0 0.00029330264078453183
not O 0 7.924202509457245e-05
always O 0 0.00018431579519528896
with O 0 4.7681645810371265e-05
a O 0 0.0005178585997782648
family O 0 0.0008492350461892784
history O 0 0.0012496188282966614
. O 0 0.0011649405350908637

Classical O 0 0.06792787462472916
familial B-Disease 1 0.9999817609786987
adenomatous I-Disease 1 0.9999978542327881
polyposis I-Disease 1 0.9999982118606567
( O 0 0.10327918082475662
FAP B-Disease 1 0.9997021555900574
) O 0 0.00045298185432329774
is O 0 0.00020546794985421002
a O 0 0.0007267651963047683
high O 0 0.009194614365696907
- O 1 0.5423793792724609
penetrance O 1 0.9986022114753723
autosomal B-Disease 1 0.9993752837181091
dominant I-Disease 1 0.9967993497848511
disease I-Disease 1 0.9999963045120239
that O 0 0.0009205920505337417
predisposes O 1 0.9972471594810486
to O 0 0.00013930998102296144
hundreds O 0 0.00044878016342408955
or O 0 0.00020142605353612453
thousands O 0 0.0008761657518334687
of O 0 0.001708935247734189
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999990463256836
and I-Disease 1 0.5962545871734619
carcinoma I-Disease 1 0.9999997615814209
and O 0 0.0003025228506885469
that O 0 0.00012640356726478785
results O 0 0.0004403887432999909
from O 0 0.0002783054660540074
truncating O 0 0.3288165032863617
mutations O 0 0.001747164293192327
in O 0 0.0001838315511122346
the O 0 0.0007174750207923353
APC B-Disease 1 0.996421217918396
gene O 0 0.005847329739481211
. O 0 0.0009590020054019988

A O 0 0.006916750688105822
variant O 0 0.015139732509851456
of O 0 0.0005912646884098649
FAP B-Disease 1 0.9998835325241089
is O 0 0.020063964650034904
attenuated B-Disease 1 0.9996963739395142
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999991655349731
coli I-Disease 1 0.9999377727508545
, O 0 0.0004344146582297981
which O 0 0.00014551027561537921
results O 0 0.0005189209477975965
from O 0 0.0004391729598864913
germ O 1 0.9947929978370667
- O 0 0.005336933769285679
line O 0 0.0014254315756261349
mutations O 0 0.0008895258652046323
in O 0 9.160102490568534e-05
the O 0 0.00020112228230573237
5 O 0 0.00045523018343374133
and O 0 9.441885049454868e-05
3 O 0 0.00021280573855619878
regions O 0 9.462308662477881e-05
of O 0 2.7941019652644172e-05
the O 0 0.0009379533003084362
APC B-Disease 1 0.9958141446113586
gene O 0 0.006858676206320524
. O 0 0.0009419026901014149

Attenuated B-Disease 1 0.9997392296791077
adenomatous I-Disease 1 0.999997615814209
polyposis I-Disease 1 0.9999982118606567
coli I-Disease 1 0.999990701675415
patients O 1 0.9998942613601685
have O 0 0.000415353337302804
" O 0 0.0010529375867918134
multiple O 0 0.011656119488179684
" O 1 0.7213199734687805
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999427795410156
( O 0 0.001297368318773806
typically O 0 0.0006020218133926392
fewer O 0 0.0005917918751947582
than O 0 0.00010639141692081466
100 O 0 0.00031513182329945266
) O 0 0.00014103834109846503
without O 0 0.0001745162153383717
the O 0 0.0003757214290089905
florid O 1 0.9866983890533447
phenotype O 0 0.026140110567212105
of O 0 9.318092634202912e-05
classical O 0 0.007537664379924536
FAP B-Disease 1 0.9996347427368164
. O 0 0.002424536971375346

Another O 0 0.002039144979789853
group O 0 0.0006176781607791781
of O 0 0.00022214400814846158
patients O 1 0.9999151229858398
with O 0 0.0003559095785021782
multiple O 0 0.28371647000312805
adenomas B-Disease 1 0.9999003410339355
has O 0 0.0007684698211960495
no O 0 0.0003109512326773256
mutations O 0 0.0008876213687472045
in O 0 0.00010073455632664263
the O 0 0.0006088869413360953
APC B-Disease 1 0.9991227984428406
gene O 0 0.0029001624789088964
, O 0 0.00014511137851513922
and O 0 0.00011024535342585295
their O 0 0.00027708677225746214
phenotype O 1 0.798647940158844
probably O 0 0.0013013470452278852
results O 0 0.00019925016385968775
from O 0 5.5574342695763335e-05
variation O 0 0.00035325129283592105
at O 0 0.00039314586319960654
a O 0 0.00096572918118909
locus O 0 0.012600802816450596
, O 0 0.0004694882081821561
or O 0 0.0007475390448234975
loci O 0 0.00827563926577568
, O 0 0.0002528914774302393
elsewhere O 0 0.0004708309134002775
in O 0 8.146244363160804e-05
the O 0 0.00027715807664208114
genome O 0 0.0051048314198851585
. O 0 0.0008598164422437549

Recently O 0 0.014021525159478188
, O 0 0.00036727412953041494
however O 0 0.00023472368775401264
, O 0 0.00010384034249000251
a O 0 0.0007461420027539134
missense O 0 0.014950418844819069
variant O 0 0.008007833734154701
of O 0 0.0002981460129376501
APC B-Disease 1 0.9973668456077576
( O 0 0.002510450780391693
I1307K O 0 0.12324666976928711
) O 0 0.0004585833812598139
was O 0 0.000662689795717597
described O 0 0.0011394629254937172
that O 0 9.781673725228757e-05
confers O 0 0.006029723212122917
an O 0 0.00017124858277384192
increased O 0 0.0013253327924758196
risk O 1 0.9647578597068787
of O 0 0.004319274798035622
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999996423721313
, O 0 0.0004413481801748276
including O 0 0.0003668136487249285
multiple O 0 0.11806320399045944
adenomas B-Disease 1 0.9997382760047913
, O 0 0.0004956800257787108
in O 0 0.0008588972850702703
Ashkenazim O 1 0.9713273048400879
. O 0 0.0015751086175441742

We O 0 0.0006379103288054466
have O 0 9.106643847189844e-05
studied O 0 0.00018103446927852929
a O 0 8.535081724403426e-05
set O 0 3.390804704395123e-05
of O 0 4.9407852202421054e-05
164 O 0 0.09067247807979584
patients O 1 0.9998114705085754
with O 0 0.0005647555226460099
multiple O 1 0.9996166229248047
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.999996542930603
and I-Disease 0 0.016817493364214897
/ I-Disease 1 0.9988503456115723
or I-Disease 0 0.02461506798863411
carcinoma I-Disease 1 0.9999995231628418
and O 0 0.0003923581098206341
analyzed O 0 0.00511188106611371
codons O 0 0.012486071325838566
1263 O 1 0.960300624370575
- O 0 0.015416617505252361
1377 O 1 0.6406774520874023
( O 0 0.0014372254954650998
exon O 0 0.026496125385165215
15G O 0 0.039641182869672775
) O 0 8.79233775776811e-05
of O 0 1.732485179672949e-05
the O 0 0.0005355298053473234
APC B-Disease 1 0.9873217940330505
gene O 0 0.0022057886235415936
for O 0 0.0006903107278048992
germ O 1 0.9954751133918762
- O 0 0.0068241870030760765
line O 0 0.0016851045656949282
variants O 0 0.002422188874334097
. O 0 0.0008325655362568796

Three O 0 0.0025518175680190325
patients O 1 0.998648464679718
with O 0 0.00017567051691003144
the O 0 0.0006072567193768919
I1307K O 0 0.30308398604393005
allele O 0 0.0050363121554255486
were O 0 0.0001239534467458725
detected O 0 0.003419147338718176
, O 0 5.828175926581025e-05
each O 0 2.5958046535379253e-05
of O 0 7.248553447425365e-05
Ashkenazi O 0 0.3035006523132324
descent O 0 0.0054258317686617374
. O 0 0.0013655246002599597

Four O 0 0.003042367519810796
patients O 1 0.9990910291671753
had O 0 0.0009818451944738626
a O 0 0.0022886001970618963
germ O 1 0.9954504370689392
- O 0 0.008841878734529018
line O 0 0.002551658544689417
E1317Q O 0 0.03818351402878761
missense O 0 0.017156071960926056
variant O 0 0.007265177555382252
of O 0 0.0002016480138991028
APC O 1 0.9979162812232971
that O 0 0.00027372557087801397
was O 0 0.0006602174253202975
not O 0 7.206071313703433e-05
present O 0 0.0001258125266758725
in O 0 0.0001583720149938017
controls O 0 0.0015067387139424682
; O 0 9.024492464959621e-05
one O 0 4.338659346103668e-05
of O 0 1.2916570085508283e-05
these O 0 4.742700912174769e-05
individuals O 0 0.000200081747607328
had O 0 0.0003854070673696697
an O 0 0.0002056678495137021
unusually O 0 0.007163792382925749
large O 0 0.00012791143672075123
number O 0 4.0645089029567316e-05
of O 0 0.00012071614764863625
metaplastic B-Disease 1 0.9970870614051819
polyps I-Disease 1 0.9927669763565063
of I-Disease 0 5.205978231970221e-05
the I-Disease 0 0.000938334153033793
colorectum I-Disease 1 0.9576541781425476
. O 0 0.0012643170775845647

There O 0 0.00044583462295122445
is O 0 0.00023876631166785955
increasing O 0 0.0004132946487516165
evidence O 0 0.00027254459564574063
that O 0 6.99132215231657e-05
there O 0 0.00013110917643643916
exist O 0 0.0007115821936167777
germ O 1 0.9970272183418274
- O 0 0.0026402482762932777
line O 0 0.0006966537912376225
variants O 0 0.00026550432085059583
of O 0 2.9385426387307234e-05
the O 0 0.0007287528133019805
APC B-Disease 1 0.9967823028564453
gene O 0 0.0026859573554247618
that O 0 0.0002589171635918319
predispose O 0 0.02138908952474594
to O 0 5.1213675760664046e-05
the O 0 6.918673170730472e-05
development O 0 0.0005318179610185325
of O 0 0.0001421168417437002
multiple O 1 0.999531626701355
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999986886978149
and I-Disease 1 0.7922176122665405
carcinoma I-Disease 1 0.9999998807907104
, O 0 0.0004671803617384285
but O 0 0.00018511626694817096
without O 0 0.0001878015318652615
the O 0 0.0003400605055503547
florid O 1 0.9881445169448853
phenotype O 0 0.030099375173449516
of O 0 0.00010835465946001932
classical O 0 0.007406806573271751
FAP B-Disease 1 0.9999123811721802
, O 0 0.0004144956765230745
and O 0 0.0001318498543696478
possibly O 0 0.0005462139961309731
with O 0 6.787069287383929e-05
importance O 0 0.007712115067988634
for O 1 0.9837760329246521
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.931058406829834
in O 0 0.0001734463730826974
the O 0 0.0001489875721745193
general O 0 0.0006062354077585042
population O 0 0.0001084804825950414
. O 0 0.00022149474534671754
. O 0 0.0007218826212920249

Genomic O 0 0.0038244472816586494
structure O 0 0.0005363085656426847
of O 0 4.1145249269902706e-05
the O 0 0.0007492589065805078
human O 1 0.9956942796707153
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999780654907227
diarrhea I-Disease 1 0.9999998807907104
( O 1 0.670391857624054
CLD B-Disease 1 0.9999830722808838
) O 0 0.0018520683515816927
gene O 0 0.005444550421088934
. O 0 0.0009785373695194721

Congenital B-Disease 1 0.9999995231628418
chloride I-Disease 1 0.9999243021011353
diarrhea I-Disease 1 0.9999998807907104
( O 1 0.7626163363456726
CLD B-Disease 1 0.9999792575836182
) O 0 0.0009857433615252376
is O 0 0.0007418490131385624
caused O 0 0.0048501091077923775
by O 0 0.0001603102427907288
mutations O 0 0.0013061159988865256
in O 0 9.072051761904731e-05
a O 0 0.00040064507629722357
gene O 0 0.0007122484385035932
which O 0 4.940229337080382e-05
encodes O 0 0.0010544850956648588
an O 0 0.0015374170616269112
intestinal O 1 0.999985933303833
anion O 1 0.9954515099525452
transporter O 1 0.9918028712272644
. O 0 0.0019162965472787619

We O 0 0.0011361700017005205
report O 0 0.0006936024874448776
here O 0 0.00011529703624546528
the O 0 0.00010050945274997503
complete O 0 0.0006792761851102114
genomic O 0 0.0013225562870502472
organization O 0 0.00047042404185049236
of O 0 2.7787904400611296e-05
the O 0 0.0007497200276702642
human O 0 0.025257855653762817
CLD B-Disease 1 0.9996858835220337
gene O 0 0.0032115133944898844
which O 0 0.00020068167941644788
spans O 0 0.007147456519305706
approximately O 0 0.0013033789582550526
39kb O 0 0.1327091008424759
, O 0 0.00024536997079849243
and O 0 0.00016016738663893193
comprises O 0 0.0012021358124911785
21 O 0 0.0019158809445798397
exons O 0 0.008472959510982037
. O 0 0.0008944173459894955

All O 0 0.0011270714458078146
exon O 0 0.06352341920137405
/ O 0 0.019269714131951332
intron O 0 0.03388265147805214
boundaries O 0 0.0003729927120730281
conform O 0 0.001949229510501027
to O 0 0.0002275352890137583
the O 0 0.0014474769122898579
GT O 1 0.9973234534263611
/ O 1 0.9161261320114136
AG O 1 0.9965327978134155
rule O 0 0.0015860949642956257
. O 0 0.0007999353110790253

An O 0 0.0003054910630453378
analysis O 0 0.00014930099132470787
of O 0 2.6084033379447646e-05
the O 0 0.0005245663342066109
putative O 0 0.02390402741730213
promoter O 0 0.015910184010863304
region O 0 0.0007718545966781676
sequence O 0 0.00016507079999428242
shows O 0 0.00030334392795339227
a O 0 0.0016129561699926853
putative O 1 0.600824236869812
TATA O 1 0.9990577101707458
box O 0 0.004545403644442558
and O 0 0.0002805103431455791
predicts O 0 0.008936751633882523
multiple O 0 0.0007968928548507392
transcription O 0 0.0010910627897828817
factor O 0 0.001210480579175055
binding O 0 0.0008383383974432945
sites O 0 0.0008209100924432278
. O 0 0.0007367763319052756

The O 0 0.00089598773047328
genomic O 0 0.004507001955062151
structure O 0 0.0021743886172771454
was O 0 0.000922959006857127
determined O 0 0.0008340949425473809
using O 0 0.00018229185661766678
DNA O 0 0.0005815798649564385
from O 0 4.798228110303171e-05
several O 0 6.523605406982824e-05
sources O 0 0.0001619123650016263
including O 0 7.228577305795625e-05
multiple O 0 0.0012784620048478246
large O 0 0.0010017165914177895
- O 0 0.01249172817915678
insert O 0 0.019147593528032303
libaries O 0 0.019528718665242195
and O 0 0.00014563158038072288
genomic O 0 0.0020185180474072695
DNA O 0 0.0010572418104857206
from O 0 0.0003659814246930182
Finnish O 1 0.9893934726715088
CLD B-Disease 1 0.9999887943267822
patients O 1 0.9998914003372192
and O 0 0.0003743380366358906
controls O 0 0.004142233170568943
. O 0 0.0011983213480561972

Exon O 0 0.08102386444807053
- O 0 0.005432958714663982
specific O 0 0.0007004764629527926
primers O 0 0.011427013203501701
developed O 0 0.0015822078566998243
in O 0 9.369807958137244e-05
this O 0 7.01246244716458e-05
study O 0 0.00043511466355994344
will O 0 9.094121196540073e-05
facilitate O 0 0.0016358434222638607
mutation O 0 0.002415721071884036
screening O 0 0.0020413752645254135
studies O 0 0.000320267427014187
of O 0 0.00010297988774254918
patients O 1 0.9999688863754272
with O 0 0.0002510074991732836
the O 0 0.007926343008875847
disease O 1 0.9999884366989136
. O 0 0.0016805960331112146

Genomic O 0 0.0035097815562039614
sequencing O 0 0.0005843432154506445
of O 0 0.00010100118379341438
a O 0 0.0057905507273972034
BAC O 1 0.9969419836997986
clone O 1 0.9889369010925293
H O 1 0.9980738162994385
_ O 0 0.0037652705796062946
RG364P16 O 0 0.0872630625963211
revealed O 0 0.0028753960505127907
the O 0 9.098233567783609e-05
presence O 0 0.00021764400298707187
of O 0 3.107386874035001e-05
another O 0 0.0005919852992519736
, O 0 0.00021071884839329869
highly O 0 0.0024195772130042315
homologous O 0 0.004532528109848499
gene O 0 0.0011803669622167945
3 O 0 0.000177344583789818
of O 0 4.4451870053308085e-05
the O 0 0.001996030565351248
CLD B-Disease 1 0.9998888969421387
gene O 0 0.00356087414547801
, O 0 0.0001211236376548186
with O 0 5.707121817977168e-05
a O 0 0.00031653797486796975
similar O 0 0.0003393295919522643
genomic O 0 0.001887024031020701
structure O 0 0.0013683985453099012
, O 0 0.0002941217098850757
recently O 0 0.0021180666517466307
identified O 0 0.00040755796362645924
as O 0 0.0001918488269438967
the O 0 0.0013405259232968092
Pendred B-Disease 1 0.9999712705612183
syndrome I-Disease 1 0.9999997615814209
gene O 0 0.08171112090349197
( O 0 0.003223400330170989
PDS B-Disease 1 0.9998238682746887
) O 0 0.000672578695230186
. O 0 0.0003299060626886785
. O 0 0.0005524999578483403

The O 0 0.0026315064169466496
APCI1307K O 1 0.9938756823539734
allele O 0 0.03444017842411995
and O 0 0.007695967797189951
cancer B-Disease 1 0.9999985694885254
risk O 0 0.17655037343502045
in O 0 0.0002181540767196566
a O 0 0.0009938097791746259
community O 0 0.0012393997749313712
- O 0 0.0024606857914477587
based O 0 0.0001485209068050608
study O 0 0.0002987275365740061
of O 0 6.156905146781355e-05
Ashkenazi O 0 0.3742285668849945
Jews O 0 0.001765153487212956
. O 0 0.0011832594173029065

Mutations O 0 0.012579817324876785
in O 0 0.0011071690823882818
APC O 1 0.9928070306777954
are O 0 0.0003127520903944969
classically O 1 0.9664621353149414
associated O 0 0.001674699829891324
with O 0 0.003049662336707115
familial B-Disease 1 0.9999973773956299
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999996423721313
( O 0 0.440805047750473
FAP B-Disease 1 0.9998263716697693
) O 0 0.0005274636205285788
, O 0 0.0001723153836792335
a O 0 0.0011829021386802197
highly O 0 0.34078124165534973
penetrant O 1 0.9998894929885864
autosomal B-Disease 1 0.9999576807022095
dominant I-Disease 1 0.9991414546966553
disorder I-Disease 1 0.9999992847442627
characterized O 1 0.9972169399261475
by O 0 0.0011837334604933858
multiple O 1 0.9988893866539001
intestinal O 1 0.9999998807907104
polyps B-Disease 1 0.999966025352478
and O 0 0.0003630507562775165
, O 0 0.0004660450795199722
without O 0 0.001504168496467173
surgical O 1 0.9999682903289795
intervention O 0 0.007834703661501408
, O 0 8.865355630405247e-05
the O 0 0.00010729808127507567
development O 0 0.0017603649757802486
of O 0 0.0024502722080796957
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.008999026380479336
CRC B-Disease 1 0.9993171691894531
) O 0 0.0008930643671192229
. O 0 0.0008799679344519973

APC B-Disease 1 0.9031094312667847
is O 0 0.0014959678519517183
a O 0 0.007740667089819908
tumour O 1 0.999990701675415
- O 0 0.15227048099040985
suppressor O 0 0.07578907907009125
gene O 0 0.0018065512413159013
, O 0 0.00014672773249913007
and O 0 0.00019390563829801977
somatic O 0 0.01768757402896881
loss O 0 0.01637376844882965
occurs O 0 0.0031142726074904203
in O 0 0.0019693307112902403
tumours B-Disease 1 0.9999804496765137
. O 0 0.0020484670531004667

The O 0 0.006259571760892868
germline O 1 0.9889683723449707
T O 1 0.9944262504577637
- O 0 0.004316210281103849
to O 0 0.0002616017882246524
- O 0 0.003480068873614073
A O 0 0.002678615041077137
transversion O 0 0.032030172646045685
responsible O 0 0.0015418232651427388
for O 0 0.00020863921963609755
the O 0 0.001066395197995007
APC O 1 0.9814245104789734
I1307K O 0 0.028814353048801422
allele O 0 0.004041692242026329
converts O 0 0.0006134928553365171
the O 0 0.0002718522446230054
wild O 0 0.0013294694945216179
- O 0 0.0023820523638278246
type O 0 0.0006573939463123679
sequence O 0 6.178244075272232e-05
to O 0 8.743551734369248e-05
a O 0 0.0015267739072442055
homopolymer O 1 0.997320830821991
tract O 1 0.9997894167900085
( O 0 0.003858382347971201
A8 O 1 0.9998152852058411
) O 0 0.0003185266104992479
that O 0 0.00012055603292537853
is O 0 0.0004566257121041417
genetically O 0 0.0032030236907303333
unstable O 1 0.9896352887153625
and O 0 0.00044907841947861016
prone O 1 0.7400897741317749
to O 0 0.00044735701521858573
somatic O 0 0.016828401014208794
mutation O 0 0.0066240341402590275
. O 0 0.0009229994029738009

The O 0 0.0018962828908115625
I1307K O 0 0.0413232259452343
allele O 0 0.007231305353343487
was O 0 0.0010797199793159962
found O 0 0.0002716221788432449
in O 0 0.00022511584393214434
6 O 0 0.0013743422459810972
. O 0 0.0006440764991566539

1 O 0 0.0010456816526129842
% O 0 7.883954094722867e-05
of O 0 0.00015801664267200977
unselected O 1 0.9831839203834534
Ashkenazi O 1 0.5963535904884338
Jews O 0 0.000896984594874084
and O 0 0.00020768793183378875
higher O 0 0.0009017741540446877
proportions O 0 0.0048089101910591125
of O 0 0.00017392316658515483
Ashkenazim O 1 0.8252787590026855
with O 0 0.0003110283287242055
family O 0 0.0011742488713935018
or O 0 0.00036305494722910225
personal O 0 0.0014549408806487918
histories O 0 0.003987044561654329
of O 0 0.0003442949091549963
CRC B-Disease 1 0.999136745929718
( O 0 0.0022634947672486305
ref O 1 0.7599625587463379
. O 0 0.00024330729502253234
2 O 0 0.000662432808894664
) O 0 0.0003000207943841815
. O 0 0.00046951507101766765

To O 0 0.0007149972952902317
evaluate O 0 0.003924807067960501
the O 0 9.195916209137067e-05
role O 0 0.0006191797438077629
of O 0 0.00012050109216943383
I1307K O 1 0.9007249474525452
in O 0 0.0020092499908059835
cancer B-Disease 1 0.9999940395355225
, O 0 0.00025349523639306426
we O 0 0.00039977749111130834
genotyped O 0 0.11695818603038788
5 O 0 0.0008767378167249262
, O 0 0.001120068016462028
081 O 1 0.9838143587112427
Ashkenazi O 0 0.08583089709281921
volunteers O 0 0.0033411486074328423
in O 0 0.00015580725448671728
a O 0 0.0006644842796958983
community O 0 0.001170933828689158
survey O 0 0.0020102341659367085
. O 0 0.0007964555406942964

Risk O 0 0.043635446578264236
of O 0 0.0003924231859855354
developing O 1 0.9996440410614014
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 0.16357874870300293
breast I-Disease 1 0.9999978542327881
and I-Disease 0 0.00038825301453471184
other I-Disease 0 0.00048027021693997085
cancers I-Disease 1 0.9998140931129456
were O 0 0.0001056781766237691
compared O 0 0.000972093315795064
between O 0 0.00078876520274207
genotyped O 1 0.9890748858451843
I1307K O 0 0.21634219586849213
carriers O 0 0.006899387110024691
and O 0 0.00035121754626743495
non O 0 0.0034902538172900677
- O 0 0.005159598775207996
carriers O 0 0.0022218714002519846
and O 0 5.609368236036971e-05
their O 0 5.886843428015709e-05
first O 0 0.0004641641862690449
- O 0 0.0055053881369531155
degree O 0 0.0018932257080450654
relatives O 0 0.002633551834151149
. O 0 0.000765863573178649

Sperm O 0 0.004467107821255922
DNA O 0 0.0013537225313484669
analysis O 0 0.00038902764208614826
in O 0 0.0003834399685729295
a O 0 0.008734882809221745
Friedreich B-Disease 1 0.9997313618659973
ataxia I-Disease 1 0.9998522996902466
premutation O 1 0.9934796094894409
carrier O 0 0.1851562261581421
suggests O 0 0.0031963016372174025
both O 0 0.0004102113889530301
meiotic O 1 0.6352591514587402
and O 0 0.0002664979547262192
mitotic O 0 0.010876879096031189
expansion O 0 0.0014633990358561277
in O 0 0.00020579947158694267
the O 0 0.0006818855181336403
FRDA B-Disease 1 0.9905974268913269
gene O 0 0.005289843305945396
. O 0 0.0008011161698959768

Friedreich B-Disease 1 0.9993351101875305
ataxia I-Disease 1 0.9998040795326233
is O 0 0.0031043761409819126
usually O 0 0.0010357560822740197
caused O 0 0.004045949783176184
by O 0 5.037041046307422e-05
an O 0 0.00012164077634224668
expansion O 0 0.0006012837984599173
of O 0 3.510701935738325e-05
a O 0 0.001922704977914691
GAA O 0 0.31475409865379333
trinucleotide O 1 0.9463251233100891
repeat O 0 0.007122015114873648
in O 0 0.00035344582283869386
intron O 0 0.03578749671578407
1 O 0 0.0002826521231327206
of O 0 2.7668751499732025e-05
the O 0 0.0008002925314940512
FRDA B-Disease 1 0.9919552206993103
gene O 0 0.005501989740878344
. O 0 0.0008729500113986433

Occasionally O 0 0.006315093953162432
, O 0 0.00031857669819146395
a O 0 0.0007114323670975864
fully O 0 0.0034340396523475647
expanded O 0 0.0019239032408222556
allele O 0 0.006114577874541283
has O 0 0.0006502002361230552
been O 0 0.0003528785309754312
found O 0 0.00025955168530344963
to O 0 0.00013264355948194861
arise O 0 0.001777387922629714
from O 0 7.636782538611442e-05
a O 0 0.0006154137663543224
premutation O 0 0.019881024956703186
of O 0 2.651688009791542e-05
100 O 0 0.00026092302869074047
or O 0 0.0001993908081203699
less O 0 0.00103728286921978
triplet O 1 0.8834770321846008
repeats O 0 0.014941875822842121
. O 0 0.0012542508775368333

We O 0 0.0008719291654415429
have O 0 0.00024732365272939205
examined O 0 0.002667661989107728
the O 0 8.896522194845602e-05
sperm O 0 0.0006157311727292836
DNA O 0 0.0002676353615242988
of O 0 2.4529274014639668e-05
a O 0 0.0019430380780249834
premutation O 1 0.9786979556083679
carrier O 0 0.12369765341281891
. O 0 0.001242883619852364

This O 0 0.0009166424861177802
mans O 0 0.01883966103196144
leucocyte O 0 0.04149147495627403
DNA O 0 0.0018098499858751893
showed O 0 0.0011568949557840824
one O 0 0.0002518503461033106
normal O 0 0.002525322139263153
allele O 0 0.002588870469480753
and O 0 0.00012027906632283702
one O 0 0.0001306079066125676
allele O 0 0.0010799102019518614
of O 0 2.451035652484279e-05
approximately O 0 0.0004063504748046398
100 O 0 0.0009005548199638724
repeats O 0 0.00850569549947977
. O 0 0.0013382553588598967

His O 0 0.003263812977820635
sperm O 0 0.0024556689895689487
showed O 0 0.0011748854303732514
an O 0 0.0002817516215145588
expanded O 0 0.001614548615179956
allele O 0 0.0033702091313898563
in O 0 0.0001916879409691319
a O 0 0.0006809711339883506
tight O 0 0.0024963882751762867
range O 0 0.0006922588800080121
centering O 0 0.0034063123166561127
on O 0 0.0001367763034068048
a O 0 0.00020287607912905514
size O 0 0.0001493897580076009
of O 0 3.6252153222449124e-05
approximately O 0 0.0011813179589807987
320 O 0 0.036024924367666245
trinucleotide O 1 0.9365840554237366
repeats O 0 0.01650872454047203
. O 0 0.0015116443391889334

His O 0 0.010142219252884388
affected O 0 0.03851557523012161
son O 0 0.019419310614466667
has O 0 0.0009429029887542129
repeat O 0 0.0034876607824116945
sizes O 0 0.00040317222010344267
of O 0 0.0001749874500092119
1040 O 1 0.9932230710983276
and O 0 0.0007842780323699117
540 O 0 0.054176539182662964
. O 0 0.0013208455638960004

These O 0 0.00016510668501723558
data O 0 0.00023798717302270234
suggest O 0 0.0006083330372348428
that O 0 0.00011598479613894597
expansion O 0 0.001387965981848538
occurs O 0 0.00048081943532451987
in O 0 7.725300383754075e-05
two O 0 7.206160080386326e-05
stages O 0 0.0015645363600924611
, O 0 7.703364099143073e-05
the O 0 0.00010265575110679492
first O 0 0.00020075480279047042
during O 0 0.0009555370197631419
meiosis O 0 0.006510475184768438
followed O 0 0.00023563158174511045
by O 0 4.888863622909412e-05
a O 0 0.0003674043982755393
second O 0 0.000510059529915452
mitotic O 0 0.012523461133241653
expansion O 0 0.004734959453344345
. O 0 0.0007346547790803015

We O 0 0.0009036830742843449
also O 0 0.00026198464911431074
show O 0 0.00024840174592100084
that O 0 3.138024112558924e-05
in O 0 3.922345786122605e-05
all O 0 3.36767261615023e-05
informative O 0 0.005894929636269808
carrier O 0 0.12304732948541641
father O 0 0.002242990769445896
to O 0 0.00033186053042300045
affected O 0 0.015442833304405212
child O 0 0.013122839853167534
transmissions O 0 0.0048877038061618805
, O 0 0.00012657049228437245
with O 0 6.465925980592147e-05
the O 0 0.00013188457523938268
notable O 0 0.00039985787589102983
exception O 0 0.000715027330443263
of O 0 3.314932473585941e-05
the O 0 0.0006072682444937527
premutation O 1 0.978127121925354
carrier O 0 0.013800036162137985
, O 0 9.09295049495995e-05
the O 0 7.032364374026656e-05
expansion O 0 0.0008705071522854269
size O 0 0.0003941763425245881
decreases O 0 0.003037315560504794
. O 0 0.00020134753140155226
. O 0 0.0004988047294318676

The O 0 0.0011911551700904965
R496H O 0 0.026023216545581818
mutation O 0 0.001807049149647355
of O 0 9.442506416235119e-05
arylsulfatase O 1 0.6422175168991089
A O 0 0.0033707572147250175
does O 0 0.0013690149644389749
not O 0 0.0005722033674828708
cause O 1 0.9881700277328491
metachromatic B-Disease 1 0.9996986389160156
leukodystrophy I-Disease 1 0.999954342842102
. O 0 0.003009514883160591

Deficiency B-Disease 1 0.9996839761734009
of I-Disease 0 0.000429539562901482
arylsulfatase I-Disease 1 0.9779515266418457
A I-Disease 0 0.014724807813763618
( O 0 0.0033290439750999212
ARSA O 1 0.9972992539405823
) O 0 0.000553100137040019
enzyme O 0 0.003136858344078064
activity O 0 0.002577293897047639
causes O 1 0.9940098524093628
metachromatic B-Disease 1 0.9998773336410522
leukodystrophy I-Disease 1 0.9999896287918091
( O 0 0.027742287144064903
MLD B-Disease 1 0.9999265670776367
) O 0 0.001816356205381453
. O 0 0.0010272186482325196

A O 0 0.0017796633765101433
number O 0 7.946632103994489e-05
of O 0 0.00023797446920070797
ARSA O 1 0.9992101192474365
gene O 0 0.007858394645154476
mutations O 0 0.003538780380040407
responsible O 0 0.004072287119925022
for O 0 0.001880418392829597
MLD B-Disease 1 0.9999299049377441
have O 0 0.0003666489210445434
been O 0 0.0006653007585555315
identified O 0 0.0015482745366171002
. O 0 0.0007375574787147343

Recently O 0 0.010978634469211102
, O 0 0.00027812825283035636
the O 0 0.00039412264595739543
R496H O 0 0.023170219734311104
mutation O 0 0.002202925505116582
of O 0 0.00020980025874450803
ARSA O 1 0.9992353916168213
was O 0 0.0016083333175629377
proposed O 0 0.0005859954981133342
to O 0 5.214986958890222e-05
be O 0 4.8018126108217984e-05
a O 0 0.00031519460026174784
cause O 0 0.004464919678866863
of O 0 0.00029374955920502543
MLD B-Disease 1 0.9999762773513794
( O 0 0.0033238111063838005
Draghia O 1 0.9910056591033936
et O 0 0.08749768137931824
al O 0 0.008921951986849308
. O 0 0.00018712336895987391
, O 0 0.0004110945446882397
1997 O 0 0.004601707216352224
) O 0 0.0004396484000608325
. O 0 0.0007077981135807931

We O 0 0.0009814777877181768
have O 0 0.0002730682317633182
investigated O 0 0.003987625706940889
the O 0 0.0003340756520628929
R496H O 0 0.07618410885334015
mutation O 0 0.0022229382302612066
and O 0 0.00011390526924515143
found O 0 0.00020452564058359712
this O 0 8.961957792052999e-05
mutation O 0 0.0012113929260522127
at O 0 0.00019514835730660707
a O 0 0.0004106801643501967
relatively O 0 0.0009722256800159812
high O 0 0.0008575480314902961
frequency O 0 0.00018632326100487262
in O 0 0.00010048156400443986
an O 0 0.0002735406160354614
African O 0 0.000730399158783257
American O 0 0.0003353315987624228
population O 0 0.00017524909344501793
( O 0 0.0007116944761946797
f O 0 0.004325673915445805
= O 0 0.0024479448329657316
0 O 0 0.0005099523696117103
. O 0 0.00017470984312240034
09 O 0 0.011143982410430908
, O 0 0.00035695498809218407
n O 0 0.003331546438857913
= O 0 0.004407825414091349
61 O 0 0.0034096715971827507
subjects O 0 0.002319485181942582
) O 0 0.0005388293066062033
. O 0 0.0006102558108977973

The O 0 0.005192460957914591
ARSA O 1 0.9890410304069519
enzyme O 0 0.007689218502491713
activity O 0 0.0009697611094452441
in O 0 0.00024607538944110274
subjects O 0 0.0009322930709458888
with O 0 0.0001065946344169788
and O 0 9.275681804865599e-05
without O 0 0.00024233634758275002
the O 0 0.000362504186341539
R496H O 1 0.5362103581428528
mutation O 0 0.003419514512643218
was O 0 0.0007907064282335341
determined O 0 0.001024002442136407
and O 0 9.943165787262842e-05
found O 0 0.0001931098522618413
to O 0 6.818954716436565e-05
be O 0 0.00012140485341660678
normal O 0 0.001820615492761135
. O 0 0.00046454500989057124

It O 0 0.0007264002924785018
is O 0 0.00041636047535575926
therefore O 0 0.0005542410654015839
concluded O 0 0.002487264107912779
that O 0 5.8766352594830096e-05
the O 0 0.0002733531582634896
R496H O 0 0.0363457053899765
mutation O 0 0.0029290984384715557
of O 0 0.00038114795461297035
ARSA O 1 0.9996721744537354
does O 0 0.0019463206408545375
not O 0 0.00018608642858453095
negatively O 0 0.0015016525285318494
influence O 0 0.00019337372214067727
the O 0 0.0001184521388495341
activity O 0 0.0004184877616353333
of O 0 0.0001684825256234035
ARSA O 1 0.9993094205856323
and O 0 0.00020457498612813652
is O 0 0.00020379699708428234
not O 0 7.515949255321175e-05
a O 0 0.00042768463026732206
cause O 0 0.014475008472800255
of O 0 0.0006640952778980136
MLD B-Disease 1 0.9998735189437866

Down O 0 0.010049834847450256
- O 0 0.002254626015201211
regulation O 0 0.0003658919595181942
of O 0 6.197426409926265e-05
transmembrane O 0 0.046610619872808456
carbonic O 1 0.9939488172531128
anhydrases O 1 0.9940469264984131
in O 0 0.011155274696648121
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9992653727531433
carcinoma I-Disease 1 0.9999986886978149
cell O 0 0.006430682260543108
lines O 0 0.0007813537959009409
by O 0 0.00014634404215030372
wild O 0 0.001865795231424272
- O 0 0.016392404213547707
type O 0 0.01408372726291418
von B-Disease 1 0.9481194019317627
Hippel I-Disease 1 0.9989323019981384
- I-Disease 1 0.6978674530982971
Lindau I-Disease 1 0.9954609274864197
transgenes O 1 0.5346994400024414
. O 0 0.0017267359653487802

To O 0 0.0011092794593423605
discover O 0 0.005000163335353136
genes O 0 0.0005502873100340366
involved O 0 0.0009212343138642609
in O 0 0.0007000393234193325
von B-Disease 1 0.9653366804122925
Hippel I-Disease 1 0.9993951320648193
- I-Disease 1 0.6314286589622498
Lindau I-Disease 1 0.9977385997772217
( O 0 0.0034157654736191034
VHL B-Disease 1 0.9990170001983643
) O 0 0.0017470321618020535
- O 0 0.011233962140977383
mediated O 0 0.052039965987205505
carcinogenesis O 1 0.9936578869819641
, O 0 0.0003431609075050801
we O 0 0.0004274901875760406
used O 0 0.003222317434847355
renal B-Disease 1 0.9999995231628418
cell I-Disease 1 0.9988910555839539
carcinoma I-Disease 1 0.9999994039535522
cell O 0 0.009468631818890572
lines O 0 0.0026816739700734615
stably O 0 0.07054921239614487
transfected O 0 0.044996410608291626
with O 0 0.00022745114983990788
wild O 0 0.0022382803726941347
- O 0 0.023534292355179787
type O 0 0.09781477600336075
VHL O 1 0.9992978572845459
- O 0 0.018437005579471588
expressing O 0 0.013358505442738533
transgenes O 0 0.3480546176433563
. O 0 0.001840141136199236

Large O 0 0.0016472215065732598
- O 0 0.003022009739652276
scale O 0 0.00126427854411304
RNA O 0 0.0018390058539807796
differential O 0 0.003696375759318471
display O 0 0.0010035679442808032
technology O 0 0.0026248854119330645
applied O 0 0.0007024913211353123
to O 0 5.9888898249482736e-05
these O 0 5.3256786486599594e-05
cell O 0 0.0020566971506923437
lines O 0 0.0008498685201629996
identified O 0 0.0007270333007909358
several O 0 0.00017172243678942323
differentially O 0 0.014073322527110577
expressed O 0 0.0007476531318388879
genes O 0 0.0002913647913374007
, O 0 6.501328607555479e-05
including O 0 5.971484642941505e-05
an O 0 0.00045140550355426967
alpha O 0 0.008586178533732891
carbonic O 1 0.9740912318229675
anhydrase O 1 0.9901429414749146
gene O 0 0.005284571088850498
, O 0 0.0008916953229345381
termed O 1 0.802362322807312
CA12 O 1 0.9933329224586487
. O 0 0.0015106193022802472

The O 0 0.00045419204980134964
deduced O 0 0.0019509743433445692
protein O 0 0.00034007380600087345
sequence O 0 0.00021062845189590007
was O 0 0.0007519788923673332
classified O 0 0.002592396689578891
as O 0 0.0001168462258647196
a O 0 0.0003188334812875837
one O 0 0.00023605812748428434
- O 0 0.0022998149506747723
pass O 0 0.0012392038479447365
transmembrane O 0 0.012670131400227547
CA O 0 0.025382008403539658
possessing O 0 0.0016234229551628232
an O 0 0.00035847147228196263
apparently O 0 0.0038022177759557962
intact O 0 0.003562911879271269
catalytic O 0 0.002723859390243888
domain O 0 0.000367719738278538
in O 0 8.573535160394385e-05
the O 0 0.00027915104874409735
extracellular O 0 0.013561702333390713
CA O 0 0.46894440054893494
module O 0 0.02265571989119053
. O 0 0.001170952687971294

Reintroduced O 0 0.035415612161159515
wild O 0 0.005389184225350618
- O 0 0.0265591349452734
type O 0 0.033380597829818726
VHL B-Disease 1 0.9978278279304504
strongly O 0 0.005823879037052393
inhibited O 0 0.015014944598078728
the O 0 0.0002827731368597597
overexpression O 0 0.004128620028495789
of O 0 4.0907139918999746e-05
the O 0 0.0006511406390927732
CA12 O 1 0.989806592464447
gene O 0 0.0012910498771816492
in O 0 0.00013140091323293746
the O 0 0.0008655404089950025
parental O 1 0.9984538555145264
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9996652603149414
carcinoma I-Disease 1 0.9999996423721313
cell O 0 0.040306076407432556
lines O 0 0.0036731581203639507
. O 0 0.0011007661232724786

Similar O 0 0.0018543192418292165
results O 0 0.0007249107584357262
were O 0 5.818763384013437e-05
obtained O 0 0.00042260170448571444
with O 0 0.0005962160066701472
CA9 O 1 0.999536395072937
, O 0 0.00034173260792158544
encoding O 0 0.0007523458916693926
another O 0 0.0011709282407537103
transmembrane O 0 0.029215987771749496
CA O 0 0.012013914063572884
with O 0 5.6534259783802554e-05
an O 0 0.00028531055431813
intact O 0 0.004872848279774189
catalytic O 0 0.007145662792026997
domain O 0 0.0019189416198059916
. O 0 0.0011760992929339409

Although O 0 0.0008829314028844237
both O 0 0.00012491110828705132
domains O 0 0.00046877405839040875
of O 0 4.518592686508782e-05
the O 0 0.0009502241155132651
VHL B-Disease 1 0.9988204836845398
protein O 0 0.0009786176960915327
contribute O 0 0.0017709900857880712
to O 0 8.892577898222953e-05
regulation O 0 0.0005839287769049406
of O 0 0.00010449354886077344
CA12 O 1 0.9941551089286804
expression O 0 0.0009693242609500885
, O 0 0.0001710359356366098
the O 0 0.0002385542175034061
elongin O 0 0.03756173700094223
binding O 0 0.000653170864097774
domain O 0 0.0007637935923412442
alone O 0 0.0016763261519372463
could O 0 0.00048807854182086885
effectively O 0 0.004340378567576408
regulate O 0 0.025445615872740746
CA9 O 1 0.9974000453948975
expression O 0 0.004012594930827618
. O 0 0.0012572375126183033

We O 0 0.0021531847305595875
mapped O 0 0.013981455937027931
CA12 O 1 0.9619484543800354
and O 0 0.0024848293978720903
CA9 O 1 0.9974924325942993
loci O 0 0.01595241203904152
to O 0 0.0003738112864084542
chromosome O 0 0.003322241362184286
bands O 0 0.0023276095744222403
15q22 O 0 0.03345954418182373
and O 0 0.0008415643242187798
17q21 O 0 0.07099443674087524
. O 0 0.0012512849643826485

2 O 0 0.0022154797334223986
respectively O 0 0.000928636931348592
, O 0 0.00029238214483484626
regions O 0 0.0012453538365662098
prone O 0 0.03658290579915047
to O 0 8.614231774117798e-05
amplification O 0 0.0017613137606531382
in O 0 0.00010254323569824919
some O 0 0.0002196951536461711
human O 0 0.07008207589387894
cancers B-Disease 1 0.9998621940612793
. O 0 0.0015565508510917425

Additional O 0 0.0011560240527614951
experiments O 0 0.0011149909114465117
are O 0 4.271979923942126e-05
needed O 0 0.0006218233029358089
to O 0 5.760757630923763e-05
define O 0 0.000572100339923054
the O 0 0.00012019479618174955
role O 0 0.0012817431706935167
of O 0 0.0002886050788220018
CA O 1 0.9987253546714783
IX O 1 0.9994519352912903
and O 0 0.0011040273820981383
CA O 1 0.9881848096847534
XII O 1 0.9938661456108093
enzymes O 0 0.0006657095509581268
in O 0 9.58717500907369e-05
the O 0 0.00010919284250121564
regulation O 0 0.0006220277864485979
of O 0 5.954663356533274e-05
pH O 0 0.02553715929389
in O 0 0.00010791415843414143
the O 0 0.00023351739218924195
extracellular O 0 0.008511479943990707
microenvironment O 0 0.2708517611026764
and O 0 7.97739703557454e-05
its O 0 0.00010078077320940793
potential O 0 0.0008316716412082314
impact O 0 0.003090614452958107
on O 0 0.002194295171648264
cancer B-Disease 1 0.9999953508377075
cell O 0 0.004609979223459959
growth O 0 0.002372975228354335
. O 0 0.0008165027247741818

A O 0 0.004208716563880444
gene O 0 0.000979003612883389
encoding O 0 0.0002931953058578074
a O 0 0.0002952120266854763
transmembrane O 0 0.003113159444183111
protein O 0 0.0004812968254555017
is O 0 0.00039223971543833613
mutated O 0 0.008386557921767235
in O 0 0.0006794063374400139
patients O 1 0.9999938011169434
with O 0 0.09601256996393204
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999996423721313
and O 0 0.3442000448703766
optic B-Disease 1 0.9999997615814209
atrophy I-Disease 1 0.9999970197677612
( O 1 0.9001989364624023
Wolfram B-Disease 1 0.9999980926513672
syndrome I-Disease 1 0.9999998807907104
) O 0 0.0014644752955064178
. O 0 0.00103602500166744

Wolfram B-Disease 1 0.9999561309814453
syndrome I-Disease 1 0.9999997615814209
( O 0 0.19032412767410278
WFS B-Disease 1 0.9999473094940186
; O 0 0.006913292221724987
OMIM O 1 0.9997262358665466
222300 O 1 0.9110498428344727
) O 0 0.0003881727170664817
is O 0 0.0004149121232330799
an O 0 0.0021534590050578117
autosomal B-Disease 1 0.999954104423523
recessive I-Disease 1 0.9999799728393555
neurodegenerative I-Disease 1 0.9999994039535522
disorder I-Disease 1 0.9999918937683105
defined O 0 0.003055347828194499
by O 0 0.0004160894895903766
young O 0 0.11234977096319199
- O 0 0.1629709005355835
onset O 1 0.9982455968856812
non O 0 0.0072513725608587265
- O 0 0.20264150202274323
immune O 1 0.9982150793075562
insulin B-Disease 1 0.9966362714767456
- I-Disease 1 0.8134217858314514
dependent I-Disease 1 0.9492396116256714
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999979734420776
and O 0 0.005053595174103975
progressive O 1 0.9998394250869751
optic B-Disease 1 0.9999974966049194
atrophy I-Disease 1 0.9999524354934692
. O 0 0.0027758884243667126

Linkage O 0 0.025566210970282555
to O 0 0.00032445963006466627
markers O 0 0.002898009493947029
on O 0 0.0006532113766297698
chromosome O 0 0.008663560263812542
4p O 1 0.994928240776062
was O 0 0.0023307211231440306
confirmed O 0 0.001726715243421495
in O 0 9.295275958720595e-05
five O 0 0.00021861902496311814
families O 0 0.0006995131261646748
. O 0 0.0008666850626468658

On O 0 0.00028036462026648223
the O 0 6.247812416404486e-05
basis O 0 5.771920768893324e-05
of O 0 9.311272151535377e-05
meiotic O 1 0.9981750249862671
recombinants O 1 0.9975844621658325
and O 0 0.010250497609376907
disease O 1 0.9999982118606567
- O 0 0.12373039871454239
associated O 0 0.0011212155222892761
haplotypes O 0 0.010021599940955639
, O 0 0.0003684944240376353
the O 0 0.0015481491573154926
WFS B-Disease 1 0.9995493292808533
gene O 0 0.003652182873338461
was O 0 0.0009264021064154804
localized O 0 0.0059377471916377544
to O 0 0.0002776431501843035
a O 0 0.005261600948870182
BAC O 1 0.9981077909469604
/ O 1 0.7477443218231201
P1 O 1 0.9702180624008179
contig O 0 0.011940468102693558
of O 0 2.9144357540644705e-05
less O 0 0.00030560579034499824
than O 0 0.00016715774836484343
250 O 0 0.0019126057159155607
kb O 0 0.018213646486401558
. O 0 0.0009320572135038674

Mutations O 0 0.006564087234437466
in O 0 0.00027606761432252824
a O 0 0.0011052797781303525
novel O 0 0.0056906589306890965
gene O 0 0.00732407858595252
( O 0 0.0017528327880427241
WFS1 O 1 0.9615663886070251
) O 0 0.00022896882728673518
encoding O 0 0.0004980794619768858
a O 0 0.0009263198589906096
putative O 0 0.010586739517748356
transmembrane O 0 0.007986264303326607
protein O 0 0.0005822114762850106
were O 0 5.70480951864738e-05
found O 0 0.00018290799926035106
in O 0 6.735161150572821e-05
all O 0 4.796915891347453e-05
affected O 0 0.0021646947134286165
individuals O 0 0.00018924532923847437
in O 0 0.0003555719740688801
six O 0 0.0027785697020590305
WFS B-Disease 1 0.9998514652252197
families O 0 0.0008962836000137031
, O 0 0.00017216199194081128
and O 0 0.00010171456960961223
these O 0 6.738198862876743e-05
mutations O 0 0.0010490028653293848
were O 0 3.562933125067502e-05
associated O 0 0.00029364091460593045
with O 0 0.00022224674466997385
the O 0 0.004342142958194017
disease O 1 0.9999955892562866
phenotype O 1 0.9768400192260742
. O 0 0.0012990327086299658

WFS1 O 1 0.9871751666069031
appears O 0 0.005276591517031193
to O 0 0.00011248684313613921
function O 0 0.0004783321637660265
in O 0 0.00023513045744039118
survival O 0 0.013430377468466759
of O 0 8.436320058535784e-05
islet O 0 0.20579411089420319
beta O 0 0.023359665647149086
- O 0 0.006727232132107019
cells O 0 0.0015173063147813082
and O 0 0.00021743803517892957
neurons O 0 0.013186299242079258
. O 0 0.0002619964361656457
. O 0 0.000686895044054836

Stable O 0 0.02134750969707966
interaction O 0 0.0006791784544475377
between O 0 0.00011843779066111892
the O 0 0.0001001683558570221
products O 0 0.00035139534156769514
of O 0 3.4830238291760907e-05
the O 0 0.001111988676711917
BRCA1 O 1 0.9998704195022583
and O 0 0.0022801742888987064
BRCA2 O 1 0.9999268054962158
tumor B-Disease 1 0.999679684638977
suppressor O 0 0.02491634152829647
genes O 0 0.00042700633639469743
in O 0 0.00019590281590353698
mitotic O 0 0.01937851309776306
and O 0 0.0009122941410169005
meiotic O 1 0.9891018271446228
cells O 0 0.011970220133662224
. O 0 0.001341556548140943

BRCA1 O 1 0.9979186654090881
and O 0 0.0034179186914116144
BRCA2 O 1 0.9947319030761719
account O 0 0.00028371450025588274
for O 0 0.00014923553681001067
most O 0 0.00020921116811223328
cases O 0 0.0006249159341678023
of O 0 6.653716263826936e-05
familial O 1 0.9996620416641235
, O 0 0.0005658807931467891
early O 0 0.012695221230387688
onset O 1 0.9999945163726807
breast B-Disease 1 0.9999984502792358
and I-Disease 0 0.012065828777849674
/ I-Disease 1 0.9998503923416138
or I-Disease 1 0.9924195408821106
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
and O 0 0.0001865351659944281
encode O 0 0.000520615023560822
products O 0 0.0004707519256044179
that O 0 4.5148619392421097e-05
each O 0 3.735087011591531e-05
interact O 0 0.0012526098871603608
with O 0 0.00031704839784651995
hRAD51 O 0 0.44022858142852783
. O 0 0.0012049725046381354

Results O 0 0.0022586239501833916
presented O 0 0.0010453922441229224
here O 0 0.0003114122955594212
show O 0 0.0006350907497107983
that O 0 0.0006148506654426455
BRCA1 O 1 0.9967334270477295
and O 0 0.001369830104522407
BRCA2 O 1 0.9948241710662842
coexist O 0 0.002980060875415802
in O 0 0.00014662159082945436
a O 0 0.0008244974305853248
biochemical O 0 0.007577033247798681
complex O 0 0.003580208867788315
and O 0 0.0006367173627950251
colocalize O 1 0.8512423038482666
in O 0 0.0006567873642779887
subnuclear O 1 0.9493542313575745
foci O 0 0.03355707600712776
in O 0 0.0005180184962227941
somatic O 0 0.024297915399074554
cells O 0 0.0016589470906183124
and O 0 6.380346894729882e-05
on O 0 9.893757669487968e-05
the O 0 0.0001352156396023929
axial O 0 0.004979148507118225
elements O 0 0.00013137308997102082
of O 0 0.00010117951751453802
developing O 0 0.0547669418156147
synaptonemal O 1 0.9614173769950867
complexes O 0 0.020215628668665886
. O 0 0.0016049601836130023

Like O 0 0.009897868148982525
BRCA1 O 1 0.9944328665733337
and O 0 0.0029983145650476217
RAD51 O 1 0.9992994070053101
, O 0 0.004487396217882633
BRCA2 O 1 0.9964330196380615
relocates O 0 0.10600372403860092
to O 0 0.0018061127047985792
PCNA O 1 0.9964271187782288
+ O 0 0.016811400651931763
replication O 0 0.0017932377522811294
sites O 0 0.0003196908510290086
following O 0 0.0005825867410749197
exposure O 0 0.023940175771713257
of O 0 0.00013958469207864255
S O 1 0.9640993475914001
phase O 0 0.006076485384255648
cells O 0 0.0014914091443642974
to O 0 0.00029339882894419134
hydroxyurea O 1 0.9986415505409241
or O 0 0.00203523738309741
UV O 1 0.9984526634216309
irradiation O 0 0.07147709280252457
. O 0 0.0010623291600495577

Thus O 0 0.0030936484690755606
, O 0 0.002415657974779606
BRCA1 O 1 0.9992690682411194
and O 0 0.001625842065550387
BRCA2 O 1 0.9980868101119995
participate O 0 0.0007531348965130746
, O 0 0.0001344455376965925
together O 0 7.070114224916324e-05
, O 0 9.206629329128191e-05
in O 0 0.00013600988313555717
a O 0 0.0010612114565446973
pathway O 0 0.024328989908099174
( O 0 0.001178278005681932
s O 0 0.060953423380851746
) O 0 0.0002182399621233344
associated O 0 0.00014749322144780308
with O 0 2.4657516405568458e-05
the O 0 6.719341035932302e-05
activation O 0 0.0007246137247420847
of O 0 2.69944139290601e-05
double O 0 0.002814173698425293
- O 0 0.005023651756346226
strand O 0 0.005229354370385408
break O 0 0.004223434254527092
repair O 1 0.9978750944137573
and O 0 0.0007685635355301201
/ O 0 0.03833647444844246
or O 0 0.0005348618142306805
homologous O 0 0.00809879694133997
recombination O 0 0.008028974756598473
. O 0 0.0015895948745310307

Dysfunction O 1 0.9972215890884399
of O 0 0.00012620339111890644
this O 0 0.0005353057640604675
pathway O 0 0.015086593106389046
may O 0 0.0007537315832450986
be O 0 9.658473572926596e-05
a O 0 0.0003724097041413188
general O 0 0.0009368638275191188
phenomenon O 0 0.0016865418292582035
in O 0 7.822470070095733e-05
the O 0 7.605582504766062e-05
majority O 0 0.00010257169196847826
of O 0 2.516405402275268e-05
cases O 0 0.0008574257954023778
of O 0 0.0001828403619583696
hereditary B-Disease 1 0.9999716281890869
breast I-Disease 1 0.9999992847442627
and I-Disease 0 0.03867390379309654
/ I-Disease 1 0.9998251795768738
or I-Disease 1 0.9963950514793396
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.000625263899564743
. O 0 0.0009456578409299254

A O 0 0.008807857520878315
novel O 0 0.007249464280903339
Arg362Ser O 0 0.17673878371715546
mutation O 0 0.0022272514179348946
in O 0 0.0001391525293001905
the O 0 0.000395542592741549
sterol O 1 0.9225987195968628
27 O 0 0.005848750937730074
- O 0 0.01180917490273714
hydroxylase O 0 0.25711578130722046
gene O 0 0.004369489382952452
( O 0 0.0014006770215928555
CYP27 O 1 0.987057626247406
) O 0 0.00030633475398644805
: O 0 0.00012172874994575977
its O 0 0.00014698426821269095
effects O 0 0.002187290694564581
on O 0 0.0002260385372210294
pre O 0 0.0023820027709007263
- O 0 0.001000034622848034
mRNA O 0 0.00023931989562697709
splicing O 0 0.0007301340810954571
and O 0 0.00012336493819020689
enzyme O 0 0.0021645596716552973
activity O 0 0.0011196411214768887
. O 0 0.0009602957288734615

A O 0 0.008668443188071251
novel O 0 0.00609074579551816
C O 0 0.008823319338262081
to O 0 0.00010837739682756364
A O 0 0.0012639379128813744
mutation O 0 0.0007379532908089459
in O 0 6.914635741850361e-05
the O 0 0.00035024990211240947
sterol O 1 0.9383566379547119
27 O 0 0.00485620740801096
- O 0 0.012376181781291962
hydroxylase O 1 0.6458943486213684
gene O 0 0.004066891502588987
( O 0 0.0010886358795687556
CYP27 O 1 0.9914079308509827
) O 0 0.00041415399755351245
was O 0 0.0007413356215693057
identified O 0 0.00033419288229197264
by O 0 6.325133290374652e-05
sequencing O 0 0.0014869098085910082
amplified O 0 0.00983609538525343
CYP27 O 1 0.9052967429161072
gene O 0 0.002225313102826476
products O 0 0.0008310854318551719
from O 0 0.00015522299509029835
a O 0 0.0017113009234890342
patient O 1 0.9979866743087769
with O 0 0.0008658489095978439
cerebrotendinous B-Disease 1 0.9994480013847351
xanthomatosis I-Disease 1 0.9990910291671753
( O 0 0.006117942743003368
CTX B-Disease 1 0.9998915195465088
) O 0 0.0013327719643712044
. O 0 0.0009539534221403301

The O 0 0.0017577458638697863
mutation O 0 0.004677531775087118
changed O 0 0.0016744310269132257
the O 0 0.0003891355881933123
adrenodoxin O 0 0.12742167711257935
cofactor O 0 0.02414151094853878
binding O 0 0.0021628346294164658
residue O 0 0.013031481765210629
362Arg O 0 0.03196706250309944
to O 0 0.0006780721596442163
362Ser O 0 0.09208977222442627
( O 0 0.0020522968843579292
CGT O 1 0.9807147979736328
362Arg O 0 0.31354090571403503
to O 0 0.001956961117684841
AGT O 1 0.9998685121536255
362Ser O 1 0.5836285948753357
) O 0 0.00028780518914572895
, O 0 8.867622818797827e-05
and O 0 7.260147685883567e-05
was O 0 0.0006285533308982849
responsible O 0 0.0025684700813144445
for O 0 0.001012027612887323
deficiency O 1 0.999991774559021
in O 0 0.00023661990417167544
the O 0 0.0005718378815799952
sterol O 1 0.9874626994132996
27 O 0 0.005054441746324301
- O 0 0.013159955851733685
hydroxylase O 0 0.07916797697544098
activity O 0 0.0006420842255465686
, O 0 0.00017630044021643698
as O 0 0.00028517298051156104
confirmed O 0 0.0008805558900348842
by O 0 3.646796176326461e-05
expression O 0 0.0002014112687902525
of O 0 4.1238894482376054e-05
mutant O 0 0.004943979904055595
cDNA O 0 0.0042768679559230804
into O 0 0.0011971176136285067
COS O 1 0.9934321641921997
- O 0 0.006035290192812681
1 O 0 0.0010710143251344562
cells O 0 0.0028539695776998997
. O 0 0.0006366697489283979

Quantitative O 0 0.004578493069857359
analysis O 0 0.0007498142658732831
showed O 0 0.0008615792612545192
that O 0 4.457897011889145e-05
the O 0 6.56011252431199e-05
expression O 0 0.0004416392184793949
of O 0 0.00010559185466263443
CYP27 O 1 0.978640615940094
gene O 0 0.0008398848003707826
mRNA O 0 0.00020335269800852984
in O 0 0.00010802215547300875
the O 0 0.0005139971617609262
patient O 1 0.995794415473938
represented O 0 0.0007280784193426371
52 O 0 0.004530278500169516
. O 0 0.0011090406915172935

5 O 0 0.0007730533834546804
% O 0 2.62994144577533e-05
of O 0 1.6688700270606205e-05
the O 0 0.00027406951994635165
normal O 0 0.003607121529057622
level O 0 0.00284281512722373
. O 0 0.0010239635594189167

As O 0 0.0007102147210389376
the O 0 0.00042256267624907196
mutation O 0 0.00306707713752985
occurred O 0 0.000881409621797502
at O 0 0.0001973110338440165
the O 0 0.00017329990805592388
penultimate O 0 0.006661704741418362
nucleotide O 0 0.0002529525081627071
of O 0 8.199083822546527e-05
exon O 0 0.019330445677042007
6 O 0 0.0018045693868771195
( O 0 0.000696351402439177
- O 0 0.0015096053248271346
2 O 0 0.00013917732576373965
position O 0 0.00021480476425495
of O 0 4.461563003133051e-05
exon O 0 0.013885967433452606
6 O 0 0.0018357333028689027
- O 0 0.005321263335645199
intron O 0 0.05228541046380997
6 O 0 0.0014494562055915594
splice O 0 0.010804632678627968
site O 0 0.0010747367050498724
) O 0 6.326472066575661e-05
of O 0 1.7237949577975087e-05
the O 0 0.0003199268248863518
gene O 0 0.001863596960902214
, O 0 0.00015225222159642726
we O 0 0.00018246678519062698
hypothesized O 0 0.003609681036323309
that O 0 5.069912731414661e-05
the O 0 0.00023980365949682891
mutation O 0 0.005132569931447506
may O 0 0.0014884894480928779
partially O 0 0.00720973638817668
affect O 0 0.0009754939819686115
the O 0 0.0001275691611226648
normal O 0 0.0012121223844587803
splicing O 0 0.0011916158255189657
efficiency O 0 0.001957518048584461
in O 0 0.0003938901354558766
exon O 0 0.014217405579984188
6 O 0 0.0009472750825807452
and O 0 0.00027248982223682106
cause O 0 0.00873645581305027
alternative O 0 0.0014769339468330145
splicing O 0 0.0029049264267086983
elsewhere O 0 0.0008509012986905873
, O 0 0.00015451639774255455
which O 0 6.746692815795541e-05
resulted O 0 0.0011244714260101318
in O 0 0.00025717337848618627
decreased O 0 0.009795389138162136
transcript O 0 0.00336825312115252
in O 0 0.00015295710181817412
the O 0 0.0008505161968059838
patient O 1 0.9992672801017761
. O 0 0.0011029719607904553

Transfection O 0 0.16308891773223877
of O 0 0.00022464542416855693
constructed O 0 0.0072413901798427105
minigenes O 0 0.43880581855773926
, O 0 0.0002021373511524871
with O 0 8.547584002371877e-05
or O 0 0.00019744351448025554
without O 0 0.00017576466780155897
the O 0 0.0002350389986531809
mutation O 0 0.001671645324677229
, O 0 0.000220193833229132
into O 0 0.000834988837596029
COS O 1 0.9958145022392273
- O 0 0.005073481239378452
1 O 0 0.0009016962721943855
cells O 0 0.0018134968122467399
confirmed O 0 0.0007366752834059298
that O 0 5.319273623172194e-05
the O 0 0.0003308616578578949
mutant O 0 0.011120236478745937
minigene O 0 0.33888721466064453
was O 0 0.0009472394012846053
responsible O 0 0.001076576067134738
for O 0 0.0001144809793913737
a O 0 0.0003279142256360501
mRNA O 0 0.0005449648597277701
species O 0 0.00030510887154377997
alternatively O 0 0.0024865828454494476
spliced O 0 0.0022411784157156944
at O 0 0.0003579701588023454
an O 0 0.0007126096170395613
activated O 0 0.04801787808537483
cryptic O 0 0.028800027444958687
5 O 0 0.000897460849955678
splice O 0 0.015196604654192924
site O 0 0.003190940245985985
88 O 0 0.0055093467235565186
bp O 0 0.02430388703942299
upstream O 0 0.002255192492157221
from O 0 8.182851888705045e-05
the O 0 0.0001362557231914252
3 O 0 0.0003252283204346895
end O 0 0.000313808472128585
of O 0 5.9855952713405713e-05
exon O 0 0.029650595039129257
6 O 0 0.0018123731715604663
. O 0 0.0007858258322812617

Our O 0 0.00088323256932199
data O 0 0.00023036544735077769
suggest O 0 0.0005993099184706807
that O 0 6.577457679668441e-05
the O 0 0.00025567764532752335
C O 0 0.006504445802420378
to O 0 0.00012597159366123378
A O 0 0.0019375149859115481
mutation O 0 0.0013864354696124792
at O 0 0.00018422037828713655
the O 0 0.00014711677795276046
penultimate O 0 0.009417160414159298
nucleotide O 0 0.0002705918741412461
of O 0 5.89194314670749e-05
exon O 0 0.011669216677546501
6 O 0 0.00031479966128244996
of O 0 3.370053309481591e-05
the O 0 0.0006796866655349731
CYP27 O 1 0.9973313808441162
gene O 0 0.0013467551907524467
not O 0 9.534550918033347e-05
only O 0 0.00016079307533800602
causes O 0 0.10269143432378769
the O 0 0.0016238820971921086
deficiency B-Disease 1 0.9999735355377197
in I-Disease 0 0.000301458960166201
the I-Disease 0 0.000787159486208111
sterol I-Disease 1 0.971837043762207
27 I-Disease 0 0.004825620912015438
- I-Disease 0 0.009789264760911465
hydroxylase I-Disease 0 0.04388384521007538
activity I-Disease 0 0.0006329552852548659
, O 0 0.00020238844444975257
but O 0 0.0002375161275267601
also O 0 0.00035019576898775995
partially O 0 0.005919424816966057
leads O 0 0.0006439732969738543
to O 0 7.1896800363902e-05
alternative O 0 0.0006509104277938604
pre O 0 0.001914743916131556
- O 0 0.0005647767684422433
mRNA O 0 0.00013424082135315984
splicing O 0 0.0002593023527879268
of O 0 2.420906093902886e-05
the O 0 0.00043965678196400404
gene O 0 0.0036847179289907217
. O 0 0.0007139433291740716

To O 0 0.00039475204539485276
our O 0 0.00033351872116327286
knowledge O 0 0.000927855959162116
, O 0 9.473232785239816e-05
this O 0 4.8176738346228376e-05
is O 0 0.00010404531349195167
the O 0 0.00010121252125827596
first O 0 0.0002350600843783468
report O 0 0.0006728633888997138
regarding O 0 0.0007671231287531555
effects O 0 0.003136642510071397
on O 0 0.0002923230640590191
pre O 0 0.0028135969769209623
- O 0 0.0007308880449272692
mRNA O 0 0.00013118456990923733
splicing O 0 0.00026906401035375893
of O 0 1.9471513951430097e-05
a O 0 0.0006526224315166473
mutation O 0 0.001789312344044447
at O 0 0.0003262686950620264
the O 0 0.00030047394102439284
- O 0 0.001554641523398459
2 O 0 0.0001484336971770972
position O 0 0.00011485240975162014
of O 0 1.3654034773935564e-05
a O 0 0.0005369589198380709
5 O 0 0.0007858782191760838
splice O 0 0.017414972186088562
site O 0 0.0035457501653581858
. O 0 0.000864437606651336

ATM O 0 0.0816645398736
germline O 1 0.5434004664421082
mutations O 0 0.0034149836283177137
in O 0 0.0004622436536010355
classical O 0 0.013224177993834019
ataxia B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999098777770996
telangiectasia I-Disease 1 0.9999977350234985
patients O 1 0.999966025352478
in O 0 0.00016708060866221786
the O 0 0.00022947258548811078
Dutch O 0 0.0016696125967428088
population O 0 0.00018528065993450582
. O 0 0.0005806056433357298

Germline O 1 0.9525288343429565
mutations O 0 0.005039913579821587
in O 0 0.00020836906332988292
the O 0 0.00036469174665398896
ATM O 0 0.016910774633288383
gene O 0 0.0011678882874548435
are O 0 2.8791420845664106e-05
responsible O 0 0.0010690275812521577
for O 0 0.0002856058708857745
the O 0 0.004489914979785681
autosomal B-Disease 1 0.9999970197677612
recessive I-Disease 1 0.9999994039535522
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9997811913490295
telangiectasia I-Disease 1 0.9999669790267944
( O 0 0.007419148925691843
A B-Disease 1 0.9988835453987122
- I-Disease 1 0.9958945512771606
T I-Disease 1 0.9994339346885681
) O 0 0.0007562908576801419
. O 0 0.00070212158607319

In O 0 0.0007584340055473149
our O 0 0.0008361133513972163
study O 0 0.0010359797161072493
, O 0 0.000134482717840001
we O 0 0.00010837191803148016
have O 0 4.742994860862382e-05
determined O 0 0.0003086789511144161
the O 0 0.00014014188491273671
ATM O 0 0.006268087774515152
mutation O 0 0.0012067373609170318
spectrum O 0 0.0011584791354835033
in O 0 0.00015410585911013186
19 O 0 0.0005535933305509388
classical O 0 0.0009119338938035071
A B-Disease 1 0.9993436932563782
- I-Disease 1 0.9996660947799683
T I-Disease 1 0.9999885559082031
patients O 1 0.9999017715454102
, O 0 0.00013977728667668998
including O 0 6.243005918804556e-05
some O 0 0.00010151157039217651
immigrant O 0 0.0009621629724279046
populations O 0 0.0005744198570027947
, O 0 0.00012967076327186078
as O 0 0.00011748114047804847
well O 0 8.066468581091613e-05
as O 0 0.00011992186773568392
12 O 0 0.0001550342421978712
of O 0 1.6893132851691917e-05
Dutch O 0 0.0006953009869903326
ethnic O 0 0.00015309893933590502
origin O 0 0.00031142591615207493
. O 0 0.0008371123112738132

Both O 0 0.00021866528550162911
the O 0 0.00017864478286355734
protein O 0 0.0012035593390464783
truncation O 0 0.021100198850035667
test O 0 0.004480087198317051
( O 0 0.0013215671060606837
PTT O 0 0.1348189264535904
) O 0 0.00012934253027196974
and O 0 3.98654374293983e-05
the O 0 0.00014415549230761826
restriction O 0 0.001973978942260146
endonuclease O 0 0.44471582770347595
fingerprinting O 0 0.05712667852640152
( O 0 0.00255787605419755
REF O 1 0.9906119704246521
) O 0 0.00015857041580602527
method O 0 0.00017332517018076032
were O 0 3.337717862450518e-05
used O 0 0.00011813314631581306
and O 0 9.78950338321738e-05
compared O 0 0.0003555689181666821
for O 0 9.124037023866549e-05
their O 0 7.379028102150187e-05
detection O 0 0.00426441989839077
efficiency O 0 0.002361506689339876
, O 0 0.00030965785845182836
identifying O 0 0.005617769435048103
76 O 0 0.0036655678413808346
% O 0 6.723238038830459e-05
and O 0 0.00010321829176973552
60 O 0 0.00023758273164276034
% O 0 1.4101030501478817e-05
of O 0 1.643092582526151e-05
the O 0 0.0003994536818936467
mutations O 0 0.0029920716769993305
, O 0 0.0002774539461825043
respectively O 0 0.0010460279881954193
. O 0 0.0006636100588366389

Most O 0 0.0070523954927921295
patients O 1 0.9995860457420349
were O 0 8.560161950299516e-05
found O 0 0.000167330916156061
to O 0 7.914392335806042e-05
be O 0 0.0001967564458027482
compound O 0 0.006180576514452696
heterozygote O 0 0.10083295404911041
. O 0 0.0008965069428086281

Seventeen O 0 0.015843799337744713
mutations O 0 0.0036951557267457247
were O 0 7.60181137593463e-05
distinct O 0 0.00039077355177141726
, O 0 9.038651478476822e-05
of O 0 2.238072920590639e-05
which O 0 7.379478483926505e-05
10 O 0 0.00015455042012035847
were O 0 3.987911986769177e-05
not O 0 0.00019254557264503092
reported O 0 0.0018854296067729592
previously O 0 0.001403906149789691
. O 0 0.0006462882156483829

Mutations O 0 0.007714808918535709
are O 0 9.889060311252251e-05
small O 0 0.00046727232984267175
deletions O 0 0.004019035492092371
or O 0 0.0003510377719067037
point O 0 0.0008629629155620933
mutations O 0 0.0027942995075136423
frequently O 0 0.0017276427242904902
affecting O 0 0.010519294999539852
splice O 0 0.025441773235797882
sites O 0 0.0012997715966776013
. O 0 0.0009706458658911288

Moreover O 0 0.008230880834162235
, O 0 0.0003639007336460054
a O 0 0.0009326528524979949
16 O 0 0.001207862515002489
. O 0 0.0006611064891330898

7 O 0 0.005852007772773504
- O 0 0.006463251076638699
kb O 0 0.009811447001993656
genomic O 0 0.0030409737955778837
deletion O 0 0.0018082113238051534
of O 0 2.184026743634604e-05
the O 0 0.00027281526126898825
3 O 0 0.0004537896311376244
end O 0 0.0003154293808620423
of O 0 2.276725172123406e-05
the O 0 0.0003426329931244254
gene O 0 0.0018875251989811659
, O 0 0.00013662352284882218
most O 0 0.0001993503246922046
likely O 0 0.0005232151015661657
a O 0 0.0002220548631157726
result O 0 0.00016316914116032422
of O 0 2.6719038942246698e-05
recombination O 0 0.00121338851749897
between O 0 0.00010026850213762373
two O 0 0.00010280406422680244
LINE O 0 0.002179756760597229
elements O 0 0.00023116190277505666
, O 0 0.0002840764063876122
was O 0 0.001354738837108016
identified O 0 0.001721388311125338
. O 0 0.0005795633769594133

The O 0 0.000720303738489747
most O 0 0.00047721181181259453
frequently O 0 0.0016849874518811703
found O 0 0.0007829185924492776
mutation O 0 0.0027850947808474302
, O 0 0.00018669744895305485
identified O 0 0.000373228220269084
in O 0 7.002052007010207e-05
three O 0 0.0001250542263733223
unrelated O 0 0.0052620102651417255
Turkish O 0 0.007244853302836418
A B-Disease 1 0.9980904459953308
- I-Disease 1 0.997395396232605
T I-Disease 1 0.999790370464325
individuals O 0 0.000376508804038167
, O 0 0.0002733255678322166
was O 0 0.0008676096913404763
previously O 0 0.0006461422308348119
described O 0 0.0006403203005902469
to O 0 3.21268271363806e-05
be O 0 3.747981827473268e-05
a O 0 0.00030458890250883996
Turkish O 0 0.0028537700418382883
A B-Disease 1 0.9805147051811218
- I-Disease 1 0.9914466142654419
T I-Disease 1 0.9993415474891663
founder O 0 0.02194233424961567
mutation O 0 0.006636420730501413
. O 0 0.0010582584654912353

The O 0 0.00044166759471409023
presence O 0 0.00044174512731842697
of O 0 5.481410335050896e-05
a O 0 0.0020414870232343674
founder O 0 0.04062877222895622
mutation O 0 0.0025357792619615793
among O 0 0.00016381936438847333
relatively O 0 0.0006693188915960491
small O 0 0.00014952782657928765
ethnic O 0 0.00010134773037862033
population O 0 6.857624975964427e-05
groups O 0 9.068842337001115e-05
in O 0 0.00023077105288393795
Western O 0 0.0009637516923248768
Europe O 0 0.0011789853451773524
could O 0 0.00033455275115557015
indicate O 0 0.0005718100583180785
a O 0 0.0005997939151711762
high O 0 0.002032405463978648
carrier O 0 0.006394670810550451
frequency O 0 0.00024799612583592534
in O 0 7.764606561977416e-05
such O 0 8.750951383262873e-05
communities O 0 0.0010871802223846316
. O 0 0.000958261254709214

In O 0 0.0036538559943437576
patients O 1 0.9991233944892883
of O 0 6.370758637785912e-05
Dutch O 0 0.001211722963489592
ethnic O 0 0.00015829940093681216
origin O 0 0.00017250674136448652
, O 0 0.0002528635086491704
however O 0 0.0002676445583347231
, O 0 0.00012104074994567782
no O 0 0.00017122145800385624
significant O 0 0.0008024180424399674
founder O 0 0.008865650743246078
effect O 0 0.0011145375901833177
could O 0 0.00034430049709044397
be O 0 0.00014529649342875928
identified O 0 0.0009712378378026187
. O 0 0.0004310108197387308

The O 0 0.0010462411446496844
observed O 0 0.001663242350332439
genetic O 0 0.002678606193512678
heterogeneity O 0 0.006372589152306318
including O 0 9.934334229910746e-05
the O 0 0.000154275112436153
relative O 0 0.0005868053995072842
high O 0 0.0008474485948681831
percentage O 0 0.00032761553302407265
of O 0 8.105747838271782e-05
splice O 0 0.08638476580381393
- O 0 0.01014724187552929
site O 0 0.002367736306041479
mutations O 0 0.0017647140193730593
had O 0 0.00037169925053603947
no O 0 0.00015718876966275275
reflection O 0 0.002884714398533106
on O 0 0.0002773003070615232
the O 0 0.0007177930674515665
phenotype O 0 0.4103810787200928
. O 0 0.0014046388678252697

All O 0 0.0011776272440329194
patients O 1 0.999351441860199
manifested O 0 0.3187211751937866
classical O 0 0.0020963428542017937
A B-Disease 1 0.9991679191589355
- I-Disease 1 0.9968036413192749
T I-Disease 1 0.9993574023246765
and O 0 0.00010416563600301743
increased O 0 0.0007200796389952302
cellular O 0 0.004091563634574413
radioresistant O 0 0.05692123994231224
DNA O 0 0.0016678442480042577
synthesis O 0 0.00241710408590734
. O 0 0.0010404880158603191

Determination O 0 0.003798950230702758
of O 0 3.220793587388471e-05
the O 0 0.00019013955898117274
genomic O 0 0.001468723639845848
structure O 0 0.0003960249887313694
of O 0 2.94736946671037e-05
the O 0 0.0006386108580045402
COL4A4 O 1 0.9975495934486389
gene O 0 0.0006580853369086981
and O 0 2.628885704325512e-05
of O 0 4.101737431483343e-05
novel O 0 0.011983513832092285
mutations O 0 0.16441887617111206
causing O 1 0.998805046081543
autosomal B-Disease 1 0.9999492168426514
recessive I-Disease 1 0.9999866485595703
Alport I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.9999995231628418
. O 0 0.006576103158295155

Autosomal B-Disease 1 0.999882698059082
recessive I-Disease 1 0.9999724626541138
Alport I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999997615814209
is O 0 0.0018112228717654943
a O 0 0.0041601043194532394
progressive O 1 0.9976757168769836
hematuric B-Disease 1 0.9994741082191467
glomerulonephritis I-Disease 1 0.9999843835830688
characterized O 1 0.986480712890625
by O 0 0.0023124227300286293
glomerular B-Disease 1 0.9999227523803711
basement I-Disease 1 0.9966967105865479
membrane I-Disease 1 0.6386154294013977
abnormalities I-Disease 1 0.9992461204528809
and O 0 0.0003539536555763334
associated O 0 0.0005503185675479472
with O 0 0.00016683577268850058
mutations O 0 0.0016765918117016554
in O 0 0.0001489103160565719
either O 0 0.0003738118102774024
the O 0 0.0006728980806656182
COL4A3 O 1 0.9952980875968933
or O 0 0.00045147951459512115
the O 0 0.0008860770612955093
COL4A4 O 1 0.9941949248313904
gene O 0 0.0017720171017572284
, O 0 7.24484198144637e-05
which O 0 2.494452564860694e-05
encode O 0 0.0001779073936631903
the O 0 0.00024977204157039523
alpha3 O 0 0.16364532709121704
and O 0 0.0005755303427577019
alpha4 O 1 0.9833961129188538
type O 1 0.8751501441001892
IV O 1 0.9998577833175659
collagen O 1 0.9996217489242554
chains O 0 0.009491861797869205
, O 0 0.0005474816425703466
respectively O 0 0.001267455518245697
. O 0 0.0006665638065896928

To O 0 0.000497665605507791
date O 0 0.0005841903621330857
, O 0 0.0003390281926840544
mutation O 0 0.0028470216784626245
screening O 0 0.001951522077433765
in O 0 6.764254794688895e-05
the O 0 8.797521149972454e-05
two O 0 7.481097418349236e-05
genes O 0 0.0005200632731430233
has O 0 0.0006237921770662069
been O 0 0.0007520921644754708
hampered O 1 0.9867262840270996
by O 0 6.72128880978562e-05
the O 0 0.0001188836176879704
lack O 0 0.0007980600348673761
of O 0 3.805335654760711e-05
genomic O 0 0.002706935629248619
structure O 0 0.0016179010272026062
information O 0 0.000780863338150084
. O 0 0.0010858941823244095

We O 0 0.0013943312224000692
report O 0 0.0009212317527271807
here O 0 0.00014552775246556848
the O 0 0.0001511805603513494
complete O 0 0.0009184176451526582
characterization O 0 0.0030689614359289408
of O 0 2.786703953461256e-05
the O 0 0.0001839465694501996
48 O 0 0.0008161164587363601
exons O 0 0.0011395300971344113
of O 0 3.800338163273409e-05
the O 0 0.0007339406874962151
COL4A4 O 1 0.993725597858429
gene O 0 0.0017918386729434133
, O 0 0.00015937958960421383
a O 0 0.0006297934451140463
comprehensive O 0 0.023300908505916595
gene O 0 0.0027180183678865433
screen O 0 0.0013684662990272045
, O 0 0.00011043674749089405
and O 0 5.116559623274952e-05
the O 0 0.00010488466796232387
subsequent O 0 0.0005843043327331543
detection O 0 0.0013103910023346543
of O 0 2.3630462237633765e-05
10 O 0 0.00036653465940617025
novel O 0 0.001403805916197598
mutations O 0 0.0012892668601125479
in O 0 0.00023859424982219934
eight O 0 0.006646399386227131
patients O 1 0.9999990463256836
diagnosed O 1 0.9999995231628418
with O 0 0.006864137947559357
autosomal B-Disease 1 0.9999755620956421
recessive I-Disease 1 0.9999912977218628
Alport I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
. O 0 0.006289219483733177

Furthermore O 0 0.00849466398358345
, O 0 0.00035280955489724874
we O 0 0.0001906164106912911
identified O 0 0.00047442602226510644
a O 0 0.00037137657636776567
glycine O 0 0.0036008935421705246
to O 0 0.00015977064322214574
alanine O 0 0.006482431665062904
substitution O 0 0.00043825400643981993
in O 0 0.00014119065599516034
the O 0 0.0005033332272432745
collagenous O 1 0.99228435754776
domain O 0 0.0010095902252942324
that O 0 0.0002050862822216004
is O 0 0.0006159312906675041
apparently O 0 0.0036727390252053738
silent O 0 0.003153563942760229
in O 0 9.448792116018012e-05
the O 0 0.0002728425897657871
heterozygous O 0 0.004358632955700159
carriers O 0 0.004189789295196533
, O 0 0.00018375406216364354
in O 0 0.00025313658989034593
11 O 0 0.0015462767332792282
. O 0 0.0008387186680920422

5 O 0 0.00089213129831478
% O 0 3.5009896237170324e-05
of O 0 1.6872587366378866e-05
all O 0 7.265451858984306e-05
control O 0 0.0015636382158845663
individuals O 0 0.0002410155429970473
, O 0 0.00017081023543141782
and O 0 8.804545359453186e-05
in O 0 0.0001084306204575114
one O 0 0.00013927039981354028
control O 0 0.0007809711969457567
individual O 0 0.0002500494010746479
homozygous O 0 0.0014747838722541928
for O 0 7.64669239288196e-05
this O 0 9.776490333024412e-05
glycine O 0 0.005662726238369942
substitution O 0 0.0016549872234463692
. O 0 0.0009899743599817157

There O 0 0.001064010546542704
has O 0 0.0006869219359941781
been O 0 0.00032431617728434503
no O 0 0.00012951740063726902
previous O 0 0.00016221847909037024
finding O 0 0.00031087713432498276
of O 0 1.6527812476851977e-05
a O 0 0.0007348262588493526
glycine O 0 0.005045600701123476
substitution O 0 0.0005444815033115447
that O 0 0.00011641737364698201
is O 0 0.00025041252956725657
not O 0 9.675490582594648e-05
associated O 0 0.00012467667693272233
with O 0 6.605516682611778e-05
any O 0 0.0002394869807176292
obvious O 0 0.027640193700790405
phenotype O 1 0.6500738859176636
in O 0 0.0005535415257327259
homozygous O 0 0.007226220332086086
individuals O 0 0.000672335154376924
. O 0 0.0010494906455278397

Founder O 1 0.8973804116249084
BRCA1 O 1 0.9977256655693054
and O 0 0.0018179630860686302
BRCA2 O 1 0.9960506558418274
mutations O 0 0.002758587244898081
in O 0 0.0002493908104952425
French O 0 0.003910783212631941
Canadian O 1 0.8761826753616333
breast B-Disease 1 0.9999994039535522
and I-Disease 1 0.9897720217704773
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.0026461740490049124
. O 0 0.001373881590552628

We O 0 0.0009740335517562926
have O 0 0.00017159723211079836
identified O 0 0.0003906741039827466
four O 0 8.6008440121077e-05
mutations O 0 0.00039596454007551074
in O 0 1.8475246179150417e-05
each O 0 1.0399429811513983e-05
of O 0 2.9538381568272598e-05
the O 0 0.00882286112755537
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999986886978149
- O 0 0.13508865237236023
susceptibility O 0 0.19335711002349854
genes O 0 0.0010661747073754668
, O 0 0.0009923563338816166
BRCA1 O 1 0.9991486072540283
and O 0 0.0012562732445076108
BRCA2 O 1 0.998497724533081
, O 0 0.00017307745292782784
in O 0 0.0001511534646851942
French O 0 0.004096326883882284
Canadian O 1 0.9796192646026611
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
and O 1 0.8431482315063477
breast B-Disease 1 1.0
/ I-Disease 1 0.9999924898147583
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.0013300386490300298
from O 0 0.0005780126666650176
Quebec O 0 0.10961438715457916
. O 0 0.0013421010226011276

To O 0 0.0011778875486925244
identify O 0 0.004727538675069809
founder O 0 0.029410019516944885
effects O 0 0.00705800112336874
, O 0 0.00026396565954200923
we O 0 0.00027404469437897205
examined O 0 0.003426017239689827
independently O 0 0.0004724288883153349
ascertained O 0 0.012254727073013783
French O 0 0.004264970775693655
Canadian O 1 0.8231620192527771
cancer B-Disease 1 0.9999891519546509
families O 0 0.0003010023501701653
for O 0 7.126363198040053e-05
the O 0 6.669609865639359e-05
distribution O 0 6.976511212997139e-05
of O 0 1.3630461580760311e-05
these O 0 4.682995131588541e-05
eight O 0 0.0005026200669817626
mutations O 0 0.003785443492233753
. O 0 0.000741339463274926

Mutations O 0 0.008220618590712547
were O 0 0.00011748528777388856
found O 0 0.00030785458511672914
in O 0 0.0001403560017934069
41 O 0 0.000667737505864352
of O 0 5.2194696763763204e-05
97 O 0 0.006090122275054455
families O 0 0.000997972092591226
. O 0 0.0012320716632530093

Six O 0 0.0006085347849875689
of O 0 5.0230017222929746e-05
eight O 0 0.0005545304156839848
mutations O 0 0.0012436143588274717
were O 0 4.07994921260979e-05
observed O 0 0.00030874719959683716
at O 0 0.0002674422867130488
least O 0 0.0003932868130505085
twice O 0 0.0022112843580543995
. O 0 0.0006295510102063417

The O 0 0.005656345281749964
BRCA1 O 1 0.9980942606925964
C4446T O 0 0.49047422409057617
mutation O 0 0.004577791318297386
was O 0 0.0006362451240420341
the O 0 0.0001367221848340705
most O 0 0.00029577064560726285
common O 0 0.0018431751523166895
mutation O 0 0.0036245582159608603
found O 0 0.00034036635770462453
, O 0 0.00012867356417700648
followed O 0 0.0002594237739685923
by O 0 9.800759289646521e-05
the O 0 0.00131046783644706
BRCA2 O 1 0.9985266923904419
8765delAG O 1 0.7454144358634949
mutation O 0 0.008529018610715866
. O 0 0.0013006050139665604

Together O 0 0.0005991471116431057
, O 0 0.00025773991364985704
these O 0 9.657810733187944e-05
mutations O 0 0.0014726731460541487
were O 0 4.47950696980115e-05
found O 0 0.00017914971977006644
in O 0 9.964009950635955e-05
28 O 0 0.0005097907269373536
of O 0 3.999330147053115e-05
41 O 0 0.0017506357980892062
families O 0 0.00034689242602325976
identified O 0 0.0004844256618525833
to O 0 6.544073403347284e-05
have O 0 7.894945883890614e-05
a O 0 0.0006467658095061779
mutation O 0 0.004017346538603306
. O 0 0.0007267943001352251

The O 0 0.0011292148847132921
odds O 0 0.004563968628644943
of O 0 5.40472574357409e-05
detection O 0 0.0013603019760921597
of O 0 1.0618239684845321e-05
any O 0 2.8096015739720315e-05
of O 0 1.242957114300225e-05
the O 0 0.00021969096269458532
four O 0 0.0008037664229050279
BRCA1 O 1 0.9982054233551025
mutations O 0 0.004287413787096739
was O 0 0.0012577867601066828
18 O 0 0.0009842521976679564
. O 0 0.0008600044529885054

7x O 1 0.9749529361724854
greater O 0 0.0014648099895566702
if O 0 0.00033136544516310096
one O 0 6.502549513243139e-05
or O 0 8.979477570392191e-05
more O 0 9.58843738771975e-05
cases O 0 0.003479731734842062
of O 0 0.0029239291325211525
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
were O 0 0.0001043525553541258
also O 0 0.00013126803969498724
present O 0 0.00011149945930810645
in O 0 9.679182403488085e-05
the O 0 0.00028607298736460507
family O 0 0.0019771296065300703
. O 0 0.0011375464964658022

The O 0 0.0009773867204785347
odds O 0 0.005087035708129406
of O 0 5.591520312009379e-05
detection O 0 0.0019723130390048027
of O 0 1.2592538951139431e-05
any O 0 3.365939483046532e-05
of O 0 1.5069520486576948e-05
the O 0 0.00032319914316758513
four O 0 0.0010400558821856976
BRCA2 O 1 0.9973467588424683
mutations O 0 0.0041736336424946785
was O 0 0.0012218690244480968
5 O 0 0.00109109899494797
. O 0 0.0007525839027948678

3x O 1 0.8715198040008545
greater O 0 0.0015400933334603906
if O 0 0.0004010253178421408
there O 0 5.686635631718673e-05
were O 0 2.0576764654833823e-05
at O 0 0.00010357057180954143
least O 0 9.992460400098935e-05
five O 0 0.00013509063865058124
cases O 0 0.001117916777729988
of O 0 0.000700119708199054
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
in O 0 0.00026690858067013323
the O 0 0.0005076682427898049
family O 0 0.0023758034221827984
. O 0 0.0013182598631829023

Interestingly O 0 0.020539673045277596
, O 0 0.00015080635785125196
the O 0 6.00752500758972e-05
presence O 0 0.00024891048087738454
of O 0 6.78974247421138e-05
a O 1 0.6409591436386108
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999988079071045
case O 0 0.03810038045048714
< O 0 0.13403137028217316
36 O 0 0.000809605058748275
years O 0 0.00017239624867215753
of O 0 3.103578637819737e-05
age O 0 0.0008907057344913483
was O 0 0.0009504659683443606
strongly O 0 0.0011423536343500018
predictive O 0 0.0029194620437920094
of O 0 2.2632171749137342e-05
the O 0 0.0001061287839547731
presence O 0 0.0001702675799606368
of O 0 8.05170839157654e-06
any O 0 2.945048618130386e-05
of O 0 1.0228619430563413e-05
the O 0 0.00017285365902353078
eight O 0 0.000652921327855438
mutations O 0 0.0036804701667279005
screened O 0 0.005715399514883757
. O 0 0.0009102971525862813

Carriers O 0 0.00759201031178236
of O 0 3.9261332858586684e-05
the O 0 0.00019607605645433068
same O 0 0.00038019358180463314
mutation O 0 0.0021471166983246803
, O 0 0.0001312987005803734
from O 0 5.630726082017645e-05
different O 0 3.540328179951757e-05
families O 0 0.0002607267815619707
, O 0 0.0001559460797579959
shared O 0 0.0005050189793109894
similar O 0 0.0010086374823004007
haplotypes O 0 0.02901005558669567
, O 0 0.00025496268062852323
indicating O 0 0.001481679966673255
that O 0 7.993608596734703e-05
the O 0 0.0002821357629727572
mutant O 0 0.007368594408035278
alleles O 0 0.002522224560379982
were O 0 8.812063606455922e-05
likely O 0 0.0005000107339583337
to O 0 6.490414671134204e-05
be O 0 5.880374737898819e-05
identical O 0 0.0001528576685814187
by O 0 5.390503793023527e-05
descent O 0 0.0005817494238726795
for O 0 0.0001611172192497179
a O 0 0.000672282709274441
mutation O 0 0.0017048530280590057
in O 0 0.00012795557267963886
the O 0 0.0003488998336251825
founder O 0 0.011129834689199924
population O 0 0.00030568212969228625
. O 0 0.0008820585790090263

The O 0 0.0003841201541945338
identification O 0 0.00040200049988925457
of O 0 9.485979535384104e-05
common O 0 0.2360537052154541
BRCA1 O 1 0.999957799911499
and O 0 0.003027745522558689
BRCA2 O 1 0.9993605017662048
mutations O 0 0.002438121708109975
will O 0 0.00013455940643325448
facilitate O 0 0.001218542573042214
carrier O 0 0.006462540477514267
detection O 0 0.00247082207351923
in O 0 0.00017227366333827376
French O 0 0.0031327756587415934
Canadian O 1 0.9500800967216492
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999998807907104
and O 1 0.8031841516494751
breast B-Disease 1 1.0
/ I-Disease 1 0.999996542930603
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.0019457836169749498
. O 0 0.0011841253144666553

Are O 0 0.0005634151166304946
Dp71 O 0 0.1438685655593872
and O 0 0.0009880911093205214
Dp140 O 1 0.9356721639633179
brain O 1 0.998715877532959
dystrophin O 1 0.9829062223434448
isoforms O 0 0.0022969197016209364
related O 0 0.0011546468595042825
to O 0 0.00044250578503124416
cognitive B-Disease 1 0.9978291392326355
impairment I-Disease 1 0.9999876022338867
in O 0 0.05255058407783508
Duchenne B-Disease 1 0.9999995231628418
muscular I-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999995231628418
? O 1 0.9450421333312988

Molecular O 0 0.012049941346049309
study O 0 0.0021244697272777557
and O 0 0.000412324967328459
neuropsychological O 0 0.41136717796325684
analysis O 0 0.00026375986635684967
were O 0 4.213568536215462e-05
performed O 0 0.0005735974991694093
concurrently O 0 0.0010874682338908315
on O 0 0.00045391422463580966
49 O 0 0.00929058063775301
patients O 1 0.9997928738594055
with O 0 0.006291213445365429
Duchenne B-Disease 1 0.9999996423721313
muscular I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9867942929267883
DMD B-Disease 1 0.9999995231628418
) O 0 0.0006269391742534935
in O 0 0.00012251267617102712
order O 0 0.00011921281839022413
to O 0 9.517584112472832e-05
find O 0 0.0003484736371319741
a O 0 0.0003542833146639168
molecular O 0 0.0011156614637002349
explanation O 0 0.0008327524992637336
for O 0 0.0001152840704889968
the O 0 0.00042158091673627496
cognitive B-Disease 1 0.9933894872665405
impairment I-Disease 1 0.999699592590332
observed O 0 0.0011460279347375035
in O 0 0.0005536687094718218
most O 0 0.016234558075666428
DMD B-Disease 1 0.9999995231628418
patients O 1 0.9999547004699707
. O 0 0.0016597058856859803

Complete O 0 0.0014512324705719948
analysis O 0 0.00016924686497077346
of O 0 3.9250960981007665e-05
the O 0 0.0008937034872360528
dystrophin O 1 0.9990721940994263
gene O 0 0.004749859217554331
was O 0 0.0008715055882930756
performed O 0 0.0006539644673466682
to O 0 7.633681525476277e-05
define O 0 0.0006659739301539958
the O 0 0.00012788288586307317
localization O 0 0.0023863622918725014
of O 0 6.758966628694907e-05
deletions O 0 0.0041708326898515224
and O 0 0.0002658685261849314
duplications O 0 0.006493005435913801
in O 0 0.00015418948896694928
relation O 0 0.0006006886251270771
to O 0 0.00011813978926511481
the O 0 0.00027678237529471517
different O 0 0.0010753184324130416
DMD B-Disease 1 0.9999805688858032
promoters O 0 0.19846110045909882
. O 0 0.0017156024696305394

Qualitative O 0 0.0034505019430071115
analysis O 0 0.0002638468868099153
of O 0 4.640009137801826e-05
the O 0 0.0006575806182809174
Dp71 O 1 0.9820252656936646
transcript O 0 0.005808548536151648
and O 0 0.00015745472046546638
testing O 0 0.0012176630552858114
for O 0 6.062375905457884e-05
the O 0 7.213991921162233e-05
specific O 0 0.00013070458953734487
first O 0 0.00022102028015069664
exon O 0 0.005335334222763777
of O 0 6.417115946533158e-05
Dp140 O 0 0.01552850753068924
were O 0 5.037247683503665e-05
also O 0 0.00011964887380599976
carried O 0 0.000216587824979797
out O 0 0.0002667674270924181
. O 0 0.0005757755716331303

Neuropsychological O 1 0.7071799635887146
analysis O 0 0.0018698605708777905
assessed O 0 0.01242679264396429
verbal O 0 0.010218985378742218
and O 0 0.0008840139489620924
visuospatial O 1 0.998320996761322
intelligence O 0 0.008339551277458668
, O 0 0.000542949594091624
verbal O 0 0.012034039944410324
memory O 0 0.026593908667564392
, O 0 0.00029265013290569186
and O 0 0.00019921144121326506
reading O 0 0.002798961941152811
skills O 0 0.0177012849599123
. O 0 0.0010457498719915748

Comparison O 0 0.001696953782811761
of O 0 9.54739807639271e-05
molecular O 0 0.002956294221803546
and O 0 0.0006016403785906732
psychometric O 1 0.9938116073608398
findings O 0 0.007208508439362049
demonstrated O 0 0.00367783778347075
that O 0 0.00019202673865947872
deletions O 0 0.002253144048154354
and O 0 0.00019536168838385493
duplications O 0 0.0052174790762364864
that O 0 0.00010111903975484893
were O 0 8.069577597780153e-05
localized O 0 0.007086110766977072
in O 0 0.00017274079436901957
the O 0 0.0004317600978538394
distal O 1 0.9821990132331848
part O 0 0.00048806413542479277
of O 0 3.8155285437824205e-05
the O 0 0.0005776385078206658
gene O 0 0.0036496573593467474
seemed O 0 0.0023311255499720573
to O 0 0.0001014724766719155
be O 0 0.0001508355635451153
preferentially O 0 0.003335419809445739
associated O 0 0.00044917516061104834
with O 0 0.0004175461654085666
cognitive B-Disease 1 0.9976282715797424
impairment I-Disease 1 0.9999034404754639
. O 0 0.0019260544795542955

Two O 0 0.001041596638970077
altered O 0 0.010155790485441685
Dp71 O 0 0.11074772477149963
transcripts O 0 0.0012796559603884816
and O 0 5.9104007959831506e-05
two O 0 0.00010020417539635673
deleted O 0 0.003760117804631591
Dp140 O 0 0.011456525884568691
DNA O 0 0.000398997770389542
sequences O 0 5.322317883837968e-05
were O 0 2.889465213229414e-05
found O 0 0.00014271694817580283
in O 0 0.00011172285303473473
four O 0 0.0005645708879455924
patients O 1 0.9999817609786987
with O 0 0.003993032965809107
severe O 1 0.9999992847442627
cerebral B-Disease 1 0.9999998807907104
dysfunction I-Disease 1 0.9999947547912598
. O 0 0.003131694858893752

These O 0 0.0006218557828105986
findings O 0 0.0028755164239555597
suggest O 0 0.000610464601777494
that O 0 5.0587950681801885e-05
some O 0 3.6496978282229975e-05
sequences O 0 0.00012388374307192862
located O 0 0.0004087343695573509
in O 0 0.0001469454582547769
the O 0 0.0004425594233907759
distal O 1 0.9794334769248962
part O 0 0.0005207606591284275
of O 0 4.217089372104965e-05
the O 0 0.00042639419552870095
gene O 0 0.0017483715200796723
and O 0 0.00012527083163149655
, O 0 0.00013867911184206605
in O 0 9.663411765359342e-05
particular O 0 0.00037147002876736224
, O 0 0.00028035181458108127
some O 0 0.0007154362392611802
DMD B-Disease 1 0.9999502897262573
isoforms O 0 0.001648475183174014
expressed O 0 0.00051114585949108
in O 0 0.0002061143022729084
the O 0 0.001132944948039949
brain O 1 0.9999648332595825
may O 0 0.0010618474334478378
be O 0 7.719827408436686e-05
related O 0 0.00033688664552755654
to O 0 6.541128095705062e-05
the O 0 0.0004528389545157552
cognitive B-Disease 1 0.9992024302482605
impairment I-Disease 1 0.999953031539917
associated O 0 0.002423466881737113
with O 0 0.002677373355254531
DMD B-Disease 1 0.9999971389770508
. O 0 0.0006874576210975647
. O 0 0.0009458849090151489

I1307K O 1 0.7603111267089844
APC O 1 0.9634180068969727
and O 0 0.001239978359080851
hMLH1 O 0 0.22643910348415375
mutations O 0 0.0018152307020500302
in O 0 0.0001342409523203969
a O 0 0.0006573832943104208
non O 0 0.0020691505633294582
- O 0 0.0026558011304587126
Jewish O 0 0.0004554233164526522
family O 0 0.00045817269710823894
with O 0 0.0003392445214558393
hereditary B-Disease 1 0.9993382096290588
non I-Disease 1 0.9961877465248108
- I-Disease 1 0.9999375343322754
polyposis I-Disease 1 0.9999995231628418
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0032027342822402716

We O 0 0.0006130913970991969
describe O 0 0.0011209265794605017
a O 0 0.0004979721852578223
French O 0 0.0017436890630051494
Canadian O 0 0.005856361705809832
hereditary B-Disease 1 0.9963259100914001
non I-Disease 1 0.9906730055809021
- I-Disease 1 0.9998937845230103
polyposis I-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.3709414303302765
HNPCC B-Disease 1 0.999988317489624
) O 0 0.0021562601905316114
kindred O 1 0.978721022605896
which O 0 0.0001502578961662948
carries O 0 0.0010780015727505088
a O 0 0.0007963948301039636
novel O 0 0.0041755447164177895
truncating O 1 0.6290131211280823
mutation O 0 0.005200793035328388
in O 0 0.0008903153357096016
hMLH1 O 0 0.44775402545928955
. O 0 0.0013891223352402449

Interestingly O 0 0.025516366586089134
, O 0 0.0005394922336563468
the O 0 0.0009018393466249108
I1307K O 1 0.5120373368263245
APC O 1 0.9813603162765503
polymorphism O 0 0.005716773681342602
, O 0 0.00024792426847852767
associated O 0 0.0001376992731820792
with O 0 3.134835424134508e-05
an O 0 0.0001878113835118711
increased O 0 0.0011894023045897484
risk O 1 0.9610215425491333
of O 0 0.008916094899177551
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0005095121450722218
is O 0 0.00029833565349690616
also O 0 0.00012217389303259552
present O 0 9.404746379004791e-05
in O 0 0.00010169905726797879
this O 0 0.00010887677490245551
family O 0 0.0013300798600539565
. O 0 0.00106826052069664

The O 0 0.0021729222498834133
I1307K O 0 0.04151950404047966
polymorphism O 0 0.004382011946290731
has O 0 0.0005176403792575002
previously O 0 0.0004549881268758327
only O 0 7.85793163231574e-05
been O 0 0.0002744837256614119
identified O 0 0.00026301253819838166
in O 0 5.1982493459945545e-05
individuals O 0 5.801835868624039e-05
of O 0 5.206826972425915e-05
self O 0 0.44160762429237366
- O 0 0.10447098314762115
reported O 0 0.005188107956200838
Ashkenazi O 0 0.050172511488199234
Jewish O 0 0.0021690567955374718
origins O 0 0.004140467382967472
. O 0 0.0014532972127199173

In O 0 0.0008917778031900525
addition O 0 0.0005476700607687235
, O 0 0.00017202874005306512
in O 0 0.00010552774620009586
this O 0 0.00011081102275056764
family O 0 0.0007337640272453427
, O 0 0.00021704054961446673
there O 0 0.00021133472910150886
appears O 0 0.001913311192765832
to O 0 7.255371747305617e-05
be O 0 9.196318569593132e-05
no O 0 0.00014718693273607641
relationship O 0 0.0009347088052891195
between O 0 0.00014233763795346022
the O 0 0.00030746625270694494
I1307K O 0 0.02491547167301178
polymorphism O 0 0.001528159249573946
and O 0 7.099183858372271e-05
the O 0 0.00012633149162866175
presence O 0 0.0007024341030046344
or O 0 0.0003949402889702469
absence O 0 0.005730871576815844
of O 0 0.0004974682815372944
cancer B-Disease 1 0.9999985694885254
. O 0 0.0003613316221162677
. O 0 0.0007784846820868552

Identification O 0 0.0008121939608827233
of O 0 4.735149923362769e-05
a O 0 0.0008644351619295776
novel O 0 0.0014403255190700293
mutation O 0 0.0009017543052323163
of O 0 2.8171167286927812e-05
the O 0 0.0005794120952486992
CPO O 0 0.20648638904094696
gene O 0 0.0012675768230110407
in O 0 0.00013665817095898092
a O 0 0.0008607537602074444
Japanese O 0 0.004848422482609749
hereditary B-Disease 1 0.9961129426956177
coproporphyria I-Disease 1 0.9919188618659973
family O 0 0.0038697475101798773
. O 0 0.0015531249810010195

Hereditary B-Disease 1 0.9951221346855164
coproporphyria I-Disease 1 0.9918631315231323
( O 0 0.006516196299344301
HCP B-Disease 1 0.9994791150093079
) O 0 0.00038905625115148723
is O 0 0.00029986354638822377
an O 0 0.0009042356396093965
autosomal B-Disease 1 0.9997692704200745
dominant I-Disease 1 0.9987114667892456
disease I-Disease 1 0.9999980926513672
characterized O 1 0.9186201095581055
by O 0 0.0004525934054981917
a O 0 0.011907372623682022
deficiency B-Disease 1 0.9999712705612183
of I-Disease 0 0.00025174880283884704
coproporphyrinogen I-Disease 1 0.9952835440635681
oxidase I-Disease 1 0.7332108020782471
( O 0 0.0023717652074992657
CPO O 0 0.15611907839775085
) O 0 0.00044566512224264443
caused O 0 0.0023254358675330877
by O 0 6.265101546887308e-05
a O 0 0.0005055516958236694
mutation O 0 0.0013367170467972755
in O 0 0.00011537952377693728
the O 0 0.0005241507897153497
CPO O 0 0.24230708181858063
gene O 0 0.004814372397959232
. O 0 0.0009760262328200042

Only O 0 0.0005821549566462636
11 O 0 0.000946200278121978
mutations O 0 0.0006107858498580754
of O 0 1.9686629457282834e-05
the O 0 0.00027040517306886613
gene O 0 0.0013178485678508878
have O 0 9.823064465308562e-05
been O 0 0.00031003504409454763
reported O 0 0.0020623912569135427
in O 0 0.0013245099689811468
HCP B-Disease 1 0.999946117401123
patients O 1 0.9999135732650757
. O 0 0.0015709528233855963

We O 0 0.0010729014175012708
report O 0 0.0009423726005479693
another O 0 0.0007097718771547079
mutation O 0 0.00127711973618716
in O 0 0.00012259892537258565
a O 0 0.0007098956266418099
Japanese O 0 0.0020442642271518707
family O 0 0.0021932474337518215
. O 0 0.0011561233550310135

Polymerase O 0 0.017915766686201096
chain O 0 0.009283490478992462
reaction O 0 0.003225963097065687
- O 0 0.003884863806888461
single O 0 0.000668646243866533
strand O 0 0.005420605186372995
conformational O 0 0.004034359008073807
polymorphism O 0 0.001527480548247695
and O 0 6.87909487169236e-05
direct O 0 0.00017888938600663096
sequence O 0 0.0001035786626744084
analyses O 0 0.0009521481697447598
demonstrated O 0 0.0023939083330333233
a O 0 0.0014491244219243526
C O 0 0.016209324821829796
to O 0 0.000519292545504868
T O 1 0.5530586838722229
substitution O 0 0.0005497772945091128
in O 0 0.00020545617735479027
exon O 0 0.006506108678877354
1 O 0 0.00018327376164961606
of O 0 1.9281516870250925e-05
the O 0 0.0004704164166469127
CPO O 0 0.03839023411273956
gene O 0 0.0011715301079675555
at O 0 0.00020515042706392705
nucleotide O 0 0.0004792010295204818
position O 0 0.0012736684875562787
85 O 0 0.0018781616818159819
, O 0 0.00020420899090822786
which O 0 8.951401832746342e-05
lies O 0 0.0010668238392099738
in O 0 9.317301737610251e-05
the O 0 0.000276741455309093
putative O 0 0.036528002470731735
presequence O 0 0.05065865442156792
for O 0 0.00018098304281011224
targeting O 0 0.0008329976117238402
to O 0 0.00024007292813621461
mitochondria O 0 0.0036716279573738575
. O 0 0.0007104004616849124

This O 0 0.0005347688565962017
mutation O 0 0.0023250672966241837
changes O 0 0.0002507871831767261
the O 0 0.00014950188051443547
codon O 0 0.0019203961128368974
for O 0 0.0001860355114331469
glutamine O 0 0.003648343263193965
to O 0 8.253657870227471e-05
a O 0 0.0006506211357191205
termination O 0 0.02228689007461071
codon O 0 0.001777751836925745
at O 0 0.0002495768421795219
amino O 0 0.000368448905646801
acid O 0 0.005918302573263645
position O 0 0.0025413865223526955
29 O 0 0.0032899745274335146
. O 0 0.0009259386570192873

MaeI O 0 0.22359855473041534
restriction O 0 0.0017448181752115488
analysis O 0 0.000478387315524742
showed O 0 0.0008727371459826827
two O 0 5.1288454415043816e-05
other O 0 9.906143532134593e-05
carriers O 0 0.0033006020821630955
in O 0 0.00016024040814954787
the O 0 0.00038355475408025086
family O 0 0.001665643067099154
. O 0 0.0011768130352720618

The O 0 0.003346332348883152
C O 1 0.93919438123703
- O 1 0.7201859354972839
T O 1 0.9897640943527222
mutation O 0 0.002886798931285739
is O 0 0.0002506705350242555
located O 0 0.0004234826483298093
within O 0 0.00014397938502952456
a O 0 0.0009681502124294639
recently O 0 0.0034974224399775267
proposed O 0 0.0011762857902795076
putative O 0 0.005853044800460339
alternative O 0 0.0010325020411983132
translation O 0 0.0009599077748134732
initiation O 0 0.005794620141386986
codon O 0 0.01169706042855978
( O 0 0.0027192002162337303
TIC O 1 0.9986673593521118
- O 0 0.004044803325086832
1 O 0 0.0005572394002228975
) O 0 0.00010704270243877545
, O 0 0.00010634760838001966
supporting O 0 0.0014241208555176854
that O 0 0.0006645131506957114
TIC O 1 0.9991637468338013
- O 0 0.0026406177785247564
1 O 0 0.00026970304315909743
is O 0 0.00014864855620544404
the O 0 0.00020536647934932262
real O 0 0.0023590060882270336
TIC O 1 0.9958133101463318
rather O 0 0.0009086272912099957
than O 0 0.0008784345118328929
TIC O 1 0.998840868473053
- O 0 0.0050807553343474865
2 O 0 0.0005315469461493194
. O 0 0.00023614549718331546
. O 0 0.0005599470459856093

Human B-Disease 0 0.002777161542326212
complement I-Disease 0 0.005873854737728834
factor I-Disease 0 0.13405963778495789
H I-Disease 1 0.999921441078186
deficiency I-Disease 1 0.9999973773956299
associated O 0 0.01006934605538845
with O 0 0.3252888321876526
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
. O 0 0.006474917754530907

This O 0 0.0003837149706669152
study O 0 0.0008731646230444312
reports O 0 0.00038362646591849625
on O 0 0.00015655304014217108
six O 0 0.0002937871031463146
cases O 0 0.0012804869329556823
of O 0 0.000348095316439867
deficiency B-Disease 1 0.9999973773956299
in I-Disease 0 0.00014881206152494997
the I-Disease 0 0.00015739453374408185
human I-Disease 0 0.0006045874324627221
complement I-Disease 0 0.0013066553510725498
regulatory I-Disease 0 0.003615382593125105
protein I-Disease 0 0.0016006213845685124
Factor I-Disease 0 0.014939632266759872
H I-Disease 1 0.9977889060974121
( O 0 0.003483288688585162
FH O 1 0.9989113807678223
) O 0 0.00015493211685679853
in O 0 4.033634104416706e-05
the O 0 3.839740020339377e-05
context O 0 0.00020478731312323362
of O 0 7.919601921457797e-05
an O 1 0.8455992937088013
acute B-Disease 1 0.9999998807907104
renal I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 0 0.004320226609706879

Five O 0 0.00026391985011287034
of O 0 3.623065276769921e-05
the O 0 0.00033063965383917093
cases O 0 0.0011267499066889286
were O 0 6.265065894694999e-05
observed O 0 0.00041025772225111723
in O 0 0.00019053589494433254
children O 0 0.0009703614632599056
presenting O 0 0.025801697745919228
with O 0 0.1437021791934967
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9615616202354431
HUS B-Disease 1 0.9999943971633911
) O 0 0.0025726319290697575
. O 0 0.0011844999389722943

Two O 0 0.00010305963951395825
of O 0 3.132116034976207e-05
the O 0 0.0003927907382603735
children O 0 0.0018989000236615539
exhibited O 0 0.04318748414516449
a O 0 0.01139736082404852
homozygous O 1 0.967688798904419
deficiency O 1 0.9999909400939941
characterized O 0 0.06263617426156998
by O 0 0.00016786021296866238
the O 0 0.00020004494581371546
absence O 0 0.0010622077388688922
of O 0 2.3562681235489435e-05
the O 0 0.00025395728880539536
150 O 0 0.002109500113874674
- O 0 0.006462179124355316
kD O 0 0.030802534893155098
form O 0 0.00018873858789447695
of O 0 7.555040065199137e-05
Factor O 0 0.0132206492125988
H O 1 0.9941925406455994
and O 0 0.00012378404790069908
the O 0 0.00019842886831611395
presence O 0 0.0007847952656447887
, O 0 0.0002157555427402258
upon O 0 0.0008188791107386351
immunoblotting O 0 0.04825539514422417
, O 0 5.84927256568335e-05
of O 0 1.2440897080523428e-05
the O 0 0.00025817842106334865
42 O 0 0.0032834606245160103
- O 0 0.006979575380682945
kD O 0 0.17775103449821472
Factor O 0 0.005245045758783817
H O 1 0.6509190797805786
- O 0 0.0012883645249530673
like O 0 0.0001457156176911667
protein O 0 0.0004819684545509517
1 O 0 0.0010125330882146955
( O 0 0.0014635802945122123
FHL O 1 0.9975578784942627
- O 0 0.004063779953867197
1 O 0 0.0005849759909324348
) O 0 9.601767669664696e-05
and O 0 0.00010857712914003059
other O 0 0.0003234852338209748
FH O 1 0.9992454051971436
- O 0 0.004015559330582619
related O 0 0.0012348508462309837
protein O 0 0.0016632108017802238
( O 0 0.0016347613418474793
FHR O 1 0.9923145174980164
) O 0 0.0006227579433470964
bands O 0 0.0018543130718171597
. O 0 0.0011594627285376191

Southern O 0 0.012712745927274227
blot O 1 0.5227728486061096
and O 0 0.00032962215482257307
PCR O 0 0.003720467910170555
analysis O 0 0.00010678425314836204
of O 0 1.5100132259249222e-05
DNA O 0 0.00029978834209032357
of O 0 1.9367027562111616e-05
one O 0 0.00047315648407675326
patient O 1 0.9992656111717224
with O 0 0.0007038986659608781
homozygous O 1 0.9892995357513428
deficiency O 1 0.999995231628418
ruled O 0 0.0037238134536892176
out O 0 0.000113753201731015
the O 0 7.370153616648167e-05
presence O 0 0.00016949752171058208
of O 0 1.3144545846444089e-05
a O 0 0.00026660569710657
large O 0 0.00021213317813817412
deletion O 0 0.0018593514105305076
of O 0 4.3099244066979736e-05
the O 0 0.0012248486746102571
FH O 1 0.9995874762535095
gene O 0 0.0017362432554364204
as O 0 0.0001693462982075289
the O 0 0.00036050050402991474
underlying O 1 0.956421971321106
defect O 1 0.9982284903526306
for O 0 0.0004885342204943299
the O 0 0.0045685432851314545
deficiency O 1 0.9999958276748657
. O 0 0.0017892596079036593

The O 0 0.0005027793231420219
other O 0 0.000100173223472666
four O 0 0.0002460842952132225
children O 0 0.0006796051166020334
presented O 0 0.0010350566590204835
with O 0 0.0007405478972941637
heterozygous O 1 0.8952370882034302
deficiency O 1 0.9999948740005493
and O 0 0.000514128478243947
exhibited O 0 0.06312903761863708
a O 0 0.0020850333385169506
normal O 0 0.0065447562374174595
immunoblotting O 0 0.052007414400577545
pattern O 0 0.0007807465153746307
of O 0 1.3229761862021405e-05
proteins O 0 7.782084867358208e-05
of O 0 5.0182519771624357e-05
the O 0 0.0018985007191076875
FH O 1 0.9997596144676208
family O 0 0.003253697417676449
. O 0 0.0010912197176367044

Factor B-Disease 1 0.5030204057693481
H I-Disease 1 0.999388575553894
deficiency I-Disease 1 0.9999381303787231
is O 0 0.00044371685362420976
the O 0 0.0001876221940619871
only O 0 0.00043118547182530165
complement B-Disease 1 0.9834550619125366
deficiency I-Disease 1 0.9999985694885254
associated O 0 0.0034343430306762457
with O 0 0.002287255832925439
HUS B-Disease 1 0.9999852180480957
. O 0 0.0031655244529247284

These O 0 0.0001786550274118781
observations O 0 0.0009754535276442766
suggest O 0 0.00070784060517326
a O 0 0.0004908251576125622
role O 0 0.002068705391138792
for O 0 0.001605452154763043
FH O 1 0.9995818734169006
and O 0 0.0015575361903756857
/ O 1 0.7312214970588684
or O 0 0.0018184478394687176
FH O 1 0.9975920915603638
receptors O 0 0.002332378178834915
in O 0 0.00012206094106659293
the O 0 0.0005484712310135365
pathogenesis O 1 0.999733030796051
of O 0 0.0015962899196892977
idiopathic O 1 0.9999998807907104
HUS B-Disease 1 0.9999986886978149
. O 0 0.001166758593171835
. O 0 0.0012447022600099444

Further O 0 0.001015303423628211
evidence O 0 0.00026420989888720214
for O 0 0.00011394361354177818
a O 0 0.00042138685239478946
major O 0 0.001214821357280016
ancient O 0 0.0015944093465805054
mutation O 0 0.4491625726222992
underlying O 1 0.999843955039978
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999995231628418
from O 0 0.0028071270789951086
linkage O 1 0.8551056981086731
disequilibrium O 1 0.9896780252456665
studies O 0 0.0010056305909529328
in O 0 0.0001244426821358502
the O 0 0.0001504809915786609
Japanese O 0 0.0008881145622581244
population O 0 0.00024640571791678667
. O 0 0.0008464148850180209

The O 0 0.02636904828250408
myotonic B-Disease 1 0.9999970197677612
dystrophy I-Disease 1 0.9999994039535522
( O 1 0.6408994197845459
DM B-Disease 1 0.999994158744812
) O 0 0.0009626439423300326
mutation O 0 0.002270122990012169
is O 0 0.00035342693445272744
an O 0 0.0011611029040068388
unstable O 1 0.9983214735984802
( O 0 0.004128589294850826
CTG O 1 0.9937273263931274
) O 0 0.0010626115836203098
n O 0 0.003108764300122857
repeat O 0 0.006118502467870712
, O 0 0.00015583637286908925
present O 0 0.00010842514166142792
at O 0 0.00018860223644878715
a O 0 0.0002840818197000772
copy O 0 0.00032269483199343085
number O 0 1.284191785089206e-05
of O 0 2.915338882303331e-05
5 O 0 0.000811625795904547
- O 0 0.0026252400130033493
37 O 0 0.0010846664663404226
repeats O 0 0.002077248878777027
on O 0 0.00024120979651343077
normal O 0 0.0014255227288231254
chromosomes O 0 0.0003089990059379488
but O 0 0.00012585753574967384
amplified O 0 0.0010703217703849077
to O 0 0.00013040432531852275
50 O 0 0.0005368689307942986
- O 0 0.003148576244711876
3000 O 0 0.008848454803228378
copies O 0 0.000651368114631623
on O 0 0.001920832903124392
DM B-Disease 1 0.9998620748519897
chromosomes O 0 0.002586236922070384
. O 0 0.000964310544077307

Previous O 0 0.0039965142495930195
findings O 0 0.0035590336192399263
in O 0 0.0003525397623889148
Caucasian O 0 0.07362712919712067
populations O 0 0.00050320103764534
of O 0 0.00011998992704320699
a O 0 0.1357678920030594
DM B-Disease 1 0.9999958276748657
founder O 0 0.3996011018753052
chromosome O 0 0.004429053049534559
raise O 0 0.0013140098890289664
a O 0 0.00040788427577354014
question O 0 0.0005269944667816162
about O 0 0.00012670562136918306
the O 0 0.00012084721674909815
molecular O 0 0.0010226959129795432
events O 0 0.0001923374948091805
involved O 0 0.0004747800121549517
in O 0 8.996576070785522e-05
the O 0 0.00026646850164979696
expansion O 0 0.004737789276987314
mutation O 0 0.0047760335728526115
. O 0 0.0007258971454575658

To O 0 0.0008291553240269423
investigate O 0 0.00632648728787899
whether O 0 0.0006848951452411711
a O 0 0.00080652697943151
founder O 0 0.007139441091567278
chromosome O 0 0.0015067488420754671
for O 0 0.00027548623620532453
the O 0 0.0022946225944906473
DM B-Disease 1 0.9999938011169434
mutation O 0 0.006465268786996603
exists O 0 0.0008433066541329026
in O 0 8.340268686879426e-05
the O 0 0.00013503796071745455
Japanese O 0 0.0007218857062980533
population O 0 8.064223220571876e-05
, O 0 0.00017434736946597695
we O 0 0.00035410013515502214
genotyped O 0 0.01697537675499916
families O 0 0.00025395024567842484
using O 0 0.0003559158358257264
polymorphic O 0 0.026108630001544952
markers O 0 0.004633320961147547
near O 0 0.001666577416472137
the O 0 0.0006745436694473028
( O 0 0.0022410911042243242
CTG O 1 0.9888596534729004
) O 0 0.0006252021412365139
n O 0 0.002576066181063652
repeat O 0 0.006188750732690096
region O 0 0.0013108698185533285
and O 0 0.00018538263975642622
constructed O 0 0.003951903432607651
haplotypes O 0 0.014177815988659859
. O 0 0.0009911204688251019

Six O 0 0.0007755336700938642
different O 0 0.00012940372107550502
haplotypes O 0 0.007110735401511192
were O 0 0.00010772076348075643
found O 0 0.0009306449792347848
and O 0 0.0014161698054522276
DM B-Disease 1 0.9999881982803345
alleles O 0 0.006500604096800089
were O 0 0.00010538634523982182
always O 0 0.001777161261998117
haplotype O 0 0.07421888411045074
A O 0 0.005035886541008949
. O 0 0.0012378036044538021

To O 0 0.0004937988705933094
find O 0 0.0004742153105325997
an O 0 8.070008334470913e-05
origin O 0 3.5892466257791966e-05
of O 0 2.7811896870844066e-05
the O 0 0.0006548413657583296
( O 0 0.002966920845210552
CTG O 1 0.9936398863792419
) O 0 0.0007486986578442156
n O 0 0.0033922537695616484
repeat O 0 0.008503178134560585
mutation O 0 0.002059328369796276
and O 0 0.00010250657214783132
to O 0 0.00016139599028974771
investigate O 0 0.00230458565056324
the O 0 8.267103839898482e-05
mechanism O 0 0.00043694896157830954
of O 0 2.362448867643252e-05
the O 0 0.0002376370830461383
expansion O 0 0.0029276334680616856
mutation O 0 0.0017420165240764618
in O 0 9.911396773532033e-05
the O 0 0.0001293049135711044
Japanese O 0 0.0006476947455666959
population O 0 6.944888446014374e-05
we O 0 0.00011077372619183734
have O 0 8.144069579429924e-05
studied O 0 0.0004966788692399859
90 O 0 0.0011903077829629183
Japanese O 0 0.006710296031087637
DM B-Disease 1 0.9999265670776367
families O 0 0.0007570422603748739
comprising O 0 0.0009895985713228583
190 O 0 0.006558715831488371
affected O 0 0.005120331887155771
and O 0 0.00038826189120300114
130 O 0 0.0043143401853740215
unaffected O 0 0.07119402289390564
members O 0 0.0008207880309782922
. O 0 0.0011595776304602623

The O 0 0.0009038914577104151
results O 0 0.001026344601996243
suggest O 0 0.0005944322911091149
that O 0 6.99485681252554e-05
a O 0 0.00035423869849182665
few O 0 0.00029841531068086624
common O 0 0.0013274336233735085
ancestral O 0 0.008185114711523056
mutations O 0 0.002863831352442503
in O 0 0.0002725030353758484
both O 0 0.0006518165464513004
Caucasian O 1 0.9579834342002869
and O 0 0.00036406610161066055
Japanese O 0 0.0016289287013933063
populations O 0 0.0007198110688477755
have O 0 0.00010564010153757408
originated O 0 0.0002875147620216012
by O 0 3.228342393413186e-05
expansion O 0 0.0003475942648947239
of O 0 1.9141398297506385e-05
an O 0 0.0003347409947309643
ancestral O 0 0.005248415283858776
n O 0 0.0036996344570070505
= O 0 0.0024851118214428425
5 O 0 0.0004459574702195823
repeat O 0 0.0022383842151612043
to O 0 0.00016715838864911348
n O 0 0.002481023082509637
= O 0 0.003337078494951129
19 O 0 0.001203597174026072
- O 0 0.0020199459977447987
37 O 0 0.0007281998987309635
copies O 0 0.00050536630442366
. O 0 0.0006114469142630696

These O 0 0.00016413567936979234
data O 0 0.00022823884501121938
support O 0 0.0009220492211170495
multistep O 0 0.0295418594032526
models O 0 0.0007696020184084773
of O 0 0.00012827296450268477
triplet O 1 0.9740719199180603
repeat O 0 0.01346258819103241
expansion O 0 0.0018629495752975345
that O 0 8.004433038877323e-05
have O 0 6.749176827725023e-05
been O 0 0.0001707804185571149
proposed O 0 0.0005367168923839927
for O 0 0.0003432263620197773
both O 0 0.0018763578264042735
DM B-Disease 1 0.9999922513961792
and O 0 0.0022757179103791714
Friedreichs B-Disease 1 0.9983819723129272
ataxia I-Disease 1 0.9997108578681946
. O 0 0.0009500539745204151
. O 0 0.0010677888058125973

The O 0 0.0005327447433955967
molecular O 0 0.0011505596339702606
basis O 0 0.00025618026847951114
of O 0 0.0005546268075704575
C6 B-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.9999988079071045
in O 0 0.0003749171446543187
the O 0 0.00043808415648527443
western O 0 0.0028494650032371283
Cape O 0 0.02086384780704975
, O 0 0.00041629577754065394
South O 0 0.0013892746064811945
Africa O 0 0.0021081294398754835
. O 0 0.0008212433313019574

Deficiency B-Disease 1 0.9998859167098999
of I-Disease 0 6.347907765302807e-05
the I-Disease 0 0.0002169122890336439
sixth I-Disease 0 0.0014778794720768929
component I-Disease 0 0.0008331798599101603
of I-Disease 0 3.716762876138091e-05
human I-Disease 0 0.001417200663127005
complement I-Disease 0 0.004937383346259594
( O 0 0.0022492893040180206
C6 O 1 0.9997262358665466
) O 0 0.0005959321861155331
has O 0 0.0005816307966597378
been O 0 0.0003838439588434994
reported O 0 0.000934226147364825
in O 0 5.859198427060619e-05
a O 0 0.00015055878611747175
number O 0 1.527805216028355e-05
of O 0 1.60925519594457e-05
families O 0 0.00018249862478114665
from O 0 9.801955457078293e-05
the O 0 0.0003233747847843915
western O 0 0.0021489737555384636
Cape O 0 0.023470284417271614
, O 0 0.0004499384085647762
South O 0 0.0013395048445090652
Africa O 0 0.0021635526791214943
. O 0 0.0006808462203480303

Meningococcal B-Disease 1 0.9999884366989136
disease I-Disease 1 0.9999953508377075
is O 0 0.004481780342757702
endemic O 1 0.5802716612815857
in O 0 0.0003445183392614126
the O 0 0.0006385779706761241
Cape O 0 0.009919733740389347
and O 0 8.324623922817409e-05
almost O 0 0.00012896640691906214
all O 0 2.5198827643180266e-05
pedigrees O 0 0.0015711241867393255
of O 0 5.206315472605638e-05
total O 0 0.0026887282729148865
C6 B-Disease 1 0.999998927116394
deficiency I-Disease 1 0.9999997615814209
( O 0 0.008145893923938274
C6Q0 O 1 0.999183714389801
) O 0 0.0003246908017899841
have O 0 9.38858138397336e-05
been O 0 0.00029117707163095474
ascertained O 0 0.005477749276906252
because O 0 0.0002562105655670166
of O 0 0.000196704117115587
recurrent O 1 0.9999887943267822
disease O 1 0.9999939203262329
. O 0 0.0027584508061408997

We O 0 0.0006808814941905439
have O 0 0.00012167906970717013
sequenced O 0 0.0006844296003691852
the O 0 7.965188706293702e-05
expressed O 0 0.00032394996378570795
exons O 0 0.0011048322776332498
of O 0 3.692679092637263e-05
the O 0 0.0011268975213170052
C6 O 1 0.9995951056480408
gene O 0 0.0022344752214848995
from O 0 0.00016130598669406027
selected O 0 0.00038219644920900464
cases O 0 0.0007716788677498698
and O 0 8.601122681284323e-05
have O 0 8.331406570505351e-05
found O 0 0.00014146596367936581
three O 0 0.00011855518823722377
molecular O 0 0.010848453268408775
defects O 1 0.9993270635604858
leading O 0 0.0011560141574591398
to O 0 0.00021892396034672856
total O 0 0.001763280015438795
deficiency O 1 0.9999977350234985
879delG O 1 0.9398254752159119
, O 0 0.00024692073930054903
which O 0 6.684701656922698e-05
is O 0 0.0001766275381669402
the O 0 0.00023152519133873284
common O 0 0.005413953214883804
defect O 1 0.998151957988739
in O 0 0.00020628729544114321
the O 0 0.0004152395704295486
Cape O 0 0.017125746235251427
and O 0 0.0003294810594525188
hitherto O 0 0.03344016522169113
unreported O 0 0.020039523020386696
, O 0 0.00037437459104694426
and O 0 0.0004742795426864177
1195delC O 0 0.449238121509552
and O 0 0.0004326203197706491
1936delG O 0 0.480379194021225
, O 0 0.00017923976702149957
which O 0 6.111016409704462e-05
have O 0 8.415301999775693e-05
been O 0 0.000291774224024266
previously O 0 0.0008595113176852465
reported O 0 0.0016219605458900332
in O 0 0.00026301376055926085
African O 0 0.002590905176475644
- O 0 0.006890847813338041
Americans O 0 0.00151063350494951
. O 0 0.0008458980009891093

We O 0 0.0009024500614032149
also O 0 0.00023399344354402274
show O 0 0.00025257968809455633
that O 0 5.95537931076251e-05
the O 0 0.0002896313089877367
879delG O 0 0.29556044936180115
and O 0 0.0008162214071489871
1195delC O 1 0.9967820644378662
defects O 1 0.9982908368110657
are O 0 6.163784564705566e-05
associated O 0 0.0002842796384356916
with O 0 0.00028178011416457593
characteristic O 1 0.9794518947601318
C6 O 1 0.9999898672103882
/ O 1 0.9960536956787109
C7 O 1 0.9990898370742798
region O 0 0.005265500862151384
DNA O 0 0.0043400730937719345
marker O 0 0.028471635654568672
haplotypes O 0 0.017062652856111526
, O 0 0.00024005622253753245
although O 0 0.00024668729747645557
small O 0 0.000143272292916663
variations O 0 0.0002398601354798302
were O 0 9.051045344676822e-05
observed O 0 0.0012269000289961696
. O 0 0.0008570987265557051

The O 0 0.0040102205239236355
1936delG O 1 0.9650671482086182
defect O 1 0.992003321647644
was O 0 0.001340301358141005
observed O 0 0.0005149199860170484
only O 0 8.456505747744814e-05
once O 0 0.0005512437783181667
in O 0 0.0001204851214424707
the O 0 0.0004319568688515574
Cape O 0 0.015242594294250011
, O 0 0.00017390308494213969
but O 0 0.00013018256868235767
its O 0 0.00023220633738674223
associated O 0 0.0009399304399266839
haplotype O 0 0.0351041704416275
could O 0 0.0002520396083127707
be O 0 0.00013767457858193666
deduced O 0 0.0025049459654837847
. O 0 0.0005305462400428951

The O 0 0.0005239042802713811
data O 0 0.00022759039711672813
from O 0 0.00010332227975595742
the O 0 0.00035912051680497825
haplotypes O 0 0.014880219474434853
indicate O 0 0.0005882364348508418
that O 0 3.581301280064508e-05
these O 0 2.6396783141535707e-05
three O 0 0.00013698240218218416
molecular O 0 0.009128552861511707
defects O 1 0.99801105260849
account O 0 0.0002160017320420593
for O 0 0.00017986174498219043
the O 0 0.0006817123503424227
defects O 1 0.9987581968307495
in O 0 7.357267168117687e-05
all O 0 2.847744690370746e-05
the O 0 0.00027748598949983716
38 O 0 0.0041474453173577785
unrelated O 0 0.09167824685573578
C6Q0 O 1 0.9966557025909424
individuals O 0 0.00040314593934454024
we O 0 0.00017415850015822798
have O 0 9.08608635654673e-05
studied O 0 0.00031241917167790234
from O 0 0.00010357728751841933
the O 0 0.0004614265344571322
Cape O 0 0.021950414404273033
. O 0 0.0008631088421680033

We O 0 0.0006663284730166197
have O 0 9.525736095383763e-05
also O 0 0.00011346665269229561
observed O 0 0.0002465570578351617
the O 0 0.00031191474408842623
879delG O 0 0.412159264087677
defect O 0 0.49612367153167725
in O 0 0.00014561423449777067
two O 0 0.00024543312611058354
Dutch O 0 0.027483243495225906
C6 B-Disease 1 0.9999891519546509
- I-Disease 1 0.9962957501411438
deficient I-Disease 1 0.9999233484268188
kindreds O 0 0.4323395788669586
, O 0 0.00032026530243456364
but O 0 0.00023960255202837288
the O 0 0.00048770508146844804
879delG O 1 0.9294735789299011
defect O 1 0.9799627065658569
in O 0 0.00029887171695008874
the O 0 0.0007156854844652116
Cape O 0 0.1676187515258789
probably O 0 0.0023297276347875595
did O 0 0.00039877870585769415
not O 0 7.631184416823089e-05
come O 0 0.00011121624993393198
from O 0 4.5099612179910764e-05
The O 0 0.00019544590031728148
Netherlands O 0 0.0009667943231761456
. O 0 0.0002610479132272303
. O 0 0.000640799873508513

Complement B-Disease 1 0.9623043537139893
C7 I-Disease 1 0.9999929666519165
deficiency I-Disease 1 0.9999994039535522
: O 0 0.0010751801310107112
seven O 0 0.0005060748662799597
further O 0 0.0010475029703229666
molecular O 0 0.044015225023031235
defects O 1 0.9996017813682556
and O 0 0.0001311673258896917
their O 0 0.00015717752103228122
associated O 0 0.0014041922986507416
marker O 0 0.026666004210710526
haplotypes O 0 0.03205670416355133
. O 0 0.0014151332434266806

Seven O 0 0.0005561384023167193
further O 0 0.00030317739583551884
molecular O 0 0.0009946859208866954
bases O 0 0.0008192846435122192
of O 0 0.000774304149672389
C7 B-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999991655349731
are O 0 0.00038804690120741725
described O 0 0.00757651636376977
. O 0 0.0013163997791707516

All O 0 0.00012001281720586121
these O 0 8.679197344463319e-05
new O 0 0.000876949168741703
molecular O 0 0.018293876200914383
defects O 1 0.997075080871582
involve O 0 0.0019966652616858482
single O 0 0.0008601892623119056
- O 0 0.0020204188767820597
nucleotide O 0 0.0003434975806158036
events O 0 0.0002487133606337011
, O 0 0.000247725285589695
deletions O 0 0.0021534531842917204
and O 0 0.00013302646402735263
substitutions O 0 0.0007894051377661526
, O 0 6.585541268577799e-05
some O 0 2.407465217402205e-05
of O 0 2.2518326659337617e-05
which O 0 0.00023789075203239918
alter O 0 0.013054931536316872
splice O 0 0.011249365285038948
sites O 0 0.0004893019795417786
, O 0 0.0001950116129592061
and O 0 0.00017847590788733214
others O 0 0.0009811000199988484
codons O 0 0.007669920567423105
. O 0 0.0008575340616516769

They O 0 0.0002895308134611696
are O 0 4.0717943193158135e-05
distributed O 0 0.00021659773483406752
along O 0 0.0002646296634338796
the O 0 0.0008936073281802237
C7 O 1 0.9997091889381409
gene O 0 0.002962969709187746
, O 0 0.00014662690227851272
but O 0 0.00011255197750870138
predominantly O 0 0.00021885009482502937
towards O 0 0.000264212692854926
the O 0 0.00024097462301142514
3 O 0 0.0009505062480457127
end O 0 0.0019454557914286852
. O 0 0.0008264387142844498

All O 0 0.00015362170233856887
were O 0 8.506300946464762e-05
found O 0 0.000304691115161404
in O 0 0.0002954505034722388
compound O 0 0.008744449354708195
heterozygous O 0 0.005891275126487017
individuals O 0 0.0007057666080072522
. O 0 0.001276335446164012

The O 0 0.007342704571783543
C6 O 1 0.9997803568840027
/ O 1 0.9930833578109741
C7 O 1 0.9993119239807129
marker O 0 0.04119664430618286
haplotypes O 0 0.017839519307017326
associated O 0 0.0006320166867226362
with O 0 0.00026034031179733574
most O 0 0.0038323798216879368
C7 B-Disease 1 0.9999606609344482
defects I-Disease 1 0.9994094371795654
are O 0 0.0001878481125459075
tabulated O 0 0.002140674740076065
. O 0 0.00032467563869431615
. O 0 0.0007815489661879838

A O 0 0.007962348870933056
genome O 0 0.007495660334825516
- O 0 0.002322301734238863
wide O 0 0.000541632529348135
search O 0 0.0005899198586121202
for O 0 0.00040938318124972284
chromosomal O 0 0.07863643765449524
loci O 0 0.021835021674633026
linked O 0 0.03144311532378197
to O 0 0.0013999128714203835
mental O 1 0.9999967813491821
health O 1 0.9999204874038696
wellness O 1 0.9995943903923035
in O 0 0.0003146361850667745
relatives O 0 0.0010914593003690243
at O 0 0.0006361323175951838
high O 0 0.006192091852426529
risk O 1 0.9188685417175293
for O 0 0.006806567311286926
bipolar B-Disease 1 0.9999997615814209
affective I-Disease 1 0.9999948740005493
disorder I-Disease 1 0.9999943971633911
among O 0 0.00041390807018615305
the O 0 0.0004733692039735615
Old O 0 0.006097712088376284
Order O 0 0.0006505888886749744
Amish O 0 0.013894489966332912
. O 0 0.001200876198709011

Bipolar B-Disease 1 0.9999985694885254
affective I-Disease 1 0.9999734163284302
disorder I-Disease 1 0.9999964237213135
( O 0 0.04990479722619057
BPAD B-Disease 1 0.9999784231185913
; O 0 0.00986175425350666
manic B-Disease 1 0.9999963045120239
- I-Disease 1 0.9998652935028076
depressive I-Disease 1 0.9999994039535522
illness I-Disease 1 0.9999946355819702
) O 0 0.0007007545209489763
is O 0 0.0005467336159199476
characterized O 0 0.007848771288990974
by O 0 0.00010588920849841088
episodes O 0 0.0007880409248173237
of O 0 0.00025024876231327653
mania B-Disease 1 0.9999203681945801
and O 0 0.0020417114719748497
/ O 1 0.9792500138282776
or O 0 0.00230235792696476
hypomania B-Disease 1 0.9997022747993469
interspersed O 0 0.002544974209740758
with O 0 0.0001255238603334874
periods O 0 0.0011500129476189613
of O 0 0.00034892093390226364
depression B-Disease 1 0.9999467134475708
. O 0 0.001648009056225419

Compelling O 0 0.008661136031150818
evidence O 0 0.0009575529838912189
supports O 0 0.0027729254215955734
a O 0 0.0004664970620069653
significant O 0 0.00073688302654773
genetic O 0 0.0011800425127148628
component O 0 0.0018950637895613909
in O 0 0.0001428409741492942
the O 0 0.0003224045503884554
susceptibility O 0 0.28856560587882996
to O 0 0.0005556769319809973
develop O 1 0.9930678606033325
BPAD B-Disease 1 0.999737560749054
. O 0 0.0013475033920258284

To O 0 0.0006071047973819077
date O 0 0.0006877875421196222
, O 0 0.00025719127734191716
however O 0 0.00028459608438424766
, O 0 0.00025923093198798597
linkage O 0 0.012007600627839565
studies O 0 0.00040801180875860155
have O 0 6.936708086868748e-05
attempted O 0 0.0005732271820306778
only O 0 4.0574952436145395e-05
to O 0 0.00012175184383522719
identify O 0 0.002531554317101836
chromosomal O 0 0.07645352929830551
loci O 0 0.01226061675697565
that O 0 0.0002696934971027076
cause O 0 0.02017485722899437
or O 0 0.00016698140825610608
increase O 0 0.00028217877843417227
the O 0 0.00019927659013774246
risk O 0 0.031229248270392418
of O 0 0.00010738508717622608
developing O 1 0.9473623037338257
BPAD B-Disease 1 0.9998331069946289
. O 0 0.0014321294147521257

To O 0 0.00037130294367671013
determine O 0 0.0005850515444763005
whether O 0 0.00029621567227877676
there O 0 7.177445513661951e-05
could O 0 0.00022988778073340654
be O 0 0.0001716518891043961
protective O 1 0.9837833046913147
alleles O 0 0.003704003058373928
that O 0 0.00018538070435170084
prevent O 0 0.005085496231913567
or O 0 0.0003582203935366124
reduce O 0 0.002899106591939926
the O 0 0.00032272739917971194
risk O 0 0.02587173879146576
of O 0 0.00015949970111250877
developing O 1 0.955744743347168
BPAD B-Disease 1 0.9998587369918823
, O 0 0.00034637542557902634
similar O 0 0.0002310814888915047
to O 0 7.744876347715035e-05
what O 0 0.00017792910512071103
is O 0 0.00010944615496555343
observed O 0 0.00024906385806389153
in O 0 0.00012297264765948057
other O 0 0.00036430670297704637
genetic B-Disease 1 0.9994778037071228
disorders I-Disease 1 0.9999994039535522
, O 0 0.0003706218267325312
we O 0 0.00036075577372685075
used O 0 0.002110048197209835
mental O 1 0.9999977350234985
health O 1 0.999950647354126
wellness O 1 0.9998194575309753
( O 0 0.0004880766791757196
absence O 0 0.001516762305982411
of O 0 7.688970799790695e-05
any O 0 0.008044598624110222
psychiatric B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999953508377075
) O 0 0.0003219054779037833
as O 0 0.000193515166756697
the O 0 0.0003316676302347332
phenotype O 0 0.04235877841711044
in O 0 0.00011230218660784885
our O 0 0.0005466559086926281
genome O 0 0.0049629611894488335
- O 0 0.0030004032887518406
wide O 0 0.00169028015807271
linkage O 0 0.014618190005421638
scan O 0 0.009500034153461456
of O 0 2.2347398044075817e-05
several O 0 0.00010298027336830273
large O 0 0.0007063856464810669
multigeneration O 1 0.7144919633865356
Old O 0 0.0035834372974932194
Order O 0 0.0005529169575311244
Amish O 0 0.009443914517760277
pedigrees O 0 0.01000275183469057
exhibiting O 0 0.014291455037891865
an O 0 0.0006796812522225082
extremely O 0 0.19759927690029144
high O 0 0.016681894659996033
incidence O 1 0.9887052178382874
of O 0 0.0005843468243256211
BPAD B-Disease 1 0.9998685121536255
. O 0 0.0018612743588164449

We O 0 0.0007562835817225277
have O 0 0.00010523250239202753
found O 0 0.00010934621968772262
strong O 0 0.00015646648535039276
evidence O 0 0.00014116495731286705
for O 0 9.328841406386346e-05
a O 0 0.0006569998804479837
locus O 0 0.007421460468322039
on O 0 0.0007833771524019539
chromosome O 0 0.007436002139002085
4p O 1 0.9011420607566833
at O 0 0.0014351808931678534
D4S2949 O 0 0.02298213355243206
( O 0 0.00047788413939997554
maximum O 0 0.0016579694347456098
GENEHUNTER O 1 0.9715537428855896
- O 0 0.004972266033291817
PLUS O 0 0.003666038392111659
nonparametric O 0 0.01515198778361082
linkage O 0 0.006807718425989151
score O 0 0.0003841281577479094
= O 0 0.0021633931901305914
4 O 0 0.0005076234810985625
. O 0 0.00022716831881552935
05 O 0 0.029096156358718872
, O 0 0.0007501866784878075
P O 0 0.025990361347794533
= O 0 0.0020026545971632004
5 O 0 0.0003285645507276058
. O 0 0.00010773411486297846
22 O 0 0.000485513883177191
x O 0 0.0013523463858291507
10 O 0 0.00033795202034525573
( O 0 0.0004397758166305721
- O 0 0.001993855694308877
4 O 0 0.0005083396681584418
) O 0 0.00022323110897559673
; O 0 0.00037079036701470613
SIBPAL O 1 0.8815730810165405
Pempirical O 0 0.023705976083874702
value O 0 0.00043087752419523895
< O 0 0.009089807979762554
3 O 0 0.0005240989848971367
x O 0 0.0018773521296679974
10 O 0 0.00044641728163696826
( O 0 0.000509023608174175
- O 0 0.0029645757749676704
5 O 0 0.0005208604270592332
) O 0 0.00015910658112261444
) O 0 0.00012052637612214312
and O 0 0.0001502593222539872
suggestive O 0 0.009823388420045376
evidence O 0 0.00024530073278583586
for O 0 0.0001254295784747228
a O 0 0.0006613963632844388
locus O 0 0.0071314554661512375
on O 0 0.0009237714693881571
chromosome O 0 0.00964097399264574
4q O 1 0.9971619844436646
at O 0 0.0013813140103593469
D4S397 O 0 0.023852376267313957
( O 0 0.0005573576199822128
maximum O 0 0.0020580284763127565
GENEHUNTER O 1 0.9849146604537964
- O 0 0.004023891873657703
PLUS O 0 0.003183626104146242
nonparametric O 0 0.015590720809996128
linkage O 0 0.007518888916820288
score O 0 0.00041336906724609435
= O 0 0.0022590141743421555
3 O 0 0.00031747095636092126
. O 0 0.0001481647341279313
29 O 0 0.0014198282733559608
, O 0 0.00045965868048369884
P O 0 0.02009757235646248
= O 0 0.0018652599537745118
2 O 0 0.0002885473077185452
. O 0 0.00011077489034505561
57 O 0 0.001729036564938724
x O 0 0.0015377532690763474
10 O 0 0.00044216300011612475
( O 0 0.0005803853855468333
- O 0 0.002671140478923917
3 O 0 0.000522526737768203
) O 0 0.00025890590040944517
; O 0 0.00030925305327400565
SIBPAL O 1 0.9327045679092407
Pempirical O 0 0.021820880472660065
value O 0 0.0004240678099449724
< O 0 0.008198991417884827
1 O 0 0.0006779703544452786
x O 0 0.0015077226562425494
10 O 0 0.00041380905895493925
( O 0 0.00043881937745027244
- O 0 0.0020697638392448425
3 O 0 0.0003404671442694962
) O 0 0.0001051016224664636
) O 0 5.248808884061873e-05
that O 0 3.159424522891641e-05
are O 0 3.146363087580539e-05
linked O 0 0.010207782499492168
to O 0 0.0008039503591135144
mental O 1 0.9999945163726807
health O 1 0.9998675584793091
wellness O 1 0.9995958209037781
. O 0 0.0012813768116757274

These O 0 0.0005229543312452734
findings O 0 0.0021038714330643415
are O 0 4.3411921069491655e-05
consistent O 0 0.0009468596545048058
with O 0 6.097726509324275e-05
the O 0 0.00017856511112768203
hypothesis O 0 0.0017534804064780474
that O 0 6.493441469501704e-05
certain O 0 0.00029132419149391353
alleles O 0 0.003490293398499489
could O 0 0.0005988131160847843
prevent O 0 0.0035726383794099092
or O 0 0.00045029670582152903
modify O 0 0.008666803129017353
the O 0 0.0006497170543298125
clinical O 1 0.9994992017745972
manifestations O 0 0.4054833948612213
of O 0 0.00029857581830583513
BPAD B-Disease 1 0.9999748468399048
and O 0 0.00031276338268071413
perhaps O 0 0.0015374948270618916
other O 0 0.0002392361784586683
related O 0 0.41272053122520447
affective B-Disease 1 0.999972939491272
disorders I-Disease 1 0.9999871253967285
. O 0 0.003236540127545595

Segregation O 0 0.14571306109428406
distortion O 0 0.08845851570367813
in O 0 0.010559074580669403
myotonic B-Disease 1 0.9999969005584717
dystrophy I-Disease 1 0.9999994039535522
. O 0 0.00775970658287406

Myotonic B-Disease 1 0.9999932050704956
dystrophy I-Disease 1 0.9999994039535522
( O 1 0.5971576571464539
DM B-Disease 1 0.999996542930603
) O 0 0.0007885736413300037
is O 0 0.00040303621790371835
an O 0 0.0010279855923727155
autosomal B-Disease 1 0.9994741082191467
dominant I-Disease 1 0.9987768530845642
disease I-Disease 1 0.999996542930603
which O 0 0.00020891634630970657
, O 0 0.00015349782188422978
in O 0 0.00011619468568824232
the O 0 0.00022279948461800814
typical O 0 0.005810768809169531
pedigree O 0 0.05035678297281265
, O 0 0.00020272545225452632
shows O 0 0.00013994533219374716
a O 0 0.00021565024508163333
three O 0 0.00011570155766094103
generation O 0 0.0028778924606740475
anticipation O 0 0.007661102339625359
cascade O 0 0.19217942655086517
. O 0 0.0010173474438488483

This O 0 0.0003046013880521059
results O 0 0.0009281584643758833
in O 0 0.0011426323326304555
infertility B-Disease 1 0.9999945163726807
and O 1 0.8467944264411926
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.31280770897865295
CDM B-Disease 1 0.999518632888794
) O 0 0.00024389354803133756
with O 0 7.023545185802504e-05
the O 0 0.0003221839142497629
disappearance O 0 0.00699028791859746
of O 0 0.0004126103885937482
DM B-Disease 1 0.9999938011169434
in O 0 0.000348415516782552
that O 0 0.0003867141203954816
pedigree O 0 0.06738182157278061
. O 0 0.0014033339684829116

The O 0 0.00041935278568416834
concept O 0 0.0007147929864004254
of O 0 0.0001436568418284878
segregation O 0 0.348944753408432
distortion O 0 0.019544126465916634
, O 0 0.00029342685593292117
where O 0 0.00016242029960267246
there O 0 0.00010201568511547521
is O 0 0.00031922911875881255
preferential O 0 0.0039504473097622395
transmission O 0 0.001682355417869985
of O 0 1.4196426491253078e-05
the O 0 0.0001184276188723743
larger O 0 0.0005967483739368618
allele O 0 0.004278466105461121
at O 0 0.0007877098978497088
the O 0 0.0021617149468511343
DM B-Disease 1 0.9999681711196899
locus O 0 0.02315828762948513
, O 0 0.0004731361987069249
has O 0 0.00040720574907027185
been O 0 0.00017801155627239496
put O 0 0.00026527783484198153
forward O 0 0.00025854571140371263
to O 0 8.817576599540189e-05
explain O 0 0.0017952140187844634
partially O 0 0.005402014125138521
the O 0 0.0002836917992681265
maintenance O 1 0.9727829694747925
of O 0 0.0004756180278491229
DM B-Disease 1 0.9999935626983643
in O 0 0.00026302580954506993
the O 0 0.0002500803966540843
population O 0 0.0002486268640495837
. O 0 0.0007464855443686247

In O 0 0.00041713076643645763
a O 0 0.0006319968379102647
survey O 0 0.0011864451225847006
of O 0 0.0003605766105465591
DM B-Disease 1 0.9999856948852539
in O 0 0.0006490585510618985
Northern O 0 0.0022063618525862694
Ireland O 0 0.0017303875647485256
, O 0 0.00039844337152317166
59 O 0 0.004080572631210089
pedigrees O 0 0.008930076844990253
were O 0 0.0002429595624562353
ascertained O 0 0.020706545561552048
. O 0 0.0008359269704669714

Sibships O 0 0.42838260531425476
where O 0 0.00035618673427961767
the O 0 0.00013368921645451337
status O 0 0.00034720226540230215
of O 0 8.847975550452247e-06
all O 0 2.0620727809728123e-05
the O 0 0.00014289544196799397
members O 0 0.0001969794393517077
had O 0 0.0005947538884356618
been O 0 0.0003305526915937662
identified O 0 0.000519855588208884
were O 0 6.563116039615124e-05
examined O 0 0.0027564316987991333
to O 0 4.295686449040659e-05
determine O 0 0.00016110231808852404
the O 0 8.572938531870022e-05
transmission O 0 0.0023539066314697266
of O 0 6.217730697244406e-05
the O 0 0.002520371461287141
DM B-Disease 1 0.9999892711639404
expansion O 0 0.004872131627053022
from O 0 0.00039440602995455265
affected O 0 0.005349179729819298
parents O 0 0.0005247088265605271
to O 0 7.185786671470851e-05
their O 0 0.0001232300855917856
offspring O 0 0.0029822022188454866
. O 0 0.0007881397032178938

Where O 0 0.0009259625221602619
the O 0 0.0006576533778570592
transmitting O 0 0.07073263078927994
parent O 0 0.028051482513546944
was O 0 0.0017249095253646374
male O 0 0.0017213072860613465
, O 0 0.0006294327904470265
58 O 0 0.005296945106238127
. O 0 0.0011799480998888612

3 O 0 0.0010215830989181995
% O 0 3.7770343624288216e-05
of O 0 3.0431307095568627e-05
the O 0 0.00041173817589879036
offspring O 0 0.002670688321813941
were O 0 0.00017289386596530676
affected O 0 0.004209036007523537
, O 0 0.0001690283534117043
and O 0 9.637809853302315e-05
in O 0 7.483123772544786e-05
the O 0 0.000122184501378797
case O 0 0.0004483457305468619
of O 0 2.2216883735381998e-05
a O 0 0.0009016219992190599
female O 0 0.0036042556166648865
transmitting O 0 0.2794263958930969
parent O 0 0.03199685737490654
, O 0 0.0008294836734421551
68 O 0 0.0061653004959225655
. O 0 0.0011976707028225064

7 O 0 0.0020114360377192497
% O 0 0.00011873406037921086
were O 0 0.00015932443784549832
affected O 0 0.006679511163383722
. O 0 0.0010841407347470522

Studies O 0 0.0020939400419592857
on O 0 0.000704094476532191
meiotic O 1 0.9104108214378357
drive O 0 0.006176799535751343
in O 0 0.0021064027678221464
DM B-Disease 1 0.9999940395355225
have O 0 0.00023454402980860323
shown O 0 0.0004416011506691575
increased O 0 0.0003107790253125131
transmission O 0 0.0012087799841538072
of O 0 1.2131562471040525e-05
the O 0 0.00010384569759480655
larger O 0 0.0005739745101891458
allele O 0 0.0038107633590698242
at O 0 0.0005966186872683465
the O 0 0.0015617456519976258
DM B-Disease 1 0.9999364614486694
locus O 0 0.014647204428911209
in O 0 0.0006050624651834369
non O 0 0.015169660560786724
- O 1 0.9409531950950623
DM O 1 0.9999185800552368
heterozygotes O 1 0.6763406991958618
for O 0 0.0010886052623391151
CTGn O 1 0.7837173342704773
. O 0 0.0015964433550834656

This O 0 0.00035915596527047455
study O 0 0.0008000496309250593
provides O 0 0.0008412206661887467
further O 0 0.00023000268265604973
evidence O 0 0.000211092468816787
that O 0 0.00013793095422443002
the O 0 0.001047241035848856
DM B-Disease 1 0.9999866485595703
expansion O 0 0.005105507094413042
tends O 0 0.002949147718027234
to O 0 0.00010669845505617559
be O 0 0.0002241819747723639
transmitted O 0 0.0045798951759934425
preferentially O 0 0.008536053821444511
. O 0 0.0008452589972876012

Diagnosis O 1 0.9997366070747375
of O 0 0.0021753159817308187
hemochromatosis B-Disease 1 0.999993085861206
. O 0 0.0042107668705284595

If O 0 0.013001538813114166
untreated O 1 0.999790608882904
, O 0 0.006398795172572136
hemochromatosis B-Disease 1 0.9999984502792358
can O 0 0.003571494948118925
cause O 1 0.9995307922363281
serious O 1 0.9999591112136841
illness O 1 0.9999963045120239
and O 0 0.00034748640609905124
early B-Disease 0 0.0016544027021154761
death I-Disease 0 0.004409722052514553
, O 0 0.00015264937246683985
but O 0 0.0002582781598903239
the O 0 0.0008473824709653854
disease O 1 0.9999767541885376
is O 0 0.00046803508303128183
still O 0 0.0007681037532165647
substantially O 0 0.018122319132089615
under O 0 0.002761980751529336
- O 1 0.9985328912734985
diagnosed O 1 0.9999884366989136
. O 0 0.0011359276250004768

The O 0 0.000840903667267412
cornerstone O 0 0.02034476213157177
of O 0 0.0001308021164732054
screening O 0 0.00825646985322237
and O 0 0.0002470017352607101
case O 0 0.002054641954600811
detection O 0 0.003687320277094841
is O 0 0.00010707169712986797
the O 0 5.86943315283861e-05
measurement O 0 0.0010147154098376632
of O 0 0.00013526566908694804
serum O 1 0.9815956950187683
transferrin O 1 0.7542920112609863
saturation O 0 0.01175478845834732
and O 0 0.00017742966883815825
the O 0 0.00043630797881633043
serum O 1 0.9326697587966919
ferritin O 1 0.9339703917503357
level O 0 0.0031385377515107393
. O 0 0.0009171164128929377

Once O 0 0.006204311735928059
the O 0 0.0021180524490773678
diagnosis O 1 0.9999656677246094
is O 0 0.0016509693814441562
suspected O 0 0.013445992954075336
, O 0 0.0005870665772818029
physicians O 1 0.8648037910461426
must O 0 0.0003029572544619441
use O 0 0.0004611157055478543
serum O 1 0.9822654724121094
ferritin O 1 0.9488602876663208
levels O 0 0.004133198410272598
and O 0 0.0009012586669996381
hepatic O 1 0.9999455213546753
iron O 1 0.9927358627319336
stores O 0 0.0019091506255790591
on O 0 0.0038926699198782444
liver O 1 0.9999970197677612
biopsy O 1 0.9999430179595947
specimens O 0 0.014705353416502476
to O 0 0.0006861592992208898
assess O 1 0.9746844172477722
patients O 1 0.9993600249290466
for O 0 6.775196379749104e-05
the O 0 0.00010065582318929955
presence O 0 0.0003742939734365791
of O 0 0.000123723060823977
iron B-Disease 1 0.9988744854927063
overload I-Disease 1 0.996394693851471
. O 0 0.00243603833951056

Liver O 1 0.9999938011169434
biopsy O 1 0.9998534917831421
is O 0 0.0009594799485057592
also O 0 0.00016435838188044727
used O 0 0.00010666142770787701
to O 0 6.003539601806551e-05
establish O 0 0.0003842479200102389
the O 0 0.00012790191976819187
presence O 0 0.0006593817379325628
or O 0 0.000292562268441543
absence O 0 0.003394325729459524
of O 0 0.0002467089507263154
cirrhosis B-Disease 1 0.9999971389770508
, O 0 0.0003808428591582924
which O 0 0.00015205984527710825
can O 0 0.0005250166286714375
affect O 0 0.22855617105960846
prognosis O 1 0.9999847412109375
and O 0 0.0006134040886536241
management O 1 0.9130101799964905
. O 0 0.001238137949258089

A O 0 0.006840475369244814
DNA O 0 0.003262221347540617
- O 0 0.0020918366499245167
based O 0 0.00019276603416074067
test O 0 0.0005051853368058801
for O 0 0.00014223316975403577
the O 0 0.0008635295671410859
HFE O 1 0.9986164569854736
gene O 0 0.0029742461629211903
is O 0 0.0003393865190446377
commercially O 0 0.0014621684094890952
available O 0 0.00018302978423889726
, O 0 7.294269016711041e-05
but O 0 4.257748878444545e-05
its O 0 4.149978485656902e-05
place O 0 6.447742634918541e-05
in O 0 8.461780817015097e-05
the O 0 0.0005559172132052481
diagnosis O 1 0.9999533891677856
of O 0 0.0006303152185864747
hemochromatosis B-Disease 1 0.9999992847442627
is O 0 0.0018189030233770609
still O 0 0.001216647564433515
being O 0 0.0010087423725053668
evaluated O 0 0.015144099481403828
. O 0 0.0007895646267570555

Currently O 0 0.0021910362411290407
, O 0 0.000169287872267887
the O 0 0.00011080414697062224
most O 0 0.0001822148624341935
useful O 0 0.0008476562215946615
role O 0 0.0007181355031207204
for O 0 0.00011340478522470221
this O 0 9.139466419583187e-05
test O 0 0.0006706718704663217
is O 0 0.00010623773414408788
in O 0 5.152892481419258e-05
the O 0 0.00016991596203297377
detection O 0 0.00662803603336215
of O 0 0.00031498222961090505
hemochromatosis B-Disease 1 0.9999988079071045
in O 0 0.0003021092270500958
the O 0 0.0002681126934476197
family O 0 0.0005376528715714812
members O 0 0.0001276688271900639
of O 0 0.00015237016486935318
patients O 1 0.9999263286590576
with O 0 0.0001136818464146927
a O 0 0.0011660685995593667
proven O 1 0.6462066173553467
case O 0 0.0006245232652872801
of O 0 4.4252999941818416e-05
the O 0 0.004317710176110268
disease O 1 0.9999960660934448
. O 0 0.0014740655897185206

It O 0 0.0003824089071713388
is O 0 0.00022124712995719165
crucial O 0 0.0022335441317409277
to O 0 0.0016318690031766891
diagnose O 1 0.9999991655349731
hemochromatosis B-Disease 1 0.9999994039535522
before O 1 0.5543466210365295
hepatic B-Disease 1 0.9999973773956299
cirrhosis I-Disease 1 0.9999992847442627
develops O 1 0.9996581077575684
because O 0 0.19774286448955536
phlebotomy O 1 0.999937891960144
therapy O 1 0.999872088432312
can O 0 0.0024557376746088266
avert O 1 0.9996107220649719
serious O 1 0.9999896287918091
chronic O 1 1.0
disease O 1 0.9999994039535522
and O 0 0.00037447066279128194
can O 0 0.00019091526337433606
even O 0 0.0002113756345352158
lead O 0 0.00019059551414102316
to O 0 8.935563528211787e-05
normal O 0 0.0015834391815587878
life O 0 0.00161736982408911
expectancy O 0 0.08473493158817291
. O 0 0.0002516091044526547
. O 0 0.0006490758969448507

Prevalence O 0 0.11307601630687714
of O 0 0.00014053130871616304
the O 0 0.0012919415021315217
I1307K O 1 0.9766498804092407
APC B-Disease 1 0.994325578212738
gene O 0 0.007204836700111628
variant O 0 0.011078955605626106
in O 0 0.00028425795608200133
Israeli O 0 0.001140737789683044
Jews O 0 0.0001511355658294633
of O 0 1.878075818240177e-05
differing O 0 0.00029032331076450646
ethnic O 0 0.00012130694813095033
origin O 0 0.00014241691678762436
and O 0 0.0004250097263138741
risk O 1 0.9989203214645386
for O 1 0.900921106338501
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.0027612936682999134

BACKGROUND O 0 0.0495082251727581
& O 0 0.12908430397510529
AIMS O 0 0.02059241570532322
Israeli O 0 0.0016690657939761877
Jews O 0 0.0001937927008839324
of O 0 3.317260416224599e-05
European O 0 0.0010803224286064506
birth O 0 0.006333536002784967
, O 0 0.0004177266964688897
i O 0 0.0020078830420970917
. O 0 0.0002086666936520487
e O 0 0.001528468681499362
. O 0 0.00011042970436392352
, O 0 0.0002604458131827414
Ashkenazim O 0 0.04233058542013168
, O 0 8.526401506969705e-05
have O 0 6.720282544847578e-05
the O 0 0.00039453309727832675
highest O 1 0.9983160495758057
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
incidence O 1 0.9942025542259216
of O 0 4.874046135228127e-05
any O 0 0.00026550228358246386
Israeli O 0 0.0014094521757215261
ethnic O 0 0.00029242257005535066
group O 0 0.0012095492566004395
. O 0 0.0009042873280122876

The O 0 0.0024510531220585108
I1307K O 0 0.3043469190597534
APC B-Disease 1 0.9828040599822998
gene O 0 0.007985777221620083
variant O 0 0.026964543387293816
was O 0 0.0013984238030388951
found O 0 0.0004597012302838266
in O 0 0.0003018512506969273
6 O 0 0.0017868408467620611
. O 0 0.0008880714303813875

1 O 0 0.0009813359938561916
% O 0 4.724329482996836e-05
of O 0 3.623953671194613e-05
American O 0 0.0005308097461238503
Jews O 0 0.0005282346392050385
, O 0 0.0002188918151659891
28 O 0 0.000328433932736516
% O 0 1.705274553387426e-05
of O 0 2.8929087420692667e-05
their O 0 0.0022999048233032227
familial O 1 0.9999995231628418
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.45742854475975037
, O 0 0.0003031970700249076
but O 0 0.0001679244014667347
not O 0 7.694758096477017e-05
in O 0 0.00013174014748074114
non O 0 0.0019786383491009474
- O 0 0.0037105302326381207
Jews O 0 0.0007559601217508316
. O 0 0.0008396359044127166

We O 0 0.0013657971285283566
assessed O 0 0.006920898798853159
the O 0 0.0007949534337967634
I1307K O 1 0.615757942199707
prevalence O 1 0.7426186800003052
in O 0 0.0003007700142916292
Israeli O 0 0.0011961396085098386
Jews O 0 0.00014825546531938016
of O 0 1.4539095900545362e-05
differing O 0 0.00022960430942475796
ethnic O 0 9.83954596449621e-05
origin O 0 0.000115349939733278
and O 0 0.000422528013586998
risk O 1 0.9978629946708679
for O 1 0.8430830240249634
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.0022690605837851763

METHODS O 0 0.0055435835383832455
DNA O 0 0.0019700767006725073
samples O 0 0.0006183281657285988
from O 0 0.00023150756896939129
500 O 0 0.0017785574309527874
unrelated O 0 0.0025771469809114933
Jews O 0 0.00018449212075211108
of O 0 3.150707925669849e-05
European O 0 0.0008548972546122968
or O 0 0.0007692379876971245
non O 0 0.002951693255454302
- O 0 0.0028413839172571898
European O 0 0.00029629419441334903
origin O 0 0.00010016119631472975
, O 0 0.00010056677274405956
with O 0 6.600504275411367e-05
or O 0 0.00018848053878173232
without O 0 0.00015814370999578387
a O 0 0.00046915336861275136
personal O 0 0.002470550360158086
and O 0 0.000975391361862421
/ O 1 0.7131876349449158
or O 0 0.00034266436705365777
family O 0 0.00046018874854780734
history O 0 0.000392638350604102
of O 0 0.0002520290727261454
neoplasia B-Disease 1 0.9999392032623291
, O 0 0.0004883149522356689
were O 0 0.00011989111226284876
examined O 0 0.004240041133016348
for O 0 0.00012306006101425737
the O 0 0.0004006859380751848
I1307K O 0 0.0651843473315239
variant O 0 0.004779402632266283
by O 0 6.00111270614434e-05
the O 0 0.0003054703411180526
allele O 0 0.005450734868645668
- O 0 0.0021531207021325827
specific O 0 0.0005683185299858451
oligonucleotide O 0 0.07800823450088501
( O 0 0.0032342812046408653
ASO O 1 0.9987747073173523
) O 0 0.0005344549426808953
method O 0 0.0010477254400029778
. O 0 0.000932109251152724

RESULTS O 0 0.0041524386033415794
In O 0 0.00035219124401919544
persons O 0 0.0006363828433677554
at O 0 0.0004492381413001567
average O 0 0.0021003284491598606
risk O 1 0.9785032868385315
for O 1 0.6815342903137207
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.0010728345951065421
I1307K O 1 0.6563012003898621
was O 0 0.0009425068274140358
found O 0 0.00022902381897438318
in O 0 0.00018199780606664717
5 O 0 0.0008428944274783134
. O 0 0.0005368612473830581

0 O 0 0.0008516167290508747
% O 0 3.98068550566677e-05
of O 0 3.1550465791951865e-05
120 O 0 0.0006806505843997002
European O 0 0.0006240496877580881
and O 0 0.00027996639255434275
1 O 0 0.001361803151667118
. O 0 0.0005641652969643474

6 O 0 0.0014986847527325153
% O 0 5.5833417718531564e-05
of O 0 5.294824222801253e-05
188 O 0 0.007456351537257433
non O 0 0.0022052640561014414
- O 0 0.0025905936490744352
European O 0 0.0005525363376364112
Jews O 0 0.0009647084516473114
( O 0 0.0014415025943890214
P O 0 0.05128687247633934
= O 0 0.0033017301466315985
0 O 0 0.0007616168004460633
. O 0 0.0002634642878547311
08 O 0 0.01745743118226528
) O 0 0.0004497047048062086
. O 0 0.0005749182309955359

It O 0 0.0010868147946894169
occurred O 0 0.0019631381146609783
in O 0 0.0003190593852195889
15 O 0 0.0013556450139731169
. O 0 0.0008453396148979664

4 O 0 0.0010155191412195563
% O 0 5.54253019799944e-05
of O 0 6.217209011083469e-05
52 O 0 0.005062613170593977
Ashkenazi O 0 0.08070773631334305
Israelis O 0 0.0039805215783417225
with O 0 0.0012588988756760955
familial O 1 0.9999769926071167
cancer B-Disease 1 0.9999991655349731
( O 0 0.0032554282806813717
P O 1 0.8781148195266724
= O 0 0.004074012860655785
0 O 0 0.000850827491376549
. O 0 0.00034221867099404335
02 O 1 0.9036449790000916
) O 0 0.00020151077478658408
and O 0 9.117200534092262e-05
was O 0 0.0005484875873662531
not O 0 0.00017002696404233575
detected O 0 0.002453533234074712
in O 0 0.00016854761634021997
51 O 0 0.0019652992486953735
non O 0 0.0016534312162548304
- O 0 0.0017916773213073611
European O 0 0.00035871146246790886
Jews O 0 0.00040755857480689883
at O 0 0.001190329436212778
increased O 0 0.202019602060318
cancer B-Disease 1 0.9999967813491821
risk O 1 0.9594101905822754
. O 0 0.0014648337382823229

Colorectal B-Disease 1 0.99998939037323
neoplasia I-Disease 1 0.9998316764831543
occurred O 0 0.03425567224621773
personally O 0 0.3763948082923889
or O 0 0.0004083696403540671
in O 0 0.0001222814607899636
the O 0 0.00012880784925073385
families O 0 0.00010275604290654883
of O 0 2.3758831957820803e-05
13 O 0 0.0003429749922361225
of O 0 5.527729808818549e-05
20 O 0 0.0015088105574250221
Ashkenazi O 1 0.6290164589881897
I1307K O 0 0.2441113293170929
carriers O 0 0.006455227266997099
, O 0 0.00020775131997652352
8 O 0 0.00022079677728470415
of O 0 4.208584505249746e-05
whom O 0 0.0011884289560839534
also O 0 0.0002001939428737387
had O 0 0.0003106146468780935
a O 0 0.00035900395596399903
personal O 0 0.001135936239734292
or O 0 0.0003060665330849588
family O 0 0.00046212380402721465
history O 0 0.000372636248357594
of O 0 0.0002626707428134978
noncolonic O 1 0.9981330037117004
neoplasia B-Disease 1 0.9994884729385376
. O 0 0.002550072968006134

CONCLUSIONS O 0 0.013340868055820465
The O 0 0.0019441129406914115
I1307K O 1 0.927352786064148
APC O 1 0.9892870187759399
variant O 0 0.025587256997823715
may O 0 0.0005750144482590258
represent O 0 0.0002203780459240079
a O 0 0.0012210033601149917
susceptibility O 1 0.9854151010513306
gene O 0 0.006078426726162434
for O 0 0.0038513480685651302
colorectal B-Disease 1 0.9999996423721313
, I-Disease 0 0.00041618943214416504
or I-Disease 0 0.0003155223384965211
other I-Disease 0 0.00015168853860814124
, I-Disease 0 0.001354674343019724
cancers I-Disease 1 0.9998784065246582
in O 0 0.0006792534841224551
Ashkenazi O 1 0.7093597054481506
Jews O 0 0.0009488020441494882
, O 0 0.00032933286274783313
and O 0 0.0003201068611815572
partially O 0 0.014318026602268219
explains O 0 0.001772947609424591
the O 0 0.0001389393291901797
higher O 0 0.0016538375057280064
incidence O 1 0.9990501999855042
of O 0 0.007561183534562588
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.0004877989995293319
European O 0 0.002128196880221367
Israelis O 0 0.00950445793569088
. O 0 0.0010523675009608269

Systematic O 0 0.0057680075988173485
analysis O 0 0.0004987987922504544
of O 0 0.0001861492492025718
coproporphyrinogen O 1 0.9895484447479248
oxidase O 1 0.8998622894287109
gene O 0 0.020179560407996178
defects O 1 0.9989922642707825
in O 0 0.0009162875940091908
hereditary B-Disease 1 0.9896591305732727
coproporphyria I-Disease 1 0.981928825378418
and O 0 0.0007176814833655953
mutation O 0 0.012077082879841328
update O 0 0.018089497461915016
. O 0 0.001009065774269402

Hereditary B-Disease 1 0.9967182278633118
coproporphyria I-Disease 1 0.9934926629066467
( O 0 0.00597827835008502
HC B-Disease 1 0.9999414682388306
) O 0 0.0006086067296564579
is O 0 0.0005831150338053703
an O 0 0.005360221490263939
acute O 1 0.999998927116394
hepatic B-Disease 1 0.999998927116394
porphyria I-Disease 1 0.9999959468841553
with O 0 0.004287876188755035
autosomal O 1 0.9985772371292114
dominant O 0 0.38977354764938354
inheritance O 0 0.3597011864185333
caused O 0 0.23436369001865387
by O 0 0.0006822163122706115
deficient B-Disease 1 0.9982170462608337
activity I-Disease 0 0.0005280065815895796
of I-Disease 0 0.00017663513426668942
coproporphyrinogen I-Disease 1 0.9906636476516724
III I-Disease 1 0.9914435744285583
oxidase I-Disease 0 0.09553609043359756
( O 0 0.0018550306558609009
CPO O 0 0.055783748626708984
) O 0 0.0006999126635491848
. O 0 0.0007631093612872064

Clinical O 1 0.9981974959373474
manifestations O 0 0.14755438268184662
of O 0 0.00014378812920767814
the O 0 0.010767580009996891
disease O 1 0.9999953508377075
are O 0 0.00012368529860395938
characterized O 1 0.9179984927177429
by O 0 0.0006350685725919902
acute O 1 0.9999926090240479
attacks O 0 0.007797813042998314
of O 0 0.000957009382545948
neurological B-Disease 1 1.0
dysfunction I-Disease 1 0.999995231628418
often O 0 0.0024475138634443283
precipitated O 1 0.9980247020721436
by O 0 0.0002906217996496707
drugs O 1 0.5485284328460693
, O 0 0.0004746834165416658
fasting O 0 0.015341056510806084
, O 0 0.0007651274790987372
cyclical O 1 0.991938054561615
hormonal O 1 0.976980447769165
changes O 0 0.0013067611726000905
, O 0 0.0007180297398008406
or O 0 0.015466123819351196
infectious B-Disease 1 0.9999943971633911
diseases I-Disease 1 0.9999911785125732
. O 0 0.0020837935153394938

Skin O 1 0.9999940395355225
photosensitivity O 1 0.9999017715454102
may O 0 0.005699388217180967
also O 0 0.00029504374833777547
be O 0 0.00013413258420769125
present O 0 0.0003267346473876387
. O 0 0.0007484857924282551

The O 0 0.0006709244335070252
seven O 0 0.0005778446793556213
exons O 0 0.004408499225974083
, O 0 0.00033119492582045496
the O 0 0.0006682302337139845
exon O 0 0.45657435059547424
/ O 0 0.026210317388176918
intron O 0 0.03822077438235283
boundaries O 0 0.0002674088755156845
and O 0 0.00010158419900108129
part O 0 0.00029528237064369023
of O 0 4.019112020614557e-05
3 O 0 0.0006271405145525932
noncoding O 0 0.006726868916302919
sequence O 0 5.7889308664016426e-05
of O 0 3.024749457836151e-05
the O 0 0.0007166058057919145
CPO O 0 0.220873162150383
gene O 0 0.0016702769789844751
were O 0 9.036807750817388e-05
systematically O 0 0.002522536087781191
analyzed O 0 0.0005702483467757702
by O 0 5.634829722112045e-05
an O 0 0.00041226009489037097
exon O 0 0.016380375251173973
- O 0 0.002086851978674531
by O 0 0.00017730433319229633
- O 0 0.005755946971476078
exon O 0 0.023246893659234047
denaturing O 0 0.19325792789459229
gradient O 0 0.035958465188741684
gel O 1 0.9803378582000732
electrophoresis O 0 0.34189102053642273
( O 0 0.004471970722079277
DGGE O 1 0.9905431866645813
) O 0 0.0004929457791149616
strategy O 0 0.002176692709326744
followed O 0 0.00014803963131271303
by O 0 1.9404445993131958e-05
direct O 0 0.00012083823094144464
sequencing O 0 0.00036204259959049523
in O 0 0.0001208871035487391
seven O 0 0.0004575542116072029
unrelated O 0 0.03811626881361008
heterozygous O 0 0.34518489241600037
HC B-Disease 1 0.9999892711639404
patients O 1 0.9999758005142212
from O 0 0.0005304137011989951
France O 0 0.0046476698480546474
, O 0 0.0008224078337661922
Holland O 0 0.041573334485292435
, O 0 0.0002338288613827899
and O 0 0.00018042270676232874
Czech O 0 0.0031730765476822853
Republic O 0 0.0013158670626580715
. O 0 0.0008393086609430611

Seven O 0 0.0023449098225682974
novel O 0 0.003850937820971012
mutations O 0 0.0015777142252773046
and O 0 7.196854858193547e-05
two O 0 5.530022826860659e-05
new O 0 0.0003193511802237481
polymorphisms O 0 0.003007958410307765
were O 0 0.00014690733223687857
detected O 0 0.010727042332291603
. O 0 0.0007950792205519974

Among O 0 0.000470353668788448
these O 0 0.00010439215111546218
mutations O 0 0.0009145988151431084
two O 0 5.5593216529814526e-05
are O 0 0.00010961420048261061
missense O 0 0.019645193591713905
( O 0 0.0012886296026408672
G197W O 0 0.17090877890586853
, O 0 0.0007598479278385639
W427R O 0 0.024483125656843185
) O 0 0.00018103256297763437
, O 0 8.036579674808308e-05
two O 0 4.933722084388137e-05
are O 0 7.762096356600523e-05
nonsense O 0 0.015441440977156162
( O 0 0.001376938191242516
Q306X O 0 0.10869699716567993
, O 0 0.0007879042532294989
Q385X O 0 0.03257645666599274
) O 0 0.0001836689334595576
, O 0 6.51943264529109e-05
two O 0 1.7262824258068576e-05
are O 0 2.6145100491703488e-05
small O 0 0.000449797953478992
deletions O 0 0.0063817864283919334
( O 0 0.0013361818855628371
662de14bp O 0 0.07966198027133942
; O 0 0.0004404009087011218
1168del3bp O 0 0.030783388763666153
removing O 0 0.004365620203316212
a O 0 0.0009614629670977592
glycine O 0 0.005768696311861277
at O 0 0.0005032907356508076
position O 0 0.0017816873732954264
390 O 0 0.013976861722767353
) O 0 0.0002345970569876954
, O 0 7.513785385526717e-05
and O 0 3.367704994161613e-05
one O 0 5.195860649109818e-05
is O 0 7.312774687306955e-05
a O 0 0.00028411162202246487
splicing O 0 0.0028804754838347435
mutation O 0 0.00415416993200779
( O 0 0.0014963826397433877
IVS1 O 1 0.9721143245697021
- O 0 0.011424318887293339
15c O 0 0.1788487583398819
- O 0 0.007975571788847446
- O 0 0.006649006623774767
> O 0 0.007762541528791189
g O 0 0.0034402331802994013
) O 0 0.00011886184802278876
which O 0 4.647812238545157e-05
creates O 0 0.0010969019494950771
a O 0 0.0005176754202693701
new O 0 0.0008075786172412336
acceptor O 0 0.05022361874580383
splice O 0 0.03308560326695442
site O 0 0.004227370489388704
. O 0 0.0008757147006690502

The O 0 0.0015758256195113063
pathological O 0 0.15145620703697205
significance O 0 0.00047163901035673916
of O 0 2.122437763318885e-05
the O 0 0.0002522454014979303
point O 0 0.0014742010971531272
mutations O 0 0.00452877813950181
G197W O 0 0.039301879703998566
, O 0 0.0006357269594445825
W427R O 0 0.014674687758088112
, O 0 0.00012447650078684092
and O 0 4.440882185008377e-05
the O 0 9.877590491669253e-05
in O 0 0.00027590023819357157
- O 0 0.006554572377353907
frame O 0 0.006025657989084721
deletion O 0 0.014679964631795883
390delGly O 0 0.04757700115442276
were O 0 0.00012410922499839216
assessed O 0 0.0026961236726492643
by O 0 3.6242196074454114e-05
their O 0 3.7353544030338526e-05
respective O 0 0.00041986952419392765
expression O 0 0.0006496694404631853
in O 0 0.00015031076327431947
a O 0 0.0006236575427465141
prokaryotic O 0 0.003153204219415784
system O 0 0.0009210578864440322
using O 0 0.00036805920535698533
site O 0 0.002484409837052226
- O 0 0.0038453007582575083
directed O 0 0.0009121039183810353
mutagenesis O 0 0.02412269078195095
. O 0 0.0014606076292693615

These O 0 0.0006805124576203525
mutations O 0 0.00408476497977972
resulted O 0 0.0015838035615161061
in O 0 0.00016305108147207648
the O 0 0.00037172940210439265
absence O 0 0.005123340059071779
or O 0 0.0002906356821767986
a O 0 0.0005276443553157151
dramatic O 0 0.0031705237925052643
decrease O 0 0.002044984372332692
of O 0 0.00012880958092864603
CPO O 0 0.15829242765903473
activity O 0 0.002305370755493641
. O 0 0.0011401065858080983

The O 0 0.0004655402444768697
two O 0 0.00020949880126863718
polymorphisms O 0 0.003886019578203559
were O 0 0.00013445423974189907
localized O 0 0.008408683352172375
in O 0 0.00036972155794501305
noncoding O 0 0.015337591990828514
part O 0 0.00029197236290201545
of O 0 1.68125334312208e-05
the O 0 0.00024771399330347776
gene O 0 0.0013557352358475327
1 O 0 0.00044517384958453476
) O 0 0.0001680820423644036
a O 0 0.0014140703715384007
C O 0 0.2638571262359619
/ O 0 0.02319033443927765
G O 0 0.00904131680727005
polymorphism O 0 0.0013638442615047097
in O 0 0.000167482256074436
the O 0 0.0006566944648511708
promotor O 1 0.9739625453948975
region O 0 0.0035965780261904
, O 0 0.00048218900337815285
142 O 0 0.0062738340348005295
bp O 0 0.022271685302257538
upstream O 0 0.0016436480218544602
from O 0 4.817057924810797e-05
the O 0 0.00011083891877206042
transcriptional O 0 0.0027244745288044214
initiation O 0 0.004295584745705128
site O 0 0.003102391492575407
( O 0 0.0011503674322739244
- O 0 0.014917746186256409
142C O 0 0.3497156798839569
/ O 0 0.04659722000360489
G O 0 0.016807183623313904
) O 0 0.00021727244893554598
, O 0 0.00011176556290592998
and O 0 8.819595677778125e-05
2 O 0 0.0004281015135347843
) O 0 0.00010836840374395251
a O 0 0.0004287549527361989
6 O 0 0.0011734197614714503
bp O 0 0.028766661882400513
deletion O 0 0.004306884482502937
polymorphism O 0 0.001479191705584526
in O 0 0.00013227725867182016
the O 0 0.00023653623065911233
3 O 0 0.0007339850417338312
noncoding O 0 0.009089240804314613
part O 0 0.00025526987155899405
of O 0 2.922590465459507e-05
the O 0 0.0006703798426315188
CPO O 0 0.36671125888824463
gene O 0 0.0029917603824287653
, O 0 0.0008077883394435048
574 O 0 0.1198020726442337
bp O 0 0.03655397146940231
downstream O 0 0.002077325014397502
of O 0 2.7056421458837576e-05
the O 0 0.00015311439346987754
last O 0 0.0004054259625263512
base O 0 0.00018433071090839803
of O 0 1.1210951925022528e-05
the O 0 0.00023506410070694983
normal O 0 0.004436578135937452
termination O 0 0.0593862310051918
codon O 0 0.012650438584387302
( O 0 0.001965671544894576
+ O 0 0.05207790806889534
574 O 1 0.6296637058258057
delATTCTT O 0 0.4418933093547821
) O 0 0.0009238405618816614
. O 0 0.0008663804037496448

Five O 0 0.0040157251060009
intragenic O 1 0.685417652130127
dimorphisms O 0 0.17633692920207977
are O 0 0.0001376899454044178
now O 0 0.0006085446220822632
well O 0 0.0003227652923669666
characterized O 0 0.013691917061805725
and O 0 0.00011214070400455967
the O 0 0.00021018787811044604
high O 0 0.0013645734870806336
degree O 0 0.0005425181589089334
of O 0 6.770779145881534e-05
allelic O 0 0.351401686668396
heterogeneity O 0 0.038919705897569656
in O 0 0.0018503465689718723
HC B-Disease 1 0.9999765157699585
is O 0 0.0012855441309511662
demonstrated O 0 0.0024877279065549374
with O 0 0.00010775651753647253
seven O 0 0.0002146004408132285
new O 0 0.0001742234017001465
different O 0 6.811409548390657e-05
mutations O 0 0.0008040966931730509
making O 0 0.0001417435851180926
a O 0 0.00012520779273472726
total O 0 4.4365646317601204e-05
of O 0 4.568472286337055e-05
nineteen O 0 0.019236130639910698
CPO O 1 0.9676790237426758
gene B-Disease 0 0.05644525587558746
defects I-Disease 1 0.9996119141578674
reported O 0 0.0040328302420675755
so O 0 0.00043634686153382063
far O 0 0.000681013276334852
. O 0 0.00027477226103655994
. O 0 0.0006968316738493741

Coincidence O 0 0.0037557671312242746
of O 0 3.8730737287551165e-05
two O 0 0.0001596131914993748
novel O 0 0.0027819143142551184
arylsulfatase O 0 0.14854978024959564
A O 0 0.0027242894284427166
alleles O 0 0.0030381991527974606
and O 0 0.0003431282239034772
mutation O 0 0.008517936803400517
459 O 1 0.8635068535804749
+ O 0 0.055875513702631
1G O 1 0.7993910312652588
> O 0 0.007977331057190895
A O 0 0.0009325231076218188
within O 0 0.0001312557578785345
a O 0 0.0005893821362406015
family O 0 0.001590503379702568
with O 0 0.0014102190034464002
metachromatic B-Disease 1 0.99974125623703
leukodystrophy I-Disease 1 0.9999556541442871
: O 0 0.0008302684873342514
molecular O 0 0.0007568128639832139
basis O 0 7.951726001920179e-05
of O 0 7.831695984350517e-05
phenotypic O 0 0.038905564695596695
heterogeneity O 0 0.08535410463809967
. O 0 0.002083995845168829

In O 0 0.0007275114767253399
a O 0 0.0009145056246779859
family O 0 0.0007074879249557853
with O 0 0.00016363438044209033
three O 0 0.00029825972160324454
siblings O 0 0.0028996646869927645
, O 0 0.00011639473086688668
one O 0 0.00012060799053870142
developed O 0 0.0017622344894334674
classical O 0 0.0011417395435273647
late O 0 0.013832729309797287
infantile O 1 0.9999778270721436
metachromatic B-Disease 1 0.9998748302459717
leukodystrophy I-Disease 1 0.9999890327453613
( O 0 0.025832969695329666
MLD B-Disease 1 0.9999549388885498
) O 0 0.0012607264798134565
, O 0 0.000985493534244597
fatal O 1 0.9997335076332092
at O 0 0.0008373053278774023
age O 0 0.0007859569159336388
5 O 0 0.0004920904175378382
years O 0 0.0003753179626073688
, O 0 0.0001877302856883034
with O 0 0.0006943537155166268
deficient O 1 0.9997969269752502
arylsulfatase O 1 0.8802000284194946
A O 0 0.009640105068683624
( O 0 0.0029355837032198906
ARSA O 1 0.9981277585029602
) O 0 0.000300851184874773
activity O 0 0.00024929383653216064
and O 0 0.0001329670922132209
increased O 0 0.0016340096481144428
galactosylsulfatide O 1 0.970701277256012
( O 0 0.0034628736320883036
GS O 1 0.9995600581169128
) O 0 0.0009874353418126702
excretion O 0 0.029439235106110573
. O 0 0.0010773506946861744

The O 0 0.00042815416236408055
two O 0 0.00012428435729816556
other O 0 0.00019797305867541581
siblings O 0 0.00421103835105896
, O 0 0.0004803951596841216
apparently O 0 0.004703488200902939
healthy O 0 0.008038581348955631
at O 0 0.0005716515006497502
12 O 0 0.0007986153941601515
( O 0 0.0005861045210622251
1 O 0 0.001619214890524745
/ O 0 0.005970762576907873
2 O 0 0.0003865655744448304
) O 0 9.625263191992417e-05
and O 0 8.367346890736371e-05
15 O 0 0.00035218551056459546
years O 0 0.0003517845179885626
, O 0 0.00016638745728414506
respectively O 0 0.00029278130386956036
, O 0 0.00011586961772991344
and O 0 9.32226175791584e-05
their O 0 0.00013131047307979316
father O 0 0.003195657627657056
, O 0 0.0005875765345990658
apparently O 0 0.004780514631420374
healthy O 0 0.010484281927347183
as O 0 0.00018364372954238206
well O 0 0.0002333509037271142
, O 0 0.0003244707768317312
presented O 0 0.00514036463573575
ARSA O 1 0.9995424747467041
and O 0 0.0014397419290617108
GS O 1 0.9958659410476685
values O 0 9.500318265054375e-05
within O 0 4.5142380258766934e-05
the O 0 9.64025457506068e-05
range O 0 0.0008509248145855963
of O 0 0.0005360054783523083
MLD B-Disease 1 0.999992847442627
patients O 1 0.9999279975891113
. O 0 0.0016644819406792521

Mutation O 0 0.019552361220121384
screening O 0 0.004628879018127918
and O 0 0.00012639006308745593
sequence O 0 0.00019967409025412053
analysis O 0 0.0007764077163301408
disclosed O 0 0.009825716726481915
the O 0 0.00016714994853828102
involvement O 0 0.0024819555692374706
of O 0 2.8141523216618225e-05
three O 0 0.00019074423471465707
different O 0 0.00038297928404062986
ARSA O 1 0.999165415763855
mutations O 0 0.0038414779119193554
being O 0 0.0002577114209998399
the O 0 9.051451343111694e-05
molecular O 0 0.0006380476988852024
basis O 0 7.562147220596671e-05
of O 0 9.061529999598861e-05
intrafamilial O 1 0.9580581784248352
phenotypic O 0 0.04893716797232628
heterogeneity O 0 0.05201927199959755
. O 0 0.0017591085052117705

The O 0 0.002248717937618494
late O 0 0.045558005571365356
infantile O 1 0.9999797344207764
patient O 1 0.9999595880508423
inherited O 1 0.997413694858551
from O 0 0.0003732007753569633
his O 0 0.002553611993789673
mother O 0 0.0048665632493793964
the O 0 0.0002578590647317469
frequent O 0 0.006216470617800951
0 O 0 0.0015112184919416904
- O 0 0.003825083374977112
type O 0 0.0036203053314238787
mutation O 0 0.006522106472402811
459 O 1 0.646609365940094
+ O 0 0.0593842975795269
1G O 1 0.81839519739151
> O 0 0.014134569093585014
A O 0 0.0019060041522607207
, O 0 0.0002004229318117723
and O 0 9.87599923973903e-05
from O 0 0.00015343887207563967
his O 0 0.0011952671920880675
father O 0 0.002217965666204691
a O 0 0.0008076217491179705
novel O 0 0.0019085274543613195
, O 0 0.0002215061103925109
single O 0 0.0010381928877905011
basepair O 0 0.27014419436454773
microdeletion O 0 0.015595889650285244
of O 0 4.813283521798439e-05
guanine O 0 0.0020792572759091854
at O 0 0.00023609551135450602
nucleotide O 0 0.00029179040575399995
7 O 0 0.0003414450620766729
in O 0 0.00022214866476133466
exon O 0 0.013965778984129429
1 O 0 0.0015207082033157349
( O 0 0.0011189950164407492
7delG O 0 0.11167524755001068
) O 0 0.0007024224614724517
. O 0 0.000837251078337431

The O 0 0.0009681917144916952
two O 0 0.0008547946345061064
clinically O 1 0.99904865026474
unaffected O 1 0.798506498336792
siblings O 0 0.003369678044691682
carried O 0 0.00030200902256183326
the O 0 0.0003197441983502358
maternal O 0 0.13019858300685883
mutation O 0 0.01682693511247635
459 O 1 0.9736779928207397
+ O 0 0.23846937716007233
1G O 1 0.9700720906257629
> O 0 0.01504443772137165
A O 0 0.0021435131784528494
and O 0 0.00011142228322569281
, O 0 9.544229396851733e-05
on O 0 0.00010964137618429959
their O 0 0.00011316217569401488
paternal O 0 0.006985321640968323
allele O 0 0.004569953307509422
, O 0 0.0002267080853926018
a O 0 0.0007169562159106135
novel O 0 0.0025883533526211977
cytosine O 0 0.004520555958151817
to O 0 0.00026327872183173895
thymidine O 0 0.015246767550706863
transition O 0 0.002289568306878209
at O 0 0.0006435819668695331
nucleotide O 0 0.001602741307578981
2435 O 1 0.5543227195739746
in O 0 0.0006755675422027707
exon O 0 0.018688295036554337
8 O 0 0.0007037745672278106
, O 0 0.0001273511297767982
resulting O 0 0.00035536897485144436
in O 0 4.742109013022855e-05
substitution O 0 0.00034784735180437565
of O 0 6.691257294733077e-05
alanine O 0 0.1257992535829544
464 O 0 0.35062363743782043
by O 0 0.0006494920235127211
valine O 1 0.9429341554641724
( O 0 0.002391448710113764
A464V O 0 0.06446579098701477
) O 0 0.0008651574025861919
. O 0 0.0007921748328953981

The O 0 0.001468863571062684
fathers O 0 0.0048387739807367325
genotype O 0 0.01965523324906826
thus O 0 0.0011589073110371828
was O 0 0.004218623973429203
7delG O 1 0.9638277292251587
/ O 0 0.3017624318599701
A464V O 0 0.0667688176035881
. O 0 0.0014655467821285129

Mutation O 0 0.0247948057949543
A464V O 0 0.03476129099726677
was O 0 0.0009173824801109731
not O 0 0.00011317338794469833
found O 0 0.00016440008766949177
in O 0 0.00018808431923389435
18 O 0 0.0014993579825386405
unrelated O 1 0.988655686378479
MLD B-Disease 1 0.9999905824661255
patients O 1 0.9998067021369934
and O 0 0.0003288406296633184
50 O 0 0.0007574160117655993
controls O 0 0.0031535488087683916
. O 0 0.0011094148503616452

A464V O 0 0.053332310169935226
, O 0 0.0005842928658239543
although O 0 0.0007897504838183522
clearly O 0 0.005411774385720491
modifying O 0 0.14129596948623657
ARSA O 1 0.9979952573776245
and O 0 0.002764724427834153
GS O 1 0.9998131394386292
levels O 0 0.007071334403008223
, O 0 0.0006924113258719444
apparently O 0 0.004432519432157278
bears O 0 0.0031685626599937677
little O 0 0.0006276805070228875
significance O 0 0.0007986462442204356
for O 0 0.0004955302574671805
clinical O 1 0.9983776807785034
manifestation O 1 0.926426351070404
of O 0 0.0005249542300589383
MLD B-Disease 1 0.9999666213989258
, O 0 0.0009631985449232161
mimicking O 0 0.08955719321966171
the O 0 0.0009371734922751784
frequent O 0 0.24098648130893707
ARSA O 1 0.9986972212791443
pseudodeficiency O 1 0.9280447959899902
allele O 0 0.023443643003702164
. O 0 0.0021903286688029766

Our O 0 0.0016685447189956903
results O 0 0.0007129057194106281
demonstrate O 0 0.0009773881174623966
that O 0 4.32179840572644e-05
in O 0 6.513982225442305e-05
certain O 0 0.0002576998667791486
genetic O 0 0.005858275108039379
conditions O 1 0.9542742371559143
MLD B-Disease 1 0.9999771118164062
- O 0 0.1787300854921341
like O 0 0.003816186683252454
ARSA O 1 0.9986565113067627
and O 0 0.001912391628138721
GS O 1 0.9983958601951599
values O 0 0.0003733125049620867
need O 0 0.0004975175834260881
not O 0 9.109050006372854e-05
be O 0 0.00011188499047420919
paralleled O 0 0.005809550639241934
by O 0 0.0007170389289967716
clinical O 1 0.9999730587005615
disease O 1 0.9999938011169434
, O 0 0.00023109557514544576
a O 0 0.0007627710001543164
finding O 0 0.0016764904139563441
with O 0 0.0005523730651475489
serious O 1 0.9994232654571533
diagnostic O 1 0.9980870485305786
and O 0 0.0010870079277083278
prognostic O 1 0.9982779026031494
implications O 0 0.2059737741947174
. O 0 0.0013254627119749784

Moreover O 0 0.009954786859452724
, O 0 0.0008509738254360855
further O 0 0.003362586023285985
ARSA O 1 0.9964767098426819
alleles O 0 0.012775222770869732
functionally O 0 0.019973983988165855
similar O 0 0.0008363727829419076
to O 0 0.0005086262826807797
A464V O 0 0.3914579153060913
might O 0 0.0008338116458617151
exist O 0 0.00014027691213414073
which O 0 2.599201070552226e-05
, O 0 4.122934115002863e-05
together O 0 2.6632545996108092e-05
with O 0 7.261581049533561e-05
0 O 0 0.0008716840529814363
- O 0 0.004010864533483982
type O 0 0.0026064880657941103
mutations O 0 0.0021480005234479904
, O 0 0.0003110698307864368
may O 0 0.003924260381609201
cause O 1 0.9903244972229004
pathological O 1 0.9998456239700317
ARSA O 1 0.9998530149459839
and O 0 0.002742118900641799
GS O 1 0.9998595714569092
levels O 0 0.002901017665863037
, O 0 0.00022632537002209574
but O 0 0.00024502677842974663
not O 0 0.0003821678110398352
clinical O 1 0.9993237257003784
outbreak O 1 0.9569294452667236
of O 0 8.587862976128235e-05
the O 0 0.007407780271023512
disease O 1 0.9999939203262329
. O 0 0.00047754988190717995
. O 0 0.0008603438618592918

Human O 1 0.9357595443725586
MLH1 O 1 0.9999657869338989
deficiency O 1 0.9999977350234985
predisposes O 1 0.9992243051528931
to O 0 0.005642593372613192
hematological B-Disease 1 0.9998717308044434
malignancy I-Disease 1 0.9999676942825317
and O 0 0.007396376691758633
neurofibromatosis B-Disease 1 0.9999910593032837
type I-Disease 0 0.4079318642616272
1 I-Disease 0 0.0028675473295152187
. O 0 0.0009689069120213389

Heterozygous O 0 0.06521417200565338
germ O 1 0.9912914037704468
- O 0 0.008278974331915379
line O 0 0.0014523204881697893
mutations O 0 0.0008952155476436019
in O 0 6.55517796985805e-05
the O 0 0.00023131912166718394
DNA O 0 0.004244869574904442
mismatch O 1 0.9938814640045166
repair O 1 0.9935164451599121
genes O 0 0.0005295604350976646
lead O 0 0.00045363217941485345
to O 0 0.0006442066514864564
hereditary B-Disease 1 0.9998421669006348
nonpolyposis I-Disease 1 0.999994158744812
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0024990492966026068

The O 0 0.014832492917776108
disease O 1 0.9999818801879883
susceptibility O 0 0.284769743680954
of O 0 9.396364475833252e-05
individuals O 0 0.0006041912129148841
who O 0 0.0014335901942104101
constitutionally O 0 0.012409885413944721
lack O 0 0.0017186348559334874
both O 0 0.00030984682962298393
wild O 0 0.002008061623200774
- O 0 0.009977549314498901
type O 0 0.0038392727728933096
alleles O 0 0.0033795435447245836
is O 0 0.0005146205076016486
unknown O 0 0.0017385737737640738
. O 0 0.0009292883332818747

We O 0 0.000619113037828356
have O 0 0.00013379278243519366
identified O 0 0.0003267386928200722
three O 0 4.2614006815711036e-05
offspring O 0 0.00048280900227837265
in O 0 0.00016718513506930321
a O 0 0.004309230018407106
hereditary B-Disease 1 0.999922513961792
nonpolyposis I-Disease 1 0.9999896287918091
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.011921154335141182
who O 0 0.009175365790724754
developed O 1 0.9970508813858032
hematological B-Disease 1 0.9999786615371704
malignancy I-Disease 1 0.9999572038650513
at O 0 0.0006217253976501524
a O 0 0.0006780407857149839
very O 0 0.0009960295865312219
early O 0 0.0008332969737239182
age O 0 0.0005899384268559515
, O 0 0.0001701716537354514
and O 0 9.930224041454494e-05
at O 0 0.00020845848484896123
least O 0 8.272245759144425e-05
two O 0 1.377091757603921e-05
of O 0 1.0343959729652852e-05
them O 0 6.558392487931997e-05
displayed O 0 0.001787696615792811
signs O 0 0.0039051480125635862
of O 0 0.0003627632977440953
neurofibromatosis B-Disease 1 0.9999943971633911
type I-Disease 0 0.17766892910003662
1 I-Disease 0 0.0034407249186187983
( O 0 0.0028800098225474358
NF1 B-Disease 1 0.9983989596366882
) O 0 0.000786595162935555
. O 0 0.0008187535568140447

DNA O 0 0.0017481202958151698
sequence O 0 0.00019018413149751723
analysis O 0 0.00039872832712717354
and O 0 0.0002587044727988541
allele O 0 0.005699483212083578
- O 0 0.001591652398929
specific O 0 0.0001889980776468292
amplification O 0 0.0023018529172986746
in O 0 0.00012573889398481697
two O 0 0.00011347899271640927
siblings O 0 0.003896902548149228
revealed O 0 0.0040792785584926605
a O 0 0.0018383011920377612
homozygous O 0 0.01941089704632759
MLH1 O 1 0.995954155921936
mutation O 0 0.011169190518558025
( O 0 0.0017830056603997946
C676T O 0 0.13039708137512207
- O 0 0.012089531868696213
- O 0 0.009995308704674244
> O 0 0.014733846299350262
Arg226Stop O 0 0.2957441806793213
) O 0 0.000602198822889477
. O 0 0.0007973104948177934

Thus O 0 0.0010674436343833804
, O 0 0.00025828281650319695
a O 0 0.0016251286724582314
homozygous O 0 0.014467692002654076
germ O 1 0.9957581162452698
- O 0 0.0161796435713768
line O 0 0.006949476432055235
MLH1 O 1 0.9966565370559692
mutation O 0 0.004984379280358553
and O 0 0.0005429721204563975
consequent O 1 0.9957571625709534
mismatch O 1 0.9998973608016968
repair O 1 0.9999725818634033
deficiency O 1 0.9999912977218628
results O 0 0.0009536572033539414
in O 0 0.0002357769844820723
a O 0 0.0034629064612090588
mutator O 1 0.9994955062866211
phenotype O 1 0.9907312989234924
characterized O 1 0.9868098497390747
by O 0 0.0029694100376218557
leukemia B-Disease 1 0.9999997615814209
and O 0 0.010978137142956257
/ O 1 0.9991707801818848
or O 0 0.29257017374038696
lymphoma B-Disease 1 1.0
associated O 0 0.0025603410322219133
with O 0 0.001536612049676478
neurofibromatosis B-Disease 1 0.9999949932098389
type I-Disease 0 0.2617618143558502
1 I-Disease 0 0.0013643670827150345
. O 0 0.0002657441364135593
. O 0 0.0005939328111708164

Missense O 0 0.11419855803251266
mutations O 0 0.003929994534701109
in O 0 0.00013581135135609657
the O 0 0.0001044103701133281
most O 0 9.241971565643325e-05
ancient O 0 0.00024133975966833532
residues O 0 0.0004696444084402174
of O 0 4.4634314690483734e-05
the O 0 0.0012093604309484363
PAX6 O 1 0.9994465708732605
paired O 0 0.006783336400985718
domain O 0 0.0009165044757537544
underlie O 0 0.038091447204351425
a O 0 0.00045382787357084453
spectrum O 0 0.001751093310303986
of O 0 0.00023729655367787927
human O 1 0.9987868666648865
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999974966049194
malformations I-Disease 1 0.9999673366546631
. O 0 0.0030897094402462244

Mutations O 0 0.0026458848733454943
of O 0 4.0186059777624905e-05
the O 0 0.0004954499891027808
human O 0 0.016597099602222443
PAX6 O 1 0.9997864365577698
gene O 0 0.05634625256061554
underlie O 1 0.9977710247039795
aniridia B-Disease 1 0.9998860359191895
( O 0 0.08353819698095322
congenital B-Disease 1 0.9999988079071045
absence I-Disease 0 0.006468154955655336
of I-Disease 0 8.288511889986694e-05
the I-Disease 0 0.0014651874080300331
iris I-Disease 1 0.9994944334030151
) O 0 0.0003010379441548139
, O 0 0.00013934160233475268
a O 0 0.0007099504000507295
rare O 0 0.03771869093179703
dominant O 0 0.24694281816482544
malformation B-Disease 1 0.999700665473938
of I-Disease 0 0.00010889855911955237
the I-Disease 0 0.0027359528467059135
eye I-Disease 1 0.9997034668922424
. O 0 0.0014554864028468728

The O 0 0.0006146611412987113
spectrum O 0 0.0030903031583875418
of O 0 0.00037787886685691774
PAX6 O 1 0.9996836185455322
mutations O 0 0.01350629236549139
in O 0 0.002131003886461258
aniridia B-Disease 1 0.9999252557754517
patients O 1 0.999902606010437
is O 0 0.0007166385767050087
highly O 0 0.004031788557767868
biased O 0 0.005609860643744469
, O 0 0.00018701171211432666
with O 0 0.00013224410940892994
92 O 0 0.0018256588373333216
% O 0 1.872406755865086e-05
of O 0 1.6210136891459115e-05
all O 0 8.231194078689441e-05
reported O 0 0.0034127349499613047
mutations O 0 0.0016645650612190366
leading O 0 0.0011143103474751115
to O 0 0.0003732631157618016
premature O 0 0.47805848717689514
truncation O 0 0.003974864725023508
of O 0 2.4953949832706712e-05
the O 0 0.00024071743246167898
protein O 0 0.0014829870779067278
( O 0 0.0007225305889733136
nonsense O 0 0.007687795907258987
, O 0 0.0002448511659167707
splicing O 0 0.0015751175815239549
, O 0 0.00033063715090975165
insertions O 0 0.004739370662719011
and O 0 0.0002538580447435379
deletions O 0 0.0036701594945043325
) O 0 0.00016417339793406427
and O 0 0.00011058206291636452
just O 0 0.00040353136137127876
2 O 0 0.0002589606447145343
% O 0 2.7563541152630933e-05
leading O 0 0.00030259901541285217
to O 0 3.182964792358689e-05
substitution O 0 9.32186158024706e-05
of O 0 9.007953849504702e-06
one O 0 8.272631384897977e-05
amino O 0 0.00028916282462887466
acid O 0 0.0022681583650410175
by O 0 0.00010436906450195238
another O 0 0.0011652146931737661
( O 0 0.001024099881760776
missense O 0 0.021264851093292236
) O 0 0.0006730474415235221
. O 0 0.0007356558926403522

The O 0 0.0008109863847494125
extraordinary O 0 0.0038279674481600523
conservation O 0 0.002956448821350932
of O 0 5.802748637506738e-05
the O 0 0.0009413056541234255
PAX6 O 1 0.9923796653747559
protein O 0 0.00047866511158645153
at O 0 0.00014697348524350673
the O 0 8.749039989197627e-05
amino O 0 0.0004494538006838411
acid O 0 0.0032615303061902523
level O 0 0.0012228598352521658
amongst O 0 0.0016964143142104149
vertebrates O 0 0.007402754854410887
predicts O 0 0.021805377677083015
that O 0 0.0004849787219427526
pathological O 1 0.9977808594703674
missense O 0 0.2543647289276123
mutations O 0 0.004136431030929089
should O 0 0.0003474905388429761
in O 0 0.000147567770909518
fact O 0 0.0005243118503130972
be O 0 0.00016804020560812205
common O 0 0.0008257380686700344
even O 0 0.0004285175527911633
though O 0 0.0002542821748647839
they O 0 4.687651016865857e-05
are O 0 3.4006847272394225e-05
hardly O 0 0.0022792587988078594
ever O 0 0.0008801326039247215
seen O 0 0.001622706768102944
in O 0 0.0009728414006531239
aniridia B-Disease 1 0.9998834133148193
patients O 1 0.9998213648796082
. O 0 0.0014572753570973873

This O 0 0.0005062951240688562
indicates O 0 0.0013483248185366392
that O 0 6.25302127446048e-05
there O 0 6.744235724909231e-05
is O 0 0.00016061622591223568
a O 0 0.0007920910138636827
heavy O 0 0.013440174050629139
ascertainment O 1 0.987658679485321
bias O 0 0.003364694770425558
in O 0 8.990409696707502e-05
the O 0 0.00011346567771397531
selection O 0 0.0003952600818593055
of O 0 0.00017231110541615635
patients O 1 0.9999622106552124
for O 0 0.0012113791890442371
PAX6 O 1 0.9996691942214966
mutation O 0 0.0033295219764113426
analysis O 0 0.0002144157770089805
and O 0 7.264441228471696e-05
that O 0 6.145712541183457e-05
the O 0 0.00037711174809373915
missing O 0 0.022987928241491318
PAX6 O 1 0.9991862177848816
missense O 0 0.26732757687568665
mutations O 0 0.009350036270916462
frequently O 0 0.004603939596563578
may O 0 0.005053010303527117
underlie O 1 0.9718090295791626
phenotypes O 0 0.021512791514396667
distinct O 0 0.0013870939146727324
from O 0 0.0007150954334065318
textbook O 1 0.9916306138038635
aniridia B-Disease 1 0.9978506565093994
. O 0 0.0017456357600167394

Here O 0 0.000656750809866935
we O 0 0.00012239521311130375
present O 0 0.00015406691818498075
four O 0 0.00030720868380740285
novel O 0 0.010360331274569035
PAX6 O 1 0.999129593372345
missense O 0 0.07745487242937088
mutations O 0 0.0032463986426591873
, O 0 0.00011990758503088728
two O 0 5.202594184083864e-05
in O 0 0.00023133082140702754
association O 0 0.010271196253597736
with O 0 0.0007440048502758145
atypical O 1 0.9998224377632141
phenotypes O 1 0.9692063331604004
ectopia B-Disease 1 0.9942483901977539
pupillae I-Disease 1 0.9751532673835754
( O 0 0.001312499982304871
displaced B-Disease 0 0.016921743750572205
pupils I-Disease 0 0.011238236911594868
) O 0 0.000781320733949542
and O 0 0.0034624559339135885
congenital B-Disease 1 0.9999997615814209
nystagmus I-Disease 1 0.9998261332511902
( O 0 0.0030517741106450558
searching B-Disease 0 0.014695271849632263
gaze I-Disease 0 0.2992137670516968
) O 0 0.0004034367448184639
, O 0 0.00012533296830952168
and O 0 5.923174830968492e-05
two O 0 4.808934681932442e-05
in O 0 0.0001825490762712434
association O 0 0.002699714619666338
with O 0 0.00011891353642567992
more O 0 0.0003787656605709344
recognizable O 1 0.5407391786575317
aniridia B-Disease 1 0.994364857673645
phenotypes O 0 0.07251694798469543
. O 0 0.0016071315621957183

Strikingly O 0 0.04911234602332115
, O 0 0.000263584399363026
all O 0 5.6179553212132305e-05
four O 0 0.00021556511637754738
mutations O 0 0.0011207093484699726
are O 0 2.9512757464544848e-05
located O 0 0.00040946638910099864
within O 0 0.0001517163182143122
the O 0 0.0011246759677305818
PAX6 O 1 0.9994868040084839
paired O 0 0.0050333598628640175
domain O 0 0.00046999240294098854
and O 0 0.0001319659495493397
affect O 0 0.0012175338342785835
amino O 0 0.0002879830717574805
acids O 0 0.0003157458850182593
which O 0 4.299276042729616e-05
are O 0 2.510360354790464e-05
highly O 0 0.0007538662757724524
conserved O 0 0.00025719666155055165
in O 0 7.738402200629935e-05
all O 0 5.585162216448225e-05
known O 0 0.0007761857123114169
paired O 0 0.0021318113431334496
domain O 0 0.0005086753517389297
proteins O 0 0.0003755781799554825
. O 0 0.0008070820476859808

Our O 0 0.001566243008710444
results O 0 0.00043407687917351723
support O 0 0.0002674249408300966
the O 0 0.00016683959984220564
hypothesis O 0 0.0011851387098431587
that O 0 4.185973375570029e-05
the O 0 0.00010013081919169053
under O 0 0.00032378232572227716
- O 0 0.0007302106823772192
representation O 0 8.639791485620663e-05
of O 0 7.92631835793145e-05
missense O 0 0.04634859040379524
mutations O 0 0.00383209902793169
is O 0 0.0008473509806208313
caused O 0 0.011385508812963963
by O 0 0.000644450425170362
ascertainment O 1 0.9975814819335938
bias O 0 0.011311407200992107
and O 0 0.00020251159730833024
suggest O 0 0.0005896809743717313
that O 0 4.169407839071937e-05
a O 0 0.0002563141460996121
substantial O 0 0.0010650154436007142
burden O 0 0.14340759813785553
of O 0 0.000395916955312714
PAX6 B-Disease 1 0.999990701675415
- I-Disease 1 0.9975118637084961
related I-Disease 1 0.943213701248169
disease I-Disease 1 0.9999960660934448
remains O 0 0.003304582554847002
to O 0 0.00014285702491179109
be O 0 0.0002481508126948029
uncovered O 0 0.005346267018467188
. O 0 0.00028293687500990927
. O 0 0.0006116533186286688

The O 0 0.0015480393776670098
chromosomal O 0 0.01194691751152277
order O 0 0.0001634712389204651
of O 0 3.500271850498393e-05
genes O 0 0.0006476907292380929
controlling O 0 0.0038445997051894665
the O 0 0.0005340062780305743
major O 0 0.012761891819536686
histocompatibility O 1 0.9994575381278992
complex O 0 0.008157174102962017
, O 0 0.0008559670532122254
properdin O 1 0.8875832557678223
factor O 0 0.004889477975666523
B O 0 0.1900111436843872
, O 0 0.00041148861055262387
and O 0 0.0006876099505461752
deficiency B-Disease 1 0.9999481439590454
of I-Disease 0 2.370639231230598e-05
the I-Disease 0 0.00011104001168860123
second I-Disease 0 0.00021722252131439745
component I-Disease 0 0.001084841089323163
of I-Disease 0 3.873051537084393e-05
complement I-Disease 0 0.004093969706445932
. O 0 0.0009750177850946784

The O 0 0.0007864640210755169
relationship O 0 0.0014526690356433392
of O 0 2.299797415616922e-05
the O 0 0.00023418181808665395
genes O 0 0.0010385281639173627
coding O 0 0.01028771884739399
for O 0 0.0016041549388319254
HLA O 1 0.9929699301719666
to O 0 0.00010483338701305911
those O 0 7.523392559960485e-05
coding O 0 0.0037162688095122576
for O 0 0.00047903755330480635
properdin O 1 0.5254040956497192
Factor O 0 0.00813312828540802
B O 0 0.41110697388648987
allotypes O 0 0.22041471302509308
and O 0 0.00029279637965373695
for O 0 0.0010297637199983
deficiency B-Disease 1 0.9999477863311768
of I-Disease 0 1.9709790649358183e-05
the I-Disease 0 9.393740037921816e-05
second I-Disease 0 0.0001466621324652806
component I-Disease 0 0.0010848302626982331
of I-Disease 0 6.0841761296615005e-05
complement I-Disease 0 0.005765656009316444
( O 0 0.0034196830820292234
C2 O 1 0.9997970461845398
) O 0 0.00047219410771504045
was O 0 0.0006167831597849727
studied O 0 0.0003775903896894306
in O 0 8.836264169076458e-05
families O 0 0.00017624867905396968
of O 0 0.00016914571460802108
patients O 1 0.9999755620956421
with O 0 0.0026632952503859997
connective O 1 0.9999954700469971
tissue O 1 0.9999958276748657
disorders O 1 0.9999991655349731
. O 0 0.0038249779026955366

Patients O 1 0.999444305896759
were O 0 0.0001958669745363295
selected O 0 0.00039910312625579536
because O 0 0.00027497776318341494
they O 0 3.337944144732319e-05
were O 0 4.381005055620335e-05
heterozygous O 0 0.0016328201163560152
or O 0 0.00039056531386449933
homozygous O 0 0.008684137836098671
for O 0 0.005803957115858793
C2 B-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999994039535522
. O 0 0.0028172091115266085

12 O 0 0.001319676055572927
families O 0 0.00024920020950958133
with O 0 0.00016833175322972238
15 O 0 0.0010930737480521202
matings O 0 0.150849848985672
informative O 0 0.02488517388701439
for O 0 0.025833217427134514
C2 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999986886978149
were O 0 0.000333736912580207
found O 0 0.0008101537241600454
. O 0 0.0007211571210063994

Of O 0 0.0003667304408736527
57 O 0 0.00731008592993021
informative O 0 0.016990438103675842
meioses O 0 0.12067396193742752
, O 0 0.0002505015872884542
two O 0 7.960556831676513e-05
crossovers O 0 0.001587927108630538
were O 0 3.996325904154219e-05
noted O 0 0.0003930682723876089
between O 0 0.0003104926727246493
the O 0 0.005045500583946705
C2 B-Disease 1 0.9999985694885254
deficiency I-Disease 1 0.9999979734420776
gene O 0 0.0033006849698722363
and O 0 0.00020156496611889452
the O 0 0.001202457002364099
HLA O 1 0.999675989151001
- O 0 0.0711173415184021
B O 0 0.027008486911654472
gene O 0 0.0009279612568207085
, O 0 5.625836274703033e-05
with O 0 4.1267063352279365e-05
a O 0 0.00025240826653316617
recombinant O 0 0.002008581766858697
fraction O 0 0.0004531014710664749
of O 0 7.44813951314427e-05
0 O 0 0.001486411551013589
. O 0 0.0005922912387177348

035 O 1 0.8340351581573486
. O 0 0.0051173497922718525

A O 0 0.01043439656496048
lod O 0 0.03734181448817253
score O 0 0.00011111691856058314
of O 0 3.522070255712606e-05
13 O 0 0.0005891152541153133
was O 0 0.00021656922763213515
calculated O 0 0.0002177448768634349
for O 0 0.00019528644043020904
linkage O 0 0.08556679636240005
between O 0 0.008240608498454094
C2 B-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999991655349731
and O 0 0.006215729285031557
HLA O 1 0.9998550415039062
- O 0 0.025880033150315285
B O 0 0.011167806573212147
at O 0 0.0002813322935253382
a O 0 0.0002919156395364553
maximum O 0 0.00039678829489275813
likelihood O 0 0.0007947042468003929
value O 0 3.952217957703397e-05
of O 0 1.0915852726611774e-05
the O 0 0.00014131632633507252
recombinant O 0 0.0023349125403910875
fraction O 0 0.0004634079523384571
of O 0 5.309310290613212e-05
0 O 0 0.001512026647105813
. O 0 0.0008428663713857532

04 O 1 0.8849338889122009
. O 0 0.0029200867284089327

18 O 0 0.001603857846930623
families O 0 0.000319396291160956
with O 0 0.00018242486112285405
21 O 0 0.001267999061383307
informative O 0 0.005014293827116489
matings O 0 0.017589503899216652
for O 0 0.000145343758049421
both O 0 0.00027198652969673276
properdin O 1 0.6446012854576111
Factor O 0 0.005421399604529142
B O 0 0.1335304230451584
allotype O 0 0.1616707742214203
and O 0 0.0012651736615225673
HLA O 1 0.9995057582855225
- O 0 0.019906694069504738
B O 0 0.01044449396431446
were O 0 7.150521560106426e-05
found O 0 0.000539021915756166
. O 0 0.000556487066205591

Of O 0 0.0003924111952073872
72 O 0 0.006860862486064434
informative O 0 0.01163577288389206
meioses O 0 0.09389949589967728
, O 0 0.0003722790570463985
three O 0 0.00023934704950079322
recombinants O 0 0.15667515993118286
were O 0 8.22913134470582e-05
found O 0 0.00019730407802853733
, O 0 7.377607107628137e-05
giving O 0 0.0003933328844141215
a O 0 0.00038632279029116035
recombinant O 0 0.0021366337314248085
fraction O 0 0.00046694334014318883
of O 0 5.416055500973016e-05
0 O 0 0.0015632750000804663
. O 0 0.0005920783733017743

042 O 0 0.3284020721912384
. O 0 0.003449496813118458

A O 0 0.009346704930067062
lod O 0 0.031092995777726173
score O 0 0.00014129772898741066
of O 0 3.2734216802055016e-05
16 O 0 0.0008527380996383727
between O 0 0.0013451178092509508
HLA O 1 0.9992831349372864
- O 0 0.012728224508464336
B O 0 0.013468427583575249
and O 0 0.00021865674352739006
Factor O 0 0.0054636443965137005
B O 0 0.08354557305574417
allotypes O 0 0.04727829620242119
was O 0 0.0005083064897917211
calculated O 0 0.0002767622936517
at O 0 0.000126931510749273
a O 0 0.00023937055084388703
maximum O 0 0.0004081915249116719
likelihood O 0 0.0007854694267734885
value O 0 2.956788921437692e-05
of O 0 1.0054860467789695e-05
the O 0 0.00013342458987608552
recombinant O 0 0.00238808267749846
fraction O 0 0.0006446129409596324
of O 0 5.9644735301844776e-05
0 O 0 0.0014293899293988943
. O 0 0.0006583093199878931

04 O 1 0.8911105394363403
. O 0 0.0026443148963153362

A O 0 0.006380710285156965
crossover O 0 0.00514459703117609
was O 0 0.0012974870624020696
shown O 0 0.0005406530108302832
to O 0 7.096044282661751e-05
have O 0 5.841497113578953e-05
occurred O 0 0.0003040245792362839
between O 0 5.342582517187111e-05
genes O 0 0.00016516936011612415
for O 0 0.00015491616795770824
Factor O 0 0.00347529468126595
B O 0 0.07272733002901077
and O 0 0.000949266308452934
HLA O 1 0.9996753931045532
- O 0 0.022017281502485275
D O 0 0.09458538889884949
, O 0 0.00012309395242482424
in O 0 0.0001567807194078341
which O 0 0.00044563235132955015
HLA O 1 0.998578667640686
- O 0 0.020621947944164276
D O 1 0.793241560459137
segregared O 0 0.029330875724554062
with O 0 0.0008075244259089231
HLA O 1 0.9987227320671082
- O 0 0.0036416936200112104
A O 0 0.0018483503954485059
and O 0 0.0005350744468159974
B O 0 0.10016895085573196
. O 0 0.0008149663335643709

These O 0 0.0003492285904940218
studies O 0 0.0006368408794514835
suggest O 0 0.00041223419248126447
that O 0 3.0682091164635494e-05
the O 0 5.0817816372727975e-05
genes O 0 0.0001720244763419032
for O 0 0.0002024834102485329
Factor O 0 0.0096284756436944
B O 1 0.9779941439628601
and O 0 0.008096055127680302
C2 B-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.999997615814209
are O 0 0.00013206263247411698
located O 0 0.0006029261858202517
outside O 0 0.0002071227499982342
those O 0 0.00011423965770518407
for O 0 0.0009335512295365334
HLA O 1 0.9996206760406494
, O 0 0.00010047399700852111
that O 0 2.8010837922920473e-05
the O 0 3.598778130253777e-05
order O 0 5.054137000115588e-05
of O 0 5.252293703961186e-05
genese O 1 0.776589572429657
is O 0 0.0014472632901743054
HLA O 1 0.9945131540298462
- O 0 0.0027052934747189283
A O 0 0.001686183037236333
, O 0 0.00035935084451921284
- O 0 0.005528578069061041
B O 0 0.010947859846055508
, O 0 0.0004023585934191942
- O 0 0.006906444672495127
D O 0 0.06949532777070999
, O 0 0.00021380434918683022
Factor O 0 0.003580163000151515
B O 0 0.48294714093208313
allotype O 1 0.9923070073127747
, O 0 0.010900893248617649
C2 B-Disease 1 0.9999985694885254
deficiency I-Disease 1 0.9999984502792358
, O 0 0.000253055477514863
that O 0 4.751415326609276e-05
the O 0 0.0001056201581377536
genes O 0 0.0005472659249790013
coding O 0 0.012314721941947937
for O 0 0.008251426741480827
C2 B-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999986886978149
and O 0 0.0007497392944060266
Factor O 0 0.00962067674845457
B O 0 0.03558884188532829
allotypes O 0 0.010723096318542957
are O 0 3.0146820790832862e-05
approximately O 0 0.00022779405117034912
3 O 0 0.0006781632546335459
- O 0 0.002666902495548129
- O 0 0.0014896903885528445
5 O 0 0.0003359719121363014
centimorgans O 0 0.007626979146152735
from O 0 0.00011861298116855323
the O 0 0.0006020016735419631
HLA O 1 0.9973129630088806
- O 0 0.0026707439683377743
A O 0 0.0019785838667303324
and O 0 0.0007850982947275043
HLA O 1 0.9993019104003906
- O 0 0.03740839660167694
B O 0 0.05625202879309654
loci O 0 0.008050492033362389
, O 0 0.00015169633843470365
and O 0 7.523407111875713e-05
that O 0 7.413319690385833e-05
the O 0 0.00021202358766458929
apparent O 0 0.006243761628866196
lack O 0 0.0011719642207026482
of O 0 6.944266351638362e-05
recombinants O 0 0.1088421419262886
between O 0 0.00010701840074034408
the O 0 0.0002457647060509771
Factor O 0 0.0053294869139790535
B O 0 0.49994155764579773
gene O 0 0.005326423794031143
and O 0 0.005316379480063915
C2 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999996423721313
gene O 0 0.011543748900294304
suggests O 0 0.0015553212724626064
that O 0 5.776016405434348e-05
these O 0 1.905357748910319e-05
two O 0 5.508181493496522e-05
genes O 0 0.0005872714682482183
lie O 0 0.0017624039901420474
in O 0 0.00013469214900396764
close O 0 0.0006916135898791254
proximity O 0 0.0007771753007546067
to O 0 8.282087947009131e-05
one O 0 0.00013473724538926035
another O 0 0.0007910195854492486
. O 0 0.0006205721874721348

Distribution O 0 0.0005944216391071677
of O 0 0.00017645821208134294
emerin O 1 0.7714127898216248
and O 0 0.0007554372423328459
lamins O 1 0.9812443852424622
in O 0 0.0002543748414609581
the O 0 0.0006657536723650992
heart O 1 0.9994727969169617
and O 0 0.0002554390812292695
implications O 0 0.013294712640345097
for O 0 0.0012981075560674071
Emery B-Disease 1 0.9995239973068237
- I-Disease 1 0.995257556438446
Dreifuss I-Disease 1 0.9999638795852661
muscular I-Disease 1 0.9999922513961792
dystrophy I-Disease 1 0.9999961853027344
. O 0 0.005226274952292442

Emerin O 0 0.1191905066370964
is O 0 0.00045045168371871114
a O 0 0.00043380429269745946
nuclear O 0 0.0012934302212670445
membrane O 0 0.0008314236183650792
protein O 0 0.00024285883409902453
which O 0 6.171718996483833e-05
is O 0 0.0003143897047266364
missing O 0 0.001883103628642857
or O 0 0.0005016744835302234
defective O 1 0.9901933073997498
in O 0 0.0009472935926169157
Emery B-Disease 1 0.9996477365493774
- I-Disease 1 0.9955436587333679
Dreifuss I-Disease 1 0.9999815225601196
muscular I-Disease 1 0.9999977350234985
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.09760358929634094
EDMD B-Disease 1 0.9999016523361206
) O 0 0.0010966021800413728
. O 0 0.0008180668810382485

It O 0 0.0006869399221614003
is O 0 0.00022869891836307943
one O 0 7.85139127401635e-05
member O 0 0.00014443727559410036
of O 0 1.819508361222688e-05
a O 0 0.0006159430486150086
family O 0 0.0006708733271807432
of O 0 0.00025864678900688887
lamina O 1 0.9996789693832397
- O 0 0.005504280794411898
associated O 0 0.00024298088101204485
proteins O 0 9.657534246798605e-05
which O 0 8.870795136317611e-05
includes O 0 0.0005875228671357036
LAP1 O 1 0.9905887842178345
, O 0 0.000790954742114991
LAP2 O 1 0.8501993417739868
and O 0 0.0005751503631472588
lamin O 1 0.9961258769035339
B O 0 0.34355178475379944
receptor O 0 0.022939827293157578
( O 0 0.004519667476415634
LBR O 1 0.9995169639587402
) O 0 0.0011647919891402125
. O 0 0.0009526662761345506

A O 0 0.004293310921639204
panel O 0 0.0018500895239412785
of O 0 8.56329788803123e-05
16 O 0 0.002109181135892868
monoclonal O 0 0.40841996669769287
antibodies O 0 0.16512253880500793
( O 0 0.002868003910407424
mAbs O 1 0.9944595098495483
) O 0 0.0006209969869814813
has O 0 0.0006009932258166373
been O 0 0.00028662470867857337
mapped O 0 0.0012729773297905922
to O 0 5.35202088940423e-05
six O 0 7.22768745617941e-05
specific O 0 8.266457734862342e-05
sites O 0 0.00011871277820318937
throughout O 0 0.00012634620361495763
the O 0 0.00021037194528616965
emerin O 0 0.03258620947599411
molecule O 0 0.0013610977912321687
using O 0 0.0006566656520590186
phage O 1 0.9267829656600952
- O 0 0.004101878963410854
displayed O 0 0.0012255813926458359
peptide O 0 0.004168725572526455
libraries O 0 0.0009174520964734256
and O 0 0.00012227620754856616
has O 0 0.0002734008594416082
been O 0 0.00012894082465209067
used O 0 0.00011673041444737464
to O 0 0.00017783073417376727
localize O 0 0.12606747448444366
emerin O 0 0.047681648284196854
in O 0 0.0003010528744198382
human O 0 0.0013991652522236109
and O 0 0.0012305901618674397
rabbit O 1 0.9989873766899109
heart O 1 0.9995920062065125
. O 0 0.0017430816078558564

Several O 0 0.0024579346645623446
mAbs O 0 0.45139211416244507
against O 0 0.00046684450353495777
different O 0 0.0003140242479275912
emerin O 1 0.9162970781326294
epitopes O 0 0.14822961390018463
did O 0 0.0007448596297763288
not O 0 0.0002611793461255729
recognize O 0 0.004624816123396158
intercalated O 0 0.42100879549980164
discs O 0 0.0035010071005672216
in O 0 0.00022337419795803726
the O 0 0.00098866643384099
heart O 1 0.9998832941055298
, O 0 0.00036335375625640154
though O 0 0.00041038388735614717
they O 0 9.515477722743526e-05
recognized O 0 0.002008856972679496
cardiomyocyte O 0 0.07567868381738663
nuclei O 0 0.002340514212846756
strongly O 0 0.0012627916876226664
, O 0 0.00013096122711431235
both O 0 0.00012745098501909524
at O 0 0.00030155328568071127
the O 0 0.0002908721216954291
rim O 0 0.021944381296634674
and O 0 0.00018887217447627336
in O 0 0.0005577232223004103
intranuclear O 1 0.9011443853378296
spots O 0 0.00582029577344656
or O 0 0.00047411906416527927
channels O 0 0.0015879491111263633
. O 0 0.0011653712717816234

A O 0 0.02665066532790661
polyclonal O 1 0.9443534016609192
rabbit O 1 0.9638540744781494
antiserum O 1 0.9713427424430847
against O 0 0.003719472559168935
emerin O 1 0.9734556674957275
did O 0 0.0011467458680272102
recognize O 0 0.0019821273162961006
both O 0 0.00011389083374524489
nuclear O 0 0.0020396022591739893
membrane O 0 0.0018760829698294401
and O 0 0.00027028581826016307
intercalated O 1 0.9377223253250122
discs O 0 0.005718205124139786
but O 0 0.0001901250652736053
, O 0 0.00012034652900183573
after O 0 0.0004306792397983372
affinity O 0 0.0011423361720517278
purification O 0 0.0037535408046096563
against O 0 0.00020789973495993763
a O 0 0.0006804729346185923
pure O 0 0.0027780767995864153
- O 0 0.007654275745153427
emerin O 0 0.02923138253390789
band O 0 0.0007058251649141312
on O 0 0.0001529040018795058
a O 0 0.00055322190746665
western O 0 0.0017487893346697092
blot O 1 0.9843888282775879
, O 0 0.00036468112375587225
it O 0 0.00034164986573159695
stained O 1 0.8590713143348694
only O 0 7.488948904210702e-05
the O 0 0.00018010679923463613
nuclear O 0 0.0025624691043049097
membrane O 0 0.0028988835401833057
. O 0 0.0007731237565167248

These O 0 0.00023574753140565008
results O 0 0.0006438018754124641
would O 0 0.000130849119159393
not O 0 5.4446925787488e-05
be O 0 6.501490133814514e-05
expected O 0 0.00032487473799847066
if O 0 0.00048131923540495336
immunostaining O 0 0.0713357925415039
at O 0 0.0010638391831889749
intercalated O 0 0.4429761469364166
discs O 0 0.004050504416227341
were O 0 6.799902621423826e-05
due O 0 0.00046956114238128066
to O 0 6.523474439745769e-05
a O 0 0.00016574580513406545
product O 0 0.00027062592562288046
of O 0 2.634577867866028e-05
the O 0 0.0006633163429796696
emerin O 1 0.989233136177063
gene O 0 0.002399274380877614
and O 0 0.00020470570598263294
, O 0 0.00025942723732441664
therefore O 0 0.0003706119314301759
, O 0 0.00012066022463841364
cast O 0 0.00018134234414901584
some O 0 5.038674862589687e-05
doubt O 0 0.0009591719135642052
upon O 0 0.00019262013665866107
the O 0 0.0001970444427570328
hypothesis O 0 0.005307221319526434
that O 0 0.0014195239637047052
cardiac B-Disease 1 0.9999963045120239
defects I-Disease 1 0.9999240636825562
in O 0 0.002129163360223174
EDMD B-Disease 1 0.9999099969863892
are O 0 0.0001660740963416174
caused O 0 0.004609200172126293
by O 0 0.00010789861698867753
absence O 0 0.0017874805489555001
of O 0 9.204662637785077e-05
emerin O 1 0.825253427028656
from O 0 0.000516328087542206
intercalated O 1 0.8785801529884338
discs O 0 0.015306167304515839
. O 0 0.001398965367116034

Although O 0 0.00594324292615056
emerin O 0 0.0903509184718132
was O 0 0.0010377319995313883
abundant O 0 0.0007493382436223328
in O 0 0.00011888384324265644
the O 0 0.00018219852063339204
membranes O 0 0.00446764612570405
of O 0 0.0001080668589565903
cardiomyocyte O 1 0.962498664855957
nuclei O 0 0.002502236980944872
, O 0 0.00020842092635575682
it O 0 0.00017089200264308602
was O 0 0.0007264161831699312
absent O 0 0.0023916272912174463
from O 0 8.150983921950683e-05
many O 0 0.0001254007511306554
non O 0 0.004339595790952444
- O 0 0.02062457613646984
myocyte O 1 0.9722031354904175
cells O 0 0.0018152238335460424
in O 0 0.00017851094889920205
the O 0 0.0010856356238946319
heart O 1 0.9994045495986938
. O 0 0.0017622780287638307

This O 0 0.00021629498223774135
distribution O 0 0.00020891314488835633
of O 0 0.00010505945101613179
emerin O 1 0.8524578213691711
was O 0 0.0006559441098943353
similar O 0 0.0001539839431643486
to O 0 5.294697984936647e-05
that O 0 5.3042444051243365e-05
of O 0 9.42111000767909e-05
lamin O 1 0.9971207976341248
A O 0 0.002808186924085021
, O 0 0.00023697505821473897
a O 0 0.000717193994205445
candidate O 0 0.0015087317442521453
gene O 0 0.0008380204671993852
for O 0 0.00014417144120670855
an O 0 0.0006037631537765265
autosomal O 1 0.9839975833892822
form O 0 0.0008836215129122138
of O 0 0.00041158549720421433
EDMD B-Disease 1 0.9999579191207886
. O 0 0.002261662855744362

In O 0 0.001106059062294662
contrast O 0 0.005937331356108189
, O 0 0.003673538565635681
lamin O 1 0.9996463060379028
B1 O 1 0.9997895359992981
was O 0 0.0029176247771829367
absent O 0 0.005725282710045576
from O 0 0.0002480488910805434
cardiomyocyte O 0 0.0878329873085022
nuclei O 0 0.0018737040227279067
, O 0 0.00020450905140023679
showing O 0 0.002117637312039733
that O 0 0.0011268509551882744
lamin O 1 0.9992082715034485
B1 O 1 0.9998055100440979
is O 0 0.0004904172965325415
not O 0 0.00011186100891791284
essential O 0 0.0006231438019312918
for O 0 0.00014120855485089123
localization O 0 0.0022446808870881796
of O 0 6.829849007772282e-05
emerin O 0 0.07260525226593018
to O 0 0.00011476602958282456
the O 0 0.00032138690585270524
nuclear O 0 0.012888742610812187
lamina O 1 0.9987970590591431
. O 0 0.0013012479757890105

Lamin O 1 0.9975780844688416
B1 O 1 0.9993135929107666
is O 0 0.0010221769334748387
also O 0 0.00022832634567748755
almost O 0 0.0006471832748502493
completely O 0 0.004278299864381552
absent O 0 0.007445433642715216
from O 0 0.0007527948473580182
skeletal O 1 0.9998635053634644
muscle O 1 0.9991088509559631
nuclei O 0 0.011305605992674828
. O 0 0.0011943806894123554

In O 0 0.005022984463721514
EDMD B-Disease 1 0.9977228045463562
, O 0 0.00022680666006635875
the O 0 0.00010074963938677683
additional O 0 0.00027991057140752673
absence O 0 0.0020713098347187042
of O 0 0.0002547835756558925
lamin O 1 0.9997796416282654
B1 O 1 0.9999309778213501
from O 0 0.0013116877526044846
heart O 1 0.9999114274978638
and O 0 0.0013879482867196202
skeletal O 1 0.9999179840087891
muscle O 1 0.999419093132019
nuclei O 0 0.004927689675241709
which O 0 0.00023193263041321188
already O 0 0.0018991169054061174
lack O 0 0.01711270958185196
emerin O 1 0.9906842708587646
may O 0 0.0011348342522978783
offer O 0 0.0006004007300361991
an O 0 0.00019763207819778472
alternative O 0 0.000913257768843323
explanation O 0 0.0009300027741119266
of O 0 3.629469938459806e-05
why O 0 0.0015838495455682278
these O 0 9.156547457678244e-05
tissues O 0 0.07307548820972443
are O 0 6.890203076181933e-05
particularly O 0 0.002997027710080147
affected O 0 0.00800120085477829
. O 0 0.00028629068401642144
. O 0 0.0006914202240295708

Genetic O 0 0.002643266227096319
mapping O 0 0.0014859471702948213
of O 0 5.4445165005745366e-05
the O 0 0.0008794662426225841
copper B-Disease 1 0.9827907085418701
toxicosis I-Disease 1 0.9990154504776001
locus O 0 0.029119256883859634
in O 0 0.0015721222152933478
Bedlington O 1 0.9966738224029541
terriers O 1 0.6403017640113831
to O 0 0.0006956705474294722
dog O 0 0.11819683760404587
chromosome O 0 0.0023980240803211927
10 O 0 0.00025468351668678224
, O 0 9.50527610257268e-05
in O 0 8.960779086919501e-05
a O 0 0.0006426741019822657
region O 0 0.002814575331285596
syntenic O 0 0.04290400817990303
to O 0 0.00017138398834504187
human O 0 0.0010981210507452488
chromosome O 0 0.003319053677842021
region O 0 0.0038493650499731302
2p13 O 0 0.4560151696205139
- O 0 0.014730897732079029
p16 O 0 0.06718293577432632
. O 0 0.0011707352241501212

Abnormal O 1 0.9955688118934631
hepatic B-Disease 1 0.9998683929443359
copper I-Disease 1 0.7560268640518188
accumulation I-Disease 0 0.06329081952571869
is O 0 0.0006207396509125829
recognized O 0 0.0011507987510412931
as O 0 0.00031212804606184363
an O 0 0.004560570698231459
inherited B-Disease 1 0.999994158744812
disorder I-Disease 1 0.999998927116394
in O 0 0.0014513029018417
man O 0 0.13424639403820038
, O 0 0.0006686500273644924
mouse O 0 0.029269874095916748
, O 0 0.0008465781575068831
rat O 1 0.9598561525344849
and O 0 0.0007888952968642116
dog O 1 0.5706539154052734
. O 0 0.0011727414093911648

The O 0 0.0008294951403513551
major O 0 0.0029452424496412277
cause O 0 0.01348506286740303
of O 0 0.0003519669990055263
hepatic B-Disease 1 0.9999923706054688
copper I-Disease 1 0.947933554649353
accumulation I-Disease 0 0.1165466383099556
in O 0 0.0004526697739493102
man O 0 0.004071993753314018
is O 0 0.00046567071694880724
a O 0 0.0019289604388177395
dysfunctional O 1 0.9951909780502319
ATP7B O 1 0.996508777141571
gene O 0 0.005820946767926216
, O 0 0.0010518257040530443
causing O 1 0.997195839881897
Wilson B-Disease 1 0.9997665286064148
disease I-Disease 1 0.9999958276748657
( O 0 0.011331812478601933
WD B-Disease 1 0.9995660185813904
) O 0 0.0009058447321876884
. O 0 0.0007741639856249094

Mutations O 0 0.009223629720509052
in O 0 0.0003617851762101054
the O 0 0.000872431555762887
ATP7B O 1 0.9873555302619934
genes O 0 0.0007135188207030296
have O 0 0.00011093482316937298
also O 0 0.00017469600425101817
been O 0 0.00030922150472179055
demonstrated O 0 0.0016149330185726285
in O 0 0.00031651658355258405
mouse O 0 0.013311588205397129
and O 0 0.0007265227613970637
rat O 1 0.9481437802314758
. O 0 0.001154496567323804

The O 0 0.00414479523897171
ATP7B O 1 0.9915101528167725
gene O 0 0.006425201427191496
has O 0 0.0006671961164101958
been O 0 0.00028305905289016664
excluded O 0 0.0007766111521050334
in O 0 5.392616367316805e-05
the O 0 8.627746137790382e-05
much O 0 0.0007228335598483682
rarer O 1 0.9734622836112976
human O 0 0.005215042736381292
copper B-Disease 1 0.9977036118507385
overload I-Disease 1 0.9999585151672363
disease O 1 0.9999911785125732
non B-Disease 0 0.014747897163033485
- I-Disease 0 0.056248608976602554
Indian I-Disease 0 0.003948871046304703
childhood I-Disease 1 0.9988620281219482
cirrhosis I-Disease 1 0.9999831914901733
, O 0 0.0009121265611611307
indicating O 0 0.007673012558370829
genetic O 0 0.006132844369858503
heterogeneity O 0 0.052115391939878464
. O 0 0.0016714225057512522

By O 0 0.0003731396282091737
investigating O 0 0.003706220770254731
the O 0 0.0004871285054832697
common O 0 0.019177986308932304
autosomal O 1 0.9995760321617126
recessive O 1 0.9994366765022278
copper B-Disease 1 0.999099612236023
toxicosis I-Disease 1 0.9999631643295288
( O 0 0.058777160942554474
CT B-Disease 1 0.99994957447052
) O 0 0.0008240858442150056
in O 0 0.0010841344483196735
Bedlington O 1 0.9990149736404419
terriers O 1 0.9055375456809998
, O 0 0.0003270980669185519
we O 0 0.00016630085883662105
have O 0 7.046676910249516e-05
identified O 0 0.0002424461126793176
a O 0 0.00021178758470341563
new O 0 0.00021966373606119305
locus O 0 0.004550222307443619
involved O 0 0.0010493906447663903
in O 0 0.0012553667183965445
progressive O 1 0.9999713897705078
liver B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
. O 0 0.003377186832949519

We O 0 0.0017720699543133378
examined O 0 0.007533727213740349
whether O 0 0.0007143428083509207
the O 0 0.0009495508274994791
WD B-Disease 1 0.9980103373527527
gene O 0 0.0065456866286695
ATP7B O 1 0.8901443481445312
was O 0 0.0012368537718430161
also O 0 0.0005370756844058633
causative O 0 0.33284175395965576
for O 0 0.0017352350987493992
CT B-Disease 1 0.9995861649513245
by O 0 0.00022466943482868373
investigating O 0 0.004827728495001793
the O 0 0.0007863977225497365
chromosomal O 0 0.12391670793294907
co O 0 0.021895170211791992
- O 0 0.0035156970843672752
localization O 0 0.0030202700290828943
of O 0 0.0001389195822412148
ATP7B O 1 0.992384672164917
and O 0 0.00038252759259194136
C04107 O 0 0.01613054797053337
, O 0 0.0001132320030592382
using O 0 0.00020360473718028516
fluorescence O 0 0.008919203653931618
in O 0 0.0004480163042899221
situ O 0 0.08568597584962845
hybridization O 0 0.003809673711657524
( O 0 0.0008245194330811501
FISH O 0 0.003570768516510725
) O 0 0.00042534066596999764
. O 0 0.0006609761039726436

C04107 O 0 0.03716832399368286
is O 0 0.0005802192026749253
an O 0 0.0005048150196671486
anonymous O 0 0.0050038183107972145
microsatellite O 0 0.06471052765846252
marker O 0 0.009030822664499283
closely O 0 0.0016818734584376216
linked O 0 0.009115622378885746
to O 0 0.0014214218826964498
CT B-Disease 1 0.9998152852058411
. O 0 0.001027319929562509

However O 0 0.002715672366321087
, O 0 0.0015069678192958236
BAC O 1 0.9808827042579651
clones O 0 0.008922787383198738
containing O 0 0.0012419488048180938
ATP7B O 1 0.9871785640716553
and O 0 0.00046251690946519375
C04107 O 0 0.022342385724186897
mapped O 0 0.002182245021685958
to O 0 0.00013571463932748884
the O 0 0.00047021734644658864
canine O 1 0.9825091361999512
chromosome O 0 0.0048352391459047794
regions O 0 0.002453920664265752
CFA22q11 O 1 0.9537981748580933
and O 0 0.0006101086037233472
CFA10q26 O 1 0.922186553478241
, O 0 0.00032607404864393175
respectively O 0 0.0004028829571325332
, O 0 0.00017928489251062274
demonstrating O 0 0.0038711868692189455
that O 0 0.0005978949484415352
WD B-Disease 1 0.9982115030288696
cannot O 0 0.0007571395835839212
be O 0 0.00014808140986133367
homologous O 0 0.004312125965952873
to O 0 0.001052807318046689
CT B-Disease 1 0.9994937181472778
. O 0 0.0010578924557194114

The O 0 0.001741088111884892
copper O 0 0.02016199380159378
transport O 0 0.01193834189325571
genes O 0 0.004294974729418755
CTR1 O 1 0.9906071424484253
and O 0 0.0008010921883396804
CTR2 O 1 0.9782625436782837
were O 0 0.00010173580812988803
also O 0 0.00024618918541818857
excluded O 0 0.0014127633767202497
as O 0 0.0002068431058432907
candidate O 0 0.0009887489723041654
genes O 0 0.0005408157012425363
for O 0 0.0012505048653110862
CT B-Disease 1 0.9998856782913208
since O 0 0.0005257156444713473
they O 0 3.9516977267339826e-05
both O 0 0.00011131056817248464
mapped O 0 0.0024408609606325626
to O 0 0.00043157325126230717
canine O 1 0.9767151474952698
chromosome O 0 0.007047081831842661
region O 0 0.0065215351060032845
CFA11q22 O 1 0.9294137954711914
. O 0 0.0015304572880268097

2 O 0 0.004609852097928524
- O 0 0.006794779561460018
22 O 0 0.0016771872760728002
. O 0 0.0008581193396821618

5 O 0 0.0043928720988333225
. O 0 0.00165277486667037

A O 0 0.004077612888067961
transcribed O 0 0.001873903558589518
sequence O 0 0.0002366496919421479
identified O 0 0.000555948936380446
from O 0 8.101968705886975e-05
the O 0 0.00030535098630934954
C04107 O 0 0.12340479344129562
- O 0 0.005575783550739288
containing O 0 0.0016416008584201336
BAC O 1 0.9839730262756348
was O 0 0.0009728353470563889
found O 0 0.00017665448831394315
to O 0 5.0215934606967494e-05
be O 0 5.9611185861285776e-05
homologous O 0 0.00099128857254982
to O 0 5.356325345928781e-05
a O 0 0.0004093348397873342
gene O 0 0.0010342888999730349
expressed O 0 0.000306776404613629
from O 0 0.00014580541756004095
human O 0 0.0018930581863969564
chromosome O 0 0.008410281501710415
2p13 O 1 0.7139601707458496
- O 0 0.020005222409963608
p16 O 0 0.10229881852865219
, O 0 0.00021384390129242092
a O 0 0.0005340197822079062
region O 0 0.0009366914164274931
devoid O 0 0.001410076511092484
of O 0 2.0262239559087902e-05
any O 0 0.00011618315329542384
positional O 0 0.00552777573466301
candidate O 0 0.0022803174797445536
genes O 0 0.001316183595918119
. O 0 0.001005553756840527

Molecular O 0 0.0030697614420205355
analysis O 0 0.00024115921405609697
of O 0 4.235952292219736e-05
the O 0 0.0007959199137985706
APC B-Disease 1 0.9901325702667236
gene O 0 0.0022007557563483715
in O 0 0.0002693468704819679
205 O 0 0.006420983001589775
families O 0 0.00039120251312851906
: O 0 0.00035885479883290827
extended O 0 0.0024220214691013098
genotype O 0 0.2193724513053894
- O 0 0.016695769503712654
phenotype O 0 0.03683847188949585
correlations O 0 0.006162245292216539
in O 0 0.0014745795633643866
FAP B-Disease 1 0.9997782111167908
and O 0 0.0002045307046500966
evidence O 0 0.00025392946554347873
for O 0 7.599521632073447e-05
the O 0 9.263677202397957e-05
role O 0 0.0004752978275064379
of O 0 5.969867197563872e-05
APC B-Disease 1 0.7813221216201782
amino O 0 0.0005426572170108557
acid O 0 0.010044675320386887
changes O 0 0.0020384369418025017
in O 0 0.44762519001960754
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
predisposition O 1 0.9992067217826843
. O 0 0.0021174135617911816

BACKGROUND O 0 0.04500522091984749
/ O 0 0.03642096742987633
AIMS O 0 0.007136710919439793
The O 0 0.0002884425048250705
development O 0 0.0028809027280658484
of O 0 0.003097209148108959
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 0.0001597118389327079
a O 0 0.00040109141264110804
variable O 0 0.0007842159830033779
range O 0 0.00026986017473973334
of O 0 7.004241342656314e-05
extracolonic O 1 0.9965928196907043
manifestations O 1 0.9676621556282043
in O 0 0.010098062455654144
familial B-Disease 1 0.9999983310699463
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999997615814209
( O 1 0.7022491097450256
FAP B-Disease 1 0.9999101161956787
) O 0 0.0006547930533997715
is O 0 0.00020571825734805316
the O 0 8.744059596210718e-05
result O 0 0.00015411012282129377
of O 0 1.3380156815401278e-05
the O 0 0.0002072849456453696
dominant O 0 0.005617500748485327
inheritance O 0 0.00862845964729786
of O 0 0.0018255762988701463
adenomatous B-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999988079071045
coli I-Disease 1 0.9999790191650391
( O 0 0.009306170046329498
APC B-Disease 1 0.9980449676513672
) O 0 0.0012743650004267693
gene O 0 0.005268838256597519
mutations O 0 0.004354881122708321
. O 0 0.0007473967270925641

In O 0 0.0006236513145267963
this O 0 0.00016673463687766343
study O 0 0.0006388503825291991
, O 0 0.00011753683793358505
direct O 0 0.00030138198053464293
mutation O 0 0.0007129665464162827
analysis O 0 9.521177707938477e-05
of O 0 3.0676910682814196e-05
the O 0 0.0007966338307596743
APC B-Disease 1 0.9969611763954163
gene O 0 0.0031499953474849463
was O 0 0.0008304647053591907
performed O 0 0.0006037094281055033
to O 0 0.00012178504402982071
determine O 0 0.001310510910116136
genotype O 0 0.08737965673208237
- O 0 0.011261108331382275
phenotype O 0 0.02020832896232605
correlations O 0 0.0024008729960769415
for O 0 0.00027874650550074875
nine O 0 0.0009983391501009464
extracolonic O 1 0.8909131288528442
manifestations O 0 0.13855582475662231
and O 0 0.00013433044659905136
to O 0 0.0001763611362548545
investigate O 0 0.0036236648447811604
the O 0 0.00034105905797332525
incidence O 1 0.8888053297996521
of O 0 0.00013787663192488253
APC B-Disease 1 0.9951238036155701
mutations O 0 0.0019020602339878678
in O 0 0.00025266926968470216
non O 0 0.4772539436817169
- O 1 0.9997490048408508
FAP O 1 0.9999979734420776
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.0025326600298285484

METHODS O 0 0.0062380894087255
The O 0 0.0024697952903807163
APC B-Disease 1 0.9878739714622498
gene O 0 0.003408530494198203
was O 0 0.0008531834464520216
analysed O 0 0.002245508600026369
in O 0 0.0002902147825807333
190 O 0 0.005874971859157085
unrelated O 0 0.02816225215792656
FAP B-Disease 1 0.9977656602859497
and O 0 0.00026134747895412147
15 O 0 0.0009402456926181912
non O 0 0.03935692086815834
- O 1 0.9995191097259521
FAP O 1 0.9999986886978149
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9998632669448853
using O 0 0.0012606807285919785
denaturing O 1 0.9757261872291565
gradient O 0 0.06480102986097336
gel O 1 0.9832072257995605
electrophoresis O 0 0.022237123921513557
, O 0 0.0001733850222080946
the O 0 0.00014222855679690838
protein O 0 0.0008880930254235864
truncation O 0 0.0142420195043087
test O 0 0.0015553907724097371
, O 0 0.00010467175161466002
and O 0 6.674592441413552e-05
direct O 0 0.00032953766640275717
sequencing O 0 0.001954764360561967
. O 0 0.0008906882721930742

RESULTS O 0 0.011972068808972836
Chain O 0 0.013511552475392818
terminating O 0 0.04347914829850197
signals O 0 0.0011190685909241438
were O 0 4.9455458793090656e-05
only O 0 0.00011173958046128973
identified O 0 0.0008214085828512907
in O 0 0.0004642577550839633
patients O 1 0.9993083477020264
belonging O 0 0.0008641643216833472
to O 0 0.00017273570119868964
the O 0 0.0009948925580829382
FAP B-Disease 1 0.9996436834335327
group O 0 0.0018353323685005307
( O 0 0.001560243428684771
105 O 0 0.021462494507431984
patients O 1 0.999584972858429
) O 0 0.0007434824947267771
. O 0 0.000587671238463372

Amino O 0 0.0023968142922967672
acid O 0 0.00914460327476263
changes O 0 0.0005826628184877336
were O 0 8.762565994402394e-05
identified O 0 0.0005491647752933204
in O 0 0.00017760536866262555
four O 0 0.0005890012835152447
patients O 1 0.9996834993362427
, O 0 0.00010713623487390578
three O 0 4.030765558127314e-05
of O 0 3.41883824148681e-05
whom O 0 0.0015224780654534698
belonged O 0 0.0009673424647189677
to O 0 5.563341619563289e-05
the O 0 0.00017929481691680849
non O 0 0.003428230294957757
- O 0 0.04816436022520065
FAP O 1 0.9984636306762695
group O 0 0.0012671406148001552
of O 0 0.004208396188914776
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999860525131226
. O 0 0.0019966023974120617

Genotype O 1 0.9345918893814087
- O 0 0.07684844732284546
phenotype O 0 0.09807287156581879
correlations O 0 0.006455866154283285
identified O 0 0.0009315144270658493
significant O 0 0.0005275578587315977
differences O 0 0.0008300699410028756
in O 0 0.00011049184104194865
the O 0 0.00012121918553020805
nature O 0 0.0007432409329339862
of O 0 3.207031841157004e-05
certain O 0 0.0007097400375641882
extracolonic O 1 0.9957212209701538
manifestations O 1 0.9828385710716248
in O 0 0.006166323088109493
FAP B-Disease 1 0.999987006187439
patients O 1 0.99986732006073
belonging O 0 0.001053507556207478
to O 0 0.00011419336806284264
three O 0 0.00018079797155223787
mutation O 0 0.002816102933138609
subgroups O 0 0.0032119881361722946
. O 0 0.0008502666605636477

CONCLUSIONS O 0 0.02016499824821949
Extended O 0 0.010007919743657112
genotype O 0 0.3977994918823242
- O 0 0.01896853558719158
phenotype O 0 0.03486565873026848
correlations O 0 0.002212990541011095
made O 0 0.00019823978072963655
in O 0 0.00013269353075884283
this O 0 0.00013407616643235087
study O 0 0.0012480688747018576
may O 0 0.0005588806816376746
have O 0 4.304494723328389e-05
the O 0 7.245747110573575e-05
potential O 0 0.0005159025895409286
to O 0 5.1927592721767724e-05
determine O 0 0.0001297390554100275
the O 0 4.3423104216344655e-05
most O 0 9.314344060840085e-05
appropriate O 0 0.000936266325879842
surveillance O 0 0.005471080541610718
and O 0 0.0007533958996646106
prophylactic O 1 0.9999247789382935
treatment O 1 0.9999265670776367
regimens O 1 0.9985128045082092
for O 0 0.0006015778635628521
those O 0 0.0007852867711335421
patients O 1 0.999944806098938
with O 0 0.0003277598589193076
mutations O 0 0.005008269101381302
associated O 0 0.00046899126027710736
with O 0 0.00026089936727657914
life O 0 0.025077952072024345
threatening O 1 0.9970730543136597
conditions O 0 0.16056790947914124
. O 0 0.0013562919339165092

This O 0 0.0003835946263279766
study O 0 0.0008751219720579684
also O 0 0.0001484036911278963
provided O 0 0.0003827986365649849
evidence O 0 0.0002510244958102703
for O 0 0.0001513829338364303
the O 0 0.00041885775863192976
pathological O 1 0.9847503900527954
nature O 0 0.0008598783169873059
of O 0 3.684219700517133e-05
amino O 0 0.0007732372032478452
acid O 0 0.009162317030131817
changes O 0 0.0006917811115272343
in O 0 0.0006660519284196198
APC O 1 0.9876660108566284
associated O 0 0.00043448677752166986
with O 0 0.00011713158892234787
both O 0 0.0006991158588789403
FAP B-Disease 1 0.9993414282798767
and O 0 0.0005191426025703549
non O 0 0.4899842441082001
- O 1 0.9997387528419495
FAP O 1 0.9999986886978149
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999938011169434
. O 0 0.0006596155581064522
. O 0 0.0010589088778942823

Inherited B-Disease 1 0.9999603033065796
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999988079071045
and O 1 0.8934403657913208
cancer B-Disease 1 0.9999988079071045
risk O 0 0.024927211925387383
of O 0 4.6954533900134265e-05
the O 0 0.0007630485924892128
APC O 1 0.9976205229759216
I1307K O 0 0.07803773880004883
polymorphism O 0 0.009448004886507988
. O 0 0.0012232372537255287

Germ O 1 0.995080828666687
- O 0 0.011170096695423126
line O 0 0.0014004670083522797
and O 0 0.0003267611318733543
somatic O 0 0.013822637498378754
truncating O 0 0.08279429376125336
mutations O 0 0.0011357387993484735
of O 0 3.987843592767604e-05
the O 0 0.0008797486661933362
APC B-Disease 1 0.9976332187652588
gene O 0 0.001558790565468371
are O 0 3.0741397495148703e-05
thought O 0 0.0005572912050411105
to O 0 0.00033504143357276917
initiate O 1 0.9950048327445984
colorectal B-Disease 1 0.9999996423721313
tumor I-Disease 1 0.9999833106994629
formation O 1 0.6725501418113708
in O 0 0.021329794079065323
familial B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
and O 0 0.010033153928816319
sporadic O 1 0.9993993043899536
colorectal O 1 0.9999997615814209
carcinogenesis O 1 0.9998413324356079
, O 0 0.0011508881580084562
respectively O 0 0.001659288303926587
. O 0 0.0008952419157139957

Recently O 0 0.009114236570894718
, O 0 0.0002805381955113262
an O 0 0.0007036837050691247
isoleucine O 1 0.9480860829353333
- O 0 0.00923803448677063
- O 0 0.004699556156992912
> O 0 0.005361091811209917
lysine O 0 0.010266087017953396
polymorphism O 0 0.0026466073468327522
at O 0 0.0008511396590620279
codon O 0 0.016146795824170113
1307 O 1 0.653355598449707
( O 0 0.0017080714460462332
I1307K O 0 0.016420545056462288
) O 0 9.565204527461901e-05
of O 0 2.6976862500305288e-05
the O 0 0.000655234616715461
APC B-Disease 1 0.9931337833404541
gene O 0 0.002555337268859148
has O 0 0.0004279721179045737
been O 0 0.00025954548618756235
identified O 0 0.0003750779724214226
in O 0 0.0001072929662768729
6 O 0 0.000528413918800652
% O 0 8.18266489659436e-05
- O 0 0.0016873987624421716
7 O 0 0.00018614853615872562
% O 0 1.740647894621361e-05
of O 0 1.7740951079758815e-05
the O 0 0.000527333642821759
Ashkenazi O 0 0.20371182262897491
Jewish O 0 0.0010960387298837304
population O 0 0.0003013653040397912
. O 0 0.0009222434018738568

To O 0 0.0009909988148137927
assess O 0 0.008191903121769428
the O 0 0.00030909330234862864
risk O 0 0.003753491211682558
of O 0 2.157500057364814e-05
this O 0 0.00014041035319678485
common O 0 0.005264901090413332
APC B-Disease 1 0.9978396892547607
allelic O 1 0.8749670386314392
variant O 1 0.9435443878173828
in O 0 0.02220863103866577
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.9999679327011108
, O 0 0.0004980998346582055
we O 0 0.00018648055265657604
have O 0 6.192056753206998e-05
analyzed O 0 0.00038222118746489286
a O 0 0.0001684557064436376
large O 0 0.00024787982692942023
cohort O 0 0.003777002915740013
of O 0 0.00013740480062551796
unselected O 1 0.9674275517463684
Ashkenazi O 0 0.3968924283981323
Jewish O 0 0.001960494089871645
subjects O 0 0.0038060666993260384
with O 0 0.0029900996014475822
adenomatous B-Disease 1 0.9999896287918091
polyps I-Disease 1 0.9996473789215088
and O 0 0.000389742199331522
. O 0 0.0008933416684158146
or O 1 0.9818313717842102
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, I-Disease 0 0.00021289750293362886
for O 0 0.0002110685163643211
the O 0 0.0008179254364222288
APC O 1 0.995131254196167
I1307K O 0 0.12579168379306793
polymorphism O 0 0.006840280722826719
. O 0 0.0009759871754795313

The O 0 0.0037538940086960793
APC O 1 0.971117377281189
I1307K O 0 0.05188662186264992
allele O 0 0.008724542334675789
was O 0 0.0012369692558422685
identified O 0 0.000826507224701345
in O 0 0.00020908654551021755
48 O 0 0.0012696521589532495
( O 0 0.0002898768871091306
10 O 0 0.000198241657926701
. O 0 6.251745799090713e-05
1 O 0 0.0001842136844061315
% O 0 3.409318742342293e-05
) O 0 9.292855975218117e-05
of O 0 0.00012472792877815664
476 O 1 0.9951489567756653
patients O 1 0.9998200535774231
. O 0 0.0014530183980241418

Compared O 0 0.001659248722717166
with O 0 8.94509648787789e-05
the O 0 0.0001304117904510349
frequency O 0 0.0002417856449028477
in O 0 6.312887853709981e-05
two O 0 3.931839091819711e-05
separate O 0 0.00011841183732030913
population O 0 7.856755109969527e-05
control O 0 0.0006267563439905643
groups O 0 7.950277358759195e-05
, O 0 0.00020758734899573028
the O 0 0.0006887652561999857
APC O 1 0.9919998645782471
I1307K O 0 0.0655081495642662
allele O 0 0.007447308395057917
is O 0 0.000412680470617488
associated O 0 0.00023113770294003189
with O 0 5.8178866311209276e-05
an O 0 0.00024858556571416557
estimated O 0 0.000569213239941746
relative O 0 0.0009155801963061094
risk O 0 0.0048062438145279884
of O 0 5.798622441943735e-05
1 O 0 0.001600996358320117
. O 0 0.0009220765205100179

5 O 0 0.0038627947214990854
- O 0 0.005319136194884777
1 O 0 0.0010681144194677472
. O 0 0.0005677449516952038

7 O 0 0.004306391347199678
for O 0 0.00464864494279027
colorectal B-Disease 1 0.9999978542327881
neoplasia I-Disease 1 0.999224066734314
( O 0 0.001688268850557506
both O 0 0.0009917713468894362
P O 1 0.6836314797401428
= O 0 0.006780869793146849
. O 0 0.0005636686692014337
01 O 1 0.9772790670394897
) O 0 0.000571910641156137
. O 0 0.0007086955010890961

Furthermore O 0 0.007253569085150957
, O 0 0.00046164769446477294
compared O 0 0.0009115981520153582
with O 0 0.0003640961367636919
noncarriers O 1 0.9344105124473572
, O 0 0.0017254722770303488
APC O 1 0.9968710541725159
I1307K O 0 0.2638424038887024
carriers O 0 0.0059976400807499886
had O 0 0.00022481042833533138
increased O 0 0.00015207042451947927
numbers O 0 5.502731437445618e-05
of O 0 0.0001138463121606037
adenomas B-Disease 1 0.9999579191207886
and O 0 0.014999931678175926
colorectal B-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9998840093612671
per O 0 0.0020207250490784645
patient O 1 0.9994230270385742
( O 0 0.0026690782979130745
P O 1 0.9035268425941467
= O 0 0.006480887997895479
. O 0 0.0005105736781843007
03 O 1 0.8658142685890198
) O 0 0.0001829055545385927
, O 0 7.00811724527739e-05
as O 0 6.999575271038339e-05
well O 0 6.754475907655433e-05
as O 0 9.904160106088966e-05
a O 0 0.0007102813106030226
younger O 0 0.0040236893109977245
age O 0 0.001618840149603784
at O 0 0.003469211747869849
diagnosis O 1 0.9999293088912964
. O 0 0.0016954344464465976

We O 0 0.001074749045073986
conclude O 0 0.003261018544435501
that O 0 0.00013955459871795028
the O 0 0.000640013488009572
APC O 1 0.9806689620018005
I1307K O 0 0.07560804486274719
variant O 0 0.013700260780751705
leads O 0 0.001487985486164689
to O 0 0.00021589527023024857
increased O 0 0.004028345458209515
adenoma B-Disease 1 0.9999860525131226
formation O 0 0.012892929837107658
and O 0 0.0001526100968476385
directly O 0 0.00043887668289244175
contributes O 0 0.005146239418536425
to O 0 9.962147305486724e-05
3 O 0 0.00028812611708417535
% O 0 7.197411468951032e-05
- O 0 0.0008974428055807948
4 O 0 0.0001009978077490814
% O 0 5.839901405124692e-06
of O 0 8.993860319606028e-06
all O 0 0.00015790954057592899
Ashkenazi O 1 0.99817955493927
Jewish O 1 0.9969372749328613
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.002867600414901972

The O 0 0.0006991518894210458
estimated O 0 0.0015265847323462367
relative O 0 0.0017095135990530252
risk O 0 0.12193531543016434
for O 0 0.0006525579956360161
carriers O 0 0.047334425151348114
may O 0 0.001199783175252378
justify O 0 0.006021509412676096
specific O 0 0.0010189673630520701
clinical O 1 0.9993857145309448
screening O 0 0.0036770966835319996
for O 0 0.0001704478927422315
the O 0 0.00031976494938135147
360 O 0 0.005153541918843985
, O 0 0.0003485697088763118
000 O 0 0.0020307968370616436
Americans O 0 0.0005485624424181879
expected O 0 0.00033525421167723835
to O 0 0.0001122013563872315
harbor O 0 0.004371041897684336
this O 0 0.0001096030100598
allele O 0 0.0039572445675730705
, O 0 0.0002488609170541167
and O 0 0.00020617127302102745
genetic O 0 0.001814014627598226
testing O 0 0.0014357728650793433
in O 0 6.32210576441139e-05
the O 0 7.501980144297704e-05
setting O 0 0.0002867572766263038
of O 0 5.712251004297286e-05
long O 0 0.009467254392802715
- O 0 0.005297548603266478
term O 0 0.0030651241540908813
- O 0 0.001867944491095841
outcome O 0 0.0007419296889565885
studies O 0 0.00036884500877931714
may O 0 0.0005133679369464517
impact O 0 0.002078054705634713
significantly O 0 0.07458940148353577
on O 0 0.4039342403411865
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.999316930770874
in O 0 0.00017494471103418618
this O 0 0.00010370873496867716
population O 0 0.0001705080212559551
. O 0 0.0006621797801926732

Localization O 0 0.00992012582719326
of O 0 0.00022407299547921866
human O 0 0.006533945444971323
BRCA1 O 1 0.9969139099121094
and O 0 0.00015064208128023893
its O 0 0.00023611757205799222
loss O 0 0.002815971616655588
in O 0 0.0002480982802808285
high O 0 0.0039052332285791636
- O 0 0.005414648912847042
grade O 0 0.006839795038104057
, O 0 0.00032653348171152174
non B-Disease 0 0.007167510222643614
- I-Disease 1 0.9809589982032776
inherited I-Disease 1 0.9997734427452087
breast I-Disease 1 0.999997615814209
carcinomas I-Disease 1 0.9999610185623169
. O 0 0.0030237683095037937

Although O 0 0.0008629948715679348
the O 0 0.0001777334400685504
link O 0 0.002196416025981307
between O 0 0.000222238915739581
the O 0 0.0014737562742084265
BRCA1 O 1 0.999972939491272
tumour B-Disease 1 0.9999963045120239
- O 0 0.046066541224718094
suppressor O 0 0.05650823190808296
gene O 0 0.0023242481984198093
and O 0 0.0006434378447011113
hereditary B-Disease 1 0.9999552965164185
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.996516227722168
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.0006644175155088305
established O 0 0.0006765152793377638
, O 0 0.0001258859847439453
the O 0 0.00013561178639065474
role O 0 0.0017150414641946554
, O 0 0.00016190447786357254
if O 0 0.0001585407881066203
any O 0 4.796677967533469e-05
, O 0 6.362731801345944e-05
of O 0 6.341269909171388e-05
BRCA1 O 1 0.9988448619842529
in O 0 0.0004219379334244877
non B-Disease 0 0.061899736523628235
- I-Disease 1 0.9944443106651306
familial I-Disease 1 0.9998742341995239
cancers I-Disease 1 0.999937891960144
is O 0 0.0014936263905838132
unclear O 0 0.0037284863647073507
. O 0 0.0009076719870790839

BRCA1 O 1 0.9942112565040588
mutations O 0 0.005911657586693764
are O 0 0.00011440207890700549
rare O 0 0.004438381176441908
in O 0 0.0007344090845435858
sporadic B-Disease 1 0.9726690053939819
cancers I-Disease 1 0.999962329864502
, O 0 0.00035576694062910974
but O 0 0.0003300415992271155
loss O 0 0.002850439166650176
of O 0 0.00022885968792252243
BRCA1 O 1 0.9995593428611755
resulting O 0 0.002108026295900345
from O 0 0.00022773952514398843
reduced O 0 0.0022489437833428383
expression O 0 0.0011239562882110476
or O 0 0.0005655343411490321
incorrect O 0 0.005089744459837675
subcellular O 0 0.011007946915924549
localization O 0 0.007910378277301788
is O 0 0.0005689908866770566
postulated O 0 0.003659453708678484
to O 0 3.680482768686488e-05
be O 0 2.475607834639959e-05
important O 0 8.77746133483015e-05
in O 0 0.00015709945000708103
non B-Disease 0 0.005270407535135746
- I-Disease 1 0.9718793034553528
familial I-Disease 1 0.9999579191207886
breast I-Disease 1 0.9999991655349731
and I-Disease 1 0.9711229801177979
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999980926513672
. O 0 0.0025875521823763847

Epigenetic O 0 0.16221526265144348
loss O 0 0.043085984885692596
, O 0 0.0005248589441180229
however O 0 0.00042564794421195984
, O 0 0.00023144841543398798
has O 0 0.0004481427604332566
not O 0 0.00014127201575320214
received O 0 0.0007759068976156414
general O 0 0.0007416642038151622
acceptance O 0 0.004139946307986975
due O 0 0.000960913544986397
to O 0 9.214955935021862e-05
controversy O 0 0.0009192755096592009
regarding O 0 0.0002554018283262849
the O 0 0.0001263160811504349
subcellular O 0 0.004586247261613607
localization O 0 0.0035356360021978617
of O 0 0.00014826508413534611
BRCA1 O 1 0.9987820982933044
proteins O 0 0.00029515090864151716
, O 0 0.0001561277313157916
reports O 0 0.00027135529671795666
of O 0 2.29608740482945e-05
which O 0 9.720832167658955e-05
have O 0 0.00011854353942908347
ranged O 0 0.0016724179731681943
from O 0 0.00010433822171762586
exclusively O 0 0.0007052120054140687
nuclear O 0 0.0021643200889229774
, O 0 0.00019691014313139021
to O 0 0.0002168502687709406
conditionally O 0 0.015794876962900162
nuclear O 0 0.0010605271672829986
, O 0 6.383012078003958e-05
to O 0 8.155859541147947e-05
the O 0 0.0007873019203543663
ER O 1 0.9996380805969238
/ O 0 0.09520426392555237
golgi O 0 0.4349665641784668
, O 0 0.00020115869119763374
to O 0 0.00016924137889873236
cytoplasmic O 0 0.004119811579585075
invaginations O 0 0.015961915254592896
into O 0 0.00012592284474521875
the O 0 0.00026595144299790263
nucleus O 0 0.006538038142025471
. O 0 0.0009604155784472823

In O 0 0.000520027766469866
an O 0 0.0002881014661397785
attempt O 0 0.001199650694616139
to O 0 0.00019001233158633113
resolve O 0 0.009920340031385422
this O 0 0.00011577198165468872
issue O 0 0.0006129739340394735
, O 0 0.00011358346091583371
we O 0 0.00010099579230882227
have O 0 9.844688611337915e-05
comprehensively O 0 0.018035663291811943
characterized O 0 0.012063175439834595
19 O 0 0.0018755829660221934
anti O 0 0.0425436869263649
- O 1 0.5044503211975098
BRCA1 O 1 0.9975645542144775
antibodies O 0 0.021251417696475983
. O 0 0.001059788977727294

These O 0 0.00034153685555793345
reagents O 0 0.014223581179976463
detect O 0 0.01035238429903984
a O 0 0.0012550594983622432
220 O 0 0.005049497354775667
- O 0 0.009691895917057991
kD O 0 0.04593244567513466
protein O 0 0.0006320055108517408
localized O 0 0.005740470252931118
in O 0 0.00014813733287155628
discrete O 0 0.0024161336477845907
nuclear O 0 0.0050605284050107
foci O 0 0.010707558132708073
in O 0 0.00019132345914840698
all O 0 0.0002146843762602657
epithelial O 1 0.9940345883369446
cell O 0 0.005692563951015472
lines O 0 0.0008523408905602992
, O 0 9.057667193701491e-05
including O 0 3.504573760437779e-05
those O 0 5.3132247558096424e-05
derived O 0 0.00036454416112974286
from O 0 0.0009381079580634832
breast B-Disease 1 0.9999947547912598
malignancies I-Disease 1 0.9987260699272156
. O 0 0.002185586839914322

Immunohistochemical O 1 0.9676886200904846
staining O 0 0.17541195452213287
of O 0 0.00045465774019248784
human O 0 0.2772238254547119
breast O 1 0.9999837875366211
specimens O 0 0.013317489065229893
also O 0 0.0007795116398483515
revealed O 0 0.4206458628177643
BRCA1 O 1 0.9968440532684326
nuclear O 0 0.005640996154397726
foci O 0 0.04054151847958565
in O 0 0.0013284215237945318
benign O 1 0.9999862909317017
breast O 1 0.9999969005584717
, O 0 0.028443122282624245
invasive B-Disease 1 0.9999957084655762
lobular I-Disease 1 0.9999995231628418
cancers I-Disease 1 0.9999536275863647
and O 0 0.000517999695148319
low B-Disease 0 0.2549457252025604
- I-Disease 1 0.9484160542488098
grade I-Disease 1 0.996067225933075
ductal I-Disease 1 0.9999872446060181
carcinomas I-Disease 1 0.9998750686645508
. O 0 0.0025338095147162676

Conversely O 0 0.03803221508860588
, O 0 0.0019990401342511177
BRCA1 O 1 0.9938957095146179
expression O 0 0.0017044739797711372
was O 0 0.0015858096303418279
reduced O 0 0.0032185225281864405
or O 0 0.0007512146839872003
undetectable O 1 0.9482572674751282
in O 0 8.56229307828471e-05
the O 0 6.82216850691475e-05
majority O 0 0.00010817975999088958
of O 0 4.4572254410013556e-05
high O 0 0.01583278365433216
- O 0 0.11092811077833176
grade O 1 0.5617733001708984
, O 0 0.002312328200787306
ductal B-Disease 1 0.9999948740005493
carcinomas I-Disease 1 0.9999626874923706
, O 0 0.0007760252919979393
suggesting O 0 0.003551729256287217
that O 0 0.0001648925681365654
absence O 0 0.0024099007714539766
of O 0 0.0002489401667844504
BRCA1 O 1 0.9997902512550354
may O 0 0.0014441718813031912
contribute O 0 0.0016834536800161004
to O 0 0.00010424771608086303
the O 0 0.00030945095932111144
pathogenesis O 1 0.9822124242782593
of O 0 1.6156413039425388e-05
a O 0 0.00019028318638447672
significant O 0 0.00026512614567764103
percentage O 0 0.0003383340372238308
of O 0 0.00016340937872882932
sporadic B-Disease 1 0.9985023736953735
breast I-Disease 1 0.9999992847442627
cancers I-Disease 1 0.9999823570251465
. O 0 0.0006635986501350999
. O 0 0.0009533291449770331

